{"meta":{"query_hash":"9135368537ec","filters":{"venue":"Multiple Sclerosis Journal"},"cohort_total":655,"direct_labels_cover":3,"predictions_cover":655,"exported":655,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9135368537ec","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+Journal"},"results":[{"id":"W1150265801","doi":"10.1177/1352458514546077","title":"2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster Session 1","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jewish General Hospital; Karadeniz Teknik Üniversitesi; Flinders University","keywords":"Session (web analytics); Joint (building); Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Psychology; Computer science; World Wide Web; Engineering; Psychiatry","score_opus":0.6440041051294333,"score_gpt":0.4428276700272841,"score_spread":0.20117643510214916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1150265801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343978,0.002913987,0.04925777,0.004663983,0.00423864,0.00064817164,0.000032179385,0.000026763633,0.0038207148],"genre_scores_gemma":[0.9740691,0.000845915,0.017541492,0.0013201679,0.0026886424,0.000008250645,0.000010989878,0.0000686822,0.0034467669],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9577012,0.017155847,0.013689077,0.001187497,0.009231389,0.0010349813],"domain_scores_gemma":[0.9741567,0.0049736737,0.013802504,0.002953959,0.0029221224,0.0011910709],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.1612997,0.00074970874,0.004226926,0.0012600992,0.0015945542,0.0057757483,0.0031271686,0.00030570553,0.014934084],"category_scores_gemma":[0.054155514,0.0003699349,0.0041880226,0.0009900205,0.00011000076,0.0012574916,0.00036730868,0.0017357968,0.00621448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006861801,0.00032118795,0.095349066,0.000031734384,0.00035607713,0.000017432854,0.00067582435,0.0010496567,0.057719868,0.000022646798,0.6870761,0.15731181],"study_design_scores_gemma":[0.006145868,0.0008006059,0.4341943,0.0020207695,0.0011117335,0.0031432759,0.0019884764,0.067164585,0.007377365,0.0030739633,0.47099754,0.0019815161],"about_ca_topic_score_codex":0.000029781377,"about_ca_topic_score_gemma":0.00004619992,"teacher_disagreement_score":0.33884522,"about_ca_system_score_codex":0.00021136862,"about_ca_system_score_gemma":0.00018158782,"threshold_uncertainty_score":0.99987525},"labels":[],"label_agreement":null},{"id":"W1534773079","doi":"10.1177/1352458515579444","title":"Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Universitetet i Bergen; Helse Vest; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Mononucleosis; Case-control study; Risk factor; Disease; Vitamin D and neurology; Demography; Internal medicine; Environmental health; Immunology; Population","score_opus":0.29767078911086164,"score_gpt":0.3490772758925649,"score_spread":0.05140648678170323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534773079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900416,0.0035019354,0.0009369368,0.00040564974,0.0008682067,0.003343189,0.00082068704,0.000042922362,0.00003884857],"genre_scores_gemma":[0.98930323,0.004483919,0.004437113,0.000081196704,0.0009009373,0.0004861249,0.000024398254,0.00008705232,0.00019600979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953581,0.00071212545,0.0011296421,0.0006399408,0.001363794,0.00079637824],"domain_scores_gemma":[0.994562,0.0015968652,0.0008473114,0.0007832627,0.0013957288,0.00081483717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028480873,0.0005398373,0.00091005926,0.00039109343,0.0008090751,0.00017246336,0.0004007949,0.00016742194,0.00006199162],"category_scores_gemma":[0.0076414626,0.0003403103,0.00042308288,0.00039537196,0.0004310441,0.00037112096,0.0003463386,0.0009290151,0.000013955478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014497116,0.0030868247,0.8909554,0.00006832016,0.0008195386,9.0328126e-7,0.013799947,0.0001036149,0.005317923,0.0000010866137,0.0063784732,0.078018285],"study_design_scores_gemma":[0.010210246,0.001901882,0.9545083,0.0003970056,0.00067976804,0.000013562515,0.02539037,0.0020584296,0.0031418721,0.00003522568,0.0013378339,0.00032551677],"about_ca_topic_score_codex":0.001981114,"about_ca_topic_score_gemma":0.00085887895,"teacher_disagreement_score":0.07769277,"about_ca_system_score_codex":0.0004220886,"about_ca_system_score_gemma":0.00043923644,"threshold_uncertainty_score":0.9999049},"labels":[],"label_agreement":null},{"id":"W1576311387","doi":"10.1177/1352458515579441","title":"Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Vertex Pharmaceuticals","keywords":"Multiple sclerosis; Transcranial magnetic stimulation; Neuromyelitis optica; Magnetic resonance imaging; Corticospinal tract; Medicine; Neuroscience; Functional magnetic resonance imaging; Nuclear magnetic resonance; Stimulation; Psychology; Radiology; Physics; Diffusion MRI; Internal medicine; Immunology","score_opus":0.18740043981590304,"score_gpt":0.31398923760363023,"score_spread":0.1265887977877272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576311387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786577,0.01781266,0.0007706059,0.0012351068,0.00029163007,0.0010506434,0.00005076499,0.00007349948,0.000057370893],"genre_scores_gemma":[0.9829617,0.0033817727,0.013003081,0.00015722375,0.00035484185,0.000028079878,0.0000075355883,0.000088232206,0.000017540602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949735,0.0005417447,0.001184361,0.0008330872,0.0013725813,0.0010947294],"domain_scores_gemma":[0.99701494,0.00055261893,0.00023834819,0.0003834911,0.0007040414,0.0011065629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017821452,0.00057977147,0.0009518559,0.0005990969,0.0004924386,0.00039970654,0.00022448246,0.00019300896,0.00006392345],"category_scores_gemma":[0.0040523303,0.0005308923,0.00018436671,0.00058356643,0.0006403707,0.0007123741,0.00016958633,0.0015127242,0.000006244883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012851319,0.00038280353,0.67575073,0.00006809103,0.000015400952,0.00009928742,0.0012640157,0.00023118145,0.15314502,0.0000019073312,0.000046826994,0.16770959],"study_design_scores_gemma":[0.014950589,0.0008314351,0.8039712,0.001130594,0.000119170465,0.0005759139,0.0006121462,0.17689851,0.00037579957,0.000029682096,0.000116645446,0.00038832962],"about_ca_topic_score_codex":0.0010802812,"about_ca_topic_score_gemma":0.00033224342,"teacher_disagreement_score":0.17666733,"about_ca_system_score_codex":0.00046300178,"about_ca_system_score_gemma":0.0002981588,"threshold_uncertainty_score":0.99971426},"labels":[],"label_agreement":null},{"id":"W1829172417","doi":"10.1177/1352458515573094","title":"Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Oligodendrocyte; Multiple sclerosis; Biology; Cerebrospinal fluid; Progenitor cell; Western blot; Parenchyma; Gene expression; Transcriptome; Microarray analysis techniques; Pathology; Immunology; Myelin; Central nervous system; Cell biology; Gene; Medicine; Stem cell; Neuroscience; Genetics","score_opus":0.20823496788358556,"score_gpt":0.25610863007719503,"score_spread":0.04787366219360947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829172417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996467,0.00013191569,0.00025561143,0.0003823937,0.001807796,0.0006921948,0.00007106196,0.00014515636,0.000046866593],"genre_scores_gemma":[0.99700165,0.0002500476,0.001091864,0.00086888304,0.00051659514,0.00014728536,0.000004191846,0.00010439052,0.000015110248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950856,0.00077850325,0.0008934355,0.00086646335,0.0013351608,0.001040831],"domain_scores_gemma":[0.9978295,0.0004464625,0.0004621019,0.00029794077,0.00023685642,0.0007271126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005652467,0.0005288127,0.00053183356,0.00052640226,0.0006700664,0.0005419797,0.0006065281,0.00018798173,0.000060335322],"category_scores_gemma":[0.0021958987,0.00048800113,0.00021613696,0.00071369536,0.00014865844,0.00083547545,0.00016338429,0.0008391128,0.00007002958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030327906,0.000440211,0.0054542394,0.000014651459,0.000010800724,0.000064034764,0.0014725024,0.00072789117,0.98734486,0.00002672384,0.000083397375,0.004057402],"study_design_scores_gemma":[0.0037574638,0.0005719444,0.009630314,0.00021282939,0.00002217437,0.00026184827,0.0004310635,0.003674834,0.98066735,0.000025150217,0.00025391308,0.0004911292],"about_ca_topic_score_codex":0.000031431657,"about_ca_topic_score_gemma":0.00019167892,"teacher_disagreement_score":0.0066775316,"about_ca_system_score_codex":0.00021085385,"about_ca_system_score_gemma":0.0002072523,"threshold_uncertainty_score":0.9997572},"labels":[],"label_agreement":null},{"id":"W1834460196","doi":"10.1177/1352458515614091","title":"Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Globus pallidus; Atrophy; Multiple sclerosis; Magnetic resonance imaging; Basal ganglia; Medicine; Central nervous system disease; Subthalamic nucleus; Nuclear medicine; Pathology; Parkinson's disease; Internal medicine; Deep brain stimulation; Disease; Radiology; Central nervous system","score_opus":0.1652316971842355,"score_gpt":0.32428517991665573,"score_spread":0.15905348273242023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834460196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946243,0.0006720171,0.00082651526,0.0009761792,0.00038201045,0.0019980771,0.000035945006,0.00010746673,0.00037748407],"genre_scores_gemma":[0.9911772,0.00096981827,0.0067623393,0.00015727704,0.0005437284,0.00018132427,0.000019330466,0.00012340893,0.0000655738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99380714,0.00068839354,0.0013802596,0.0010135563,0.0018344069,0.0012762288],"domain_scores_gemma":[0.9964673,0.00041461212,0.0004389714,0.0006926475,0.00071312307,0.0012733607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024336472,0.00069440587,0.0011925644,0.0010573879,0.00062440865,0.00036838927,0.00040879322,0.00021896145,0.0002369708],"category_scores_gemma":[0.001976502,0.0006045648,0.00034331813,0.0010186743,0.00040323896,0.0008381493,0.00029548755,0.0015630485,0.00024681466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020696763,0.0016486343,0.9621692,0.000067683635,0.0002838946,0.00010628188,0.0052817585,0.00039114422,0.019591298,0.0000028157826,0.0012486686,0.007138969],"study_design_scores_gemma":[0.03671315,0.001443842,0.9454434,0.0007425643,0.00017362916,0.00013026319,0.009598894,0.004221474,0.0008458787,0.000026552812,0.00011936109,0.00054102065],"about_ca_topic_score_codex":0.0014711889,"about_ca_topic_score_gemma":0.0033733165,"teacher_disagreement_score":0.03464347,"about_ca_system_score_codex":0.0008432906,"about_ca_system_score_gemma":0.00020607148,"threshold_uncertainty_score":0.9996406},"labels":[],"label_agreement":null},{"id":"W1856687084","doi":"10.1177/1352458515599073","title":"Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; St. Francis Xavier University; University of Manitoba; University of Calgary; Dalhousie University; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Anxiety; Depression (economics); Medicine; Psychiatry; Multiple sclerosis; Incidence (geometry); Mental health; Odds ratio; Prospective cohort study; Internal medicine","score_opus":0.13749075565584384,"score_gpt":0.3196705339360339,"score_spread":0.18217977828019005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856687084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933233,0.0015609538,0.00009187645,0.00068919425,0.00019881867,0.0037890463,0.000117839976,0.00017160509,0.00005733338],"genre_scores_gemma":[0.99607897,0.0010692545,0.0018377309,0.00023038127,0.00019571562,0.000347214,0.00003067344,0.00013079238,0.00007928619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932093,0.00090722716,0.0011827879,0.0011556263,0.0020843972,0.0014606296],"domain_scores_gemma":[0.99521834,0.00040254986,0.0008849424,0.000625247,0.0011605266,0.0017084035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030869907,0.0007267229,0.0014899562,0.00074095826,0.00090061536,0.00020341542,0.00032892197,0.00023702071,0.000031755113],"category_scores_gemma":[0.004093843,0.0005597182,0.00020724483,0.0011174834,0.00039890158,0.00073255744,0.00042206817,0.0018566013,0.0000122800875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002322952,0.0038570238,0.9717817,0.000034348042,0.0003529147,0.000108177715,0.0080026835,0.0002362376,0.0015440065,2.17518e-7,0.0007399806,0.011019784],"study_design_scores_gemma":[0.04356829,0.00221457,0.9308112,0.003138454,0.00012995889,0.00009246525,0.016881173,0.0023006406,0.00030918734,0.0000031234663,0.00003719576,0.0005136922],"about_ca_topic_score_codex":0.0024474235,"about_ca_topic_score_gemma":0.018226853,"teacher_disagreement_score":0.041245338,"about_ca_system_score_codex":0.0017907125,"about_ca_system_score_gemma":0.00044784043,"threshold_uncertainty_score":0.99968797},"labels":[],"label_agreement":null},{"id":"W1893794029","doi":"10.1177/1352458515594041","title":"The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame; Hôpital Charles-Le Moyne","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Novartis Pharma; EMD Serono; H. Lundbeck A/S; Eli Lilly and Company; CSL Behring; Biogen; Associazione Italiana Sclerosi Multipla; Sanofi; European Commission; Pfizer; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; National Research Foundation","keywords":"Multiple sclerosis; Persistence (discontinuity); Medicine; Immunology","score_opus":0.22713318913554484,"score_gpt":0.3184297553659268,"score_spread":0.09129656623038199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893794029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906489,0.00673757,0.000010472085,0.0008734402,0.00032459025,0.0011989854,0.000023093748,0.00003602948,0.00014691515],"genre_scores_gemma":[0.9840991,0.014895829,0.00049263844,0.00006937406,0.00014966595,0.00013654865,0.00000493669,0.000056595494,0.00009533685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612206,0.00063458405,0.0008367894,0.00048806434,0.0010934009,0.0008251082],"domain_scores_gemma":[0.99662197,0.0015365727,0.00031717328,0.0006275759,0.0003372942,0.00055941875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024953133,0.0005112554,0.0009728142,0.0003425069,0.0006091332,0.00014807397,0.00033057106,0.0001515284,0.000018743614],"category_scores_gemma":[0.0022911208,0.00028331135,0.00039236894,0.0004097946,0.00065111666,0.00021306066,0.00013203637,0.0006405842,0.000019023813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063391426,0.0004598711,0.6128663,0.000027714797,0.0004383083,0.000015881973,0.0020508664,0.00019233576,0.07140405,0.0000019934103,0.0004874018,0.30571613],"study_design_scores_gemma":[0.026474554,0.0076893596,0.93586993,0.0005884994,0.000057290774,0.000042687494,0.0009077768,0.0029057462,0.023317644,0.0000050618814,0.0018997341,0.000241685],"about_ca_topic_score_codex":0.00055431336,"about_ca_topic_score_gemma":0.0003861665,"teacher_disagreement_score":0.32300365,"about_ca_system_score_codex":0.0007783422,"about_ca_system_score_gemma":0.0001857028,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W1893840820","doi":"10.1177/1352458515586086","title":"Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Glutamine; Glutamate receptor; Creatine; Multiple sclerosis; Medicine; Internal medicine; Amyotrophic lateral sclerosis; Choline; Biomarker; Confidence interval; Endocrinology; Gastroenterology; Biology; Biochemistry; Disease; Immunology; Amino acid","score_opus":0.1502959326861515,"score_gpt":0.33536690691931803,"score_spread":0.18507097423316654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893840820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911377,0.0052319528,0.00026207147,0.0009915229,0.00055103545,0.001191325,0.00007989998,0.00022944289,0.00032507113],"genre_scores_gemma":[0.98077875,0.0019060407,0.015355218,0.00032655546,0.0011905169,0.00010366334,0.000029894803,0.0001676391,0.0001416974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938338,0.00042106226,0.001137403,0.00094304624,0.002067365,0.0015973694],"domain_scores_gemma":[0.9947137,0.0006358638,0.0005610925,0.0006937032,0.0010630063,0.0023325868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018571257,0.0007245631,0.0011897645,0.0006648787,0.00072644,0.0006047745,0.00041415243,0.00025414964,0.00019075476],"category_scores_gemma":[0.0055546616,0.0006278083,0.00038255396,0.00075970095,0.0007198301,0.00084693613,0.0006596914,0.0012763481,0.00011329346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024657482,0.0010102288,0.6906034,0.00013013539,0.0007885437,0.00045494924,0.0031056674,0.00012564578,0.15735844,0.000012327894,0.007414504,0.13653046],"study_design_scores_gemma":[0.027318537,0.00073579745,0.946415,0.0020171246,0.00023185437,0.0009982452,0.0012258475,0.008692072,0.009341208,0.00005506818,0.002221634,0.00074759015],"about_ca_topic_score_codex":0.00030919848,"about_ca_topic_score_gemma":0.00010704133,"teacher_disagreement_score":0.25581166,"about_ca_system_score_codex":0.0006455493,"about_ca_system_score_gemma":0.00039849646,"threshold_uncertainty_score":0.99961734},"labels":[],"label_agreement":null},{"id":"W1940540259","doi":"10.1177/1352458510375568","title":"Meeting Review: The management of multiple sclerosis in children: a European view","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Pediatrics; Population; Clinical trial; Intensive care medicine; Cognition; Physical therapy; Psychiatry; Pathology","score_opus":0.07895769089397592,"score_gpt":0.2966382770612843,"score_spread":0.2176805861673084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940540259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673817,0.021389155,0.00006924603,0.0047380063,0.00045887846,0.0027052746,0.00004172289,0.00008780965,0.0031281796],"genre_scores_gemma":[0.8600933,0.13347575,0.0049011325,0.00087525573,0.0003865992,0.000092659335,0.0000150043,0.00008908054,0.00007124827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994624,0.0006591061,0.0016374637,0.0006021349,0.0014719674,0.0010052845],"domain_scores_gemma":[0.9969241,0.00043359722,0.00065518543,0.0010815791,0.00048072462,0.00042482137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005478415,0.00049606984,0.0009996066,0.0003473099,0.00058755866,0.00011426954,0.0009431257,0.00010372367,0.00025305137],"category_scores_gemma":[0.00160393,0.00033276933,0.0005786159,0.0010232122,0.00045873105,0.0002471417,0.0006516297,0.0020351121,0.00010371582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002287127,0.0015691527,0.6237369,0.0016954481,0.0010960422,0.00004557896,0.0006935262,0.00005377773,0.10842759,0.000017140252,0.010599202,0.25183693],"study_design_scores_gemma":[0.0056775385,0.00013494525,0.9688283,0.015517311,0.00024189912,0.00013925745,0.0002587428,0.00038510765,0.002597722,0.0000050228446,0.005896019,0.0003180979],"about_ca_topic_score_codex":0.0001533805,"about_ca_topic_score_gemma":0.00017183386,"teacher_disagreement_score":0.34509143,"about_ca_system_score_codex":0.00013229279,"about_ca_system_score_gemma":0.00006760968,"threshold_uncertainty_score":0.99991244},"labels":[],"label_agreement":null},{"id":"W1959008146","doi":"10.1177/1352458515595132","title":"Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; Hospital for Sick Children; York University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cerebellum; Neuropsychology; Cognition; Multiple sclerosis; Brain size; Psychology; Audiology; Medicine; Magnetic resonance imaging; Expanded Disability Status Scale; Frontal lobe; Neuroscience; Psychiatry; Radiology","score_opus":0.06086575164846521,"score_gpt":0.27058420204301353,"score_spread":0.20971845039454834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1959008146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968684,0.00042907416,0.00017877111,0.00063679187,0.000118378644,0.0016410643,0.00006445873,0.000024521813,0.000038587743],"genre_scores_gemma":[0.998186,0.00082474254,0.00046935785,0.00022631836,0.0001659617,0.000057453675,0.000008770822,0.00004151124,0.000019883611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682987,0.00025077682,0.0006323171,0.00042183738,0.0011537451,0.00071144657],"domain_scores_gemma":[0.997421,0.00014155099,0.0002969561,0.0003202218,0.00117691,0.0006433148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010699539,0.00033045665,0.00063128554,0.00033038593,0.00032389362,0.00007168021,0.0002721006,0.00012037268,0.000009857273],"category_scores_gemma":[0.002785555,0.0002131154,0.0001227918,0.00077127723,0.0004033753,0.00029140178,0.0003279519,0.00076446915,0.000013701249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002136924,0.00038876527,0.97366154,0.0000442001,0.00012407279,0.0000017012854,0.0008935706,0.00012673736,0.014479657,5.9472126e-7,0.00018667674,0.0079555595],"study_design_scores_gemma":[0.018630374,0.0007482555,0.9577532,0.005657272,0.000083463754,0.000088287125,0.00051787,0.0012123716,0.015056711,0.0000016381448,0.000021299076,0.00022926478],"about_ca_topic_score_codex":0.00029542146,"about_ca_topic_score_gemma":0.00046086547,"teacher_disagreement_score":0.01649345,"about_ca_system_score_codex":0.00032032107,"about_ca_system_score_gemma":0.00021958884,"threshold_uncertainty_score":0.8690594},"labels":[],"label_agreement":null},{"id":"W1963729408","doi":"10.1177/1352458512471876","title":"The Multiple Sclerosis Intimacy and Sexuality Questionnaire — re-validation and development of a 15-item version with a large US sample","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Sample (material); Human sexuality; Psychology; Clinical psychology; Psychometrics; Medicine; Developmental psychology; Psychiatry; Gender studies; Sociology","score_opus":0.08310433867471291,"score_gpt":0.2959736657401284,"score_spread":0.2128693270654155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963729408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325824,0.0010211775,0.0029455083,0.001467185,0.00010393724,0.001081209,0.00004426783,0.00005545664,0.00002304706],"genre_scores_gemma":[0.9764463,0.0023270508,0.02077041,0.000098803124,0.00012632605,0.0001251237,0.000027842094,0.00004430328,0.000033853143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965449,0.00032645895,0.0008760825,0.0004844664,0.0010560222,0.00071208895],"domain_scores_gemma":[0.9963455,0.001278954,0.0004720101,0.00040837313,0.0009876423,0.00050750107],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0017537582,0.00036910293,0.000575828,0.00022598318,0.0018249933,0.00032640743,0.00020526852,0.000130837,0.00009551452],"category_scores_gemma":[0.0036148948,0.00023585679,0.000087213746,0.00033400883,0.00048141732,0.00055989076,0.00035883512,0.0005810916,0.00001658963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006178382,0.00032666227,0.8763264,0.00018421686,0.00029276576,0.0000013759159,0.0029635315,0.0000123066375,0.04728299,0.000004534857,0.0010654875,0.07092188],"study_design_scores_gemma":[0.007120623,0.00035372752,0.97172195,0.001210218,0.00006455139,0.000030616273,0.0028289391,0.00362626,0.011065076,0.000014059604,0.0016992538,0.00026473225],"about_ca_topic_score_codex":0.0006129543,"about_ca_topic_score_gemma":0.0007867824,"teacher_disagreement_score":0.095395535,"about_ca_system_score_codex":0.00024141814,"about_ca_system_score_gemma":0.00022371112,"threshold_uncertainty_score":0.99947447},"labels":[],"label_agreement":null},{"id":"W1963889958","doi":"10.1177/1352458515579440","title":"Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; St. Michael's Hospital; Ontario Brain Institute; University of Toronto; University Health Network","funders":"","keywords":"Trigeminal neuralgia; Fractional anisotropy; Multiple sclerosis; Diffusion MRI; Fluid-attenuated inversion recovery; Neuroimaging; Medicine; Neuropathic pain; Trigeminal nerve; Pathology; Anesthesia; Neuroscience; Psychology; Magnetic resonance imaging; Radiology","score_opus":0.12153299854358864,"score_gpt":0.2603143732909866,"score_spread":0.138781374747398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963889958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967942,0.00043530925,0.0001067874,0.0009252905,0.0005881317,0.0006397752,0.00013460097,0.0002073494,0.00016851583],"genre_scores_gemma":[0.9969726,0.00016532018,0.00095611636,0.00051002874,0.0004367049,0.000047052607,0.00015095189,0.000110245026,0.00065093074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961487,0.00027718666,0.00071029284,0.00060875044,0.001284783,0.00097028556],"domain_scores_gemma":[0.9964447,0.0004487965,0.0006057358,0.00046983565,0.0006780033,0.0013529069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005404252,0.0006285801,0.0009496989,0.0003285058,0.00050636224,0.00026297465,0.00031587778,0.00030745968,0.00014221872],"category_scores_gemma":[0.0015109228,0.00044269074,0.00038726005,0.0006033728,0.0002144496,0.0005338899,0.00009902327,0.0012079129,0.00008530918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040164604,0.0021330877,0.8304824,0.000030326572,0.0006273309,0.00062916684,0.0005486696,0.000029445113,0.14724638,0.000002601326,0.0037924722,0.010461659],"study_design_scores_gemma":[0.020993393,0.0018021191,0.96219766,0.0009234311,0.0005552093,0.0005797499,0.00018240383,0.00088603265,0.01099229,0.000012398877,0.00040271546,0.00047259268],"about_ca_topic_score_codex":0.000119065546,"about_ca_topic_score_gemma":0.00009043084,"teacher_disagreement_score":0.13625409,"about_ca_system_score_codex":0.00051151693,"about_ca_system_score_gemma":0.00028718286,"threshold_uncertainty_score":0.9998025},"labels":[],"label_agreement":null},{"id":"W1964447312","doi":"10.1191/1352458504ms1036oa","title":"Cervical cord atrophy assessment on magnetic resonance imaging: PRO MiSe trial","year":2004,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Multiple sclerosis; Atrophy; Spinal cord; Clinical trial; Cord; Nuclear medicine; Radiology; Surgery; Pathology","score_opus":0.26893492290091914,"score_gpt":0.4225708523278115,"score_spread":0.15363592942689236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964447312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024118073,0.99242085,0.0019342329,0.00087507255,0.00056662,0.0033520274,0.00006588335,0.00023924507,0.0005219589],"genre_scores_gemma":[0.00026944067,0.9617783,0.035201192,0.00037767916,0.0012465987,0.0005755026,0.0000551452,0.00017203548,0.00032412686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965044,0.00017455207,0.0012177895,0.00076326105,0.0007460132,0.0005939528],"domain_scores_gemma":[0.99755645,0.00022974994,0.00068246835,0.0008868486,0.00018151909,0.00046297623],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032416105,0.00065586384,0.0016852643,0.0003163537,0.0003689133,0.00016199097,0.0004932498,0.00021250294,0.00016132939],"category_scores_gemma":[0.00017538374,0.00050733576,0.0010575295,0.0004413707,0.00016001928,0.000090526315,0.00012781302,0.0023567735,0.000075664146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013410811,0.00066079735,0.000039856848,0.0012244519,0.000019816316,0.00010804872,0.0000058589026,0.0000014356622,0.00001409141,0.00008800831,0.0021723085,0.99432427],"study_design_scores_gemma":[0.017604645,0.0013898078,0.00040883632,0.024604555,0.00063763466,0.0007920388,0.0000033405324,0.000058592603,0.0000041128196,0.00017989759,0.95388776,0.00042880193],"about_ca_topic_score_codex":0.000005736004,"about_ca_topic_score_gemma":4.1863808e-7,"teacher_disagreement_score":0.9938955,"about_ca_system_score_codex":0.0008436849,"about_ca_system_score_gemma":0.00069969846,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W1965665283","doi":"10.1177/1352458511431729","title":"The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame","funders":"Biogen; Novartis Pharma; Sanofi","keywords":"Multiple sclerosis; Medicine; Expanded Disability Status Scale; Cerebrospinal fluid; Internal medicine; Lumbar puncture; McDonald criteria; Gastroenterology; Immunology","score_opus":0.17817861646960662,"score_gpt":0.285962768091985,"score_spread":0.1077841516223784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965665283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538124,0.0015620906,0.00035693307,0.00037020168,0.00018798823,0.00084431295,0.00005073951,0.000063480904,0.0011830432],"genre_scores_gemma":[0.9804898,0.0044865804,0.014383287,0.00010487708,0.00027231514,0.00011676113,0.000008609141,0.00008225769,0.000055548637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513304,0.0003802321,0.0012782741,0.0005312798,0.0014857149,0.0011914659],"domain_scores_gemma":[0.995969,0.0013997701,0.0005807767,0.0006867544,0.0007936929,0.00057000294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018531292,0.0005017321,0.00091278856,0.0005478903,0.0009771639,0.0001368795,0.00064189057,0.00017470238,0.00027857092],"category_scores_gemma":[0.003313432,0.0003131992,0.00035132084,0.0008905751,0.0009312439,0.00051991676,0.00026418956,0.0011633456,0.000027441705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013915437,0.00083441264,0.9162338,0.000075020325,0.00041081116,0.000047464753,0.0016569897,0.00004774207,0.07085197,0.000055138466,0.0003920464,0.008003107],"study_design_scores_gemma":[0.008378007,0.0006220151,0.9711661,0.001841624,0.000101120706,0.000115753675,0.001368191,0.00082848314,0.0150444545,0.00007215706,0.0001217991,0.00034032654],"about_ca_topic_score_codex":0.0028978116,"about_ca_topic_score_gemma":0.004543243,"teacher_disagreement_score":0.05580751,"about_ca_system_score_codex":0.00037561264,"about_ca_system_score_gemma":0.0003469856,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W1965936322","doi":"10.1177/1352458506070704","title":"Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Magnetic resonance imaging; Placebo; Clinical trial; Randomized controlled trial; Clinically isolated syndrome; Lesion; Surgery; Internal medicine; Pediatrics; Radiology; Pathology","score_opus":0.07372830957651066,"score_gpt":0.3016159711945199,"score_spread":0.22788766161800922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965936322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934135,0.00015230273,0.00017160486,0.0002704839,0.00065814547,0.0046427,0.00008603961,0.000030316052,0.00057491456],"genre_scores_gemma":[0.99767536,0.00018087967,0.0011240899,0.00006121921,0.0004594899,0.000051051564,0.00006539502,0.00009512505,0.00028741293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940629,0.0006165333,0.001675307,0.0005289512,0.002093537,0.0010227527],"domain_scores_gemma":[0.9938171,0.0007940798,0.0012572164,0.0006582879,0.0026593064,0.00081402337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025686822,0.0005216682,0.0011620921,0.0007602458,0.0006816084,0.00008610476,0.0005202351,0.00018144037,0.00012856895],"category_scores_gemma":[0.0020046697,0.00031667075,0.00068602304,0.00078242057,0.00054836954,0.00028240905,0.0001810911,0.00087881717,0.000020035719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38862228,0.0009254868,0.59240156,0.000050027233,0.0007413789,0.000024164301,0.0005178875,0.00008729821,0.008243984,9.461614e-7,0.00019471165,0.008190303],"study_design_scores_gemma":[0.42034915,0.0005853276,0.5737123,0.00054169144,0.00027444665,0.00001022256,0.00014076174,0.00037905134,0.0038011044,3.1732748e-7,0.000030252142,0.00017541544],"about_ca_topic_score_codex":0.001765342,"about_ca_topic_score_gemma":0.007773681,"teacher_disagreement_score":0.031726863,"about_ca_system_score_codex":0.00047401752,"about_ca_system_score_gemma":0.00041208867,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W1965997336","doi":"10.1177/1352458512460605","title":"Scoring treatment response in patients with relapsing multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Immunology","score_opus":0.12705088316048876,"score_gpt":0.2940942887571419,"score_spread":0.16704340559665312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965997336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608517,0.0010046139,0.00019682708,0.0005534513,0.0005254654,0.0013059112,0.000041578067,0.000114953014,0.00017203462],"genre_scores_gemma":[0.990511,0.0011112901,0.007210986,0.00014424846,0.00057383603,0.00013902383,0.000023009605,0.0001440119,0.0001425821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941947,0.0006456948,0.0010303832,0.00061813486,0.0015381369,0.0019729345],"domain_scores_gemma":[0.996088,0.0011166335,0.0003885908,0.0007250859,0.00049944816,0.0011822161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020120365,0.0006763335,0.0010218186,0.000947013,0.00081490027,0.00020154683,0.00028340172,0.00021264653,0.00017733009],"category_scores_gemma":[0.0026899332,0.00049536506,0.00034631137,0.0008959273,0.00027887573,0.0010437693,0.00020017508,0.0009882881,0.0001152938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014808823,0.0023836084,0.9250183,0.00003364711,0.00028427466,0.000015293415,0.0019747303,0.00014138925,0.028620481,9.705504e-7,0.00025163713,0.026466833],"study_design_scores_gemma":[0.028221326,0.0020515646,0.9610549,0.001917804,0.00011651885,0.000031656386,0.0006102417,0.0005322446,0.0041930918,0.0000011523775,0.00077302754,0.0004964481],"about_ca_topic_score_codex":0.0002364847,"about_ca_topic_score_gemma":0.000140227,"teacher_disagreement_score":0.036036614,"about_ca_system_score_codex":0.0022733372,"about_ca_system_score_gemma":0.00023818684,"threshold_uncertainty_score":0.9997498},"labels":[],"label_agreement":null},{"id":"W1966077481","doi":"10.1177/1352458513517280","title":"Progressive multiple sclerosis does not associate with rs996343 and rs2046748","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Psychology; Neuroscience; Psychiatry","score_opus":0.0965273471910253,"score_gpt":0.27892999442192556,"score_spread":0.18240264723090027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966077481","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44226667,0.0045720986,0.00013553466,0.5421519,0.0017745432,0.0065547726,0.0013387927,0.0006315467,0.0005741073],"genre_scores_gemma":[0.71634215,0.013922599,0.016266048,0.22236803,0.019504959,0.002075858,0.000621828,0.0012629206,0.0076356195],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9876431,0.0008768458,0.0019502911,0.002067878,0.0042310813,0.003230805],"domain_scores_gemma":[0.99047714,0.0022169305,0.0019891153,0.0014457749,0.0025112852,0.0013597674],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0014703115,0.0020377869,0.0032378866,0.0011838085,0.0019327982,0.0016491369,0.0010188731,0.0019157098,0.0009085427],"category_scores_gemma":[0.003555219,0.0012775405,0.0009289728,0.0007132824,0.0015969512,0.0009423402,0.000886687,0.009768174,0.0002973717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012150303,0.0005945044,0.11951479,0.001130523,0.004250213,0.0013751619,0.0011804388,0.000009682894,0.02488744,8.68839e-7,0.81157714,0.034264203],"study_design_scores_gemma":[0.03364565,0.0029647928,0.7273363,0.016159076,0.0022568004,0.0017384879,0.0011202624,0.0016654744,0.015894463,0.000036324593,0.19302101,0.0041613705],"about_ca_topic_score_codex":0.0005202292,"about_ca_topic_score_gemma":0.00016363767,"teacher_disagreement_score":0.61855614,"about_ca_system_score_codex":0.0011455639,"about_ca_system_score_gemma":0.0006048348,"threshold_uncertainty_score":0.99938726},"labels":[],"label_agreement":null},{"id":"W1966562413","doi":"10.1177/1352458514521308","title":"Birth outcomes of pregnancies fathered by men with multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Cohort; Population; Birth weight; Multivariate analysis; Pregnancy; Cohort study; Demography; Pediatrics; Gerontology; Internal medicine; Psychiatry; Environmental health","score_opus":0.07369110276768734,"score_gpt":0.27428767417602495,"score_spread":0.20059657140833762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966562413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997676,0.0012846296,0.0032802704,0.0017540667,0.00019023297,0.0012032188,0.0002108722,0.0001885249,0.00191144],"genre_scores_gemma":[0.9873351,0.0023570643,0.008300032,0.00026607793,0.00024362453,0.00012519423,0.000026712965,0.0001509567,0.0011952495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425817,0.0003957865,0.0012606634,0.0007316458,0.0020633226,0.0012904118],"domain_scores_gemma":[0.9952032,0.0012112682,0.00077342737,0.000961696,0.0010092603,0.0008411642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013578788,0.00071947684,0.0016601013,0.00048033003,0.00068874285,0.00017735719,0.0006433656,0.00023195671,0.00030100785],"category_scores_gemma":[0.0030971463,0.0004912944,0.0005464869,0.0006586111,0.000757709,0.0004673614,0.0002798734,0.00093939854,0.000056071844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007951664,0.0007475039,0.70759964,0.0001553142,0.00077122747,0.0000041127705,0.00078826153,0.00007391758,0.25726372,0.000007975017,0.009963787,0.02182938],"study_design_scores_gemma":[0.0155123,0.0013350636,0.925979,0.001505927,0.00018429814,0.000043879387,0.00095127115,0.0035718137,0.046272073,0.000013045916,0.0040857824,0.0005455262],"about_ca_topic_score_codex":0.00038292326,"about_ca_topic_score_gemma":0.00020856972,"teacher_disagreement_score":0.2183794,"about_ca_system_score_codex":0.0002641644,"about_ca_system_score_gemma":0.00017965162,"threshold_uncertainty_score":0.9997539},"labels":[],"label_agreement":null},{"id":"W1966824567","doi":"10.1177/1352458509345920","title":"‘Time is brain’ also in multiple sclerosis","year":2009,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Neuroscience; Psychology; Psychiatry","score_opus":0.14102039203987857,"score_gpt":0.3043496335505447,"score_spread":0.1633292415106661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966824567","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08784578,0.0038219516,0.000067209934,0.9010176,0.0012073306,0.0032431828,0.0006936007,0.0004222687,0.0016810923],"genre_scores_gemma":[0.09410032,0.013476858,0.005472262,0.8572283,0.01747442,0.00036417335,0.0007081437,0.0008124873,0.010363063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98511994,0.0011045751,0.003127646,0.002249738,0.004466401,0.0039316895],"domain_scores_gemma":[0.99125284,0.00283183,0.0013314502,0.0021007194,0.0012875983,0.0011955632],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0026379235,0.0021214439,0.003854216,0.0028823111,0.001169281,0.0007813233,0.001724943,0.0027000837,0.0030248235],"category_scores_gemma":[0.006490573,0.0019100867,0.0020854434,0.0017161864,0.0009945423,0.0007631507,0.00068189326,0.013399468,0.0020175453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053195003,0.00064655085,0.01783586,0.00030884772,0.00072876515,0.00094976224,0.00097166165,0.00003546603,0.027829563,1.8637833e-7,0.9181812,0.031980194],"study_design_scores_gemma":[0.018998621,0.0010776013,0.34193948,0.008259942,0.00037524127,0.0005511849,0.00021402382,0.0037761575,0.0023176468,0.000039234295,0.6202167,0.0022341497],"about_ca_topic_score_codex":0.00048186272,"about_ca_topic_score_gemma":0.00017594949,"teacher_disagreement_score":0.32410362,"about_ca_system_score_codex":0.002146492,"about_ca_system_score_gemma":0.0008467846,"threshold_uncertainty_score":0.99915266},"labels":[],"label_agreement":null},{"id":"W1970393648","doi":"10.1177/1352458509106230","title":"Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of British Columbia; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Mitoxantrone; Immune system; Multiple sclerosis; Medicine; Immune modulation; Antibody; Immunology; Glatiramer acetate; Combination therapy; Immunotherapy; Oncology; Internal medicine; Chemotherapy","score_opus":0.0952274905675262,"score_gpt":0.3188835299187216,"score_spread":0.22365603935119538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970393648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037886,0.0015572669,0.0010211858,0.0039704456,0.000887476,0.0016798379,0.00010580031,0.00015541888,0.00024372246],"genre_scores_gemma":[0.9892646,0.0073609324,0.0015355035,0.0005936334,0.00065146544,0.00011978299,0.00020703758,0.00009609592,0.0001709192],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99362385,0.0005619413,0.0018647028,0.00084046106,0.0017915271,0.0013175206],"domain_scores_gemma":[0.996779,0.00046501102,0.000673027,0.0007478557,0.0008084584,0.00052660477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015434794,0.0007082088,0.0012514009,0.00076521386,0.00097190967,0.0003581091,0.0005428932,0.0004411498,0.0006932557],"category_scores_gemma":[0.0013925075,0.00062842295,0.00055767846,0.0009686298,0.00025625806,0.0010970064,0.00017193765,0.0015041721,0.00007448214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002907898,0.0017866197,0.013153685,0.00002316844,0.00013053097,0.0000064515552,0.0016957892,0.00016848781,0.84406906,0.0000031758632,0.0025930665,0.13346207],"study_design_scores_gemma":[0.023641959,0.0008814913,0.6121704,0.0007564076,0.00002703403,0.000011637017,0.0002796946,0.007013274,0.3543973,0.00007519922,0.00031946422,0.0004261362],"about_ca_topic_score_codex":0.0002918852,"about_ca_topic_score_gemma":0.000040772313,"teacher_disagreement_score":0.5990167,"about_ca_system_score_codex":0.0006770089,"about_ca_system_score_gemma":0.00019212325,"threshold_uncertainty_score":0.9996167},"labels":[],"label_agreement":null},{"id":"W1970927198","doi":"10.1177/1352458511428464","title":"Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Gray (unit); Neuroscience; Neuroimaging; Medicine; Psychology; Nuclear medicine","score_opus":0.16996852822369524,"score_gpt":0.31126497211693593,"score_spread":0.1412964438932407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970927198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936165,0.0007303561,0.002400878,0.0012264292,0.0004556544,0.0007621895,0.00004669178,0.00006252599,0.00069875026],"genre_scores_gemma":[0.9799688,0.0016783826,0.017402608,0.0005357931,0.00018773148,0.00008455669,0.000013968438,0.000100293284,0.00002786837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946409,0.0004891225,0.0016356936,0.0007044704,0.0012376738,0.0012921691],"domain_scores_gemma":[0.9959892,0.0014498823,0.0005098767,0.00066076644,0.0007516606,0.0006386162],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016105549,0.0005493939,0.0012411476,0.00097330613,0.00039970592,0.00008921171,0.000511199,0.00020474858,0.0014061085],"category_scores_gemma":[0.0040768315,0.0004628612,0.00050853344,0.00082164485,0.00057590683,0.0005804163,0.0003489436,0.001647077,0.00024906773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014817255,0.0008033437,0.6546855,0.00008537686,0.00017043379,0.000046164532,0.001469634,0.000012970313,0.33402708,0.00002283759,0.0017715535,0.005423374],"study_design_scores_gemma":[0.007176628,0.0005890006,0.8728082,0.0013891255,0.00009601998,0.00005505629,0.0013259765,0.0022671914,0.11380026,0.00008077099,0.000031428888,0.00038031494],"about_ca_topic_score_codex":0.0020086966,"about_ca_topic_score_gemma":0.00065933226,"teacher_disagreement_score":0.22022682,"about_ca_system_score_codex":0.00029024418,"about_ca_system_score_gemma":0.00016316804,"threshold_uncertainty_score":0.9997823},"labels":[],"label_agreement":null},{"id":"W1970963099","doi":"10.1177/135245850000600207","title":"Cost and health related quality of life consequences of multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; McMaster University; Nexus Clinical Research (Canada)","funders":"Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Health care; Physical therapy; Quality-adjusted life year; Expanded Disability Status Scale; Cost effectiveness; Psychiatry; Nursing","score_opus":0.3555741367552577,"score_gpt":0.38168002761249914,"score_spread":0.026105890857241465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970963099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832333,0.005274378,0.00007164116,0.004421064,0.0001479426,0.001078243,0.00020866242,0.00006235034,0.00041240518],"genre_scores_gemma":[0.97211534,0.022907406,0.004269067,0.00033571874,0.00011776936,0.00003637192,0.000019595844,0.000051459756,0.00014728769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937252,0.00075176556,0.002674484,0.0005517711,0.001397491,0.00089933287],"domain_scores_gemma":[0.9952847,0.001102816,0.0012015363,0.0005722808,0.00073967065,0.001099029],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039625894,0.00042458368,0.0018414933,0.00040295476,0.00054359034,0.00006494086,0.00033436864,0.00021399802,0.0011002014],"category_scores_gemma":[0.0038420341,0.00035315045,0.00042594728,0.0006886469,0.0016470948,0.00031789514,0.00013942427,0.000878231,0.00002321976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014976275,0.00073356595,0.7089801,0.00046346395,0.00056659826,0.000004107876,0.0019133064,0.00012683246,0.18220603,0.000019273997,0.0020007403,0.10148836],"study_design_scores_gemma":[0.010814734,0.00067468116,0.9740805,0.001595277,0.000055139903,0.000055618064,0.0011296676,0.0008027119,0.010178147,0.00003492636,0.00029469142,0.00028392585],"about_ca_topic_score_codex":0.0036245417,"about_ca_topic_score_gemma":0.00042411676,"teacher_disagreement_score":0.2651004,"about_ca_system_score_codex":0.00022912103,"about_ca_system_score_gemma":0.00064564066,"threshold_uncertainty_score":0.99989206},"labels":[],"label_agreement":null},{"id":"W1972876345","doi":"10.1191/1352458504ms1007oa","title":"Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Toxicity; Internal medicine; Gastroenterology; Liver toxicity; Surgery; Immunology","score_opus":0.1509522817518502,"score_gpt":0.31558199734574205,"score_spread":0.16462971559389186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972876345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990964,0.0007224984,0.002686326,0.0029854144,0.00021244616,0.0019859497,0.00021084196,0.00019755478,0.00003495498],"genre_scores_gemma":[0.9842584,0.004922745,0.009442647,0.00014640875,0.0003299122,0.0005567707,0.00003779926,0.00012857084,0.00017675635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99642617,0.00009289788,0.00082643726,0.00075812754,0.0007393733,0.0011570284],"domain_scores_gemma":[0.9973579,0.00056591874,0.00022569452,0.0005145567,0.0005400844,0.0007958211],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0003281016,0.0007001133,0.001102533,0.00049822684,0.0014696941,0.00030173597,0.00022161994,0.00017626204,0.000059059304],"category_scores_gemma":[0.00044829177,0.00048326797,0.00045265432,0.00035688316,0.0004042464,0.0005142101,0.00009077263,0.00056764897,0.000016283911],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042137834,0.0016655312,0.4367674,0.00020401928,0.0020199558,0.00003268259,0.002084058,0.0004833901,0.5340367,0.000009785936,0.00007662731,0.018406056],"study_design_scores_gemma":[0.04043967,0.0034439405,0.8242967,0.0012723926,0.00042154835,0.00021253887,0.0013738184,0.00035478597,0.12723693,0.000008859363,0.0004374883,0.0005013128],"about_ca_topic_score_codex":0.00034438545,"about_ca_topic_score_gemma":0.0010589098,"teacher_disagreement_score":0.40679976,"about_ca_system_score_codex":0.0009835614,"about_ca_system_score_gemma":0.00023443134,"threshold_uncertainty_score":0.99983025},"labels":[],"label_agreement":null},{"id":"W1973067526","doi":"10.1177/1352458508095131","title":"Defining the natural history of MS: the need for complete data and rigorous definitions","year":2008,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Natural (archaeology); Computer science; Epistemology; Data science; Medicine; History; Philosophy; Psychiatry; Archaeology","score_opus":0.2733681012331404,"score_gpt":0.31147826660162947,"score_spread":0.038110165368489046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973067526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005786297,0.10888863,0.0007132181,0.8703329,0.0037977153,0.0038972201,0.0052729826,0.000120076074,0.0011909889],"genre_scores_gemma":[0.31970334,0.09456424,0.023326598,0.5359434,0.01774075,0.0007795209,0.004808339,0.0006378299,0.0024960064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561256,0.00045517294,0.0010611011,0.00062326767,0.0013450263,0.00090285734],"domain_scores_gemma":[0.99102956,0.005547694,0.0008579627,0.0016165435,0.00078453287,0.00016370711],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014142422,0.000547461,0.0010858101,0.00030777117,0.0013329108,0.00010934408,0.0014484618,0.00036956102,0.00006728428],"category_scores_gemma":[0.004416045,0.00030302958,0.00046882118,0.00020097995,0.0018502407,0.00020972647,0.00083763903,0.004614519,0.000012438076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018799822,0.00006056887,0.0018785533,0.00022030696,0.00079248217,0.000030556024,0.0009986298,0.000004232048,0.00095516624,0.0000133148305,0.9908218,0.004036433],"study_design_scores_gemma":[0.004426376,0.00023394114,0.03354079,0.000996816,0.00059887784,0.0007058566,0.00050376565,0.0046797795,0.000025540006,0.000036254125,0.9538792,0.00037281492],"about_ca_topic_score_codex":0.00027636279,"about_ca_topic_score_gemma":0.00016337045,"teacher_disagreement_score":0.33438948,"about_ca_system_score_codex":0.00056085124,"about_ca_system_score_gemma":0.0007334685,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W1974775914","doi":"10.1177/135245850000600210","title":"Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Biopsychosocial model; CIDI; Depression (economics); Medicine; Population; Psychiatry; Clinical psychology; National Comorbidity Survey; Comorbidity; Environmental health","score_opus":0.07727314593194598,"score_gpt":0.29848621100913264,"score_spread":0.22121306507718666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974775914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961249,0.0012998307,0.00006803422,0.0005437216,0.0003453215,0.00095416204,0.0000719991,0.00009059985,0.00050140143],"genre_scores_gemma":[0.9916215,0.003944068,0.0034288133,0.00008961917,0.00045661768,0.000075980926,0.000053892807,0.000090638976,0.00023885486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504936,0.0003709198,0.0015482382,0.0006415996,0.0013915112,0.0009983899],"domain_scores_gemma":[0.9974614,0.0006096851,0.00047436007,0.0005275417,0.00038493925,0.0005421117],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011289812,0.0004872756,0.0010856788,0.0007415969,0.00054953096,0.00010878249,0.00038809885,0.00037008757,0.0018455],"category_scores_gemma":[0.0016403468,0.00042115906,0.0005170318,0.0010132362,0.00029136968,0.00049232674,0.00012996067,0.0011322605,0.00014079358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018844815,0.000820238,0.81132877,0.00006962929,0.00014615526,0.000012752065,0.00067874184,0.00027579252,0.09275159,8.825135e-7,0.0007529114,0.09127808],"study_design_scores_gemma":[0.012664905,0.00029350762,0.97243637,0.0021889925,0.000088192275,0.00005347782,0.0002518817,0.0054570553,0.0059182025,0.000027313428,0.00025608865,0.00036402384],"about_ca_topic_score_codex":0.0011573245,"about_ca_topic_score_gemma":0.0004035587,"teacher_disagreement_score":0.16110761,"about_ca_system_score_codex":0.00039145196,"about_ca_system_score_gemma":0.00011438933,"threshold_uncertainty_score":0.99982405},"labels":[],"label_agreement":null},{"id":"W1978426087","doi":"10.1177/1352458512465136","title":"Observational studies of treatment effectiveness: useful, useless or somewhere in between?","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Observational study; Multiple sclerosis; Medicine; Internal medicine; Psychiatry","score_opus":0.5150001251313869,"score_gpt":0.40978027275724865,"score_spread":0.10521985237413828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978426087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9087215,0.0043485523,0.00003217977,0.08267161,0.0006807723,0.002993429,0.0004262848,0.000070055714,0.000055609988],"genre_scores_gemma":[0.9077419,0.04088293,0.0045472463,0.028414654,0.013279956,0.0018468443,0.00062931876,0.00050265546,0.0021544956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931516,0.0011332945,0.0018870992,0.0008609972,0.0017245966,0.0012424327],"domain_scores_gemma":[0.9897616,0.006581466,0.0009925935,0.00073170086,0.0016390968,0.00029354464],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013016224,0.0010040625,0.0034148707,0.0011056734,0.00034633113,0.00012545665,0.0005144788,0.00091230735,0.0003923111],"category_scores_gemma":[0.0033567683,0.0006625659,0.00079051615,0.00075423415,0.00061052496,0.00040233857,0.00028924184,0.003086273,0.00007715883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062968227,0.00048009126,0.7497696,0.0020533316,0.0042704265,0.00025175614,0.00080140383,0.00006807026,0.0048500043,6.678829e-7,0.22699149,0.009833446],"study_design_scores_gemma":[0.010907458,0.002021243,0.9378891,0.008068943,0.0004957477,0.000059418337,0.00044020006,0.00010142873,0.0020425587,0.000031137188,0.037349317,0.000593453],"about_ca_topic_score_codex":0.00035981325,"about_ca_topic_score_gemma":0.0001961651,"teacher_disagreement_score":0.18964216,"about_ca_system_score_codex":0.002992463,"about_ca_system_score_gemma":0.0010072635,"threshold_uncertainty_score":0.9995825},"labels":[],"label_agreement":null},{"id":"W1978928514","doi":"10.1177/1352458513507822","title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neuromyelitis optica; Hiccups; Population; Vertigo; Vomiting; Pediatrics; Brainstem; Trigeminal neuralgia; Ataxia; Optic neuritis; Multiple sclerosis; Anesthesia; Internal medicine; Surgery; Immunology","score_opus":0.0800234183058476,"score_gpt":0.293007724955086,"score_spread":0.2129843066492384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978928514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963048,0.000050160488,0.000039171802,0.0005710306,0.00023304862,0.00232582,0.000021929718,0.000032527958,0.0004215203],"genre_scores_gemma":[0.9975134,0.00022744376,0.0016623245,0.00013247736,0.00012469038,0.00019515255,0.000009420438,0.000049868162,0.000085188054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633,0.0003438619,0.0011666105,0.00039997188,0.0010822698,0.0006772701],"domain_scores_gemma":[0.99734247,0.00048667222,0.00032225816,0.0004267021,0.0010031835,0.00041871288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044548273,0.00030379495,0.0006287808,0.00059879664,0.00023795244,0.00010856089,0.00027914593,0.00008258824,0.00035975993],"category_scores_gemma":[0.0019990674,0.00024395937,0.00018864904,0.0004618902,0.00013936067,0.0004753191,0.00021688482,0.00071029156,0.00009440909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016799473,0.004326285,0.96587133,0.00006844587,0.00015380987,0.000033602544,0.0039343596,0.00009655675,0.009628984,0.0000012495351,0.00076707196,0.014950331],"study_design_scores_gemma":[0.016992673,0.0011997751,0.9729584,0.00042156863,0.000043436325,0.00001452973,0.00495101,0.0029158108,0.00026511587,0.0000041443222,0.000053680316,0.00017987755],"about_ca_topic_score_codex":0.00075305573,"about_ca_topic_score_gemma":0.00036814337,"teacher_disagreement_score":0.016824678,"about_ca_system_score_codex":0.00022077287,"about_ca_system_score_gemma":0.00007277966,"threshold_uncertainty_score":0.9948374},"labels":[],"label_agreement":null},{"id":"W1980181887","doi":"10.1177/1352458506070659","title":"Identifying reliable change in tactile temporal thresholds in multiple sclerosis: test-retest reliability","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Reliability (semiconductor); Multiple sclerosis; Audiology; Sensory threshold; Psychology; Medicine; Physical medicine and rehabilitation; Cognitive psychology","score_opus":0.1808226291541926,"score_gpt":0.32257374267434236,"score_spread":0.14175111352014977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980181887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917576,0.0022897588,0.00008666012,0.002009378,0.00066485495,0.002215739,0.00010078332,0.00020560567,0.00066967227],"genre_scores_gemma":[0.9884008,0.0025108238,0.0064815385,0.0003170547,0.0012322478,0.0006067343,0.000067063236,0.00016567354,0.00021802179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99172187,0.0003692439,0.0023460968,0.0013228664,0.0019667353,0.0022731866],"domain_scores_gemma":[0.99555075,0.0013725782,0.000629072,0.001126374,0.0006554176,0.0006658302],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003521467,0.00084757886,0.0015545825,0.00149184,0.00074441533,0.00043808977,0.0007121968,0.00049493415,0.00036600602],"category_scores_gemma":[0.005173585,0.0007797654,0.0005512274,0.002104637,0.00049011107,0.00158335,0.0005192477,0.0026753875,0.00014935646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005773454,0.0020423597,0.9223915,0.00020807372,0.00003945963,0.0001325463,0.0008105718,0.00033449673,0.06629516,0.0000036038125,0.0030255285,0.004139361],"study_design_scores_gemma":[0.013066121,0.00038472353,0.96414053,0.0032113711,0.000047597474,0.00008625521,0.0007163404,0.010272146,0.006237084,0.00010899543,0.0010352699,0.0006935727],"about_ca_topic_score_codex":0.014865966,"about_ca_topic_score_gemma":0.013787193,"teacher_disagreement_score":0.06005808,"about_ca_system_score_codex":0.0017809484,"about_ca_system_score_gemma":0.00030267704,"threshold_uncertainty_score":0.9996255},"labels":[],"label_agreement":null},{"id":"W1981166534","doi":"10.1191/1352458503ms960oa","title":"Depressive symptoms in a treated multiple sclerosis cohort","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Cohort; Medicine; Cohort study; Depression (economics); Depressive symptoms; Psychiatry; Internal medicine; Cognition","score_opus":0.08829095200082727,"score_gpt":0.29308264660378563,"score_spread":0.20479169460295837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981166534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922091,0.0019813196,0.0003432018,0.0004599882,0.00044988305,0.001830118,0.00006181075,0.00018906259,0.002475541],"genre_scores_gemma":[0.99152553,0.0044631385,0.0023617654,0.00035082843,0.00032856048,0.00036380935,0.000031365253,0.00015907912,0.0004159385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929001,0.00080083206,0.0015487021,0.0010768725,0.0017453468,0.0019281979],"domain_scores_gemma":[0.99552524,0.0010557116,0.00048540658,0.00093496306,0.0008146599,0.0011840436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017494712,0.0008105917,0.0014844148,0.001095214,0.0008131093,0.00030606694,0.0005028033,0.00040190553,0.00075374957],"category_scores_gemma":[0.007186544,0.00068924425,0.000657799,0.0014411977,0.00045737147,0.0005818123,0.00020476231,0.0018246934,0.00021074453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005374723,0.00095680164,0.874655,0.000050214363,0.0005936488,0.00012546504,0.00044724572,0.00023138791,0.1090083,0.0000113421875,0.0020544922,0.011328598],"study_design_scores_gemma":[0.018780569,0.00040954485,0.9425346,0.0012858527,0.00019201038,0.00026996824,0.0003661624,0.002374801,0.031257484,0.000020287569,0.0018681046,0.00064061175],"about_ca_topic_score_codex":0.0004759758,"about_ca_topic_score_gemma":0.0004970967,"teacher_disagreement_score":0.07775081,"about_ca_system_score_codex":0.0010495039,"about_ca_system_score_gemma":0.00034929125,"threshold_uncertainty_score":0.9995559},"labels":[],"label_agreement":null},{"id":"W1985235854","doi":"10.1177/135245850000600509","title":"Multiple sclerosis, disease modifying treatments and depression: a critical methodological review","year":2000,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Depression (economics); Mood; Psychiatry; Disease; Psychology; Clinical psychology; Mood disorders; Multiple sclerosis; Major depressive disorder; Placebo; Medicine; Anxiety; Alternative medicine; Internal medicine","score_opus":0.5577539936427163,"score_gpt":0.46577594370169356,"score_spread":0.09197804994102271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985235854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014925444,0.99417686,0.0002295937,0.00070419133,0.0005010896,0.003347132,0.00045322155,0.00019940357,0.00023923679],"genre_scores_gemma":[0.0007153794,0.98380333,0.01151226,0.0006930046,0.0014674863,0.0011355574,0.00019380433,0.00027237725,0.000206808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98761874,0.0035357613,0.0027697461,0.0019552996,0.0021572097,0.0019632191],"domain_scores_gemma":[0.9867304,0.006939636,0.00082401274,0.0014337559,0.0005849706,0.0034872394],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030861732,0.0017854944,0.006588359,0.00072440796,0.0015383218,0.00044595497,0.0007810935,0.0007608926,0.0017623238],"category_scores_gemma":[0.02601716,0.0012222127,0.0026781377,0.00086814415,0.0009201184,0.00047804546,0.000812281,0.0032885051,0.00022458589],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039310835,0.00081348687,0.0020746198,0.040818322,0.0010910757,0.0003384638,0.00004843816,0.000001430295,0.000028030992,0.0000014423249,0.0074664894,0.9469251],"study_design_scores_gemma":[0.005331594,0.00035551251,0.019812316,0.4101314,0.008978278,0.0011179232,0.000039147264,0.00026204152,0.0000082559045,0.000016786085,0.55256236,0.001384424],"about_ca_topic_score_codex":0.00003334294,"about_ca_topic_score_gemma":0.0000057912966,"teacher_disagreement_score":0.94554067,"about_ca_system_score_codex":0.0006734593,"about_ca_system_score_gemma":0.0007180591,"threshold_uncertainty_score":0.9997615},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W1985863851","doi":"10.1177/1352458514521310","title":"Administrative databases for observational studies in multiple sclerosis: power or peril?","year":2014,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Observational study; Medicine; MEDLINE; Database; Computer science; Psychiatry; Political science; Internal medicine","score_opus":0.9193335190700312,"score_gpt":0.5021998921628826,"score_spread":0.4171336269071486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985863851","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03523543,0.009379014,0.0066354703,0.92585516,0.007011919,0.0038855493,0.01158002,0.00013296094,0.00028446107],"genre_scores_gemma":[0.09921624,0.0023760884,0.03126143,0.8496841,0.0115855,0.0017229024,0.0015450692,0.000331045,0.00227761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98798835,0.0009333137,0.008074571,0.0013530304,0.00039807556,0.001252639],"domain_scores_gemma":[0.98001903,0.011855725,0.0063958075,0.0008756358,0.0005620196,0.0002917696],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012364842,0.0008340959,0.0031255542,0.0009580548,0.0008616558,0.00041407833,0.0009149208,0.0007255366,0.0008644084],"category_scores_gemma":[0.03227849,0.00087581796,0.00062154105,0.0003397133,0.00035435378,0.0012221,0.00015922218,0.0019531841,0.000542884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016412191,0.00014628512,0.031738732,0.0007391535,0.00041706933,0.000011437142,0.0015948629,0.00015449093,0.000012239221,0.00044495048,0.96450406,0.00007260538],"study_design_scores_gemma":[0.005719804,0.00042000806,0.045073967,0.002986846,0.000049580533,0.00006423512,0.0029703951,0.0027658357,0.000015828839,0.0013844488,0.9371276,0.001421462],"about_ca_topic_score_codex":0.00023080406,"about_ca_topic_score_gemma":0.00097394054,"teacher_disagreement_score":0.076171055,"about_ca_system_score_codex":0.0018020023,"about_ca_system_score_gemma":0.0007153565,"threshold_uncertainty_score":0.99936926},"labels":[],"label_agreement":null},{"id":"W1987304611","doi":"10.1191/1352458505ms1222oa","title":"Upregulation of TRAIL expression on human T lymphocytes by interferon b and glatiramer acetate","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada; McGill University","keywords":"Glatiramer acetate; Downregulation and upregulation; In vivo; In vitro; Interferon; Multiple sclerosis; Tumor necrosis factor alpha; Apoptosis; Immunology; CD3; Receptor; Chemistry; Biology; Cancer research; Medicine; Molecular biology; Internal medicine; Antigen; CD8; Biochemistry","score_opus":0.03710836405683279,"score_gpt":0.25474287810179275,"score_spread":0.21763451404495995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987304611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500585,0.0007090902,0.0039528087,0.00007860254,0.00007206974,0.000084450585,0.000008800288,0.00000533874,0.000083009654],"genre_scores_gemma":[0.9972334,0.00040312906,0.0017740775,0.000053477692,0.00020335244,0.0000030490814,0.00004568875,0.000017094631,0.00026674662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999236,0.00005246788,0.00025698,0.00017865276,0.0001401429,0.00013575322],"domain_scores_gemma":[0.9995581,0.000010173791,0.00017603852,0.00012624734,0.00005410762,0.000075351185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015648457,0.00012118982,0.00012160269,0.0000468356,0.0001458852,0.000034835848,0.00007476618,0.000111306195,0.000039589195],"category_scores_gemma":[0.000018091972,0.000099723286,0.00006926696,0.00002936277,0.00004809171,0.000012659124,0.000037349848,0.00007212767,0.0000016094658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012526943,0.000059987804,0.00072663295,0.000005417773,0.000014789621,8.8461846e-8,0.0000945809,0.00076596456,0.9458173,0.000008381278,0.0007970888,0.051584486],"study_design_scores_gemma":[0.0016109704,0.0003975164,0.01648601,0.00009332131,0.000011907886,0.000010087952,0.000039450882,0.0013100728,0.9773463,0.000042304666,0.002531303,0.00012074764],"about_ca_topic_score_codex":0.000004871028,"about_ca_topic_score_gemma":0.000008621405,"teacher_disagreement_score":0.051463738,"about_ca_system_score_codex":0.000022311491,"about_ca_system_score_gemma":0.000010173871,"threshold_uncertainty_score":0.40665978},"labels":[],"label_agreement":null},{"id":"W1988098374","doi":"10.1191/1352458505ms1190oa","title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Methylprednisolone; Immune system; Nitric oxide; Medicine; Mechanism (biology); Tumor necrosis factor alpha; Disease; Immunology; Apoptosis; Mechanism of action; Extravasation; Inflammation; Cytokine; Microglia; Neuroscience; Pharmacology; Biology; Internal medicine","score_opus":0.3692665200133362,"score_gpt":0.4033581294156865,"score_spread":0.03409160940235029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988098374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008915841,0.9867856,0.00010597951,0.00028556073,0.00042268573,0.0031160787,0.00026346213,0.000019180545,0.00008564742],"genre_scores_gemma":[0.08551031,0.91200584,0.0014206971,0.0000128288975,0.00048803023,0.00036148334,0.00003153499,0.000096052194,0.00007319879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99166274,0.0016495929,0.0032786704,0.0005687413,0.0019358873,0.0009043406],"domain_scores_gemma":[0.98969984,0.005177636,0.002824847,0.0013386704,0.00072152494,0.00023745549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031251805,0.00084741117,0.0040564425,0.00085878687,0.00047751848,0.000067946174,0.0010508172,0.0004919745,0.00006934622],"category_scores_gemma":[0.002040739,0.00043202782,0.0023926527,0.0012391973,0.0007049933,0.00016938889,0.00016853363,0.0011409112,0.000011228715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038303682,0.0020998903,0.0005804612,0.0025734839,0.0015477729,0.0000050231924,0.0015370881,0.00001914801,0.0060477657,0.000017907145,0.00024735133,0.98494107],"study_design_scores_gemma":[0.029115053,0.009749764,0.045956947,0.08459628,0.009385594,0.0003839876,0.0070693893,0.0015127428,0.019402644,0.00008249872,0.7909804,0.0017647059],"about_ca_topic_score_codex":0.0005418524,"about_ca_topic_score_gemma":0.0008314714,"teacher_disagreement_score":0.98317635,"about_ca_system_score_codex":0.0007995754,"about_ca_system_score_gemma":0.0005439242,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W1988510033","doi":"10.1177/1352458514556303","title":"Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; St. Michael's Hospital; The Scarborough Hospital; Health Sciences Centre; Women's College Hospital; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Epidemiology; Medicine; Multiple sclerosis; Incidence (geometry); Algorithm; Disease burden; Population; Demography; Computer science; Internal medicine; Environmental health; Mathematics","score_opus":0.23554736585337574,"score_gpt":0.372692536325335,"score_spread":0.13714517047195926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988510033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587876,0.0002561696,0.0011928316,0.0017545996,0.00009199056,0.00066805875,0.0001347679,0.000008086339,0.0000147671],"genre_scores_gemma":[0.9286455,0.0001497708,0.070827246,0.00012082944,0.0000941371,0.00003949292,0.00008382633,0.000021621898,0.00001759529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680406,0.0005179356,0.0010618642,0.00052008714,0.0005923671,0.0005036803],"domain_scores_gemma":[0.99630207,0.0016214639,0.00041264927,0.00063514913,0.00031832204,0.00071033364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029171947,0.00027459755,0.0007710518,0.00019102973,0.00029521456,0.000027866376,0.0004028231,0.000071104856,0.00002954213],"category_scores_gemma":[0.006520572,0.00019701602,0.000042809977,0.00020296568,0.00030308476,0.00024799892,0.00049901655,0.00046354314,6.0281087e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052272266,0.00014912055,0.87510026,0.00008611599,0.00015589634,0.000006385347,0.0026401242,0.00048865745,0.0067382976,0.0000057422244,0.00022600488,0.11388067],"study_design_scores_gemma":[0.0027141196,0.0002392186,0.96127474,0.0006270212,0.000059431586,0.000018233002,0.0007860085,0.030039692,0.0033327646,0.000014038923,0.00071966124,0.00017507764],"about_ca_topic_score_codex":0.42860457,"about_ca_topic_score_gemma":0.8614596,"teacher_disagreement_score":0.43285504,"about_ca_system_score_codex":0.00031553517,"about_ca_system_score_gemma":0.0011475785,"threshold_uncertainty_score":0.803408},"labels":[],"label_agreement":null},{"id":"W1989531971","doi":"10.1177/135245850000600606","title":"Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society; University of Victoria; National Multiple Sclerosis Society","keywords":"Neuropsychology; Psychology; Clinical psychology; Neuropsychological assessment; Neuropsychological test; Intervention (counseling); Cognition; Psychiatry","score_opus":0.12287503230053289,"score_gpt":0.3162649411889916,"score_spread":0.19338990888845875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989531971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583393,0.00023531946,0.000031867974,0.0009020631,0.00043332987,0.0016788066,0.00017366356,0.00019016974,0.00052084815],"genre_scores_gemma":[0.9935946,0.0026121815,0.0011868936,0.00092322304,0.00097459333,0.00030686654,0.00007362378,0.00013812631,0.00018992282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931453,0.0006190453,0.0015718515,0.0010502536,0.0018347807,0.0017788023],"domain_scores_gemma":[0.996883,0.00065051584,0.00037427826,0.00042424054,0.0008674981,0.0008004746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001193064,0.00074351585,0.0012091261,0.0006043153,0.0012493917,0.00032994154,0.00053859863,0.00041265748,0.0013789503],"category_scores_gemma":[0.0017483444,0.0006451566,0.00068586215,0.00093548885,0.00061116816,0.00058561575,0.00017183204,0.0020244708,0.00028929993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034636902,0.0035985943,0.5559359,0.000040106566,0.00013793125,0.000087822744,0.0013892198,0.000017289554,0.094484724,3.6677793e-7,0.002452181,0.33839217],"study_design_scores_gemma":[0.020894956,0.0012762288,0.97253025,0.0004426455,0.00013751887,0.000055007156,0.00050848164,0.0011733489,0.0013045731,0.0000058521564,0.0010677071,0.0006034287],"about_ca_topic_score_codex":0.00017681268,"about_ca_topic_score_gemma":0.000115958945,"teacher_disagreement_score":0.41659436,"about_ca_system_score_codex":0.000507191,"about_ca_system_score_gemma":0.00015366085,"threshold_uncertainty_score":0.9996},"labels":[],"label_agreement":null},{"id":"W1990367147","doi":"10.1177/1352458512436595","title":"Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Serono Symposia International Foundation; European Committee for Treatment and Research in Multiple Sclerosis; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Sanofi; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Disease; Demographics; Family history; Medical record; Young adult; Demography; Internal medicine; Pediatrics; Immunology","score_opus":0.07137228223706386,"score_gpt":0.2760600211986346,"score_spread":0.20468773896157072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990367147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629873,0.0016350483,0.000030058362,0.0002326216,0.0007118265,0.00074088114,0.00018714316,0.000028948749,0.00013472674],"genre_scores_gemma":[0.99140924,0.0059799063,0.0014536419,0.00021279675,0.0005796553,0.00008698489,0.000017255214,0.00008388248,0.00017666238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994222,0.0003946581,0.001746901,0.00045484418,0.001467449,0.001714138],"domain_scores_gemma":[0.9962443,0.0013337398,0.0005704596,0.00046595364,0.00055091386,0.0008346447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023291511,0.00033896512,0.0013332337,0.00039885243,0.00030842802,0.00025415537,0.00041119306,0.00021097308,0.0005473479],"category_scores_gemma":[0.006358398,0.00047306993,0.00024486455,0.0010017991,0.00023916957,0.00059055904,0.00024947675,0.0013145645,0.000010305803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008429969,0.0009639653,0.9501565,0.00018532896,0.00009423802,0.000050856375,0.00072809064,0.000016026499,0.019806031,3.5491928e-7,0.002784997,0.02512932],"study_design_scores_gemma":[0.0041692513,0.00011665109,0.9871453,0.0045560175,0.000041628908,0.00012703906,0.0010209811,0.0006037547,0.0007164639,0.0000012444045,0.0011023682,0.00039930033],"about_ca_topic_score_codex":0.8091047,"about_ca_topic_score_gemma":0.97012883,"teacher_disagreement_score":0.16102417,"about_ca_system_score_codex":0.0014410854,"about_ca_system_score_gemma":0.0009606026,"threshold_uncertainty_score":0.9997721},"labels":[],"label_agreement":null},{"id":"W1990704394","doi":"10.1191/1352458505ms1126oa","title":"Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre; Hôpital Notre-Dame; St. Michael's Hospital; University Hospital; Ottawa Hospital","funders":"University of British Columbia","keywords":"Medicine; Multiple sclerosis; Placebo; Magnetic resonance imaging; Internal medicine; Dosing; Gastroenterology; Lesion; Randomized controlled trial; Surgery; Pathology; Immunology; Radiology","score_opus":0.2978339590507148,"score_gpt":0.3571284223480456,"score_spread":0.05929446329733079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990704394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687315,0.0029288402,0.00024475562,0.002073712,0.000578116,0.0069625224,0.00014043193,0.00010203938,0.000096435724],"genre_scores_gemma":[0.9908321,0.005071213,0.0020114684,0.00020986923,0.0013002984,0.00032319358,0.00005091424,0.000150727,0.00005023775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891015,0.0027541975,0.002898271,0.0013604978,0.0026484237,0.0012370865],"domain_scores_gemma":[0.98978823,0.0050326507,0.0010802639,0.0029346778,0.00069735287,0.0004668485],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008431206,0.0008519716,0.0026811569,0.00059398246,0.0008577924,0.00038013607,0.002459618,0.00022519827,0.00040858518],"category_scores_gemma":[0.005862401,0.00054322334,0.0005268214,0.0010298442,0.0006575591,0.0010024947,0.0015115388,0.0024433201,0.00007304835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13954061,0.013617692,0.73279715,0.00001969302,0.002421988,0.00002637293,0.020644514,0.0005138226,0.023227826,8.2525804e-7,0.0024358572,0.064753674],"study_design_scores_gemma":[0.36498845,0.0025959185,0.5872095,0.0011664737,0.00028900988,0.000008341752,0.02452834,0.018141465,0.0005123897,0.000008828647,0.0001595736,0.00039170394],"about_ca_topic_score_codex":0.005522476,"about_ca_topic_score_gemma":0.02207382,"teacher_disagreement_score":0.22544782,"about_ca_system_score_codex":0.0004918079,"about_ca_system_score_gemma":0.00025721287,"threshold_uncertainty_score":0.9998581},"labels":[],"label_agreement":null},{"id":"W1990917514","doi":"10.1177/1352458510384008","title":"Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Myelin; Luxol fast blue stain; Multiple sclerosis; White matter; Magnetization transfer; Pathology; Myelin basic protein; Expanded Disability Status Scale; Glial fibrillary acidic protein; Magnetic resonance imaging; Chemistry; Biology; Medicine; Internal medicine; Central nervous system; Immunology; Immunohistochemistry; Radiology","score_opus":0.03626906730659938,"score_gpt":0.25802916105199886,"score_spread":0.22176009374539948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990917514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988042,0.008339898,0.00011271048,0.0021193698,0.00044511395,0.00029582472,0.00006439968,0.000041855405,0.0005388529],"genre_scores_gemma":[0.986477,0.0021222965,0.010445288,0.00045961543,0.00032753896,0.000026942864,0.000010019866,0.00004137784,0.000089926165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972067,0.00022220932,0.00080035644,0.0005136807,0.00064428966,0.00061276805],"domain_scores_gemma":[0.9978573,0.0004836217,0.0002853586,0.000464863,0.00043476283,0.0004741503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039267103,0.00033271094,0.00079333334,0.000310734,0.0003763811,0.00008179172,0.00029691053,0.00018188596,0.0010126234],"category_scores_gemma":[0.0010668032,0.0002551309,0.00018172969,0.000233754,0.00089940976,0.00023665793,0.00031701956,0.0013625264,0.000043695985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002791748,0.00020921112,0.7051279,0.000020479103,0.000021291095,0.00006563002,0.0005714168,6.5332137e-7,0.24789944,0.0000048264546,0.0012428241,0.044557136],"study_design_scores_gemma":[0.0046777492,0.00023192598,0.98751926,0.0002046011,0.000070550464,0.00034073796,0.00021627205,0.0013418217,0.0031164733,0.000048720703,0.001999692,0.00023216373],"about_ca_topic_score_codex":0.00023099408,"about_ca_topic_score_gemma":0.00023982029,"teacher_disagreement_score":0.28239137,"about_ca_system_score_codex":0.000066996356,"about_ca_system_score_gemma":0.00007806384,"threshold_uncertainty_score":0.9999901},"labels":[],"label_agreement":null},{"id":"W1991460270","doi":"10.1177/1352458507080733","title":"Validation of the Multiple Sclerosis International Quality of Life questionnaire","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Quality of life (healthcare); Checklist; Construct validity; Discriminant validity; Reliability (semiconductor); Scale (ratio); External validity; Multiple sclerosis; Medicine; Clinical psychology; Psychometrics; Psychology; Physical therapy; Internal consistency; Psychiatry; Social psychology","score_opus":0.17518544664910574,"score_gpt":0.3521559668013095,"score_spread":0.17697052015220377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991460270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192446,0.00045007488,0.0034047577,0.00194163,0.0010974756,0.0006178568,0.000077794946,0.000044554497,0.0004413685],"genre_scores_gemma":[0.9950643,0.00083301985,0.0031764307,0.00018241552,0.00058172364,0.000016210764,0.000013872451,0.000042373103,0.00008960797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945825,0.00039541474,0.0019166993,0.00036933346,0.0021658977,0.00057018903],"domain_scores_gemma":[0.99477303,0.0009259731,0.0012984693,0.0006504084,0.0019263168,0.00042580185],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043289973,0.00030853416,0.00075089926,0.00040968318,0.0004192418,0.000058560894,0.0006583633,0.00019214528,0.00019374772],"category_scores_gemma":[0.015488755,0.00022074964,0.0006707733,0.00067162013,0.0005884608,0.00034410236,0.00034590176,0.0007597047,0.00001267425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073609466,0.00045817066,0.61487836,0.00009424518,0.00027049478,7.041024e-7,0.0005053653,0.00015854085,0.37117785,0.000025401076,0.0006433463,0.011051442],"study_design_scores_gemma":[0.0048670075,0.00011758481,0.81828153,0.0009895378,0.000053036954,0.000011008002,0.00053105166,0.00050599285,0.17426598,0.000023154285,0.00019547893,0.00015863976],"about_ca_topic_score_codex":0.0004455334,"about_ca_topic_score_gemma":0.00021715692,"teacher_disagreement_score":0.20340317,"about_ca_system_score_codex":0.00034780763,"about_ca_system_score_gemma":0.00029678454,"threshold_uncertainty_score":0.9928042},"labels":[],"label_agreement":null},{"id":"W1991643405","doi":"10.1177/1352458507084266","title":"Through the eyes of a child: research insights gained through the study of childhood multiple sclerosis","year":2007,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Clinical neurology; Developmental psychology; Neuroscience; Psychiatry","score_opus":0.23184495182908016,"score_gpt":0.3683210655924814,"score_spread":0.13647611376340124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991643405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5012576,0.013862104,0.00030478238,0.46325687,0.0019339848,0.015055985,0.00049393304,0.00021002069,0.003624724],"genre_scores_gemma":[0.923231,0.011679268,0.0010628026,0.05507256,0.0075626425,0.000509441,0.000101354584,0.00040879773,0.00037213296],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9772945,0.0043443097,0.0040271194,0.0017003493,0.009617374,0.003016346],"domain_scores_gemma":[0.9789598,0.010057735,0.0024566841,0.0036515605,0.0045382073,0.00033601176],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.006115198,0.001615477,0.0033875422,0.0013175793,0.004094102,0.00040888056,0.0038513243,0.0013873242,0.00029399016],"category_scores_gemma":[0.009522318,0.00088379916,0.0017677468,0.0036094398,0.0037717903,0.000644678,0.0020236073,0.016551903,0.000064884014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016380628,0.006624403,0.016723096,0.0007186912,0.006070626,0.00020853829,0.065362476,0.00021020405,0.007312567,0.000012095856,0.88890886,0.0062103663],"study_design_scores_gemma":[0.030789822,0.006502719,0.5690202,0.010223746,0.0016648384,0.00034445184,0.045263764,0.00034134078,0.008150571,0.000208128,0.3257918,0.0016986061],"about_ca_topic_score_codex":0.0038449687,"about_ca_topic_score_gemma":0.0012201264,"teacher_disagreement_score":0.5631171,"about_ca_system_score_codex":0.00070102466,"about_ca_system_score_gemma":0.0007552365,"threshold_uncertainty_score":0.9999091},"labels":[],"label_agreement":null},{"id":"W1992531794","doi":"10.1191/135248506ms1267oa","title":"The relation between menarche and the age of first symptoms in a multiple sclerosis cohort","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Menarche; Medicine; Multiple sclerosis; Cohort; Population; Pediatrics; Age of onset; Cohort study; Demography; Internal medicine; Disease; Immunology","score_opus":0.08959393901813134,"score_gpt":0.28123874248510305,"score_spread":0.1916448034669717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992531794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897467,0.0025960898,0.00029925126,0.004946854,0.00014889633,0.0016241487,0.000037838807,0.00004111148,0.0005590952],"genre_scores_gemma":[0.99216497,0.0061220075,0.0007530022,0.00006600312,0.00049314776,0.00016649638,0.000027023083,0.000055506927,0.00015182012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953002,0.0006431033,0.0013995187,0.0004499563,0.0013488091,0.00085846684],"domain_scores_gemma":[0.99317086,0.005108413,0.0005075011,0.0006114433,0.00038973664,0.0002120557],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0043572397,0.0003848389,0.00091248605,0.00031937528,0.0015075625,0.00022878565,0.00045396166,0.0001909924,0.00002462175],"category_scores_gemma":[0.0035781027,0.00021526952,0.0003492803,0.00069310557,0.0017363501,0.00026086706,0.0003301523,0.0012119465,0.00000943048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087731506,0.00015848904,0.97750175,0.000050178667,0.0003019134,0.000006906277,0.00076542445,0.00015731435,0.01007527,0.000052376243,0.00087412406,0.009178962],"study_design_scores_gemma":[0.014988315,0.00015707072,0.9762051,0.0007475204,0.00015938093,0.000022022574,0.00038973344,0.0041943477,0.0011808452,0.00015281474,0.0015955043,0.00020736206],"about_ca_topic_score_codex":0.0017716385,"about_ca_topic_score_gemma":0.0027946723,"teacher_disagreement_score":0.014111,"about_ca_system_score_codex":0.00032417808,"about_ca_system_score_gemma":0.00008926901,"threshold_uncertainty_score":0.99979234},"labels":[],"label_agreement":null},{"id":"W1996771233","doi":"10.1177/1352458507076989","title":"Binding antibodies: Vancouver's perspective","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Antibody; Medicine; Interferon beta; Immunology; Perspective (graphical); Interferon","score_opus":0.09803620989031762,"score_gpt":0.3399826878967504,"score_spread":0.24194647800643276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996771233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784014,0.0010876129,0.0033308705,0.0010684639,0.0015700208,0.0006623274,0.000027015254,0.0001943024,0.013657977],"genre_scores_gemma":[0.9875341,0.0017563499,0.00804028,0.00029244533,0.0014220139,0.000009629067,0.000004259171,0.00007069722,0.0008701903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960853,0.00009885753,0.0007378451,0.00049700146,0.0013176455,0.001263344],"domain_scores_gemma":[0.9967292,0.0006253064,0.00028010856,0.0004057459,0.001144621,0.0008150217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022165466,0.00037695942,0.0006485737,0.00072858756,0.0009909751,0.00015255023,0.00029124055,0.00016420805,0.0004228877],"category_scores_gemma":[0.0032502688,0.0003055944,0.00045193743,0.00065733376,0.00033680475,0.00037349213,0.00020018517,0.0012164396,0.0001784335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011268291,0.0006448124,0.5594344,0.00006541473,0.00074107863,0.00027549965,0.0033988608,0.000025215253,0.3666531,0.00006443084,0.03641831,0.031151988],"study_design_scores_gemma":[0.0074160793,0.0005245005,0.93497235,0.0007213754,0.00011714219,0.00027103312,0.017592115,0.00046946623,0.028839206,0.00006174301,0.0085389195,0.00047606882],"about_ca_topic_score_codex":0.00015466187,"about_ca_topic_score_gemma":0.0006368537,"teacher_disagreement_score":0.3755379,"about_ca_system_score_codex":0.0011584685,"about_ca_system_score_gemma":0.00018928136,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W1996975196","doi":"10.1191/1352458505ms1200cr","title":"Neuromyelitis optica with hypothalamic involvement","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Medicine; Pathology; Neuroscience; Immunology; Psychology","score_opus":0.23918158387338267,"score_gpt":0.3555429929514433,"score_spread":0.11636140907806064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996975196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002560753,0.99500746,0.00011013372,0.00048342015,0.00038414524,0.002371503,0.00012996355,0.00015506751,0.0011022225],"genre_scores_gemma":[0.00047177865,0.9870762,0.007847025,0.00020862742,0.0027828095,0.0003769444,0.00010100217,0.00032951776,0.00080608344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992804,0.0005005313,0.0018285954,0.0010790376,0.0021640945,0.0016237546],"domain_scores_gemma":[0.9952603,0.0008116509,0.00095788727,0.0011341326,0.00063692033,0.001199117],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009874628,0.0013495461,0.0041526724,0.0009832144,0.00071308727,0.00042651032,0.0007729289,0.000453705,0.00070619007],"category_scores_gemma":[0.0009385836,0.00085643784,0.001550576,0.0008392718,0.00046356456,0.00030585568,0.00043870934,0.0032406282,0.00046882025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009397667,0.00042443015,0.00031723964,0.004944074,0.0014314238,0.00023956284,0.00010455195,0.000007893128,0.000044195054,0.0000036551644,0.0035025785,0.9888864],"study_design_scores_gemma":[0.0037143568,0.0008105784,0.0038352413,0.045307267,0.0017700385,0.0020456428,0.00007841297,0.0000907727,0.00000992351,0.0000014745848,0.9415331,0.000803183],"about_ca_topic_score_codex":0.000030656687,"about_ca_topic_score_gemma":0.000052617463,"teacher_disagreement_score":0.98808324,"about_ca_system_score_codex":0.0012467272,"about_ca_system_score_gemma":0.0011629397,"threshold_uncertainty_score":0.99992555},"labels":[],"label_agreement":null},{"id":"W1997079576","doi":"10.1177/135245850000600603","title":"Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Peroxynitrite; Medicine; Placebo; Uric acid; Antioxidant; Internal medicine; Endocrinology; Immunology; Chemistry; Biochemistry; Pathology","score_opus":0.20876449591271362,"score_gpt":0.31356243200209366,"score_spread":0.10479793608938004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997079576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417675,0.0010877878,0.0007073689,0.0004778583,0.000092828814,0.002303848,0.00084113906,0.00008518782,0.00022721333],"genre_scores_gemma":[0.9808633,0.0042485036,0.013677243,0.0002093877,0.0003032413,0.00028196475,0.000033502238,0.0001574288,0.00022544773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947327,0.00043643775,0.0013354814,0.0008823978,0.0011216353,0.0014913443],"domain_scores_gemma":[0.99646455,0.0007061752,0.0004585122,0.0008476498,0.00062293536,0.00090017804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010660953,0.0007599437,0.0015224707,0.0007147058,0.0006122752,0.00015333337,0.00041708158,0.00023128881,0.0010693322],"category_scores_gemma":[0.00041244426,0.00056383555,0.0005107629,0.0008603011,0.00047207111,0.0006710387,0.000081060985,0.0006049166,0.000041134197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049044522,0.002783138,0.24590756,0.00013265622,0.00093447615,0.000048663605,0.0017521944,0.0014281276,0.5044722,0.0000028811085,0.00006160117,0.23757204],"study_design_scores_gemma":[0.03497358,0.004079534,0.88256913,0.0009971858,0.0003077092,0.00023850438,0.0009633787,0.005139379,0.06977668,0.000018898494,0.0003572774,0.0005787379],"about_ca_topic_score_codex":0.0010561001,"about_ca_topic_score_gemma":0.0021198543,"teacher_disagreement_score":0.6366616,"about_ca_system_score_codex":0.0007346994,"about_ca_system_score_gemma":0.00043988865,"threshold_uncertainty_score":0.99984384},"labels":[],"label_agreement":null},{"id":"W1997203784","doi":"10.1177/1352458513504251","title":"Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Depressive symptoms; Hospital Anxiety and Depression Scale; Depression (economics); Multiple sclerosis; Anxiety; Medicine; Latent class model; Psychology; Psychiatry; Clinical psychology","score_opus":0.07584306808951044,"score_gpt":0.2860943064292159,"score_spread":0.21025123833970547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997203784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948086,0.0022766558,0.00002333969,0.00043022088,0.00031589402,0.0019503167,0.00010286243,0.00005100973,0.00004107937],"genre_scores_gemma":[0.99505883,0.0032572604,0.00045784347,0.00025019626,0.00039535563,0.00046892176,0.000013615065,0.00008423601,0.000013721339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995194,0.0003117114,0.0013292931,0.00073221454,0.0011935451,0.0012391881],"domain_scores_gemma":[0.9973614,0.00056024885,0.00049572444,0.0005028781,0.00044842562,0.00063127576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074548094,0.000575835,0.0011990088,0.001064139,0.00026642793,0.00019604918,0.0004147009,0.00030527762,0.0004586388],"category_scores_gemma":[0.0018443896,0.00048169683,0.0002818256,0.000610651,0.00030706808,0.0010185485,0.0005266167,0.0014622717,0.000016711268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024296941,0.00046612468,0.91654384,0.00021159119,0.00018675819,0.00003440639,0.0050038337,0.000038719878,0.052981082,8.335215e-7,0.00014153057,0.024148317],"study_design_scores_gemma":[0.012930769,0.00038506175,0.9682575,0.0041545248,0.00005082479,0.000041651485,0.0010136442,0.010652366,0.002070452,0.000004022512,0.00003609028,0.00040309425],"about_ca_topic_score_codex":0.005893848,"about_ca_topic_score_gemma":0.0032440466,"teacher_disagreement_score":0.051713664,"about_ca_system_score_codex":0.00045460399,"about_ca_system_score_gemma":0.00010607947,"threshold_uncertainty_score":0.9997635},"labels":[],"label_agreement":null},{"id":"W1998973561","doi":"10.1177/1352458514547407","title":"Ten-year follow-up of the ‘minimal MRI lesion’ subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Marshall Space Flight Center; National Institutes of Health; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Lesion; Magnetic resonance imaging; Clinically isolated syndrome; Quartile; Clinical trial; Radiology; Expanded Disability Status Scale; Internal medicine; Surgery; Confidence interval","score_opus":0.13388370044376247,"score_gpt":0.31131728259390395,"score_spread":0.1774335821501415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998973561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885821,0.00048069513,0.0015367646,0.004009002,0.00259808,0.002263988,0.00015843661,0.00009016747,0.00028077426],"genre_scores_gemma":[0.99040276,0.001595073,0.0034985216,0.00032334027,0.00331112,0.00017006381,0.00003840994,0.000113007656,0.0005477345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922159,0.0014391094,0.0016586161,0.0008183721,0.0026908878,0.0011771293],"domain_scores_gemma":[0.99350333,0.0025415234,0.0010943057,0.0014554345,0.00086192554,0.0005434637],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0034820999,0.0006598406,0.0012087103,0.00024323276,0.0017006525,0.00027903504,0.0013255351,0.00033581382,0.00061504403],"category_scores_gemma":[0.007180775,0.00037719446,0.0014300896,0.00082097336,0.0008013753,0.00042207996,0.0006582537,0.0017453341,0.00011802173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044199448,0.0018038617,0.66087246,0.00010707294,0.0013084637,0.00000445089,0.0025775009,0.0001221853,0.20730767,0.000077462864,0.030026177,0.051593263],"study_design_scores_gemma":[0.110888086,0.0014551199,0.85779506,0.0016244751,0.0003998197,0.000021259442,0.0012129999,0.0028606819,0.015619921,0.0001100685,0.007571771,0.0004407322],"about_ca_topic_score_codex":0.0007460292,"about_ca_topic_score_gemma":0.00082757446,"teacher_disagreement_score":0.19692262,"about_ca_system_score_codex":0.000352299,"about_ca_system_score_gemma":0.0003830836,"threshold_uncertainty_score":0.999868},"labels":[],"label_agreement":null},{"id":"W2000414235","doi":"10.1191/1352458503ms964oa","title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British C olumbia","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Myasthenia gravis; Multiple sclerosis; Medicine; Pathogenesis; Pediatrics; Immunology","score_opus":0.05868104228575564,"score_gpt":0.254147240616558,"score_spread":0.1954661983308024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000414235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972406,0.0014003858,0.00018538018,0.00011517658,0.00024444365,0.00037740535,0.0001837134,0.000029525603,0.00022336096],"genre_scores_gemma":[0.9944422,0.0017143401,0.0034651281,0.00013755503,0.000083628154,0.000017484566,0.000024174366,0.00004084235,0.00007460737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971669,0.00021622799,0.00095564267,0.00044482196,0.000583248,0.0006331851],"domain_scores_gemma":[0.998361,0.00021066892,0.00035717853,0.00033817033,0.00023675417,0.0004962533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092508073,0.00028069763,0.0007731247,0.000291678,0.00024734903,0.00017184822,0.00019383196,0.00018214728,0.00037599518],"category_scores_gemma":[0.0008498649,0.0003151606,0.00023857267,0.0004407283,0.00027522407,0.00024066496,0.000037338577,0.0006804748,0.000017391716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013630422,0.0005842792,0.91516197,0.00007856833,0.00005850184,0.00005902602,0.00051432353,0.000009021706,0.051604062,0.000021563912,0.0011265314,0.030645827],"study_design_scores_gemma":[0.009503976,0.00041791608,0.975833,0.0015781882,0.00006811358,0.0010799448,0.00047515018,0.00032467922,0.008192454,0.00012454925,0.0020638711,0.00033814245],"about_ca_topic_score_codex":0.0006182698,"about_ca_topic_score_gemma":0.0010229751,"teacher_disagreement_score":0.06067102,"about_ca_system_score_codex":0.000093723866,"about_ca_system_score_gemma":0.00013836031,"threshold_uncertainty_score":0.99993},"labels":[],"label_agreement":null},{"id":"W2001110565","doi":"10.1177/1352458514538110","title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; European Committee for Treatment and Research in Multiple Sclerosis","keywords":"Kappa; Optical coherence tomography; Clinically isolated syndrome; Medicine; Medical physics; Test (biology); Retinal; Cohen's kappa; Computer science; Artificial intelligence; Optometry; Multiple sclerosis; Ophthalmology; Mathematics; Machine learning","score_opus":0.17671126256298503,"score_gpt":0.3528978875698814,"score_spread":0.17618662500689636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001110565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984802,0.00026918383,0.008092131,0.003382712,0.0008382639,0.002105111,0.00019840231,0.00005537421,0.0002568432],"genre_scores_gemma":[0.9940426,0.0002610301,0.0041248747,0.00041844585,0.0007397884,0.00024829592,0.000020296955,0.00007280015,0.00007190254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939102,0.0013345544,0.0017800687,0.0006015758,0.0013873528,0.0009862275],"domain_scores_gemma":[0.99392986,0.002789813,0.0008867559,0.00085448177,0.0011591451,0.00037992766],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005928964,0.00045131103,0.0011973188,0.00036555,0.0006738749,0.00015167684,0.0006324373,0.00024186773,0.00011925688],"category_scores_gemma":[0.018315086,0.00032339804,0.00077538815,0.00056475104,0.00047410303,0.00033890078,0.00020336939,0.0008862515,0.000012573092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020528778,0.0005330602,0.5111188,0.0002454841,0.0001686161,7.007599e-7,0.00066911627,0.0002738373,0.47142848,0.000038587048,0.0020109802,0.011459395],"study_design_scores_gemma":[0.021018935,0.0004395498,0.910144,0.0014533579,0.00010556526,0.000016519309,0.00041134696,0.011861302,0.05324403,0.00013628652,0.0008628365,0.0003063223],"about_ca_topic_score_codex":0.00028178742,"about_ca_topic_score_gemma":0.0004017623,"teacher_disagreement_score":0.41818446,"about_ca_system_score_codex":0.0003730474,"about_ca_system_score_gemma":0.0001967561,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W2007895122","doi":"10.1177/135245850501100123","title":"Pathologic Classification Systems in MS: What is their Significance?","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical significance; Pathology; Psychiatry","score_opus":0.33702484826797857,"score_gpt":0.38580667135155006,"score_spread":0.048781823083571485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007895122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021760026,0.99420047,0.00006425646,0.0005059254,0.0011287351,0.003267545,0.00014437878,0.00010561203,0.00036547126],"genre_scores_gemma":[0.0040793763,0.99151564,0.00049554487,0.00018189436,0.0022451275,0.0009099298,0.00010634607,0.000184442,0.00028172092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921357,0.0012603003,0.0026557245,0.0011756612,0.00138721,0.001385388],"domain_scores_gemma":[0.99504566,0.0011122788,0.0014573735,0.0011457138,0.00058119406,0.0006577667],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027681997,0.0011382867,0.0042095026,0.0013453225,0.00045750357,0.0009828334,0.0008509567,0.0009180332,0.00028698746],"category_scores_gemma":[0.0010359229,0.00077669055,0.0014159152,0.0011754981,0.0003516178,0.00082084147,0.00026204696,0.0033465151,0.0003922751],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054245324,0.00043193268,0.00049698516,0.0047633094,0.0003428638,0.00008071802,0.00059453456,0.0000073973183,0.0001970599,0.0000030494064,0.0032046356,0.9898233],"study_design_scores_gemma":[0.0023137068,0.00021672013,0.0067198263,0.0763512,0.00042168237,0.0006331426,0.00287852,0.0008245061,0.000007775112,0.0000032771516,0.9088807,0.0007489252],"about_ca_topic_score_codex":0.00009043672,"about_ca_topic_score_gemma":0.000046655823,"teacher_disagreement_score":0.98907435,"about_ca_system_score_codex":0.003006732,"about_ca_system_score_gemma":0.00079691934,"threshold_uncertainty_score":0.9994684},"labels":[],"label_agreement":null},{"id":"W2009156994","doi":"10.1191/1352458502ms810oa","title":"Cytokine production in T lymphocytemicroglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Microglia; Multiple sclerosis; Cytokine; Medicine; Immunology; Pharmacology; Inflammation","score_opus":0.17003342961674386,"score_gpt":0.27452928030763246,"score_spread":0.1044958506908886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009156994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916598,0.000061097686,0.0023063228,0.0032061047,0.0013624683,0.0012036478,0.000062206345,0.00012262627,0.000015712021],"genre_scores_gemma":[0.99485385,0.0011589753,0.0006995944,0.0024958896,0.00019175219,0.00015233546,0.000011171715,0.00008875977,0.00034766123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99639326,0.00047668407,0.0010779392,0.0008683609,0.0005312221,0.00065255014],"domain_scores_gemma":[0.9983413,0.0004121633,0.0005389032,0.00035513245,0.00017285452,0.00017963564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049480563,0.00040857258,0.000410092,0.00059796433,0.00046888844,0.00034160473,0.00035925864,0.00016331558,0.00025102485],"category_scores_gemma":[0.0011931583,0.00040481746,0.00019683117,0.0008677062,0.00006657497,0.00095745147,0.000055129054,0.00058716885,0.0001270294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028795048,0.0005516893,0.00062255695,0.0000135074915,0.000007691401,0.000005118186,0.0008940619,0.0007998905,0.98334444,0.000036328318,0.0016696623,0.011767107],"study_design_scores_gemma":[0.006602707,0.00015894885,0.0016164121,0.00014791144,0.00001475822,0.00008329081,0.00007953156,0.12397345,0.8663525,0.00010499182,0.0005223938,0.00034310998],"about_ca_topic_score_codex":0.000027926177,"about_ca_topic_score_gemma":0.0000764493,"teacher_disagreement_score":0.12317356,"about_ca_system_score_codex":0.00038138466,"about_ca_system_score_gemma":0.00003155175,"threshold_uncertainty_score":0.9998404},"labels":[],"label_agreement":null},{"id":"W2009611974","doi":"10.1177/1352458512444751","title":"Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"Departament de Salut, Generalitat de Catalunya","keywords":"Multiple sclerosis; Medicine; Prevalence; Cross-sectional study; Demography; Epidemiology; Pediatrics; Internal medicine; Pathology; Immunology","score_opus":0.09526381451252357,"score_gpt":0.3031978890711598,"score_spread":0.20793407455863622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009611974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366325,0.0031114703,0.0000429372,0.0011340657,0.00022064633,0.001325023,0.00015322125,0.0000348602,0.00031450397],"genre_scores_gemma":[0.9938225,0.0028222646,0.002006269,0.00035110972,0.0005601153,0.00020118702,0.000017460838,0.000073951516,0.00014512296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99347013,0.0010369556,0.0014170667,0.0005505729,0.0018847306,0.0016405688],"domain_scores_gemma":[0.9962406,0.0014281449,0.00046828625,0.0009209311,0.00031955354,0.0006224769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005455113,0.00054070615,0.0009862225,0.0008200049,0.00035935934,0.00014818618,0.00083832303,0.00024921828,0.0006551356],"category_scores_gemma":[0.0058191293,0.0003954859,0.00045096947,0.0012454789,0.00053930026,0.0009670498,0.00038018505,0.0016847369,0.00006291154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008609366,0.0017829101,0.9344927,0.0004127859,0.000093383176,0.000026962076,0.006323118,0.000047270874,0.048676357,0.000008376129,0.0015351237,0.005740084],"study_design_scores_gemma":[0.009819259,0.0002766957,0.98121727,0.0018547755,0.00008633546,0.00010438647,0.0024533514,0.0011545375,0.0018910962,0.0000051094194,0.00076874107,0.00036843546],"about_ca_topic_score_codex":0.002010093,"about_ca_topic_score_gemma":0.0016181563,"teacher_disagreement_score":0.04678526,"about_ca_system_score_codex":0.0005571704,"about_ca_system_score_gemma":0.00025474263,"threshold_uncertainty_score":0.9998497},"labels":[],"label_agreement":null},{"id":"W2012272935","doi":"10.1177/1352458513518259","title":"Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Inje University; World Bank Group","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Ordinal Scale; Medicine; Scale (ratio); Statistics; Mathematics; Geography; Cartography; Psychiatry","score_opus":0.2492007932855591,"score_gpt":0.33424011987217234,"score_spread":0.08503932658661323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012272935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177414,0.00022956899,0.0015355363,0.0025895534,0.0006779583,0.0024902658,0.00051976606,0.000058489157,0.00012473356],"genre_scores_gemma":[0.9909155,0.00053656375,0.0072473446,0.00016238181,0.00058261334,0.0003504838,0.000027067126,0.00009018807,0.00008787704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99309886,0.0009365561,0.0018373237,0.0009223572,0.0015987561,0.0016061496],"domain_scores_gemma":[0.99362826,0.0027932257,0.0006177011,0.0015024974,0.00073720794,0.00072108797],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037714278,0.0006032869,0.0014270768,0.00016238424,0.0008779959,0.00011756515,0.0007962373,0.00029502765,0.00013546369],"category_scores_gemma":[0.011656069,0.0004088772,0.0010484386,0.00082690065,0.0021456399,0.00039701755,0.00052885176,0.0012197644,0.000011939619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012934168,0.0021556977,0.85987484,0.00028197138,0.00012610381,2.1795411e-7,0.00088413677,0.00011395899,0.093548074,0.0000060111,0.00089325727,0.040822335],"study_design_scores_gemma":[0.015115891,0.00038093136,0.9423243,0.0008811303,0.000099363686,0.000008941003,0.00063591974,0.009989988,0.028944599,0.000120637196,0.0011184636,0.00037987033],"about_ca_topic_score_codex":0.0012223845,"about_ca_topic_score_gemma":0.006055615,"teacher_disagreement_score":0.08244944,"about_ca_system_score_codex":0.0011025128,"about_ca_system_score_gemma":0.00021740749,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W2015050903","doi":"10.1177/1352458515581436","title":"Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"European Commission; Biogen","keywords":"Berg Balance Scale; Medicine; Placebo; Balance (ability); Physical therapy; Preferred walking speed; Randomized controlled trial; Posturography; Physical medicine and rehabilitation; Internal medicine","score_opus":0.06912946438971042,"score_gpt":0.33114270893381376,"score_spread":0.26201324454410335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015050903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251556,0.0023916895,0.00017603356,0.00030449062,0.0009600275,0.0032828292,0.000010024283,0.000039573046,0.00031976006],"genre_scores_gemma":[0.9961305,0.0015124234,0.00041521504,0.00023056073,0.00080931105,0.000624805,0.0000071705967,0.00002496094,0.0002450452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673665,0.0012431052,0.0009293292,0.00028112778,0.00029444273,0.0005153202],"domain_scores_gemma":[0.99797416,0.0007737481,0.0005224561,0.00015634089,0.00018106413,0.00039221343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038380318,0.00020719517,0.0007236378,0.00015752083,0.00047907792,0.000059861653,0.00012018387,0.0002113379,0.000020023337],"category_scores_gemma":[0.0015836024,0.00016133083,0.00010248722,0.0001356185,0.00007084381,0.00030965006,0.00007869307,0.0009021409,0.000015062019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57878524,0.001666225,0.31756136,0.00022873268,0.00022499757,0.000036706893,0.012741295,0.000029674984,0.048724774,0.00003542056,0.0066360175,0.033329565],"study_design_scores_gemma":[0.8135064,0.00034337988,0.1772461,0.00050175464,0.000048185168,0.000011273935,0.0014017771,0.0057218783,0.00000833012,0.00022448003,0.0007933923,0.00019301599],"about_ca_topic_score_codex":0.00008311232,"about_ca_topic_score_gemma":0.00021630063,"teacher_disagreement_score":0.2347212,"about_ca_system_score_codex":0.00012581213,"about_ca_system_score_gemma":0.00017756924,"threshold_uncertainty_score":0.65788805},"labels":[],"label_agreement":null},{"id":"W2016306773","doi":"10.1191/1352458505ms1219sr","title":"Tactile temporal thresholds detect relapse-related changes in multiple sclerosis: a preliminary study","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Tactile and Sensory Interactions","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Audiology; Medicine; Sensory threshold; Physical medicine and rehabilitation; Psychology; Cognitive psychology; Immunology","score_opus":0.13352812620196916,"score_gpt":0.28248660439908413,"score_spread":0.14895847819711497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016306773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955171,0.00012667415,0.00003817919,0.0012907662,0.0012894479,0.00096763787,0.000045360317,0.00024156255,0.00048330176],"genre_scores_gemma":[0.9974266,0.00029777279,0.000414093,0.00053721847,0.00048044464,0.00014923827,0.0000036232814,0.00010384128,0.00058716745],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954485,0.0006938293,0.0011019019,0.00088649074,0.00084397953,0.0010252864],"domain_scores_gemma":[0.9973218,0.00091265765,0.00057819806,0.00064667047,0.00012150904,0.0004191647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004733052,0.00053307315,0.0005824533,0.00082358596,0.0010780324,0.00042450248,0.0007440533,0.00026324563,0.0006761249],"category_scores_gemma":[0.0016076753,0.0004955002,0.00029312877,0.0009437947,0.00015581836,0.001443273,0.00019895389,0.0018790722,0.00041398092],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013947344,0.0035704141,0.19875607,0.000012674003,0.00007169255,0.00021744306,0.007104786,0.004127994,0.75145584,0.000004227337,0.0027045177,0.030579591],"study_design_scores_gemma":[0.012655693,0.002702938,0.5525723,0.0006508835,0.0001195976,0.0010760749,0.005927683,0.021698937,0.39551592,0.000045535613,0.005752396,0.0012820648],"about_ca_topic_score_codex":0.00027243228,"about_ca_topic_score_gemma":0.004207906,"teacher_disagreement_score":0.35593995,"about_ca_system_score_codex":0.00042375465,"about_ca_system_score_gemma":0.000092416194,"threshold_uncertainty_score":0.99974966},"labels":[],"label_agreement":null},{"id":"W2017412635","doi":"10.1177/1352458512438454","title":"A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society","keywords":"Medicine; Transplantation; Clinical trial; Randomized controlled trial; Multiple sclerosis; Hematopoietic stem cell transplantation; Stem cell; Disease; Internal medicine; Surgery; Intensive care medicine; Physical therapy; Immunology","score_opus":0.05443925455572737,"score_gpt":0.289801992512282,"score_spread":0.23536273795655463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017412635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669335,0.004379709,0.007019956,0.00073607167,0.0012561398,0.019029103,0.00017542338,0.0001275696,0.000342543],"genre_scores_gemma":[0.9824334,0.005805564,0.005639593,0.00015890658,0.0009919493,0.0046545244,0.000046098878,0.000110362904,0.0001596251],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931926,0.0011443171,0.0023442034,0.0005618389,0.0014659436,0.001291094],"domain_scores_gemma":[0.99114233,0.0042221597,0.0021445816,0.00047227333,0.0013432072,0.0006754736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040555256,0.0006698559,0.003584704,0.000592309,0.0007290292,0.0001320034,0.00030268516,0.0003596619,0.000121230376],"category_scores_gemma":[0.0029294065,0.0004821042,0.0020666982,0.00038234424,0.0005469048,0.00076780707,0.000073361916,0.00076057034,0.000023526323],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86056685,0.0024364602,0.008968989,0.00057310495,0.0012990329,0.00001094246,0.0037521948,0.00007493496,0.116858,0.00003388009,0.00045799988,0.004967609],"study_design_scores_gemma":[0.9033011,0.0014021058,0.056046616,0.001701306,0.0017230393,0.00019092154,0.00085315324,0.0023745603,0.031904414,0.00004121167,0.00003389591,0.0004276528],"about_ca_topic_score_codex":0.000048351114,"about_ca_topic_score_gemma":0.00002303437,"teacher_disagreement_score":0.084953584,"about_ca_system_score_codex":0.00037839697,"about_ca_system_score_gemma":0.0002639009,"threshold_uncertainty_score":0.9997631},"labels":[],"label_agreement":null},{"id":"W2018427555","doi":"10.1177/1352458512474706","title":"Retinal nerve fiber layer thickness in benign multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Nerve fiber layer; Optic neuritis; Medicine; Multiple sclerosis; Retinal; Ophthalmology; Expanded Disability Status Scale; Atrophy; Optical coherence tomography; Pathology","score_opus":0.1321560716710385,"score_gpt":0.3010018885308205,"score_spread":0.168845816859782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018427555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889609,0.0010724276,0.00022960248,0.0050592786,0.00053792144,0.0018742135,0.000048557486,0.00018871459,0.002028391],"genre_scores_gemma":[0.9844055,0.0017153989,0.010068839,0.0006766168,0.0010673509,0.00044682215,0.000033882014,0.00017645783,0.0014091155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921924,0.00066827587,0.0017653534,0.0010842973,0.0021286074,0.0021610602],"domain_scores_gemma":[0.9945801,0.0012531284,0.0005125496,0.0010279741,0.0013385379,0.0012877253],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020904485,0.0008497799,0.0014022964,0.0009863348,0.00089548825,0.0005483775,0.00078617677,0.00048222576,0.0049977233],"category_scores_gemma":[0.004160085,0.00070456846,0.0007136352,0.0012159932,0.00065621384,0.0011415003,0.00055170717,0.0026853012,0.0019400776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077359384,0.0011935256,0.59164435,0.00018833597,0.00027505428,0.00010409983,0.0018260223,0.0003303168,0.323267,0.000008037528,0.026263706,0.054125916],"study_design_scores_gemma":[0.012302026,0.00043779766,0.96546096,0.0017407972,0.00009855668,0.0002666656,0.0015663292,0.005762751,0.009021087,0.000054424305,0.002531065,0.00075751764],"about_ca_topic_score_codex":0.0022266423,"about_ca_topic_score_gemma":0.00063175627,"teacher_disagreement_score":0.3738166,"about_ca_system_score_codex":0.00078187895,"about_ca_system_score_gemma":0.0003065657,"threshold_uncertainty_score":0.99961555},"labels":[],"label_agreement":null},{"id":"W2020085437","doi":"10.1177/1352458507087468","title":"Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Aegera Therapeutics (Canada); Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Dalhousie Medical Research Foundation; National Multiple Sclerosis Society","keywords":"XIAP; Inhibitor of apoptosis; Survivin; Multiple sclerosis; Apoptosis; Immunology; Pathogenesis; Biology; Immune system; Demyelinating disease; Cancer research; Programmed cell death; Caspase; Genetics","score_opus":0.023705179765680862,"score_gpt":0.1955905409909953,"score_spread":0.17188536122531442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020085437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972452,0.001431278,0.0005590715,0.000034627854,0.00024023994,0.00044927228,0.000024082741,0.000008490424,0.000007716046],"genre_scores_gemma":[0.99755114,0.00074073795,0.0014142694,0.000010821859,0.00014102575,0.0000299473,0.00002731479,0.00003319389,0.000051568313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796873,0.00023684355,0.00082078844,0.0002719779,0.0004243288,0.0002773246],"domain_scores_gemma":[0.9986678,0.00001918603,0.0006527146,0.00034686338,0.00024517768,0.00006826528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044142824,0.00020430778,0.0002984455,0.00015767782,0.00032298322,0.000015681235,0.00029195473,0.0002637788,0.000011624214],"category_scores_gemma":[0.00023510061,0.00016032372,0.00026967778,0.00023534335,0.00012580556,0.000028328965,0.0001898529,0.00023725358,0.0000011282542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027463044,0.0002020004,0.013052684,0.00003106653,0.000026512836,5.031946e-7,0.00021282119,0.002361381,0.98272973,8.1507915e-7,0.000021700755,0.0010861782],"study_design_scores_gemma":[0.0017098177,0.000064082524,0.42779917,0.00032155827,0.000008236513,0.000007270758,0.00008812287,0.00079405744,0.5690847,0.000009996818,0.000013394644,0.00009961097],"about_ca_topic_score_codex":0.00008164082,"about_ca_topic_score_gemma":0.00001196336,"teacher_disagreement_score":0.4147465,"about_ca_system_score_codex":0.0000583066,"about_ca_system_score_gemma":0.00008716032,"threshold_uncertainty_score":0.6537812},"labels":[],"label_agreement":null},{"id":"W2020947088","doi":"10.1177/1352458513501230","title":"Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Asymptomatic; McDonald criteria; Clinically isolated syndrome; Cohort; Magnetic resonance imaging; Pediatrics; Internal medicine; Radiology","score_opus":0.09125668181315834,"score_gpt":0.3081421807616698,"score_spread":0.2168854989485115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020947088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919513,0.00019683657,0.00051843084,0.0019021565,0.00008596385,0.0050875004,0.00024188939,0.000008114061,0.000007836947],"genre_scores_gemma":[0.99601686,0.00102938,0.0021144662,0.00007590895,0.000036331836,0.0006530114,0.000024603121,0.000037844442,0.000011615456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970027,0.00020728026,0.0012516442,0.0003433445,0.0007039928,0.0004909883],"domain_scores_gemma":[0.9951887,0.0014023692,0.00084791204,0.0005752641,0.0016948372,0.00029091476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012694203,0.00024594154,0.0006846462,0.00029411245,0.00029283913,0.00004442657,0.00040176432,0.0001516866,0.000050684983],"category_scores_gemma":[0.0025783072,0.00013863543,0.00019733445,0.0005572954,0.0006146007,0.00021415012,0.00010220388,0.00039816153,0.0000013897353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007634817,0.00051838387,0.95979184,0.00016613155,0.00026624463,9.147463e-8,0.00052073615,0.00007278734,0.028316827,0.0000031015627,0.00034998555,0.009230378],"study_design_scores_gemma":[0.0055264547,0.00064822513,0.96740603,0.0007795747,0.0001437831,0.0000018700993,0.00023304479,0.02163368,0.0034386744,0.0000141296305,0.000043470125,0.00013108317],"about_ca_topic_score_codex":0.051959082,"about_ca_topic_score_gemma":0.022354823,"teacher_disagreement_score":0.029604262,"about_ca_system_score_codex":0.00017526832,"about_ca_system_score_gemma":0.00031664062,"threshold_uncertainty_score":0.99548465},"labels":[],"label_agreement":null},{"id":"W2021159412","doi":"10.1177/135245850000600205","title":"Diagnostic brain MRI findings in primary progressive multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Radiology; Central nervous system disease; Lesion; Mri scan; Nuclear medicine; Pathology; Internal medicine","score_opus":0.07052779601430365,"score_gpt":0.2895847382709688,"score_spread":0.21905694225666517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021159412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853917,0.002880649,0.000089146175,0.007317519,0.00035006416,0.0021277992,0.0000991191,0.00021305413,0.0015309916],"genre_scores_gemma":[0.98125654,0.009176246,0.005277996,0.0018269776,0.00090590876,0.0004392923,0.00007099919,0.00017430742,0.00087173004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925065,0.00054245733,0.0016548774,0.0011204837,0.002040785,0.002134887],"domain_scores_gemma":[0.99320185,0.0039506103,0.0003269682,0.0008541554,0.0004997097,0.0011667119],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019376803,0.0008370149,0.0014457336,0.00094542204,0.0009349182,0.00041295376,0.00073766615,0.00039642572,0.0032264988],"category_scores_gemma":[0.008432242,0.00073017017,0.0006527769,0.0013904115,0.00064311497,0.0008351307,0.00030747135,0.0022337995,0.00062596245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014663287,0.0016636368,0.7534191,0.00020071195,0.00031508255,0.00038904528,0.001727671,0.0003877724,0.060583048,0.0000023858267,0.024810502,0.15503472],"study_design_scores_gemma":[0.016140863,0.0006269904,0.9672553,0.0033373851,0.000090433015,0.00030412927,0.00035286913,0.0022522702,0.0037335856,0.000020603737,0.005174108,0.00071149215],"about_ca_topic_score_codex":0.00024919966,"about_ca_topic_score_gemma":0.00022687907,"teacher_disagreement_score":0.21383618,"about_ca_system_score_codex":0.0012262509,"about_ca_system_score_gemma":0.000406185,"threshold_uncertainty_score":0.9999201},"labels":[],"label_agreement":null},{"id":"W2021696430","doi":"10.1177/1352458514540357","title":"Bibliometric profile of the global scientific research on multiple sclerosis (2003–2012)","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Geography; Data science; Computer science; Psychiatry","score_opus":0.2747564037285854,"score_gpt":0.38053301495158426,"score_spread":0.10577661122299886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021696430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878984,0.001221863,0.0002922391,0.0023398171,0.002287557,0.0019683077,0.00023935914,0.0001053677,0.0036470578],"genre_scores_gemma":[0.99415284,0.0009114171,0.0025214623,0.00021551769,0.0008719008,0.0001393403,0.000016837766,0.00008810626,0.0010825691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98759013,0.0016850983,0.0013968854,0.0010971387,0.0061183753,0.0021123758],"domain_scores_gemma":[0.98783034,0.0024349887,0.0006393656,0.002019099,0.005979134,0.0010970426],"candidate_categories":["metaresearch","metaepi_narrow","bibliometrics","sts"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.009703381,0.00057444576,0.0010528632,0.014580454,0.003027192,0.0006942874,0.001652769,0.0003277491,0.0005867299],"category_scores_gemma":[0.038506716,0.00037921156,0.00064518856,0.08872714,0.0022425535,0.00052325794,0.0010443464,0.0022251157,0.00038148067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009606304,0.0017936563,0.68522334,0.00022452165,0.0003150742,0.0000050178937,0.00029165542,0.00017101063,0.115033135,0.00013613653,0.08882452,0.10702132],"study_design_scores_gemma":[0.0066394005,0.0008919994,0.93835795,0.0015577147,0.00007024198,0.000042620977,0.000341801,0.004203955,0.03165995,0.000065612636,0.015826523,0.00034225773],"about_ca_topic_score_codex":0.00023205348,"about_ca_topic_score_gemma":0.00024033531,"teacher_disagreement_score":0.2531346,"about_ca_system_score_codex":0.001037146,"about_ca_system_score_gemma":0.0008090008,"threshold_uncertainty_score":0.999866},"labels":[],"label_agreement":null},{"id":"W2022418012","doi":"10.1177/1352458508096567","title":"Setting the agenda for multiple sclerosis rehabilitation research","year":2008,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Multiple sclerosis; Rehabilitation; Physical medicine and rehabilitation; Medicine; Physical therapy; Psychiatry","score_opus":0.3389668451321856,"score_gpt":0.38240071621346744,"score_spread":0.04343387108128183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022418012","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030406075,0.0037986236,0.00076519797,0.9516827,0.0025140825,0.009025687,0.00093984767,0.00032108114,0.0005466925],"genre_scores_gemma":[0.35974964,0.035766937,0.07765637,0.42288235,0.08111215,0.009052768,0.0022740508,0.0021933164,0.009312395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98374534,0.0027089166,0.002411048,0.001809053,0.005632842,0.0036928067],"domain_scores_gemma":[0.95972335,0.02973056,0.0010752464,0.002123617,0.0067264135,0.0006208167],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009609843,0.0012735584,0.001977556,0.0017147035,0.0066629113,0.0008468629,0.0017707648,0.0016538741,0.00024757037],"category_scores_gemma":[0.058565844,0.0009044981,0.0018979334,0.0018444405,0.0022522784,0.00053200545,0.0008197377,0.013531063,0.00025660676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007137655,0.00029697333,0.011874378,0.0007470179,0.0008339196,0.00009834572,0.0024857763,0.000052644646,0.011965957,0.0000012480713,0.9459533,0.02497664],"study_design_scores_gemma":[0.009760349,0.0015254973,0.11189119,0.004113528,0.0003064314,0.00037562536,0.0016882683,0.0029643194,0.0013085543,0.00006252265,0.86501,0.0009937027],"about_ca_topic_score_codex":0.00033521667,"about_ca_topic_score_gemma":0.00014127226,"teacher_disagreement_score":0.52880037,"about_ca_system_score_codex":0.002047816,"about_ca_system_score_gemma":0.0013833776,"threshold_uncertainty_score":0.9996422},"labels":[],"label_agreement":null},{"id":"W2023797462","doi":"10.1191/1352458505ms1144oa","title":"The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Depression (economics); Discontinuation; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Psychiatry; Rating scale; Clinical psychology; Psychology","score_opus":0.1391694580439447,"score_gpt":0.305925328844874,"score_spread":0.1667558708009293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023797462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943168,0.0015842222,0.00015111541,0.0025021716,0.00010782373,0.0011579165,0.000030908035,0.00006169233,0.00008730473],"genre_scores_gemma":[0.9946911,0.0023275982,0.0020580627,0.00015933046,0.0004793407,0.00009980728,0.000025781039,0.00008221525,0.000076776916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591696,0.0004200599,0.00093090907,0.0005714075,0.0012221466,0.000938496],"domain_scores_gemma":[0.99526644,0.002853061,0.0003638633,0.0005623588,0.00043485672,0.0005193995],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0014036158,0.00046049932,0.0006475183,0.00039975025,0.0014113169,0.00032965865,0.00037024688,0.00019839541,0.00003928999],"category_scores_gemma":[0.0017773804,0.00027352246,0.00017468743,0.0005001149,0.0004351647,0.0006184111,0.00023769047,0.0014529059,0.000028926725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020907812,0.00029560755,0.84689444,0.000015029955,0.00013410182,0.0000012238745,0.00061565294,0.000037473186,0.0010942995,0.0000019356003,0.00053783436,0.14828159],"study_design_scores_gemma":[0.017838277,0.0010075846,0.9773285,0.00093681866,0.000047560858,0.0000059302147,0.00023629556,0.00042071028,0.00090731995,0.000009446055,0.0009587518,0.00030284337],"about_ca_topic_score_codex":0.000104282095,"about_ca_topic_score_gemma":0.0005711959,"teacher_disagreement_score":0.14797875,"about_ca_system_score_codex":0.00039650997,"about_ca_system_score_gemma":0.000092356095,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W2024251669","doi":"10.1177/1352458511427514","title":"Relapses do not matter in relation to long-term disability: Yes","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Multiple sclerosis; Term (time); Medicine; Relation (database); Physical medicine and rehabilitation; Psychology; Physical therapy; Psychiatry; Physics; Computer science","score_opus":0.16180337888770607,"score_gpt":0.32424741119623124,"score_spread":0.16244403230852517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024251669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454856,0.00019705149,0.0002803148,0.0024906376,0.00036687404,0.000838611,0.000016519922,0.000056738656,0.001204717],"genre_scores_gemma":[0.99356097,0.0005064322,0.004506506,0.0006493446,0.00036605043,0.00009195034,0.000007387715,0.00006164817,0.00024970985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659383,0.00024560362,0.00090421276,0.000550816,0.00089481095,0.00081072253],"domain_scores_gemma":[0.9980553,0.00030244075,0.00018259774,0.0005911283,0.00027104086,0.00059750077],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011441604,0.0003350857,0.0005991384,0.0004065834,0.0003286016,0.00012498864,0.00030624057,0.0001673597,0.002084521],"category_scores_gemma":[0.0015211838,0.00027330927,0.00025937185,0.0005113736,0.00026729668,0.0004567121,0.00026259286,0.0009271798,0.0007526583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095145305,0.0006026008,0.95084167,0.000066921515,0.00008763999,0.000035828798,0.0025246202,0.00001319366,0.023609856,0.000004605844,0.0014746614,0.01978698],"study_design_scores_gemma":[0.003295295,0.0003131454,0.99003094,0.0009037737,0.00004309876,0.000066939996,0.000276548,0.0000700031,0.004575029,0.000024286832,0.00012574099,0.00027520154],"about_ca_topic_score_codex":0.00017745334,"about_ca_topic_score_gemma":0.00030743892,"teacher_disagreement_score":0.0391893,"about_ca_system_score_codex":0.000535167,"about_ca_system_score_gemma":0.000066574874,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W2025358672","doi":"10.1177/1352458513484547","title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Multiple sclerosis; Medicine; Acute disseminated encephalomyelitis; Neuromyelitis optica; Demyelinating Disorder; Pediatrics; Clinically isolated syndrome; Encephalomyelitis; Immunology","score_opus":0.12281433637285197,"score_gpt":0.3067056860104898,"score_spread":0.18389134963763784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025358672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731572,0.0026210153,0.0049019353,0.0054956037,0.002748262,0.0094954185,0.0010141053,0.00040962588,0.00015681935],"genre_scores_gemma":[0.9669122,0.011720193,0.013116923,0.00038430945,0.0044523063,0.002910581,0.00020579438,0.00024982987,0.000047824873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99032575,0.00089159416,0.0027140635,0.0014949696,0.0021475998,0.0024259966],"domain_scores_gemma":[0.98936903,0.0049268417,0.001008818,0.0011031175,0.0019275192,0.0016646894],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0029967036,0.001126539,0.001514417,0.0013681678,0.0037575944,0.0014216593,0.0013339733,0.00036207764,0.00043864627],"category_scores_gemma":[0.013586942,0.0008711377,0.00087580306,0.001715256,0.00026728783,0.0011351435,0.0011570284,0.0016052874,0.0002575119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008114454,0.002918075,0.91678214,0.0005197688,0.00084049033,0.000010654442,0.0037217329,0.00039686545,0.019786635,0.000013688063,0.020879183,0.033319343],"study_design_scores_gemma":[0.013702783,0.0011091552,0.94678515,0.0007592841,0.0006871726,0.00005068872,0.009051209,0.026048379,0.00008748233,0.000011598293,0.0008414194,0.0008656873],"about_ca_topic_score_codex":0.0011896039,"about_ca_topic_score_gemma":0.0005411443,"teacher_disagreement_score":0.032453656,"about_ca_system_score_codex":0.0008357102,"about_ca_system_score_gemma":0.00021600664,"threshold_uncertainty_score":0.99961495},"labels":[],"label_agreement":null},{"id":"W2025694051","doi":"10.1177/1352458507084264","title":"Natural history of secondary-progressive multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Age of onset; Expanded Disability Status Scale; Natural history; Population; Pediatrics; Internal medicine; Disease; Immunology","score_opus":0.14037438966095195,"score_gpt":0.28525029468680385,"score_spread":0.1448759050258519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025694051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972073,0.021936318,0.0001447747,0.0007731756,0.0019981742,0.00094993174,0.00008788568,0.00017303713,0.0018636651],"genre_scores_gemma":[0.98144937,0.007082699,0.00788601,0.00046471044,0.00090498634,0.000085634005,0.00003596968,0.00012811337,0.001962488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99401784,0.00033952636,0.0015109332,0.0007625159,0.0020455895,0.0013235677],"domain_scores_gemma":[0.9948983,0.0008116578,0.00090027397,0.00088161783,0.001589709,0.00091840816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089850463,0.00067112467,0.0014527605,0.0007905532,0.0007018901,0.000048532595,0.0006680369,0.0002861455,0.0015602157],"category_scores_gemma":[0.0036650726,0.00056620216,0.0009854207,0.00055189384,0.0015745909,0.0006342621,0.00041054582,0.0021171302,0.00011916923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018700741,0.0012424119,0.28561804,0.00025718746,0.0009880844,0.00025854463,0.0036939264,0.000037357142,0.5620012,0.0000063192206,0.09726436,0.04676249],"study_design_scores_gemma":[0.013946071,0.00069067255,0.94391084,0.0011469859,0.0001486708,0.0009999448,0.0006164789,0.0023676541,0.022521576,0.0000066667976,0.013032674,0.00061175914],"about_ca_topic_score_codex":0.00023858226,"about_ca_topic_score_gemma":0.00006476218,"teacher_disagreement_score":0.65829283,"about_ca_system_score_codex":0.001739031,"about_ca_system_score_gemma":0.0012445854,"threshold_uncertainty_score":0.99967897},"labels":[],"label_agreement":null},{"id":"W2025697993","doi":"10.1177/1352458512456613","title":"‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Observational study; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Pediatrics; Internal medicine; Psychiatry","score_opus":0.5437792632147593,"score_gpt":0.399133312620413,"score_spread":0.14464595059434632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025697993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907237,0.0022304177,0.0013377417,0.0011706142,0.001530698,0.0022691272,0.0003382666,0.00031689185,0.00008249323],"genre_scores_gemma":[0.9641615,0.0019855965,0.028407509,0.0008920545,0.0038220973,0.0002824941,0.00015760933,0.00020175365,0.000089387715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9880773,0.0018877871,0.0028148133,0.0013439425,0.0035984651,0.0022776804],"domain_scores_gemma":[0.987511,0.005260638,0.0010549667,0.0015539448,0.0020333545,0.0025861368],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005357028,0.0010319841,0.0017978746,0.00052649324,0.0016578265,0.00051341136,0.0011883047,0.00046766727,0.0022236828],"category_scores_gemma":[0.020162085,0.000887964,0.0007534385,0.00102837,0.0009483246,0.0025708415,0.0006869508,0.0025775698,0.00067762955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023306352,0.004790704,0.90363944,0.000029979892,0.0008666656,0.000021539843,0.007756868,0.000114743074,0.07212342,0.000011519079,0.0026701703,0.0056443186],"study_design_scores_gemma":[0.016881121,0.0023106546,0.96202433,0.0016275021,0.0004391063,0.00003731691,0.0113876555,0.0026889513,0.0012094162,0.00001962672,0.00050389365,0.0008703958],"about_ca_topic_score_codex":0.0008112281,"about_ca_topic_score_gemma":0.00039899835,"teacher_disagreement_score":0.07091401,"about_ca_system_score_codex":0.00064020883,"about_ca_system_score_gemma":0.0007998017,"threshold_uncertainty_score":0.99972355},"labels":[],"label_agreement":null},{"id":"W2026497829","doi":"10.1177/1352458512470310","title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Medicine; Antibody; Multiple sclerosis; Aquaporin 4; Immunology; Immunoglobulin G; Pathology; Experimental autoimmune encephalomyelitis","score_opus":0.09708425003817218,"score_gpt":0.3268405672589309,"score_spread":0.22975631722075873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026497829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914907,0.003654795,0.00036222622,0.0009844325,0.00072402536,0.0009673537,0.00004295455,0.00011909831,0.0016543983],"genre_scores_gemma":[0.97514045,0.009980682,0.011119628,0.00016673547,0.0032238574,0.000063747095,0.0000197654,0.000107423926,0.00017772596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99398786,0.00046682387,0.0012902446,0.00063309167,0.0014915575,0.0021303978],"domain_scores_gemma":[0.996414,0.0009542978,0.000468042,0.00052842725,0.0005455154,0.0010897119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018808801,0.00064554415,0.0011358118,0.0010459995,0.0007834615,0.0002172256,0.00041929132,0.00022710867,0.00033713048],"category_scores_gemma":[0.0061085885,0.00055202557,0.000494989,0.0011195134,0.00031026048,0.00095218717,0.00040831664,0.0018804355,0.0002474897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000513168,0.00063404255,0.89286727,0.00021059414,0.00017136209,0.0001264321,0.0036729355,0.00009243578,0.09205207,0.000014176932,0.00050946296,0.00913605],"study_design_scores_gemma":[0.0061314926,0.00034419599,0.9782099,0.00062297547,0.0001302611,0.00036175371,0.0016917132,0.0017132837,0.009723601,0.000008468047,0.0005321069,0.00053024467],"about_ca_topic_score_codex":0.00033399646,"about_ca_topic_score_gemma":0.000055556608,"teacher_disagreement_score":0.08534264,"about_ca_system_score_codex":0.00053437054,"about_ca_system_score_gemma":0.0002267417,"threshold_uncertainty_score":0.9996931},"labels":[],"label_agreement":null},{"id":"W2027200886","doi":"10.1177/1352458508099143","title":"Social anxiety in a multiple sclerosis clinic population","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"Dalhousie University","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Expanded Disability Status Scale; Social anxiety; Psychiatry; Multiple sclerosis; Depression (economics); Medicine; Population; Clinical psychology; Psychology; Quality of life (healthcare); Physical therapy","score_opus":0.2634675235834458,"score_gpt":0.3476363671300395,"score_spread":0.08416884354659371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027200886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951603,0.0005833942,0.00014458862,0.0018908541,0.00042744962,0.0010006508,0.000041240823,0.00016696288,0.00058456336],"genre_scores_gemma":[0.9869172,0.0070737,0.0035589174,0.00044551204,0.0013602936,0.00011990979,0.000059189082,0.00011608488,0.00034920513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99392414,0.00048502698,0.001631612,0.00080568885,0.0017196584,0.0014338774],"domain_scores_gemma":[0.99722946,0.00055394945,0.0005069313,0.0005059398,0.0005482472,0.00065550086],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0015657055,0.00058081286,0.0012188132,0.00082467095,0.0017671362,0.0001295828,0.0004227397,0.00040273546,0.00056307076],"category_scores_gemma":[0.0030382713,0.00052788324,0.00076584565,0.0011703136,0.00045094657,0.0006407806,0.00028199388,0.0018632656,0.00028252503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009654279,0.00087308785,0.93036807,0.000058622143,0.00016174176,0.00005232174,0.0016797663,0.000052382275,0.03319421,0.000002247783,0.008876766,0.023715382],"study_design_scores_gemma":[0.013396558,0.0002718192,0.97924703,0.0004928902,0.000058426336,0.00020815281,0.00045813044,0.002568104,0.0013140064,0.000020394999,0.0014794678,0.00048499508],"about_ca_topic_score_codex":0.0006780215,"about_ca_topic_score_gemma":0.00059075194,"teacher_disagreement_score":0.048879012,"about_ca_system_score_codex":0.0009004791,"about_ca_system_score_gemma":0.00024671044,"threshold_uncertainty_score":0.9997173},"labels":[],"label_agreement":null},{"id":"W2029459149","doi":"10.1177/1352458509345903","title":"Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Rolipram; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Medicine; Neuroprotection; Pharmacology; Autoimmunity; In vivo; Encephalomyelitis; Clinical trial; Phosphodiesterase; Immunology; Internal medicine; Disease; Chemistry; Biology; Enzyme","score_opus":0.0809961044682882,"score_gpt":0.2973789276538074,"score_spread":0.2163828231855192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029459149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728187,0.0008808675,0.0001668903,0.023135714,0.00026551422,0.002337239,0.000061261984,0.00012698892,0.00020684303],"genre_scores_gemma":[0.9911737,0.0016672332,0.002939323,0.00252521,0.0008864898,0.00025137918,0.000028456794,0.000099797806,0.0004284357],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99451494,0.00043506952,0.0010548178,0.0009298445,0.0015063966,0.0015589199],"domain_scores_gemma":[0.9961732,0.0008312162,0.00033199156,0.00090693624,0.0006382609,0.0011183894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011136215,0.00082549336,0.0010886879,0.00065730046,0.0010527722,0.0005883713,0.00043517802,0.00023629035,0.00016132239],"category_scores_gemma":[0.0017955516,0.0005041277,0.0003914127,0.0014195591,0.00030679218,0.0007060453,0.0001679573,0.0011035049,0.00014763954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00571264,0.0025361716,0.22557764,0.00004209743,0.00048982864,0.00020926725,0.0069574453,0.0007149039,0.6221407,0.000007394851,0.0061541265,0.12945776],"study_design_scores_gemma":[0.024136253,0.007666419,0.9071032,0.0014849865,0.0002604033,0.0002490564,0.0027709068,0.0013017837,0.04780063,0.000011129085,0.006408417,0.00080682925],"about_ca_topic_score_codex":0.00038793875,"about_ca_topic_score_gemma":0.0017147183,"teacher_disagreement_score":0.6815255,"about_ca_system_score_codex":0.0009755916,"about_ca_system_score_gemma":0.00031611725,"threshold_uncertainty_score":0.999741},"labels":[],"label_agreement":null},{"id":"W2030810833","doi":"10.1177/1352458511414041","title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Comorbidity; Interquartile range; Visual impairment; Hazard ratio; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Confidence interval; Psychiatry","score_opus":0.13711316487777922,"score_gpt":0.3094305174417259,"score_spread":0.17231735256394667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030810833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979096,0.0002570286,0.00007928794,0.00022656255,0.00034963558,0.0008188129,0.000072425304,0.000058996295,0.00022763445],"genre_scores_gemma":[0.9954556,0.002839932,0.001143758,0.00008738971,0.00030284122,0.00005592278,0.000018454284,0.000064008535,0.00003205899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949152,0.0006223583,0.0012704827,0.0006178078,0.0016366863,0.00093745743],"domain_scores_gemma":[0.9969115,0.0010789441,0.000595357,0.00038026506,0.00054621935,0.0004876761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024627836,0.00047435466,0.0011128468,0.0004487239,0.0004210053,0.000059074373,0.00024019381,0.00030287993,0.00034055384],"category_scores_gemma":[0.004124809,0.00041812114,0.0004669341,0.0005540814,0.0006454559,0.00045976837,0.0002288938,0.001080787,0.00002451039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015534745,0.002455933,0.9293731,0.00013439431,0.00036059672,0.000009514972,0.0024589517,0.00002562704,0.055314247,0.000008127952,0.00023627077,0.0080697695],"study_design_scores_gemma":[0.011330089,0.00115403,0.96296304,0.0008525823,0.00012319301,0.000007473264,0.0020808983,0.0030531618,0.018004924,0.000018522003,0.000067398316,0.00034470632],"about_ca_topic_score_codex":0.0010905223,"about_ca_topic_score_gemma":0.001404477,"teacher_disagreement_score":0.037309323,"about_ca_system_score_codex":0.0008825881,"about_ca_system_score_gemma":0.00012767978,"threshold_uncertainty_score":0.9998271},"labels":[],"label_agreement":null},{"id":"W2031952471","doi":"10.1177/135245850000600108","title":"Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Cameco (Canada)","funders":"Medical Research Council","keywords":"Oxidative stress; Menadione; Macrophage; Myelin; Lesion; Inflammation; Biology; Chemistry; Cell biology; Immunology; Biochemistry; Pathology; Endocrinology; In vitro; Central nervous system; Medicine","score_opus":0.1432409063247949,"score_gpt":0.33777756261580627,"score_spread":0.19453665629101138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031952471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934274,0.0007815848,0.00042216596,0.0022885557,0.00039285645,0.0013287711,0.00026064736,0.00019210867,0.0009059074],"genre_scores_gemma":[0.98151416,0.011885188,0.0023567053,0.00036251475,0.001328694,0.00015856321,0.000033311077,0.00012185375,0.00223904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955008,0.00046683752,0.00091366173,0.000723292,0.0011723659,0.0012230636],"domain_scores_gemma":[0.996927,0.0006399392,0.00026759354,0.0007469478,0.00049646845,0.000922034],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005655782,0.0005982624,0.0008608902,0.00041874615,0.0013387088,0.00032186368,0.00051917887,0.00022128856,0.011046988],"category_scores_gemma":[0.0011237215,0.00041329642,0.00037810366,0.0007391799,0.00024985932,0.0005350085,0.00016177376,0.0017064991,0.0005591573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002976362,0.0012636586,0.010832336,0.00012490666,0.00065142347,0.00036912292,0.0015718972,0.0012274148,0.5779526,0.0000024444519,0.0034133424,0.39961448],"study_design_scores_gemma":[0.015318679,0.0026828086,0.63630515,0.0016413601,0.00029432256,0.001513149,0.0023110507,0.0077930293,0.29291224,0.000026658648,0.038114596,0.0010869855],"about_ca_topic_score_codex":0.00013644971,"about_ca_topic_score_gemma":0.00048011934,"teacher_disagreement_score":0.6254728,"about_ca_system_score_codex":0.0003877532,"about_ca_system_score_gemma":0.00028962537,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W2032071249","doi":"10.1177/1352458507085801","title":"Argentine Patagonia: prevalence and clinical features of multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Multiple sclerosis; Demography; Population; Incidence (geometry); Prevalence; Geography; Medicine","score_opus":0.18022371036141147,"score_gpt":0.3418067466174209,"score_spread":0.16158303625600942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032071249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143183,0.0054593105,0.00022639446,0.0010334158,0.00052766525,0.0008592435,0.00014650366,0.00009597992,0.00021964207],"genre_scores_gemma":[0.91916347,0.071195684,0.007948779,0.0002042303,0.00077554554,0.000036073994,0.000014939304,0.000078242236,0.00058303005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944034,0.00046115663,0.0017427168,0.00081151666,0.0015480097,0.0010331497],"domain_scores_gemma":[0.99508077,0.0013864802,0.00070837844,0.00076797267,0.0010148194,0.0010415734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018444278,0.0005426739,0.0013775876,0.00044106366,0.00091165246,0.00007971401,0.00046744256,0.00031494733,0.00028603562],"category_scores_gemma":[0.0069087627,0.00043701113,0.000715082,0.0005384762,0.0014389794,0.0004176467,0.0005050583,0.0015616042,0.000036430076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092303264,0.0009928768,0.90627044,0.00027378925,0.0005090349,0.000047593432,0.00039529722,0.00000651655,0.061613068,0.00000303871,0.008804233,0.020161085],"study_design_scores_gemma":[0.010025008,0.0008083262,0.97559327,0.0011961418,0.00022162661,0.00055386,0.00013654226,0.0006911601,0.009128869,0.0000060351067,0.0012668169,0.00037232248],"about_ca_topic_score_codex":0.00016016726,"about_ca_topic_score_gemma":0.00008234396,"teacher_disagreement_score":0.07226837,"about_ca_system_score_codex":0.00013312782,"about_ca_system_score_gemma":0.0002632221,"threshold_uncertainty_score":0.9998082},"labels":[],"label_agreement":null},{"id":"W2033735368","doi":"10.1177/1352458510377770","title":"Challenges in screening for depression in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Depression (economics); Multiple sclerosis; Rating scale; Center for Epidemiologic Studies Depression Scale; Medicine; Psychological intervention; Population; Psychiatry; Depressive symptoms; Clinical psychology; Psychology; Environmental health; Cognition","score_opus":0.33873310580961435,"score_gpt":0.3517637553763881,"score_spread":0.013030649566773744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033735368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903632,0.0027238275,0.00084650307,0.0030115873,0.0006765526,0.001758911,0.00004140696,0.000099239056,0.00047876782],"genre_scores_gemma":[0.9609517,0.008398352,0.029062975,0.00015272868,0.00081128377,0.00043977497,0.000018892026,0.00011735896,0.000046947418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950571,0.00022976902,0.0012392736,0.0009135796,0.0010494994,0.0015107475],"domain_scores_gemma":[0.9961906,0.0016420892,0.00033496183,0.00070067594,0.00046962977,0.0006620494],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029461025,0.0005375358,0.0010458475,0.0012206787,0.00053306983,0.00016717576,0.00052812026,0.00042399758,0.00012312547],"category_scores_gemma":[0.007289664,0.0004665625,0.0004424417,0.0006075624,0.00025584252,0.000573509,0.00031053415,0.0024050777,0.000024625184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009212514,0.0005277229,0.51489764,0.000097463955,0.00005638996,0.000017421104,0.0007040448,0.00012081416,0.27065676,0.0000050122485,0.00037060233,0.21162489],"study_design_scores_gemma":[0.018575737,0.00024895874,0.9474108,0.0019323842,0.000031883854,0.0000731816,0.0010499229,0.015434135,0.013051552,0.000034803317,0.0017144919,0.00044212234],"about_ca_topic_score_codex":0.000262997,"about_ca_topic_score_gemma":0.007988627,"teacher_disagreement_score":0.43251318,"about_ca_system_score_codex":0.00024325814,"about_ca_system_score_gemma":0.00015172042,"threshold_uncertainty_score":0.9998964},"labels":[],"label_agreement":null},{"id":"W2037409902","doi":"10.1177/1352458510381259","title":"Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Experimental autoimmune encephalomyelitis; Myelin oligodendrocyte glycoprotein; Immunology; Multiple sclerosis; Immune system; Proinflammatory cytokine; Autoimmune disease; T cell; Context (archaeology); Interferon; Medicine; Bone marrow; Biology; Inflammation; Antibody","score_opus":0.05365358914862301,"score_gpt":0.303671895765425,"score_spread":0.250018306616802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037409902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646086,0.0007565435,0.000023729484,0.000826706,0.00062067766,0.0007750018,0.000020012487,0.000045037184,0.0004714327],"genre_scores_gemma":[0.9951588,0.000363634,0.0035915824,0.00009227635,0.0003469866,0.00009346503,0.000005879457,0.00005884376,0.00028854437],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99636066,0.00015139955,0.0011824158,0.00044297104,0.0011020155,0.000760518],"domain_scores_gemma":[0.99804735,0.00016724465,0.00039011898,0.0005961252,0.0003829244,0.0004162153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010141513,0.0003593351,0.00079931424,0.0005518973,0.00021251368,0.000037648213,0.00042259623,0.00020426964,0.0010920812],"category_scores_gemma":[0.0009053966,0.0003103406,0.00036233512,0.00037566788,0.00037491595,0.00038301933,0.00030469827,0.0014065171,0.000052323197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055053964,0.00055342144,0.24123177,0.00006286556,0.000111019996,0.000016343005,0.002982068,0.0000029738208,0.7465963,0.000011654663,0.00061183,0.0072692307],"study_design_scores_gemma":[0.0062237564,0.00042090393,0.80530506,0.0008354664,0.00001883983,0.000110333545,0.00089627755,0.0006401813,0.18418634,0.000016612417,0.0011271012,0.00021909695],"about_ca_topic_score_codex":0.00017602678,"about_ca_topic_score_gemma":0.0001073876,"teacher_disagreement_score":0.5640733,"about_ca_system_score_codex":0.00027041335,"about_ca_system_score_gemma":0.00027657946,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W2037425477","doi":"10.1177/1352458510382554","title":"Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Intensive Care Society; University of Leeds; Hospital for Sick Children; Multiple Sclerosis Society; Action Medical Research; NHS Health Scotland","keywords":"Medicine; Acute disseminated encephalomyelitis; Pediatrics; Stridor; Epidemiology; Intensive care; Population; Incidence (geometry); Intensive care unit; Emergency medicine; Intensive care medicine; Airway; Surgery; Disease; Internal medicine","score_opus":0.04167366819705982,"score_gpt":0.3126446622878463,"score_spread":0.2709709940907865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037425477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549264,0.00039920417,0.00006628419,0.0010295053,0.0009908073,0.0016016689,0.00012736135,0.00017272055,0.000119782955],"genre_scores_gemma":[0.9957628,0.00017924923,0.0022111742,0.0003925653,0.0009921071,0.00015494082,0.00012037517,0.000088709996,0.00009805436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995793,0.00024477992,0.0008847239,0.00066307664,0.0014679744,0.00094644225],"domain_scores_gemma":[0.99362886,0.0005956672,0.00036140272,0.0006922468,0.0039072577,0.0008145898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006077298,0.00050684856,0.00082159106,0.0006641515,0.0009670579,0.00026016837,0.0004318243,0.00022684052,0.0005464078],"category_scores_gemma":[0.005452357,0.00040803297,0.0004388146,0.0008631531,0.00013705515,0.00033419917,0.00020303493,0.002114355,0.00008219188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047386784,0.0004190796,0.92565864,0.000054420485,0.00040496778,0.00016520213,0.0037283623,0.00004943217,0.04105632,8.6563e-7,0.0012632255,0.026725614],"study_design_scores_gemma":[0.008451427,0.0007828396,0.9719891,0.00025767004,0.0003804978,0.00014646469,0.015510017,0.000976956,0.0008631632,0.0000046798277,0.00021087643,0.0004262836],"about_ca_topic_score_codex":0.00034015498,"about_ca_topic_score_gemma":0.00070481555,"teacher_disagreement_score":0.04633048,"about_ca_system_score_codex":0.00035185387,"about_ca_system_score_gemma":0.00031779916,"threshold_uncertainty_score":0.99983716},"labels":[],"label_agreement":null},{"id":"W2039942440","doi":"10.1191/1352458502ms776oa","title":"Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; University of Toronto; Hospital for Sick Children","funders":"Multiple Sclerosis Society of Canada","keywords":"Remyelination; Astrogliosis; Myelin basic protein; Myelin; Oligodendrocyte; Genetically modified mouse; Multiple sclerosis; Medicine; Immunology; Pathology; Endocrinology; Internal medicine; Biology; Transgene; Central nervous system; Biochemistry","score_opus":0.13218723502597188,"score_gpt":0.3026428177222813,"score_spread":0.17045558269630942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039942440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926654,0.0024833365,0.000023295454,0.0042165862,0.00013782334,0.0003821774,0.00001791908,0.000036556474,0.000036901205],"genre_scores_gemma":[0.9935361,0.0042459345,0.0014915273,0.00030782048,0.0002856997,0.00003278563,0.000009325066,0.00003472045,0.000056044726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977811,0.00021551875,0.0008513097,0.00037090888,0.0003945733,0.00038656942],"domain_scores_gemma":[0.99844086,0.000449688,0.00022303937,0.00019148419,0.00013548165,0.0005594742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007593554,0.00023735115,0.0004448866,0.00027202297,0.00022123104,0.00010822366,0.00008977501,0.00013060172,0.00014665489],"category_scores_gemma":[0.0010140272,0.00019393172,0.0002307802,0.00022010112,0.000091946786,0.00021529758,0.000029791518,0.00052655465,0.00003273111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023944664,0.00148731,0.883863,0.000035799894,0.000100720725,0.0005024908,0.0006035601,0.000052051175,0.009235246,0.0000068583304,0.0002358187,0.10363773],"study_design_scores_gemma":[0.009000326,0.00040273962,0.97756493,0.00056340353,0.00019376198,0.0002780327,0.0002479662,0.009853735,0.0014137577,0.00005254628,0.00019590388,0.00023287885],"about_ca_topic_score_codex":0.000055133944,"about_ca_topic_score_gemma":0.00012862659,"teacher_disagreement_score":0.10340486,"about_ca_system_score_codex":0.00014146483,"about_ca_system_score_gemma":0.000033605225,"threshold_uncertainty_score":0.7908306},"labels":[],"label_agreement":null},{"id":"W2040220974","doi":"10.1177/1352458508101037","title":"Reflections on 2008","year":2008,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Academic Writing and Publishing","field":"Arts and Humanities","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Impact factor; Audience measurement; Publishing; Quality (philosophy); Psychology; Medicine; Political science; Law; Philosophy; Epistemology","score_opus":0.17127745348299725,"score_gpt":0.3055030837246057,"score_spread":0.13422563024160847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040220974","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027894,0.0006996618,0.000015455775,0.00058048003,0.906447,0.00009389869,0.00041800132,0.00017322277,0.09129335],"genre_scores_gemma":[0.004327834,0.0031744414,0.00011909753,0.00028897965,0.9706071,0.000014954625,0.00016395582,0.000104646555,0.02119896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969366,0.00018426575,0.0006692639,0.00038171912,0.0012414532,0.0005867076],"domain_scores_gemma":[0.9970766,0.0011923589,0.0005647983,0.0002729338,0.0006377642,0.00025556804],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070385984,0.00040659908,0.0004684874,0.00041513133,0.003020677,0.0014588761,0.0006456416,0.00074446126,0.001122943],"category_scores_gemma":[0.0026953658,0.0003519787,0.00038472808,0.00006701488,0.0002477566,0.0005637119,0.0000668677,0.0057204817,0.00031317823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035105342,0.000067365974,0.000010234379,0.000013167029,0.00006512852,0.000013185471,0.006421834,0.000023004792,0.000013747879,0.00023119668,0.99178916,0.0013168819],"study_design_scores_gemma":[0.0006737787,0.0001247291,0.000029086359,0.0006094144,0.000041773223,0.000023928296,0.0008358363,0.000015128191,0.0000065318445,0.00009444661,0.997146,0.00039932094],"about_ca_topic_score_codex":0.00039616393,"about_ca_topic_score_gemma":0.00039391278,"teacher_disagreement_score":0.070094384,"about_ca_system_score_codex":0.00027090267,"about_ca_system_score_gemma":0.00035346713,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W2040728132","doi":"10.1177/1352458506071174","title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Neuromyelitis optica; Optic neuritis; Medicine; Myelitis; Multiple sclerosis; Methylprednisolone; Central nervous system; Autoantibody; Transverse myelitis; Immunology; Internal medicine; Gastroenterology; Spinal cord; Antibody","score_opus":0.059103471578565506,"score_gpt":0.28712473643766345,"score_spread":0.22802126485909796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040728132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966295,0.00032582134,0.0004819314,0.00045081024,0.00017659356,0.0010047845,0.000042967873,0.000033703804,0.00085393083],"genre_scores_gemma":[0.9960324,0.0006626677,0.0027366222,0.00017323343,0.00023634882,0.000019461246,0.000018111594,0.000068019755,0.00005309259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610496,0.00018927429,0.00087655097,0.0004305508,0.0013227733,0.0010759032],"domain_scores_gemma":[0.9968636,0.0011582503,0.00034367963,0.00037924337,0.0007380383,0.0005171669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011336236,0.00037627178,0.0007636956,0.00065687986,0.0002306357,0.00005605612,0.00027130859,0.00013496916,0.00015684415],"category_scores_gemma":[0.0010240875,0.0002734481,0.00021980463,0.0007113947,0.00036378554,0.00024418696,0.00014089106,0.0009081701,0.000020166868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044042966,0.0017189601,0.81174105,0.00009513092,0.0003260329,0.00007985872,0.0018083631,0.000059479175,0.021182153,0.000008582527,0.00011763034,0.15845844],"study_design_scores_gemma":[0.020310871,0.0015757543,0.96786517,0.0009970339,0.0000720042,0.000035141395,0.00028907665,0.00033454812,0.007971997,0.000003672587,0.0002979662,0.00024674486],"about_ca_topic_score_codex":0.00009635323,"about_ca_topic_score_gemma":0.00018425767,"teacher_disagreement_score":0.1582117,"about_ca_system_score_codex":0.00033713627,"about_ca_system_score_gemma":0.00012454682,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W2041554374","doi":"10.1191/1352458505ms1168oa","title":"Severity of chronic pain and its relationship to quality of life in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Medicine; Chronic pain; Depression (economics); Quality of life (healthcare); Multiple sclerosis; McGill Pain Questionnaire; Physical therapy; Anxiety; Osteoarthritis; Rheumatoid arthritis; Internal medicine; Pain catastrophizing; Visual analogue scale; Psychiatry; Alternative medicine; Pathology","score_opus":0.2403712403511937,"score_gpt":0.34946043243010116,"score_spread":0.10908919207890747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041554374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923987,0.0029394706,0.00053543446,0.0028291447,0.000096318516,0.0009824251,0.00009579085,0.00003517892,0.00008754305],"genre_scores_gemma":[0.992012,0.0017041714,0.0054918127,0.00026910563,0.00035244442,0.000059633236,0.000008382032,0.000047615074,0.00005483148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994622,0.0010053255,0.0019288396,0.0005056177,0.00117996,0.00075823686],"domain_scores_gemma":[0.9948657,0.0025238649,0.0006128725,0.00047945755,0.0007213236,0.00079679466],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058499733,0.00036233905,0.0012218589,0.0007281701,0.00029031458,0.0000441178,0.0003100682,0.00022108204,0.00016050051],"category_scores_gemma":[0.024058087,0.00033236743,0.0002926004,0.0009038849,0.00025700819,0.00039613358,0.0002901207,0.000911753,0.000021279284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007376894,0.00067182665,0.80320734,0.0003635448,0.000115264615,0.0000011839089,0.0011781905,0.00065539265,0.16131617,0.000015025269,0.0005541314,0.031184249],"study_design_scores_gemma":[0.0077555613,0.00052779744,0.96835124,0.0013815194,0.00003205896,0.0000061908245,0.00047297144,0.0126401,0.008317756,0.00001037653,0.00022905548,0.00027539278],"about_ca_topic_score_codex":0.0005403085,"about_ca_topic_score_gemma":0.0027280808,"teacher_disagreement_score":0.16514389,"about_ca_system_score_codex":0.0005640366,"about_ca_system_score_gemma":0.00036504882,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2043373435","doi":"10.1177/1352458507076961","title":"Multiple sclerosis susceptibility and the X chromosome","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Genetics; Locus (genetics); Biology; Microsatellite; Genetic linkage; Multiple sclerosis; Allele; Trait; Immunology; Gene","score_opus":0.1099400964624682,"score_gpt":0.30539147028123925,"score_spread":0.19545137381877103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043373435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755616,0.002843032,0.0014810464,0.004853533,0.000583226,0.0015563623,0.00004135037,0.00016435128,0.0009209244],"genre_scores_gemma":[0.9877657,0.0057211947,0.003940254,0.000868329,0.0012908482,0.000057592566,0.000011296345,0.00008937809,0.0002553654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99412644,0.00046288874,0.0013539152,0.0007960812,0.0016868348,0.0015738524],"domain_scores_gemma":[0.99347997,0.003204183,0.00043676552,0.00096356403,0.0008208163,0.0010947095],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.007546453,0.0005954948,0.0011275565,0.00039886506,0.0018150914,0.00037362613,0.00053105864,0.0002629671,0.0003512711],"category_scores_gemma":[0.007506883,0.00037516456,0.0006200579,0.0007265333,0.0021278872,0.00044178372,0.0005365078,0.0017598192,0.00009900504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055830823,0.000719135,0.6447399,0.00014835151,0.00066371734,0.000052563344,0.0025134229,0.000022548333,0.24490248,0.00006774952,0.0045116795,0.09607538],"study_design_scores_gemma":[0.025603583,0.00033848177,0.9548706,0.00050166826,0.00016925063,0.00029544896,0.0015101524,0.0018266689,0.011611394,0.000076001415,0.0027844706,0.00041231254],"about_ca_topic_score_codex":0.0003456735,"about_ca_topic_score_gemma":0.000857651,"teacher_disagreement_score":0.31013066,"about_ca_system_score_codex":0.00045312347,"about_ca_system_score_gemma":0.00016620592,"threshold_uncertainty_score":0.99987},"labels":[],"label_agreement":null},{"id":"W2043472471","doi":"10.1191/1352458503ms958oa","title":"Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Magnetization transfer; Magnetic resonance imaging; Nuclear medicine; Lesion; Central nervous system disease; Pathology; Internal medicine; Radiology","score_opus":0.10770040285057866,"score_gpt":0.3200785667297669,"score_spread":0.21237816387918826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043472471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887653,0.0009584558,0.00030313598,0.005158682,0.0007217794,0.0018620645,0.00008822443,0.00022049913,0.0019218507],"genre_scores_gemma":[0.9882733,0.00081359706,0.007848215,0.0012468693,0.00025329474,0.00023278153,0.000022721304,0.00015616795,0.0011530011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917078,0.0008122435,0.0020973866,0.0011965322,0.001891908,0.0022941162],"domain_scores_gemma":[0.9950846,0.0012529669,0.00039538075,0.0011453128,0.0005794793,0.0015423007],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038743247,0.0008559133,0.0014553465,0.0007977829,0.0011458911,0.0003702546,0.00064458605,0.0004257916,0.0013041897],"category_scores_gemma":[0.009229465,0.00080176134,0.00059045176,0.0017322125,0.0007469038,0.0008027028,0.00042819383,0.0021761672,0.00036349436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071774883,0.0015240469,0.8553011,0.0002058467,0.00027836135,0.000059072096,0.0062682605,0.00058684254,0.091592,0.0000384845,0.008033912,0.035394367],"study_design_scores_gemma":[0.012097217,0.00067546853,0.9390539,0.001343478,0.000071710194,0.00019877702,0.0025380536,0.0013696,0.022440465,0.00005664624,0.01925547,0.00089923677],"about_ca_topic_score_codex":0.0015060342,"about_ca_topic_score_gemma":0.001361649,"teacher_disagreement_score":0.08375282,"about_ca_system_score_codex":0.002204044,"about_ca_system_score_gemma":0.00032676914,"threshold_uncertainty_score":0.99960876},"labels":[],"label_agreement":null},{"id":"W2045091008","doi":"10.1177/1352458512439119","title":"Natural, innate improvements in multiple sclerosis disability","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Expanded Disability Status Scale; Medicine; Observational study; Natural history study; Logistic regression; Clinical trial; Clinical endpoint; Confidence interval; Physical therapy; Internal medicine; Pediatrics; Demography; Psychiatry","score_opus":0.1464856655963924,"score_gpt":0.3227992360109472,"score_spread":0.17631357041455478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045091008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921383,0.0026545643,0.000088031826,0.0016436657,0.0015008925,0.0014282796,0.000064709944,0.00014665462,0.00033489248],"genre_scores_gemma":[0.99122685,0.002768963,0.0036514052,0.000577118,0.0012600434,0.00020132156,0.000035930414,0.00011786188,0.0001605249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929709,0.00049205293,0.0015522968,0.0007564842,0.0017817449,0.0024465155],"domain_scores_gemma":[0.99602085,0.00082148664,0.00043899514,0.00091546436,0.0005063692,0.0012968193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029458778,0.0007167298,0.0011621073,0.0005059848,0.00080303865,0.00023147035,0.0005767378,0.00028387894,0.00045783535],"category_scores_gemma":[0.004948904,0.00058724004,0.0005976892,0.0010878907,0.0006899328,0.001398288,0.0005995785,0.0022138518,0.00022034472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006200635,0.0018015224,0.7370488,0.00010255537,0.00019505956,0.00000730793,0.0007940507,0.000017279446,0.20479572,0.0000035289117,0.0017186488,0.05289547],"study_design_scores_gemma":[0.01126581,0.00024408913,0.9653494,0.0007468451,0.00007323573,0.000050808594,0.0007740805,0.0020324648,0.016759284,0.0000126991,0.0021345997,0.000556708],"about_ca_topic_score_codex":0.0005775474,"about_ca_topic_score_gemma":0.0004972248,"teacher_disagreement_score":0.22830059,"about_ca_system_score_codex":0.0015104824,"about_ca_system_score_gemma":0.00014194332,"threshold_uncertainty_score":0.9996579},"labels":[],"label_agreement":null},{"id":"W2047413783","doi":"10.1177/1352458514528762","title":"Risk of relapse phenotype recurrence in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université Laval; Cégep de Lévis; Hôpital Notre-Dame","funders":"Fleni; Monash University","keywords":"Multiple sclerosis; Medicine; Phenotype; Oncology; Psychiatry; Biology; Genetics; Gene","score_opus":0.11270801621476442,"score_gpt":0.29564239464373676,"score_spread":0.18293437842897234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047413783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941814,0.001196557,0.0014388089,0.00064831856,0.00062577263,0.0008118167,0.000083749175,0.00008438132,0.00092917355],"genre_scores_gemma":[0.9799994,0.008838929,0.010239139,0.00014265066,0.0005185339,0.000066413086,0.000015465566,0.00008967312,0.00008975084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99395823,0.0009003382,0.0016339589,0.0007489496,0.0015475712,0.0012109177],"domain_scores_gemma":[0.9946014,0.001993075,0.00086490065,0.000943662,0.00087277347,0.00072416477],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036607154,0.0005474515,0.0013134824,0.00087243615,0.0005319662,0.00010538477,0.0006258593,0.000287173,0.00027631284],"category_scores_gemma":[0.018011749,0.00046441346,0.0005490683,0.001169878,0.00057175505,0.00043278164,0.0003452915,0.0019332545,0.00013039527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010315636,0.00079876016,0.7830296,0.00013027922,0.0002053684,0.0000071977906,0.0009404645,0.0004004553,0.10316313,0.000016497092,0.0019856181,0.10829104],"study_design_scores_gemma":[0.011267273,0.0007002248,0.95694834,0.001942352,0.00012492691,0.000026011861,0.0003795474,0.017703261,0.009145167,0.000092304705,0.0012485957,0.00042200868],"about_ca_topic_score_codex":0.0007786779,"about_ca_topic_score_gemma":0.0007773202,"teacher_disagreement_score":0.17391871,"about_ca_system_score_codex":0.00038167668,"about_ca_system_score_gemma":0.00020428674,"threshold_uncertainty_score":0.9997808},"labels":[],"label_agreement":null},{"id":"W2049683216","doi":"10.1177/135245850000600502","title":"Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Peptide; Immunology; Internal medicine; Chemistry","score_opus":0.029234455766703065,"score_gpt":0.22615880334552763,"score_spread":0.19692434757882457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049683216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865615,0.00028818529,0.00008788322,0.00011979105,0.00019069294,0.00048622105,0.00008818865,0.000009997517,0.00007286436],"genre_scores_gemma":[0.9974748,0.00079111115,0.00113166,0.00019079035,0.00012739876,0.000046947694,0.000033925167,0.000053851283,0.00014950774],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99683046,0.00039787358,0.0009987869,0.00059555355,0.0004059408,0.00077137887],"domain_scores_gemma":[0.9987089,0.00008278398,0.00021099459,0.00048302134,0.00023372691,0.00028059626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074258086,0.00037476016,0.00049867004,0.0004088322,0.0001381754,0.00008041025,0.000580558,0.0002508336,0.00025020374],"category_scores_gemma":[0.00062820234,0.00036923724,0.0002204355,0.0003925521,0.00013402948,0.000029810762,0.0001361336,0.0003569408,0.00007853299],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029008696,0.0006155183,0.23745432,0.00001946421,0.000032805754,0.000009449186,0.00035524726,0.0030493098,0.7382031,2.59422e-7,0.0003553763,0.017004278],"study_design_scores_gemma":[0.0030072012,0.0015207678,0.758533,0.0006321574,0.00001542171,0.000023057219,0.00015737329,0.00040570903,0.2349435,0.0000047724848,0.00040067715,0.00035634183],"about_ca_topic_score_codex":0.00031588398,"about_ca_topic_score_gemma":0.0004617823,"teacher_disagreement_score":0.5210787,"about_ca_system_score_codex":0.0001243876,"about_ca_system_score_gemma":0.00014549698,"threshold_uncertainty_score":0.99987596},"labels":[],"label_agreement":null},{"id":"W2049733663","doi":"10.1177/1352458511422097","title":"Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Natural history; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Demography; Age of onset; Pediatrics; Survival analysis; Disease; Internal medicine; Immunology","score_opus":0.1265162919507938,"score_gpt":0.2859786609938437,"score_spread":0.15946236904304992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049733663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996124,0.0010538023,0.00003413443,0.00033791372,0.0005522955,0.00077258964,0.0007804793,0.00007244054,0.000272344],"genre_scores_gemma":[0.9925258,0.0008340059,0.005610824,0.00013799942,0.00029630482,0.00013501945,0.00010227686,0.0000944731,0.00026327083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933777,0.0004325411,0.0019237995,0.0009368084,0.001980377,0.0013487645],"domain_scores_gemma":[0.99656475,0.00053119333,0.0006044124,0.00078937784,0.0005787386,0.0009315158],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013462947,0.00047530432,0.0014408128,0.0002573099,0.000617625,0.00026121186,0.00066541217,0.000309791,0.0019844817],"category_scores_gemma":[0.002285444,0.00056256505,0.00046269325,0.0011196871,0.0009057002,0.0005223518,0.0004010379,0.001395616,0.000008440682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006032645,0.0015621182,0.88003856,0.00008812265,0.0002025834,0.00008148851,0.00073952455,0.000005295839,0.016354658,1.5929695e-7,0.010354782,0.08996947],"study_design_scores_gemma":[0.00999118,0.00043974948,0.97961056,0.0025961418,0.000086620814,0.00004322129,0.0008582274,0.0006161334,0.004417231,0.000012747805,0.00083602127,0.0004921642],"about_ca_topic_score_codex":0.9371822,"about_ca_topic_score_gemma":0.9843274,"teacher_disagreement_score":0.09957203,"about_ca_system_score_codex":0.0012310958,"about_ca_system_score_gemma":0.00073570496,"threshold_uncertainty_score":0.9996826},"labels":[],"label_agreement":null},{"id":"W2049871497","doi":"10.1177/1352458511411061","title":"Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Placebo; Medicine; Multiple sclerosis; Depression (economics); Quality of life (healthcare); Beck Depression Inventory; Internal medicine; Physical therapy; Clinical trial; Psychiatry; Anxiety; Alternative medicine","score_opus":0.17284795054402027,"score_gpt":0.33392886294287094,"score_spread":0.16108091239885067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049871497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712497,0.001656371,0.0001505232,0.000055751458,0.00037093446,0.0005416897,0.0000462697,0.000016242373,0.00003723265],"genre_scores_gemma":[0.9983424,0.00038264613,0.0008359258,0.00017976956,0.00014810155,0.000025238085,0.000022929626,0.000054075164,0.000008947947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546707,0.0009318398,0.0019173597,0.000546648,0.00041045272,0.00072660524],"domain_scores_gemma":[0.99802434,0.000089938,0.0008841299,0.00048784935,0.00013771206,0.00037605152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034306312,0.00038970762,0.0009427461,0.00042237356,0.0002770755,0.00004499699,0.00042001336,0.00024003236,0.00006319226],"category_scores_gemma":[0.0013779679,0.0003437617,0.0003411837,0.00047409005,0.00008946116,0.000036779536,0.00017108259,0.0006714075,0.000003784641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004835397,0.00647082,0.49572062,0.000027626817,0.00017722265,0.000007419578,0.007121236,0.0020206396,0.4739652,0.0000047966337,0.00015469332,0.009494332],"study_design_scores_gemma":[0.033892836,0.0039347704,0.9337376,0.0005361429,0.000024970677,0.000010776703,0.002288128,0.0015174209,0.023516925,0.00003364335,0.00002254553,0.00048429306],"about_ca_topic_score_codex":0.005408896,"about_ca_topic_score_gemma":0.0016882273,"teacher_disagreement_score":0.45044827,"about_ca_system_score_codex":0.00011511,"about_ca_system_score_gemma":0.00029680476,"threshold_uncertainty_score":0.9999014},"labels":[],"label_agreement":null},{"id":"W2050175727","doi":"10.1177/1352458507088106","title":"Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging","keywords":"Atrophy; White matter; Multiple sclerosis; Pathology; Lesion; Fiber tract; Corticospinal tract; Medicine; Expanded Disability Status Scale; Pathogenesis; Magnetic resonance imaging; Diffusion MRI; Anatomy; Radiology","score_opus":0.15435305877938077,"score_gpt":0.30165010955625376,"score_spread":0.147297050776873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050175727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653144,0.0002411251,0.0002330726,0.009634598,0.00043169182,0.0015781688,0.00021572331,0.00008776866,0.0010464228],"genre_scores_gemma":[0.98455244,0.0026557804,0.0031192452,0.0052229566,0.00058646244,0.00024977291,0.000031383443,0.00024565356,0.003336313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906415,0.0006753459,0.0022645115,0.0014602181,0.0025835647,0.0023748586],"domain_scores_gemma":[0.9956232,0.0010811577,0.00054323726,0.001142116,0.00044231937,0.0011680118],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013081875,0.0011214039,0.0017864158,0.0018314843,0.0009442882,0.0002460962,0.0007607134,0.0005747628,0.009744537],"category_scores_gemma":[0.000785502,0.0008824983,0.00077439955,0.0012274889,0.00062064076,0.00088949373,0.00037422683,0.0035256147,0.0036958528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039924015,0.0029729984,0.93698496,0.00012328826,0.0001747062,0.0006837007,0.0035068474,0.0020556778,0.01138768,2.4009714e-7,0.02798576,0.010131753],"study_design_scores_gemma":[0.018519472,0.0007099855,0.96694726,0.0021348307,0.00007362112,0.000563083,0.0008941196,0.002534704,0.0052592964,0.000002576483,0.0014757549,0.00088529725],"about_ca_topic_score_codex":0.00053763716,"about_ca_topic_score_gemma":0.0013206063,"teacher_disagreement_score":0.02996231,"about_ca_system_score_codex":0.0014562755,"about_ca_system_score_gemma":0.00038339163,"threshold_uncertainty_score":0.9993626},"labels":[],"label_agreement":null},{"id":"W2050322688","doi":"10.1177/1352458514531348","title":"Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; University of Missouri; Princeton University; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen","keywords":"Psychological intervention; Medicine; Focus group; Multiple sclerosis; Alternative medicine; Session (web analytics); Relevance (law); MEDLINE; Health care; Family medicine; Psychology; Psychiatry","score_opus":0.28142241811258845,"score_gpt":0.36563490045210456,"score_spread":0.08421248233951611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050322688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892068,0.0018764951,0.0005844887,0.0034743117,0.0003860129,0.0013037635,0.000015871718,0.00013979872,0.0030124548],"genre_scores_gemma":[0.98052305,0.008346456,0.009237718,0.00017407122,0.000810327,0.00026579475,0.000019935993,0.00011108874,0.00051156746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99156195,0.0011849735,0.0018254404,0.0010629657,0.002592248,0.0017724088],"domain_scores_gemma":[0.9915273,0.0037824055,0.00059461826,0.001105423,0.0019494031,0.0010408502],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010619837,0.0005341433,0.0010796621,0.0016576465,0.0014942291,0.00045813865,0.00056701637,0.0003368159,0.00009780852],"category_scores_gemma":[0.035654463,0.00047207455,0.0002605497,0.002262738,0.0010049209,0.00063117343,0.00054862146,0.0026929216,0.000089597685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047649106,0.00039468118,0.67476124,0.00013993186,0.00009010457,0.00004386667,0.0012607564,0.000048856713,0.2561713,0.000033227618,0.003977525,0.06260204],"study_design_scores_gemma":[0.007394764,0.00052493304,0.9598937,0.0028007913,0.00003914932,0.0003937261,0.0023195206,0.011975618,0.005593695,0.00010122616,0.008499384,0.0004635072],"about_ca_topic_score_codex":0.0007616661,"about_ca_topic_score_gemma":0.0009507335,"teacher_disagreement_score":0.28513247,"about_ca_system_score_codex":0.0006368682,"about_ca_system_score_gemma":0.00033917202,"threshold_uncertainty_score":0.9998057},"labels":[],"label_agreement":null},{"id":"W2051588049","doi":"10.1177/1352458514551594","title":"Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Lesion; Multiple sclerosis; Medicine; Intensity (physics); Nuclear medicine; Pathology; Radiology","score_opus":0.1578637544711017,"score_gpt":0.3144957273046325,"score_spread":0.15663197283353078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051588049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931622,0.0019453784,0.0016195645,0.0018881939,0.00024045396,0.00092621223,0.00006396541,0.000045054676,0.00010899135],"genre_scores_gemma":[0.96323633,0.012356976,0.023718271,0.0002013583,0.00029591465,0.00003928586,0.000010417361,0.000070137925,0.00007128843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951041,0.00060368807,0.0013240367,0.0006919993,0.0014864367,0.00078976876],"domain_scores_gemma":[0.9957535,0.0013280665,0.0006021435,0.00047729778,0.0009481639,0.0008908085],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029835505,0.00049904425,0.0011128747,0.00083711266,0.00044449494,0.00015001911,0.00026364607,0.00021841675,0.000050294188],"category_scores_gemma":[0.013198431,0.00042602705,0.00017333764,0.0005476161,0.00036461672,0.00046752844,0.0003290154,0.0009802898,0.000014085049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015805706,0.000532693,0.75765574,0.00036655154,0.00021188853,0.000011262657,0.0032109274,0.00018373478,0.19428663,0.00002886969,0.004153954,0.037777152],"study_design_scores_gemma":[0.010866213,0.0014428145,0.9679447,0.0013712345,0.00016359225,0.00003921884,0.0011017211,0.005570857,0.010842552,0.000078919315,0.00017787429,0.00040031518],"about_ca_topic_score_codex":0.0015051479,"about_ca_topic_score_gemma":0.0039202627,"teacher_disagreement_score":0.21028891,"about_ca_system_score_codex":0.00025451597,"about_ca_system_score_gemma":0.00030103925,"threshold_uncertainty_score":0.99981916},"labels":[],"label_agreement":null},{"id":"W2052610851","doi":"10.1177/135245850000600612","title":"The Immunological Rationale for Bone Marrow Transplantation in Multiple Sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Bone marrow transplantation; Transplantation; Bone marrow; Immunology; Pathology; Internal medicine","score_opus":0.14053426378639552,"score_gpt":0.2989657048133035,"score_spread":0.15843144102690795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052610851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870678,0.0028936237,0.00069381105,0.006403831,0.00029300354,0.0020444426,0.00012154041,0.00008606479,0.0003958547],"genre_scores_gemma":[0.95994395,0.03282477,0.0048772255,0.0003289183,0.0004862132,0.00060039794,0.00007491432,0.000058865688,0.0008047702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99600327,0.00032562736,0.0011204393,0.0005195468,0.0009533253,0.0010778105],"domain_scores_gemma":[0.99632955,0.0022950307,0.00021237393,0.0004167725,0.0004249721,0.00032127684],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018653749,0.00039019494,0.00062250445,0.00026695308,0.0016999067,0.00028944097,0.00037765107,0.0002208244,0.0005845814],"category_scores_gemma":[0.0018758829,0.0002685636,0.00047357922,0.00049410906,0.00042964885,0.0003854488,0.000047364694,0.00091010646,0.000098237164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102816,0.0011302627,0.09516081,0.0001374643,0.00036345155,0.000042441574,0.0019094718,0.00094003056,0.38199112,0.000045378314,0.005597576,0.5024004],"study_design_scores_gemma":[0.018553054,0.00056679803,0.9482892,0.00063061755,0.000085007625,0.00017604603,0.00072130753,0.0107093165,0.0075644795,0.00010882464,0.012207032,0.00038827697],"about_ca_topic_score_codex":0.000105671425,"about_ca_topic_score_gemma":0.00065332087,"teacher_disagreement_score":0.85312843,"about_ca_system_score_codex":0.00037246456,"about_ca_system_score_gemma":0.0001681016,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2052712688","doi":"10.1177/1352458508097921","title":"Neuromyelitis optica and multiple sclerosis in sisters","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Medicine; Human leukocyte antigen; Population; Immunology; Antigen; Environmental health","score_opus":0.17748016409803954,"score_gpt":0.2872376722819923,"score_spread":0.10975750818395277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052712688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310577,0.0016188321,0.00015973822,0.0029671572,0.00034793126,0.00081954314,0.00004349009,0.00011955433,0.0008179616],"genre_scores_gemma":[0.9740725,0.018197645,0.0062254467,0.00062292174,0.0004769037,0.000057669888,0.000012369706,0.00010441396,0.00023011076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505436,0.00032902168,0.0011493542,0.0008232411,0.0012730293,0.0013709788],"domain_scores_gemma":[0.99668866,0.0009811381,0.0002675524,0.0005907659,0.00040051035,0.0010713582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009046869,0.00058807805,0.0010959866,0.0008036753,0.00095965,0.00017554013,0.00035359222,0.00022932215,0.00019099588],"category_scores_gemma":[0.0035928963,0.000507755,0.00037939035,0.000750096,0.0008205284,0.00055043213,0.00038681753,0.0014440796,0.00007728279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076456956,0.0005692981,0.83325446,0.00010545956,0.00018601182,0.00037597326,0.0017406237,0.00014098237,0.13342008,0.0000050458316,0.0028332425,0.026604235],"study_design_scores_gemma":[0.011644836,0.000474993,0.97493494,0.0008675464,0.00005029051,0.0011005743,0.00054510735,0.004593833,0.0034142046,0.000009195118,0.0019045298,0.00045994215],"about_ca_topic_score_codex":0.0003214261,"about_ca_topic_score_gemma":0.00019300892,"teacher_disagreement_score":0.14168046,"about_ca_system_score_codex":0.00038050566,"about_ca_system_score_gemma":0.00020231232,"threshold_uncertainty_score":0.9997374},"labels":[],"label_agreement":null},{"id":"W2052748265","doi":"10.1191/1352458505ms1124oa","title":"The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course?","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Marshall Space Flight Center; Multiple Sclerosis Society","keywords":"Test (biology); Multiple sclerosis; Audiology; Disease; Medicine; Psychology; Psychiatry; Pathology","score_opus":0.04353811264214161,"score_gpt":0.28434516575288843,"score_spread":0.24080705311074682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052748265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820065,0.00019477322,0.000011959018,0.016408939,0.0005119071,0.00059045554,0.00010652625,0.000029706149,0.00013922904],"genre_scores_gemma":[0.99394655,0.0012127693,0.0002260571,0.0023891984,0.0010123064,0.00009701664,0.00003345605,0.000029779674,0.0010528404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985401,0.00005651914,0.00031740754,0.00025990477,0.0004573185,0.00036871698],"domain_scores_gemma":[0.9983653,0.00024326723,0.00019488581,0.00022366413,0.00031115528,0.0006617244],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001819997,0.00023204685,0.00023771892,0.00008035309,0.00095216057,0.0003998089,0.00006897169,0.00008826505,0.0013503733],"category_scores_gemma":[0.00046002964,0.00014419189,0.000120981815,0.00019428344,0.00011061113,0.00048335284,0.00003424259,0.00031533162,0.00010828264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023781215,0.0020619787,0.5751654,0.000019735242,0.001272727,0.00006669701,0.0025581936,0.00008821747,0.004362653,0.0000025904305,0.18039119,0.23163253],"study_design_scores_gemma":[0.007749358,0.00088131445,0.9723759,0.0009566332,0.00039706862,0.0001251664,0.0014030439,0.00091454305,0.0011281826,0.000007801315,0.013863989,0.00019697695],"about_ca_topic_score_codex":0.000029865987,"about_ca_topic_score_gemma":0.0001725948,"teacher_disagreement_score":0.39721057,"about_ca_system_score_codex":0.00035588024,"about_ca_system_score_gemma":0.00020071873,"threshold_uncertainty_score":0.9995625},"labels":[],"label_agreement":null},{"id":"W2053615666","doi":"10.1177/1352458512447597","title":"Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Optic neuritis; Visual evoked potentials; Medicine; Evoked potential; Transverse myelitis; Audiology; Spinal cord; Ophthalmology; Immunology","score_opus":0.07933465481186845,"score_gpt":0.31242650510137016,"score_spread":0.2330918502895017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053615666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777514,0.00021500458,0.00034624338,0.00024233774,0.0003404129,0.0008736964,0.000024379502,0.00001913691,0.00016366037],"genre_scores_gemma":[0.9984035,0.00012723287,0.0008744775,0.000056111676,0.0004176411,0.00004026721,0.000022366503,0.00004631837,0.000012067601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944194,0.00057322206,0.0006977205,0.00027471466,0.0032398938,0.000795024],"domain_scores_gemma":[0.9972204,0.00015468519,0.00030871452,0.00026790233,0.0016032886,0.0004450003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025269536,0.0002786401,0.0005483659,0.00042784514,0.00016494318,0.00004670004,0.00016269232,0.000104399915,0.000480912],"category_scores_gemma":[0.0015767344,0.0002086344,0.00017061023,0.00036938165,0.0001796772,0.00051558524,0.00012468666,0.0005983106,0.000023614855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006355665,0.0013089279,0.8988921,0.00003643311,0.00020851674,0.0000031570778,0.00048086178,0.00024007376,0.0088751605,4.30529e-7,0.0001683863,0.08915036],"study_design_scores_gemma":[0.018408522,0.0007754101,0.971432,0.00041977124,0.00027102328,0.000012869802,0.00021127069,0.0069543747,0.0012920088,0.0000021407154,0.000030563395,0.000190097],"about_ca_topic_score_codex":0.000120559154,"about_ca_topic_score_gemma":0.000039268372,"teacher_disagreement_score":0.08896026,"about_ca_system_score_codex":0.0004257973,"about_ca_system_score_gemma":0.00019866136,"threshold_uncertainty_score":0.85078645},"labels":[],"label_agreement":null},{"id":"W2054962526","doi":"10.1177/1352458513507816","title":"Predictors and dynamics of postpartum relapses in women with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame","funders":"Medical Research Council; Novartis Pharma; Sanofi","keywords":"Medicine; Pregnancy; Multiple sclerosis; Postpartum period; Observational study; Obstetrics; Logistic regression; Expanded Disability Status Scale; Internal medicine","score_opus":0.04471579156247234,"score_gpt":0.25050048256732693,"score_spread":0.20578469100485458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054962526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956334,0.00062213244,0.00013675647,0.0019299624,0.00014415612,0.0011943034,0.00007270254,0.00006602443,0.00020056796],"genre_scores_gemma":[0.98889446,0.0062571447,0.004082611,0.00016770611,0.0001430673,0.00024243642,0.0000137788675,0.00008975298,0.0001090695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957753,0.0002282062,0.0010730124,0.00057489926,0.0011541329,0.0011944447],"domain_scores_gemma":[0.99675447,0.0007220852,0.00043421955,0.0005135986,0.0007251529,0.00085049437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091438665,0.0004909877,0.0010705118,0.00073264405,0.0003168627,0.0001652741,0.00031425912,0.00021010722,0.00030334032],"category_scores_gemma":[0.0014987782,0.00036744933,0.00014109215,0.00073515455,0.00071400154,0.00068318244,0.00021951506,0.0010315367,0.000022963786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001430126,0.0005684171,0.92461205,0.0001868875,0.0003354079,0.000014153299,0.002419962,0.00008605519,0.04798723,0.000004755876,0.0008464774,0.021508476],"study_design_scores_gemma":[0.009929307,0.001339927,0.9721174,0.0017966619,0.000053983505,0.0000895974,0.003680148,0.008680333,0.0018591227,0.00002375127,0.00008544342,0.0003442717],"about_ca_topic_score_codex":0.0008057973,"about_ca_topic_score_gemma":0.00084559835,"teacher_disagreement_score":0.047505397,"about_ca_system_score_codex":0.00066897157,"about_ca_system_score_gemma":0.00018274812,"threshold_uncertainty_score":0.99987775},"labels":[],"label_agreement":null},{"id":"W2055670101","doi":"10.1177/1352458510378021","title":"Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Natalizumab; Multiple sclerosis; Neuropsychology; Cohort; Medicine; Cognition; Neuropsychological test; Psychology; Physical therapy; Audiology; Internal medicine; Psychiatry","score_opus":0.08293361720354528,"score_gpt":0.32292379078953776,"score_spread":0.23999017358599248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055670101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750906,0.00016594533,0.00001806358,0.0005685534,0.00032681148,0.0008936118,0.00015437865,0.000034865632,0.00032869665],"genre_scores_gemma":[0.9990035,0.00021487707,0.00027756914,0.0001069876,0.00021521043,0.000072200586,0.00002443429,0.00003751138,0.00004768062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956691,0.00052496605,0.00077350106,0.00041874318,0.0020986586,0.0005149887],"domain_scores_gemma":[0.99713725,0.00052776415,0.000362034,0.00044312823,0.0012634747,0.00026632712],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016776436,0.00030780892,0.00048334958,0.00028309922,0.00041600372,0.00013680368,0.00029085166,0.00019621634,0.00044804194],"category_scores_gemma":[0.0140523,0.00020151837,0.00018291202,0.00045237693,0.0005496681,0.00035176554,0.0002560013,0.0012758013,0.000005971714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002476169,0.00054298714,0.92457217,0.00003209407,0.000073554,0.0000028580855,0.0004979605,0.000052252544,0.030620696,0.000002467923,0.00077851274,0.042576816],"study_design_scores_gemma":[0.007919506,0.00028661158,0.9800016,0.0009188999,0.000102506856,0.000033935783,0.00014124603,0.008656347,0.0015852824,0.00004610633,0.00012643168,0.00018151946],"about_ca_topic_score_codex":0.00044451532,"about_ca_topic_score_gemma":0.0006575768,"teacher_disagreement_score":0.055429425,"about_ca_system_score_codex":0.0001649585,"about_ca_system_score_gemma":0.00012661048,"threshold_uncertainty_score":0.99425274},"labels":[],"label_agreement":null},{"id":"W2059349666","doi":"10.1177/1352458511418629","title":"Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Michael's Hospital","funders":"","keywords":"Medicine; Titer; Glatiramer acetate; Multiple sclerosis; Internal medicine; Antibody; Gastroenterology; Neutralizing antibody; Interferon beta; Randomized controlled trial; Immunology","score_opus":0.3023020924661958,"score_gpt":0.34502276223390443,"score_spread":0.04272066976770861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059349666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926926,0.0015711931,0.00031259202,0.003002923,0.0013201338,0.0033907439,0.000065394735,0.00015006117,0.00091771164],"genre_scores_gemma":[0.98600477,0.0050188685,0.00519742,0.0017408972,0.0013257541,0.0005050128,0.000019099527,0.00013502229,0.000053170654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914156,0.0012297034,0.0023243967,0.0011134992,0.0018759639,0.0020408463],"domain_scores_gemma":[0.99511886,0.0014869126,0.0006009868,0.0012979811,0.0005369449,0.0009583452],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0050371853,0.0008981036,0.001671942,0.0016762984,0.001102219,0.0004533715,0.0014697067,0.0003570769,0.00024012076],"category_scores_gemma":[0.0027227798,0.00062849536,0.001195621,0.0018941528,0.00063819595,0.00069397665,0.00048102063,0.0025150923,0.00017073429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05995549,0.0051884917,0.80193776,0.00018077745,0.0011136065,0.00018455744,0.028926633,0.00004821158,0.0506741,0.00005365808,0.012952393,0.0387843],"study_design_scores_gemma":[0.06939154,0.0037764467,0.9132434,0.0015873541,0.00026398498,0.00012425068,0.005152007,0.00037164596,0.0041451524,0.00006334216,0.0011768468,0.00070402137],"about_ca_topic_score_codex":0.0007842323,"about_ca_topic_score_gemma":0.0015365268,"teacher_disagreement_score":0.111305624,"about_ca_system_score_codex":0.00029865836,"about_ca_system_score_gemma":0.00019910577,"threshold_uncertainty_score":0.99978614},"labels":[],"label_agreement":null},{"id":"W2059898472","doi":"10.1177/1352458514564590","title":"Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Trust; Ministère de la Santé et des Services sociaux; Wellcome Trust","keywords":"Genome-wide association study; Multiple sclerosis; Context (archaeology); Disease; Medicine; Single-nucleotide polymorphism; Genetics; Gene; Biology; Internal medicine; Immunology; Genotype","score_opus":0.13765125678233298,"score_gpt":0.2897771080637355,"score_spread":0.15212585128140255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059898472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541397,0.012879539,0.00009730576,0.00032686474,0.00010925903,0.00089677394,0.00021574316,0.000035646837,0.000024905143],"genre_scores_gemma":[0.9854007,0.012126579,0.0018353806,0.0002041506,0.00011573544,0.00010572025,0.00014016597,0.000054676282,0.000016933993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99521166,0.00059679575,0.0012694423,0.00080393726,0.0011360286,0.0009821521],"domain_scores_gemma":[0.9962312,0.0007711653,0.00050282234,0.00057987403,0.00044899838,0.0014659136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00206106,0.0005182809,0.001671008,0.0014250182,0.00027125693,0.00013175778,0.00027920425,0.00023892126,0.00003863506],"category_scores_gemma":[0.0024380398,0.00045511368,0.00031794998,0.0017926318,0.0007265465,0.00038204025,0.00080681074,0.0008759721,0.000002183151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025548842,0.0006614076,0.9688913,0.00013100564,0.0006716785,0.00022671364,0.0018909689,0.0016337183,0.008339529,7.121421e-7,0.00023520875,0.014762878],"study_design_scores_gemma":[0.010662243,0.00018553232,0.9069792,0.0008043928,0.0004796031,0.000016031898,0.00068600534,0.079536565,0.00021588984,0.000010311635,0.000058940623,0.00036530162],"about_ca_topic_score_codex":0.00080289703,"about_ca_topic_score_gemma":0.0058144364,"teacher_disagreement_score":0.077902846,"about_ca_system_score_codex":0.00087994465,"about_ca_system_score_gemma":0.0002614442,"threshold_uncertainty_score":0.9997901},"labels":[],"label_agreement":null},{"id":"W2065198908","doi":"10.1177/1352458507076988","title":"Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Antibody; Medicine; Interferon; Interferon beta; Virology; Immunology","score_opus":0.3478707443885182,"score_gpt":0.3952532679387781,"score_spread":0.04738252355025985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065198908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888731,0.005757258,0.0009004613,0.0020207367,0.0003499061,0.0013716504,0.00005018214,0.00006260903,0.00061407214],"genre_scores_gemma":[0.97989106,0.013079042,0.006167465,0.00015198067,0.0004482774,0.00005480744,0.000010214598,0.00006391207,0.00013321401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964664,0.0002840108,0.0010994852,0.0005045063,0.00071575755,0.0009298427],"domain_scores_gemma":[0.99657196,0.0012936142,0.00049200206,0.0005882325,0.0005478965,0.0005062933],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0019018763,0.00045796076,0.0009190905,0.000391008,0.0014465635,0.0004655091,0.00052233716,0.00014848627,0.00006362778],"category_scores_gemma":[0.0012050504,0.00029066467,0.00031536608,0.00042839634,0.00078785094,0.0005464604,0.0004988826,0.00054592773,0.000008334808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015251058,0.00097126473,0.45285183,0.00009960074,0.0006337941,0.00002344612,0.005038956,0.00005198335,0.37382138,0.00003063678,0.00082311453,0.16412888],"study_design_scores_gemma":[0.0075876233,0.0012482317,0.92718804,0.002320596,0.0002132765,0.00015677144,0.0039548664,0.00095022103,0.05434176,0.000018764755,0.0017411837,0.00027864566],"about_ca_topic_score_codex":0.0010814063,"about_ca_topic_score_gemma":0.00123161,"teacher_disagreement_score":0.4743362,"about_ca_system_score_codex":0.00037785192,"about_ca_system_score_gemma":0.00014522299,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2066703886","doi":"10.1177/1352458509355461","title":"Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Fractional anisotropy; White matter; Diffusion MRI; Grey matter; Magnetic resonance imaging; Multiple sclerosis; Hyperintensity; Depression (economics); Psychology; Medicine; Nuclear medicine; Radiology; Psychiatry","score_opus":0.07328913343466291,"score_gpt":0.27926450485650717,"score_spread":0.20597537142184424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066703886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377376,0.001061948,0.00025032845,0.0022574016,0.0004659621,0.0011698701,0.000069162066,0.0001872896,0.0007642696],"genre_scores_gemma":[0.9918901,0.0028089865,0.003157417,0.0011940262,0.0005617179,0.000069699294,0.000053995893,0.00009170112,0.00017238174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99361324,0.00039444983,0.0015134576,0.0008385986,0.0018744064,0.0017658735],"domain_scores_gemma":[0.9963789,0.0006479172,0.0004565526,0.0007279306,0.0009175006,0.0008711892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011502554,0.00071020355,0.0011398877,0.0010728803,0.0009179087,0.00038091527,0.0005677086,0.00021498214,0.00025565096],"category_scores_gemma":[0.0038868277,0.00060065975,0.0005384068,0.0008202608,0.00029309507,0.0009437899,0.0002867462,0.0014979886,0.000090688896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009247601,0.0015094118,0.86152977,0.00005174295,0.000072655865,0.000044675082,0.001079456,0.00013561863,0.0545443,0.0000028531142,0.002892633,0.07721211],"study_design_scores_gemma":[0.018816255,0.000412549,0.96419823,0.0015711244,0.0000657103,0.00004590624,0.0008111306,0.0084849,0.004104789,0.000030697305,0.0008839063,0.00057479716],"about_ca_topic_score_codex":0.00034340337,"about_ca_topic_score_gemma":0.00017317929,"teacher_disagreement_score":0.10266845,"about_ca_system_score_codex":0.00072582957,"about_ca_system_score_gemma":0.00014994445,"threshold_uncertainty_score":0.99964446},"labels":[],"label_agreement":null},{"id":"W2067663958","doi":"10.1177/1352458510391837","title":"Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis","year":2010,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Surrogate endpoint; Clinical trial; Placebo; Lesion; Internal medicine; Surgery; Radiology; Pathology; Immunology","score_opus":0.3715157068469907,"score_gpt":0.37935466283444463,"score_spread":0.007838955987453933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067663958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045921193,0.98306894,0.00007540606,0.00042667644,0.0014055916,0.0068522724,0.0031949298,0.00016382552,0.00022020857],"genre_scores_gemma":[0.0029722007,0.9790141,0.011802828,0.00019900501,0.0014409106,0.002564801,0.0003158984,0.0005034988,0.0011867774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884704,0.0010160524,0.003323576,0.0019809792,0.0024382821,0.0027707373],"domain_scores_gemma":[0.98751855,0.0065298523,0.0016012088,0.0015975413,0.0012681623,0.0014846795],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0031293142,0.0019430756,0.005651005,0.002324061,0.0015964693,0.00054128194,0.0016927824,0.001771361,0.00036867126],"category_scores_gemma":[0.019558495,0.0015970634,0.0027541844,0.0018725523,0.0009162474,0.00062483444,0.0009596842,0.006866567,0.00032680904],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006181276,0.0008997496,0.0023694192,0.0029607157,0.00043642055,0.00006575287,0.00050649064,0.000002969464,0.00083606306,0.000007664871,0.004814067,0.98648256],"study_design_scores_gemma":[0.014399229,0.0011441258,0.13013548,0.065930516,0.0016700756,0.0004027254,0.0003585875,0.00019172052,0.00023476755,0.00003434388,0.7838208,0.0016776182],"about_ca_topic_score_codex":0.0004367459,"about_ca_topic_score_gemma":0.0019281419,"teacher_disagreement_score":0.9848049,"about_ca_system_score_codex":0.0012538116,"about_ca_system_score_gemma":0.0021315017,"threshold_uncertainty_score":0.9997033},"labels":[],"label_agreement":null},{"id":"W2067777541","doi":"10.1177/1352458514533846","title":"Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Guideline; Clinical trial; Magnetic resonance imaging; Odds ratio; Lesion; Cohort; Medical physics; Radiology; Internal medicine; Pathology; Psychiatry","score_opus":0.4590526859922196,"score_gpt":0.43068479568666235,"score_spread":0.028367890305557253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067777541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865634,0.0015074091,0.0025622102,0.0048049525,0.0010409337,0.0012089601,0.00003951387,0.00008501466,0.00009468323],"genre_scores_gemma":[0.9792618,0.0033935101,0.015355237,0.00034799965,0.0014316217,0.00007162242,0.000008895686,0.000093769806,0.00003552249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890994,0.0039810226,0.003416297,0.0008441313,0.0017618648,0.00089732715],"domain_scores_gemma":[0.9879613,0.008038285,0.0012911027,0.00086996204,0.0011887801,0.0006505685],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021711301,0.0005540061,0.001927646,0.0008120733,0.00043554956,0.000120843346,0.00043280737,0.0002797404,0.00009755189],"category_scores_gemma":[0.05591331,0.0004511644,0.0007654875,0.00078716857,0.00050395116,0.0003896705,0.00019287184,0.0014741957,0.000024447281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019859138,0.00026791482,0.5481214,0.000053656946,0.00002025582,0.000003100393,0.00013759002,0.00070975727,0.14827466,6.196487e-7,0.0004286741,0.29999647],"study_design_scores_gemma":[0.0145785,0.0005638188,0.8168767,0.0045351675,0.00006777085,0.0000045779516,0.00016368597,0.13404822,0.028356628,0.0000145788235,0.0004835325,0.0003067781],"about_ca_topic_score_codex":0.00031031398,"about_ca_topic_score_gemma":0.00010591286,"teacher_disagreement_score":0.2996897,"about_ca_system_score_codex":0.00043748942,"about_ca_system_score_gemma":0.00029731868,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W2068169278","doi":"10.1177/1352458507076994","title":"Clinical significance of glatiramer acetate antibodies","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Teva Pharmaceuticals (Canada)","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Antibody; Immunology; Antigen; Remyelination; Medicine; In vitro; Pharmacology; Chemistry; Internal medicine; Biochemistry; Myelin; Central nervous system","score_opus":0.0781630640935224,"score_gpt":0.3150464879561985,"score_spread":0.23688342386267608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068169278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443025,0.010047018,0.0031123543,0.00010314258,0.0017688501,0.00014086373,0.000013376014,0.000031156218,0.00035300455],"genre_scores_gemma":[0.9949104,0.002463115,0.0012066322,0.00015567873,0.00009084112,0.0000017110373,0.0000062437084,0.000021872707,0.0011435115],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977333,0.0004510316,0.0010683511,0.00019527413,0.00007151266,0.00048051905],"domain_scores_gemma":[0.99792284,0.0010426915,0.0005340556,0.00026867096,0.00019537717,0.000036390284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025566532,0.00018698564,0.00047501174,0.00016516178,0.00031417355,0.00002398238,0.00033388665,0.00023562512,0.00054083025],"category_scores_gemma":[0.0005083367,0.00015011373,0.00034991422,0.0001583277,0.0006197043,0.00016553025,0.000053254273,0.00067782996,0.00017320692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016319938,0.00020923904,0.12593518,0.0000064309666,0.00030027158,0.000003848568,0.0003767958,0.000004983137,0.76791805,0.000023674726,0.0010365106,0.102553],"study_design_scores_gemma":[0.0028474545,0.00030356742,0.6177126,0.0000998733,0.00003080431,0.000089828405,0.00033193894,0.0000031640047,0.35368624,0.000029895593,0.024702648,0.00016196215],"about_ca_topic_score_codex":0.00003646155,"about_ca_topic_score_gemma":0.000011165696,"teacher_disagreement_score":0.49177745,"about_ca_system_score_codex":0.000026057138,"about_ca_system_score_gemma":0.00007496035,"threshold_uncertainty_score":0.612146},"labels":[],"label_agreement":null},{"id":"W2068621861","doi":"10.1191/1352458503ms890cr","title":"Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia Hospital","funders":"","keywords":"Magnetic resonance imaging; Medicine; Subclinical infection; Multiple sclerosis; Weakness; Neurological examination; Radiology; White matter; Pathology; Surgery","score_opus":0.11315162277365372,"score_gpt":0.3495906413341083,"score_spread":0.23643901856045457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068621861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641956,0.010768833,0.00017472621,0.0008463517,0.0003393749,0.0011475917,0.0000805512,0.000033317367,0.00018968992],"genre_scores_gemma":[0.9895693,0.001945308,0.00752779,0.00027071495,0.0002949587,0.00012470632,0.000013923668,0.00006790312,0.00018539332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943506,0.0010913622,0.0017185577,0.00054486666,0.0015239147,0.0007706594],"domain_scores_gemma":[0.994857,0.002636426,0.00074549695,0.00063673797,0.00072882563,0.00039552082],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025824916,0.0003587882,0.00090713624,0.00034234714,0.00039507236,0.00009356949,0.00044542394,0.00017350393,0.00068367645],"category_scores_gemma":[0.009374124,0.0002690334,0.00062968343,0.00064579584,0.0012258334,0.00034731178,0.0003285249,0.001083485,0.000030719897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020919796,0.00073685736,0.8218169,0.00008719993,0.000102988844,0.0000339123,0.0008927592,0.000019551568,0.04697528,0.000005952362,0.0038790973,0.12335749],"study_design_scores_gemma":[0.0071180966,0.00044832888,0.9825956,0.0014436117,0.00012526465,0.00010749589,0.00093765295,0.0009671755,0.0044925935,0.000018148248,0.0015128556,0.00023314869],"about_ca_topic_score_codex":0.000052091702,"about_ca_topic_score_gemma":0.00004472476,"teacher_disagreement_score":0.1607787,"about_ca_system_score_codex":0.00024269952,"about_ca_system_score_gemma":0.00035218758,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W2069614919","doi":"10.1177/1352458508101877","title":"What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?","year":2009,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"CINAHL; Medicine; Psychological intervention; Psychosocial; Physical therapy; MEDLINE; Randomized controlled trial; Medical prescription; Quality of life (healthcare); Exercise prescription; Meta-analysis; PsycINFO; Physical medicine and rehabilitation; Evidence-based medicine; Alternative medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.30852877835541037,"score_gpt":0.40388154075467614,"score_spread":0.09535276239926577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069614919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009520942,0.98487896,0.0003591308,0.0002536782,0.0006498883,0.012275585,0.00059018144,0.000025313298,0.00001515778],"genre_scores_gemma":[0.019939233,0.97593206,0.0025145446,0.000022755048,0.00025562654,0.0011332252,0.00003150733,0.0001466752,0.000024377658],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9872082,0.005536536,0.003887941,0.0007915233,0.001738488,0.00083732465],"domain_scores_gemma":[0.97765243,0.012974358,0.00555203,0.00154596,0.001975168,0.00030006547],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014212062,0.0010660309,0.00863634,0.0005836169,0.00062880386,0.00013199006,0.0014398879,0.0004229291,0.000055599634],"category_scores_gemma":[0.015837986,0.00045082576,0.0068080393,0.0010049806,0.0010022477,0.00038327428,0.0003532758,0.0014992191,0.0000010999162],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001198654,0.00061737245,0.00056350604,0.3725578,0.0030394746,0.0000014891658,0.00056157657,0.0000165147,0.0014671105,0.000009769476,0.00022312923,0.6197436],"study_design_scores_gemma":[0.0057408973,0.0008973516,0.033451006,0.941181,0.009423408,0.000051993506,0.00090876594,0.000026081363,0.0024839933,0.000014468831,0.00537148,0.00044952883],"about_ca_topic_score_codex":0.000053061794,"about_ca_topic_score_gemma":0.0001259186,"teacher_disagreement_score":0.6192941,"about_ca_system_score_codex":0.00033267576,"about_ca_system_score_gemma":0.0007385643,"threshold_uncertainty_score":0.99979436},"labels":[],"label_agreement":null},{"id":"W2070532347","doi":"10.1177/1352458509106212","title":"Assessing disability progression with the Multiple Sclerosis Functional Composite","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Marshall Space Flight Center; U.S. Food and Drug Administration; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Natalizumab; Expanded Disability Status Scale; Tumor progression; Internal medicine; Immunology; Cancer","score_opus":0.15916972394199919,"score_gpt":0.3407200830062368,"score_spread":0.1815503590642376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070532347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738939,0.00076366804,0.0046225404,0.018443404,0.00030685402,0.0012827013,0.000023009625,0.00022346014,0.0004404769],"genre_scores_gemma":[0.98828226,0.00044178113,0.008793447,0.0010203733,0.0011614357,0.00009061984,0.000038223432,0.00006901235,0.000102843034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409956,0.00053429994,0.0008821664,0.0008071773,0.0024229055,0.0012538958],"domain_scores_gemma":[0.9958927,0.0010672489,0.000496714,0.0008661558,0.0009043793,0.00077277713],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018619787,0.00063497166,0.00084216153,0.00019654976,0.002797513,0.0010100636,0.0004885762,0.00020075616,0.00023374996],"category_scores_gemma":[0.0011006012,0.0003573583,0.00049604697,0.0008431894,0.0010546388,0.0011125143,0.00020098938,0.0018234464,0.000053956886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019782202,0.0015393723,0.50056326,0.000048680187,0.00028778918,0.000021647782,0.00044749293,0.0003989868,0.2800764,0.000005898275,0.0048886514,0.20974357],"study_design_scores_gemma":[0.0077709947,0.00083304854,0.9724882,0.0012422496,0.00017227809,0.00023959458,0.0008852449,0.003483995,0.010828881,0.000013144299,0.001616665,0.00042568176],"about_ca_topic_score_codex":0.000043785476,"about_ca_topic_score_gemma":0.00007586094,"teacher_disagreement_score":0.47192496,"about_ca_system_score_codex":0.0006455219,"about_ca_system_score_gemma":0.00023419365,"threshold_uncertainty_score":0.9998878},"labels":[],"label_agreement":null},{"id":"W2071187169","doi":"10.1177/1352458509350307","title":"Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Research Nova Scotia; Canadian Institutes of Health Research; Dalhousie University; Health Research Board","keywords":"Medicine; Multiple sclerosis; Population; Disease; Expanded Disability Status Scale; Clinical trial; Randomized controlled trial; Physical therapy; Family medicine; Internal medicine; Psychiatry; Environmental health","score_opus":0.07698403910704203,"score_gpt":0.34697230562340625,"score_spread":0.2699882665163642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071187169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925663,0.00094563694,0.00007466779,0.00133996,0.00023307402,0.004440772,0.00009184304,0.00029102797,0.000016741064],"genre_scores_gemma":[0.99451697,0.0003037858,0.0034616268,0.00011585544,0.0005296901,0.00060553517,0.0003471686,0.00009581643,0.000023559669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99282813,0.00047068959,0.0011619817,0.0010876828,0.003164841,0.0012866934],"domain_scores_gemma":[0.9948655,0.00024397804,0.0006495401,0.0006698451,0.00135537,0.0022157768],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0013017267,0.0007189004,0.0008000739,0.0007211757,0.0020561526,0.00059366325,0.00030356288,0.00014718107,0.0000854053],"category_scores_gemma":[0.00446412,0.0005978973,0.000494697,0.000686162,0.00028412297,0.0009895705,0.0001862846,0.00090843486,0.000011022218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021580518,0.0018346801,0.8476603,0.00024236349,0.00010959215,0.000023876913,0.00030762586,0.0005944336,0.0013277392,7.82695e-7,0.000120137585,0.14562044],"study_design_scores_gemma":[0.015290644,0.0004483521,0.88322765,0.0038593705,0.00040854004,0.000004403938,0.00008207562,0.09591423,0.00023206651,0.00003142068,0.00001569827,0.0004855531],"about_ca_topic_score_codex":0.00011748155,"about_ca_topic_score_gemma":0.00019251154,"teacher_disagreement_score":0.1451349,"about_ca_system_score_codex":0.0009236051,"about_ca_system_score_gemma":0.0003095122,"threshold_uncertainty_score":0.99964726},"labels":[],"label_agreement":null},{"id":"W2072924355","doi":"10.1177/1352458514546790","title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Natalizumab; Pregnancy; Medicine; Obstetrics; Miscarriage; Fetus; Premature birth; Prospective cohort study; Multiple sclerosis; Gynecology; Gestation; Internal medicine; Immunology; Biology","score_opus":0.09738529578808428,"score_gpt":0.3143172657045213,"score_spread":0.216931969916437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072924355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176615,0.0039304513,0.0006849659,0.0006435514,0.0004331258,0.0020447166,0.0000066542807,0.000060172304,0.00043022106],"genre_scores_gemma":[0.9976599,0.0001701283,0.001164483,0.00017531127,0.00009571715,0.000268972,0.0000083686145,0.000034372984,0.00042271957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734634,0.0002554384,0.00083766686,0.00038566964,0.0007368937,0.0004379742],"domain_scores_gemma":[0.9984942,0.00038734157,0.0003172397,0.00030727504,0.0001533583,0.00034058472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075900025,0.00029636326,0.00088108215,0.00027311963,0.0002806684,0.00009784667,0.00015950127,0.00012216173,0.000058226735],"category_scores_gemma":[0.0028762408,0.00022170058,0.0002735014,0.000260611,0.00006517049,0.0004835828,0.000060934086,0.0005651562,0.000007194328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003647699,0.0009888335,0.9776072,0.00003956587,0.00029162515,0.000052234416,0.0016589327,0.000009486128,0.0008555895,0.000034755863,0.00002518424,0.018071856],"study_design_scores_gemma":[0.06402582,0.00077219825,0.928541,0.0047216485,0.0001731928,0.00007697485,0.0005008381,0.00075416826,0.000086828535,0.00011740223,0.000027127335,0.00020277653],"about_ca_topic_score_codex":0.000029438239,"about_ca_topic_score_gemma":0.000084897234,"teacher_disagreement_score":0.06366105,"about_ca_system_score_codex":0.00017760371,"about_ca_system_score_gemma":0.0001959478,"threshold_uncertainty_score":0.9040687},"labels":[],"label_agreement":null},{"id":"W2073107052","doi":"10.1177/1352458514523692","title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Hemolytic anemia; Multiple sclerosis; Internal medicine; Pediatrics; Microangiopathic hemolytic anemia; Interferon beta-1a; Complication; Gastroenterology; Plasmapheresis; Immunology; Platelet; Interferon beta; Antibody","score_opus":0.05475181792089281,"score_gpt":0.23515836579819868,"score_spread":0.18040654787730587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073107052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941486,0.00059425307,0.00019580364,0.00025846704,0.0034848268,0.0009477787,0.00007702263,0.00015479776,0.00013844363],"genre_scores_gemma":[0.99870294,0.00010522759,0.0002702564,0.00033264572,0.00012256415,0.000072222065,0.00015733583,0.000118019954,0.00011880974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452114,0.0012253136,0.001672471,0.00091349165,0.00033353348,0.0013340756],"domain_scores_gemma":[0.996561,0.0012827476,0.00087306777,0.0008732833,0.0002178135,0.00019211313],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012696915,0.000704129,0.0011488054,0.0006406511,0.00080235436,0.00022232432,0.0010854808,0.0003886655,0.0009750878],"category_scores_gemma":[0.0017533118,0.00064962625,0.00040837887,0.0004446781,0.00025718968,0.00050786574,0.00039275858,0.0013668429,0.0012182186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010118635,0.002028064,0.7378389,0.00010989892,0.00040826207,0.000014077175,0.0007128365,0.0010638691,0.24028781,0.00006840827,0.004965235,0.011490772],"study_design_scores_gemma":[0.016182244,0.001264955,0.966279,0.003961485,0.00012759963,0.00013413359,0.00026096372,0.0004378637,0.010238315,0.00012528767,0.00024206506,0.00074614404],"about_ca_topic_score_codex":0.00033161824,"about_ca_topic_score_gemma":0.0002857546,"teacher_disagreement_score":0.23004949,"about_ca_system_score_codex":0.0008350254,"about_ca_system_score_gemma":0.000089863075,"threshold_uncertainty_score":0.99993813},"labels":[],"label_agreement":null},{"id":"W2074128816","doi":"10.1191/1352458503ms903oa","title":"Patient and community preferences for treatments and health states in multiple sclerosis","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Respondent; Medicine; Quality of life (healthcare); Multiple sclerosis; Family medicine; Gerontology; Disease; Health economics; Community health; Demography; Public health; Psychiatry; Nursing; Internal medicine","score_opus":0.2846911395605672,"score_gpt":0.35104593332551415,"score_spread":0.06635479376494696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074128816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931829,0.0035877328,0.00016960048,0.0009931001,0.00013046109,0.0016866724,0.00014211389,0.00003969638,0.00006770026],"genre_scores_gemma":[0.97233385,0.018443465,0.0084773945,0.00035054213,0.000047030728,0.0002382164,0.00003257043,0.000047029866,0.000029875093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963449,0.0009288322,0.0008507301,0.00042576622,0.0005326159,0.0009171347],"domain_scores_gemma":[0.99700487,0.00135708,0.00031628506,0.00034133915,0.00028029634,0.00070010725],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0021588407,0.00040679984,0.000853438,0.00038210923,0.0015686114,0.00018949721,0.00012975652,0.00011939742,0.00002970827],"category_scores_gemma":[0.00210899,0.00032291378,0.00013749384,0.00028267104,0.0003389521,0.00029349176,0.00014469384,0.0009767454,0.0000028438628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042891054,0.0012545423,0.87804246,0.000221985,0.00023785663,0.0000025992308,0.006591889,0.000030816038,0.0064110192,0.0000054136362,0.0008568929,0.10591562],"study_design_scores_gemma":[0.012879988,0.0023368134,0.9723073,0.0010730197,0.00004624795,0.000043139768,0.0068579414,0.0012371814,0.00218488,0.00015204595,0.0006066723,0.00027472517],"about_ca_topic_score_codex":0.0016043659,"about_ca_topic_score_gemma":0.002471263,"teacher_disagreement_score":0.105640896,"about_ca_system_score_codex":0.00040020264,"about_ca_system_score_gemma":0.00018449822,"threshold_uncertainty_score":0.9999223},"labels":[],"label_agreement":null},{"id":"W2074733161","doi":"10.1177/135245850000600309","title":"Confabulation and multiple sclerosis: a rare association","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Memory and Neural Mechanisms","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Confabulation (neural networks); Psychology; Amnesia; Multiple sclerosis; Neuroscience; Frontal lobe; Context (archaeology); Neuropsychology; Cognition; Episodic memory; Neuropsychological assessment; Cognitive psychology; Psychiatry","score_opus":0.17802218245320597,"score_gpt":0.26947723633001963,"score_spread":0.09145505387681366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074733161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976553,0.000099282086,0.00015083245,0.0006968124,0.00052841747,0.00028003863,0.00003611588,0.00011196926,0.00044125944],"genre_scores_gemma":[0.9961317,0.00095222035,0.00038937858,0.0012272126,0.00031911585,0.000011090078,0.0000032051814,0.000032677184,0.00093340233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756044,0.00041565736,0.00048118844,0.0004441919,0.00059259107,0.0005059563],"domain_scores_gemma":[0.99850994,0.0006168659,0.00030461894,0.00020035823,0.00007718996,0.00029104945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005799214,0.00024083094,0.00027133344,0.00012183914,0.0009293297,0.00039983052,0.00023372448,0.00016703868,0.001279041],"category_scores_gemma":[0.0014068206,0.00022083048,0.00012271854,0.00026614557,0.00005275862,0.0007763267,0.000042031694,0.0004919978,0.00022590798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015395513,0.00008611427,0.008531495,0.0000073460587,0.0000084326275,0.0000087441595,0.00037601858,0.0002510854,0.94797593,0.000021464566,0.00057978876,0.041999593],"study_design_scores_gemma":[0.0034986392,0.00017306973,0.08725809,0.0001869925,0.00003166611,0.0001338443,0.00008040663,0.012475256,0.8938779,0.00036059876,0.0015571563,0.00036637942],"about_ca_topic_score_codex":0.000008352839,"about_ca_topic_score_gemma":0.000012742927,"teacher_disagreement_score":0.0787266,"about_ca_system_score_codex":0.00013916212,"about_ca_system_score_gemma":0.000028418537,"threshold_uncertainty_score":0.9996339},"labels":[],"label_agreement":null},{"id":"W2075877026","doi":"10.1177/1352458513489853","title":"CRYAB modulates the activation of CD4 <sup>+</sup> T cells from relapsing–remitting multiple sclerosis patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Cytokine; Medicine; Immunology; Encephalomyelitis; T cell; CD8; Immune system","score_opus":0.040508655124709185,"score_gpt":0.23478996158266616,"score_spread":0.19428130645795696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075877026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643576,0.0002080974,0.0020623773,0.00029761283,0.00015553467,0.00069110765,0.00006394606,0.000016930999,0.00006862833],"genre_scores_gemma":[0.9944987,0.000310488,0.0042745066,0.00014848134,0.00044858313,0.00006566767,0.000095305484,0.000069736285,0.00008847239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703264,0.00042224256,0.0007480961,0.0004734145,0.0006939384,0.0006296853],"domain_scores_gemma":[0.9977299,0.00027459624,0.00037447872,0.00063746993,0.0007338784,0.00024967015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006265795,0.000307779,0.00030829632,0.0001230363,0.0005973666,0.00022238844,0.0006632677,0.00030305935,0.00019166636],"category_scores_gemma":[0.0015225803,0.00023465684,0.0002636421,0.00023896869,0.00018356793,0.00006150408,0.00034655238,0.0005890346,0.00006198998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089455876,0.00019847203,0.08124058,0.000011868048,0.0001045854,2.1154231e-7,0.00034257252,0.004340386,0.8876925,3.6207763e-7,0.0020515483,0.023927473],"study_design_scores_gemma":[0.0020397734,0.00019555654,0.16316582,0.00023959442,0.000017413187,0.0000016605206,0.00031922097,0.016740337,0.8164534,0.000033366065,0.0005490283,0.00024485853],"about_ca_topic_score_codex":0.0008786704,"about_ca_topic_score_gemma":0.000021695132,"teacher_disagreement_score":0.08192524,"about_ca_system_score_codex":0.00009920833,"about_ca_system_score_gemma":0.00010507027,"threshold_uncertainty_score":0.9569028},"labels":[],"label_agreement":null},{"id":"W2076224442","doi":"10.1177/1352458506070943","title":"Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005)","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Immunosuppression; Medicine; Clinical trial; Magnetic resonance imaging; Intensive care medicine; Medical physics; Pathology; Immunology; Radiology","score_opus":0.10857163179573183,"score_gpt":0.29567875969736734,"score_spread":0.18710712790163553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076224442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772082,0.013802843,0.0021154967,0.0033614219,0.00034423763,0.0023305558,0.00060046127,0.000113527945,0.00012326248],"genre_scores_gemma":[0.97218394,0.01996876,0.0053512156,0.0000628948,0.0006262662,0.00038107828,0.00011388335,0.00010000183,0.0012119388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99579257,0.00023433405,0.0011787362,0.000714847,0.0009536554,0.0011258349],"domain_scores_gemma":[0.9966001,0.0008887477,0.0005263243,0.0006389956,0.0007274408,0.00061839167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005092205,0.0006529332,0.0014542623,0.00039118246,0.00085119,0.00020330127,0.00027017773,0.0002035594,0.00031835856],"category_scores_gemma":[0.0006148021,0.0003994719,0.0007376719,0.00029855414,0.00060350494,0.00032472928,0.00012325255,0.00022940389,0.000009880273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002220312,0.002932232,0.29911894,0.00014814566,0.00062954664,0.000012613101,0.0005434675,0.00008049963,0.58581644,0.000022087757,0.0032452021,0.10523054],"study_design_scores_gemma":[0.022943439,0.0014587123,0.8790849,0.00087685196,0.00029804953,0.000026247686,0.00048115346,0.0045180055,0.07887843,0.00005670699,0.010894215,0.00048330525],"about_ca_topic_score_codex":0.00044841281,"about_ca_topic_score_gemma":0.0001689928,"teacher_disagreement_score":0.57996595,"about_ca_system_score_codex":0.00035247544,"about_ca_system_score_gemma":0.0002421195,"threshold_uncertainty_score":0.99984574},"labels":[],"label_agreement":null},{"id":"W2079172650","doi":"10.1191/1352458504ms1083oa","title":"Multiple sclerosis gender issues: clinical practices of women neurologists","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Discontinuation; Breastfeeding; Multiple sclerosis; Glatiramer acetate; Pregnancy; Family medicine; Reproductive health; Disease; Obstetrics and gynaecology; Natalizumab; Pediatrics; Obstetrics; Psychiatry; Internal medicine; Population","score_opus":0.3547212749573583,"score_gpt":0.4156737202397511,"score_spread":0.0609524452823928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079172650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093056,0.0019998944,0.00047440364,0.003904635,0.00092455937,0.0010277423,0.000060493236,0.00017060623,0.0005070933],"genre_scores_gemma":[0.96780246,0.01629286,0.0132114645,0.0009433131,0.0014190226,0.00011482957,0.000015049582,0.00010776822,0.00009322033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916683,0.0008096955,0.0024345028,0.0010198611,0.0021160478,0.0019516104],"domain_scores_gemma":[0.9918025,0.0018731949,0.0022803703,0.0011244604,0.0013405739,0.0015788943],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052876095,0.0006748652,0.0017871566,0.0005941541,0.0007006623,0.0002205717,0.000831969,0.0004561853,0.0004643523],"category_scores_gemma":[0.02726919,0.00055002456,0.0009005911,0.0008292624,0.0011294673,0.00078753143,0.0005398567,0.0022414757,0.00019276132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003197191,0.0034337419,0.8473487,0.00027431987,0.0012597478,0.00010888864,0.0033315958,0.00065542565,0.11604663,0.000028511804,0.0026633407,0.021651892],"study_design_scores_gemma":[0.018263953,0.0019954192,0.9623939,0.00056600163,0.00017995381,0.00019395402,0.001655719,0.00051370234,0.007874914,0.000101731275,0.0057702404,0.0004905052],"about_ca_topic_score_codex":0.0005518643,"about_ca_topic_score_gemma":0.00013145054,"teacher_disagreement_score":0.11504519,"about_ca_system_score_codex":0.00086956983,"about_ca_system_score_gemma":0.0007010394,"threshold_uncertainty_score":0.9996951},"labels":[],"label_agreement":null},{"id":"W2080270161","doi":"10.1177/135245850100700606","title":"Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting clinical course","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Myelin; Remyelination; Concentric; Lesion; Pathology; Pathogenesis; Medicine; Central nervous system; Immunology; Internal medicine","score_opus":0.11706648513721615,"score_gpt":0.3312075394348427,"score_spread":0.21414105429762656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080270161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921796,0.002499324,0.00068986585,0.0017991267,0.0006944295,0.0010973904,0.000018774148,0.00013608387,0.00088542677],"genre_scores_gemma":[0.98225504,0.010120448,0.0056763664,0.0006433563,0.0009839846,0.00008204419,0.000013386305,0.000121942125,0.00010340133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99192345,0.0009359027,0.002279224,0.00094186835,0.0020135723,0.0019059563],"domain_scores_gemma":[0.99483943,0.0014717904,0.0008283281,0.00069943315,0.0009773179,0.0011836819],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004091061,0.0006489044,0.0013966745,0.0004797471,0.00078209816,0.00030984066,0.0004525034,0.0003265261,0.00035654433],"category_scores_gemma":[0.004284165,0.000510843,0.0005053184,0.0015628807,0.0005590267,0.00063150015,0.0003473052,0.0027734472,0.00009149545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019329425,0.0013743318,0.86568886,0.00004388508,0.00030148434,0.00058759877,0.0010674362,0.0004563465,0.0041211154,0.0000018882326,0.0014530352,0.12297105],"study_design_scores_gemma":[0.016835334,0.0013696798,0.96212864,0.004912899,0.00015986324,0.0011388384,0.0024549095,0.008349832,0.00039600776,0.0000033294261,0.0016759747,0.0005747008],"about_ca_topic_score_codex":0.00031637106,"about_ca_topic_score_gemma":0.0006982586,"teacher_disagreement_score":0.12239634,"about_ca_system_score_codex":0.00066085864,"about_ca_system_score_gemma":0.0006273863,"threshold_uncertainty_score":0.99973434},"labels":[],"label_agreement":null},{"id":"W2080859771","doi":"10.1177/1352458513516528","title":"Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metabolomics; Pathogenesis; Multiple sclerosis; Metabolite; Choline; Cerebrospinal fluid; Metabolome; Chemistry; Medicine; Internal medicine; Pathology; Biochemistry; Immunology; Chromatography","score_opus":0.09206724863939346,"score_gpt":0.28314625544626326,"score_spread":0.1910790068068698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080859771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899634,0.0062262393,0.00096342823,0.0010004659,0.00043099304,0.0010758919,0.000014030907,0.00012851851,0.00019701624],"genre_scores_gemma":[0.96745324,0.010227832,0.021081202,0.00036225352,0.00053015776,0.0001746563,0.000019545776,0.000118462835,0.000032661836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945147,0.00074929727,0.0013418715,0.0009944079,0.0011710909,0.0012286222],"domain_scores_gemma":[0.99646693,0.0010373299,0.0004042701,0.0006708213,0.0004745834,0.0009460553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023261576,0.00067277317,0.0012852714,0.0012257035,0.0009223359,0.0002843152,0.00041866014,0.00031838476,0.000057037236],"category_scores_gemma":[0.0050490405,0.0005548025,0.00037379775,0.00095375755,0.0005511288,0.0005855758,0.00043068515,0.0010785664,0.00005486558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007000217,0.00031340396,0.37094846,0.00013753767,0.00027136793,0.00001633563,0.0010355915,0.00006328966,0.5519415,0.000012699159,0.00023306017,0.0743267],"study_design_scores_gemma":[0.012462912,0.00035714128,0.91303164,0.0011491895,0.00014065935,0.000067521294,0.0011528236,0.021849284,0.047788538,0.00008453061,0.0013376775,0.0005780649],"about_ca_topic_score_codex":0.0003469815,"about_ca_topic_score_gemma":0.0005949175,"teacher_disagreement_score":0.5420832,"about_ca_system_score_codex":0.000412104,"about_ca_system_score_gemma":0.00018432687,"threshold_uncertainty_score":0.99969035},"labels":[],"label_agreement":null},{"id":"W2084404808","doi":"10.1177/1352458509106779","title":"Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; Hôpital Notre-Dame; University of Alberta; University of Calgary","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Minocycline; Medicine; Multiple sclerosis; Placebo; Natalizumab; Magnetic resonance imaging; Clinical endpoint; Internal medicine; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Antibiotics; Radiology; Immunology; Chemistry","score_opus":0.09012657667490344,"score_gpt":0.289785313866564,"score_spread":0.19965873719166055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084404808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950505,0.000267421,0.00004394076,0.0016325858,0.00027325226,0.007792983,0.00006347925,0.000047618505,0.00037368998],"genre_scores_gemma":[0.99289185,0.0006306512,0.0055702715,0.00018265666,0.0001852841,0.0002491864,0.00011469696,0.000086984255,0.00008842013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925403,0.00053795846,0.0026073882,0.0008937569,0.0018799991,0.0015406002],"domain_scores_gemma":[0.99488395,0.0009659112,0.0013474482,0.0006546784,0.0013040038,0.0008440132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026498686,0.0007331673,0.001943393,0.0034912697,0.00039679353,0.00018025002,0.0004342289,0.0003186549,0.000028845261],"category_scores_gemma":[0.0034307044,0.00054533227,0.00030852962,0.0022697628,0.00029104718,0.0007286429,0.00007919414,0.0017082182,0.000009279473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66021353,0.0029027273,0.32370552,0.00003908753,0.00025026972,0.000024837142,0.0013736213,0.00089945423,0.002448276,0.0000012680513,0.00013532462,0.00800605],"study_design_scores_gemma":[0.52619857,0.002668775,0.46375522,0.0024992337,0.00010093707,0.0000043105983,0.0002953813,0.0035100742,0.0006195188,0.0000016021737,0.00004119032,0.00030516816],"about_ca_topic_score_codex":0.01484737,"about_ca_topic_score_gemma":0.08571922,"teacher_disagreement_score":0.1400497,"about_ca_system_score_codex":0.001062288,"about_ca_system_score_gemma":0.0006012509,"threshold_uncertainty_score":0.99969983},"labels":[],"label_agreement":null},{"id":"W2086164539","doi":"10.1177/1352458514564492","title":"Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heritability; Confidence interval; Meta-analysis; Twin study; Demography; Population; Medicine; Polychoric correlation; Environmental health; Biology; Genetics; Internal medicine; Mathematics","score_opus":0.6045651878235708,"score_gpt":0.42972281535086937,"score_spread":0.17484237247270146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086164539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0200426,0.97620684,0.000040546744,0.00012740787,0.0002835632,0.0028506322,0.00036655838,0.0000508763,0.00003097447],"genre_scores_gemma":[0.06983533,0.9243464,0.004745759,0.000027651582,0.00021356228,0.00061019446,0.00006321887,0.00012325088,0.0000346505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99094445,0.0017703811,0.0032619883,0.0011446094,0.0018658006,0.0010127742],"domain_scores_gemma":[0.9941906,0.0019590736,0.0015737626,0.0010256225,0.0005054627,0.0007455275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0059820875,0.0012108408,0.0078108283,0.00087475637,0.00035303354,0.00010708728,0.0004789634,0.00054457725,0.00009612934],"category_scores_gemma":[0.0076607936,0.00086983707,0.0016442148,0.0008249776,0.0015954875,0.0005028595,0.00085021945,0.0019221841,0.000025274196],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030321453,0.0016497052,0.009523878,0.024969468,0.0086058965,0.000032655862,0.0016431344,0.000094872565,0.0002647125,0.0000015866423,0.0009042104,0.95200664],"study_design_scores_gemma":[0.05079452,0.0051519433,0.25665593,0.24700068,0.06966981,0.0017069861,0.012410451,0.00622605,0.00065418234,0.00029771042,0.34248483,0.0069469223],"about_ca_topic_score_codex":0.00019681218,"about_ca_topic_score_gemma":0.0001729176,"teacher_disagreement_score":0.9450597,"about_ca_system_score_codex":0.001721147,"about_ca_system_score_gemma":0.00047855984,"threshold_uncertainty_score":0.9993752},"labels":[],"label_agreement":null},{"id":"W2086900658","doi":"10.1177/1352458515569098","title":"Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Myelin Repair Foundation","keywords":"Sample size determination; Lesion; Multiple sclerosis; Medicine; Magnetic resonance imaging; Clinical trial; Nuclear medicine; Percentile; Radiology; Statistics; Mathematics; Pathology","score_opus":0.41396155585310357,"score_gpt":0.42495341242445117,"score_spread":0.010991856571347602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086900658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602775,0.0028811544,0.030979095,0.0014285262,0.0004821756,0.003524661,0.000343527,0.000072606446,0.00001074707],"genre_scores_gemma":[0.9532418,0.00062415353,0.04519936,0.000047149915,0.0004033975,0.00036857958,0.000023076525,0.000053637465,0.00003880358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953112,0.00045494077,0.0020930634,0.00059911463,0.00092510105,0.0006165964],"domain_scores_gemma":[0.9929483,0.0035002958,0.00060473225,0.0003969542,0.0020423653,0.0005073739],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031392928,0.00036662773,0.0012375752,0.000453375,0.00042762907,0.000034229633,0.00019034032,0.0001765662,0.000028515748],"category_scores_gemma":[0.025591949,0.00031665398,0.00050536584,0.00048416716,0.0010355712,0.0003927563,0.00026186634,0.00066887407,0.0000011231957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013018573,0.0012595638,0.84367496,0.0004210231,0.00062674645,0.000005319227,0.0019184084,0.0003776717,0.05455826,0.000011775622,0.0015868505,0.09425756],"study_design_scores_gemma":[0.012450502,0.001063708,0.9265682,0.0019527628,0.00022240281,0.000048289203,0.002057774,0.034403916,0.020345725,0.00017072732,0.00039776118,0.00031823094],"about_ca_topic_score_codex":0.00031106835,"about_ca_topic_score_gemma":0.00036010818,"teacher_disagreement_score":0.09393933,"about_ca_system_score_codex":0.0003173098,"about_ca_system_score_gemma":0.00030999567,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W2087661946","doi":"10.1191/1352458503ms924oa","title":"The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sonic hedgehog; Myelin basic protein; Myelin; White matter; Oligodendrocyte; Cleavage (geology); Western blot; Myelin-associated glycoprotein; Hedgehog signaling pathway; Biology; Molecular biology; Chemistry; Cell biology; Signal transduction; Biochemistry; Central nervous system; Endocrinology; Medicine; Gene; Magnetic resonance imaging","score_opus":0.05075290348435549,"score_gpt":0.2361219612946219,"score_spread":0.1853690578102664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087661946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938024,0.0030794558,0.0011076337,0.0012488253,0.0002009261,0.00038197933,0.000053867156,0.0000067687715,0.000118096425],"genre_scores_gemma":[0.995738,0.0008332937,0.0012331927,0.0018485619,0.0001206731,0.000043437507,0.0000035424714,0.000048403253,0.0001308556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744445,0.0003363607,0.00071498216,0.0004669625,0.0003869153,0.00065032433],"domain_scores_gemma":[0.99856263,0.00021035009,0.0002841822,0.0005179382,0.0002129842,0.00021192344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015254192,0.00032200592,0.000325798,0.00010782584,0.000823246,0.000195092,0.00043747603,0.0001356273,0.000040660703],"category_scores_gemma":[0.0006453618,0.00021339665,0.00022217628,0.00028212043,0.0002334319,0.0000122630345,0.00019957029,0.00033274014,0.000029057392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015869546,0.00011573187,0.3684792,0.000020014517,0.000114252194,0.0000018784258,0.0023264254,0.0009406327,0.61849487,0.0000038853154,0.008007906,0.001336488],"study_design_scores_gemma":[0.0023324213,0.00025980108,0.38536918,0.0003293899,0.000058775153,0.000035374884,0.0029865215,0.00045484744,0.5955243,0.000021838267,0.012181818,0.00044570968],"about_ca_topic_score_codex":0.0000777466,"about_ca_topic_score_gemma":0.00037534005,"teacher_disagreement_score":0.022970555,"about_ca_system_score_codex":0.000066733024,"about_ca_system_score_gemma":0.0000992571,"threshold_uncertainty_score":0.8702063},"labels":[],"label_agreement":null},{"id":"W2089500985","doi":"10.1177/1352458513477228","title":"Cerebral white matter blood flow and energy metabolism in multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Phosphocreatine; White matter; Cerebral blood flow; Creatine; Medicine; Multiple sclerosis; In vivo magnetic resonance spectroscopy; Pathology; Magnetic resonance imaging; Energy metabolism; Internal medicine; Radiology","score_opus":0.06410469857743946,"score_gpt":0.2504889488079194,"score_spread":0.18638425023047994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089500985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898117,0.0025886728,0.0003202797,0.004913781,0.0004819193,0.00068677694,0.00006253508,0.000107703985,0.0010265916],"genre_scores_gemma":[0.9783354,0.0044317855,0.013407119,0.0015568682,0.00083963707,0.00031446354,0.000025321695,0.00014608407,0.000943354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99433947,0.00042178837,0.0013219814,0.00093703676,0.0012763295,0.0017034081],"domain_scores_gemma":[0.99667823,0.00048732685,0.0003404788,0.0007168672,0.0006049779,0.0011721216],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086545304,0.0007440781,0.0013144015,0.0009794605,0.00067850633,0.0005797988,0.00045204177,0.00033268504,0.0029761137],"category_scores_gemma":[0.00096466,0.0006145799,0.00042885804,0.0007518161,0.00048001125,0.0010550901,0.00053539325,0.0013220727,0.00033548038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022858744,0.00068261597,0.87315536,0.00007899676,0.0003763344,0.000027326432,0.00085560523,0.00007019744,0.07995574,0.000006751907,0.0121424785,0.032420002],"study_design_scores_gemma":[0.013798647,0.00018320567,0.9676834,0.000705557,0.00016161283,0.00021355544,0.0005219248,0.010952074,0.0034708977,0.000042976826,0.0016730847,0.00059310754],"about_ca_topic_score_codex":0.0017654394,"about_ca_topic_score_gemma":0.0007960016,"teacher_disagreement_score":0.094528,"about_ca_system_score_codex":0.00020424901,"about_ca_system_score_gemma":0.00012965381,"threshold_uncertainty_score":0.9996306},"labels":[],"label_agreement":null},{"id":"W2090193300","doi":"10.1177/1352458512437814","title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; University of Calgary; McGill University; University of Manitoba; Alberta Health; University of Alberta","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society","keywords":"Hyperlipidemia; Medicine; Diabetes mellitus; Comorbidity; Internal medicine; Population; Cohort; Pediatrics; Endocrinology; Environmental health","score_opus":0.33710085680590995,"score_gpt":0.33253995338960335,"score_spread":0.004560903416306605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090193300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927938,0.0048068142,0.00053260865,0.00030823643,0.00020876265,0.0010222,0.0002668192,0.000023846862,0.000036885365],"genre_scores_gemma":[0.9766917,0.008520495,0.014243563,0.00007190539,0.00024023296,0.00014643303,0.00003060336,0.000046130852,0.000008884197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665886,0.00033843334,0.001198006,0.00033467895,0.0007259771,0.00074402185],"domain_scores_gemma":[0.9956496,0.0021526364,0.00058041577,0.00034889657,0.0008954623,0.00037299382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020873537,0.0003226723,0.000942435,0.00046131937,0.00035930765,0.00003946772,0.00017679983,0.00017418645,0.00004159727],"category_scores_gemma":[0.0064860084,0.000281833,0.00031467516,0.00036749704,0.0005458942,0.00059280545,0.00012807737,0.00047088123,0.0000022127574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022374824,0.0006285778,0.7211385,0.0008261908,0.00020060503,5.445007e-7,0.0011034615,0.00006040772,0.27274385,0.000019101826,0.00034377535,0.0027112646],"study_design_scores_gemma":[0.005765213,0.00042659644,0.86640674,0.0027192864,0.00023913042,0.000016572589,0.0013009115,0.0017118109,0.12106377,0.000040042447,0.000087726854,0.000222173],"about_ca_topic_score_codex":0.000065602995,"about_ca_topic_score_gemma":0.000028238299,"teacher_disagreement_score":0.15168008,"about_ca_system_score_codex":0.00015055208,"about_ca_system_score_gemma":0.0001498327,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W2090719688","doi":"10.1177/1352458511402113","title":"The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Correlation; Intensity (physics); Voxel; White matter; Lesion; Medicine; Nuclear medicine; Magnetic resonance imaging; Mathematics; Physics; Pathology; Radiology; Geometry; Optics","score_opus":0.39528812407272684,"score_gpt":0.38758149495390276,"score_spread":0.007706629118824082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090719688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610186,0.00022684138,0.0004687278,0.00085620116,0.00053932355,0.0010675234,0.00007617425,0.000045592788,0.000617731],"genre_scores_gemma":[0.99338037,0.0036967355,0.0023776186,0.000113135495,0.00021669193,0.00007779647,0.000011925132,0.000057614387,0.00006810785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99456686,0.00082968717,0.002190966,0.00055124855,0.0008533591,0.0010078702],"domain_scores_gemma":[0.99262136,0.004164142,0.00066233374,0.0008702423,0.0011083763,0.0005735608],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038458016,0.000433098,0.0010886679,0.00087038154,0.000792314,0.00007930465,0.00049660396,0.00028698533,0.0001903901],"category_scores_gemma":[0.020151254,0.0002869609,0.0009381031,0.0012377901,0.0007389955,0.00030004914,0.00028447705,0.0023658865,0.00007865729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026217853,0.002375779,0.96926904,0.000010143773,0.00029899628,0.000022232394,0.0019357813,0.00038980588,0.0076011606,0.000031674506,0.002244648,0.01319898],"study_design_scores_gemma":[0.008118367,0.0012641214,0.96997106,0.000993584,0.00005702798,0.000040063514,0.0010609982,0.017655043,0.00044947796,0.000116456315,0.000029870766,0.00024392483],"about_ca_topic_score_codex":0.003844942,"about_ca_topic_score_gemma":0.0038043906,"teacher_disagreement_score":0.017265238,"about_ca_system_score_codex":0.00070190534,"about_ca_system_score_gemma":0.00047834666,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2093444580","doi":"10.1177/1352458509348418","title":"Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Cerebrospinal fluid; Multiple sclerosis; Medicine; Intrathecal; Pathophysiology; Antibody; Rubella; Internal medicine; Measles; Albumin; Immunology; Anesthesia","score_opus":0.059234836418149736,"score_gpt":0.2686212757729252,"score_spread":0.20938643935477547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093444580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918617,0.004582588,0.000007863011,0.0051128673,0.00014452924,0.0008213629,0.00004428534,0.000054695458,0.000045653964],"genre_scores_gemma":[0.99072266,0.008240729,0.0004871629,0.00030226467,0.00010880078,0.000023691806,0.0000035469443,0.000032682103,0.00007848693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955109,0.0010153096,0.0011339681,0.00060374965,0.00088703836,0.00084905105],"domain_scores_gemma":[0.99704164,0.001227212,0.00042688468,0.0004991163,0.00039922373,0.00040591558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015089021,0.00048825564,0.001015785,0.00040861563,0.0005855171,0.00015312542,0.00043007257,0.00029169445,0.00006275822],"category_scores_gemma":[0.005473488,0.0003101373,0.00028235203,0.0008492096,0.0010615096,0.00026054544,0.00034423376,0.0013978544,0.000009267298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042795306,0.00073165237,0.50977767,0.00003555346,0.00012187149,0.00003966262,0.00110869,0.00002351789,0.463546,0.0000075568005,0.0003375152,0.019990804],"study_design_scores_gemma":[0.009623821,0.0018231771,0.980095,0.00085464714,0.00009524314,0.000211979,0.00053584506,0.0043937326,0.0019836784,0.000066522894,0.000025769466,0.00029053845],"about_ca_topic_score_codex":0.00006222523,"about_ca_topic_score_gemma":0.000025466836,"teacher_disagreement_score":0.4703174,"about_ca_system_score_codex":0.00013392269,"about_ca_system_score_gemma":0.0001543177,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W2095210906","doi":"10.1177/1352458513500551","title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Acorda Therapeutics; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Fingolimod; Lymphocyte; Medicine; Discontinuation; Multiple sclerosis; Placebo; Internal medicine; Immunology; Peripheral blood lymphocyte; Pathology","score_opus":0.03061297707406864,"score_gpt":0.21565698090269395,"score_spread":0.1850440038286253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095210906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750537,0.0006777975,0.0012912132,0.00002793806,0.00004609981,0.00010541509,0.0000050418835,0.0000050191125,0.00033610995],"genre_scores_gemma":[0.99683213,0.00030072578,0.0025430617,0.000044900808,0.00013719535,0.000013240001,0.0000088244,0.00001290026,0.000107042535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957025,0.000027425578,0.00011385372,0.000095862495,0.00008918423,0.00010340015],"domain_scores_gemma":[0.9996272,0.000014475949,0.0000937287,0.00009298493,0.00011466598,0.000056956127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009279592,0.00007508765,0.000085662636,0.000038172748,0.00011702617,0.000038343576,0.00004704155,0.000047787347,0.00005905086],"category_scores_gemma":[0.000028353374,0.000050843584,0.000023974875,0.00006326362,0.00005784615,0.000012045374,0.000011461513,0.000072212075,0.0000047962217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117013544,0.00007296572,0.71934205,0.000008443011,0.000073422365,4.1569626e-7,0.00013000952,0.00014770232,0.27429655,0.000024141582,0.0007109634,0.0050762934],"study_design_scores_gemma":[0.0040207305,0.0005326182,0.9034794,0.00009371608,0.000026188523,0.00013072179,0.00013480552,0.000406333,0.08504873,0.000033823173,0.0058633876,0.0002295417],"about_ca_topic_score_codex":0.000049919632,"about_ca_topic_score_gemma":0.00001044418,"teacher_disagreement_score":0.18924782,"about_ca_system_score_codex":0.0000057856505,"about_ca_system_score_gemma":0.00007103924,"threshold_uncertainty_score":0.20733412},"labels":[],"label_agreement":null},{"id":"W2095979340","doi":"10.1191/1352458505ms1223oa","title":"Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of α4 integrin","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Encephalomyelitis; Multiple sclerosis; Inflammation; Pathology; Immunology","score_opus":0.06559445643393817,"score_gpt":0.2965430409808947,"score_spread":0.2309485845469565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095979340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964496,0.0011712085,0.0004527068,0.00062299875,0.000120117205,0.00054720434,0.0000615021,0.00003442235,0.0005402783],"genre_scores_gemma":[0.9747757,0.0012446909,0.023250373,0.00007201853,0.00038795563,0.000047680696,0.0000137793595,0.000052833893,0.00015501796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686205,0.00015483424,0.0009053822,0.00037784365,0.001098656,0.0006012195],"domain_scores_gemma":[0.9978883,0.00016612821,0.00046425013,0.00041855418,0.0006247506,0.00043798893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043193472,0.0003470078,0.00080530904,0.00035363328,0.00018582652,0.000038445196,0.0003177271,0.00013264145,0.00047407587],"category_scores_gemma":[0.00024011976,0.00024448638,0.00032899703,0.0003319878,0.00045109662,0.00025989336,0.00023948823,0.0006533678,0.000013144957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019077632,0.00096529117,0.019171545,0.00006853702,0.00058125105,0.000029574381,0.0020363354,0.00006974184,0.9625768,0.000005333274,0.0011733659,0.011414457],"study_design_scores_gemma":[0.008898468,0.001633897,0.13477172,0.0016368746,0.0001147817,0.00018759882,0.0012450037,0.0009671778,0.8496228,0.0000012985442,0.0006939371,0.00022647451],"about_ca_topic_score_codex":0.00009555842,"about_ca_topic_score_gemma":0.000048800448,"teacher_disagreement_score":0.115600176,"about_ca_system_score_codex":0.0001944616,"about_ca_system_score_gemma":0.00018836813,"threshold_uncertainty_score":0.99698657},"labels":[],"label_agreement":null},{"id":"W2096555658","doi":"10.1177/1352458508089226","title":"Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Calgary; University of Alberta","funders":"","keywords":"Incidence (geometry); Demography; Multiple sclerosis; Medicine; Population; Prevalence; Epidemiology; McDonald criteria; Environmental health; Internal medicine; Immunology","score_opus":0.07548102177299536,"score_gpt":0.2823439619819707,"score_spread":0.20686294020897533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096555658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996786,0.00064827147,0.00027613473,0.0009274525,0.00021399852,0.00095664547,0.00009950641,0.00001627521,0.00007569712],"genre_scores_gemma":[0.99310714,0.0029237478,0.0034809194,0.00017863963,0.00014088061,0.000051740728,0.0000087392145,0.00004218717,0.000065980086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99474907,0.00044121314,0.0016058681,0.00050525833,0.0017728186,0.0009257687],"domain_scores_gemma":[0.9944254,0.002121371,0.00063283124,0.0005536738,0.0015945883,0.00067209976],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015715573,0.000380555,0.0011183821,0.00057989656,0.00035385703,0.000021265914,0.00048629634,0.00015035005,0.0001197176],"category_scores_gemma":[0.02030932,0.00034928907,0.00024953554,0.001074373,0.00036854143,0.0003386551,0.00029805716,0.0007111735,0.000007997471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010564183,0.00029821342,0.7329299,0.00018405923,0.00008386715,0.000022283106,0.0007870258,0.00049529085,0.26158237,0.0000024176466,0.00073341443,0.0018247927],"study_design_scores_gemma":[0.00506198,0.00032980542,0.8933612,0.0029354172,0.000047751506,0.00017581011,0.00021238643,0.0018250077,0.095687434,0.0000027825176,0.00010610965,0.0002543219],"about_ca_topic_score_codex":0.57014835,"about_ca_topic_score_gemma":0.51382387,"teacher_disagreement_score":0.16589493,"about_ca_system_score_codex":0.0010310635,"about_ca_system_score_gemma":0.0013764816,"threshold_uncertainty_score":0.99989593},"labels":[],"label_agreement":null},{"id":"W2099462160","doi":"10.1177/1352458507085759","title":"Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glatiramer acetate; Mitoxantrone; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Adverse effect; Magnetic resonance imaging; Internal medicine; Confidence interval; Gastroenterology; Surgery; Nuclear medicine; Chemotherapy; Radiology; Immunology","score_opus":0.14905469875367341,"score_gpt":0.2854956197840501,"score_spread":0.13644092103037667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099462160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926983,0.0030195161,0.0005619163,0.0017341427,0.00044398912,0.0011917084,0.000024085466,0.00013696445,0.00018936743],"genre_scores_gemma":[0.9684895,0.018947538,0.010674905,0.00043679168,0.0007897261,0.00023197291,0.00001711952,0.00015902064,0.00025338578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943787,0.0004160811,0.0011544827,0.00086362724,0.0017072973,0.0014798467],"domain_scores_gemma":[0.9970873,0.0004486283,0.00043192317,0.00069765473,0.0006437677,0.00069073506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009744869,0.0007023751,0.001124518,0.00094710494,0.0009321874,0.00017568923,0.00032383387,0.0002906203,0.00036765946],"category_scores_gemma":[0.0009035859,0.0005271071,0.00038920692,0.0012165739,0.0007376889,0.00094857265,0.00015979359,0.0020342637,0.00010470165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055399872,0.0008806208,0.74831825,0.00003441901,0.0003376811,0.00019509085,0.0026863164,0.00026838534,0.20130934,5.161141e-7,0.0009875845,0.039441798],"study_design_scores_gemma":[0.021213608,0.00087722775,0.95970505,0.0015573857,0.000054316642,0.0006384286,0.00065061526,0.0021007129,0.011442174,0.0000061626383,0.0011801403,0.00057415024],"about_ca_topic_score_codex":0.00042854293,"about_ca_topic_score_gemma":0.00050633354,"teacher_disagreement_score":0.21138681,"about_ca_system_score_codex":0.0006701514,"about_ca_system_score_gemma":0.00030139223,"threshold_uncertainty_score":0.99971807},"labels":[],"label_agreement":null},{"id":"W2100170145","doi":"10.1177/1352458508096680","title":"High frequency of adverse health behaviors in multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Overweight; Population; Obesity; Logistic regression; Behavioral Risk Factor Surveillance System; Environmental health; Socioeconomic status; Public health; Gerontology; Demography; Internal medicine; Pathology","score_opus":0.17167442542039996,"score_gpt":0.31765505104145536,"score_spread":0.1459806256210554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100170145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473727,0.0014192623,0.00019665255,0.0015422053,0.00053303974,0.0011867372,0.00014854512,0.000099616016,0.00013666462],"genre_scores_gemma":[0.9720064,0.010142032,0.016778221,0.000341619,0.0003607132,0.0001011612,0.000038495535,0.00010821847,0.0001231401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99320185,0.00047884884,0.0021824539,0.0007420317,0.0018597194,0.0015351052],"domain_scores_gemma":[0.99596876,0.00054814713,0.0008744442,0.0008227746,0.0007361578,0.0010497026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016253474,0.0006050816,0.0016771423,0.0011977316,0.0008529734,0.00002472447,0.00054753816,0.00026478813,0.0006526407],"category_scores_gemma":[0.002304488,0.0005400486,0.0006522149,0.0012760978,0.0007940918,0.00053066865,0.0002643047,0.0015817649,0.00007575305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039988052,0.0014585551,0.84974307,0.00012596013,0.00015228504,0.000094547664,0.0018891406,0.00019743483,0.13418765,0.000007408057,0.0014879176,0.010256121],"study_design_scores_gemma":[0.013282435,0.00067464553,0.9753023,0.0015333345,0.00004701373,0.00022204625,0.00084852293,0.00037082282,0.0071778763,0.0000118058015,0.00012212191,0.00040709402],"about_ca_topic_score_codex":0.0060128197,"about_ca_topic_score_gemma":0.0018308279,"teacher_disagreement_score":0.12700978,"about_ca_system_score_codex":0.0010145287,"about_ca_system_score_gemma":0.0008169001,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W2102179492","doi":"10.1177/1352458506070319","title":"The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Minocycline; Immune system; Medicine; Neuroscience; Immunology; Psychology; Biology; Antibiotics; Microbiology","score_opus":0.2900977318572744,"score_gpt":0.3943405373314306,"score_spread":0.10424280547415621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102179492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803281,0.0019222067,0.00026718344,0.012213526,0.0011740193,0.0037817904,0.00012925164,0.00013113904,0.000052816595],"genre_scores_gemma":[0.9915002,0.0030875285,0.0016014227,0.0015823235,0.001463186,0.00024286086,0.000015555783,0.000168271,0.00033864693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9883763,0.0016826758,0.003409571,0.001307071,0.0026381814,0.0025861945],"domain_scores_gemma":[0.986955,0.008259786,0.00075150875,0.0014765786,0.0009738015,0.0015833274],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021041138,0.000884818,0.0017997348,0.0010035927,0.0020265614,0.0004908175,0.0013582853,0.00026820903,0.00016968709],"category_scores_gemma":[0.016189523,0.00065006444,0.00054470944,0.001813839,0.00053765817,0.00028238917,0.0009396233,0.0026693926,0.00021508028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054139618,0.007428479,0.5001488,0.000023442799,0.00054840866,0.00008044941,0.0037359665,0.000023009163,0.34023565,4.4906773e-7,0.014660609,0.078975126],"study_design_scores_gemma":[0.025094403,0.00930437,0.9414084,0.00060467655,0.00012124027,0.00003511781,0.005353849,0.00052900775,0.0079384,0.0000040651867,0.00898462,0.0006218426],"about_ca_topic_score_codex":0.0012703638,"about_ca_topic_score_gemma":0.010283317,"teacher_disagreement_score":0.44125962,"about_ca_system_score_codex":0.0009143376,"about_ca_system_score_gemma":0.0003141463,"threshold_uncertainty_score":0.99963146},"labels":[],"label_agreement":null},{"id":"W2102473502","doi":"10.1177/1352458512444661","title":"Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Clinically isolated syndrome; McDonald criteria; Medicine; Physical medicine and rehabilitation; Pediatrics; Psychology; Physical therapy; Psychiatry","score_opus":0.1794129889964637,"score_gpt":0.349014254819803,"score_spread":0.16960126582333931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102473502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949399,0.0010492838,0.00013262307,0.0009917637,0.0005309433,0.0021112724,0.00007545972,0.000046262718,0.00012246492],"genre_scores_gemma":[0.99579567,0.0007982705,0.0024908017,0.0002302602,0.00036503703,0.00016069615,0.0000181632,0.000091475704,0.000049609243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99170023,0.0014189396,0.0016285824,0.00051859266,0.0034884815,0.0012451804],"domain_scores_gemma":[0.99528545,0.0006386816,0.0008111001,0.0009098812,0.0017382317,0.0006166252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00900711,0.00050437235,0.0010197653,0.00047875926,0.0004893045,0.000105631974,0.00062100124,0.00028955843,0.0005689926],"category_scores_gemma":[0.0053697373,0.00032142634,0.00046764725,0.0011462703,0.00055159425,0.00065907254,0.0003586228,0.0015543847,0.000043719443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011862151,0.0013240227,0.9343978,0.000030984516,0.00068647997,0.0000016665321,0.00074248685,0.00018758679,0.04882129,9.2527125e-7,0.000892741,0.011727787],"study_design_scores_gemma":[0.014812904,0.00092518894,0.9706484,0.0015428857,0.0005613468,0.00035232154,0.00026031464,0.008636528,0.0018768946,0.000009651172,0.00003420794,0.000339349],"about_ca_topic_score_codex":0.00037603168,"about_ca_topic_score_gemma":0.00024184084,"teacher_disagreement_score":0.046944395,"about_ca_system_score_codex":0.00057906733,"about_ca_system_score_gemma":0.0005002906,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2102575453","doi":"10.1177/1352458513486519","title":"2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; McDonald criteria; Cohort; Expanded Disability Status Scale; Clinically isolated syndrome; Pediatrics; Magnetic resonance imaging; Internal medicine; Psychiatry; Radiology","score_opus":0.0705414655702983,"score_gpt":0.29780099153340955,"score_spread":0.22725952596311125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102575453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877274,0.0015025367,0.000053978707,0.006648828,0.0004367622,0.0027172691,0.00056422147,0.00017151225,0.0001774712],"genre_scores_gemma":[0.9902647,0.0046934714,0.0015540208,0.0011595493,0.00059571187,0.0006556254,0.00015175197,0.00019855742,0.00072660187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915169,0.00074916176,0.0014963191,0.0012874838,0.0026791678,0.0022709968],"domain_scores_gemma":[0.99256265,0.0017856592,0.0013533613,0.00096012605,0.0018746058,0.0014635838],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016942378,0.0010454198,0.0017888594,0.00091623823,0.0012225974,0.00049723964,0.0006555277,0.00052929326,0.002163456],"category_scores_gemma":[0.004990608,0.00083396275,0.0005871605,0.0015635118,0.0007146991,0.0009842514,0.00060727284,0.0022487245,0.00037644987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095361826,0.001730138,0.90754604,0.00008623562,0.0007219687,0.00019328298,0.0016243883,0.000042758536,0.025844103,2.074977e-7,0.05897903,0.0022782364],"study_design_scores_gemma":[0.015526098,0.0006772242,0.9698486,0.0020464219,0.00043733182,0.0002789829,0.0005274914,0.0065541244,0.0031492836,0.000008059629,0.00008031601,0.0008661068],"about_ca_topic_score_codex":0.0015597959,"about_ca_topic_score_gemma":0.002308086,"teacher_disagreement_score":0.062302526,"about_ca_system_score_codex":0.0016240919,"about_ca_system_score_gemma":0.0005172262,"threshold_uncertainty_score":0.9994111},"labels":[],"label_agreement":null},{"id":"W2102772856","doi":"10.1177/1352458508091367","title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary","funders":"National Eye Institute; Baker Foundation; Ottawa Hospital Research Institute; Biogen; Research to Prevent Blindness","keywords":"Nerve fiber layer; Optic neuritis; Retinal; Optic nerve; Medicine; Ophthalmology; Optical coherence tomography; Nerve fiber; Retina; Anatomy; Multiple sclerosis; Neuroscience; Biology","score_opus":0.12239503844088438,"score_gpt":0.32396498182406247,"score_spread":0.20156994338317807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102772856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959152,0.00094988814,0.0002482063,0.00026823982,0.0002769025,0.0018942563,0.000027024023,0.00012549302,0.0002948161],"genre_scores_gemma":[0.98744476,0.0002416871,0.010779932,0.000102319565,0.00093324616,0.00023103373,0.0000031648322,0.000111351845,0.00015248907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941988,0.00040438067,0.0010964046,0.000913667,0.0020071736,0.001379557],"domain_scores_gemma":[0.9965992,0.00039247388,0.00029779473,0.0006077347,0.0012235251,0.000879263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000994482,0.0006190328,0.0010391551,0.00056055223,0.001212174,0.00027065954,0.00038927366,0.00019190108,0.00067562074],"category_scores_gemma":[0.0012099948,0.000521691,0.0006109345,0.00097128423,0.0009859777,0.00065925514,0.00033777044,0.0018886862,0.000088264474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018685879,0.0022714792,0.95982873,0.00006393882,0.00056958426,0.0035082386,0.004072771,0.000115107905,0.024516977,0.0000011515654,0.0002636461,0.002919812],"study_design_scores_gemma":[0.008373651,0.0015194083,0.9774415,0.0009019285,0.00027349533,0.004018121,0.0017178396,0.0012164146,0.003947933,0.0000083348295,0.000062122555,0.00051924714],"about_ca_topic_score_codex":0.00012643189,"about_ca_topic_score_gemma":0.000051746563,"teacher_disagreement_score":0.020569043,"about_ca_system_score_codex":0.00044063033,"about_ca_system_score_gemma":0.000263245,"threshold_uncertainty_score":0.9997235},"labels":[],"label_agreement":null},{"id":"W2104742284","doi":"10.1177/1352458510367661","title":"Disease onset in familial and sporadic primary progressive multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Disease; Age of onset; Multiple sclerosis; Family aggregation; Degenerative disease; Population; Central nervous system disease; Internal medicine; Pediatrics; Immunology","score_opus":0.07232019047034279,"score_gpt":0.2882992623615152,"score_spread":0.21597907189117244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104742284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926384,0.0022382892,0.00004507899,0.0023396215,0.0007258039,0.0015212824,0.00018612391,0.00013022797,0.00017514975],"genre_scores_gemma":[0.9876929,0.0036620754,0.006563493,0.00063457247,0.00093484536,0.00021646723,0.00006476249,0.000116515395,0.00011439061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99475944,0.00027642856,0.0011195162,0.0009415896,0.001488971,0.0014140386],"domain_scores_gemma":[0.9957164,0.0007531151,0.00039194853,0.00076920487,0.0004947838,0.0018745693],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014363148,0.0006578276,0.0010621316,0.0006715508,0.0007667231,0.00032300717,0.00045135617,0.00029051845,0.00028522004],"category_scores_gemma":[0.0045066113,0.00055705494,0.00037500504,0.00069428724,0.0010070868,0.00062814355,0.00046004818,0.002688784,0.00006087492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018819023,0.0009219831,0.81293344,0.00015987335,0.00012794032,0.0002547413,0.00055662746,0.000011662461,0.12556317,0.000004096288,0.001545068,0.056039467],"study_design_scores_gemma":[0.013487267,0.0003147941,0.9788616,0.0010884197,0.0001074664,0.00021421975,0.00032995624,0.0027685107,0.0012858913,0.000037496084,0.00097012,0.0005342871],"about_ca_topic_score_codex":0.00021924976,"about_ca_topic_score_gemma":0.0005665802,"teacher_disagreement_score":0.16592811,"about_ca_system_score_codex":0.0003334846,"about_ca_system_score_gemma":0.000544476,"threshold_uncertainty_score":0.9996881},"labels":[],"label_agreement":null},{"id":"W2105242813","doi":"10.1177/1352458512445201","title":"The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"Multiple Sclerosis Society","keywords":"Funnel plot; Medicine; Psychological intervention; Meta-analysis; MEDLINE; Publication bias; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Mood; Clinical psychology; Psychiatry; Nursing; Internal medicine","score_opus":0.7480843048039773,"score_gpt":0.5176749175928677,"score_spread":0.2304093872111096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105242813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033169375,0.9908238,0.0000820512,0.00062852335,0.0008588291,0.0038545472,0.0003511557,0.000043767042,0.000040402963],"genre_scores_gemma":[0.121322565,0.8768345,0.0006125185,0.00008090104,0.00027497602,0.00056046876,0.00007443445,0.00012443957,0.0001152087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9690723,0.011540804,0.014223396,0.001035432,0.0026040417,0.00152406],"domain_scores_gemma":[0.95646423,0.028516639,0.010508368,0.0021195104,0.0010087808,0.0013824989],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.024506995,0.0011812138,0.019240744,0.0020407424,0.00069571275,0.00010797866,0.0012989817,0.00083068735,0.00023706067],"category_scores_gemma":[0.045983147,0.0006907963,0.02599529,0.0033520935,0.0010781623,0.00021700801,0.00061341765,0.004391793,0.000050705723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007069591,0.0048474446,0.018346943,0.036145184,0.2914639,0.0000056676786,0.00039474803,0.000032350697,0.00002795157,0.00002161436,0.0010527392,0.6469545],"study_design_scores_gemma":[0.016240418,0.0026294147,0.5279759,0.061229557,0.35396582,0.000020367454,0.00043478256,0.00022042544,0.000025652718,0.000016889084,0.03590352,0.0013372445],"about_ca_topic_score_codex":0.0013443723,"about_ca_topic_score_gemma":0.002414762,"teacher_disagreement_score":0.64561725,"about_ca_system_score_codex":0.0005286776,"about_ca_system_score_gemma":0.0011099207,"threshold_uncertainty_score":0.99955434},"labels":[],"label_agreement":null},{"id":"W2105823731","doi":"10.1177/135245850100700406","title":"Interferon β-1a and depression in relapsing - remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Depression (economics); Placebo; Medicine; Multiple sclerosis; Rating scale; Internal medicine; Beck Depression Inventory; Randomization; Center for Epidemiologic Studies Depression Scale; Beck Hopelessness Scale; Epidemiology; Clinical trial; Physical therapy; Psychiatry; Psychology; Anxiety; Depressive symptoms","score_opus":0.3852893289964776,"score_gpt":0.41701055514739305,"score_spread":0.03172122615091544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105823731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261934,0.0031782354,0.0016933089,0.00049568585,0.0006547175,0.0011055731,0.00015070374,0.000060650338,0.000041766492],"genre_scores_gemma":[0.9807484,0.011589505,0.0059636123,0.00017865334,0.0011715583,0.000036624446,0.00022412221,0.00007109126,0.000016425665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918316,0.0018042128,0.002676971,0.0013462094,0.0014584198,0.0008826025],"domain_scores_gemma":[0.9907836,0.0047489377,0.0011693576,0.0021969983,0.00044962842,0.00065148075],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00720816,0.00050476723,0.0016782995,0.0007166825,0.0007381428,0.00028528323,0.001256147,0.00041215515,0.00014036502],"category_scores_gemma":[0.014261563,0.0003401223,0.0004778488,0.0013509791,0.0005167722,0.0010425048,0.0015977108,0.0020646262,0.0000057056723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030279865,0.00096126174,0.8398384,0.000015610116,0.0009159697,0.000016902703,0.001032985,0.0002546208,0.02773185,1.3942403e-7,0.00044125787,0.09851115],"study_design_scores_gemma":[0.04463682,0.00055531965,0.8229735,0.0022087279,0.001034756,0.000015038147,0.0019858344,0.1255068,0.00066684105,0.000005857665,0.00013706082,0.00027343738],"about_ca_topic_score_codex":0.0017023915,"about_ca_topic_score_gemma":0.0031760442,"teacher_disagreement_score":0.12525219,"about_ca_system_score_codex":0.00019905862,"about_ca_system_score_gemma":0.0001514218,"threshold_uncertainty_score":0.9999051},"labels":[],"label_agreement":null},{"id":"W2105913548","doi":"10.1177/1352458514564487","title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":510,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Genentech; Multiple Sclerosis Society; Cleveland Clinic; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; National Heart, Lung, and Blood Institute; Pfizer; U.S. Department of Defense; Sanofi; MedDay Pharmaceuticals; GlaxoSmithKline; National Multiple Sclerosis Society; Biogen; Gilead Sciences","keywords":"Multiple sclerosis; Psychiatry; Incidence (geometry); Medicine; Systematic review; MEDLINE","score_opus":0.16130572927536932,"score_gpt":0.36064317461077444,"score_spread":0.19933744533540512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105913548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020022619,0.99015385,0.000021343507,0.00037903033,0.00037772092,0.008648003,0.00010949437,0.000043914388,0.000066414774],"genre_scores_gemma":[0.0026851324,0.99466884,0.00074500585,0.00007117782,0.00020810343,0.0013457418,0.000010908036,0.00014065593,0.00012442964],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98878163,0.0023947912,0.004292758,0.00093953393,0.0023771613,0.0012141389],"domain_scores_gemma":[0.99020827,0.003738092,0.0028873757,0.0015159326,0.0008917666,0.0007585734],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008898335,0.0010916126,0.006300546,0.00084061443,0.00067365676,0.00020263124,0.001383779,0.00041068144,0.000024258916],"category_scores_gemma":[0.018787378,0.00064309075,0.0012956659,0.0018928193,0.0008214877,0.00034835568,0.0007129799,0.0023948564,0.00003958633],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062630694,0.00024696387,0.004533488,0.78892195,0.00045805774,0.000005054279,0.00015964142,0.0000013077312,0.000006108775,0.0000021269607,0.0011757519,0.20442693],"study_design_scores_gemma":[0.0026125798,0.00035951656,0.010047478,0.9628882,0.004156926,0.0002649332,0.00018964826,0.00017502512,8.8479186e-7,0.0000150595415,0.018670714,0.0006190461],"about_ca_topic_score_codex":0.0001051637,"about_ca_topic_score_gemma":0.00041611167,"teacher_disagreement_score":0.20380789,"about_ca_system_score_codex":0.0007018813,"about_ca_system_score_gemma":0.0010748843,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2106505062","doi":"10.1177/1352458507078393","title":"Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital; Cameco (Canada); Provincial Laboratory of Public Health; University of Saskatchewan; University of Alberta","funders":"","keywords":"Mental health; Medicine; Quality of life (healthcare); Psychological intervention; Depression (economics); Population; Beck Depression Inventory; Intrusiveness; Psychiatry; Expanded Disability Status Scale; Multiple sclerosis; Clinical psychology; Gerontology; Psychology; Anxiety; Environmental health","score_opus":0.20442908356771025,"score_gpt":0.3482621397014887,"score_spread":0.14383305613377848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106505062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905832,0.0017956868,0.0015854613,0.0043993844,0.00012234374,0.0013019231,0.000039749128,0.000033497763,0.00013875758],"genre_scores_gemma":[0.9961329,0.00080128876,0.0023798044,0.00039715963,0.00015751953,0.000046301153,0.000012700181,0.00004787884,0.000024423263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99334854,0.0012551653,0.0022230034,0.0003993888,0.0018243716,0.00094953325],"domain_scores_gemma":[0.9940906,0.0026336059,0.0015493559,0.0006773133,0.0006812483,0.00036783828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011147696,0.00036823953,0.0010658532,0.00045842526,0.00082436315,0.00009238631,0.0005799902,0.00015991364,0.00005966858],"category_scores_gemma":[0.00463864,0.00020055816,0.00035480323,0.0013364509,0.0007071528,0.00031474818,0.00012761397,0.0013878336,0.0000053351037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026249462,0.00071596913,0.7134965,0.00020681827,0.0002953289,0.0000054943835,0.019180898,0.00047659615,0.25096974,0.000011833939,0.000500412,0.011515454],"study_design_scores_gemma":[0.0077863634,0.001316017,0.9639586,0.0013282661,0.000050555598,0.00003608606,0.019249458,0.0014494108,0.0045626527,0.000007824165,0.000052161617,0.00020261075],"about_ca_topic_score_codex":0.0024173819,"about_ca_topic_score_gemma":0.004198365,"teacher_disagreement_score":0.25046209,"about_ca_system_score_codex":0.00028526157,"about_ca_system_score_gemma":0.0005234594,"threshold_uncertainty_score":0.81785244},"labels":[],"label_agreement":null},{"id":"W2106988882","doi":"10.1177/1352458513477230","title":"Expression of cathepsins S and D signals a distinctive biochemical trait in CD34 <sup>+</sup> hematopoietic stem cells of relapsing–remitting multiple sclerosis patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Multiple sclerosis; Haematopoiesis; Cathepsin; Stem cell; CD34; Biology; Cytokine; Pathogenesis; Immunology; Cathepsin D; Proteases; Bone marrow; Enzyme; Cell biology; Biochemistry","score_opus":0.05127720962451044,"score_gpt":0.24970314296172663,"score_spread":0.1984259333372162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106988882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977562,0.0006663352,0.00029699883,0.00011028143,0.000058650206,0.0009792332,0.00006248562,0.000021382713,0.000048447815],"genre_scores_gemma":[0.99712294,0.0001847796,0.0024443178,0.00003443826,0.00005692088,0.000048828177,0.000011678545,0.00006605793,0.000030054425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996245,0.00029602362,0.0012773547,0.0004939827,0.0010280368,0.00065960194],"domain_scores_gemma":[0.9971649,0.0007477828,0.0005966864,0.00034154207,0.0006842507,0.00046485144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006464706,0.00035390383,0.00089717633,0.00042640656,0.00018312273,0.000065966415,0.00028596478,0.00027058885,0.00020242717],"category_scores_gemma":[0.00090713945,0.0002945899,0.00027037866,0.00051810814,0.00036597482,0.00034057786,0.00023053196,0.0007790298,0.000010373846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003250419,0.0010576649,0.33429837,0.00024762322,0.00004487991,0.0000035459589,0.0045335046,0.00013434177,0.6516587,4.069484e-7,0.0002677173,0.0074281646],"study_design_scores_gemma":[0.009170203,0.000490651,0.41408962,0.004293365,0.000060778726,0.000020632291,0.0038846429,0.0071752397,0.56050205,0.00002751469,0.0000061795417,0.0002790842],"about_ca_topic_score_codex":0.00039024008,"about_ca_topic_score_gemma":0.000008603599,"teacher_disagreement_score":0.09115665,"about_ca_system_score_codex":0.00023254164,"about_ca_system_score_gemma":0.00011310803,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W2107189247","doi":"10.1177/1352458515601513","title":"Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Montreal Neurological Institute and Hospital; Women and Children’s Health Research Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; MEDLINE; Intensive care medicine; Immunology; Chemistry","score_opus":0.19818088000202835,"score_gpt":0.33979687441035755,"score_spread":0.1416159944083292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107189247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001074338,0.99341553,0.00012501067,0.00011859957,0.0002990795,0.0045755818,0.00037112864,0.000016859867,0.000003889428],"genre_scores_gemma":[0.0013650389,0.9949506,0.0005839985,0.00037846522,0.00052285084,0.0018155281,0.00014618374,0.00013916905,0.00009815969],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99466395,0.0010159772,0.0018441989,0.0007838432,0.00074844155,0.00094357616],"domain_scores_gemma":[0.9964002,0.00058206246,0.0010798374,0.0010224252,0.00062829617,0.00028717768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003195757,0.0008631512,0.0031479932,0.00019180356,0.00036010734,0.00036933564,0.0013089981,0.0005244831,0.000011602087],"category_scores_gemma":[0.0048762225,0.00050036615,0.0015219967,0.0003869078,0.00031299458,0.000028925057,0.0005524493,0.00095058506,0.000022567177],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015928158,0.0006058245,0.00034730832,0.8893065,0.003284673,0.000017150565,0.00014460443,0.0000034476705,0.009188643,0.0000023232076,0.04557737,0.05136288],"study_design_scores_gemma":[0.002088092,0.00030134417,0.00015443593,0.6541353,0.0014999772,0.00017689922,0.00008596617,0.00004954464,0.00032200434,0.000007311956,0.34018984,0.0009892576],"about_ca_topic_score_codex":0.000028137772,"about_ca_topic_score_gemma":0.000084970256,"teacher_disagreement_score":0.2946125,"about_ca_system_score_codex":0.00023647267,"about_ca_system_score_gemma":0.0003335733,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W2107328537","doi":"10.1177/1352458512446169","title":"Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg)","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Demographic Trends and Gender Preferences","field":"Social Sciences","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sex ratio; Multiple sclerosis; Demography; Male to female; Medicine; Digit ratio; Female to male; Rate ratio; Population; Confidence interval; Epidemiology; Internal medicine; Immunology","score_opus":0.24276253987182958,"score_gpt":0.3200699499479974,"score_spread":0.07730741007616784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107328537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728561,0.0011285801,0.0006072652,0.0042786263,0.0012457569,0.00037592166,0.000056494886,0.00004436067,0.019406877],"genre_scores_gemma":[0.9968878,0.000582427,0.00075051736,0.00043764798,0.0009982669,0.000027304359,0.000005700207,0.000013303021,0.00029702706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637914,0.00079055945,0.0005992894,0.00020895306,0.0013885621,0.0006335204],"domain_scores_gemma":[0.9982846,0.0007118292,0.00037267694,0.00017256974,0.00024398995,0.00021436937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045807688,0.00018178648,0.0002726879,0.00026878226,0.0008310723,0.00025324256,0.0007012164,0.00012914764,0.00032570655],"category_scores_gemma":[0.0007838765,0.00013146085,0.00023354018,0.00071485504,0.00041830362,0.0008449467,0.000057463843,0.00044376106,0.000017510325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035310517,0.0004437332,0.91811204,0.000008789636,0.000055792978,7.0100214e-7,0.05078175,0.000048138332,0.0018809307,0.0012264022,0.0111465175,0.016259916],"study_design_scores_gemma":[0.0011683122,0.000039478375,0.9723823,0.00009877151,0.000021048972,0.0000075954717,0.012204493,0.00013572446,0.00032089473,0.0006159997,0.012795303,0.00021008961],"about_ca_topic_score_codex":0.0010891041,"about_ca_topic_score_gemma":0.005703986,"teacher_disagreement_score":0.05427027,"about_ca_system_score_codex":0.0000887042,"about_ca_system_score_gemma":0.00014823792,"threshold_uncertainty_score":0.639202},"labels":[],"label_agreement":null},{"id":"W2107480122","doi":"10.1177/1352458508099477","title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Multiple sclerosis; Comorbidity; Medicine; MEDLINE; Psychiatry","score_opus":0.144334292568887,"score_gpt":0.31325398692794226,"score_spread":0.16891969435905527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107480122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853087,0.0040681306,0.00006990979,0.0088043725,0.00024262922,0.0010502854,0.000056152225,0.000060931077,0.0003388931],"genre_scores_gemma":[0.97249395,0.026000278,0.0008052205,0.00020598012,0.00032407165,0.000036063255,0.000016307027,0.00004158129,0.000076560464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958838,0.00040289634,0.0011147094,0.00050563086,0.0011060378,0.0009868983],"domain_scores_gemma":[0.99692476,0.0012387845,0.00039909736,0.00054701837,0.00036959423,0.0005207567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014407865,0.0004460122,0.00083657773,0.0003833192,0.000993549,0.00020521319,0.0004067415,0.00019228163,0.00005815857],"category_scores_gemma":[0.0020487802,0.00031413892,0.00029837675,0.00061130145,0.0006896511,0.00032776347,0.0002021275,0.0010224651,0.0000137038005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020013389,0.0012758835,0.43411174,0.0000825361,0.0005337014,0.000061778934,0.003729224,0.0003292054,0.4119036,0.000050153227,0.007947919,0.13797292],"study_design_scores_gemma":[0.013721623,0.00074285956,0.9616232,0.0012648087,0.000076111544,0.00010565163,0.0030403929,0.0065266723,0.011405542,0.00015588205,0.0010151878,0.00032206505],"about_ca_topic_score_codex":0.0009224545,"about_ca_topic_score_gemma":0.0006924786,"teacher_disagreement_score":0.5275114,"about_ca_system_score_codex":0.00047191864,"about_ca_system_score_gemma":0.00016827625,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W2107569441","doi":"10.1177/1352458508101939","title":"Proof of concept studies for tissue-protective agents in multiple sclerosis","year":2009,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Placebo; Medicine; Clinical trial; Clinical study design; Proof of concept; Clinical endpoint; Sample size determination; Randomized controlled trial; Treatment effect; Physical medicine and rehabilitation; Intensive care medicine; Computer science; Pathology; Alternative medicine; Statistics; Psychiatry","score_opus":0.4719566677639761,"score_gpt":0.43587226485570935,"score_spread":0.036084402908266755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107569441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069124385,0.9860192,0.0006228942,0.0002400238,0.0005461633,0.011081843,0.00065858464,0.00007814449,0.00006191607],"genre_scores_gemma":[0.010437587,0.97999376,0.005902912,0.000082858154,0.0010363741,0.001893343,0.00011540041,0.00025999383,0.0002777739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99010324,0.0009741672,0.003804361,0.0014234494,0.0018496067,0.0018451614],"domain_scores_gemma":[0.9907402,0.003066532,0.0024275547,0.0010613054,0.002008435,0.0006959637],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022322615,0.0015641866,0.008051352,0.0018109361,0.00067029847,0.00013802687,0.0010033716,0.0008544319,0.00009015237],"category_scores_gemma":[0.013017951,0.0012129444,0.0022505398,0.0015428653,0.00088898843,0.00039127973,0.0004989501,0.0024848334,0.000020379986],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046903617,0.0011644351,0.0003750262,0.014123176,0.0023454756,0.00003055847,0.0012749042,0.00004849116,0.00048069388,0.000002543625,0.006484894,0.97320074],"study_design_scores_gemma":[0.032053374,0.005861843,0.019055974,0.30858994,0.0045246934,0.00027259596,0.0021962458,0.00078937004,0.0051638675,0.00011928218,0.61837995,0.002992878],"about_ca_topic_score_codex":0.00011109747,"about_ca_topic_score_gemma":0.00022222631,"teacher_disagreement_score":0.97020787,"about_ca_system_score_codex":0.0019361033,"about_ca_system_score_gemma":0.0008996084,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W2108926058","doi":"10.1177/1352458512470730","title":"Piet Mondrian’s trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"Agencja Badań Medycznych","keywords":"Multiple sclerosis; Mondrian; Medicine; Neuroscience; Psychology; Immunology; Art; Visual arts","score_opus":0.117860913057767,"score_gpt":0.2698007645620776,"score_spread":0.15193985150431058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108926058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618691,0.007556665,0.0076125553,0.018307237,0.00063494546,0.003371816,0.00004041051,0.00014924281,0.00045803044],"genre_scores_gemma":[0.9886518,0.008084722,0.0016384072,0.0004570441,0.00060356146,0.00029745555,0.000012330399,0.000087857814,0.00016683727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995001,0.00063378474,0.0010759856,0.00070935616,0.0012648763,0.0013149641],"domain_scores_gemma":[0.9965739,0.0014016398,0.00039922923,0.0006149529,0.0003866364,0.00062361086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018759338,0.0005882037,0.001032617,0.00065137283,0.0011868379,0.0004768647,0.00044445964,0.0002907597,0.0005836988],"category_scores_gemma":[0.0026551357,0.00038328167,0.0003788525,0.0005735561,0.0010195958,0.00075417774,0.0003606569,0.0017432957,0.00013877144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022910314,0.0006372358,0.7265452,0.00015114539,0.00057398865,0.000018682165,0.0050286264,0.0003336951,0.23837003,0.00027329577,0.010651163,0.015125892],"study_design_scores_gemma":[0.02474837,0.00029050658,0.94828385,0.0009439301,0.00009409197,0.00010919295,0.0033622293,0.019668657,0.0009446827,0.0009085961,0.00022822966,0.00041768828],"about_ca_topic_score_codex":0.0023837797,"about_ca_topic_score_gemma":0.0018777993,"teacher_disagreement_score":0.23742534,"about_ca_system_score_codex":0.0014640959,"about_ca_system_score_gemma":0.00019817,"threshold_uncertainty_score":0.9998619},"labels":[],"label_agreement":null},{"id":"W2109265148","doi":"10.1177/135245850501100122","title":"MRI Correlates of MS Pathologic Subtypes","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Neural correlates of consciousness; Medicine; Pathology; Magnetic resonance imaging; Radiology; Cognition; Psychiatry","score_opus":0.20176283075805304,"score_gpt":0.3704165779671115,"score_spread":0.16865374720905849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109265148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077201263,0.99616265,0.00007906048,0.00010732388,0.00063643703,0.0013616966,0.00016364416,0.0000775428,0.0006396329],"genre_scores_gemma":[0.0034103615,0.9909314,0.0037339688,0.000039180024,0.0012706799,0.00010745504,0.00006720809,0.00016092634,0.00027880017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938243,0.00059084897,0.0023583986,0.0007265341,0.0013873908,0.001112525],"domain_scores_gemma":[0.9948572,0.0012754744,0.0016571601,0.00087423855,0.00068672164,0.00064922415],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014923228,0.000940495,0.004721306,0.00093274534,0.00035874845,0.00010165884,0.00075059215,0.00060866034,0.0011179489],"category_scores_gemma":[0.002250544,0.0006383145,0.0022542635,0.00076734624,0.00045676174,0.00020611763,0.00043286316,0.0027182095,0.00046051157],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083239596,0.0003505962,0.0077437786,0.0051768566,0.0008855384,0.000094467214,0.00013617799,0.000012923662,0.00007181439,0.0000029090309,0.0029766143,0.9824651],"study_design_scores_gemma":[0.00321753,0.00062028645,0.02406761,0.05574187,0.0024462214,0.0017648475,0.00016314897,0.0002018594,0.00003421424,0.000008690892,0.9108797,0.00085403526],"about_ca_topic_score_codex":0.00012608265,"about_ca_topic_score_gemma":0.00010147444,"teacher_disagreement_score":0.9816111,"about_ca_system_score_codex":0.00095146906,"about_ca_system_score_gemma":0.001156787,"threshold_uncertainty_score":0.99979514},"labels":[],"label_agreement":null},{"id":"W2109752119","doi":"10.1177/1352458513475723","title":"Magnetic resonance imaging outcomes from a phase III trial of teriflunomide","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto; St. Michael's Hospital","funders":"Universität Innsbruck; Warszawski Uniwersytet Medyczny; Universidade de Coimbra; Centre Hospitalier Universitaire de Nantes; Universidad de Chile; Academy of Military Medical Sciences; Universität Rostock; Medizinische Universität Innsbruck","keywords":"Teriflunomide; Magnetic resonance imaging; Multiple sclerosis; Medicine; Nuclear magnetic resonance; Phase (matter); Radiology; Physics; Psychiatry; Fingolimod","score_opus":0.08717246974494447,"score_gpt":0.3241591583027233,"score_spread":0.23698668855777882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109752119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909459,0.0036529573,0.00022843182,0.002408401,0.00056200847,0.0015212415,0.00010209633,0.0000640513,0.00051495736],"genre_scores_gemma":[0.9904223,0.0014279907,0.0065513854,0.0003579596,0.00068273343,0.00016958639,0.000016095037,0.000060265374,0.00031169364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99613404,0.00021494392,0.0012945922,0.00045842063,0.0011138186,0.00078418944],"domain_scores_gemma":[0.9971094,0.0006908663,0.0004257765,0.000629077,0.0006053872,0.0005394692],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006502405,0.00038514446,0.0011025883,0.0003368324,0.00031861127,0.00017694164,0.0004018046,0.00009737329,0.0028197577],"category_scores_gemma":[0.002079232,0.00029429374,0.0005063191,0.00028424276,0.00036867513,0.0004520076,0.00022976947,0.0006999185,0.00012921685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019259695,0.0015750098,0.20160721,0.00002790464,0.00014397225,0.000026125996,0.00072659267,0.000004814451,0.3184655,0.0000018955155,0.00922798,0.4489333],"study_design_scores_gemma":[0.25733426,0.00082922814,0.72904456,0.0004536136,0.00009890473,0.000015078205,0.00045053742,0.003063859,0.005948624,0.00003320031,0.0024700828,0.0002580392],"about_ca_topic_score_codex":0.001248895,"about_ca_topic_score_gemma":0.00003246747,"teacher_disagreement_score":0.5274374,"about_ca_system_score_codex":0.00018242112,"about_ca_system_score_gemma":0.00016161417,"threshold_uncertainty_score":0.99995095},"labels":[],"label_agreement":null},{"id":"W2110767197","doi":"10.1177/1352458514546785","title":"Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Università degli Studi di Sassari; Universitetet i Bergen; McGill University Health Centre; Multiple Sclerosis Society of Canada; McGill University; Multiple Sclerosis Society; Helse Vest; Fondazione Italiana Sclerosi Multipla","keywords":"Odds ratio; Medicine; Risk factor; Multiple sclerosis; Demography; Logistic regression; Obesity; Body mass index; Case-control study; Population; Overweight; Epidemiology; Internal medicine; Environmental health","score_opus":0.05554544088432382,"score_gpt":0.2742067437311857,"score_spread":0.2186613028468619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110767197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321246,0.0016505015,0.000097989185,0.002651928,0.00017582324,0.0019282417,0.000034975517,0.000025267704,0.00022278252],"genre_scores_gemma":[0.9899393,0.008558239,0.0006601503,0.0002169169,0.0003300876,0.00014737772,0.0000014614592,0.000059020538,0.00008748587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945,0.0017627018,0.0011532074,0.00058314344,0.0012132362,0.0007877224],"domain_scores_gemma":[0.9894109,0.008459744,0.0005851558,0.0008114777,0.00035638464,0.00037637394],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0068352283,0.00047105807,0.0011513305,0.00026280287,0.0010805135,0.00023137513,0.0004867585,0.00013731312,0.00007724674],"category_scores_gemma":[0.015180474,0.0002448834,0.00029408338,0.0005360357,0.0015709378,0.00025507098,0.00060047215,0.0014820431,0.000013083512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016110003,0.0007323753,0.9345403,0.000054952085,0.00052276015,0.000003994628,0.0065441853,0.00007215992,0.033155978,0.000013686909,0.0003399153,0.02240874],"study_design_scores_gemma":[0.024869753,0.00068279577,0.9573903,0.00038383747,0.00029348538,0.00003642962,0.005379997,0.009263054,0.0011255118,0.00006301854,0.000272614,0.0002391718],"about_ca_topic_score_codex":0.001231799,"about_ca_topic_score_gemma":0.0014331974,"teacher_disagreement_score":0.032030467,"about_ca_system_score_codex":0.00010472198,"about_ca_system_score_gemma":0.000067734996,"threshold_uncertainty_score":0.9986056},"labels":[],"label_agreement":null},{"id":"W2110897431","doi":"10.1177/1352458512474090","title":"Labor induction and augmentation in women with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute; University of British Columbia","keywords":"Medicine; Confidence interval; Odds ratio; Cohort; Multiple sclerosis; Population; Cohort study; Expanded Disability Status Scale; Obstetrics; Labor induction; Proportional hazards model; Gynecology; Internal medicine; Immunology","score_opus":0.07998561984373619,"score_gpt":0.2810743202194326,"score_spread":0.20108870037569643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110897431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476933,0.00042669036,0.00014852523,0.0030319085,0.00016824347,0.001245112,0.000018429599,0.000077708144,0.00011403899],"genre_scores_gemma":[0.9898847,0.0031448128,0.0054114894,0.00050173706,0.00035039368,0.00050853676,0.000010095949,0.00006943977,0.000118837444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659646,0.00022024834,0.00070987275,0.00054790365,0.00093634345,0.0009891905],"domain_scores_gemma":[0.99784935,0.00032142267,0.00027026192,0.000329567,0.0005634451,0.0006659632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007938347,0.0003942631,0.0006246674,0.00064869964,0.0004768592,0.00033366415,0.00016844898,0.00016543664,0.000455308],"category_scores_gemma":[0.000896491,0.00030246333,0.00007452184,0.00075548614,0.00031252656,0.0010566022,0.000137002,0.0009073587,0.00008292543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010631974,0.00038254278,0.59827054,0.00007429996,0.0001658379,0.000009314933,0.0028391588,0.00007078819,0.28222615,0.000001684382,0.0012243645,0.113672145],"study_design_scores_gemma":[0.012748837,0.00074276986,0.9735942,0.0007948848,0.000031487813,0.000085285596,0.0049327114,0.0018964503,0.0045531294,0.000023718874,0.00027773992,0.00031878747],"about_ca_topic_score_codex":0.00087387324,"about_ca_topic_score_gemma":0.0003858571,"teacher_disagreement_score":0.37532368,"about_ca_system_score_codex":0.00072955026,"about_ca_system_score_gemma":0.00013293514,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W2111613885","doi":"10.1177/1352458511414039","title":"Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Clinically isolated syndrome; Construct validity; Item response theory; Clinical trial; Medicine; Expanded Disability Status Scale; Psychology; Psychometrics; Physical therapy; Clinical psychology; Internal medicine; Psychiatry","score_opus":0.1493264308341575,"score_gpt":0.29319344675073045,"score_spread":0.14386701591657294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111613885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265105,0.00018319144,0.0032120128,0.0007837544,0.00048034103,0.0024021782,0.000091627146,0.000094847885,0.00010099823],"genre_scores_gemma":[0.9843559,0.0005574815,0.0142131215,0.00024360028,0.00017351574,0.00022594485,0.000034062345,0.00015107114,0.00004527872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922937,0.0006364694,0.0022870267,0.0009742173,0.002280228,0.0015283587],"domain_scores_gemma":[0.9938433,0.0016981462,0.001203499,0.00084979174,0.0015176849,0.00088758953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003702843,0.0007585994,0.0013922758,0.003184306,0.0011111449,0.00025301104,0.0005662345,0.0003223811,0.00012818292],"category_scores_gemma":[0.0037399249,0.0005555331,0.00038714343,0.0047589983,0.00043704433,0.0006609459,0.00051343074,0.0017229951,0.000011751327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035425979,0.001375076,0.9634515,0.00008708188,0.0005187622,0.0000054493835,0.004030456,0.00031736615,0.008814408,0.0000043544587,0.00014682769,0.017706128],"study_design_scores_gemma":[0.016526764,0.0039420035,0.9688656,0.0032866853,0.0002065594,0.000029203475,0.0017520968,0.00433581,0.00046883663,0.000007670575,0.00001843121,0.00056034373],"about_ca_topic_score_codex":0.00097445794,"about_ca_topic_score_gemma":0.00023867527,"teacher_disagreement_score":0.017145785,"about_ca_system_score_codex":0.0006393636,"about_ca_system_score_gemma":0.00027252253,"threshold_uncertainty_score":0.99968964},"labels":[],"label_agreement":null},{"id":"W2111959241","doi":"10.1191/1352458504ms992oa","title":"Multiple sclerosis and alcohol: a study of problem drinking","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Alcohol; Environmental health; Psychology; Psychiatry; Biology","score_opus":0.2204880410900095,"score_gpt":0.3418251555076328,"score_spread":0.12133711441762332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111959241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657494,0.0005887833,0.0004747432,0.00070151687,0.00021561077,0.001253279,0.000004481711,0.000076243814,0.00011040601],"genre_scores_gemma":[0.991374,0.000607215,0.0073096957,0.00038086838,0.0002004005,0.000046287798,0.0000032784978,0.000049820257,0.000028401118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975078,0.00014197332,0.00082259584,0.0003742469,0.0006421038,0.00051125936],"domain_scores_gemma":[0.99821955,0.00020425311,0.000416412,0.00031042253,0.0003019115,0.0005474473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009044804,0.0002777549,0.00063100376,0.00035875195,0.0005034164,0.00008406239,0.00014268521,0.00013899282,0.00006832368],"category_scores_gemma":[0.00034735433,0.00023686023,0.00015085514,0.00031949877,0.00012568686,0.00023210769,0.000103806466,0.000684488,0.00002402056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005671469,0.0017994505,0.89365023,0.00017851603,0.00019442421,0.00003146988,0.0043426105,0.0002105787,0.08369155,0.000019060357,0.00011284067,0.015202096],"study_design_scores_gemma":[0.026670871,0.0015505982,0.96487284,0.0014536025,0.00018006818,0.00025369466,0.0013583387,0.000284998,0.0029693379,0.00004615489,0.0001384528,0.00022104332],"about_ca_topic_score_codex":0.00031223448,"about_ca_topic_score_gemma":0.00038368488,"teacher_disagreement_score":0.08072221,"about_ca_system_score_codex":0.00019363943,"about_ca_system_score_gemma":0.0001747716,"threshold_uncertainty_score":0.96588796},"labels":[],"label_agreement":null},{"id":"W2112063945","doi":"10.1177/1352458514564485","title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Multiple Sclerosis Society; Genentech; Novartis Pharmaceuticals Corporation; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Cleveland Clinic; Teva Pharmaceutical Industries; Bayer HealthCare; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Biogen; Pfizer; MedDay Pharmaceuticals; GlaxoSmithKline; Gilead Sciences","keywords":"Multiple sclerosis; Medicine; Peripheral; Incidence (geometry); Disease; Vascular disease; Cardiology; Stroke (engine); Internal medicine; Immunology","score_opus":0.08095027036917916,"score_gpt":0.30970297849247946,"score_spread":0.22875270812330029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112063945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005038962,0.98818856,0.000026861635,0.000088974026,0.00018878806,0.0062522837,0.00018958113,0.000018118006,0.000007850167],"genre_scores_gemma":[0.019158587,0.9794173,0.0005023923,0.00007661425,0.00013328786,0.00056107907,0.000009492259,0.00010650271,0.00003469307],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9900885,0.0029117323,0.0032741101,0.0008788324,0.002094734,0.0007520674],"domain_scores_gemma":[0.99300766,0.0017950068,0.0021831885,0.0016704313,0.0006640407,0.0006796824],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0050422344,0.0009118222,0.0071978173,0.0004439846,0.00032085637,0.000087881555,0.0008494497,0.00029462777,0.000043597705],"category_scores_gemma":[0.01671042,0.00055946334,0.0024667606,0.00083918025,0.0009599582,0.00023997258,0.000930021,0.0013997784,0.000003002349],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028671235,0.00016140814,0.040972292,0.92969865,0.0010990513,0.0000024369342,0.00018106741,0.0000030540748,0.000063135594,0.0000016131493,0.00007532818,0.027713288],"study_design_scores_gemma":[0.0013303799,0.0001020003,0.14742148,0.84271395,0.0060834214,0.000042157382,0.000040844832,0.00028983795,0.0000074925883,0.0000017234883,0.0015654791,0.00040120384],"about_ca_topic_score_codex":0.00016854744,"about_ca_topic_score_gemma":0.00003156114,"teacher_disagreement_score":0.106449194,"about_ca_system_score_codex":0.00037986215,"about_ca_system_score_gemma":0.0005764481,"threshold_uncertainty_score":0.9996857},"labels":[],"label_agreement":null},{"id":"W2114080475","doi":"10.1177/1352458511417835","title":"Multiple sclerosis and depression","year":2011,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Psychosocial; Depression (economics); Medicine; Quality of life (healthcare); Mood; Randomized controlled trial; Psychiatry; Clinical psychology; Mindfulness; Mood disorders; Affect (linguistics); Psychology; Anxiety; Internal medicine","score_opus":0.2937370974242926,"score_gpt":0.35762058994847534,"score_spread":0.06388349252418274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114080475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009530087,0.9943074,0.00012717058,0.00006143488,0.0010252845,0.002392932,0.00020532872,0.00022202499,0.0007054015],"genre_scores_gemma":[0.00389762,0.98821473,0.004589469,0.00011074527,0.0018972128,0.00039228983,0.00009544539,0.0003826118,0.0004198893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920646,0.00080192636,0.00231589,0.0015458415,0.0014484767,0.0018232666],"domain_scores_gemma":[0.9931992,0.0014473147,0.0013474022,0.0013344503,0.000800746,0.0018708647],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016767965,0.0016336147,0.0049614403,0.0013591355,0.0013441207,0.00045932032,0.0008553695,0.0010926636,0.00057517807],"category_scores_gemma":[0.004635018,0.0011838947,0.0019221345,0.0008615517,0.0006722048,0.0005128901,0.0011863478,0.0036641778,0.0003605864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020563637,0.00045265295,0.0072765267,0.0070613264,0.0011328004,0.00005763908,0.00034009904,3.6646134e-7,0.00022528926,0.0000020406833,0.006854806,0.97639084],"study_design_scores_gemma":[0.0058465065,0.0003672229,0.032654565,0.07911508,0.0023989629,0.0010964035,0.00018466271,0.00010327844,0.00008307465,0.000008464867,0.87683266,0.0013091379],"about_ca_topic_score_codex":0.000143815,"about_ca_topic_score_gemma":0.00006452212,"teacher_disagreement_score":0.9750817,"about_ca_system_score_codex":0.0006242589,"about_ca_system_score_gemma":0.0005875727,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2114728329","doi":"10.1177/1352458509347150","title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Multiple sclerosis; Receiver operating characteristic; Confounding; Rating scale; Population; Psychiatry; Psychology; Expanded Disability Status Scale; Medicine; Internal medicine","score_opus":0.05894340111054678,"score_gpt":0.2692807458743455,"score_spread":0.2103373447637987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114728329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606997,0.0001523886,0.00093999924,0.00064769835,0.000235593,0.0017694854,0.00012127982,0.000038389557,0.000025218465],"genre_scores_gemma":[0.9868783,0.0009163315,0.011658848,0.00016161852,0.00022221939,0.00005980228,0.000024880774,0.000044371067,0.00003367413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711084,0.00014532618,0.0006378737,0.0004679846,0.001047224,0.0005907699],"domain_scores_gemma":[0.9970009,0.00041954342,0.00048427103,0.00049004867,0.0012541448,0.0003510896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005199477,0.00034353245,0.00055802625,0.00017535654,0.0007889125,0.00017228685,0.00025917834,0.0001478596,0.000013823307],"category_scores_gemma":[0.002110276,0.00020738131,0.0002912069,0.00036479053,0.0002804706,0.000617028,0.0001459693,0.0004634687,0.0000015944082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094587763,0.0007326925,0.8824125,0.000048746897,0.000085827676,3.4310983e-7,0.00065896136,0.00007238752,0.071178496,4.559836e-7,0.0013086352,0.042555105],"study_design_scores_gemma":[0.010879005,0.00086850475,0.9019958,0.0010390391,0.00013222659,0.000010999514,0.00023000216,0.0017550957,0.082686946,0.000007670414,0.00017108241,0.00022362177],"about_ca_topic_score_codex":0.000051536965,"about_ca_topic_score_gemma":0.000031433843,"teacher_disagreement_score":0.042331483,"about_ca_system_score_codex":0.00014970807,"about_ca_system_score_gemma":0.000082636805,"threshold_uncertainty_score":0.8456764},"labels":[],"label_agreement":null},{"id":"W2114998283","doi":"10.1177/1352458514542363","title":"Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Multiple sclerosis; Atrophy; Medicine; Neuroscience; Cognition; Physical medicine and rehabilitation; Pathology; Psychology; Psychiatry","score_opus":0.07064335417150497,"score_gpt":0.2698732605159684,"score_spread":0.19922990634446341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114998283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385583,0.00026237487,0.002621743,0.000703971,0.0007223225,0.0011004121,0.00007643627,0.00018274903,0.00047418667],"genre_scores_gemma":[0.9923436,0.0012695217,0.0035176692,0.00033559653,0.0019951512,0.00011168323,0.000053183252,0.00012837458,0.0002452137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946252,0.00062271045,0.0009339679,0.00090108125,0.0016003791,0.0013166445],"domain_scores_gemma":[0.9945922,0.0018997093,0.00047244414,0.00044979888,0.0012485553,0.0013372819],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0014257156,0.00065198744,0.0010114401,0.00042133097,0.0016358499,0.00052229426,0.00023458086,0.00027833265,0.00026154958],"category_scores_gemma":[0.0077975905,0.0004975525,0.00030244453,0.00057089096,0.0006895244,0.0006600915,0.00032659495,0.0016378537,0.00008476909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046337694,0.0005119676,0.92152935,0.00016440236,0.0008265845,0.000030637137,0.00091557804,0.00016224851,0.05009749,0.0000040435007,0.002034417,0.019089516],"study_design_scores_gemma":[0.021538416,0.0014269125,0.95316833,0.0012664795,0.00044689607,0.00029176546,0.0007851947,0.015516507,0.0042518233,0.00002227226,0.00067959406,0.0006057791],"about_ca_topic_score_codex":0.00018533702,"about_ca_topic_score_gemma":0.0001583773,"teacher_disagreement_score":0.04584567,"about_ca_system_score_codex":0.00025059405,"about_ca_system_score_gemma":0.00019056334,"threshold_uncertainty_score":0.99974763},"labels":[],"label_agreement":null},{"id":"W2115103546","doi":"10.1177/1352458506072167","title":"Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Remyelination; Multiple sclerosis; Astrocytosis; Myelin basic protein; Myelin; Medicine; Immunology; Experimental autoimmune encephalomyelitis; In vivo; Demyelinating disease; Cancer research; Combination therapy; Pharmacology; Biology; Central nervous system; Internal medicine; Immunohistochemistry","score_opus":0.13202293009807345,"score_gpt":0.35370644913832344,"score_spread":0.22168351904025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115103546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514276,0.0015370377,0.0014035881,0.00080872234,0.0001613143,0.0006558793,0.000069903355,0.00004111798,0.00017967937],"genre_scores_gemma":[0.9937205,0.000878149,0.004088129,0.00014153055,0.0010155201,0.000030771484,0.00004572149,0.00005289109,0.000026819953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511945,0.0006302375,0.0012848788,0.0004285597,0.0015254493,0.0010114128],"domain_scores_gemma":[0.9955474,0.0023305218,0.0004655142,0.0006085828,0.000475237,0.00057275116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041761003,0.00035682187,0.000858485,0.0005757256,0.0005491735,0.00009043006,0.00061655487,0.0001574347,0.00009287407],"category_scores_gemma":[0.0038018364,0.0002290814,0.000333709,0.0006891815,0.00030775397,0.00036485356,0.00023754107,0.0010120465,0.000006612371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089668104,0.00087843585,0.74353456,0.00016295168,0.00019949584,0.00008512395,0.0042274343,0.00033957002,0.13046141,0.000008560844,0.00038148699,0.11882428],"study_design_scores_gemma":[0.0055837017,0.0006416682,0.97202283,0.0006932971,0.00012852464,0.000054839205,0.003998115,0.0011614301,0.015059448,0.000041898726,0.00038548396,0.00022877217],"about_ca_topic_score_codex":0.0004960452,"about_ca_topic_score_gemma":0.0003883049,"teacher_disagreement_score":0.22848825,"about_ca_system_score_codex":0.0003190052,"about_ca_system_score_gemma":0.00017341747,"threshold_uncertainty_score":0.93416685},"labels":[],"label_agreement":null},{"id":"W2115474937","doi":"10.1177/1352458508101944","title":"Anti-α-glucose–based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cohort; Multiple sclerosis; Medicine; Internal medicine; Biomarker; Antibody; Gastroenterology; Immunology; Biology","score_opus":0.08375616481045695,"score_gpt":0.2883952567213804,"score_spread":0.20463909191092344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115474937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450197,0.0014893247,0.0003860868,0.02097178,0.0005234147,0.0017027799,0.00010481948,0.00019778142,0.00012207223],"genre_scores_gemma":[0.9908414,0.0042056115,0.0011084646,0.0027494526,0.00074455066,0.00020242964,0.000015112581,0.0000890045,0.00004397715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926074,0.00077835773,0.0013637478,0.0011437514,0.0021255922,0.0019811532],"domain_scores_gemma":[0.9955214,0.0014787735,0.000522072,0.0011888682,0.0004927664,0.0007961024],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023284978,0.0009059843,0.0014478955,0.0007099,0.0014581187,0.000406684,0.000881684,0.000417949,0.00026442928],"category_scores_gemma":[0.0040330742,0.0006052033,0.0009209305,0.0011325123,0.0008265967,0.0006061053,0.00037437546,0.0029565443,0.00007909877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057031643,0.002514406,0.89785993,0.00008005554,0.000185321,0.0002416633,0.0006013158,0.0013396331,0.05875878,0.0000018576153,0.0030524526,0.029661434],"study_design_scores_gemma":[0.010918975,0.001417694,0.94807255,0.00110107,0.00012569522,0.00010276214,0.00013236568,0.028561749,0.007284438,0.000016876851,0.0017174407,0.00054839987],"about_ca_topic_score_codex":0.00020577737,"about_ca_topic_score_gemma":0.0007968875,"teacher_disagreement_score":0.05147434,"about_ca_system_score_codex":0.0004955298,"about_ca_system_score_gemma":0.0002659668,"threshold_uncertainty_score":0.99984187},"labels":[],"label_agreement":null},{"id":"W2115977309","doi":"10.1177/1352458507076411","title":"Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Grey matter; Magnetic resonance imaging; Expanded Disability Status Scale; Globus pallidus; Nuclear medicine; Medicine; Caudate nucleus; Psychology; White matter; Radiology; Basal ganglia; Internal medicine; Psychiatry; Central nervous system","score_opus":0.061461826365315886,"score_gpt":0.27957573182267487,"score_spread":0.21811390545735898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115977309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990218,0.0029482374,0.00077776815,0.0026798518,0.00044367556,0.0015399997,0.000038312835,0.00013957023,0.0012146233],"genre_scores_gemma":[0.9914121,0.0012025865,0.005044289,0.0011518414,0.00064340606,0.00008912001,0.00001904886,0.0001764603,0.00026112355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926028,0.00037420352,0.0016006931,0.0012415538,0.0019414213,0.0022392971],"domain_scores_gemma":[0.9947094,0.0021321506,0.0004150171,0.0011005156,0.0006557139,0.0009872138],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027980125,0.0008780076,0.0011999797,0.0006506796,0.0007818132,0.0003291215,0.0006113121,0.0002481058,0.0008010505],"category_scores_gemma":[0.0025742708,0.0006830704,0.000412013,0.0012505021,0.0016122847,0.0006188249,0.0003089808,0.002387118,0.0004947373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031275877,0.0013151262,0.8988787,0.000094845134,0.00005779965,0.00012722061,0.0011276565,0.0003825439,0.016412944,0.0000027672447,0.0021834844,0.07628931],"study_design_scores_gemma":[0.013486731,0.0007377409,0.9638664,0.002590344,0.000074906835,0.00012327664,0.0015837756,0.013519424,0.002464167,0.000020093801,0.000828416,0.00070469413],"about_ca_topic_score_codex":0.0004834452,"about_ca_topic_score_gemma":0.0019736455,"teacher_disagreement_score":0.07558461,"about_ca_system_score_codex":0.0012773765,"about_ca_system_score_gemma":0.00012783674,"threshold_uncertainty_score":0.9999144},"labels":[],"label_agreement":null},{"id":"W2116526010","doi":"10.1177/1352458511422244","title":"Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute","keywords":"Medicine; Pregnancy; Incidence (geometry); Odds ratio; Obstetrics; Population; Gestation; Vaginal delivery; Gestational age; Pediatrics; Internal medicine","score_opus":0.14244962692372048,"score_gpt":0.2945252923043973,"score_spread":0.1520756653806768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116526010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549,0.00029091316,0.0003730018,0.0012096977,0.00030342344,0.001619432,0.00010447283,0.00018850589,0.00042054744],"genre_scores_gemma":[0.98621213,0.0006112279,0.010944498,0.0009106366,0.00026423958,0.00066079834,0.000008153569,0.00017555307,0.00021278298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99335474,0.00029801315,0.0011941884,0.0010480718,0.0019058777,0.002199116],"domain_scores_gemma":[0.9950944,0.0005189475,0.00031945886,0.0009635631,0.0005739011,0.0025296924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013529821,0.00082210015,0.0013835544,0.0011789408,0.0007562741,0.00025102988,0.0007302462,0.00017346282,0.00062011596],"category_scores_gemma":[0.0023838647,0.00062806444,0.00035373494,0.0010632917,0.00036664808,0.0007417762,0.00052379945,0.0012986739,0.00018180608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00913203,0.0013463699,0.8989154,0.0001478658,0.0004326584,0.00020566593,0.016765743,0.00010434735,0.04213796,0.000003913422,0.00039709386,0.03041095],"study_design_scores_gemma":[0.015491784,0.0010729241,0.9693294,0.0015400797,0.00006612593,0.000037849004,0.005548505,0.0006983719,0.005043296,0.000011596202,0.00043028157,0.0007297802],"about_ca_topic_score_codex":0.0003378263,"about_ca_topic_score_gemma":0.0002705067,"teacher_disagreement_score":0.07041401,"about_ca_system_score_codex":0.0012921717,"about_ca_system_score_gemma":0.00035097825,"threshold_uncertainty_score":0.99961704},"labels":[],"label_agreement":null},{"id":"W2118096703","doi":"10.1177/1352458514540844","title":"How useful are MS registries?","year":2014,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical neurology; MEDLINE; Neuroscience; Psychology; Chemistry; Psychiatry","score_opus":0.10887535660433517,"score_gpt":0.24223977521564166,"score_spread":0.1333644186113065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118096703","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020826202,0.011334142,0.00036372436,0.96126574,0.0040253303,0.00082225376,0.00016501776,0.00026729982,0.00093029486],"genre_scores_gemma":[0.22515033,0.006819028,0.0005185165,0.70300925,0.047230374,0.00007544259,0.00045730596,0.00042750634,0.016312247],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99518114,0.0003568287,0.0010049077,0.00079811556,0.0016181497,0.0010408511],"domain_scores_gemma":[0.99541056,0.00036353501,0.001748347,0.001146495,0.0006794083,0.00065163337],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005447234,0.0008251746,0.0016131849,0.00048615615,0.00051829655,0.00090818485,0.000577655,0.0020756598,0.0003765619],"category_scores_gemma":[0.0013038976,0.0006104756,0.0012809365,0.0003265666,0.00026250957,0.00021278679,0.000099197925,0.005056516,0.00022819548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010486614,0.00009047551,0.017943127,0.00035576668,0.0006000585,0.00067744055,0.000050109775,0.0000049224295,0.0013896575,4.415587e-7,0.97738254,0.0014005695],"study_design_scores_gemma":[0.0047367676,0.00018690515,0.043587808,0.013745773,0.0010256674,0.0028965978,0.00016945937,0.00009599523,0.00035295865,0.000012719884,0.9324769,0.00071248424],"about_ca_topic_score_codex":0.000031555417,"about_ca_topic_score_gemma":0.0000034070713,"teacher_disagreement_score":0.2582565,"about_ca_system_score_codex":0.00042815818,"about_ca_system_score_gemma":0.0003000535,"threshold_uncertainty_score":0.9996347},"labels":[],"label_agreement":null},{"id":"W2118372228","doi":"10.1191/1352458502ms769oa","title":"International consensus statement on the use of disease-modifying agents in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Statement (logic); Multiple sclerosis; Voting; Consensus conference; Medicine; Family medicine; Disease; Steering committee; Alternative medicine; MEDLINE; Political science; Psychiatry; Pathology; Internal medicine; Law; Engineering","score_opus":0.5148747468519949,"score_gpt":0.3560688506872489,"score_spread":0.15880589616474594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118372228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452616,0.0002873102,0.00009908908,0.012840056,0.0005669089,0.0011051624,0.000229439,0.00004591783,0.00029994716],"genre_scores_gemma":[0.99035007,0.005783136,0.002356806,0.00079296477,0.00026842713,0.00010514545,0.000016262931,0.000063342806,0.00026383746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949275,0.00045789374,0.0013335388,0.00052606483,0.0019149403,0.0008400175],"domain_scores_gemma":[0.99565613,0.002050122,0.0005236928,0.00065147,0.0005615978,0.00055699376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010986618,0.00042119794,0.00062493293,0.0006278153,0.00049593125,0.00021941592,0.000496059,0.00010111838,0.0013608158],"category_scores_gemma":[0.006586192,0.00029683858,0.0004167591,0.0005070659,0.00043231936,0.00026359514,0.000297627,0.0009802483,0.00010114385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024522713,0.0028415304,0.8266862,0.00011205418,0.0007755677,0.00009800231,0.0017288732,0.005491182,0.04691309,0.000024918008,0.07251284,0.040363446],"study_design_scores_gemma":[0.008322515,0.00025745036,0.87966794,0.0017821181,0.000062774605,0.000012695636,0.00044826727,0.09628342,0.0019409417,0.000008205608,0.0109255565,0.00028809166],"about_ca_topic_score_codex":0.00021904989,"about_ca_topic_score_gemma":0.000101235404,"teacher_disagreement_score":0.09079224,"about_ca_system_score_codex":0.000655965,"about_ca_system_score_gemma":0.00007535632,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W2118598578","doi":"10.1177/1352458509355462","title":"A randomized trial of memantine as treatment for spasticity in multiple sclerosis","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux; National Multiple Sclerosis Society","keywords":"Spasticity; Memantine; Modified Ashworth scale; Multiple sclerosis; Randomized controlled trial; Medicine; Placebo; Physical therapy; Physical medicine and rehabilitation; Psychology; Internal medicine; Psychiatry","score_opus":0.1948002845081289,"score_gpt":0.35093360852870165,"score_spread":0.15613332402057276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118598578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669356,0.00072321465,0.0015450806,0.003151494,0.0004507698,0.006865743,0.00008574767,0.00007402447,0.00041037967],"genre_scores_gemma":[0.9837823,0.0054369275,0.008869401,0.00023160396,0.00083944557,0.00053691445,0.000030574727,0.00006321606,0.0002096519],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99418426,0.00057308015,0.0021571368,0.0006855885,0.0012171435,0.0011827782],"domain_scores_gemma":[0.9939107,0.0033109235,0.0008007238,0.00059486425,0.00077717134,0.0006056719],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031065028,0.00064001384,0.002913014,0.0008834222,0.00041698248,0.000112241585,0.00035311343,0.00025815645,0.00016215468],"category_scores_gemma":[0.014096341,0.00047179338,0.0015366233,0.00064249826,0.00043733453,0.00027796786,0.00008657549,0.0005728592,0.000021324411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84446263,0.004130171,0.0066589448,0.00007756465,0.0005776176,0.000015975522,0.00091125275,0.00019969992,0.097109854,0.00003217186,0.00048285958,0.045341246],"study_design_scores_gemma":[0.8785061,0.0049225627,0.08170152,0.0010767543,0.00035082197,0.00003161588,0.00025429932,0.008888227,0.023487957,0.00014087952,0.00027671587,0.0003625395],"about_ca_topic_score_codex":0.0005547809,"about_ca_topic_score_gemma":0.00026175458,"teacher_disagreement_score":0.075042576,"about_ca_system_score_codex":0.0005665288,"about_ca_system_score_gemma":0.00036209275,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W2118948764","doi":"10.1177/1352458514538334","title":"Identifying individuals with multiple sclerosis in an electronic medical record","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medical record; Medicine; Medical prescription; Electronic medical record; Diagnosis code; MEDLINE; Family medicine; Chart; Medical emergency; Internal medicine; Population; Nursing","score_opus":0.10881662590877705,"score_gpt":0.32381123168379233,"score_spread":0.21499460577501528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118948764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916022,0.00045459336,0.0034552861,0.0027310196,0.000321947,0.0009511067,0.000018829498,0.00019175181,0.00027331314],"genre_scores_gemma":[0.98551524,0.0030666387,0.009136682,0.00079213025,0.0010253763,0.00018031456,0.000038961276,0.00016745794,0.00007720267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907171,0.0009885873,0.0014735687,0.0010871222,0.0033823221,0.0023512722],"domain_scores_gemma":[0.9950236,0.001209035,0.0005056782,0.00093881,0.0006168003,0.0017060766],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0049763396,0.00071588863,0.0013537623,0.0011295795,0.00082553417,0.00048105375,0.00094415504,0.00043155949,0.0008223085],"category_scores_gemma":[0.0055112927,0.00056382513,0.00035067144,0.0012074742,0.0004900183,0.0010290939,0.00036551632,0.003035283,0.0001281515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077007426,0.00091208646,0.8734732,0.0000859086,0.00026320794,0.00003873517,0.000931362,0.00007106057,0.024527645,0.00002142303,0.0007990698,0.098106176],"study_design_scores_gemma":[0.017666742,0.0017138778,0.95952773,0.0024450095,0.00010643764,0.0002286293,0.0008048257,0.011114846,0.0031266366,0.000085534426,0.0025121898,0.00066755334],"about_ca_topic_score_codex":0.0004450426,"about_ca_topic_score_gemma":0.0061373143,"teacher_disagreement_score":0.09743862,"about_ca_system_score_codex":0.0008007727,"about_ca_system_score_gemma":0.0006473498,"threshold_uncertainty_score":0.9996813},"labels":[],"label_agreement":null},{"id":"W2118969721","doi":"10.1177/1352458509359727","title":"The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"Multiple Sclerosis Society","keywords":"Mesenchymal stem cell; Multiple sclerosis; Remyelination; Stem cell; Medicine; Transplantation; Stem-cell therapy; Regenerative medicine; Regeneration (biology); Cell therapy; Immunology; Pathology; Central nervous system; Biology; Surgery; Internal medicine; Myelin","score_opus":0.10512478994437145,"score_gpt":0.31161315185422545,"score_spread":0.20648836190985398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118969721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435574,0.00025412635,0.00031482408,0.00092776166,0.0014508764,0.0023579933,0.00006802673,0.000016924647,0.0002537188],"genre_scores_gemma":[0.99790776,0.00034793388,0.0006090481,0.000029113962,0.00030744323,0.00013530848,0.000012482742,0.00004335137,0.00060756464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99632776,0.00028654595,0.0011580548,0.0003587977,0.0014270747,0.0004417545],"domain_scores_gemma":[0.99661887,0.0010381304,0.00079894584,0.0005998774,0.0007338624,0.00021029223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019750742,0.00027353555,0.00046265483,0.00015023437,0.0005770627,0.00010313182,0.00053515815,0.00013499637,0.00008487652],"category_scores_gemma":[0.00028115942,0.00014992549,0.0005586965,0.00022005427,0.00029764388,0.00007800641,0.00006762844,0.0005502802,0.000004837514],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002845151,0.0016786854,0.14352605,0.000056474644,0.00053231587,0.000056445202,0.0013017866,0.00007735576,0.8323443,0.000017751561,0.00010911504,0.017454572],"study_design_scores_gemma":[0.018176476,0.0025810425,0.6773794,0.0002638,0.0006225763,0.0014603944,0.0044190283,0.0043169293,0.28978625,0.000042315205,0.0007351524,0.00021663305],"about_ca_topic_score_codex":0.00038228478,"about_ca_topic_score_gemma":0.0006716948,"teacher_disagreement_score":0.5425581,"about_ca_system_score_codex":0.00015263073,"about_ca_system_score_gemma":0.0003676075,"threshold_uncertainty_score":0.6113784},"labels":[],"label_agreement":null},{"id":"W2119516839","doi":"10.1191/1352458502ms767xx","title":"The role of MRI as a surrogate outcome measure in multiple sclerosis","year":2002,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Clinical trial; Surrogate endpoint; Disease; Pathology; Radiology; Psychiatry","score_opus":0.26632659133914205,"score_gpt":0.35765787954063966,"score_spread":0.0913312882014976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119516839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014933003,0.9927438,0.000013761038,0.00040053733,0.0007096254,0.0033347842,0.00022423774,0.000100882324,0.0009790653],"genre_scores_gemma":[0.030385077,0.96672505,0.00073666195,0.000057180187,0.00074904744,0.0005030853,0.000037939004,0.00031655002,0.0004894029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98678344,0.0017248888,0.004645023,0.0012343675,0.0033123128,0.002299973],"domain_scores_gemma":[0.9891668,0.0043798815,0.0023665056,0.0018397642,0.0011795944,0.0010674492],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0047913026,0.0015981254,0.005901035,0.0014345644,0.0013029238,0.0004130427,0.0018405026,0.0009615067,0.00035106903],"category_scores_gemma":[0.01089095,0.0010282127,0.0032753712,0.0020427138,0.00095824385,0.00036520098,0.0008199154,0.00478647,0.0004528668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002777212,0.0007624135,0.029845458,0.0032649955,0.0013288162,0.00005107,0.00044282744,0.000013467262,0.00040467232,0.0000088549195,0.001287231,0.96231246],"study_design_scores_gemma":[0.008753009,0.0005618132,0.02891305,0.0624429,0.0014875047,0.00041985643,0.0009083119,0.00082935183,0.00013508995,0.000027446382,0.894209,0.0013126571],"about_ca_topic_score_codex":0.00057552557,"about_ca_topic_score_gemma":0.00087737094,"teacher_disagreement_score":0.9609998,"about_ca_system_score_codex":0.0013579954,"about_ca_system_score_gemma":0.00077337306,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W2120619359","doi":"10.1177/1352458511432327","title":"Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Genentech; Sanofi; Bayer HealthCare; Teva Pharmaceutical Industries; Eisai; UCB Pharma; Bayer Vital; Abbott Laboratories; Celgene; Biogen; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Universitätsspital Basel","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; Biomarker; Internal medicine; Cohort; Population; Antibody; Cohort study; Predictive value; Gastroenterology; Immunology","score_opus":0.078011698650318,"score_gpt":0.32901778758942357,"score_spread":0.2510060889391056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120619359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596405,0.0006188943,0.00025576635,0.000121331424,0.00016913144,0.0025495887,0.00024290373,0.000031439162,0.00004687501],"genre_scores_gemma":[0.99618185,0.00092827046,0.0025187982,0.000025449997,0.00007182041,0.00019538247,0.000016818598,0.000045780056,0.00001583146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657553,0.00027366338,0.0008273937,0.0006443955,0.0010115537,0.000667488],"domain_scores_gemma":[0.9972044,0.0003365329,0.0005688786,0.00046236315,0.0010385119,0.00038930948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014511887,0.0003894544,0.0011370401,0.0012459101,0.00034312363,0.000053153326,0.00024784575,0.00029528467,0.000060605955],"category_scores_gemma":[0.0017503311,0.00029340512,0.00040356765,0.0013636396,0.00024031074,0.00045316236,0.00030902887,0.00095988926,0.0000010379958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046080495,0.005177786,0.92859447,0.00010728076,0.0020954977,0.000010488343,0.003543911,0.000010722923,0.01259708,8.146637e-7,0.00007235047,0.043181524],"study_design_scores_gemma":[0.013456812,0.0025938742,0.9697205,0.00052700413,0.00085494854,0.0000036786478,0.0014232678,0.0037216607,0.0074323835,0.000013783405,0.000011740397,0.00024036963],"about_ca_topic_score_codex":0.00023469665,"about_ca_topic_score_gemma":0.000551123,"teacher_disagreement_score":0.042941153,"about_ca_system_score_codex":0.00021962634,"about_ca_system_score_gemma":0.00007941011,"threshold_uncertainty_score":0.9999518},"labels":[],"label_agreement":null},{"id":"W2121106726","doi":"10.1177/1352458512459684","title":"Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Disease; Pathology; Clinically isolated syndrome; Immunology","score_opus":0.08223809029154454,"score_gpt":0.31004725929179217,"score_spread":0.2278091690002476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121106726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989959,0.0062527354,0.00010676271,0.002141966,0.00022701768,0.0010048754,0.00012655585,0.000073241616,0.000107814805],"genre_scores_gemma":[0.98949796,0.004593587,0.0047661527,0.0002286618,0.0005585373,0.00017289663,0.000041440828,0.00008005115,0.000060709393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957441,0.000311776,0.0007259401,0.00054996996,0.0013183976,0.0013497883],"domain_scores_gemma":[0.99663234,0.000509569,0.0003235661,0.00034380364,0.0003764089,0.0018142887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015736398,0.0005075381,0.00073925406,0.0004068801,0.0009895238,0.0002622755,0.00017176963,0.00017692831,0.00008898533],"category_scores_gemma":[0.0014957492,0.00038605332,0.0001547591,0.00050276064,0.0005936903,0.00087939645,0.00025560483,0.0009831062,0.000011285043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00199433,0.0010101903,0.9609772,0.00010929167,0.00025062883,0.000021169626,0.0007426206,0.000019197314,0.013222183,0.000008182773,0.0013371917,0.02030782],"study_design_scores_gemma":[0.011929609,0.00048849906,0.9803226,0.0019220437,0.00021660686,0.00010232399,0.000737198,0.0029897655,0.0005083405,0.0000063042726,0.00034908665,0.00042764854],"about_ca_topic_score_codex":0.00008881147,"about_ca_topic_score_gemma":0.00015631861,"teacher_disagreement_score":0.019880172,"about_ca_system_score_codex":0.00037589495,"about_ca_system_score_gemma":0.0002618145,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W2121218425","doi":"10.1177/1352458515599072","title":"Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mitacs; Cleveland Clinic; Biogen; National Institute of Neurological Disorders and Stroke; American Academy of Neurology","keywords":"Atrophy; Multiple sclerosis; Interferon beta-1a; Placebo; Medicine; White matter; Internal medicine; Relapsing remitting; Brain size; Gastroenterology; Pathology; Magnetic resonance imaging; Immunology; Interferon beta; Radiology","score_opus":0.06954738527371836,"score_gpt":0.30236952765164443,"score_spread":0.2328221423779261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121218425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948987,0.0009055301,0.00075428706,0.00077875,0.00053170853,0.0014473881,0.000058166235,0.00009214626,0.000533351],"genre_scores_gemma":[0.9959669,0.00059072406,0.0023215367,0.00021835077,0.0005068273,0.00015244282,0.000036186037,0.00013799153,0.000069015245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914279,0.0015875624,0.0019646985,0.0011412964,0.0024263568,0.0014521793],"domain_scores_gemma":[0.9945866,0.0013555243,0.00092594157,0.0011176158,0.0010179591,0.0009963751],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0055664624,0.00088658836,0.002644744,0.0024806703,0.00037413294,0.0002209509,0.0006444958,0.00039465763,0.0002329007],"category_scores_gemma":[0.0055169873,0.0006918853,0.0015198999,0.0028631233,0.0005063523,0.0004838238,0.0004129967,0.0023890948,0.000151774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005508766,0.00071622664,0.9126168,0.00018760154,0.002510194,0.00004516337,0.0022007679,0.0019674012,0.06328091,0.0000025573925,0.0015429327,0.009420698],"study_design_scores_gemma":[0.018062867,0.0056043253,0.9315167,0.002859431,0.0013119872,0.000036102327,0.0008179056,0.006774034,0.032340396,0.000013014136,0.00008004937,0.0005832077],"about_ca_topic_score_codex":0.00057708786,"about_ca_topic_score_gemma":0.00033620975,"teacher_disagreement_score":0.030940516,"about_ca_system_score_codex":0.001825952,"about_ca_system_score_gemma":0.00016962804,"threshold_uncertainty_score":0.99991244},"labels":[],"label_agreement":null},{"id":"W2121397527","doi":"10.1177/1352458509345914","title":"Thalamic stimulation in multiple sclerosis: evidence for a ‘demyelinative thalamotomy’","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Deep brain stimulation; Thalamus; White matter; Multiple sclerosis; Thalamic stimulator; Thalamotomy; Essential tremor; Neuroscience; Medicine; Stimulation; Cortex (anatomy); Pathology; Magnetic resonance imaging; Parkinson's disease; Psychology; Radiology; Disease","score_opus":0.24866860668062965,"score_gpt":0.338975561023911,"score_spread":0.09030695434328137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121397527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924171,0.0012316558,0.0019201646,0.002722592,0.00019132395,0.0013629965,0.00001703593,0.000063435335,0.000073706484],"genre_scores_gemma":[0.99337393,0.00077994977,0.0039641205,0.0015117516,0.00017994411,0.000083583865,0.000014501019,0.000028009337,0.000064182714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978152,0.00013054699,0.0006143564,0.00046091125,0.000420212,0.00055878016],"domain_scores_gemma":[0.9982882,0.00074346445,0.0002564238,0.00023833448,0.0002303883,0.00024314605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045695298,0.00030557506,0.0005068717,0.0002642381,0.00029107163,0.00009135449,0.00017288105,0.00016745493,0.00006321666],"category_scores_gemma":[0.0017035847,0.00023763122,0.00031504445,0.00034608552,0.00006978321,0.00042321594,0.000030254305,0.00046398348,0.000026813615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027909414,0.0018218627,0.86803657,0.000033969223,0.00008396341,0.000068342204,0.00043979863,0.0014982116,0.05096716,0.000026821303,0.00056333153,0.073669024],"study_design_scores_gemma":[0.012991765,0.0017465161,0.9596633,0.00096858724,0.00009658337,0.00002994705,0.00008022378,0.020610726,0.0020424558,0.0015279541,0.000034667788,0.0002073142],"about_ca_topic_score_codex":0.000025371157,"about_ca_topic_score_gemma":0.00003592033,"teacher_disagreement_score":0.09162668,"about_ca_system_score_codex":0.00020042712,"about_ca_system_score_gemma":0.00007201856,"threshold_uncertainty_score":0.969032},"labels":[],"label_agreement":null},{"id":"W2121776596","doi":"10.1177/1352458509106714","title":"The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Rasch model; Cronbach's alpha; Psychology; Construct validity; Scale (ratio); Reliability (semiconductor); Clinical psychology; Psychometrics; Content validity; Developmental psychology","score_opus":0.11340163379341925,"score_gpt":0.33185436665460094,"score_spread":0.2184527328611817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121776596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994791,0.00060107553,0.00013076435,0.0036930237,0.00013905199,0.00038549403,0.0000066003217,0.00001451341,0.00023849116],"genre_scores_gemma":[0.9964716,0.0006650806,0.0024740521,0.00011520556,0.00013268486,0.000008006918,0.0000031600778,0.0000130785065,0.000117132906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977116,0.00018532184,0.00055561395,0.00018751119,0.00095418567,0.00040573915],"domain_scores_gemma":[0.9983288,0.00045012715,0.00026253678,0.0002992945,0.0004266501,0.00023261496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011908982,0.0001908286,0.00028926766,0.00009638169,0.0011903301,0.00009685311,0.00022451495,0.000065422144,0.000030081306],"category_scores_gemma":[0.001084467,0.00009066581,0.00018838487,0.0002832192,0.00025977276,0.0001368272,0.00012703167,0.0004564703,0.000003963021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005875255,0.00037414217,0.4464244,0.000027889182,0.00033817146,0.000002194356,0.002753368,0.00032553403,0.36525843,0.000023365423,0.004756136,0.17912886],"study_design_scores_gemma":[0.0017710616,0.00016928924,0.9097439,0.0002933453,0.000029579884,0.000044652537,0.0003402396,0.0005670025,0.08607889,0.00003801823,0.0008318986,0.0000921166],"about_ca_topic_score_codex":0.000015074203,"about_ca_topic_score_gemma":0.000025940719,"teacher_disagreement_score":0.4633195,"about_ca_system_score_codex":0.00018491088,"about_ca_system_score_gemma":0.00025806978,"threshold_uncertainty_score":0.91551775},"labels":[],"label_agreement":null},{"id":"W2122283731","doi":"10.1177/1352458512464686","title":"Mesenchymal stem cells as treatment for MS – progress to date","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Mesenchymal stem cell; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Medicine; Neuroprotection; Clinical trial; Stem cell; Magnetic resonance imaging; Encephalomyelitis; Neuroscience; Stem-cell therapy; Progenitor cell; Central nervous system; Cell therapy; Regeneration (biology); Pathology; Immunology; Pharmacology; Internal medicine; Biology; Radiology; Cell biology","score_opus":0.43056284665087285,"score_gpt":0.4246007062888203,"score_spread":0.005962140362052559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122283731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047605092,0.98915726,0.00013919157,0.00022574117,0.0013800048,0.007598617,0.0002002582,0.00007182848,0.0007510609],"genre_scores_gemma":[0.00049151096,0.98102975,0.004206698,0.00005709794,0.0031005235,0.0013733883,0.0000964967,0.00028169734,0.009362868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938054,0.00047503994,0.0015748094,0.000861007,0.00142563,0.0018581282],"domain_scores_gemma":[0.9945753,0.0007078849,0.0007242491,0.000973984,0.000501845,0.0025167395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017467197,0.0010317768,0.0033538952,0.0007285986,0.00049097056,0.00035164665,0.0006845074,0.00059642113,0.0008409394],"category_scores_gemma":[0.0001329286,0.0006765484,0.0018430438,0.00058725214,0.00011878,0.00018073517,0.00025106317,0.0010094442,0.0018192816],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024318259,0.00063029106,0.00015812491,0.006729381,0.0008484001,0.00008287333,0.00019552506,0.000001022719,0.00017121821,0.000006333587,0.0024246988,0.98850894],"study_design_scores_gemma":[0.002673215,0.0020024425,0.00006194177,0.015839012,0.002237965,0.0008748196,0.00005494591,0.000024371384,0.0009064638,0.0000011827111,0.9747356,0.0005879963],"about_ca_topic_score_codex":0.000044067678,"about_ca_topic_score_gemma":0.0000138390005,"teacher_disagreement_score":0.98792094,"about_ca_system_score_codex":0.0012355392,"about_ca_system_score_gemma":0.0011895921,"threshold_uncertainty_score":0.9995686},"labels":[],"label_agreement":null},{"id":"W2122999365","doi":"10.1177/1352458512450354","title":"Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Placebo; Medicine; Subgroup analysis; Internal medicine; Clinical trial; Oncology; Immunology; Alternative medicine; Pathology; Fingolimod; Confidence interval","score_opus":0.25083960982849857,"score_gpt":0.38691556742966565,"score_spread":0.13607595760116709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122999365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085075,0.002835937,0.0011217628,0.0002252986,0.00090973196,0.0036146562,0.00007724918,0.000067157656,0.00029745462],"genre_scores_gemma":[0.9900224,0.0024870352,0.006018494,0.00005572854,0.0008581015,0.00028985675,0.000031409534,0.00012037192,0.00011658191],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99073845,0.0010954492,0.0037958974,0.0006741712,0.0019509195,0.0017451002],"domain_scores_gemma":[0.99322724,0.0022117049,0.0019160492,0.00091426086,0.0007972778,0.0009334603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0050894925,0.00078478566,0.0035704607,0.0016799823,0.00040266145,0.00011451361,0.0006085222,0.00039308277,0.00045591092],"category_scores_gemma":[0.007048323,0.0006365077,0.001388896,0.0013004092,0.00063822005,0.00096315553,0.00034110143,0.0013915927,0.000014746876],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34172085,0.0039987313,0.08832505,0.000121052675,0.00084005797,0.000008168996,0.0019934415,0.00018509582,0.55373037,0.000003597562,0.000539482,0.00853412],"study_design_scores_gemma":[0.557854,0.0016237467,0.34882796,0.0016992075,0.0005149671,0.000029909974,0.0011729498,0.0062746694,0.08139747,0.0000050627928,0.00013014283,0.00046991816],"about_ca_topic_score_codex":0.0013228756,"about_ca_topic_score_gemma":0.00035208778,"teacher_disagreement_score":0.47233286,"about_ca_system_score_codex":0.00060294475,"about_ca_system_score_gemma":0.00032849426,"threshold_uncertainty_score":0.99960864},"labels":[],"label_agreement":null},{"id":"W2123678451","doi":"10.1177/1352458513494491","title":"Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Vrije Universiteit Amsterdam","keywords":"Multiple sclerosis; Medicine; Interferon beta; Clinically isolated syndrome; Interferon beta-1b; Interferon beta-1a; Internal medicine; BETA (programming language); Clinical trial; Oncology; Immunology","score_opus":0.10911489260672029,"score_gpt":0.33090474113412066,"score_spread":0.22178984852740036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123678451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937953,0.00025988676,0.0002417475,0.0019161317,0.0004458707,0.002900811,0.000014979973,0.00005131049,0.00037396172],"genre_scores_gemma":[0.994793,0.0023593144,0.0019435192,0.00012299232,0.0003438501,0.00018555006,0.000010436619,0.00006254498,0.00017877608],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99399626,0.0006732844,0.002843922,0.0005243336,0.0010857522,0.0008764463],"domain_scores_gemma":[0.9959498,0.001358341,0.00086173817,0.000517156,0.00074311276,0.00056983414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027459904,0.00042688736,0.0016955626,0.00068976876,0.00016862087,0.00015324693,0.000495747,0.00028378345,0.00070538046],"category_scores_gemma":[0.004221814,0.00032299449,0.00071160094,0.00057353004,0.0009829872,0.00042647164,0.00024432124,0.0013754262,0.00016921922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47726378,0.0057605617,0.05558972,0.0002705218,0.0015635638,0.00010634584,0.003222419,0.00015606757,0.3973329,0.000004248551,0.0065079015,0.052221958],"study_design_scores_gemma":[0.6961495,0.010170421,0.2782208,0.0025932929,0.00017935336,0.00015605667,0.0013153945,0.005211507,0.00533107,0.000067342764,0.00010979989,0.000495414],"about_ca_topic_score_codex":0.00014915934,"about_ca_topic_score_gemma":0.00002930311,"teacher_disagreement_score":0.39200184,"about_ca_system_score_codex":0.00021890052,"about_ca_system_score_gemma":0.00023243188,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W2126266265","doi":"10.1191/1352458504ms1028oa","title":"Primary progressive multiple sclerosis: cerebrospinal fluid considerations","year":2004,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Pathological; Disease; Central nervous system; Demyelinating disease; Central nervous system disease; Pathology; Neuroscience; Psychology; Internal medicine; Immunology","score_opus":0.23279537779163348,"score_gpt":0.3595521033709321,"score_spread":0.1267567255792986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126266265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033683502,0.98998845,0.00020542608,0.0005846916,0.0014133933,0.005782525,0.0006927781,0.000436933,0.0005589958],"genre_scores_gemma":[0.004092516,0.9774973,0.012231234,0.00041567502,0.0029508818,0.0014785205,0.0004868691,0.00053575635,0.00031128278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870582,0.001055801,0.00392718,0.0020178885,0.0032179747,0.0027229413],"domain_scores_gemma":[0.9897975,0.0020236596,0.0022635155,0.0018533571,0.0019314114,0.0021305645],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0017790219,0.0023290622,0.0066711577,0.0016732847,0.0027777085,0.0012242001,0.0010221973,0.0013267596,0.0013097719],"category_scores_gemma":[0.0067231744,0.001842457,0.0037253457,0.0013651411,0.0012813743,0.00082333235,0.0009671126,0.0052665076,0.00084122247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046135244,0.0026607057,0.001557663,0.033638515,0.0049364935,0.0007210331,0.0005938342,0.000053351665,0.0012181698,0.00003921748,0.020500727,0.93361896],"study_design_scores_gemma":[0.022048049,0.0018912824,0.023456743,0.30978215,0.0061927657,0.0072725806,0.00028597016,0.00014261667,0.00021515993,0.00009343426,0.6250351,0.003584115],"about_ca_topic_score_codex":0.00008186542,"about_ca_topic_score_gemma":0.000047271144,"teacher_disagreement_score":0.9300348,"about_ca_system_score_codex":0.003917268,"about_ca_system_score_gemma":0.005623354,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W2126517980","doi":"10.1177/1352458514559298","title":"Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Manitoba Health Research Council; Lawson Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Social Sciences and Humanities Research Council of Canada; Child and Family Research Institute; Sanofi","keywords":"Medicine; Early childhood; Retrospective cohort study; Odds ratio; Pediatrics; Cohort; Cohort study; Mental health; Logistic regression; Child development; Population; Vulnerability (computing); Confidence interval; Psychiatry; Psychology; Developmental psychology; Environmental health; Internal medicine","score_opus":0.0919503146672521,"score_gpt":0.29833378701627006,"score_spread":0.20638347234901794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126517980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954913,0.000061667335,0.000040606792,0.00004106225,0.0011434528,0.0012128373,0.00007103594,0.000105023675,0.0018329686],"genre_scores_gemma":[0.9985716,0.000047607264,0.00067561347,0.000034660636,0.00043945294,0.00007065699,0.000010858673,0.00006568505,0.00008387929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994245,0.0007017255,0.0009948746,0.00059322553,0.0024987264,0.0009664265],"domain_scores_gemma":[0.9967324,0.0003027396,0.0007310689,0.0004480516,0.00085563783,0.00093009457],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0033418667,0.0004385219,0.00077439606,0.0003971533,0.0013248111,0.00035388075,0.00087723497,0.00021134783,0.00023955219],"category_scores_gemma":[0.002337307,0.00038535078,0.00040880078,0.0008773054,0.0003691789,0.0007552436,0.00017567552,0.0007513689,0.00012394504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018697779,0.0021932833,0.92501265,0.0000015706654,0.00038492156,0.000009219676,0.06708347,0.00013231151,0.0002809787,0.000008775521,0.0011165002,0.0035893566],"study_design_scores_gemma":[0.0042904345,0.00093581673,0.97780246,0.00016124299,0.000055606735,0.00000531597,0.015853826,0.000024627174,0.00029530306,0.000042043317,0.000089457775,0.0004438863],"about_ca_topic_score_codex":0.00728856,"about_ca_topic_score_gemma":0.0025918547,"teacher_disagreement_score":0.052789804,"about_ca_system_score_codex":0.0022536216,"about_ca_system_score_gemma":0.001311479,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2127478877","doi":"10.1191/1352458505ms1149oa","title":"Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Standardization; Medicine; Interpretation (philosophy); Clinical trial; Magnetic resonance imaging; Disease; Medical physics; Physical therapy; Psychology; Pathology; Radiology; Psychiatry; Computer science","score_opus":0.14715431458710163,"score_gpt":0.380521040263865,"score_spread":0.2333667256767634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127478877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847006,0.00096612616,0.004617579,0.0071383,0.00011488793,0.0022809068,0.00012117854,0.0000123567215,0.000048065605],"genre_scores_gemma":[0.98960423,0.003225095,0.0061932113,0.00023859639,0.00029152358,0.000397644,0.00001714657,0.000027812508,0.0000047439107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545187,0.00091907935,0.0017865949,0.00034951084,0.0010281149,0.00046485243],"domain_scores_gemma":[0.9937334,0.004631904,0.0006400697,0.00037481557,0.0005088506,0.00011095516],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0065426356,0.00025513914,0.0008324852,0.00034304615,0.00022053403,0.0000920539,0.00039663754,0.00014342746,0.000015430232],"category_scores_gemma":[0.009687104,0.0001453261,0.000343368,0.00054504187,0.00057670317,0.0003681578,0.00010344066,0.0006444001,8.994004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018114571,0.001192877,0.8771553,0.00018983378,0.00013725471,0.0000016990232,0.012066666,0.0009863019,0.009115264,0.00008248148,0.0006128821,0.09664798],"study_design_scores_gemma":[0.009134527,0.0013622843,0.9481227,0.0013341154,0.000100546575,0.0000137013,0.0049802237,0.03184456,0.0024112065,0.00006225523,0.00047921189,0.00015466916],"about_ca_topic_score_codex":0.00017490523,"about_ca_topic_score_gemma":0.0024363485,"teacher_disagreement_score":0.096493304,"about_ca_system_score_codex":0.00011465192,"about_ca_system_score_gemma":0.00023009516,"threshold_uncertainty_score":0.9986547},"labels":[],"label_agreement":null},{"id":"W2127555980","doi":"10.1177/1352458515578770","title":"Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Universitetet i Bergen; Helse Vest; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Harvard T.H. Chan School of Public Health; Biogen; Sanofi","keywords":"Medicine; Multiple sclerosis; Vitamin D and neurology; Cod liver oil; Vitamin; Internal medicine; Risk factor; Physiology; Gastroenterology; Immunology","score_opus":0.242726996760548,"score_gpt":0.2997247063648875,"score_spread":0.0569977096043395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127555980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997337,0.001384851,0.00024442925,0.00023077591,0.00014138446,0.000537773,0.00006035969,0.000026296075,0.000037128462],"genre_scores_gemma":[0.9938745,0.0028253994,0.0026738974,0.000039908733,0.00018784132,0.000023398698,0.0000030779634,0.00005308334,0.00031888534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629694,0.0006161294,0.00086710363,0.00035524147,0.0013141485,0.00055041333],"domain_scores_gemma":[0.9959159,0.0015596891,0.0006402272,0.00055944966,0.0008525229,0.00047219262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023791885,0.00032083693,0.0008089694,0.0003319013,0.0004838052,0.00010415242,0.000308169,0.00011220544,0.000032586217],"category_scores_gemma":[0.0067494228,0.00020495392,0.00023524198,0.00041989476,0.0006922516,0.0003191,0.00049444364,0.00084274414,0.000012097812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050861377,0.001425706,0.9084081,0.00009623747,0.0007405771,0.000021910902,0.016640555,0.0003466036,0.04102966,5.2063484e-7,0.0030849378,0.027696589],"study_design_scores_gemma":[0.009137111,0.0014739434,0.9572995,0.00072328653,0.0004506976,0.00008349724,0.015701847,0.008380653,0.006096731,0.000002333416,0.0004417437,0.00020868488],"about_ca_topic_score_codex":0.000974558,"about_ca_topic_score_gemma":0.00026428336,"teacher_disagreement_score":0.04889138,"about_ca_system_score_codex":0.00012816272,"about_ca_system_score_gemma":0.00012930586,"threshold_uncertainty_score":0.8357778},"labels":[],"label_agreement":null},{"id":"W2128220462","doi":"10.1177/1352458510391343","title":"<i>Staphylococcus aureus</i> harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Enterotoxin; Multiple sclerosis; Staphylococcus aureus; Medicine; Microbiology; Dermatology; Immunology; Bacteria; Escherichia coli; Biology; Gene","score_opus":0.17029343295552904,"score_gpt":0.3024080888005764,"score_spread":0.13211465584504736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128220462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837895,0.0011175174,0.00705585,0.0005578587,0.00084372953,0.004034796,0.0012801399,0.00037425457,0.0009463529],"genre_scores_gemma":[0.96643627,0.0035299633,0.026708504,0.0004311636,0.0010951716,0.0010234799,0.000027271037,0.0002280593,0.0005201232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934105,0.0003887687,0.0015757252,0.0011189984,0.0014836479,0.0020223488],"domain_scores_gemma":[0.9941611,0.0010943258,0.0008544307,0.0010876377,0.0012881517,0.0015143297],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013690185,0.00089925504,0.0012672334,0.00092475384,0.0022206118,0.0004295904,0.00082435797,0.00037753631,0.0014692631],"category_scores_gemma":[0.0060486547,0.0007803461,0.0012670044,0.00075843366,0.00043584098,0.0008510787,0.00042303264,0.0016188315,0.0002444677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002587542,0.0017247772,0.5285897,0.00021586647,0.0012822237,0.000025978512,0.0061860974,0.00005503466,0.4152226,0.000013860139,0.0047543054,0.03934201],"study_design_scores_gemma":[0.01622644,0.0013822283,0.8371054,0.0012137902,0.00032121205,0.00004658665,0.0012044148,0.003262157,0.13534093,0.00009605769,0.0029976019,0.0008031611],"about_ca_topic_score_codex":0.00063302123,"about_ca_topic_score_gemma":0.00043421853,"teacher_disagreement_score":0.3085157,"about_ca_system_score_codex":0.0006475362,"about_ca_system_score_gemma":0.00040820832,"threshold_uncertainty_score":0.99946475},"labels":[],"label_agreement":null},{"id":"W2129345488","doi":"10.1177/1352458513519179","title":"Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health; SickKids Foundation; University of Toronto; University of British Columbia; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Immigration; Demography; Population; Odds ratio; Risk factor; Family history; Environmental health; Internal medicine; Immunology; Geography","score_opus":0.07087259934569513,"score_gpt":0.26478388184723733,"score_spread":0.19391128250154221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129345488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973373,0.00071260147,0.00012040045,0.000667134,0.00020626819,0.00077416014,0.00011199948,0.000022094531,0.00004804266],"genre_scores_gemma":[0.99312276,0.005752138,0.0007000849,0.00010529094,0.00020634613,0.000033439213,0.000016321193,0.000041126506,0.000022525814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955088,0.00080763473,0.001017797,0.00046555776,0.0014590621,0.0007411838],"domain_scores_gemma":[0.9964938,0.0017534337,0.00054902874,0.00054068735,0.00030974866,0.00035328098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022593425,0.0003904976,0.000762869,0.00031639036,0.0006048719,0.00010038323,0.0004176739,0.00013603967,0.000054331587],"category_scores_gemma":[0.005266821,0.00025754175,0.00021012357,0.00049749523,0.00025375962,0.00026179448,0.00013586055,0.0009905979,0.0000025500271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021876923,0.00018922023,0.9766145,0.00016731952,0.00010682196,0.0000030353465,0.0018733278,0.00016161063,0.00936047,0.000004108951,0.00039501116,0.010905802],"study_design_scores_gemma":[0.0042946413,0.00026403824,0.9841889,0.0008390899,0.0001244141,0.00002067252,0.001126457,0.0071327155,0.0014867032,0.000010541378,0.00026907795,0.00024275189],"about_ca_topic_score_codex":0.48592368,"about_ca_topic_score_gemma":0.477545,"teacher_disagreement_score":0.010663051,"about_ca_system_score_codex":0.00032458396,"about_ca_system_score_gemma":0.00017015201,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W2129757393","doi":"10.1191/1352458505ms1192oa","title":"Regional variation of multiple sclerosis prevalence in Canada","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Demography; Logistic regression; Confounding; Odds ratio; Medicine; Odds; Multiple sclerosis; Epidemiology; Prevalence; Internal medicine","score_opus":0.1174418285751787,"score_gpt":0.2834842559907382,"score_spread":0.16604242741555947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129757393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993375,0.0015277504,0.00033420522,0.0034403072,0.00026852894,0.0007127331,0.000081439735,0.000032559856,0.00022748506],"genre_scores_gemma":[0.98516464,0.005605344,0.00800868,0.00042030154,0.0005450531,0.00006100139,0.000012778336,0.00005255969,0.0001296353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950544,0.0002791522,0.0013717902,0.0005262927,0.001842399,0.0009259198],"domain_scores_gemma":[0.9968257,0.0008444753,0.0005464348,0.000523265,0.0007283095,0.0005318151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011665779,0.00038486155,0.0008003358,0.0004859143,0.00028879815,0.000055435907,0.00043927354,0.00013966259,0.00046731048],"category_scores_gemma":[0.0024074996,0.00034701958,0.00026379997,0.00070269196,0.00018616939,0.000482344,0.0001735299,0.000933318,0.00002401876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068092166,0.0005414612,0.7959683,0.00021625354,0.00017365284,0.000013391864,0.00090340973,0.0024478976,0.15692323,0.0000068423833,0.0048820004,0.037242625],"study_design_scores_gemma":[0.007017995,0.00014839652,0.9653389,0.0014183176,0.000054792356,0.000070290385,0.00037271093,0.016517593,0.0075597693,0.0000062307427,0.0012040304,0.00029101185],"about_ca_topic_score_codex":0.26895687,"about_ca_topic_score_gemma":0.6180489,"teacher_disagreement_score":0.34909204,"about_ca_system_score_codex":0.0023408195,"about_ca_system_score_gemma":0.0019642795,"threshold_uncertainty_score":0.9998982},"labels":[],"label_agreement":null},{"id":"W2129967156","doi":"10.1177/1352458513507821","title":"Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; National Institutes of Health; Serono Symposia International Foundation; Bayer HealthCare; Acorda Therapeutics; Multiple Sclerosis Society; Biogen; Sanofi; National Multiple Sclerosis Society","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Internal medicine; Discontinuation; Clinical endpoint; Dimethyl fumarate; Physical therapy; Expanded Disability Status Scale; Randomized controlled trial; Immunology; Fingolimod","score_opus":0.08007616229311648,"score_gpt":0.28900248005295964,"score_spread":0.20892631775984316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129967156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864265,0.0005456572,0.00023876184,0.0007758016,0.0013558561,0.010125263,0.00005379421,0.00015111858,0.00032730072],"genre_scores_gemma":[0.9940148,0.00068251847,0.002618049,0.00019641768,0.0007797004,0.0013220125,0.00006642342,0.00018709878,0.0001329807],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99180603,0.00085997285,0.0024387704,0.0010516288,0.001960136,0.0018834757],"domain_scores_gemma":[0.99326473,0.0024713983,0.0010038853,0.0008861713,0.0012406715,0.0011331303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016686857,0.0010026761,0.002676651,0.0010175537,0.0007617304,0.00066969986,0.000608525,0.0003542957,0.00085154513],"category_scores_gemma":[0.0044025346,0.0007218892,0.0008712678,0.0006900968,0.00048667844,0.0010468916,0.00028188454,0.0019431775,0.00020328563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8969072,0.003783567,0.042074226,0.000056692905,0.001045723,0.0000580346,0.0007686452,0.00011471468,0.024215484,6.712172e-7,0.0015153303,0.029459676],"study_design_scores_gemma":[0.8662965,0.014703116,0.11090299,0.0016490063,0.00037821362,0.0000308614,0.0005711843,0.0038046546,0.000834294,0.0000029113157,0.00014567246,0.0006805909],"about_ca_topic_score_codex":0.00041647718,"about_ca_topic_score_gemma":0.0003075267,"teacher_disagreement_score":0.06882876,"about_ca_system_score_codex":0.0011497331,"about_ca_system_score_gemma":0.0003280901,"threshold_uncertainty_score":0.9995232},"labels":[],"label_agreement":null},{"id":"W2130049682","doi":"10.1191/1352458505ms1196oa","title":"MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Placebo; Nuclear medicine; Clinical trial; Lesion; Gastroenterology; Internal medicine; Radiology; Surgery; Pathology; Immunology","score_opus":0.10089763253783987,"score_gpt":0.2975885841402293,"score_spread":0.19669095160238945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130049682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253655,0.0021163728,0.00006182431,0.008164059,0.0005316082,0.0031847325,0.0005086071,0.00018774977,0.0027085058],"genre_scores_gemma":[0.9909192,0.0020995298,0.0024418735,0.0011368257,0.002828496,0.00015845722,0.00009502178,0.00018712318,0.00013348994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9901061,0.0025036498,0.0022634163,0.0013162112,0.002158476,0.0016521175],"domain_scores_gemma":[0.9933586,0.002871643,0.000823172,0.0016343467,0.0006087436,0.00070348266],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005064858,0.00089784723,0.0012326291,0.0005300376,0.0013996755,0.00058060023,0.0013376112,0.00021110674,0.0003386111],"category_scores_gemma":[0.0055910503,0.0006212292,0.00052838586,0.00093289,0.0005182149,0.0005034681,0.0007050491,0.0036161365,0.0006271465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008816668,0.009508195,0.2971504,0.00003109432,0.0013653132,0.0005910954,0.02470711,0.0014002579,0.045414172,0.0000017120365,0.018942967,0.592071],"study_design_scores_gemma":[0.033466626,0.0015896735,0.9476029,0.0016032764,0.00012949333,0.00006188296,0.007102279,0.001160823,0.0031675927,0.0000061907026,0.0035237386,0.00058549154],"about_ca_topic_score_codex":0.00088538235,"about_ca_topic_score_gemma":0.0015561809,"teacher_disagreement_score":0.65045255,"about_ca_system_score_codex":0.0009614328,"about_ca_system_score_gemma":0.00032673593,"threshold_uncertainty_score":0.99990034},"labels":[],"label_agreement":null},{"id":"W2130686328","doi":"10.1177/1352458513485653","title":"Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Multiple sclerosis; Acute disseminated encephalomyelitis; Relapsing remitting; Autoantibody; Medicine; Encephalomyelitis; Immunology; Myelin; Experimental autoimmune encephalomyelitis; Myelin basic protein; Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Central nervous system; Antibody; Internal medicine","score_opus":0.07375390770311861,"score_gpt":0.29273967519761257,"score_spread":0.21898576749449394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130686328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865703,0.0012979747,0.0009726295,0.005635502,0.0015008565,0.002097223,0.0005794173,0.00058841205,0.000757683],"genre_scores_gemma":[0.95000756,0.003560446,0.04151496,0.0007909412,0.0020854396,0.00032333727,0.00015109076,0.00025177386,0.0013144383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99082094,0.000500173,0.002219567,0.0015982286,0.0022809922,0.0025801233],"domain_scores_gemma":[0.9910955,0.0023251679,0.00081007875,0.0012804015,0.0022988254,0.0021900684],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014567787,0.0011666779,0.0018411417,0.00083138037,0.0022660827,0.0012524741,0.0010588771,0.00044154868,0.0013913512],"category_scores_gemma":[0.016390767,0.0010112544,0.000869367,0.0013154979,0.00059069257,0.0011326995,0.0010373171,0.0021387106,0.0011280236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030743392,0.00032066138,0.3811095,0.00006859447,0.00080546644,0.00006319399,0.0029630328,0.00006107589,0.49475014,0.0000021073186,0.025790017,0.09375877],"study_design_scores_gemma":[0.005474713,0.00046235634,0.95458865,0.005799465,0.0003323262,0.00011252907,0.0033124143,0.006138842,0.020821946,0.0000593257,0.0018559687,0.0010414672],"about_ca_topic_score_codex":0.0035135515,"about_ca_topic_score_gemma":0.00052198704,"teacher_disagreement_score":0.5734791,"about_ca_system_score_codex":0.0008570645,"about_ca_system_score_gemma":0.00025181024,"threshold_uncertainty_score":0.99978435},"labels":[],"label_agreement":null},{"id":"W2131040457","doi":"10.1177/1352458514564494","title":"Towards a better understanding of <i>pseudoatrophy</i> in the brain of multiple sclerosis patients","year":2015,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Clinical neurology; Neuroscience; Psychiatry","score_opus":0.2006148878248142,"score_gpt":0.2677472813446265,"score_spread":0.06713239351981229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131040457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9194132,0.00013874666,0.00049901684,0.07640187,0.0012125002,0.0010186739,0.0010724969,0.00002540906,0.00021808743],"genre_scores_gemma":[0.85535425,0.00011968058,0.00041541312,0.14312607,0.0007743949,0.000042039035,0.000034628356,0.00010943902,0.000024084442],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99203825,0.0021718396,0.0015107956,0.00082115154,0.002560866,0.00089709414],"domain_scores_gemma":[0.9953127,0.0017607793,0.0014805469,0.0008577698,0.00040136208,0.00018686437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009163412,0.00068261166,0.0009786661,0.0006709034,0.00028553104,0.00022423641,0.001816443,0.00043250548,0.000072995004],"category_scores_gemma":[0.0040603722,0.0005148791,0.00061688514,0.0008568576,0.0006047043,0.00029131386,0.0002993871,0.0022223648,0.00001397438],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019303532,0.0006276116,0.037363242,0.00017309548,0.000048786533,0.0000589574,0.0016550184,0.00043104147,0.2872724,0.000006941467,0.6710422,0.0011276742],"study_design_scores_gemma":[0.022182785,0.002223817,0.19926977,0.0033775198,0.00048839557,0.00010151292,0.0012377223,0.0013248184,0.7417125,0.0016699379,0.023651438,0.0027597593],"about_ca_topic_score_codex":0.000090003894,"about_ca_topic_score_gemma":0.000034501765,"teacher_disagreement_score":0.6473908,"about_ca_system_score_codex":0.0003418801,"about_ca_system_score_gemma":0.00033780176,"threshold_uncertainty_score":0.9997303},"labels":[],"label_agreement":null},{"id":"W2131078277","doi":"10.1177/1352458512436594","title":"Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Research Canada; McGill University; University of British Columbia","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Sanofi","keywords":"Teriflunomide; Medicine; Adverse effect; Discontinuation; Internal medicine; Placebo; Multiple sclerosis; Asymptomatic; Population; Interim analysis; Gastroenterology; Surgery; Randomized controlled trial; Fingolimod; Immunology; Pathology","score_opus":0.1454125951690546,"score_gpt":0.35551265568532137,"score_spread":0.21010006051626676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131078277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955442,0.00091106707,0.00014394439,0.00023503434,0.00074328785,0.0021937478,0.00014089282,0.000045194654,0.000042653435],"genre_scores_gemma":[0.9961725,0.0012703589,0.0019771154,0.000060453836,0.0002594111,0.000053543707,0.000019841364,0.000096710166,0.00009008343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99372387,0.0005897628,0.0023509392,0.00067419704,0.0013662137,0.0012950164],"domain_scores_gemma":[0.9959737,0.0009267021,0.0007669707,0.00079745066,0.0005002511,0.0010349286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033359013,0.0005438117,0.0016511196,0.0011042618,0.00030883605,0.00008910134,0.00043292317,0.00020637231,0.000055772463],"category_scores_gemma":[0.00554838,0.0004904667,0.0003281692,0.0010204428,0.00030964424,0.00059183885,0.0005638269,0.0009733513,0.0000148983745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020036295,0.0043270667,0.6834671,0.000111952104,0.00038367248,0.000020582665,0.01950421,0.00007731234,0.20361923,6.165594e-7,0.00032732944,0.068124644],"study_design_scores_gemma":[0.098432235,0.0024453534,0.8856362,0.0024391355,0.00019362925,0.000037832575,0.003586367,0.00030723706,0.006452971,5.0074004e-7,0.00010406328,0.00036448627],"about_ca_topic_score_codex":0.00064737647,"about_ca_topic_score_gemma":0.0007756597,"teacher_disagreement_score":0.20216909,"about_ca_system_score_codex":0.00038496868,"about_ca_system_score_gemma":0.00014163325,"threshold_uncertainty_score":0.9997547},"labels":[],"label_agreement":null},{"id":"W2132728908","doi":"10.1177/1352458506074177","title":"The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; White matter; Lesion; Atrophy; Abnormality; Magnetic resonance imaging; Pathology; Medicine; Central nervous system disease; Brain size; Intensity (physics); Radiology; Internal medicine; Physics; Optics","score_opus":0.07853500148478784,"score_gpt":0.28707746888217395,"score_spread":0.2085424673973861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132728908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160564,0.001023028,0.0033077886,0.0024821586,0.00027726748,0.000823906,0.00003885753,0.000039143775,0.00040221718],"genre_scores_gemma":[0.99459237,0.0016206247,0.0028246497,0.00021885715,0.00041636243,0.00003382977,0.000011297154,0.00006435429,0.00021765771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994572,0.00040837214,0.0017112547,0.0005567185,0.001463818,0.001287867],"domain_scores_gemma":[0.9961721,0.0015238863,0.00054567656,0.0005231798,0.00063142134,0.00060375954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052222903,0.0004477091,0.00081262615,0.00048034385,0.0009456128,0.00017522498,0.00037052258,0.0002974448,0.00024964154],"category_scores_gemma":[0.001225048,0.0003276842,0.0003493162,0.0006766859,0.0010572874,0.0005225024,0.0003437958,0.0015085471,0.000054185046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017895862,0.00034533677,0.9528817,0.000082949686,0.00014839607,0.000036510097,0.0009929975,0.0001151228,0.021258526,0.000007544903,0.0013402716,0.021001093],"study_design_scores_gemma":[0.0070485435,0.0003496506,0.9803266,0.0006623818,0.00006270651,0.00018732225,0.0007971013,0.0073845345,0.0024224631,0.000035837955,0.00041945901,0.0003033772],"about_ca_topic_score_codex":0.00037788498,"about_ca_topic_score_gemma":0.0013405184,"teacher_disagreement_score":0.027444957,"about_ca_system_score_codex":0.00042247344,"about_ca_system_score_gemma":0.00013420949,"threshold_uncertainty_score":0.9999175},"labels":[],"label_agreement":null},{"id":"W2132906244","doi":"10.1177/1352458514536086","title":"Depression in multiple sclerosis: A long-term longitudinal study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Depression (economics); Medicine; Multiple sclerosis; Observational study; Comorbidity; Antidepressant; Epidemiology; Population; Expanded Disability Status Scale; Logistic regression; Psychiatry; Internal medicine; Psychology; Anxiety","score_opus":0.19287784208498948,"score_gpt":0.3392148490697939,"score_spread":0.1463370069848044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132906244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938127,0.0009444652,0.0015635438,0.00050005835,0.00063134334,0.0020352849,0.00001751918,0.00018949303,0.0003056005],"genre_scores_gemma":[0.99486554,0.0012050404,0.0020455937,0.00018491899,0.0010996605,0.00029629847,0.000019465218,0.00014999926,0.00013348403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99213916,0.00092006987,0.0016755768,0.0012493163,0.00223489,0.0017809625],"domain_scores_gemma":[0.9954351,0.0010778208,0.000520005,0.0011746986,0.0006678924,0.0011244685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031361056,0.0008187579,0.0014997303,0.00114011,0.0010685744,0.0004214366,0.00077979226,0.0002970858,0.00037378597],"category_scores_gemma":[0.0046511563,0.00067136856,0.00055189116,0.0010447723,0.00035476685,0.0006980509,0.0006650056,0.0021035157,0.00021718595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013175061,0.003332348,0.903849,0.000101112586,0.0002757521,0.000113110334,0.0010218188,0.00014573535,0.034313846,0.0000010002428,0.0006830696,0.05484572],"study_design_scores_gemma":[0.024140375,0.0011802032,0.96470284,0.0021157444,0.00015464617,0.00016912863,0.00065030914,0.0036042884,0.0025422412,0.0000077510385,0.00011463115,0.0006178477],"about_ca_topic_score_codex":0.00032488146,"about_ca_topic_score_gemma":0.0018337368,"teacher_disagreement_score":0.060853854,"about_ca_system_score_codex":0.0006484078,"about_ca_system_score_gemma":0.00017867796,"threshold_uncertainty_score":0.99957377},"labels":[],"label_agreement":null},{"id":"W2132936146","doi":"10.1177/1352458514533229","title":"Characterizing cognitive function during relapse in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"IC Design Education Center; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen; EMD Serono; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Medicine; Psychology; Neuroscience; Psychiatry","score_opus":0.11142035007989425,"score_gpt":0.28269579529364647,"score_spread":0.1712754452137522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132936146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949173,0.00047385812,0.0009212952,0.0010670328,0.0007497137,0.0009513346,0.000036398458,0.00018684233,0.00069626316],"genre_scores_gemma":[0.9942921,0.0021813628,0.0011369081,0.0005413012,0.0012939147,0.00016785646,0.000041221603,0.00013672622,0.00020862812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9944152,0.0005713044,0.00130038,0.00087979663,0.0013437376,0.0014895491],"domain_scores_gemma":[0.99642116,0.0010874324,0.0004987484,0.00051833,0.0006644043,0.00080993574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019741864,0.0006214587,0.0010746965,0.0010527603,0.0010967872,0.00029487238,0.00031802143,0.00030466792,0.0003292328],"category_scores_gemma":[0.006854819,0.0005661952,0.00048449193,0.0009029967,0.00032038303,0.00085352384,0.00031915295,0.0019318361,0.00028090228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002081219,0.0005065403,0.452318,0.00012366903,0.0002230115,0.00002377728,0.0008811291,0.000037044498,0.51023453,0.0000033030033,0.00020591085,0.033361845],"study_design_scores_gemma":[0.018072972,0.0005237788,0.94944805,0.0031775841,0.00014558976,0.000113425,0.0010348338,0.004252308,0.022148686,0.000013605677,0.0005448973,0.0005242488],"about_ca_topic_score_codex":0.00019114462,"about_ca_topic_score_gemma":0.00030679005,"teacher_disagreement_score":0.49713007,"about_ca_system_score_codex":0.00055755046,"about_ca_system_score_gemma":0.0001223087,"threshold_uncertainty_score":0.99967897},"labels":[],"label_agreement":null},{"id":"W2133141213","doi":"10.1177/1352458507080468","title":"Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Antibody; Gastroenterology; Cohort; Interferon beta-1a; Immunology; Interferon beta","score_opus":0.12448759202791758,"score_gpt":0.3536020782661566,"score_spread":0.229114486238239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133141213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115264,0.00036018857,0.00023637172,0.0001897933,0.0010240873,0.0062537408,0.00044070143,0.00012836716,0.00021412715],"genre_scores_gemma":[0.99688345,0.0008590493,0.000806749,0.00018623158,0.00033474804,0.0003523937,0.00027766218,0.00026638093,0.000033340646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98839617,0.002001822,0.0030230305,0.0017836472,0.0020423913,0.0027529635],"domain_scores_gemma":[0.9877286,0.006198088,0.001109722,0.0013796837,0.0016032102,0.001980721],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004901114,0.0014571074,0.0027007782,0.0031632588,0.0011452578,0.00027397028,0.0008585948,0.0005582843,0.00015637909],"category_scores_gemma":[0.0048896596,0.0012693568,0.0011335383,0.0018785491,0.0005665148,0.0006337847,0.0002703133,0.001828241,0.00008083625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012557487,0.010448008,0.80258656,0.00022696683,0.000921382,0.00017376471,0.0019970709,0.00035885358,0.15065534,7.2426184e-7,0.000059154932,0.020014718],"study_design_scores_gemma":[0.043621734,0.010342035,0.8196975,0.008681283,0.00031366126,0.0000114926515,0.0013651669,0.00040336957,0.11471153,0.0000010671604,0.000012419487,0.0008387254],"about_ca_topic_score_codex":0.04162055,"about_ca_topic_score_gemma":0.1309953,"teacher_disagreement_score":0.08937476,"about_ca_system_score_codex":0.005367624,"about_ca_system_score_gemma":0.0009308093,"threshold_uncertainty_score":0.99981785},"labels":[],"label_agreement":null},{"id":"W2134454343","doi":"10.1177/1352458513513059","title":"Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Fingolimod; Multiple sclerosis; Medicine; Placebo; Internal medicine; Randomized controlled trial; Physical therapy; Pathology; Immunology; Alternative medicine","score_opus":0.15307827210247577,"score_gpt":0.33146574560855674,"score_spread":0.17838747350608097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134454343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950429,0.00035789696,0.000099303834,0.000894258,0.00042153732,0.0025079185,0.00030758677,0.00010218993,0.00026640363],"genre_scores_gemma":[0.99026895,0.0010320247,0.0076884883,0.00012247814,0.00037512233,0.00018997904,0.000068603804,0.0001204427,0.00013393819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924994,0.00072243204,0.0024861556,0.0010467202,0.0018862927,0.0013589956],"domain_scores_gemma":[0.99449813,0.0016333639,0.00088633614,0.001118532,0.0010450617,0.0008185527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017663377,0.0006764963,0.001646267,0.0010535021,0.00054832903,0.00027710726,0.0006738148,0.00028930325,0.0005980921],"category_scores_gemma":[0.0076986784,0.00058154657,0.00045422098,0.0011948572,0.00033247843,0.0008542894,0.0005176535,0.0017483515,0.00016543036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006181286,0.012010129,0.5580164,0.00006510969,0.0007911029,0.00007057875,0.014853774,0.00055926375,0.3424005,0.000001019965,0.0074651064,0.057585757],"study_design_scores_gemma":[0.093607776,0.002303169,0.8678251,0.0018178169,0.00014357649,0.000014845899,0.012134595,0.016596666,0.0048650196,0.000022869392,0.00016783827,0.0005007445],"about_ca_topic_score_codex":0.018025795,"about_ca_topic_score_gemma":0.002484364,"teacher_disagreement_score":0.33753547,"about_ca_system_score_codex":0.0005417418,"about_ca_system_score_gemma":0.000213149,"threshold_uncertainty_score":0.9996636},"labels":[],"label_agreement":null},{"id":"W2134747655","doi":"10.1177/1352458515572405","title":"A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"IC Design Education Center; “la Caixa” Foundation; Biogen","keywords":"Paced Auditory Serial Addition Test; Montreal Cognitive Assessment; Cognition; Rehabilitation; Cognitive rehabilitation therapy; Randomized controlled trial; Medicine; Recall; Trail Making Test; Multiple sclerosis; Physical therapy; Visual memory; Audiology; Physical medicine and rehabilitation; Cognitive impairment; Psychology; Internal medicine; Psychiatry","score_opus":0.20235064827951993,"score_gpt":0.351425998276342,"score_spread":0.1490753499968221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134747655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543464,0.0003244224,0.00263688,0.0018290543,0.0003603986,0.04021533,0.00013363459,0.000088827735,0.00006504273],"genre_scores_gemma":[0.9841048,0.000058570135,0.009230906,0.0001634545,0.0004806522,0.0057135373,0.000055307304,0.00014228732,0.000050446008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9898982,0.0023388471,0.0023800647,0.00089520245,0.0031922297,0.001295444],"domain_scores_gemma":[0.9684511,0.01952084,0.0010924827,0.0007476044,0.009034122,0.0011538853],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011495972,0.0007872405,0.003263739,0.00071501354,0.00076672423,0.00031223072,0.00052654545,0.00009768369,0.000028436014],"category_scores_gemma":[0.10992291,0.00043253842,0.0008915069,0.0010427589,0.0008526227,0.0003766832,0.00027896205,0.0007521822,0.000021832944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7705088,0.021136843,0.1796047,0.000078779405,0.0026700909,0.000002017694,0.008219604,0.0004016553,0.0019235492,0.0000021959797,0.00048439688,0.014967355],"study_design_scores_gemma":[0.6820222,0.043528914,0.26093853,0.0012492294,0.0015781213,0.0000042142156,0.0068580722,0.0031368062,0.00027801582,0.0000135078735,0.00003194019,0.00036042058],"about_ca_topic_score_codex":0.00048051725,"about_ca_topic_score_gemma":0.00095193216,"teacher_disagreement_score":0.09842694,"about_ca_system_score_codex":0.000557349,"about_ca_system_score_gemma":0.0005036185,"threshold_uncertainty_score":0.99981266},"labels":[],"label_agreement":null},{"id":"W2135074145","doi":"10.1191/135248506ms1270oa","title":"Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Expanded Disability Status Scale; Quartile; Placebo; Physical therapy; Interferon beta-1a; Clinical trial; Randomized controlled trial; Internal medicine; Interferon beta; Confidence interval; Pathology; Psychiatry; Alternative medicine","score_opus":0.4079972269186082,"score_gpt":0.4078974773737938,"score_spread":0.00009974954481439813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135074145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936243,0.0023234836,0.00003646107,0.0007759951,0.00020642405,0.0022182183,0.0006939187,0.00004482355,0.00007633067],"genre_scores_gemma":[0.9963037,0.0021708517,0.00056659104,0.000082108265,0.00064097345,0.00010066459,0.00005543076,0.0000690163,0.000010660468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99090385,0.0016751649,0.0037215317,0.0007842219,0.0020359957,0.00087921583],"domain_scores_gemma":[0.9896763,0.005506047,0.0020837786,0.0011060993,0.0011977393,0.00043006873],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007545147,0.000575263,0.0019801166,0.00050040754,0.00038919452,0.000118993295,0.0005200049,0.00024999666,0.000056357185],"category_scores_gemma":[0.01795564,0.00038010723,0.00058383506,0.0010863846,0.0005161717,0.0003874068,0.0003391933,0.0011511048,0.0000035897253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053279065,0.0030586822,0.8534654,0.000044072312,0.00066462683,0.0000115774355,0.0032166988,0.000090706904,0.12705338,8.0740926e-7,0.0005885628,0.0064775934],"study_design_scores_gemma":[0.029253084,0.00086459797,0.95910096,0.0008641893,0.00016095319,0.000005858711,0.003499712,0.0013422314,0.0045562834,0.000020469251,0.000016860648,0.00031480964],"about_ca_topic_score_codex":0.10564606,"about_ca_topic_score_gemma":0.029027915,"teacher_disagreement_score":0.1224971,"about_ca_system_score_codex":0.0002574615,"about_ca_system_score_gemma":0.00037262187,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W2135440918","doi":"10.1177/1352458508096878","title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Differential diagnosis; Medical diagnosis; Medicine; Demyelinating Disorder; McDonald criteria; Neurology; Intensive care medicine; Pathology; Pediatrics; Immunology; Psychiatry","score_opus":0.1716670000508236,"score_gpt":0.29068156935442263,"score_spread":0.11901456930359902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135440918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937423,0.0016918327,0.0007458919,0.0007136002,0.0005229734,0.0013723185,0.00018936745,0.00021630517,0.00080542814],"genre_scores_gemma":[0.9781156,0.008786117,0.01141498,0.00012817804,0.00088986364,0.0002773955,0.00005417736,0.00014807092,0.00018562419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99291044,0.000518586,0.0018326198,0.0009206472,0.0022860037,0.0015316758],"domain_scores_gemma":[0.99422127,0.0013325945,0.0008064487,0.0009802849,0.0015222591,0.0011371399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067594356,0.0007902399,0.0018191825,0.0008791691,0.0012550907,0.0001073908,0.00064085,0.00037029377,0.0007602058],"category_scores_gemma":[0.004764867,0.000658446,0.0010617134,0.0010890459,0.0014021231,0.00023661589,0.0004326563,0.0015769847,0.00006788594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016871546,0.0029767307,0.76364213,0.0002125819,0.0010204371,0.00008273592,0.0015939288,0.000120517594,0.20966566,0.000009076106,0.011523261,0.007465807],"study_design_scores_gemma":[0.016743088,0.0006830209,0.91599274,0.00088416226,0.0002561842,0.00068682287,0.00085966464,0.0052427202,0.05755727,0.000008086802,0.0004969883,0.0005892462],"about_ca_topic_score_codex":0.00042628078,"about_ca_topic_score_gemma":0.000067705136,"teacher_disagreement_score":0.15235063,"about_ca_system_score_codex":0.0004201653,"about_ca_system_score_gemma":0.00041624674,"threshold_uncertainty_score":0.9995867},"labels":[],"label_agreement":null},{"id":"W2135686765","doi":"10.1177/1352458512444326","title":"MRI-based clinical trials in relapsing–remitting MS: new sample size calculations based on a longitudinal model","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Actua; Simon Fraser University","funders":"Chongqing University of Arts and Sciences","keywords":"Sample size determination; Clinical trial; Multiple sclerosis; Medicine; Magnetic resonance imaging; Negative binomial distribution; Lesion; Statistics; Radiology; Mathematics; Pathology; Poisson distribution","score_opus":0.4930818613757792,"score_gpt":0.4618427091295853,"score_spread":0.03123915224619389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135686765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7638131,0.0007052959,0.2215637,0.009124543,0.001448552,0.0022586768,0.00014116627,0.0002171523,0.0007278522],"genre_scores_gemma":[0.8950648,0.00029874788,0.101087295,0.0011432563,0.002130155,0.000060659735,0.000019430374,0.00009192791,0.000103742714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99061114,0.002283948,0.0031780074,0.00066718925,0.0017129414,0.00154679],"domain_scores_gemma":[0.9624917,0.03285339,0.0011755984,0.0009053802,0.00053666736,0.0020372819],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020295033,0.00054887595,0.0019281689,0.00070441415,0.0006619534,0.00019756299,0.00034514515,0.00038841262,0.0006061207],"category_scores_gemma":[0.14599673,0.00044556486,0.001279941,0.0008024043,0.00025261423,0.0004192863,0.0001230604,0.0022727028,0.00005784414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019616329,0.0015798477,0.8941838,0.0000468436,0.00015751008,0.000008821184,0.00027213973,0.07596865,0.003321918,0.000008026767,0.0074275695,0.015063193],"study_design_scores_gemma":[0.012158498,0.00022410818,0.54819375,0.0010626061,0.000110360874,0.000007774492,0.00007938883,0.43725663,0.00025941213,0.000025665824,0.0003666569,0.00025514432],"about_ca_topic_score_codex":0.0004311662,"about_ca_topic_score_gemma":0.00022763952,"teacher_disagreement_score":0.36128798,"about_ca_system_score_codex":0.00076432683,"about_ca_system_score_gemma":0.0010445415,"threshold_uncertainty_score":0.9997996},"labels":[],"label_agreement":null},{"id":"W2135746117","doi":"10.1177/1352458509357065","title":"Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; St. Michael's Hospital","funders":"","keywords":"Fingolimod; Medicine; Adverse effect; Multiple sclerosis; Placebo; Internal medicine; Clinical trial; Surgery; Pathology; Immunology","score_opus":0.07880616782050656,"score_gpt":0.2823788777459828,"score_spread":0.20357270992547624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135746117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982035,0.0005799749,0.00021406438,0.000114447575,0.00034466156,0.00038129112,0.000056756493,0.000018302662,0.000086963155],"genre_scores_gemma":[0.9970721,0.0003785333,0.0017469012,0.00018061101,0.0004951349,0.000012610608,0.000035551333,0.00003490747,0.000043674423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971682,0.00023730971,0.0010499207,0.00052762404,0.00043559933,0.0005813649],"domain_scores_gemma":[0.9985546,0.000041622803,0.0004320332,0.00051462423,0.00022100307,0.00023614167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011453795,0.00032748323,0.00051487185,0.00026325995,0.0003557557,0.00008141847,0.00050229335,0.00020338138,0.00001718544],"category_scores_gemma":[0.00082297745,0.00030752993,0.00022284621,0.00034794913,0.000064905274,0.000031943684,0.00014738523,0.00041211804,0.0000043111895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024145024,0.005458047,0.011180499,0.0000059854056,0.000075787124,0.000007764392,0.0016171029,0.0017932174,0.9562445,0.0000033209174,0.0008835447,0.020315677],"study_design_scores_gemma":[0.14430453,0.016389709,0.31745145,0.000501149,0.00016906548,0.00005104102,0.004915702,0.00319905,0.5083389,0.000053141244,0.0034087184,0.0012175635],"about_ca_topic_score_codex":0.00016342492,"about_ca_topic_score_gemma":0.00020742283,"teacher_disagreement_score":0.44790566,"about_ca_system_score_codex":0.00003334504,"about_ca_system_score_gemma":0.000087702254,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2136139191","doi":"10.1177/1352458508097299","title":"Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health","keywords":"Medicine; Tolerability; Immunogenicity; Interferon beta-1a; Multiple sclerosis; Confidence interval; Adverse effect; Internal medicine; Clinical endpoint; Clinical trial; Antibody; Gastroenterology; Immunology; Interferon beta","score_opus":0.12092357691772825,"score_gpt":0.3048185937232836,"score_spread":0.18389501680555537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136139191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956423,0.00047277033,0.00090252794,0.0002214124,0.0001126686,0.0025046435,0.00007558193,0.000031447697,0.000036616373],"genre_scores_gemma":[0.9942538,0.0010434595,0.004374981,0.000029645575,0.000102104124,0.000019877061,0.0000567514,0.000068249734,0.000051131483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99402344,0.0003281253,0.0027152407,0.0006608754,0.00148053,0.0007917851],"domain_scores_gemma":[0.99642694,0.00060444896,0.0011711178,0.0005942195,0.0007087329,0.00049455446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014872534,0.0005200197,0.0014146087,0.0011263932,0.00034708108,0.000047320802,0.00029983497,0.00029970828,0.000032913507],"category_scores_gemma":[0.0024517102,0.000434061,0.00022192602,0.0011663466,0.00018824395,0.0010194211,0.00027883478,0.0014227373,0.0000025079073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057017177,0.004923689,0.8773617,0.000074731965,0.00028127394,0.000010075934,0.011979233,0.0010562155,0.02138409,0.0000010303665,0.00011508234,0.025795681],"study_design_scores_gemma":[0.12568799,0.0067670406,0.85491395,0.0025649238,0.000088319954,0.0000146554685,0.0011401549,0.0058260215,0.002658325,0.0000067880273,0.000020706384,0.0003111529],"about_ca_topic_score_codex":0.0031193614,"about_ca_topic_score_gemma":0.0029743023,"teacher_disagreement_score":0.0686708,"about_ca_system_score_codex":0.0006235132,"about_ca_system_score_gemma":0.00045583074,"threshold_uncertainty_score":0.9998111},"labels":[],"label_agreement":null},{"id":"W2136756445","doi":"10.1177/1352458511399611","title":"Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Teva Pharmaceutical Industries; Sanofi","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Natalizumab; Medicine; Physical therapy; Quality of life (healthcare); Proportional hazards model; Central nervous system disease; Clinical trial; Internal medicine; Immunology","score_opus":0.11368700742756044,"score_gpt":0.279010791005736,"score_spread":0.16532378357817556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136756445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917725,0.00059017504,0.00005696831,0.00032370476,0.00018780906,0.0068368292,0.00007999206,0.0001014499,0.000050594703],"genre_scores_gemma":[0.99392277,0.0010529023,0.0036697276,0.00016168522,0.00014244855,0.00081162347,0.000058691723,0.00016796551,0.000012215036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907243,0.0009587675,0.0020186289,0.0016138951,0.00220678,0.0024775828],"domain_scores_gemma":[0.9947203,0.0012219594,0.00081342354,0.0011553,0.0006293252,0.0014597183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013298524,0.0012079917,0.0022957618,0.0010626412,0.00037029464,0.00012423129,0.0005543266,0.00043410572,0.00010785577],"category_scores_gemma":[0.003697094,0.00085324165,0.00041645585,0.0018880619,0.00083172147,0.0008740581,0.00047830865,0.0015604417,0.000009974551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03460632,0.010738675,0.8392691,0.0002285087,0.00025789355,0.000078668985,0.008372047,0.00008979423,0.009194677,9.58169e-7,0.00001636104,0.09714698],"study_design_scores_gemma":[0.1054104,0.014035688,0.8655252,0.0044455114,0.0001453624,0.000011009057,0.0012922544,0.0013272034,0.0070939194,0.00000820019,0.0000074293184,0.00069782557],"about_ca_topic_score_codex":0.0154984575,"about_ca_topic_score_gemma":0.02464427,"teacher_disagreement_score":0.09644916,"about_ca_system_score_codex":0.002507575,"about_ca_system_score_gemma":0.00062716537,"threshold_uncertainty_score":0.99939185},"labels":[],"label_agreement":null},{"id":"W2136964907","doi":"10.1177/1352458510388823","title":"High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; BETA (programming language); Interferon beta; Internal medicine; Oncology; Immunology","score_opus":0.1151051219175144,"score_gpt":0.29566413686628784,"score_spread":0.18055901494877344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136964907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947298,0.00091991393,0.00008180835,0.0007529046,0.000638701,0.0022500788,0.0003826592,0.00009662513,0.00014749759],"genre_scores_gemma":[0.9920727,0.0026760607,0.0037253376,0.000097795135,0.0008550455,0.00033928012,0.000017340784,0.00011706475,0.000099376666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99251693,0.0010506714,0.00209345,0.0008826317,0.0019802975,0.0014760337],"domain_scores_gemma":[0.9913189,0.0041993107,0.0010050177,0.0015078239,0.0011791541,0.0007898383],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0047377567,0.0008204412,0.0015385975,0.0008936265,0.0012521388,0.0002986872,0.0011850619,0.000285277,0.0007273514],"category_scores_gemma":[0.0121969385,0.00055484654,0.000707898,0.0010400742,0.0012747108,0.00072836335,0.000710357,0.004115171,0.00008719499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009453155,0.0042284294,0.9053082,0.00008626869,0.00067949516,0.00010043687,0.0036011161,0.00006743954,0.078688644,0.000015939913,0.00080331357,0.005475414],"study_design_scores_gemma":[0.014524696,0.0015865834,0.9721356,0.00075348606,0.00048701593,0.00015014654,0.0040147,0.0012767033,0.0044784327,0.000036733178,0.000063554944,0.00049231545],"about_ca_topic_score_codex":0.022771016,"about_ca_topic_score_gemma":0.04232928,"teacher_disagreement_score":0.07421021,"about_ca_system_score_codex":0.00031845865,"about_ca_system_score_gemma":0.00040216552,"threshold_uncertainty_score":0.9996903},"labels":[],"label_agreement":null},{"id":"W2137537898","doi":"10.1177/1352458512455958","title":"Impact of sleep disorder treatment on fatigue in multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"American Academy of Sleep Medicine","keywords":"Epworth Sleepiness Scale; Polysomnography; Medicine; Pittsburgh Sleep Quality Index; Sleep disorder; Physical therapy; Sleep (system call); Internal medicine; Insomnia; Psychiatry; Sleep quality","score_opus":0.22384573214762477,"score_gpt":0.36054927660546776,"score_spread":0.136703544457843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137537898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570066,0.0015201784,0.00021486898,0.00038308188,0.00036937842,0.0011555504,0.00018598704,0.000055520464,0.000414775],"genre_scores_gemma":[0.9929654,0.004200964,0.001744799,0.000067352856,0.0006100924,0.00015415919,0.000031786927,0.00010846648,0.000116998606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948907,0.0003922452,0.0012582752,0.00051293324,0.0012620314,0.0016838547],"domain_scores_gemma":[0.9963448,0.0010069927,0.000473574,0.000753153,0.0003890182,0.001032462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010479554,0.0006951918,0.0013261206,0.000997733,0.00040719417,0.000079244324,0.00033198923,0.00024871578,0.00058458926],"category_scores_gemma":[0.0020867416,0.0004901126,0.0010484834,0.0008639228,0.0003173784,0.0005247491,0.00015677935,0.0008573622,0.00010170387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013790225,0.004470368,0.84591883,0.00004211325,0.0005841982,0.0000071924405,0.0017005941,0.0012743267,0.07628162,0.0000034739012,0.0007852304,0.06755302],"study_design_scores_gemma":[0.015790867,0.0024626632,0.9678493,0.0008347727,0.000102326456,0.00003360963,0.00049028324,0.0035134407,0.008212489,0.0000035689895,0.00030627847,0.0004003626],"about_ca_topic_score_codex":0.0023615065,"about_ca_topic_score_gemma":0.00069481897,"teacher_disagreement_score":0.1219305,"about_ca_system_score_codex":0.0016896037,"about_ca_system_score_gemma":0.0001952455,"threshold_uncertainty_score":0.999755},"labels":[],"label_agreement":null},{"id":"W2138229533","doi":"10.1177/1352458512459986","title":"Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Multiple sclerosis; Sonographer; Ultrasound; Supine position; Internal jugular vein; Surgery; Radiology","score_opus":0.06387821660600027,"score_gpt":0.26906598875237214,"score_spread":0.20518777214637188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138229533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934289,0.0015056652,0.00013431426,0.00027714277,0.00056853064,0.0037234845,0.00021336012,0.00012797711,0.00002066551],"genre_scores_gemma":[0.99678314,0.00013576612,0.0012501944,0.0005262609,0.00087347085,0.00019537451,0.000017147953,0.00019788647,0.000020750316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932896,0.00032093067,0.0015010627,0.0009094926,0.0018369047,0.002142004],"domain_scores_gemma":[0.99594986,0.0003244837,0.0007670756,0.0012484242,0.0005846169,0.0011255593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001307244,0.00090871355,0.001410439,0.0008200953,0.0009841147,0.0002525024,0.00062153366,0.00033151134,0.0005248883],"category_scores_gemma":[0.0005258961,0.00074811385,0.0005013737,0.0012651817,0.00030916094,0.00093316607,0.00017323141,0.0017297164,0.00008733952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021165588,0.030244749,0.9476046,0.00011896081,0.00066371256,0.00008170234,0.010762141,0.00023158918,0.002364808,4.5043308e-7,0.00024554087,0.005565196],"study_design_scores_gemma":[0.04933042,0.01198674,0.9309685,0.0010421805,0.00085008465,0.0007514347,0.0031896946,0.0003724813,0.00069342594,0.0000010212194,0.00004346324,0.00077051716],"about_ca_topic_score_codex":0.0007461972,"about_ca_topic_score_gemma":0.000988433,"teacher_disagreement_score":0.04721386,"about_ca_system_score_codex":0.001659523,"about_ca_system_score_gemma":0.0003847291,"threshold_uncertainty_score":0.999497},"labels":[],"label_agreement":null},{"id":"W2139255064","doi":"10.1177/1352458507086667","title":"Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Natalizumab; Medicine; Cost effectiveness; Observational study; Cohort; Quality-adjusted life year; Clinical trial; Population; Cohort study; Physical therapy; Randomized controlled trial; Expanded Disability Status Scale; Multiple sclerosis; Internal medicine; Psychiatry; Environmental health","score_opus":0.2982927285160438,"score_gpt":0.40713462731703237,"score_spread":0.10884189880098855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139255064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622879,0.004021809,0.028113293,0.00095214165,0.00019357055,0.004199758,0.000102051294,0.000031077114,0.00009839709],"genre_scores_gemma":[0.986774,0.0073230136,0.005170136,0.000027939219,0.00024889276,0.000372514,0.00001985706,0.00004618645,0.000017459228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969405,0.00042135874,0.0006648745,0.00036611833,0.0009994939,0.0006076391],"domain_scores_gemma":[0.9962026,0.0019330338,0.000209132,0.00038944182,0.00093867345,0.0003271037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013472716,0.00032874054,0.000854627,0.00024070311,0.00049815804,0.000056385237,0.00023698153,0.0000643963,0.000019488802],"category_scores_gemma":[0.002084357,0.00018829756,0.00025959496,0.00038750406,0.00021830008,0.00031025257,0.00007745798,0.00048709346,0.000002673744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13654122,0.0063855792,0.26961312,0.0010413456,0.0037781666,0.00019040276,0.028038869,0.22739418,0.038536098,0.000046625013,0.0029770264,0.28545737],"study_design_scores_gemma":[0.13114972,0.00772819,0.5875156,0.007734593,0.0007553238,0.0011531553,0.005198905,0.22152652,0.021578358,0.00004770277,0.014722621,0.00088931486],"about_ca_topic_score_codex":0.0009224925,"about_ca_topic_score_gemma":0.00051005464,"teacher_disagreement_score":0.31790248,"about_ca_system_score_codex":0.00091453025,"about_ca_system_score_gemma":0.0008453211,"threshold_uncertainty_score":0.76785517},"labels":[],"label_agreement":null},{"id":"W2139655506","doi":"10.1177/1352458507077175","title":"Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Jewish General Hospital; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society","keywords":"Psychosocial; Biopsychosocial model; Medicine; Physical therapy; Depression (economics); Psychology; Clinical psychology; Psychiatry","score_opus":0.14300408430002154,"score_gpt":0.3120863215242343,"score_spread":0.16908223722421278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139655506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544525,0.00087812875,0.0002645326,0.0015977472,0.00044098438,0.001023114,0.00007239636,0.00011658364,0.00016128592],"genre_scores_gemma":[0.9961374,0.0016029218,0.0014483293,0.00013422998,0.00033247613,0.00004723461,0.00004362503,0.00009910274,0.00015471807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99460715,0.00025108608,0.0011697196,0.0006872292,0.001823,0.001461786],"domain_scores_gemma":[0.996364,0.0009311452,0.0005917446,0.00035506082,0.0005359375,0.0012220881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022584465,0.00056673156,0.0008551297,0.00073484227,0.00084263354,0.00025935535,0.0002570634,0.00033769256,0.00012356567],"category_scores_gemma":[0.0025712715,0.000449735,0.0002977105,0.00082889665,0.00031124952,0.00061041256,0.00013954389,0.0016880507,0.000017428232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013555301,0.0006259502,0.97472537,0.00004557329,0.00027466734,0.00006252491,0.0020918436,0.000043068285,0.012015043,0.0000045749875,0.00069485424,0.008060978],"study_design_scores_gemma":[0.01367224,0.0003637598,0.97981954,0.0011277526,0.0001702994,0.000027631366,0.0021654568,0.00057025877,0.0014521185,0.00001580376,0.00013891298,0.0004762329],"about_ca_topic_score_codex":0.00057854125,"about_ca_topic_score_gemma":0.0023132982,"teacher_disagreement_score":0.012316709,"about_ca_system_score_codex":0.0013233672,"about_ca_system_score_gemma":0.00019213448,"threshold_uncertainty_score":0.99979544},"labels":[],"label_agreement":null},{"id":"W2140051179","doi":"10.1191/1352458505ms1205oa","title":"Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society","keywords":"Natalizumab; Multiple sclerosis; Medicine; Internal medicine; Placebo; Lesion; Gastroenterology; Clinical trial; Phases of clinical research; Surgery; Pathology; Immunology","score_opus":0.14144824002174747,"score_gpt":0.348538242617605,"score_spread":0.20709000259585755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140051179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939746,0.0021091208,0.00010753352,0.0018205694,0.0002441801,0.0015097979,0.00006328966,0.000045005247,0.00012586422],"genre_scores_gemma":[0.98537564,0.008232263,0.0054558963,0.00012368117,0.0004797002,0.00014833293,0.000015998246,0.00007207495,0.00009640771],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99469817,0.0004290825,0.0020135655,0.00067710306,0.0010982864,0.0010838003],"domain_scores_gemma":[0.99687034,0.0011799511,0.0005095077,0.000512175,0.00035588592,0.0005721214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002453632,0.00049729325,0.0013680359,0.0013789966,0.0005655422,0.00009640423,0.0003272846,0.0002751542,0.00017394616],"category_scores_gemma":[0.006677864,0.00043710577,0.0003270006,0.0010313023,0.00042789546,0.0006666864,0.00044261653,0.0014033885,0.000014195405],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050282527,0.008009082,0.08599086,0.00019337144,0.00022162093,0.000061307706,0.0058513596,0.00025246988,0.6272667,0.0000103786115,0.0009008749,0.22095945],"study_design_scores_gemma":[0.44627526,0.0050484487,0.44973338,0.0046195607,0.000104491344,0.00010254277,0.0023710886,0.015784994,0.07428347,0.000021858077,0.00097416504,0.00068072043],"about_ca_topic_score_codex":0.000658935,"about_ca_topic_score_gemma":0.004698316,"teacher_disagreement_score":0.5529832,"about_ca_system_score_codex":0.00056919694,"about_ca_system_score_gemma":0.00030206016,"threshold_uncertainty_score":0.9998081},"labels":[],"label_agreement":null},{"id":"W2140360882","doi":"10.1177/1352458514559865","title":"Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Jewish General Hospital; Cégep de Lévis; Université de Montréal; Hôpital Notre-Dame","funders":"NIH Clinical Center; Novartis Pharma; Multiple Sclerosis Society; York University; Teva Pharmaceutical Industries; Biogen; NYU Langone Medical Center; Sanofi","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Propensity score matching; Interferon beta-1a; Internal medicine; Natalizumab; Hazard ratio; Magnetic resonance imaging; Interferon beta; Immunology; Confidence interval","score_opus":0.1326666379516044,"score_gpt":0.32838512792949787,"score_spread":0.19571848997789346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140360882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250895,0.00065826444,0.0047454224,0.00027717644,0.00022846957,0.0010181506,0.000028303604,0.0000521611,0.000483096],"genre_scores_gemma":[0.99056226,0.0007679691,0.008285328,0.000050951356,0.00016048737,0.000067555025,0.000020032454,0.000060630202,0.000024788673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555653,0.0010164655,0.0012145907,0.00059805,0.0008001748,0.000814165],"domain_scores_gemma":[0.994184,0.0037758455,0.0005441931,0.00044521634,0.0006240111,0.00042674268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031615691,0.00046980986,0.0014625543,0.0007205934,0.00049774855,0.00012837959,0.00025986135,0.00019347659,0.000041107505],"category_scores_gemma":[0.002839727,0.00040222297,0.00029832785,0.0006641847,0.0005199797,0.0005499442,0.00032548734,0.0011328107,0.000013867121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013366747,0.00035482104,0.63294464,0.0002781175,0.0002464033,0.0000018757058,0.0022203594,0.0006887905,0.34237063,0.00002769759,0.00007361545,0.019456375],"study_design_scores_gemma":[0.011340668,0.0006933062,0.90957916,0.004801519,0.0001003315,0.000029537041,0.0006248031,0.037908122,0.03445763,0.00006786899,0.0000761982,0.00032083722],"about_ca_topic_score_codex":0.00029523845,"about_ca_topic_score_gemma":0.00034674216,"teacher_disagreement_score":0.30791298,"about_ca_system_score_codex":0.0003314463,"about_ca_system_score_gemma":0.00009023522,"threshold_uncertainty_score":0.99984294},"labels":[],"label_agreement":null},{"id":"W2140925893","doi":"10.1177/1352458511434068","title":"Epidemiology in multiple sclerosis has had its day: there are no more unanswered questions - No","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Multiple sclerosis; Epidemiology; Medicine; Clinical neurology; MEDLINE; Psychology; Neuroscience; Psychiatry; Biology; Pathology","score_opus":0.3837436415628885,"score_gpt":0.3428027299823878,"score_spread":0.04094091158050067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140925893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97877574,0.007115005,0.0008178964,0.0053216564,0.0020646902,0.0026062864,0.00039904218,0.0004241563,0.0024755339],"genre_scores_gemma":[0.97597265,0.008151604,0.012198911,0.0011621087,0.0011014398,0.00036189187,0.000049027287,0.00019766211,0.0008047012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913024,0.0015712831,0.002304116,0.0012910761,0.0011467946,0.0023843716],"domain_scores_gemma":[0.99203634,0.0022518996,0.0010317912,0.0012626043,0.0019803594,0.0014369799],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0039280914,0.0009898224,0.0021707728,0.0009969523,0.0013897286,0.00011661616,0.0009576522,0.0006670289,0.0019321727],"category_scores_gemma":[0.027777335,0.0008229789,0.00085009413,0.0010047733,0.0010517372,0.0007550057,0.0005515434,0.0027583065,0.001662653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013590211,0.0017797631,0.9218664,0.00018770639,0.0005506837,0.0001444455,0.002634031,0.00011762119,0.05117727,0.0000251492,0.013037258,0.0071206195],"study_design_scores_gemma":[0.009816396,0.00058998907,0.9690603,0.0030740649,0.00013007973,0.000104253035,0.001099021,0.008356971,0.0028099155,0.000049609644,0.0041532153,0.0007561991],"about_ca_topic_score_codex":0.001570905,"about_ca_topic_score_gemma":0.0017670926,"teacher_disagreement_score":0.048367355,"about_ca_system_score_codex":0.000827827,"about_ca_system_score_gemma":0.00043982943,"threshold_uncertainty_score":0.99991035},"labels":[],"label_agreement":null},{"id":"W2141372130","doi":"10.1177/1352458513503598","title":"The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Quality of life (healthcare); Medicine; Affect (linguistics); Sexual dysfunction; Population; Multilevel model; Explained variation; Physical disability; Analysis of variance; Multivariate analysis; Multivariate statistics; Gerontology; Demography; Clinical psychology; Psychology; Physical therapy; Psychiatry; Internal medicine; Environmental health","score_opus":0.13997081790795887,"score_gpt":0.33547442895183,"score_spread":0.19550361104387112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141372130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944281,0.0008607962,0.000101515376,0.0025097032,0.00016820114,0.0017004367,0.00006456013,0.000045190238,0.000121473226],"genre_scores_gemma":[0.9971019,0.0018507144,0.0005263835,0.000092049704,0.00012827128,0.00013459042,0.000018609917,0.000070763715,0.0000767109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933533,0.0009811885,0.0024067783,0.00052018877,0.001647807,0.001090704],"domain_scores_gemma":[0.99321723,0.0025061027,0.0015787818,0.0008162062,0.0011370643,0.00074463774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003221177,0.00048967765,0.0015728427,0.0005388979,0.0006241718,0.000107174106,0.00040465477,0.00019422607,0.00025930456],"category_scores_gemma":[0.0057576154,0.00028422827,0.00040290144,0.0011974201,0.0005350991,0.00037987984,0.00015115942,0.0012855915,0.000039828967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034949312,0.001169461,0.87084883,0.00016405454,0.0006186703,9.4008726e-7,0.0014912059,0.0023178365,0.09015445,0.0000045293505,0.0032855987,0.026449503],"study_design_scores_gemma":[0.013081892,0.0036754156,0.9728951,0.00091440167,0.000028454262,0.000013548396,0.0023326555,0.0057123047,0.0010771927,0.00001305569,0.0000094696225,0.00024650787],"about_ca_topic_score_codex":0.03774342,"about_ca_topic_score_gemma":0.007108219,"teacher_disagreement_score":0.10204628,"about_ca_system_score_codex":0.0008025414,"about_ca_system_score_gemma":0.0007557361,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W2141582945","doi":"10.1177/1352458512471877","title":"High rates of physician services utilization at least five years before multiple sclerosis diagnosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Family medicine; Psychiatry","score_opus":0.1329821153201995,"score_gpt":0.317162884705423,"score_spread":0.1841807693852235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141582945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944589,0.0025965923,0.0000872587,0.0005996383,0.0007562356,0.00095949037,0.0003124937,0.00011055765,0.000118838434],"genre_scores_gemma":[0.9895877,0.0053013302,0.0025701532,0.0004102477,0.0014456573,0.00018279486,0.00016240175,0.00014162743,0.00019805592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947056,0.0003375556,0.0012216092,0.0005828342,0.0016676245,0.001484744],"domain_scores_gemma":[0.995895,0.00063152914,0.00084333133,0.0007100627,0.0009819668,0.0009380799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010153863,0.00062302523,0.0012134959,0.00055737543,0.00080189994,0.00013387311,0.0005243642,0.000285162,0.000497514],"category_scores_gemma":[0.0010105683,0.0005450818,0.00057160907,0.0009915358,0.00045995446,0.0010471914,0.0005641889,0.00074752694,0.00021562864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055775704,0.0012041591,0.85828227,0.00030232576,0.0005535564,0.0000050887184,0.0037848928,0.00016804278,0.07296324,0.00001070959,0.0029822255,0.05918575],"study_design_scores_gemma":[0.00580969,0.00041523515,0.9110213,0.0015829538,0.00023928392,0.00002264252,0.0018300357,0.0014464369,0.07555717,0.000010357233,0.0016646474,0.0004002606],"about_ca_topic_score_codex":0.00072121195,"about_ca_topic_score_gemma":0.0005994996,"teacher_disagreement_score":0.05878549,"about_ca_system_score_codex":0.00061089284,"about_ca_system_score_gemma":0.000106394655,"threshold_uncertainty_score":0.99970007},"labels":[],"label_agreement":null},{"id":"W2141927521","doi":"10.1177/1352458514564488","title":"The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"Canadian Institutes of Health Research; Teva Pharmaceutical Industries","keywords":"Medicine; Irritable bowel syndrome; Population; Fibromyalgia; Incidence (geometry); Comorbidity; Disease; Internal medicine; Physical therapy","score_opus":0.08774498040869426,"score_gpt":0.332461587882921,"score_spread":0.24471660747422674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141927521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011187115,0.99172646,0.00012095929,0.00038363732,0.00010552902,0.0063887285,0.0000856676,0.000040791132,0.000029521201],"genre_scores_gemma":[0.011738965,0.98568505,0.0011968846,0.000059417063,0.00014464659,0.00095733814,0.000018483517,0.00013568817,0.000063537715],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98962665,0.0025969981,0.003710267,0.0010737274,0.0017649546,0.0012273941],"domain_scores_gemma":[0.9896392,0.005233033,0.002520408,0.0013140104,0.00057508814,0.0007182577],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0068814917,0.0011676116,0.0057467944,0.00059320685,0.0008393797,0.00024350408,0.0010201265,0.00025982238,0.000024974815],"category_scores_gemma":[0.01930847,0.0007247271,0.0011661164,0.00088540156,0.0015091507,0.00031950235,0.0009048099,0.0023024366,0.00001397123],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006820709,0.00023332436,0.009201139,0.84611267,0.0003622421,0.000021076152,0.00006437331,0.0000016277421,0.00013504493,0.0000026967712,0.00024943752,0.14354815],"study_design_scores_gemma":[0.0016928129,0.00049611094,0.025200296,0.9612918,0.002865561,0.0016221968,0.00010390979,0.0007750369,0.0000024850851,0.000008175374,0.005337223,0.0006044154],"about_ca_topic_score_codex":0.00013551411,"about_ca_topic_score_gemma":0.00031758758,"teacher_disagreement_score":0.14294374,"about_ca_system_score_codex":0.00034100277,"about_ca_system_score_gemma":0.00038672567,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W2142494199","doi":"10.1177/1352458510388543","title":"Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Multiple sclerosis; Medicine; Intrathecal; Cerebrospinal fluid; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Cohort; Clinically isolated syndrome; Immunology; Surgery","score_opus":0.12973574860272352,"score_gpt":0.3940297134961396,"score_spread":0.26429396489341606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142494199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433905,0.00043498116,0.00026351734,0.0026567865,0.00037602268,0.0012560353,0.0003278602,0.000047669382,0.0002980971],"genre_scores_gemma":[0.9821709,0.0014079044,0.015515814,0.00007330135,0.00036876442,0.00035216048,0.000016697772,0.000056643992,0.00003780974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99353176,0.0011555861,0.001484205,0.0008148333,0.0020137012,0.0009999275],"domain_scores_gemma":[0.9871642,0.008857891,0.00089609023,0.00064033974,0.0013899753,0.0010514986],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002866848,0.0005744271,0.001455322,0.0017268771,0.00039907565,0.00013375412,0.00047036225,0.00023087431,0.00083265756],"category_scores_gemma":[0.03144273,0.00044377724,0.00088558416,0.0030469643,0.0008169054,0.00046202602,0.00026080708,0.0018281336,0.00004145828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019833812,0.0025658128,0.9199623,0.0003662915,0.003218467,0.000098165765,0.023889793,0.00007589067,0.017284565,0.000084250205,0.00078612124,0.011834531],"study_design_scores_gemma":[0.0070774746,0.00076340383,0.97314465,0.000504098,0.0020371277,0.000004558672,0.005081603,0.0069327946,0.00392349,0.00005165255,0.000042400115,0.0004367668],"about_ca_topic_score_codex":0.00017477195,"about_ca_topic_score_gemma":0.0006823295,"teacher_disagreement_score":0.05318233,"about_ca_system_score_codex":0.00023369628,"about_ca_system_score_gemma":0.00056722004,"threshold_uncertainty_score":0.9998014},"labels":[],"label_agreement":null},{"id":"W2143237038","doi":"10.1177/1352458512470311","title":"Methods and measures: what’s new for MS?","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rasch model; Ask price; Multiple sclerosis; Psychology; Psychological intervention; Preference; Clinical psychology; Cognitive psychology; Psychiatry; Developmental psychology; Mathematics; Statistics","score_opus":0.5200704806374683,"score_gpt":0.4763480036313983,"score_spread":0.043722477006070015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143237038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046995183,0.9859292,0.00865222,0.0004715122,0.0016855561,0.003015077,0.0000590863,0.0000818116,0.00010086488],"genre_scores_gemma":[0.000009954822,0.8797535,0.11414518,0.00012992977,0.0045097745,0.0003205489,0.000044869277,0.00022710142,0.00085915317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400747,0.0009469558,0.0016621682,0.0008072431,0.0010607493,0.0015154356],"domain_scores_gemma":[0.9927783,0.0029645103,0.0009029875,0.0007580873,0.000610694,0.0019854484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00481342,0.0010392495,0.004207601,0.0007710066,0.00075298845,0.000808042,0.0004984894,0.0006900014,0.00022215409],"category_scores_gemma":[0.005056895,0.0007299867,0.0018029753,0.00045966596,0.0002760878,0.0008202197,0.00038234045,0.0019587935,0.000059254024],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009843687,0.00014325656,0.0000917304,0.008259916,0.0014414199,0.000003780644,0.00029705616,1.9726204e-7,0.00012074501,0.000004626666,0.008908517,0.98063034],"study_design_scores_gemma":[0.0032477046,0.00026452454,0.0008099958,0.03473992,0.003547567,0.00052248524,0.00017617375,0.000032021137,0.000029148525,0.000019960115,0.95598596,0.0006245559],"about_ca_topic_score_codex":0.00004422469,"about_ca_topic_score_gemma":0.000032043634,"teacher_disagreement_score":0.98000574,"about_ca_system_score_codex":0.00054705323,"about_ca_system_score_gemma":0.0009707028,"threshold_uncertainty_score":0.9995151},"labels":[],"label_agreement":null},{"id":"W2143322448","doi":"10.1177/1352458513512709","title":"Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Multiple Sclerosis Society; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Remyelination; Medicine; Magnetic resonance imaging; Clinical trial; Drug development; Preclinical research; Drug; Medical physics; Neuroscience; Pathology; Pharmacology; Radiology; Psychology; Internal medicine; Immunology; Central nervous system","score_opus":0.35659155730095476,"score_gpt":0.3726138033485424,"score_spread":0.01602224604758762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143322448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019641658,0.9739266,0.00028089277,0.00024187496,0.00043605187,0.0050812676,0.00008147132,0.00010224813,0.00020795307],"genre_scores_gemma":[0.010560595,0.92494875,0.06194121,0.00021087784,0.00055887486,0.001042152,0.000037021775,0.00038341925,0.0003170845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98726535,0.0010237581,0.0045542545,0.001897511,0.002321177,0.0029379702],"domain_scores_gemma":[0.9946365,0.0011076902,0.00091274374,0.0011613192,0.0007903726,0.0013914077],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0034095317,0.0017546578,0.0048332005,0.003577959,0.00070041063,0.0005673727,0.0013536703,0.00047218913,0.00026213707],"category_scores_gemma":[0.0023839294,0.0015324418,0.0009821166,0.0025074033,0.00029826217,0.00089258346,0.001400664,0.0032208846,0.0002806795],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017934192,0.0005825182,0.015404177,0.002624629,0.0000850817,0.00015396847,0.0016438834,0.0003563639,0.0016036602,0.0000014902854,0.0025685944,0.9747963],"study_design_scores_gemma":[0.012251,0.00025303155,0.1100885,0.22380686,0.00044044564,0.00045767523,0.0010691368,0.034113035,0.00019018183,0.000010796138,0.6141202,0.003199158],"about_ca_topic_score_codex":0.0023164954,"about_ca_topic_score_gemma":0.0020015973,"teacher_disagreement_score":0.97159714,"about_ca_system_score_codex":0.0056638736,"about_ca_system_score_gemma":0.0020786934,"threshold_uncertainty_score":0.99951994},"labels":[],"label_agreement":null},{"id":"W2143322657","doi":"10.1177/1352458514564489","title":"A systematic review of the incidence and prevalence of cancer in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Cleveland Clinic; Cleveland Clinic Foundation; Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Biogen; National Multiple Sclerosis Society; GlaxoSmithKline; Gilead Sciences; Sanofi; EMD Serono","keywords":"Medicine; Incidence (geometry); Population; Multiple sclerosis; Cancer; Prostate cancer; Cancer registry; Epidemiology; Internal medicine; Cervical cancer; Breast cancer; MEDLINE; Oncology; Gynecology; Immunology; Environmental health","score_opus":0.15562907664906814,"score_gpt":0.3693136924138727,"score_spread":0.21368461576480455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143322657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012336476,0.99225867,0.000015758993,0.00017495235,0.00027092337,0.0057387766,0.00026674665,0.000017365539,0.00002314547],"genre_scores_gemma":[0.011339039,0.98702466,0.00035404298,0.00012550417,0.00015581126,0.0008016895,0.000003868477,0.00010003861,0.00009536636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99030244,0.001953135,0.0042768633,0.0007241525,0.0019684471,0.000774966],"domain_scores_gemma":[0.990364,0.0029291147,0.0039704666,0.0014003096,0.0009643662,0.00037172966],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045696585,0.0008368795,0.0073115155,0.0005976068,0.00025708313,0.00005306382,0.0012336953,0.00036451872,0.000121727295],"category_scores_gemma":[0.019141303,0.0004859854,0.0015947486,0.0013541109,0.00079493143,0.00019437079,0.0008221912,0.0017377833,0.000007895556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027681604,0.00016332098,0.014798815,0.914135,0.00056967215,0.0000026099779,0.00015514831,0.0000022093966,0.0002189099,0.0000012890974,0.00019702512,0.06972832],"study_design_scores_gemma":[0.0014455384,0.00012295473,0.045688022,0.9469581,0.0036929988,0.000090597874,0.00003696911,0.0001663615,0.0000548399,0.0000015105455,0.0013827183,0.00035936944],"about_ca_topic_score_codex":0.00033623356,"about_ca_topic_score_gemma":0.0002945085,"teacher_disagreement_score":0.06936895,"about_ca_system_score_codex":0.0005425737,"about_ca_system_score_gemma":0.00079917937,"threshold_uncertainty_score":0.9997592},"labels":[],"label_agreement":null},{"id":"W2143424812","doi":"10.1191/1352458504ms1009oa","title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Experimental autoimmune encephalomyelitis; Cannabinoid receptor; Multiple sclerosis; Cannabinoid; Agonist; Myelin oligodendrocyte glycoprotein; Intravital microscopy; Cannabinoid receptor type 2; Immunology; Immune system; Encephalomyelitis; Pharmacology; Chemistry; Receptor; Medicine; Internal medicine; Microcirculation","score_opus":0.0705255941332783,"score_gpt":0.321607670073763,"score_spread":0.2510820759404847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143424812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894808,0.0008572242,0.00029074005,0.0077306167,0.00061481516,0.0005447906,0.000086401305,0.00008360569,0.00031098543],"genre_scores_gemma":[0.9933284,0.00023342879,0.0027701845,0.00042855198,0.0007510428,0.00017694241,0.000056827186,0.00008633999,0.002168303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967094,0.00013991992,0.00084081833,0.0005407127,0.0008284236,0.0009407123],"domain_scores_gemma":[0.998281,0.0000162769,0.0001985104,0.000458335,0.00034741763,0.00069844257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050662906,0.0003843454,0.0005657584,0.0005359489,0.0005393809,0.00031870542,0.00035906816,0.00013195965,0.00076373265],"category_scores_gemma":[0.00018653276,0.00035248182,0.00034771117,0.0004273474,0.00027683467,0.00078021357,0.00012276278,0.0013162475,0.000088894965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009503273,0.001328276,0.005207443,0.000021985563,0.000046508918,0.00009967197,0.0031386341,0.0041595134,0.97454935,0.000050232316,0.0043075965,0.006140484],"study_design_scores_gemma":[0.03837656,0.002727149,0.24557807,0.0017282137,0.00011067722,0.00223662,0.009736246,0.03409596,0.6458937,0.00027726925,0.017697524,0.0015420411],"about_ca_topic_score_codex":0.0017877812,"about_ca_topic_score_gemma":0.0008351574,"teacher_disagreement_score":0.32865566,"about_ca_system_score_codex":0.001843407,"about_ca_system_score_gemma":0.001115631,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W2144048982","doi":"10.1177/135245850100700104","title":"Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Nitrite; Nitrate; Disease; Central nervous system disease; Correlation; Internal medicine; Immunology; Chemistry","score_opus":0.04006739764467384,"score_gpt":0.22659343025380438,"score_spread":0.18652603260913053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144048982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682915,0.00018167552,0.0015344264,0.0001888344,0.00015704599,0.00089050195,0.000047388334,0.00006295025,0.00010803256],"genre_scores_gemma":[0.9976497,0.00020399479,0.0014149391,0.00024369231,0.00024117516,0.000039596296,0.000024350036,0.00007218275,0.00011033407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975372,0.00019019007,0.00043811122,0.00047355492,0.000727481,0.00063344825],"domain_scores_gemma":[0.9980176,0.0002533142,0.0002913323,0.00031581175,0.00040013748,0.000721816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042090536,0.00041016904,0.0005448412,0.00035086923,0.00035387155,0.00014593457,0.00011553059,0.00012849177,0.00010000242],"category_scores_gemma":[0.00040029097,0.00029917757,0.000103691586,0.0005286259,0.00015086702,0.00070650177,0.00004289655,0.00072928215,0.000039941126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017209258,0.0008784641,0.9590722,0.000064929445,0.00009286495,0.000063016654,0.00012426323,0.0003326971,0.015571778,6.073639e-7,0.0000832009,0.0065067364],"study_design_scores_gemma":[0.036738746,0.0014510019,0.9519624,0.0015793592,0.000153406,0.000052869644,0.000041222225,0.006731141,0.00084981427,0.000005889296,0.000062054074,0.00037211127],"about_ca_topic_score_codex":0.00010264975,"about_ca_topic_score_gemma":0.000068328365,"teacher_disagreement_score":0.01952949,"about_ca_system_score_codex":0.00020572635,"about_ca_system_score_gemma":0.00017251425,"threshold_uncertainty_score":0.99994606},"labels":[],"label_agreement":null},{"id":"W2144515779","doi":"10.1177/1352458512452920","title":"Reproductive decision making after the diagnosis of multiple sclerosis (MS)","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Clinical decision making; Psychology; Physical medicine and rehabilitation; Intensive care medicine; Psychiatry","score_opus":0.14376768140360913,"score_gpt":0.3340458934095041,"score_spread":0.19027821200589495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144515779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630726,0.007781997,0.0011337415,0.0017796605,0.0011955709,0.001300977,0.000092213064,0.00008577604,0.0003228306],"genre_scores_gemma":[0.9776993,0.0072462596,0.011628448,0.00042259286,0.002344345,0.00046530753,0.0000059145555,0.00012275534,0.0000650902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935246,0.0005252952,0.0014645723,0.000727426,0.0021685099,0.0015896119],"domain_scores_gemma":[0.9929248,0.0031149029,0.00073456543,0.0014326127,0.0011289066,0.0006642006],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036594695,0.0006105017,0.0010774117,0.000543089,0.00096466887,0.00017517392,0.0006669593,0.00024690063,0.0009527756],"category_scores_gemma":[0.011941073,0.00039896774,0.00085784635,0.0010187363,0.0007436452,0.00088076945,0.00070477254,0.0014012773,0.00013847376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024379801,0.0009894975,0.85130316,0.00007938793,0.00048109892,0.000007896956,0.0028091706,0.00007165106,0.021728847,0.0000042539323,0.007384962,0.11270208],"study_design_scores_gemma":[0.003972453,0.00028519044,0.96656126,0.0023261101,0.00026426712,0.00014442125,0.0011462928,0.00044948285,0.020590419,0.00003053644,0.003832652,0.0003968955],"about_ca_topic_score_codex":0.0001330998,"about_ca_topic_score_gemma":0.00009806331,"teacher_disagreement_score":0.115258105,"about_ca_system_score_codex":0.0004654911,"about_ca_system_score_gemma":0.00013206888,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W2144563695","doi":"10.1177/1352458510379615","title":"Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Neuropsychology; Multiple sclerosis; Depression (economics); Receiver operating characteristic; Psychometrics; Psychology; Neuropsychological test; Clinical psychology; Medicine; Neuropsychological assessment; Cognition; Psychiatry; Internal medicine","score_opus":0.12870536134629856,"score_gpt":0.3222738879534721,"score_spread":0.19356852660717355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144563695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964293,0.000074635565,0.0002332312,0.00095238036,0.0013954752,0.00059376884,0.00007220108,0.000059026966,0.0001899463],"genre_scores_gemma":[0.9958046,0.0003257874,0.0031061645,0.00016602145,0.000449346,0.000019947955,0.000009437712,0.000050184703,0.00006851622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9957785,0.00065049116,0.001054373,0.000511294,0.0014018388,0.0006034898],"domain_scores_gemma":[0.99628526,0.0005086736,0.0006830941,0.001003838,0.0010019769,0.0005171607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016924995,0.0003669487,0.0007528871,0.00026366572,0.00040247422,0.000067747555,0.00088477007,0.00028354538,0.00039552065],"category_scores_gemma":[0.0067145173,0.00023713954,0.0006185875,0.00054370146,0.0010169056,0.00035024373,0.00046214447,0.0018617254,0.00002366835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006990332,0.0008712058,0.44788817,0.000052739608,0.00006448468,0.0000039799884,0.00030166304,0.000026490101,0.5358337,0.000004726888,0.0012465132,0.013007266],"study_design_scores_gemma":[0.0044122315,0.00075970695,0.8550021,0.0006724014,0.00008243827,0.00009263652,0.00014442249,0.0029951169,0.13519524,0.000019384375,0.0004450954,0.00017921465],"about_ca_topic_score_codex":0.00025671787,"about_ca_topic_score_gemma":0.0003062364,"teacher_disagreement_score":0.40711394,"about_ca_system_score_codex":0.00009533937,"about_ca_system_score_gemma":0.00014048418,"threshold_uncertainty_score":0.967027},"labels":[],"label_agreement":null},{"id":"W2145552726","doi":"10.1191/1352458505ms1211oa","title":"Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Brock University; PharmIdeas (Canada)","funders":"Bayer Canada; IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Medicine; Multiple sclerosis; Cost effectiveness; Cost–utility analysis; Quality-adjusted life year; Cost–benefit analysis; Marginal cost; Psychiatry","score_opus":0.13125389230491277,"score_gpt":0.340622009433365,"score_spread":0.20936811712845224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145552726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970605,0.0005267894,0.00012721737,0.0006844838,0.00033692282,0.00082665577,0.000013297042,0.000022598997,0.00040155987],"genre_scores_gemma":[0.99628925,0.00013031276,0.0029758723,0.000059966034,0.00041014492,0.0000487855,0.000015710544,0.000045176293,0.000024806019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587667,0.00040324245,0.0012767151,0.00037826246,0.0014486795,0.0006164267],"domain_scores_gemma":[0.99816185,0.00028672483,0.00048059286,0.00029872693,0.00052228605,0.0002498275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035990472,0.00027446664,0.000664524,0.0005366363,0.00021054043,0.00006549201,0.0002243763,0.00011709333,0.0002574531],"category_scores_gemma":[0.0017251204,0.0002511005,0.0004226687,0.00020739743,0.00007520204,0.0004650983,0.00016186594,0.00055715034,0.000049937928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046820383,0.0011069338,0.71432,0.000042643063,0.00027243482,0.0000015391672,0.0013113543,0.0065797726,0.054763507,0.000001234459,0.00040650743,0.22072583],"study_design_scores_gemma":[0.014695889,0.0007767658,0.9175019,0.0011354086,0.00016793,0.0000046770533,0.00036562938,0.049955126,0.015055358,0.000008591621,0.00011690865,0.00021580947],"about_ca_topic_score_codex":0.00007727917,"about_ca_topic_score_gemma":0.00046047303,"teacher_disagreement_score":0.22051002,"about_ca_system_score_codex":0.0022886943,"about_ca_system_score_gemma":0.00021951397,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2145849448","doi":"10.1191/135248505ms1277oa","title":"The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society; Ministère de la Santé et des Services sociaux","keywords":"Neurofilament; Multiple sclerosis; Medicine; Biomarker; Expanded Disability Status Scale; Pathology; Internal medicine; Oncology; Immunology; Biology; Immunohistochemistry","score_opus":0.07247690757229011,"score_gpt":0.2702592895792274,"score_spread":0.1977823820069373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145849448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525804,0.0018524664,0.0015623164,0.0069679953,0.0012079839,0.0015557752,0.00036391066,0.00030074205,0.00093075196],"genre_scores_gemma":[0.98840415,0.0020107506,0.0056382427,0.00046546987,0.002356993,0.00009440423,0.000062907384,0.00013073413,0.0008363487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916849,0.0004190108,0.0015028864,0.0010883351,0.0030313528,0.002273528],"domain_scores_gemma":[0.9944103,0.0014102603,0.0007300834,0.0010166623,0.0010566013,0.0013761108],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001559256,0.0010120327,0.0011622693,0.0002696122,0.00324945,0.00096739933,0.0009887876,0.00039497565,0.00025291624],"category_scores_gemma":[0.0021662167,0.0006577571,0.00080146844,0.0012047794,0.0014203677,0.0006554957,0.0005061169,0.0016853098,0.00018492922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072800955,0.0007279773,0.78978413,0.000064940876,0.0012871996,0.000107866195,0.00015565283,0.00042557577,0.0774733,0.000041226343,0.06877421,0.053877823],"study_design_scores_gemma":[0.016825523,0.0006877511,0.9563611,0.0010152347,0.00030751148,0.0005623997,0.0005465772,0.004424382,0.011831602,0.00007441365,0.006573579,0.0007899064],"about_ca_topic_score_codex":0.0030858472,"about_ca_topic_score_gemma":0.0047881156,"teacher_disagreement_score":0.16657698,"about_ca_system_score_codex":0.001233481,"about_ca_system_score_gemma":0.0010597747,"threshold_uncertainty_score":0.99958736},"labels":[],"label_agreement":null},{"id":"W2146662840","doi":"10.1177/1352458506070775","title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Observational study; Epidemiology; Medicine; Strengthening the reporting of observational studies in epidemiology; Cohort; Disease registry; Cohort study; Data sharing; Population; Family medicine; MEDLINE; Disease; Alternative medicine; Pathology; Environmental health; Political science","score_opus":0.3314225773228368,"score_gpt":0.41647747663601564,"score_spread":0.08505489931317883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146662840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064285,0.0008746436,0.00023374046,0.0046797763,0.00042935004,0.0018501999,0.0008058853,0.00008291811,0.00040061114],"genre_scores_gemma":[0.9743502,0.0037883006,0.01952949,0.00021529735,0.0010447544,0.0003098537,0.0002773598,0.000101142505,0.00038359707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944836,0.00031232042,0.0012350794,0.00089251465,0.00176083,0.0013156476],"domain_scores_gemma":[0.99417627,0.0021487453,0.00035437723,0.00065699447,0.0020562434,0.0006073937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002988477,0.00049816485,0.0009543844,0.0012732656,0.001051393,0.0005072883,0.00059086626,0.00029859605,0.0000776996],"category_scores_gemma":[0.0042406833,0.00041938247,0.0002501344,0.0010018983,0.00071938435,0.0010977857,0.0003449132,0.0014694891,0.000011996721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019537231,0.002048625,0.8877503,0.00011632111,0.0002391004,0.00004148308,0.0007379416,0.00017125285,0.07479333,0.000067977744,0.0048683635,0.027211571],"study_design_scores_gemma":[0.016841156,0.0006865125,0.96046317,0.0008884414,0.000038994687,0.000048926486,0.0040348205,0.00918043,0.0026404895,0.00014977234,0.0046245595,0.0004027023],"about_ca_topic_score_codex":0.0012657145,"about_ca_topic_score_gemma":0.0057917866,"teacher_disagreement_score":0.07271288,"about_ca_system_score_codex":0.00083419046,"about_ca_system_score_gemma":0.00037509008,"threshold_uncertainty_score":0.9998258},"labels":[],"label_agreement":null},{"id":"W2146793337","doi":"10.1177/1352458508092263","title":"Comorbidity, socioeconomic status and multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Comorbidity; Medicine; Socioeconomic status; Odds ratio; Odds; Population; Multiple sclerosis; Internal medicine; Psychiatry; Logistic regression; Environmental health","score_opus":0.17024175857842802,"score_gpt":0.30374353929628856,"score_spread":0.13350178071786054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146793337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930681,0.0026525194,0.00016742254,0.0018759553,0.0005310249,0.0007950727,0.000107927444,0.00018822831,0.00061376987],"genre_scores_gemma":[0.94959897,0.04393969,0.0044210306,0.00063483027,0.0008863016,0.00004514457,0.000028953662,0.00011998127,0.00032510018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512,0.0002822761,0.0010806434,0.0008042757,0.0010597225,0.0016531075],"domain_scores_gemma":[0.9959862,0.0008757946,0.0004045067,0.00064254407,0.00053101365,0.0015599334],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000937514,0.0006254604,0.0011527409,0.0005397166,0.0020378917,0.0002267183,0.000351123,0.0002745886,0.0006670074],"category_scores_gemma":[0.0016808411,0.0005558009,0.00049147895,0.00029673384,0.001133814,0.0006216688,0.0005105415,0.0014616211,0.00034390684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004938858,0.0004712081,0.88620687,0.00007246022,0.00041215649,0.000057444806,0.0014001466,0.000048568625,0.07893522,0.0000056844983,0.013841306,0.018055052],"study_design_scores_gemma":[0.011725722,0.00044985805,0.97219086,0.00032664931,0.00009991061,0.0005894481,0.0006620895,0.0028018989,0.0050037676,0.000023621764,0.005586017,0.0005401514],"about_ca_topic_score_codex":0.00053174817,"about_ca_topic_score_gemma":0.00020393876,"teacher_disagreement_score":0.085984,"about_ca_system_score_codex":0.00064765307,"about_ca_system_score_gemma":0.00036898055,"threshold_uncertainty_score":0.99968934},"labels":[],"label_agreement":null},{"id":"W2147284521","doi":"10.1177/1352458508090662","title":"Timing of birth and disease progression in multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Season of birth; Expanded Disability Status Scale; Medicine; Disease; Cohort; Pediatrics; Demography; Cohort study; Proportional hazards model; Live birth; Survival analysis; Natural history study; Pregnancy; Internal medicine; Biology; Immunology; Psychiatry","score_opus":0.19586384228039783,"score_gpt":0.3246930564400865,"score_spread":0.12882921415968868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147284521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942178,0.0032394328,0.00018451775,0.0011023489,0.00016157086,0.0008391927,0.000049741437,0.00006271614,0.00014264612],"genre_scores_gemma":[0.9797117,0.012359577,0.007304914,0.00013463834,0.00024576057,0.00007448477,0.000010683959,0.00006881694,0.000089402856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960131,0.00024750305,0.0010445842,0.0005645819,0.0012561544,0.00087405625],"domain_scores_gemma":[0.996943,0.0005570907,0.00038536743,0.00046064515,0.00043104158,0.0012228322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089557015,0.00041089504,0.00088206487,0.0007603828,0.000651383,0.000058083948,0.00025461044,0.00014367285,0.00013837189],"category_scores_gemma":[0.004652401,0.00033319785,0.0002845796,0.0006597661,0.00073100784,0.00041857647,0.00032566534,0.0008492977,0.000015247001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013035212,0.0007224698,0.84638494,0.00021300526,0.000089124376,0.00010032182,0.0010834506,0.000058486236,0.11287208,0.0000021004334,0.0010766949,0.036093827],"study_design_scores_gemma":[0.009502539,0.0003249703,0.9711577,0.002639283,0.00004669834,0.000115937146,0.00035381594,0.009261957,0.005944362,0.000014032283,0.00033947415,0.00029922996],"about_ca_topic_score_codex":0.00013948478,"about_ca_topic_score_gemma":0.00008057735,"teacher_disagreement_score":0.12477279,"about_ca_system_score_codex":0.00021539805,"about_ca_system_score_gemma":0.00032195167,"threshold_uncertainty_score":0.999912},"labels":[],"label_agreement":null},{"id":"W2147300306","doi":"10.1177/1352458512469694","title":"“Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Diplopia; Medicine; Quality of life (healthcare); Population; Visual impairment; Optic neuritis; Optometry; Visual acuity; Multiple sclerosis; Ophthalmology; Psychiatry","score_opus":0.1650824893381386,"score_gpt":0.36253505757058274,"score_spread":0.19745256823244414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147300306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941004,0.005820636,0.000023689827,0.0028171882,0.00026411124,0.0007353978,0.000021953854,0.00002716872,0.0008798199],"genre_scores_gemma":[0.99645406,0.001953294,0.0006266982,0.000432765,0.00028001776,0.000055987017,0.00001166696,0.000043271404,0.00014223534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936025,0.0013245243,0.0019001133,0.00036292215,0.00167112,0.0011387888],"domain_scores_gemma":[0.99629414,0.0014462647,0.0006703369,0.0007901856,0.00026843816,0.0005306197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074563464,0.0003566827,0.0010391133,0.00051659474,0.00033753505,0.000058276262,0.00059959135,0.0002439406,0.0003652783],"category_scores_gemma":[0.0076063653,0.00024051369,0.00039429896,0.00094199885,0.00056659826,0.0004056091,0.0003761011,0.0016675079,0.00006219647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088073633,0.0013528501,0.9313977,0.00014608559,0.00009695377,0.0000148367435,0.0066549834,0.00006721215,0.05156551,0.000020752446,0.0029906395,0.004811789],"study_design_scores_gemma":[0.008543271,0.00019457868,0.9838515,0.000987001,0.00002383087,0.000072163406,0.0036410107,0.0005878826,0.00067256374,0.000022073627,0.0011731375,0.00023096873],"about_ca_topic_score_codex":0.000798857,"about_ca_topic_score_gemma":0.00080312026,"teacher_disagreement_score":0.052453868,"about_ca_system_score_codex":0.0005824172,"about_ca_system_score_gemma":0.00018343708,"threshold_uncertainty_score":0.9807864},"labels":[],"label_agreement":null},{"id":"W2148230714","doi":"10.1191/1352458504ms1061oa","title":"Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed?","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health; National Cancer Institute; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging","keywords":"Multiple sclerosis; Atrophy; Magnetic resonance imaging; Medicine; Lesion; Brain size; Central nervous system disease; Brain tissue; Nuclear medicine; Radiology; Pathology; Internal medicine; Psychiatry","score_opus":0.2671658653315179,"score_gpt":0.324011680754471,"score_spread":0.05684581542295308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148230714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97099644,0.001486817,0.00177829,0.021701315,0.0010842215,0.0021014058,0.00019545709,0.0004004869,0.0002555841],"genre_scores_gemma":[0.97638714,0.0041356827,0.014745566,0.0016889578,0.0020881128,0.00021066541,0.000071185816,0.0002625445,0.00041011363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99133193,0.0004340805,0.0017272696,0.0012733864,0.0029369544,0.0022964033],"domain_scores_gemma":[0.9940663,0.00096314406,0.00077573897,0.001182601,0.0012334625,0.001778783],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013138482,0.0010935004,0.0015618182,0.0010432404,0.0024789823,0.00080674345,0.00087378535,0.0005072245,0.0009848743],"category_scores_gemma":[0.0075309956,0.0008290366,0.0010159579,0.0012604858,0.0007491452,0.0009496423,0.0007500023,0.0020938222,0.000545357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055396035,0.001776181,0.018161047,0.00024462325,0.0009949361,0.00035988237,0.011856442,0.0013847501,0.7705547,0.000007346769,0.019891653,0.16922879],"study_design_scores_gemma":[0.0647122,0.0076412833,0.79234254,0.007008916,0.0005409742,0.0010979412,0.00983447,0.0027097587,0.07282654,0.00009959161,0.038579576,0.002606223],"about_ca_topic_score_codex":0.0007604721,"about_ca_topic_score_gemma":0.00063584046,"teacher_disagreement_score":0.7741815,"about_ca_system_score_codex":0.0014719464,"about_ca_system_score_gemma":0.00086611486,"threshold_uncertainty_score":0.99992836},"labels":[],"label_agreement":null},{"id":"W2148405577","doi":"10.1177/1352458513513968","title":"Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Multiple sclerosis; Medicine; Environmental health; Immunology","score_opus":0.07731133212571668,"score_gpt":0.2796404342942833,"score_spread":0.20232910216856664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148405577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942541,0.0017815984,0.00012855622,0.0016664393,0.00024969067,0.0016169237,0.000040036746,0.000057230893,0.0002053835],"genre_scores_gemma":[0.9904259,0.0074670976,0.0009773403,0.00026193043,0.0005500317,0.00010679803,0.000004606118,0.00008778322,0.000118520926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99464273,0.0011469659,0.0010511974,0.0008443358,0.0012273355,0.0010874498],"domain_scores_gemma":[0.9954736,0.0023252203,0.00040217815,0.0007833067,0.000318061,0.00069760147],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0041923607,0.00059159246,0.0010201216,0.00049000006,0.0013998245,0.0004389219,0.00041196778,0.00019851742,0.00010279964],"category_scores_gemma":[0.005906054,0.00039185895,0.00022203675,0.00057191506,0.00065742433,0.00041305405,0.0005790527,0.001821496,0.00004048246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042874098,0.0007570745,0.89689493,0.00004418604,0.00026048927,0.000012895658,0.005248603,0.00007621304,0.02550729,0.0000029273106,0.00055026973,0.0702164],"study_design_scores_gemma":[0.013451252,0.0012920278,0.96999836,0.0004222084,0.00017289347,0.00007599344,0.006247948,0.0063328976,0.00083816523,0.000025609343,0.00074931694,0.00039335125],"about_ca_topic_score_codex":0.000758672,"about_ca_topic_score_gemma":0.0022708566,"teacher_disagreement_score":0.07310343,"about_ca_system_score_codex":0.00018305171,"about_ca_system_score_gemma":0.00007081045,"threshold_uncertainty_score":0.9999002},"labels":[],"label_agreement":null},{"id":"W2149681150","doi":"10.1177/1352458512462918","title":"The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Epidemiology; Latin Americans; Multiple sclerosis; Incidence (geometry); Etiology; Medicine; Demography; Pediatrics; Geography; Pathology; Psychiatry","score_opus":0.30018572237982794,"score_gpt":0.3783897468268543,"score_spread":0.07820402444702634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149681150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052404455,0.98906946,0.000043610053,0.0019166501,0.00036662197,0.008345966,0.000108213055,0.000033202574,0.00006388427],"genre_scores_gemma":[0.002497308,0.9936509,0.0008007493,0.0004829394,0.00043015036,0.0018510371,0.000029301675,0.00014095676,0.0001166153],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98152936,0.009213556,0.0056224857,0.0007419682,0.0012209318,0.0016717011],"domain_scores_gemma":[0.95889276,0.033879325,0.0042620325,0.0017295392,0.0006068472,0.000629492],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015187781,0.0011154208,0.011080538,0.00049536146,0.0009487832,0.000080531805,0.001227066,0.0004639467,0.000047842794],"category_scores_gemma":[0.05206931,0.00050223584,0.0022328997,0.0012858774,0.002366455,0.00017869202,0.0008282825,0.0031974125,0.00005360646],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021612775,0.00023522545,0.004293745,0.64483756,0.0020417315,0.000006823551,0.00056523597,0.0000020482453,0.000007542384,0.000032604145,0.0014641514,0.34629717],"study_design_scores_gemma":[0.005355709,0.00018003113,0.011653468,0.90451616,0.007401188,0.0003210575,0.00046925625,0.0003626531,0.0000012100015,0.000013439823,0.0691255,0.0006002998],"about_ca_topic_score_codex":0.00045133263,"about_ca_topic_score_gemma":0.00024977795,"teacher_disagreement_score":0.3456969,"about_ca_system_score_codex":0.00053003646,"about_ca_system_score_gemma":0.00040952984,"threshold_uncertainty_score":0.9997429},"labels":[],"label_agreement":null},{"id":"W2150009720","doi":"10.1177/1352458514524997","title":"Altered functional connectivity and performance variability in relapsing–remitting multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McGill University; Montreal Neurological Institute and Hospital; Dalhousie University","funders":"Dalhousie University; Multiple Sclerosis Society of Canada; Genome Canada","keywords":"Default mode network; Multiple sclerosis; Resting state fMRI; Cognition; Functional connectivity; Effects of sleep deprivation on cognitive performance; Neuroscience; Prefrontal cortex; Task (project management); Psychology; Audiology; Medicine; Psychiatry","score_opus":0.11109152187671933,"score_gpt":0.2726678026500689,"score_spread":0.16157628077334957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150009720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251807,0.00024920542,0.003943959,0.0010926962,0.00072010624,0.0007090315,0.00001998275,0.00011831184,0.00062864256],"genre_scores_gemma":[0.99138266,0.0014233801,0.0056773894,0.00029777773,0.00097405986,0.00008333055,0.0000148329655,0.0000728973,0.000073655996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99459195,0.0009999691,0.0011533723,0.000930517,0.0011522385,0.001171929],"domain_scores_gemma":[0.99438304,0.0033158115,0.00040445887,0.00061598653,0.0005768899,0.0007038252],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0071702255,0.000529435,0.0010126038,0.0005258413,0.0010584032,0.00023434298,0.00025165165,0.00027342903,0.00018938945],"category_scores_gemma":[0.01557943,0.00046940465,0.00027337158,0.00062729645,0.000500081,0.00070876896,0.00036597034,0.0017954558,0.00003613457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090882316,0.0004284428,0.8068421,0.00014492072,0.000101616475,0.0000021410297,0.00043124394,0.0002285796,0.09007502,0.000008955109,0.00044620375,0.10038199],"study_design_scores_gemma":[0.009592298,0.0003998754,0.8952694,0.0012127068,0.000053475596,0.0001130026,0.00019978243,0.089069024,0.0033264705,0.000046957128,0.0003209346,0.0003960869],"about_ca_topic_score_codex":0.00021411772,"about_ca_topic_score_gemma":0.00020245783,"teacher_disagreement_score":0.099985905,"about_ca_system_score_codex":0.0006090477,"about_ca_system_score_gemma":0.00017384742,"threshold_uncertainty_score":0.99977577},"labels":[],"label_agreement":null},{"id":"W2150321048","doi":"10.1177/1352458514555789","title":"How safe is natalizumab during pregnancy?","year":2014,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Natalizumab; Multiple sclerosis; Pregnancy; Medicine; Clinical neurology; Psychology; Psychiatry; Neuroscience; Biology","score_opus":0.028581727016462218,"score_gpt":0.2267848616105359,"score_spread":0.19820313459407368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150321048","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015957913,0.076133996,0.00018601409,0.00038134595,0.919858,0.0004869674,0.0005475931,0.00011135853,0.0006989835],"genre_scores_gemma":[0.16055775,0.0047732415,0.0001487418,0.000022792661,0.77306205,0.00009386414,0.0004624527,0.00022575863,0.060653377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562186,0.0008753787,0.0009130481,0.0011519113,0.00037342234,0.0010643884],"domain_scores_gemma":[0.99611646,0.00052528124,0.0012851205,0.0011740739,0.00078196696,0.00011711415],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005503895,0.00082676177,0.0012895886,0.0003591847,0.0011407215,0.00047878883,0.0011312598,0.00226005,0.00074372353],"category_scores_gemma":[0.0020149455,0.0007016373,0.0007291883,0.00018167742,0.00027248988,0.00043161315,0.00028963282,0.0031223584,0.00092288706],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012884925,0.000085165,0.0006835514,0.00036265585,0.0007537355,0.000029297405,0.00059906446,0.0000013994382,0.043292407,0.0000033814715,0.9483117,0.0057488135],"study_design_scores_gemma":[0.005102544,0.00020661813,0.002111122,0.0065171025,0.00018745913,0.00042095705,0.00010812247,3.7897385e-7,0.029422706,0.00004360553,0.9550067,0.00087268435],"about_ca_topic_score_codex":0.000050254206,"about_ca_topic_score_gemma":0.000020686015,"teacher_disagreement_score":0.15896195,"about_ca_system_score_codex":0.0002912116,"about_ca_system_score_gemma":0.0002714764,"threshold_uncertainty_score":0.999855},"labels":[],"label_agreement":null},{"id":"W2152511465","doi":"10.1177/1352458510362442","title":"Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing—remitting multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Medicine; Relapsing remitting; Interferon beta-1a; Post-hoc analysis; Placebo; Internal medicine; Pathology; Interferon beta; Immunology","score_opus":0.12906964744477878,"score_gpt":0.295110106199752,"score_spread":0.1660404587549732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152511465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547005,0.0013672268,0.00034144087,0.00073376676,0.00071763556,0.0009484153,0.0000569436,0.000063237014,0.00030129572],"genre_scores_gemma":[0.98118186,0.0025856525,0.015374663,0.000067856105,0.0005448419,0.00002393966,0.000025515,0.000106140695,0.00008950509],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9943261,0.00020541411,0.002283272,0.0006347609,0.0014917493,0.0010586674],"domain_scores_gemma":[0.9952031,0.0012041569,0.0012008704,0.000773169,0.00097347214,0.0006452417],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019836214,0.0005495107,0.0014352329,0.001138831,0.00030662803,0.0000888013,0.0005524419,0.00053951715,0.00036106643],"category_scores_gemma":[0.004251705,0.00049160124,0.0006203132,0.00097548263,0.00029597894,0.00055726094,0.00034045684,0.0025664584,0.000016919497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002309557,0.0005070256,0.26376268,0.00015260975,0.0001807399,0.000007424397,0.0021141325,0.00040819467,0.5817355,0.0000145818185,0.00046567555,0.14834188],"study_design_scores_gemma":[0.011632654,0.0017220466,0.8453388,0.003397666,0.00014203928,0.00019909673,0.00069756934,0.007675929,0.12849467,0.000030295007,0.00023843875,0.00043076658],"about_ca_topic_score_codex":0.000992352,"about_ca_topic_score_gemma":0.001938618,"teacher_disagreement_score":0.58157617,"about_ca_system_score_codex":0.0002795089,"about_ca_system_score_gemma":0.00032983595,"threshold_uncertainty_score":0.99975353},"labels":[],"label_agreement":null},{"id":"W2153132118","doi":"10.1177/1352458513490550","title":"Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Atrophy; Medicine; Gold standard (test); Neuroscience; Pathology; Psychology; Internal medicine; Psychiatry","score_opus":0.10980257750327606,"score_gpt":0.30291278108840825,"score_spread":0.1931102035851322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153132118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52224785,0.003224476,0.000023776847,0.46722418,0.0004638657,0.0058288085,0.00088050094,0.0000382657,0.000068273184],"genre_scores_gemma":[0.87464535,0.011796991,0.0008355435,0.10753919,0.002840411,0.0016937352,0.000117929456,0.00027658025,0.00025424277],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9923266,0.0014875263,0.0019165705,0.00081634434,0.002081345,0.0013715943],"domain_scores_gemma":[0.99019164,0.006013195,0.0013744145,0.0014436005,0.00076639245,0.00021074052],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020651664,0.0010765443,0.0022549129,0.00064141763,0.00060355215,0.00020093298,0.0011247963,0.0006998089,0.00044048406],"category_scores_gemma":[0.0012901278,0.00058541395,0.001837386,0.00075143075,0.0012952155,0.00030354675,0.00050388696,0.0039648367,0.000016104728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039995005,0.0006728953,0.23186459,0.00045959526,0.003359051,0.000044279528,0.0042089084,0.0001257448,0.008266941,3.8914183e-7,0.71315795,0.033840153],"study_design_scores_gemma":[0.027858922,0.006186724,0.699186,0.006552539,0.00067299436,0.000049936447,0.0015886471,0.00079965335,0.008988382,0.000021256516,0.24715932,0.00093558506],"about_ca_topic_score_codex":0.0027110407,"about_ca_topic_score_gemma":0.0011263804,"teacher_disagreement_score":0.46732146,"about_ca_system_score_codex":0.0013641911,"about_ca_system_score_gemma":0.00023571745,"threshold_uncertainty_score":0.9996597},"labels":[],"label_agreement":null},{"id":"W2153143281","doi":"10.1177/1352458509103173","title":"Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; Interferon beta-1a; Magnetic resonance imaging; Internal medicine; Relapsing remitting; Central nervous system disease; McDonald criteria; Population; Interferon beta; Radiology; Immunology","score_opus":0.04562587334698104,"score_gpt":0.30925535537916465,"score_spread":0.2636294820321836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153143281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964144,0.00007352445,0.0021618304,0.0003677518,0.00008340366,0.0007615009,0.00007029385,0.00002819464,0.000039089242],"genre_scores_gemma":[0.9947307,0.000253574,0.004689162,0.00015339472,0.00005343603,0.0000060624725,0.0000671209,0.000038440932,0.000008122072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948819,0.0005423212,0.0019389034,0.00055077195,0.0014352938,0.0006507659],"domain_scores_gemma":[0.9960895,0.00087780366,0.0010023828,0.0007639115,0.0007399333,0.00052647595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015342683,0.00042352115,0.0018242295,0.0017556637,0.00012431727,0.000054825745,0.00040994052,0.00020736987,0.0003357191],"category_scores_gemma":[0.0019437338,0.00031162368,0.0007382192,0.002220456,0.0002224742,0.0001833711,0.000070157206,0.0011158781,0.0000056318754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029964857,0.003890433,0.92635626,0.000044460423,0.002192828,0.000019107789,0.00046358388,0.0049485094,0.0037660673,7.5000565e-7,0.00017956585,0.0281736],"study_design_scores_gemma":[0.022907684,0.017481254,0.9314049,0.0012643381,0.0013747303,0.0000018439355,0.000053451113,0.024844442,0.00041181175,0.0000029366697,0.000007856732,0.00024475227],"about_ca_topic_score_codex":0.00020075566,"about_ca_topic_score_gemma":0.000077892975,"teacher_disagreement_score":0.027928848,"about_ca_system_score_codex":0.00024062136,"about_ca_system_score_gemma":0.00018727101,"threshold_uncertainty_score":0.9999336},"labels":[],"label_agreement":null},{"id":"W2153591084","doi":"10.1177/1352458513488841","title":"Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"IC Design Education Center; Biogen; Abbott Laboratories","keywords":"Stroop effect; Cognition; Multiple sclerosis; Neuropsychology; Audiology; Cognitive test; Physical medicine and rehabilitation; Trail Making Test; Neuropsychological assessment; Paced Auditory Serial Addition Test; Physical therapy; Test (biology); Psychology; Medicine; Psychiatry","score_opus":0.20235209661219367,"score_gpt":0.3236635123413567,"score_spread":0.12131141572916304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153591084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94605005,0.00008366576,0.049480207,0.00070076215,0.00027375392,0.0031704216,0.0001442252,0.00006458971,0.00003232397],"genre_scores_gemma":[0.9468945,0.00019604749,0.051549375,0.00027620676,0.00048669844,0.00038995824,0.00010004408,0.00008967527,0.000017445833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953957,0.00045183612,0.0010780203,0.0005808825,0.0014779497,0.0010155848],"domain_scores_gemma":[0.99252975,0.0022788057,0.00081338576,0.00043840092,0.0034286627,0.00051102135],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011910434,0.00052360154,0.0009263362,0.0003131298,0.0013722565,0.00058304676,0.00039516776,0.00015456002,0.00012879832],"category_scores_gemma":[0.0021349324,0.00032206805,0.0004159226,0.0005919446,0.0005551721,0.0009233801,0.00028585608,0.00077986345,0.000014242632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051162834,0.0010213479,0.8535041,0.00010836788,0.0007370321,0.0000012679031,0.00055007223,0.0002537062,0.021113778,8.720826e-7,0.0013626127,0.120835215],"study_design_scores_gemma":[0.017413996,0.0014535733,0.92446494,0.002125296,0.0002351415,0.000010694052,0.0010188789,0.0438776,0.008976129,0.000004784569,0.00007991235,0.0003390316],"about_ca_topic_score_codex":0.0002898943,"about_ca_topic_score_gemma":0.000054195327,"teacher_disagreement_score":0.12049618,"about_ca_system_score_codex":0.00022197835,"about_ca_system_score_gemma":0.00019917764,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W2154048571","doi":"10.1191/1352458505ms1210oa","title":"A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Biogen","keywords":"Multiple sclerosis; Medicine; Interferon beta; Cyclophosphamide; Randomized controlled trial; Interferon beta-1b; Internal medicine; Interferon beta-1a; BETA (programming language); Oncology; Physical therapy; Chemotherapy; Immunology","score_opus":0.08615269954019235,"score_gpt":0.295605311949173,"score_spread":0.20945261240898067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154048571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930794,0.00011046116,0.00018637876,0.0009798434,0.00018546994,0.0051045986,0.000045818157,0.00005833077,0.00024965144],"genre_scores_gemma":[0.995851,0.0011961826,0.0019190771,0.00020746184,0.00024300456,0.000383125,0.00004325875,0.000107502434,0.00004940503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993934,0.0010996328,0.0014210817,0.00061037677,0.0020767897,0.0008581143],"domain_scores_gemma":[0.9950313,0.0018492498,0.0009821516,0.0005977158,0.0011384351,0.0004011527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021344353,0.00064302376,0.0019375947,0.0009372453,0.00040141458,0.00011078347,0.00038309288,0.00021780808,0.000103292885],"category_scores_gemma":[0.0017020976,0.00041185945,0.00042774767,0.0007973486,0.00061237265,0.00057192467,0.000101914,0.0016025766,0.000015574342],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81494135,0.0072875996,0.10219913,0.000034543016,0.00077555486,0.000002906791,0.0018713382,0.00035832668,0.003030718,0.000005827972,0.00008750911,0.0694052],"study_design_scores_gemma":[0.52546,0.0064936914,0.4524974,0.0011206523,0.00007065776,0.0000019924057,0.00021699267,0.00051193,0.013353495,0.0000038544595,0.0000313245,0.00023802226],"about_ca_topic_score_codex":0.00025493582,"about_ca_topic_score_gemma":0.00041077723,"teacher_disagreement_score":0.35029826,"about_ca_system_score_codex":0.0007145471,"about_ca_system_score_gemma":0.00024281276,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W2154410602","doi":"10.1177/1352458511410343","title":"The psychosocial and cognitive impact of longstanding ‘benign’ multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psychosocial; Depression (economics); Quality of life (healthcare); Cohort; Multiple sclerosis; Beck Depression Inventory; Physical therapy; Expanded Disability Status Scale; Cohort study; Internal medicine; Pediatrics; Psychiatry; Anxiety","score_opus":0.2073903280951165,"score_gpt":0.34303958012011765,"score_spread":0.13564925202500114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154410602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942671,0.0023847613,0.0005846827,0.00025277102,0.0003429675,0.0009044219,0.00012619194,0.000059671176,0.0010774125],"genre_scores_gemma":[0.99005127,0.0077175237,0.0015016661,0.000056319885,0.00045780875,0.00005995346,0.000007016598,0.000079675614,0.0000687723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958777,0.00035139907,0.0010260657,0.00051456766,0.0011173604,0.0011129006],"domain_scores_gemma":[0.995559,0.0016206721,0.0006126801,0.00040833149,0.0010600651,0.0007392633],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001693023,0.0004925258,0.0008621607,0.00034435108,0.0016259104,0.00019541832,0.00036930188,0.00020614488,0.00027165125],"category_scores_gemma":[0.0042150887,0.00031619598,0.00073106185,0.00055553677,0.0011689403,0.00039409602,0.00027774458,0.0010405126,0.000021309648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035084037,0.00051445566,0.83041024,0.000053348944,0.0014819007,0.000014891238,0.0048569376,0.0000025518875,0.071289346,0.000014092354,0.0016634449,0.08619038],"study_design_scores_gemma":[0.008967705,0.0011567506,0.9778412,0.0010627018,0.00024487916,0.000094573435,0.0027866217,0.00071714894,0.006673241,0.000064478554,0.00007611299,0.0003146006],"about_ca_topic_score_codex":0.0006773468,"about_ca_topic_score_gemma":0.0003023973,"teacher_disagreement_score":0.14743094,"about_ca_system_score_codex":0.00029542137,"about_ca_system_score_gemma":0.0002463727,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W2154470507","doi":"10.1177/1352458507082942","title":"Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Canada","keywords":"Glatiramer acetate; Multiple sclerosis; Medicine; Depressant; Interferon beta; Pharmacology; Interferon; Immunology","score_opus":0.14164316037404107,"score_gpt":0.30514039776956586,"score_spread":0.1634972373955248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154470507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967672,0.0006266887,0.0003359385,0.00073046953,0.0001648577,0.0011875012,0.000034610286,0.000059255413,0.00009346404],"genre_scores_gemma":[0.9900117,0.0053697857,0.0039432826,0.00015427546,0.00019120975,0.000072523755,0.000016746972,0.00008324407,0.0001572179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954338,0.0003107282,0.001119805,0.0007027158,0.0010791922,0.0013537563],"domain_scores_gemma":[0.99671835,0.0015333402,0.00045443865,0.0003994819,0.000353907,0.00054045557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021115958,0.0005446666,0.0010979765,0.0010159379,0.00031848572,0.00029970813,0.00017684868,0.0002553197,0.000053263615],"category_scores_gemma":[0.0019395915,0.00040908842,0.00018352256,0.00075860176,0.00021452301,0.0007754276,0.00016024115,0.0010482547,0.000018384482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002002654,0.00083362835,0.8696083,0.000035680736,0.0002502296,0.000101561156,0.0018141647,0.00021954087,0.09489791,9.059368e-7,0.00013172411,0.030103741],"study_design_scores_gemma":[0.020552712,0.0010481059,0.95670795,0.0013761718,0.000082293955,0.000054818604,0.0009513106,0.0034916503,0.015020038,0.000002831543,0.00032938112,0.00038272122],"about_ca_topic_score_codex":0.0028301205,"about_ca_topic_score_gemma":0.016008358,"teacher_disagreement_score":0.08709971,"about_ca_system_score_codex":0.0021810965,"about_ca_system_score_gemma":0.00012431412,"threshold_uncertainty_score":0.9998361},"labels":[],"label_agreement":null},{"id":"W2154741407","doi":"10.1177/1352458512446038","title":"Reply: ‘Obstructive sleep apnea is associated with fatigue in multiple sclerosis’ by Kaminska et al.","year":2012,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Multiple sclerosis; Obstructive sleep apnea; Medicine; Physical medicine and rehabilitation; Sleep (system call); Sleep apnea; Cardiology; Physical therapy; Internal medicine; Psychiatry","score_opus":0.09591355103709585,"score_gpt":0.28802544359828797,"score_spread":0.1921118925611921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154741407","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4398084,0.0022141035,0.0012925033,0.5467771,0.0022012074,0.0040218164,0.0024902758,0.00035739838,0.0008371522],"genre_scores_gemma":[0.5758076,0.0003604938,0.0024060428,0.4167916,0.0017556113,0.00027338404,0.0014170159,0.0006405163,0.0005477903],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98773104,0.0014838637,0.0019502243,0.0017887253,0.0039857375,0.0030604245],"domain_scores_gemma":[0.99244314,0.0017953072,0.0017355388,0.0014925717,0.0015100244,0.0010234304],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002344277,0.0016282271,0.0025188783,0.0015296434,0.00067286455,0.0005136148,0.0010887774,0.001675407,0.0010077376],"category_scores_gemma":[0.0030669891,0.0013925085,0.000796128,0.0015358065,0.000867417,0.0010816606,0.00042032092,0.014033014,0.00016620391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079782977,0.0008475757,0.26205155,0.000117818614,0.001969036,0.0005647904,0.0014287103,0.000018477585,0.014290617,7.1401746e-7,0.7069077,0.011005153],"study_design_scores_gemma":[0.035453234,0.0014460972,0.6891216,0.004625956,0.0010117154,0.0010437475,0.0009924963,0.0035763988,0.011841383,0.000027191034,0.24771585,0.0031443136],"about_ca_topic_score_codex":0.0005612992,"about_ca_topic_score_gemma":0.00015655962,"teacher_disagreement_score":0.45919186,"about_ca_system_score_codex":0.0028151288,"about_ca_system_score_gemma":0.00030424687,"threshold_uncertainty_score":0.99990547},"labels":[],"label_agreement":null},{"id":"W2156451473","doi":"10.1177/1352458506074684","title":"Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Multiple sclerosis; Radiology; Clinically isolated syndrome; Presentation (obstetrics)","score_opus":0.04156355667155457,"score_gpt":0.29026158711203387,"score_spread":0.2486980304404793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156451473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961506,0.00033824678,0.001071449,0.0009955033,0.00007655179,0.00080682326,0.0002993717,0.00004848781,0.00021295469],"genre_scores_gemma":[0.9969725,0.00028131262,0.0019895963,0.0004935551,0.00004494592,0.000014650927,0.00008153248,0.000055296263,0.00006662258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591506,0.00016273496,0.0013555671,0.0005762975,0.0013001114,0.00069022697],"domain_scores_gemma":[0.9964623,0.00094812736,0.00062019506,0.00049078616,0.0009602015,0.00051840994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017344009,0.00033310585,0.00061063207,0.00043303007,0.00029513723,0.000071904615,0.00020311702,0.00013292395,0.000093364244],"category_scores_gemma":[0.0013847038,0.00025350775,0.00013450255,0.0005757751,0.00043215096,0.00018059713,0.00006258834,0.00071882794,0.00000899297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014073816,0.0010083243,0.88386667,0.000045975194,0.000059020003,0.000025441643,0.000283865,0.000006379595,0.03057612,4.2492343e-7,0.0021325029,0.06792146],"study_design_scores_gemma":[0.018551515,0.0073828623,0.9578246,0.0010227503,0.00007891353,0.000017575452,0.00011147873,0.013362107,0.00078601093,0.0000013974095,0.0006111762,0.00024961834],"about_ca_topic_score_codex":0.00003727939,"about_ca_topic_score_gemma":0.00001139271,"teacher_disagreement_score":0.07395792,"about_ca_system_score_codex":0.00017019927,"about_ca_system_score_gemma":0.00012775439,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W2157110530","doi":"10.1177/1352458511433918","title":"Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children; York University","funders":"Canadian Institutes of Health Research","keywords":"Psychosocial; Clinical psychology; Psychology; Population; Multiple sclerosis; Depression (economics); Somatization; Expanded Disability Status Scale; Medicine; Psychiatry; Anxiety","score_opus":0.21761513446351352,"score_gpt":0.3287303821970075,"score_spread":0.11111524773349399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157110530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978595,0.00040660714,0.00010428361,0.00035903094,0.0001944318,0.0008630601,0.00008721996,0.00009401368,0.000031847743],"genre_scores_gemma":[0.9984265,0.00023844338,0.00074545946,0.00013256117,0.0001882677,0.00006406458,0.00003575714,0.00011010287,0.000058847672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952175,0.00029030582,0.0007498311,0.0005296813,0.0016678203,0.0015448751],"domain_scores_gemma":[0.9973659,0.00032674774,0.0003815277,0.00036202773,0.00046429344,0.0010995192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008914765,0.00066405284,0.0010983979,0.00061791315,0.00062603806,0.00018828841,0.00023794346,0.0002309916,0.000085678344],"category_scores_gemma":[0.0011306652,0.00042499564,0.00021203178,0.00062290474,0.0004886311,0.00088195235,0.00019154261,0.0012926502,0.000010351653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005584066,0.0026327881,0.984384,0.00005118091,0.00029636998,0.000011761242,0.0012761238,0.000027854898,0.0083723795,9.744114e-7,0.00010075999,0.002287411],"study_design_scores_gemma":[0.01560773,0.00073739985,0.9768195,0.0034212158,0.00016451433,0.00003204348,0.0013372389,0.0002986977,0.0010673235,9.809714e-7,0.000019333742,0.00049401994],"about_ca_topic_score_codex":0.0002815061,"about_ca_topic_score_gemma":0.0015226777,"teacher_disagreement_score":0.015049323,"about_ca_system_score_codex":0.00064131303,"about_ca_system_score_gemma":0.00014647361,"threshold_uncertainty_score":0.9998202},"labels":[],"label_agreement":null},{"id":"W2157552088","doi":"10.1177/1352458510395981","title":"Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: A preliminary study","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Multiple Sclerosis Society of Canada; University of Calgary; Teva Pharmaceutical Industries; University of British Columbia; Multiple Sclerosis Society; Biogen","keywords":"Lesion; Multiple sclerosis; Texture (cosmology); Persistence (discontinuity); Medicine; Pathology; Artificial intelligence; Immunology; Computer science","score_opus":0.1465536430655179,"score_gpt":0.28699989364689027,"score_spread":0.14044625058137236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157552088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946053,0.0020352139,0.00017535518,0.00054625474,0.00017211524,0.00205399,0.00019952458,0.000104935156,0.00010732615],"genre_scores_gemma":[0.9935323,0.0044663176,0.001092839,0.00015168234,0.00014168209,0.0002252441,0.000055220473,0.00010342243,0.00023126243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935431,0.0006979772,0.0014609805,0.0012669311,0.0015743999,0.0014566114],"domain_scores_gemma":[0.9966533,0.00047425868,0.00044870086,0.0008893395,0.00046451236,0.0010698431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00127899,0.0008750846,0.0017881234,0.0016810037,0.00096581486,0.00022375653,0.00054450554,0.00029657924,0.0005003138],"category_scores_gemma":[0.00055223337,0.0006932286,0.0011756327,0.0014874473,0.001076316,0.0004146989,0.0006326471,0.0013731511,0.00004747064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044567683,0.0045982315,0.9364009,0.00010114951,0.007328329,0.00018421673,0.029383807,0.00018671191,0.012573408,4.1297946e-7,0.00091377145,0.0038722996],"study_design_scores_gemma":[0.014452613,0.0026957295,0.95104474,0.00066673575,0.0041698962,0.00010825761,0.013389697,0.011531468,0.0012688446,0.0000031874845,0.000039376908,0.0006294381],"about_ca_topic_score_codex":0.00041344023,"about_ca_topic_score_gemma":0.0023919984,"teacher_disagreement_score":0.01599411,"about_ca_system_score_codex":0.0006258157,"about_ca_system_score_gemma":0.00010449187,"threshold_uncertainty_score":0.9995519},"labels":[],"label_agreement":null},{"id":"W2157779324","doi":"10.1177/1352458509356367","title":"The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Bayer HealthCare; Sanofi","keywords":"California Verbal Learning Test; Fornix; Verbal learning; Fractional anisotropy; Diffusion MRI; Psychology; Verbal memory; Neuropsychology; Audiology; Memory impairment; White matter; Population; Medicine; Cognition; Neuroscience; Magnetic resonance imaging; Hippocampus","score_opus":0.05880083695575717,"score_gpt":0.2744356159255862,"score_spread":0.21563477896982902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157779324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942142,0.0010192377,0.0000508606,0.0034145578,0.00036288082,0.0007372167,0.00008311894,0.000089326626,0.000028616429],"genre_scores_gemma":[0.9871723,0.010246092,0.0011752435,0.00009585176,0.0010206345,0.00008398007,0.000022570171,0.000065114735,0.00011818753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99532294,0.00034650922,0.0010166396,0.0006264053,0.0015053581,0.0011821607],"domain_scores_gemma":[0.99187875,0.006037233,0.00058619457,0.00043166356,0.00051613187,0.0005500201],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00304634,0.00045275968,0.0006710893,0.00026572432,0.0022281248,0.00057739316,0.00040732452,0.00021900161,0.000061272425],"category_scores_gemma":[0.01488218,0.0003217234,0.00021412104,0.00043376157,0.00029617146,0.00065355294,0.00047520842,0.002992462,0.000065238484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002241262,0.00012513601,0.7534623,0.000031913794,0.00007911132,0.000005083709,0.00077795703,0.000039220096,0.19355342,6.6383876e-8,0.0005077891,0.051193837],"study_design_scores_gemma":[0.00535821,0.00026782433,0.95266426,0.0020801648,0.000097904456,0.000018071658,0.0007903645,0.03386045,0.003296977,0.0000038399576,0.0012397309,0.00032221264],"about_ca_topic_score_codex":0.00075582584,"about_ca_topic_score_gemma":0.0007679281,"teacher_disagreement_score":0.19920191,"about_ca_system_score_codex":0.00075982884,"about_ca_system_score_gemma":0.0001667896,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W2158300762","doi":"10.1177/1352458510366013","title":"Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Multiple Sclerosis Trust","keywords":"Physical medicine and rehabilitation; Physical therapy; Multiple sclerosis; Activities of daily living; Medicine; Foot (prosody); Randomized controlled trial; Functional electrical stimulation; Psychology; Stimulation; Surgery","score_opus":0.06836079110423059,"score_gpt":0.31155739828531115,"score_spread":0.24319660718108055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158300762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970384,0.000044546956,0.0010083608,0.00015626539,0.0005995908,0.0009422099,0.00012132306,0.000025691646,0.0000635776],"genre_scores_gemma":[0.9982533,0.00001498553,0.0008709982,0.00023584571,0.0004083496,0.00009679935,0.000035482215,0.000048685873,0.000035564757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965324,0.0005810656,0.0007379291,0.00036019506,0.0009605692,0.0008278689],"domain_scores_gemma":[0.99713224,0.0009767666,0.0005648337,0.00030069367,0.0006104689,0.0004149837],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0020658649,0.0003181126,0.0004058373,0.00043825764,0.0019790602,0.000090588124,0.00027660714,0.00030156123,0.00006610199],"category_scores_gemma":[0.0008196957,0.00022519684,0.00014315934,0.00071179995,0.000070795686,0.0005349705,0.00004330968,0.0019121149,0.000013532359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080534903,0.00024859948,0.7164315,0.00002080027,0.000050719384,2.113803e-7,0.0011344856,0.0016207838,0.27659842,0.0000035077373,0.0003895567,0.0026960392],"study_design_scores_gemma":[0.0025571666,0.00030957026,0.93882847,0.0006705658,0.000036942052,0.0000082393135,0.00033538666,0.05668268,0.00029564105,0.0000038384155,0.000028723258,0.00024280598],"about_ca_topic_score_codex":0.03465456,"about_ca_topic_score_gemma":0.3992074,"teacher_disagreement_score":0.36455286,"about_ca_system_score_codex":0.001144517,"about_ca_system_score_gemma":0.0019562568,"threshold_uncertainty_score":0.9993202},"labels":[],"label_agreement":null},{"id":"W2158343881","doi":"10.1177/1352458509359726","title":"Does MRI lesion activity regress in secondary progressive multiple sclerosis?","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck KGaA","keywords":"Multiple sclerosis; Medicine; Lesion; Clinical neurology; Magnetic resonance imaging; Radiology; Pathology; Neuroscience; Psychology; Psychiatry","score_opus":0.09696441350255926,"score_gpt":0.3215835097101504,"score_spread":0.22461909620759113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158343881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993903,0.00063139107,0.00015642881,0.0045360583,0.002023822,0.0017688654,0.0001137686,0.00020480154,0.00062585005],"genre_scores_gemma":[0.98753834,0.0023621104,0.0074882368,0.0002967461,0.0015209374,0.0002728218,0.000026009548,0.00015192281,0.000342889],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99337476,0.0005013385,0.0012216193,0.0011900547,0.0018842209,0.001828014],"domain_scores_gemma":[0.9949954,0.0010970604,0.00070368155,0.0011582065,0.0008711567,0.0011745014],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022260663,0.0008261494,0.0013532259,0.0009819029,0.0011016777,0.0004481344,0.00077534805,0.00057479524,0.0011222202],"category_scores_gemma":[0.004475253,0.0005300289,0.00076326256,0.0009005014,0.00084708555,0.0011225283,0.00063161313,0.0052609737,0.00012540998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013015483,0.0011375123,0.33343357,0.00013534998,0.00018766655,0.00013365154,0.00062949583,0.000016157854,0.51326185,0.000003573357,0.0022995619,0.14746006],"study_design_scores_gemma":[0.012653187,0.00037566014,0.89718795,0.0015817098,0.0000752995,0.00016358845,0.00051083567,0.0026607092,0.081504755,0.000031664884,0.0026245755,0.0006300656],"about_ca_topic_score_codex":0.00039121424,"about_ca_topic_score_gemma":0.0025831414,"teacher_disagreement_score":0.5637544,"about_ca_system_score_codex":0.00047562204,"about_ca_system_score_gemma":0.0005485043,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W2159596132","doi":"10.1177/1352458514564491","title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Canadian Institutes of Health Research","keywords":"Comorbidity; Medicine; Incidence (geometry); Epidemiology; Population; MEDLINE; Demography; Environmental health; Psychiatry; Pathology","score_opus":0.3153023179724875,"score_gpt":0.38515113024039827,"score_spread":0.06984881226791079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159596132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080011896,0.9914653,0.000007180022,0.00012689069,0.00026923342,0.0069558024,0.0003185615,0.00002171835,0.00003520888],"genre_scores_gemma":[0.00481149,0.99381024,0.00047644775,0.00012007538,0.00012127857,0.0004948516,0.000009685983,0.00009694137,0.000058980608],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98823947,0.0028958467,0.004647144,0.0007532383,0.0026651612,0.000799143],"domain_scores_gemma":[0.98984706,0.002250949,0.004120546,0.0017472488,0.001502116,0.0005320902],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008131574,0.0009273875,0.008158246,0.00056079595,0.0002353123,0.00006153133,0.0014460323,0.00039923762,0.00007185337],"category_scores_gemma":[0.02393892,0.0005493737,0.0016104174,0.0016296022,0.0008697756,0.00029835862,0.0012312568,0.0020292501,0.000013546939],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003274071,0.00031567665,0.004268409,0.95369065,0.00048325743,0.0000075177854,0.00023437364,8.9949856e-7,0.000060369806,0.000002223637,0.00068454567,0.040219355],"study_design_scores_gemma":[0.0018695679,0.00018456475,0.019398388,0.9702695,0.0035969273,0.00028995844,0.00008418912,0.00008205308,0.000022213688,0.0000047241992,0.0037939392,0.00040400116],"about_ca_topic_score_codex":0.00016384247,"about_ca_topic_score_gemma":0.00010085173,"teacher_disagreement_score":0.039815355,"about_ca_system_score_codex":0.0007225907,"about_ca_system_score_gemma":0.0013022727,"threshold_uncertainty_score":0.9996958},"labels":[],"label_agreement":null},{"id":"W2159638157","doi":"10.1177/1352458507079658","title":"Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Health Canada; Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Drug; Adverse effect; Intensive care medicine; Pharmacology; Psychiatry","score_opus":0.1014780728284497,"score_gpt":0.3214054326858235,"score_spread":0.2199273598573738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159638157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878161,0.0053745727,0.0003798774,0.003841088,0.001047319,0.0009198457,0.000039714687,0.000030713294,0.0005507997],"genre_scores_gemma":[0.9954631,0.0020752405,0.0011224301,0.00066835404,0.00051604625,0.000025325897,0.000004259836,0.000036660924,0.00008863614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809504,0.00007000333,0.0006071238,0.00026653238,0.00041863648,0.000542689],"domain_scores_gemma":[0.9968886,0.0013266195,0.0005019042,0.0003173303,0.0005672703,0.00039831133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023194223,0.00019183641,0.00035117194,0.000185726,0.0006825448,0.00003052856,0.0001476216,0.00009697824,0.00008584396],"category_scores_gemma":[0.0015954606,0.00014034919,0.00036710812,0.0002581867,0.00018723341,0.00025843916,0.000037027046,0.0005783825,0.0000063850425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005786561,0.00094909663,0.46513987,0.000090013986,0.0041326066,0.00020509023,0.024696069,0.00020210457,0.31317163,0.00007580515,0.008700041,0.17685112],"study_design_scores_gemma":[0.00276152,0.00016155912,0.934967,0.00018865819,0.00033902188,0.00019360008,0.016376378,0.00047076397,0.003648995,0.000056776706,0.040660195,0.00017557952],"about_ca_topic_score_codex":0.05277949,"about_ca_topic_score_gemma":0.02993858,"teacher_disagreement_score":0.4698271,"about_ca_system_score_codex":0.00066600344,"about_ca_system_score_gemma":0.00024434252,"threshold_uncertainty_score":0.9877625},"labels":[],"label_agreement":null},{"id":"W2159648344","doi":"10.1191/1352458504ms1065oa","title":"HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Kuwait University","keywords":"Multiple sclerosis; Human leukocyte antigen; Population; Medicine; Immunology; Environmental health; Antigen","score_opus":0.155047213482379,"score_gpt":0.34552783016132943,"score_spread":0.19048061667895044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159648344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967995,0.00014543092,0.00037318995,0.00064498966,0.00034461936,0.0014829513,0.00008585162,0.00007871448,0.000044751552],"genre_scores_gemma":[0.98662925,0.0003733391,0.012190917,0.00020917463,0.00036998763,0.00008487934,0.00003028923,0.00008987371,0.000022270877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416435,0.00037002587,0.001820759,0.0008854365,0.0015200262,0.0012393914],"domain_scores_gemma":[0.99626493,0.00033512153,0.00048908364,0.0009923418,0.0008003936,0.0011181145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020600392,0.000539175,0.0012876687,0.0010340945,0.0004504497,0.00014425091,0.0005551841,0.0002791874,0.0001430632],"category_scores_gemma":[0.00427761,0.00048586074,0.0004223702,0.0011360897,0.00025951443,0.0007922365,0.00028122272,0.0009247371,0.000053761734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089740026,0.001164866,0.7374506,0.00009260154,0.00004232387,0.000017930392,0.001373678,0.0030073435,0.22124088,0.0000016382494,0.00005400474,0.034656756],"study_design_scores_gemma":[0.0102915615,0.0011660877,0.9517846,0.0017312068,0.000046718986,0.000038673752,0.0007743302,0.0021662947,0.031492002,0.0000526603,0.000035248933,0.0004206285],"about_ca_topic_score_codex":0.002961205,"about_ca_topic_score_gemma":0.021107312,"teacher_disagreement_score":0.21433401,"about_ca_system_score_codex":0.0011370509,"about_ca_system_score_gemma":0.00024126803,"threshold_uncertainty_score":0.9997593},"labels":[],"label_agreement":null},{"id":"W2160062436","doi":"10.1177/1352458512458555","title":"Prolactin in multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Multiple sclerosis; Prolactin; Medicine; Pathophysiology; Optic neuritis; Internal medicine; Myelin; Clinically isolated syndrome; Oncology; Central nervous system; Immunology; Hormone","score_opus":0.40745137398099485,"score_gpt":0.37556432567064907,"score_spread":0.03188704831034578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160062436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015859541,0.9916965,0.000052915133,0.0002363118,0.0013575547,0.004196139,0.00019832655,0.00020831797,0.00046803238],"genre_scores_gemma":[0.018247465,0.9735423,0.0031413757,0.00012416998,0.002934966,0.00095205347,0.000148717,0.00048313662,0.0004258522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98794085,0.0013989715,0.0035621785,0.0014502476,0.0024267365,0.0032209952],"domain_scores_gemma":[0.99197865,0.002250168,0.0016783508,0.0015462224,0.00064422225,0.0019024153],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0038484468,0.0019220657,0.0064193727,0.0025353387,0.0008955816,0.00046765042,0.0012182546,0.0013113891,0.00088103296],"category_scores_gemma":[0.004859146,0.0014926963,0.002779489,0.0021366791,0.00052123197,0.00080516585,0.00087269605,0.0062673264,0.0011705355],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005316887,0.0013936416,0.017270174,0.0096511915,0.0009183592,0.00008044602,0.00039317564,0.000003317897,0.00028484853,0.0000017173636,0.0026625118,0.9668089],"study_design_scores_gemma":[0.0072758743,0.00031668498,0.08617854,0.06453234,0.0017931799,0.000691985,0.00021340395,0.00014836968,0.000039048275,0.000003168425,0.83732843,0.0014789823],"about_ca_topic_score_codex":0.00015940313,"about_ca_topic_score_gemma":0.00033130177,"teacher_disagreement_score":0.96532995,"about_ca_system_score_codex":0.002507239,"about_ca_system_score_gemma":0.001143816,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2160153676","doi":"10.1177/1352458512461393","title":"Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Multiple sclerosis; Etiology; Medicine; Inflammatory bowel disease; Ulcerative colitis; Disease; Magnetic resonance imaging; Inflammatory Bowel Diseases; Pathology; Immunology; Radiology","score_opus":0.04685277910526274,"score_gpt":0.26483531883739825,"score_spread":0.2179825397321355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160153676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018226901,0.9778381,0.000060344682,0.00029170248,0.0016687058,0.0015866334,0.0002588177,0.000059119193,0.000009680842],"genre_scores_gemma":[0.00503132,0.99086154,0.00050198816,0.0003750909,0.0021645003,0.0003282709,0.00022274845,0.0003138052,0.00020072007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944672,0.0007115076,0.001500267,0.0012821576,0.00065523875,0.0013836398],"domain_scores_gemma":[0.9950238,0.00018459727,0.000933736,0.001144243,0.00032118455,0.0023924783],"candidate_categories":["metaepi_narrow","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000782588,0.0014427671,0.0016055127,0.0005198032,0.00077124854,0.002644651,0.0008510465,0.0014910998,0.0000964568],"category_scores_gemma":[0.00045882497,0.0012986669,0.0009816646,0.0002515522,0.00037510582,0.00043752114,0.0010771293,0.0013668351,0.0001340276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002784349,0.00021718712,0.0039918805,0.004556812,0.0005493796,0.00005296672,0.0002916729,0.000011534014,0.0018608148,0.0000034797183,0.0029061832,0.9852797],"study_design_scores_gemma":[0.0023073237,0.00014329565,0.01343356,0.03330288,0.0014724681,0.00016969611,0.00094786746,0.000037205617,0.00012748787,0.000006907178,0.9463541,0.0016971906],"about_ca_topic_score_codex":0.0000060113593,"about_ca_topic_score_gemma":0.00006171195,"teacher_disagreement_score":0.98358244,"about_ca_system_score_codex":0.00020436007,"about_ca_system_score_gemma":0.0004793263,"threshold_uncertainty_score":0.9998322},"labels":[],"label_agreement":null},{"id":"W2161512169","doi":"10.1177/1352458514557986","title":"Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Prothena; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Dosing; Placebo; Regimen; Internal medicine; Multiple sclerosis; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Immunology","score_opus":0.12458225293336551,"score_gpt":0.2962346911310162,"score_spread":0.1716524381976507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161512169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735106,0.0010772743,0.001571996,0.005494253,0.0010811401,0.0010992276,0.0003648031,0.00023801377,0.0017222239],"genre_scores_gemma":[0.97948223,0.0034710884,0.013993194,0.00068340515,0.001678436,0.00011249845,0.00011843381,0.00016023211,0.0003004734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992412,0.0006719529,0.002019429,0.0013420118,0.0017834688,0.0017711485],"domain_scores_gemma":[0.9940442,0.0021910989,0.00067797856,0.0013477325,0.00066122087,0.0010777789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025269187,0.00081626,0.0015370721,0.0007849169,0.0006915895,0.00034055483,0.0008540024,0.00036652997,0.0003188897],"category_scores_gemma":[0.008033819,0.00071306236,0.0006201582,0.0007923209,0.00047396062,0.000765536,0.0004973146,0.0022206085,0.0005152694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01340798,0.0020227432,0.5091831,0.00014386613,0.0006718517,0.00007646633,0.0047505526,0.0015031411,0.32753894,0.000028129909,0.015955701,0.12471751],"study_design_scores_gemma":[0.033510223,0.0009205381,0.9192493,0.0029190336,0.00010640603,0.000033144006,0.0010613818,0.011951203,0.014186235,0.00005432198,0.01524192,0.000766297],"about_ca_topic_score_codex":0.00093640754,"about_ca_topic_score_gemma":0.0013062508,"teacher_disagreement_score":0.41006616,"about_ca_system_score_codex":0.000762821,"about_ca_system_score_gemma":0.00017903557,"threshold_uncertainty_score":0.99953204},"labels":[],"label_agreement":null},{"id":"W2161822858","doi":"10.1177/1352458512442438","title":"Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Bayer HealthCare; Multiple Sclerosis Society","keywords":"Multiple sclerosis; Interferon beta-1b; Clinically isolated syndrome; Cognition; Placebo; Medicine; Internal medicine; Interferon beta-1a; Effects of sleep deprivation on cognitive performance; Interferon beta; Immunology; Psychiatry; Pathology","score_opus":0.051477351688210514,"score_gpt":0.2659384182336004,"score_spread":0.2144610665453899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161822858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693686,0.0005821392,0.00013178801,0.00009698828,0.00024699263,0.0017893363,0.000086217595,0.000026082345,0.00010362084],"genre_scores_gemma":[0.997145,0.0016686755,0.0006768107,0.00006217827,0.00017075174,0.00015241155,0.000024799836,0.000080512094,0.000018872457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954966,0.0003021643,0.0011120074,0.00044137676,0.0015572681,0.001090619],"domain_scores_gemma":[0.9950329,0.0023095487,0.00075964176,0.00035071737,0.0010078765,0.0005392983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009204895,0.0005383426,0.0012217138,0.0007705503,0.0002605826,0.00002760404,0.00029005765,0.00017656793,0.000065006425],"category_scores_gemma":[0.002644529,0.0003986773,0.00031160092,0.0006883857,0.00048592547,0.0005261718,0.00022591786,0.00097534887,0.0000256345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008779772,0.0056116455,0.96130896,0.0010727965,0.00050481653,0.0000027674569,0.002592263,0.00012411694,0.00976556,0.0000012171241,0.00012594298,0.010110154],"study_design_scores_gemma":[0.025656894,0.0050215204,0.8745363,0.014639784,0.00018594852,0.0000040473165,0.00039948293,0.0003963664,0.07883085,3.4588058e-7,0.00001703918,0.00031143162],"about_ca_topic_score_codex":0.00012436448,"about_ca_topic_score_gemma":0.00013900014,"teacher_disagreement_score":0.08677266,"about_ca_system_score_codex":0.00047360398,"about_ca_system_score_gemma":0.00012684155,"threshold_uncertainty_score":0.9998465},"labels":[],"label_agreement":null},{"id":"W2162412742","doi":"10.1177/1352458513507817","title":"Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; NeuroRx Research (Canada)","funders":"IC Design Education Center; Biogen","keywords":"Dimethyl fumarate; Multiple sclerosis; Medicine; Placebo; Quality of life (healthcare); Expanded Disability Status Scale; Relapsing remitting; Internal medicine; Visual analogue scale; Clinical trial; Physical therapy; Pathology; Psychiatry; Alternative medicine","score_opus":0.12470611725036007,"score_gpt":0.2995743925628379,"score_spread":0.17486827531247784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162412742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396855,0.00037414883,0.00017558887,0.001179667,0.00019076972,0.0038127122,0.00003392176,0.00008301015,0.00018162411],"genre_scores_gemma":[0.9948744,0.00020768587,0.0038658872,0.00034496753,0.00014142075,0.00032467174,0.000015686841,0.00013306401,0.00009220765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913124,0.001260831,0.0022759968,0.0008484438,0.0029407803,0.0013615696],"domain_scores_gemma":[0.9925171,0.002380481,0.0013613595,0.0012281043,0.0017811579,0.0007317765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003526805,0.0007952514,0.0019107456,0.0005863098,0.0008705938,0.0002792411,0.000731316,0.00019032272,0.00022808698],"category_scores_gemma":[0.006668622,0.00043219968,0.000351589,0.0010900616,0.0006492236,0.0007670191,0.0004045104,0.0018450642,0.000049775103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025600158,0.0037180828,0.97584766,0.00010176111,0.0009440816,0.0000035197488,0.0025374398,0.00042797448,0.004601078,0.0000014886559,0.0004416266,0.008815288],"study_design_scores_gemma":[0.036531974,0.0019092764,0.953846,0.0011939878,0.00013335733,0.000004040937,0.004961585,0.0005335053,0.00036787835,0.0000051939564,0.000020261898,0.0004929691],"about_ca_topic_score_codex":0.0030039651,"about_ca_topic_score_gemma":0.0025165551,"teacher_disagreement_score":0.033971958,"about_ca_system_score_codex":0.0004036879,"about_ca_system_score_gemma":0.000326671,"threshold_uncertainty_score":0.99981296},"labels":[],"label_agreement":null},{"id":"W2162850888","doi":"10.1177/1352458513505693","title":"Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Teva Pharmaceutical Industries","keywords":"Mononucleosis; Odds ratio; Multiple sclerosis; Confidence interval; Medicine; Measles; Demography; Vitamin D and neurology; Internal medicine; Gastroenterology; Immunology; Virus; Vaccination","score_opus":0.07413399038390671,"score_gpt":0.2747479595841738,"score_spread":0.20061396920026708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162850888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517655,0.0012022328,0.00008239906,0.0005032818,0.00020983566,0.0025331008,0.00008787537,0.00005568734,0.00014902989],"genre_scores_gemma":[0.9885624,0.010069471,0.0006576548,0.00004649122,0.00020608243,0.00022803705,0.000005631793,0.00008102439,0.0001431841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949819,0.0007795654,0.0013258371,0.0005793889,0.0015333374,0.0007999931],"domain_scores_gemma":[0.99480337,0.0018586712,0.0010066361,0.00088556757,0.00087549724,0.0005702844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011994044,0.00056191813,0.0012939273,0.00038864312,0.0009995301,0.0001431884,0.00044648122,0.00017513671,0.0004162073],"category_scores_gemma":[0.002790556,0.00034829855,0.0005089688,0.00048370904,0.0007192247,0.0003292598,0.0007902485,0.0009945605,0.000033783792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034801383,0.0015854922,0.8592337,0.000111495494,0.0013807083,0.0000018836765,0.003379174,0.00008601825,0.11821344,0.0000012186578,0.0011652425,0.014493609],"study_design_scores_gemma":[0.008533858,0.0010820855,0.96644956,0.0005177811,0.00055104325,0.000019173038,0.0023633495,0.0027396346,0.017331852,0.000014826374,0.00010653056,0.00029030748],"about_ca_topic_score_codex":0.0018114028,"about_ca_topic_score_gemma":0.0021542308,"teacher_disagreement_score":0.10721585,"about_ca_system_score_codex":0.00030329544,"about_ca_system_score_gemma":0.00005324142,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W2163203687","doi":"10.1177/1352458509106856","title":"Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); Children's Hospital Research Institute of Manitoba; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Experimental autoimmune encephalomyelitis; Multiple sclerosis; Medicine; Spinal cord; Tumor necrosis factor alpha; Immunology; Myelin; Central nervous system; Proinflammatory cytokine; Dorsal root ganglion; Myelin basic protein; Encephalomyelitis; Pathology; Inflammation; Endocrinology","score_opus":0.05862987081228601,"score_gpt":0.28571413604125073,"score_spread":0.22708426522896472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163203687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981051,0.00052093476,0.00013666434,0.00045481286,0.00021240365,0.00039550653,0.000010559626,0.00002424826,0.00013976402],"genre_scores_gemma":[0.9982892,0.00001471827,0.0012313403,0.00027264084,0.000117358395,0.000014749199,0.000011521484,0.000017329316,0.000031088697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981567,0.00015140863,0.00055763224,0.00021459296,0.0005611673,0.00035849478],"domain_scores_gemma":[0.9991916,0.00007743109,0.00026053053,0.00027818806,0.00008877473,0.0001034747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039912114,0.00022127747,0.00037872035,0.00016331287,0.00018723804,0.00006547724,0.00019182773,0.00008440266,0.00018041556],"category_scores_gemma":[0.00010330883,0.0001522147,0.00021414312,0.00025258242,0.000037556994,0.00022923014,0.000019447232,0.00031674936,0.000010016223],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021790224,0.0008906809,0.03319804,0.000006061505,0.000045600464,0.0000619244,0.0031698467,0.00001391494,0.94564325,0.00005551189,0.00004108387,0.016656175],"study_design_scores_gemma":[0.0042831255,0.00072086643,0.81114036,0.00024795247,0.000034203495,0.00009645382,0.00051558524,0.00047396088,0.18217829,0.00017447895,0.000023583527,0.00011113308],"about_ca_topic_score_codex":0.00016308749,"about_ca_topic_score_gemma":0.000012506208,"teacher_disagreement_score":0.7779423,"about_ca_system_score_codex":0.00026595502,"about_ca_system_score_gemma":0.00010387619,"threshold_uncertainty_score":0.62071353},"labels":[],"label_agreement":null},{"id":"W2163795029","doi":"10.1177/1352458511430704","title":"Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Multiple sclerosis; MEDLINE; Food and drug administration; Intensive care medicine; Family medicine; Orphan drug; Pathology; Psychiatry; Pharmacology; Bioinformatics","score_opus":0.5914290582407363,"score_gpt":0.39444364853626807,"score_spread":0.19698540970446826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163795029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141526,0.0035725893,0.0017937616,0.00038076096,0.0002985509,0.0019735624,0.00010521819,0.000057332305,0.0004029909],"genre_scores_gemma":[0.9562559,0.004480741,0.038325652,0.00010689657,0.0005643633,0.00009481247,0.000015167485,0.0000745778,0.00008185791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956497,0.0003104255,0.0012721189,0.0004970778,0.0014910874,0.0007796035],"domain_scores_gemma":[0.9952669,0.0009704632,0.0007725415,0.0004006016,0.0020332052,0.0005562959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037787273,0.00039153206,0.00072998204,0.00047310902,0.0005494516,0.00008123243,0.0002235772,0.00016315923,0.00016549391],"category_scores_gemma":[0.0038916548,0.00033468963,0.00029554774,0.00040611604,0.000249515,0.00018934197,0.00015151358,0.00045941529,0.000007509741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192191,0.0006729176,0.6973193,0.00032427802,0.00073699857,0.0000027728818,0.005185877,0.00006691221,0.103948385,0.000017491095,0.002662259,0.18734354],"study_design_scores_gemma":[0.02092145,0.00086794863,0.934856,0.0004343991,0.0011973341,0.000034995977,0.0020245058,0.021950595,0.016764931,0.0001712149,0.0004093986,0.0003672007],"about_ca_topic_score_codex":0.00028981146,"about_ca_topic_score_gemma":0.00012861766,"teacher_disagreement_score":0.23753667,"about_ca_system_score_codex":0.00025461245,"about_ca_system_score_gemma":0.00051783817,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W2163982375","doi":"10.1177/1352458514564486","title":"A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Biogen; Canadian Institutes of Health Research; IC Design Education Center; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Incidence (geometry); Medicine; Seizure Disorders; Epilepsy; Sleep (system call); Pediatrics; Psychiatry","score_opus":0.07869031043790795,"score_gpt":0.3200282810729547,"score_spread":0.24133797063504678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163982375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026212663,0.9902385,0.00005184012,0.0003327783,0.0001616255,0.0064039263,0.00013671204,0.000020279493,0.000033062413],"genre_scores_gemma":[0.048567444,0.95020294,0.00045810893,0.000083211475,0.00007139612,0.0004674699,0.000006677265,0.000102524544,0.00004023718],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9913231,0.0019627411,0.0034687093,0.00082757685,0.0016323061,0.0007855336],"domain_scores_gemma":[0.9917792,0.003231949,0.0029224663,0.0012364499,0.00043004626,0.00039987633],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039796447,0.0009203212,0.006044341,0.0006144308,0.0003496847,0.00006787494,0.0009557901,0.0003897899,0.000036175883],"category_scores_gemma":[0.017142918,0.0005638785,0.001191011,0.0011710313,0.0011707271,0.00025140346,0.0009065197,0.0016892782,0.000003897271],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031622985,0.00019474115,0.02476297,0.85927075,0.00047124826,8.512108e-7,0.00028202773,0.000002418872,0.00005507447,0.0000021303624,0.00009655993,0.114829585],"study_design_scores_gemma":[0.0019846137,0.00021394603,0.06706676,0.92519546,0.0027595726,0.00008761715,0.000120372584,0.000409353,0.000006943234,0.000008790552,0.0016992207,0.00044737666],"about_ca_topic_score_codex":0.0002113474,"about_ca_topic_score_gemma":0.00066026027,"teacher_disagreement_score":0.11438221,"about_ca_system_score_codex":0.00025619738,"about_ca_system_score_gemma":0.00031479844,"threshold_uncertainty_score":0.9996813},"labels":[],"label_agreement":null},{"id":"W2164081593","doi":"10.1191/1352458505ms1177oa","title":"Reappraisal of Lhermitte’s sign in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Natural history; Cohort; McDonald criteria; Pediatrics; Internal medicine; Psychiatry","score_opus":0.16101217365423529,"score_gpt":0.322095995751591,"score_spread":0.1610838220973557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164081593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914676,0.0016083347,0.0004958462,0.0029983285,0.00037784816,0.0010134646,0.00006912803,0.00011538645,0.0018540828],"genre_scores_gemma":[0.98181087,0.003875341,0.012421993,0.0003556397,0.0010517422,0.000093931856,0.00001693698,0.00011887286,0.0002546838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99377847,0.00041625716,0.0018761146,0.00073815783,0.0017671165,0.0014238991],"domain_scores_gemma":[0.995799,0.0012486499,0.0006052937,0.00080641784,0.0007445622,0.00079607195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020837595,0.0006072455,0.0013870802,0.001054917,0.0004152728,0.00011886605,0.0006112208,0.00032986197,0.0006714427],"category_scores_gemma":[0.004663584,0.00053138117,0.0006454622,0.0010929935,0.0005597938,0.00065892696,0.00032255356,0.0015736662,0.00016273286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011949454,0.0015528055,0.47346103,0.00012103858,0.00026840882,0.000030155235,0.0013409345,0.00084422546,0.37234375,0.0000120333325,0.0060186414,0.14281203],"study_design_scores_gemma":[0.014424093,0.0004996428,0.9324163,0.0014469565,0.00008176626,0.0001045744,0.00074779004,0.007978346,0.03590733,0.000008129014,0.005903641,0.0004814019],"about_ca_topic_score_codex":0.00041934403,"about_ca_topic_score_gemma":0.0009263436,"teacher_disagreement_score":0.45895532,"about_ca_system_score_codex":0.00041104332,"about_ca_system_score_gemma":0.00033089472,"threshold_uncertainty_score":0.9997138},"labels":[],"label_agreement":null},{"id":"W2164267257","doi":"10.1177/1352458509359725","title":"Neurofilament light as a prognostic marker in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biogen; IC Design Education Center; Ministère de la Santé et des Services sociaux; Sanofi","keywords":"Multiple sclerosis; Neurofilament; Medicine; Cerebrospinal fluid; Confidence interval; Odds ratio; Internal medicine; Lumbar puncture; Pathology; Amyotrophic lateral sclerosis; Central nervous system disease; Gastroenterology; Disease; Immunology; Immunohistochemistry","score_opus":0.0951121904387074,"score_gpt":0.29525463731154317,"score_spread":0.20014244687283578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164267257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880457,0.0004490897,0.0000645682,0.00600033,0.0014231062,0.0018910549,0.000030146508,0.00018536167,0.0019106744],"genre_scores_gemma":[0.9900106,0.0018721081,0.005198542,0.00087754923,0.0010404609,0.00034038792,0.000019857378,0.00016791835,0.00047258177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931401,0.0003931172,0.0015084691,0.0010503207,0.002008392,0.0018995962],"domain_scores_gemma":[0.9953119,0.001149879,0.00043843285,0.0010199012,0.0007216662,0.0013581841],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020047924,0.0007776696,0.0011555948,0.0010642493,0.0008236306,0.0004424056,0.0007087886,0.00039497935,0.001426858],"category_scores_gemma":[0.010529198,0.0006514864,0.0006120026,0.001117974,0.00042325206,0.0005736716,0.000517383,0.0035954905,0.00062813447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067385443,0.0009570131,0.5273648,0.00006346757,0.00013556433,0.00012836215,0.0005333911,0.000017087757,0.44871548,0.000008088518,0.0030726641,0.018330235],"study_design_scores_gemma":[0.0113743,0.0005938288,0.9552562,0.0010506929,0.00010036421,0.00040008465,0.00042599987,0.0034429564,0.019249482,0.00003202215,0.0074691973,0.0006048418],"about_ca_topic_score_codex":0.00039448036,"about_ca_topic_score_gemma":0.0013228944,"teacher_disagreement_score":0.429466,"about_ca_system_score_codex":0.00038399704,"about_ca_system_score_gemma":0.00043048034,"threshold_uncertainty_score":0.9995936},"labels":[],"label_agreement":null},{"id":"W2165469641","doi":"10.1177/1352458513508837","title":"Exercising away the blues: can it help multiple sclerosis-related depression?","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Mood; CLARITY; Medicine; Psychiatry; Physical medicine and rehabilitation; Psychology; Physical therapy; Alternative medicine; Clinical psychology","score_opus":0.24183030058778848,"score_gpt":0.3586178863786763,"score_spread":0.11678758579088783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165469641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017996932,0.986553,0.000078330064,0.0017140383,0.0020801348,0.0064279055,0.00031781368,0.0003528495,0.00067620754],"genre_scores_gemma":[0.012549602,0.9789994,0.0017331255,0.0004625482,0.002295087,0.0012791316,0.00022666535,0.00063096464,0.0018234774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9846869,0.002065577,0.004411628,0.002019194,0.003675284,0.0031413955],"domain_scores_gemma":[0.9866831,0.004261392,0.002662387,0.0027962509,0.0015485449,0.0020483811],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0035269584,0.0024870818,0.006330477,0.0014079548,0.003667063,0.0014792648,0.0025292342,0.0015407507,0.0016985438],"category_scores_gemma":[0.0069445623,0.0014770478,0.003872392,0.002047744,0.0012036967,0.000652288,0.0016003486,0.0075049885,0.0013248951],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111954556,0.0006129002,0.0028383678,0.0042287284,0.0022559168,0.000069515016,0.0011580932,0.000028039749,0.0007824438,0.0000015882204,0.045851797,0.94206065],"study_design_scores_gemma":[0.0076897233,0.0003472947,0.012495707,0.12950796,0.003732933,0.0012067745,0.0016588934,0.0008321351,0.00021179853,0.000014616109,0.840194,0.0021081637],"about_ca_topic_score_codex":0.00063225976,"about_ca_topic_score_gemma":0.0003363124,"teacher_disagreement_score":0.9399525,"about_ca_system_score_codex":0.0018323446,"about_ca_system_score_gemma":0.0014767742,"threshold_uncertainty_score":0.99975544},"labels":[],"label_agreement":null},{"id":"W2166380491","doi":"10.1177/1352458512460602","title":"Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; National Research Council Institute for Biodiagnostics; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Susceptibility weighted imaging; Multiple sclerosis; Medicine; Pathology; Spinal cord; White matter; Experimental autoimmune encephalomyelitis; Hyperintensity; Magnetic resonance imaging; Lesion; Immunology; Radiology","score_opus":0.07558396503557392,"score_gpt":0.2956727301939619,"score_spread":0.220088765158388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166380491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109954,0.005233368,0.0012701541,0.0009701181,0.00014231277,0.001108899,0.000050073784,0.00006270384,0.000062823936],"genre_scores_gemma":[0.9892218,0.002194443,0.007892472,0.00019225261,0.00022878707,0.00014144983,0.00006244198,0.000057409754,0.000008941756],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99537677,0.0005836092,0.0012346527,0.00048575678,0.0012503668,0.0010688507],"domain_scores_gemma":[0.9975925,0.0006736794,0.0005135871,0.00044873988,0.00040723523,0.00036427708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024290932,0.00045633357,0.0006891607,0.0005862624,0.00068574736,0.00014469297,0.0003690914,0.00018335407,0.00006850642],"category_scores_gemma":[0.0011413575,0.00034795474,0.00024766845,0.00065071235,0.0005694803,0.0010356907,0.00024366486,0.00088473863,0.000009196479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027055776,0.00075433496,0.3863055,0.00005611632,0.000042477473,0.0000021345047,0.0043204734,0.00008745488,0.5949773,0.00000905036,0.000085386935,0.013089203],"study_design_scores_gemma":[0.005577145,0.0001723689,0.79440963,0.00057527533,0.000073738316,0.000083292725,0.0034602305,0.07648755,0.11886194,0.000022296954,0.000009479121,0.00026702246],"about_ca_topic_score_codex":0.00037522218,"about_ca_topic_score_gemma":0.00009032556,"teacher_disagreement_score":0.47611538,"about_ca_system_score_codex":0.0005240971,"about_ca_system_score_gemma":0.00010987883,"threshold_uncertainty_score":0.99989724},"labels":[],"label_agreement":null},{"id":"W2166602371","doi":"10.1177/1352458510365586","title":"Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Teva Pharmaceutical Industries","keywords":"Expanded Disability Status Scale; Medicine; Interquartile range; Multiple sclerosis; Spinal cord; White matter; Glatiramer acetate; Placebo; Cord; Internal medicine; Urology; Gastroenterology; Nuclear medicine; Anesthesia; Surgery; Magnetic resonance imaging; Pathology; Radiology","score_opus":0.07348340894632772,"score_gpt":0.3025347368070753,"score_spread":0.2290513278607476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166602371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995942,0.00028899987,0.000017324912,0.00083477725,0.0004624188,0.0020898834,0.00004283787,0.0000719436,0.00024979218],"genre_scores_gemma":[0.99332803,0.000512482,0.0050153276,0.00014578509,0.0005925734,0.00019284585,0.000021871696,0.00010639163,0.00008469496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943148,0.000420677,0.0015279994,0.00085227104,0.0016113489,0.0012729149],"domain_scores_gemma":[0.99671394,0.0004967789,0.0003876519,0.0007613712,0.00085074705,0.00078950234],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019172804,0.00058326975,0.0013752049,0.0007756305,0.0004892027,0.00019370607,0.00049605983,0.00027450066,0.0005252171],"category_scores_gemma":[0.0016138194,0.00042204055,0.00027746597,0.00051985885,0.00065024215,0.00045513347,0.00075858115,0.0024428815,0.000056970788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018796853,0.0023023216,0.6484281,0.000107209904,0.00019270697,0.000050463936,0.0022064324,0.000015918951,0.32835272,0.0000013224579,0.00027354076,0.01618959],"study_design_scores_gemma":[0.027408661,0.0019467364,0.95370704,0.00055553735,0.000119537166,0.000104099374,0.0038984078,0.0016610335,0.009994463,0.000009569879,0.0001754906,0.00041944336],"about_ca_topic_score_codex":0.000607596,"about_ca_topic_score_gemma":0.0015198248,"teacher_disagreement_score":0.31835827,"about_ca_system_score_codex":0.00021383993,"about_ca_system_score_gemma":0.00016205687,"threshold_uncertainty_score":0.9998585},"labels":[],"label_agreement":null},{"id":"W2167412674","doi":"10.1177/1352458506071161","title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Anxiety; Psychiatry; Panic disorder; Generalized anxiety disorder; Anxiety disorder; Psychosocial; Agoraphobia; Psychology; Clinical psychology; Social anxiety; Depression (economics); Medicine","score_opus":0.11303309424381826,"score_gpt":0.3198231508235496,"score_spread":0.20679005657973137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167412674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480456,0.0013335629,0.00064445124,0.00077627157,0.0008061331,0.001101493,0.000050375416,0.00009835841,0.00038476786],"genre_scores_gemma":[0.97151756,0.025181502,0.002196502,0.0004212784,0.00046949807,0.0000331733,0.000028990014,0.000097222895,0.000054249413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99447507,0.0003691595,0.0018571994,0.00085457094,0.0009395246,0.0015045073],"domain_scores_gemma":[0.99526924,0.0021341047,0.0004537905,0.00054083817,0.0004951771,0.0011068238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004173159,0.00061437296,0.0011275106,0.00065334927,0.0007217206,0.00017483933,0.00036992494,0.00041543448,0.00010790271],"category_scores_gemma":[0.005682309,0.00047179038,0.0005255883,0.00074624404,0.0007713219,0.00047699356,0.00043022737,0.0020981447,0.000047880956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008900625,0.0011032658,0.7323326,0.000035246256,0.000151607,0.000004751768,0.0008125253,0.00001570668,0.004010377,0.0000017381046,0.001058414,0.25958374],"study_design_scores_gemma":[0.017471502,0.0006262744,0.9726769,0.0007179465,0.000045800203,0.000022994884,0.0012934186,0.00286767,0.0008851114,0.000034345754,0.0029029793,0.00045509686],"about_ca_topic_score_codex":0.00020680443,"about_ca_topic_score_gemma":0.0017421035,"teacher_disagreement_score":0.25912863,"about_ca_system_score_codex":0.0003494374,"about_ca_system_score_gemma":0.000121316836,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W2167461562","doi":"10.1177/1352458511432328","title":"Obstructive sleep apnea is associated with fatigue in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Epworth Sleepiness Scale; Medicine; Obstructive sleep apnea; Polysomnography; Physical therapy; Expanded Disability Status Scale; Excessive daytime sleepiness; Multiple sclerosis; Body mass index; Depression (economics); Multiple Sleep Latency Test; Internal medicine; Sleep disorder; Apnea; Insomnia; Psychiatry","score_opus":0.21585565229932238,"score_gpt":0.292958377297438,"score_spread":0.07710272499811563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167461562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994036,0.00050984253,0.00093670277,0.000572145,0.0003698037,0.0013097808,0.00013931995,0.00018376984,0.0019426283],"genre_scores_gemma":[0.9898872,0.00080039026,0.007941867,0.00051320373,0.00028514388,0.00019609928,0.00003261943,0.00016782508,0.00017565352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935489,0.00046140762,0.0013439188,0.0010097064,0.0018212114,0.0018148514],"domain_scores_gemma":[0.99556094,0.0007989174,0.0006784126,0.000802234,0.00115947,0.0010000208],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013436849,0.0008193633,0.0014299797,0.0009803721,0.00084027834,0.00018619881,0.0006399027,0.00039873135,0.0009736416],"category_scores_gemma":[0.0038251053,0.00064992544,0.00048534726,0.0015308609,0.0007352166,0.00079029263,0.0003139991,0.0020394758,0.00010275066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019144393,0.001503159,0.92570466,0.000053669137,0.0010332204,0.0001591269,0.008810804,0.000062960054,0.030897235,0.0000063500156,0.0013009288,0.028553432],"study_design_scores_gemma":[0.016186468,0.00085854135,0.95539737,0.0015796276,0.00017034338,0.00010596077,0.0025088135,0.005745835,0.016588466,0.000037993737,0.00012427365,0.00069630565],"about_ca_topic_score_codex":0.00087171147,"about_ca_topic_score_gemma":0.0014381758,"teacher_disagreement_score":0.029692695,"about_ca_system_score_codex":0.000955436,"about_ca_system_score_gemma":0.00023955005,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W2168030494","doi":"10.1177/1352458514551453","title":"Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Toronto Rehabilitation Institute; McGill University; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; University Health Network; University of Manitoba; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Central nervous system; Menarche; Autoimmunity; Demyelinating disease; Young adult; Acute disseminated encephalomyelitis; Encephalomyelitis; Magnetic resonance imaging; Pediatrics; Physiology; Internal medicine; Disease; Immunology","score_opus":0.07660951780008202,"score_gpt":0.28487256377150033,"score_spread":0.20826304597141831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168030494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974377,0.00081625,0.00010853382,0.00023511812,0.00009674883,0.0012150451,0.0000414376,0.000013836251,0.000035304907],"genre_scores_gemma":[0.99533176,0.0011059094,0.0033736383,0.000019444538,0.000058526006,0.00006718862,0.000007767772,0.000031260617,0.000004484737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367106,0.0019724744,0.0023286117,0.00036649153,0.0009343901,0.0007269621],"domain_scores_gemma":[0.9959156,0.0019962662,0.0010753326,0.0005468704,0.00028384212,0.00018212365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075339484,0.00035691538,0.0013840189,0.0005198557,0.00030021495,0.000047113772,0.0006868113,0.00015143203,0.000009899227],"category_scores_gemma":[0.0038974795,0.00020301946,0.00022657255,0.00070553453,0.0009571134,0.00025502685,0.00035023826,0.0010985637,9.84556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010977231,0.00055129256,0.9290826,0.00022293774,0.00018511768,6.6581185e-7,0.00864778,0.00073764834,0.036608487,0.0000093991075,0.0000033506478,0.022853028],"study_design_scores_gemma":[0.012250964,0.00014206598,0.9494867,0.0017169343,0.00005816307,0.000014232284,0.0042142295,0.011881452,0.020051178,0.0000068186896,0.0000031050085,0.00017420077],"about_ca_topic_score_codex":0.007751604,"about_ca_topic_score_gemma":0.017209144,"teacher_disagreement_score":0.022678826,"about_ca_system_score_codex":0.00027616695,"about_ca_system_score_gemma":0.00016359813,"threshold_uncertainty_score":0.9988559},"labels":[],"label_agreement":null},{"id":"W2168098956","doi":"10.1177/1352458514559297","title":"Validity of four screening scales for major depression in MS","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Hotchkiss Brain Institute; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Alberta Innovates - Health Solutions; University of Calgary; Canada Research Chairs; Alberta Health Services","keywords":"Patient Health Questionnaire; Receiver operating characteristic; Depression (economics); Medicine; Hospital Anxiety and Depression Scale; Rating scale; Psychometrics; Anxiety; Physical therapy; Psychiatry; Clinical psychology; Psychology; Depressive symptoms; Internal medicine","score_opus":0.33276547643926696,"score_gpt":0.36493897191115166,"score_spread":0.032173495471884694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168098956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839467,0.0005941515,0.013256573,0.0007762314,0.00026287427,0.000847305,0.000047942394,0.000036217963,0.0002319945],"genre_scores_gemma":[0.9554109,0.0003426703,0.043509267,0.00006623124,0.00047334738,0.0000729593,0.000010957712,0.00004397851,0.00006970537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696267,0.00023097392,0.00081018585,0.0003376993,0.0010078413,0.00065065804],"domain_scores_gemma":[0.99724287,0.00070270256,0.00032035456,0.00032554968,0.00083568547,0.00057284016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025772618,0.00024907538,0.0007050885,0.0004375628,0.00020918327,0.000057186073,0.00026737482,0.00014661011,0.000035637975],"category_scores_gemma":[0.00619168,0.00019688923,0.00031452702,0.0003411548,0.0001732652,0.00027725214,0.00019513724,0.00054024125,0.00000710217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014363793,0.00032956785,0.8869173,0.00011507253,0.00008378639,0.000011767363,0.00041326438,0.00027352202,0.0735935,0.0000016004385,0.004371144,0.032453112],"study_design_scores_gemma":[0.0143432245,0.0004338265,0.9505057,0.0011045217,0.000050464576,0.0000590795,0.0005499905,0.008256644,0.023675133,0.00005840455,0.00077022763,0.00019278249],"about_ca_topic_score_codex":0.00015278383,"about_ca_topic_score_gemma":0.00024408732,"teacher_disagreement_score":0.06358841,"about_ca_system_score_codex":0.00020444742,"about_ca_system_score_gemma":0.00012857444,"threshold_uncertainty_score":0.80289096},"labels":[],"label_agreement":null},{"id":"W2168428527","doi":"10.1191/1352458504ms1004oa","title":"Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Interferon beta; Interferon beta-1b; Antibody; Immunology; BETA (programming language); Interferon; Interferon beta-1a; Virology","score_opus":0.17562929616522577,"score_gpt":0.350103154021096,"score_spread":0.17447385785587022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168428527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950313,0.0020236098,0.00022486482,0.0008994608,0.0006812476,0.00091754063,0.000024035584,0.000044259818,0.00015369257],"genre_scores_gemma":[0.99400705,0.0030249523,0.0024725108,0.00010528965,0.00024662673,0.00003368177,0.0000048845322,0.00008007394,0.000024949188],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945518,0.00047390655,0.0017578504,0.0006433045,0.0015493366,0.0010238315],"domain_scores_gemma":[0.99538237,0.0018372587,0.0010523271,0.00081433274,0.0006007806,0.00031290925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00135447,0.0005898234,0.0015070809,0.00092115643,0.0005423791,0.000089407054,0.0006735263,0.00023018951,0.000024944055],"category_scores_gemma":[0.00624028,0.0004074318,0.00095232174,0.0012635133,0.0007465094,0.0003643596,0.00044609164,0.0015495677,0.000007928632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005920624,0.00082459213,0.47477058,0.00042769473,0.0003507433,0.000011784936,0.0011613361,0.0018121988,0.51615846,0.000009356534,0.00009523808,0.0037859697],"study_design_scores_gemma":[0.007832706,0.0007194236,0.61263424,0.011284185,0.00016758466,0.000022917737,0.00044838045,0.0002975768,0.3663662,0.000016600221,0.000006455307,0.00020370094],"about_ca_topic_score_codex":0.0012720816,"about_ca_topic_score_gemma":0.0006219103,"teacher_disagreement_score":0.14979222,"about_ca_system_score_codex":0.0006030084,"about_ca_system_score_gemma":0.00023073045,"threshold_uncertainty_score":0.99983776},"labels":[],"label_agreement":null},{"id":"W2169155838","doi":"10.1177/1352458512469696","title":"Copy number variation in pediatric multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Stony Brook University; Multiple Sclerosis Society; University of California, San Francisco; Massachusetts General Hospital; National Multiple Sclerosis Society; Mayo Clinic","keywords":"Multiple sclerosis; Copy-number variation; Variation (astronomy); Clinical neurology; Medicine; Genetics; Biology; Neuroscience; Gene; Genome; Immunology","score_opus":0.04034046466346305,"score_gpt":0.22861915655529438,"score_spread":0.18827869189183133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169155838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628556,0.0005327264,0.0017187528,0.00009754394,0.0007263311,0.00014597578,0.000034643526,0.000014112966,0.0004443643],"genre_scores_gemma":[0.99303925,0.0011451484,0.003544127,0.00015155916,0.0018271668,0.000030190813,0.000044589626,0.000035607307,0.00018235299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832827,0.00015652583,0.00048688217,0.00023443776,0.00022299206,0.00057091383],"domain_scores_gemma":[0.9991459,0.00004680607,0.00022235009,0.00024449805,0.00012162361,0.00021876782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006145958,0.00021425952,0.00019350374,0.00010534067,0.00026119998,0.000104615276,0.00022613491,0.0002001693,0.0002337195],"category_scores_gemma":[0.00022190346,0.00020987642,0.00015068121,0.00020039911,0.00003134569,0.00004734476,0.000106496525,0.00024145342,0.00011909546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005714746,0.00022172027,0.90793425,0.000009676742,0.000026894382,5.4388045e-7,0.00044249312,0.00026777797,0.089377575,0.000026496577,0.0010801684,0.00055524573],"study_design_scores_gemma":[0.001904323,0.000056674726,0.97870475,0.000020590509,0.000032626514,0.000049423827,0.00017591116,0.00013322882,0.016764028,0.000024661933,0.0018502561,0.0002835285],"about_ca_topic_score_codex":0.000113279,"about_ca_topic_score_gemma":0.00010145572,"teacher_disagreement_score":0.07261355,"about_ca_system_score_codex":0.000084253705,"about_ca_system_score_gemma":0.00007811657,"threshold_uncertainty_score":0.8558512},"labels":[],"label_agreement":null},{"id":"W2169229493","doi":"10.1177/1352458514564490","title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Medical Center, University of Rochester; EMD Serono; National Institutes of Health; MedDay Pharmaceuticals; Technische Universität München; Università degli Studi di Genova; Gentofte Hospital; Bayer HealthCare; Institut National de la Santé et de la Recherche Médicale; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Children's Hospital of Philadelphia; NYU Langone Medical Center; Teva Pharmaceutical Industries; University of Rochester; Pfizer; Biogen; Gilead Sciences; Yale University; Eli Lilly and Company; U.S. Department of Defense; Sanofi; University College London; Cleveland Clinic; Canadian Institutes of Health Research; Amylin Pharmaceuticals; Genentech; Vrije Universiteit Amsterdam; National Multiple Sclerosis Society","keywords":"Medicine; Incidence (geometry); Disease; Population; Multiple sclerosis; Psoriasis; MEDLINE; Comorbidity; Epidemiology; Internal medicine; Immunology; Environmental health","score_opus":0.1307681602214866,"score_gpt":0.34034962099568905,"score_spread":0.20958146077420245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169229493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014163889,0.99139243,0.000027122087,0.00018895666,0.00023540233,0.0064763906,0.00022219063,0.000024683566,0.000016434058],"genre_scores_gemma":[0.025576523,0.9729701,0.00041567622,0.00010910271,0.00010849001,0.0006008312,0.000010144487,0.00010836623,0.00010075286],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.989037,0.002471385,0.004740847,0.0007805506,0.0021542835,0.00081595813],"domain_scores_gemma":[0.9893614,0.0032542867,0.0040142033,0.0019212759,0.00088250084,0.00056630984],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051735253,0.0009204342,0.0073743337,0.0006602793,0.00031103755,0.00006538859,0.0014044798,0.0002995314,0.00007511721],"category_scores_gemma":[0.03407938,0.00054746744,0.0019652783,0.00134878,0.0009367379,0.00023532697,0.0010573318,0.0017417672,0.0000127458325],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005686428,0.00029310156,0.012449566,0.95617324,0.00047332168,0.000006581852,0.00013539917,0.0000026238981,0.00015668051,0.0000024049903,0.00015260716,0.030097593],"study_design_scores_gemma":[0.0015082533,0.00011686828,0.11223015,0.8803762,0.0038326613,0.000069670066,0.000023869958,0.00031809093,0.000014364185,0.0000026881783,0.001133633,0.0003735394],"about_ca_topic_score_codex":0.00012452331,"about_ca_topic_score_gemma":0.000036453435,"teacher_disagreement_score":0.09978059,"about_ca_system_score_codex":0.00046281717,"about_ca_system_score_gemma":0.0009008414,"threshold_uncertainty_score":0.9996977},"labels":[],"label_agreement":null},{"id":"W2169459006","doi":"10.1177/1352458506070928","title":"Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Myelin; Luxol fast blue stain; Multiple sclerosis; Pathology; Relaxometry; Magnetic resonance imaging; Histopathology; Remyelination; Nuclear magnetic resonance; Chemistry; Medicine; Nuclear medicine; Central nervous system; Radiology; Physics; Internal medicine; Immunology; Spin echo","score_opus":0.1417452837391413,"score_gpt":0.3052127361807104,"score_spread":0.16346745244156907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169459006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87042046,0.00038593763,0.12351907,0.004350922,0.00012215508,0.00055430207,0.000022122751,0.00020891489,0.00041611586],"genre_scores_gemma":[0.9147881,0.00010367548,0.084228985,0.00039661408,0.00013377087,0.0000944911,0.000041348303,0.000056478097,0.00015653885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819523,0.000084002015,0.0005713439,0.00038845808,0.0002585634,0.00050240237],"domain_scores_gemma":[0.9989839,0.00015620085,0.00018384203,0.00032022753,0.00022163763,0.00013419749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002978929,0.000242738,0.00034428257,0.00035614433,0.0003951694,0.00005870511,0.00014969781,0.00006727625,0.00005439209],"category_scores_gemma":[0.000111426845,0.00017830214,0.00011436635,0.00028380912,0.00023122808,0.00028309337,0.000053861928,0.00067274953,0.00004503584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025796844,0.00044371575,0.6571402,0.000010727232,0.0000073524534,0.000087777786,0.0003267005,0.002156828,0.33461383,0.00026495208,0.0012888429,0.0034010988],"study_design_scores_gemma":[0.00474372,0.00019259522,0.95992225,0.0004879548,0.00006908626,0.00075504516,0.0002667752,0.014026115,0.015157327,0.0008253447,0.0032220932,0.00033168792],"about_ca_topic_score_codex":0.00016584291,"about_ca_topic_score_gemma":0.00015546563,"teacher_disagreement_score":0.3194565,"about_ca_system_score_codex":0.00022415433,"about_ca_system_score_gemma":0.00005405874,"threshold_uncertainty_score":0.727095},"labels":[],"label_agreement":null},{"id":"W2170433606","doi":"10.1177/1352458508093892","title":"Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon β-1a: analysis of the PRISMS study","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"Merck KGaA","keywords":"Multiple sclerosis; Medicine; Disease; Limiting; Physical therapy; Internal medicine; Immunology","score_opus":0.06095092396963838,"score_gpt":0.2680302757092021,"score_spread":0.20707935173956374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170433606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958272,0.00006609712,0.00019951329,0.00061286887,0.00006483687,0.0025939532,0.00056460797,0.000025744295,0.000045168683],"genre_scores_gemma":[0.99741155,0.0005196125,0.0014632986,0.00004472146,0.000039849183,0.00020370794,0.00018078476,0.00006140949,0.000075090924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606025,0.00046089923,0.0010839001,0.00055093865,0.0011963916,0.0006476286],"domain_scores_gemma":[0.9964445,0.0002931977,0.00066318765,0.0007937964,0.0010900057,0.0007152895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033446308,0.00046965893,0.0011060437,0.0013278383,0.0005982626,0.000045244742,0.000344576,0.000097634795,0.00021512304],"category_scores_gemma":[0.0005477743,0.00027991505,0.00034907262,0.0027363666,0.0003605341,0.0003377594,0.00009955873,0.00039022873,0.000002050332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00498138,0.0045548887,0.9578485,0.00002098233,0.00330529,0.000009115207,0.0034352704,0.024270488,0.00022042662,2.3419634e-7,0.00009948665,0.0012539208],"study_design_scores_gemma":[0.019179177,0.004806039,0.96192926,0.00069747865,0.0018493655,0.0000030993415,0.0010331258,0.009845186,0.00039878767,2.3594794e-7,0.000018231718,0.00023999675],"about_ca_topic_score_codex":0.057645205,"about_ca_topic_score_gemma":0.120964356,"teacher_disagreement_score":0.063319154,"about_ca_system_score_codex":0.0016450371,"about_ca_system_score_gemma":0.0008235885,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W2171821866","doi":"10.1177/1352458512458169","title":"Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of Toronto","funders":"IC Design Education Center; Innovative Medicines Initiative; Wellcome Trust; Biogen","keywords":"Repurposing; Medicine; Expediting; Clinical trial; Multiple sclerosis; Management; Psychiatry; Pathology","score_opus":0.48127786316580623,"score_gpt":0.4644677317707142,"score_spread":0.01681013139509202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171821866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034235918,0.9768696,0.000059594724,0.002951961,0.0024583116,0.014887212,0.0016401422,0.00016858228,0.00062226795],"genre_scores_gemma":[0.005829474,0.9672881,0.0049840384,0.0003535472,0.009082164,0.010998241,0.0004645208,0.0004644989,0.0005354123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847788,0.0025748487,0.0026871176,0.0016992553,0.0050062495,0.0032536788],"domain_scores_gemma":[0.97762895,0.011154698,0.0024933382,0.0015231778,0.006022448,0.0011773815],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.009553833,0.0016422383,0.0035128503,0.0016683093,0.0040635117,0.0015283158,0.0025284337,0.0009256799,0.00046413223],"category_scores_gemma":[0.02070402,0.0009993338,0.0022699644,0.0021333592,0.0015439894,0.00061283447,0.001365912,0.0063102865,0.00033800775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011615785,0.0014158661,0.0006525185,0.004480308,0.0039879587,0.00007415649,0.0021597557,0.000007884528,0.0002579843,0.000023760605,0.056593034,0.9291852],"study_design_scores_gemma":[0.006663967,0.0012739328,0.0021836173,0.06652242,0.001414232,0.0003417869,0.0020545607,0.00037915332,0.00026724473,0.000014603405,0.91789484,0.0009896591],"about_ca_topic_score_codex":0.000031168147,"about_ca_topic_score_gemma":0.000049171475,"teacher_disagreement_score":0.92819554,"about_ca_system_score_codex":0.002680486,"about_ca_system_score_gemma":0.0025315695,"threshold_uncertainty_score":0.9996325},"labels":[],"label_agreement":null},{"id":"W2172299842","doi":"10.1177/1352458507088104","title":"Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Surrogate endpoint; Multiple sclerosis; Magnetic resonance imaging; Medicine; McDonald criteria; Clinical trial; Pathology; Radiology; Immunology","score_opus":0.16700613420333058,"score_gpt":0.32224179365824873,"score_spread":0.15523565945491816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172299842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971898,0.017180465,0.0010784537,0.0045498842,0.0011958405,0.0026175303,0.00025194895,0.00040536374,0.000822481],"genre_scores_gemma":[0.9663328,0.010380222,0.018379647,0.0011795743,0.0011178127,0.0004374975,0.000034767934,0.00022626262,0.0019114373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927995,0.0003061632,0.0018077417,0.0011276978,0.0018565085,0.0021023606],"domain_scores_gemma":[0.9939617,0.001847119,0.0005331642,0.0010044951,0.0014315449,0.0012219661],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001651356,0.00084938767,0.0014624088,0.0007280654,0.0025005143,0.0002613813,0.0007277186,0.0002405968,0.00045544832],"category_scores_gemma":[0.010428532,0.000741038,0.0011060846,0.0008148293,0.00087121665,0.0007133973,0.00039504727,0.0013900177,0.0003257393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018594835,0.0006890335,0.82921785,0.00013590558,0.00013519471,0.00015723612,0.0010168025,0.000049010083,0.07977973,0.0000131313645,0.017223267,0.06972334],"study_design_scores_gemma":[0.020744216,0.00084694265,0.9297759,0.0011048344,0.00016784434,0.0010788259,0.00062204374,0.0065209954,0.007980387,0.000040869843,0.030315509,0.00080164516],"about_ca_topic_score_codex":0.00032507296,"about_ca_topic_score_gemma":0.00012919339,"teacher_disagreement_score":0.10055801,"about_ca_system_score_codex":0.0006316083,"about_ca_system_score_gemma":0.0004071625,"threshold_uncertainty_score":0.9995041},"labels":[],"label_agreement":null},{"id":"W2173315418","doi":"10.1177/1352458515616701","title":"Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; Biogen; Allergan; Eli Lilly and Company","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Inclusion (mineral); Brain size; Disease; Psychology; Pathology; Magnetic resonance imaging; Immunology; Radiology","score_opus":0.12325563741630512,"score_gpt":0.31995931057430665,"score_spread":0.19670367315800152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173315418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071556,0.0028473467,0.0006019492,0.004243147,0.00021230798,0.0012151394,0.000083990475,0.00003073849,0.000049813454],"genre_scores_gemma":[0.99054897,0.0064978013,0.002467149,0.00007227808,0.0001776281,0.000055428754,0.000002704451,0.000083001214,0.000095032636],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9922515,0.0012064606,0.0023563907,0.00076092774,0.0024023906,0.0010223031],"domain_scores_gemma":[0.991362,0.003811594,0.0016033029,0.0009428346,0.0016379661,0.0006423067],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0059468444,0.0005335912,0.0018037708,0.0012801208,0.0002905109,0.000028420807,0.0007113281,0.0002729545,0.00017008116],"category_scores_gemma":[0.040964585,0.00040119851,0.000624007,0.0014515666,0.00075731816,0.0009157164,0.00127879,0.00096182415,0.000012685054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009114608,0.0007252503,0.4442908,0.0006856593,0.00007012208,0.0000123103,0.000862708,0.00005961266,0.51363873,0.0000010893963,0.00022140706,0.030317713],"study_design_scores_gemma":[0.013544949,0.0012294106,0.8733614,0.06257997,0.0000728552,0.000008129951,0.0001663473,0.0032433984,0.04537046,0.00002072716,0.00005307291,0.00034926765],"about_ca_topic_score_codex":0.00060935196,"about_ca_topic_score_gemma":0.00039559358,"teacher_disagreement_score":0.46826828,"about_ca_system_score_codex":0.00082442677,"about_ca_system_score_gemma":0.00064201775,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2174409614","doi":"10.1177/1352458515602336","title":"Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; McGill University; Mental Health Research Canada; Hospital for Sick Children; York University","funders":"","keywords":"Precuneus; Resting state fMRI; Thalamus; Anterior cingulate cortex; Cognition; Multiple sclerosis; Posterior cingulate; Medicine; Neuroscience; Effects of sleep deprivation on cognitive performance; Cortex (anatomy); Cingulate cortex; Audiology; Psychology; Cardiology; Central nervous system; Psychiatry","score_opus":0.1742270362341723,"score_gpt":0.31416682117691375,"score_spread":0.13993978494274145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174409614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768054,0.00020231641,0.0000990382,0.00056022115,0.00019597383,0.0009700317,0.00017699391,0.000033185937,0.00008168321],"genre_scores_gemma":[0.99820626,0.00021211198,0.0009021511,0.00017434546,0.0003119757,0.00006136496,0.00004629698,0.000032910208,0.000052578394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718916,0.00039863444,0.0005496235,0.000472951,0.00081411557,0.0005755044],"domain_scores_gemma":[0.9962313,0.0014312997,0.00021817596,0.00012805802,0.0011671489,0.00082397513],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012275875,0.00029218895,0.0004439036,0.00047712558,0.00049226725,0.00015819343,0.00008996601,0.000091343085,0.000022066375],"category_scores_gemma":[0.011757886,0.00025420112,0.00005458493,0.00044779602,0.00020898378,0.0006204887,0.00023005294,0.00084617554,0.00001182635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024432312,0.0001308076,0.9900544,0.00007482416,0.00005601358,0.000007823273,0.0016184226,0.00008435617,0.0004224487,3.987079e-7,0.00076116767,0.004346098],"study_design_scores_gemma":[0.013943089,0.0007987608,0.97922933,0.0003914491,0.00006464646,0.000039552822,0.0005021335,0.004467979,0.00025711316,0.000035547433,0.000013064972,0.00025730958],"about_ca_topic_score_codex":0.00013197616,"about_ca_topic_score_gemma":0.0002446515,"teacher_disagreement_score":0.0114998575,"about_ca_system_score_codex":0.0001857061,"about_ca_system_score_gemma":0.00018335515,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W2174668862","doi":"10.1177/1352458515603802","title":"Progressive MS: from pathophysiology to drug discovery","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Neuroscience; Drug discovery; Disease; Neuroinflammation; Druggability; Neurodegeneration; Multiple sclerosis; Medicine; Engineering ethics; Bioinformatics; Biology; Psychiatry; Genetics; Pathology; Engineering","score_opus":0.19782378144136764,"score_gpt":0.38658791781634333,"score_spread":0.1887641363749757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174668862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001455544,0.99218416,0.00007346557,0.00045728523,0.0014026725,0.0030472705,0.0010458946,0.0001218145,0.00021190027],"genre_scores_gemma":[0.00031276233,0.9879715,0.0042406144,0.00030610015,0.005129653,0.0006974185,0.00039302165,0.00026382823,0.0006851199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922876,0.0010854101,0.0019042665,0.0013231384,0.0018676991,0.0015319121],"domain_scores_gemma":[0.99364114,0.0011144609,0.0010925521,0.0012597676,0.0010457883,0.0018463114],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012824255,0.0012700623,0.005431991,0.0008611941,0.00052117946,0.0005077369,0.0010598017,0.0005566617,0.00034742395],"category_scores_gemma":[0.0036877706,0.0008673219,0.0018235092,0.0008807829,0.00036040568,0.0004483522,0.0011538245,0.0028713015,0.0010371899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002672703,0.0004462535,0.00021905669,0.002290893,0.0013825075,0.0003249312,0.0005373991,0.0000037489228,0.00023897263,0.0000011289607,0.07052537,0.92376244],"study_design_scores_gemma":[0.0028114978,0.00048336937,0.002283796,0.046261836,0.0014183456,0.00019133886,0.00024107331,0.000021743115,0.000021844335,0.000044577686,0.9453001,0.0009204676],"about_ca_topic_score_codex":0.0001759,"about_ca_topic_score_gemma":0.000040023715,"teacher_disagreement_score":0.922842,"about_ca_system_score_codex":0.0013648208,"about_ca_system_score_gemma":0.0016360236,"threshold_uncertainty_score":0.9997406},"labels":[],"label_agreement":null},{"id":"W2175006891","doi":"10.1177/1352458515615224","title":"Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Multiple sclerosis; Cerebellum; Demyelinating disease; Medicine; Neuroscience; Immunology; Psychology; Internal medicine","score_opus":0.11634667155560653,"score_gpt":0.30502988613374976,"score_spread":0.18868321457814324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175006891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993535,0.0011322201,0.00007998621,0.0038264475,0.00044753466,0.0007076694,0.000065993736,0.000041199535,0.00016395039],"genre_scores_gemma":[0.9966167,0.001045835,0.0013061567,0.00018836417,0.00064708246,0.000042063086,0.0000071335667,0.00005154712,0.00009512614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99577606,0.0005028098,0.001013153,0.00037544797,0.0015350669,0.0007974421],"domain_scores_gemma":[0.99667937,0.00046958955,0.00046909077,0.000513682,0.00091188634,0.0009564138],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019875763,0.00031745492,0.00061733153,0.00040925745,0.00032129092,0.00007177998,0.0005508836,0.00011460469,0.000056617275],"category_scores_gemma":[0.011815869,0.00021545657,0.00040462823,0.0009988053,0.0002777806,0.00027920678,0.0004638288,0.00062780397,0.00001893475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061035855,0.00045247746,0.98581266,0.000120910336,0.000062693405,0.000021923019,0.0012461413,0.000121506935,0.005000284,0.0000031359896,0.0048931176,0.00165478],"study_design_scores_gemma":[0.007294071,0.0001561071,0.98513234,0.00044723536,0.00010804605,0.00003186895,0.0006868023,0.004078975,0.0016857969,0.00008871181,0.00008616114,0.00020385996],"about_ca_topic_score_codex":0.0001695475,"about_ca_topic_score_gemma":0.00014498486,"teacher_disagreement_score":0.009828293,"about_ca_system_score_codex":0.00042853213,"about_ca_system_score_gemma":0.00074599165,"threshold_uncertainty_score":0.996508},"labels":[],"label_agreement":null},{"id":"W2203540357","doi":"10.1177/1352458515618020","title":"Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Lung transplantation; Interferon beta-1b; Internal medicine; Pulmonary hypertension; Interferon beta; BETA (programming language); Lung; Gastroenterology; Pathology; Immunology","score_opus":0.16097800271971083,"score_gpt":0.29112971229749385,"score_spread":0.13015170957778302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203540357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952916,0.00075092615,0.000017717324,0.001347325,0.0010883285,0.001226539,0.00004316168,0.00008309005,0.0001512947],"genre_scores_gemma":[0.9968645,0.0009090795,0.0006285814,0.00080512743,0.00023965961,0.0000722885,0.00018088515,0.000100055455,0.00019983569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568677,0.00035323997,0.0009996505,0.0006917318,0.0012441021,0.0010244894],"domain_scores_gemma":[0.9966033,0.00015971318,0.00022189521,0.0005756033,0.0007436358,0.0016958191],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006471704,0.0005118912,0.00086134986,0.00074283977,0.00029857305,0.00014817916,0.00034843734,0.00028529728,0.00020861131],"category_scores_gemma":[0.000520176,0.0003911036,0.00032038701,0.00063398527,0.00011647261,0.0005027722,0.00022077348,0.0008408995,0.00043175634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009667382,0.0042550964,0.8579829,0.000012436318,0.0001852018,0.0013276391,0.00020685047,0.00002408628,0.076588005,3.2952244e-7,0.0018193026,0.047930814],"study_design_scores_gemma":[0.024442153,0.0030674734,0.96517897,0.0009064736,0.000053933207,0.0005614734,0.00015395574,0.0010485357,0.003931019,0.000014798011,0.0002690039,0.0003721882],"about_ca_topic_score_codex":0.00018019752,"about_ca_topic_score_gemma":0.000066003384,"teacher_disagreement_score":0.10719613,"about_ca_system_score_codex":0.00074104127,"about_ca_system_score_gemma":0.00020444422,"threshold_uncertainty_score":0.9998541},"labels":[],"label_agreement":null},{"id":"W2215855864","doi":"10.1177/1352458515621624","title":"Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Lawson Foundation; Child and Family Research Institute; Multiple Sclerosis Trust; Multiple Sclerosis Society; Research Manitoba; European Committee for Treatment and Research in Multiple Sclerosis; U.S. Department of Veterans Affairs; Teva Pharmaceutical Industries; Canadian Institute for Advanced Research; Sanofi; National Multiple Sclerosis Society; Biogen","keywords":"Multiple sclerosis; Medicine; Developmental psychology; Psychology; Early childhood; Pediatrics; Psychiatry","score_opus":0.1586364175409802,"score_gpt":0.3048482244957118,"score_spread":0.1462118069547316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215855864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962816,0.00080485316,0.000257348,0.00095087016,0.00056548853,0.0005583065,0.00020960104,0.00008299762,0.0002889393],"genre_scores_gemma":[0.9915926,0.00037757927,0.0069405152,0.00024041446,0.0006699804,0.000018317984,0.000082214676,0.000046993955,0.000031377233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955393,0.000701826,0.0011600576,0.00045236942,0.0012832187,0.000863191],"domain_scores_gemma":[0.9967327,0.0007000653,0.0007572824,0.00022830533,0.00040140032,0.0011802487],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0027856543,0.0003192444,0.0005973235,0.00024623956,0.0015611661,0.0002479377,0.00061196194,0.00023042952,0.000049553324],"category_scores_gemma":[0.0036666628,0.00031418784,0.00017410913,0.00051926565,0.00064102456,0.00085251295,0.00022921375,0.0006433456,0.00003502478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002855414,0.00022160665,0.96827406,0.000008283911,0.000075297045,7.476236e-7,0.013242734,0.000023728528,0.000038918475,0.00003508184,0.0017054408,0.016345577],"study_design_scores_gemma":[0.0033218865,0.00014202327,0.98453915,0.00030369198,0.00003107932,0.000017272412,0.010480233,0.00001879061,0.00007096589,0.00014465569,0.0005821067,0.00034812107],"about_ca_topic_score_codex":0.0035262522,"about_ca_topic_score_gemma":0.002201167,"teacher_disagreement_score":0.016265143,"about_ca_system_score_codex":0.00090610195,"about_ca_system_score_gemma":0.0015495026,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W2257149495","doi":"10.1177/1352458515606526","title":"Physical activity and pediatric multiple sclerosis: Developing a research agenda","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Neurocognitive; Medicine; Disease; Physical activity; Depression (economics); MEDLINE; Physical therapy; Pediatrics; Psychology; Physical medicine and rehabilitation; Gerontology; Cognition; Psychiatry; Pathology","score_opus":0.5836140953063959,"score_gpt":0.4635964834458713,"score_spread":0.12001761186052456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257149495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027171157,0.967404,0.000106471656,0.0004168567,0.0006649815,0.0035396784,0.00024885783,0.00021215712,0.00023583887],"genre_scores_gemma":[0.017926658,0.97258973,0.0029273985,0.000048912578,0.0051294966,0.000646699,0.000056892786,0.0003848097,0.00028941286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862268,0.0027543223,0.0016588944,0.0019390258,0.0045194407,0.0029015278],"domain_scores_gemma":[0.9890146,0.003909713,0.0010779641,0.0013247869,0.002567313,0.0021055718],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007109435,0.0016432292,0.00561843,0.00253287,0.0021002202,0.00090331386,0.0011240307,0.0009456722,0.00005535034],"category_scores_gemma":[0.010220506,0.0012674959,0.0015789275,0.0029547324,0.0009454573,0.0007038133,0.002086262,0.007422036,0.00038028564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025200352,0.0008838193,0.0018852364,0.011699029,0.0008929439,0.000110150984,0.00072985195,0.0000016971561,0.00029933295,0.000004115835,0.013497726,0.9697441],"study_design_scores_gemma":[0.010277149,0.0011398944,0.038622104,0.046327513,0.002850733,0.0009780726,0.00057739223,0.000832888,0.00011790072,0.000036052246,0.8957168,0.002523522],"about_ca_topic_score_codex":0.00018727926,"about_ca_topic_score_gemma":0.00008457583,"teacher_disagreement_score":0.96722054,"about_ca_system_score_codex":0.0026599397,"about_ca_system_score_gemma":0.003920181,"threshold_uncertainty_score":0.99963146},"labels":[],"label_agreement":null},{"id":"W2271738643","doi":"10.1177/1352458515623862","title":"MS arising during Tocilizumab therapy for rheumatoid arthritis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Tocilizumab; Medicine; Neuromyelitis optica; Multiple sclerosis; Rheumatoid arthritis; Complication; Immunology; Internal medicine","score_opus":0.09439489377069125,"score_gpt":0.3035789517136868,"score_spread":0.20918405794299555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271738643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853663,0.0039916593,0.004005523,0.0043806774,0.000513853,0.0012377138,0.00007112765,0.0001563774,0.00027676972],"genre_scores_gemma":[0.9271581,0.0659696,0.0052272426,0.00015404703,0.0008606937,0.00019263485,0.000004461003,0.00009406784,0.00033914286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964776,0.00012962788,0.0008335192,0.0005275902,0.0009056715,0.0011259634],"domain_scores_gemma":[0.997258,0.00072622724,0.0002895831,0.00047617385,0.0006687863,0.00058122526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000901174,0.00038931213,0.0007329428,0.00033639208,0.001077946,0.00019563886,0.00028639298,0.00016013457,0.00058370933],"category_scores_gemma":[0.0023166693,0.00024960237,0.0005607814,0.00023362116,0.00025984997,0.00044598366,0.00012500511,0.00042735957,0.00007487128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017557265,0.00025086917,0.062068224,0.000035745856,0.0003045771,0.000015909092,0.0004071185,0.0000046494492,0.6014741,0.000008218603,0.0043947613,0.32928008],"study_design_scores_gemma":[0.045297597,0.0008332332,0.78335637,0.0032387858,0.000016460895,0.00046397603,0.0003370219,0.00019798326,0.150781,0.000114995935,0.01484449,0.00051809195],"about_ca_topic_score_codex":0.00004612612,"about_ca_topic_score_gemma":0.00006183646,"teacher_disagreement_score":0.72128814,"about_ca_system_score_codex":0.00045289268,"about_ca_system_score_gemma":0.00018011105,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W2274742391","doi":"10.1177/1352458515588582","title":"In multiple sclerosis anxiety, not depression, is related to gender","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Multiple sclerosis; Population; Etiology; Psychiatry; Psychology; Clinical psychology; Medicine","score_opus":0.24169075816506508,"score_gpt":0.33999098252796994,"score_spread":0.09830022436290486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274742391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713356,0.0011247735,0.000417019,0.0067216023,0.0010025755,0.0015236025,0.00010171984,0.00018402662,0.0017910952],"genre_scores_gemma":[0.9847367,0.0012732772,0.008913897,0.0030758837,0.00058611215,0.00018230415,0.000025283834,0.00016668583,0.0010398959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992399,0.00044164708,0.0017128771,0.0011289114,0.0025353748,0.0017822172],"domain_scores_gemma":[0.99469846,0.00045089918,0.0003837405,0.0010098451,0.0012955562,0.0021615042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025515931,0.000738098,0.0012290742,0.0011625201,0.0005989833,0.00030156435,0.0007027621,0.00044354566,0.0005030389],"category_scores_gemma":[0.004681477,0.00062969216,0.0005168474,0.0016364268,0.0002632764,0.0007736686,0.0007368981,0.0017865635,0.0007567426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012493507,0.00078140036,0.6918887,0.00005179362,0.0002104953,0.000064828586,0.003426056,0.00078088633,0.14617777,0.0000034774596,0.1415877,0.013777573],"study_design_scores_gemma":[0.017449858,0.00031667267,0.92802125,0.00082674413,0.00008364584,0.00020097135,0.0010553497,0.0051043564,0.033400767,0.00007727396,0.012755488,0.0007076275],"about_ca_topic_score_codex":0.0007808746,"about_ca_topic_score_gemma":0.0002995307,"teacher_disagreement_score":0.23613258,"about_ca_system_score_codex":0.0011001792,"about_ca_system_score_gemma":0.00042038818,"threshold_uncertainty_score":0.99961543},"labels":[],"label_agreement":null},{"id":"W2281587378","doi":"10.1177/1352458515607652","title":"What to make of cannabis and cognition in MS: In search of clarity amidst the haze","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cannabis; Cognition; Multiple sclerosis; Effects of cannabis; Psychology; CLARITY; Cognitive psychology; Medicine; Psychiatry","score_opus":0.1793932699447606,"score_gpt":0.38107936281476695,"score_spread":0.20168609287000636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281587378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026878972,0.9674855,0.0000042904117,0.0035579014,0.0002211533,0.0016533353,0.00009918669,0.0000047127714,0.00009494904],"genre_scores_gemma":[0.00850298,0.9903827,0.00006384493,0.00007846435,0.00017907255,0.00009679507,0.000025861696,0.0000440001,0.0006262864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963753,0.0005948723,0.0011815256,0.000322879,0.0010384965,0.00048691232],"domain_scores_gemma":[0.99819374,0.00005866428,0.00031550255,0.00036673446,0.0006797796,0.00038555762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003861599,0.00029107058,0.0017191332,0.00091384834,0.00006480766,0.00011871412,0.00030068282,0.00032144802,0.00006709761],"category_scores_gemma":[0.0006313253,0.00019013198,0.00031029092,0.00096139987,0.00028605288,0.00014434743,0.0002239565,0.0017522702,0.000004483534],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020082184,0.00030312696,0.0021648668,0.006339128,0.00008491351,0.0000325958,0.0010062349,0.0000062200543,0.00012787992,0.0000041734224,0.008477387,0.9812527],"study_design_scores_gemma":[0.00433088,0.0008157744,0.08579408,0.07360793,0.0003759603,0.0004564311,0.0026325164,0.00009136053,0.00012747533,0.000032004333,0.8313501,0.0003854846],"about_ca_topic_score_codex":0.0012553429,"about_ca_topic_score_gemma":0.0029735,"teacher_disagreement_score":0.98086715,"about_ca_system_score_codex":0.0004890221,"about_ca_system_score_gemma":0.0012359879,"threshold_uncertainty_score":0.77533567},"labels":[],"label_agreement":null},{"id":"W2293079710","doi":"10.1177/1352458516630396","title":"The relationship of age with the clinical phenotype in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Age of onset; Medicine; Young adult; Internal medicine; Affect (linguistics); Pediatrics; Disease; Immunology; Psychology","score_opus":0.2938941819590893,"score_gpt":0.35909867901082526,"score_spread":0.06520449705173598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293079710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814202,0.0009451161,0.0007486465,0.015154937,0.00030723918,0.0009810004,0.000027526916,0.000044470595,0.0003708238],"genre_scores_gemma":[0.9928556,0.0042063994,0.00163199,0.00021101115,0.00049644447,0.00009417073,0.0000026398839,0.00006501716,0.00043673583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490434,0.00096213416,0.001395451,0.00046991053,0.001352843,0.000915303],"domain_scores_gemma":[0.9842798,0.013129342,0.00062786957,0.00095171,0.00062353525,0.00038775196],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048237625,0.00036064404,0.0007371868,0.00023586326,0.0011256585,0.00013171246,0.00070557167,0.00018828064,0.00007888431],"category_scores_gemma":[0.013460764,0.00014374725,0.00041292582,0.0007600556,0.0017569639,0.00028421433,0.000262581,0.0012800948,0.00006338509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660796,0.00032986345,0.9010488,0.00002178213,0.0002247991,0.000014283772,0.0004648212,0.000020401392,0.021985916,0.00006007365,0.004137557,0.07022566],"study_design_scores_gemma":[0.010354415,0.0004864377,0.98290545,0.0013380039,0.0000760029,0.000023409542,0.00069011044,0.0002065138,0.00088171643,0.00006803115,0.0027650378,0.00020489132],"about_ca_topic_score_codex":0.00013703096,"about_ca_topic_score_gemma":0.0020120754,"teacher_disagreement_score":0.081856675,"about_ca_system_score_codex":0.00025283176,"about_ca_system_score_gemma":0.0002975123,"threshold_uncertainty_score":0.99484926},"labels":[],"label_agreement":null},{"id":"W2293314724","doi":"10.1177/1352458515595876","title":"Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; University of British Columbia; Hospital for Sick Children; McGill University; University of Calgary","funders":"Hospital for Sick Children","keywords":"Multiple sclerosis; Medicine; Cytomegalovirus; Seroprevalence; Herpes simplex virus; Virus; Prospective cohort study; Virology; Immunology; Herpesviridae; Cohort; Viral disease; Serology; Antibody; Internal medicine","score_opus":0.08407825877589259,"score_gpt":0.3126955497438281,"score_spread":0.22861729096793554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293314724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974161,0.0005511495,0.0002494987,0.0004156471,0.000059726444,0.0010283069,0.000015855534,0.000027768678,0.00023595583],"genre_scores_gemma":[0.9942127,0.00035124162,0.005070128,0.000048727787,0.00017064787,0.000062638566,0.00000825635,0.000031792297,0.00004387753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975009,0.00015142575,0.0006547946,0.00032362543,0.00095199206,0.0004172449],"domain_scores_gemma":[0.998438,0.000117793636,0.00027059537,0.00021183,0.0006013005,0.00036047472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012371095,0.0002353275,0.0006324853,0.0003869953,0.00012121792,0.00005808328,0.00013257176,0.00009654121,0.00001886636],"category_scores_gemma":[0.0014862589,0.00016779738,0.00008451035,0.00032647126,0.00031213093,0.00031479198,0.00011618612,0.00035958065,0.000003874874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009650607,0.0002807297,0.9835202,0.00002341693,0.00024895096,0.0000065630056,0.0012685463,0.00006688626,0.009917926,0.000009204942,0.00013316778,0.003559333],"study_design_scores_gemma":[0.011800314,0.00093360816,0.98209244,0.00028419026,0.00007130536,0.00011688744,0.00041769946,0.00046439172,0.0035982293,0.000041917603,0.000012268398,0.00016672468],"about_ca_topic_score_codex":0.00030392237,"about_ca_topic_score_gemma":0.00025244177,"teacher_disagreement_score":0.010835254,"about_ca_system_score_codex":0.0002800179,"about_ca_system_score_gemma":0.00014715425,"threshold_uncertainty_score":0.68425786},"labels":[],"label_agreement":null},{"id":"W2307653230","doi":"10.1177/1352458516639759","title":"Lymphomatoid papulosis and fingolimod—A new connection?","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Lymphomatoid papulosis; Fingolimod; Multiple sclerosis; Connection (principal bundle); Medicine; Dermatology; Internal medicine; Mathematics; Immunology","score_opus":0.051495471104873805,"score_gpt":0.24060229625556445,"score_spread":0.18910682515069066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307653230","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03400927,0.0088013755,0.00066982757,0.95197624,0.002054221,0.00080002926,0.00018656452,0.00033241176,0.0011700566],"genre_scores_gemma":[0.060930043,0.008029973,0.0031648024,0.86758614,0.035027023,0.00006949365,0.00018875128,0.0005683564,0.024435407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967516,0.00015710936,0.00081090815,0.00060653687,0.00081666716,0.00085714844],"domain_scores_gemma":[0.99747753,0.000461502,0.0006290791,0.0006406877,0.00025792856,0.0005332818],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025821012,0.0006276648,0.0010096726,0.00036250261,0.00068003585,0.00044426334,0.00029105612,0.00086680346,0.0026419866],"category_scores_gemma":[0.00074737513,0.0004719115,0.00053104357,0.00016442726,0.00019707007,0.00020295489,0.0001618678,0.001581306,0.00027415564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013619626,0.000050792787,0.017795783,0.00012515126,0.00040705007,0.00038897732,0.00006736544,6.404134e-7,0.0023403012,0.0000011786292,0.95590216,0.022784382],"study_design_scores_gemma":[0.006399875,0.00019802511,0.0723528,0.0028120137,0.00055338704,0.004756791,0.00003497218,0.000032576612,0.00040569628,0.00013945543,0.91172594,0.000588458],"about_ca_topic_score_codex":0.00020940644,"about_ca_topic_score_gemma":0.0000059238355,"teacher_disagreement_score":0.0843901,"about_ca_system_score_codex":0.00044337707,"about_ca_system_score_gemma":0.0006929483,"threshold_uncertainty_score":0.99977326},"labels":[],"label_agreement":null},{"id":"W2312891533","doi":"10.1177/1352458516641208","title":"Distraction adds to the cognitive burden in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre; University of Toronto; Carleton University; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Psychology; Cognitive impairment; Cognition; Distraction; Audiology; Developmental psychology; Physical medicine and rehabilitation; Medicine; Cognitive psychology; Psychiatry","score_opus":0.16257325820934496,"score_gpt":0.3220560803377602,"score_spread":0.15948282212841522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312891533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97152203,0.00043110125,0.0026097586,0.022391824,0.0006539555,0.0016320891,0.0002008003,0.00010704065,0.00045138074],"genre_scores_gemma":[0.9931432,0.0027280264,0.0009406447,0.00063703244,0.0015897847,0.0003176296,0.000012670549,0.000090705355,0.00054028304],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99492663,0.00045176226,0.0010380932,0.00074377505,0.0015128254,0.001326912],"domain_scores_gemma":[0.99515814,0.0022916796,0.0003142675,0.0006018985,0.0007929004,0.0008410929],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018660199,0.0005119593,0.0007406341,0.0005987075,0.00088589964,0.00023539641,0.0005217481,0.00020608395,0.0006141811],"category_scores_gemma":[0.010016977,0.0002853662,0.00041755024,0.00093751494,0.00037558525,0.0005582347,0.00035484094,0.0010433324,0.0007662232],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002046504,0.00048087587,0.3275244,0.000034641358,0.00028425886,0.000039484978,0.001636905,0.00005733125,0.32074508,0.000004706362,0.008578223,0.3385676],"study_design_scores_gemma":[0.010643437,0.000476377,0.9654479,0.0029224954,0.000085393855,0.00009383735,0.0018480748,0.00057719636,0.011282234,0.000015298854,0.0062047415,0.00040304012],"about_ca_topic_score_codex":0.0005803687,"about_ca_topic_score_gemma":0.0017151865,"teacher_disagreement_score":0.6379235,"about_ca_system_score_codex":0.0008191705,"about_ca_system_score_gemma":0.0002067511,"threshold_uncertainty_score":0.9999598},"labels":[],"label_agreement":null},{"id":"W2317727574","doi":"10.1177/1352458516641775","title":"Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Multiple sclerosis; Medicine; Pathology; Parenchyma; Immunology; Natalizumab; Pathogenesis; Immune system; Central nervous system; Inflammation; Internal medicine","score_opus":0.07150906413559634,"score_gpt":0.2904811260581463,"score_spread":0.21897206192254998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317727574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945726,0.00020937754,0.0030732648,0.001316459,0.00023659054,0.00038723534,0.00006775888,0.00005797737,0.00007873058],"genre_scores_gemma":[0.9960822,0.0021124792,0.0014064796,0.000045553534,0.00021405981,0.000024938061,0.000009606209,0.000028667215,0.00007600279],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973547,0.00032253875,0.0005640652,0.00042554777,0.0007728206,0.00056033616],"domain_scores_gemma":[0.9984401,0.00038909205,0.00031820248,0.00030354262,0.0002523733,0.0002966735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093617116,0.00028604877,0.00068867585,0.0002074228,0.0004101472,0.000082869876,0.00018656226,0.0001776295,0.00014225324],"category_scores_gemma":[0.0021113544,0.00016502113,0.00029169515,0.00021412356,0.00054494967,0.00048071027,0.00029704365,0.00047579082,0.000012223827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008559358,0.0002244847,0.11424043,0.000023227467,0.00015508952,0.00005620408,0.00014138968,1.2279916e-7,0.7685534,0.000006880626,0.00001916483,0.11572369],"study_design_scores_gemma":[0.0063236943,0.0008312554,0.90587413,0.0005491525,0.00005459535,0.00023720083,0.00006568056,0.000102759215,0.08548592,0.000013788128,0.00027284404,0.00018899473],"about_ca_topic_score_codex":0.000020560767,"about_ca_topic_score_gemma":0.0000069608295,"teacher_disagreement_score":0.79163367,"about_ca_system_score_codex":0.00018165288,"about_ca_system_score_gemma":0.00008532074,"threshold_uncertainty_score":0.6729367},"labels":[],"label_agreement":null},{"id":"W2320749905","doi":"10.1177/1352458516638941","title":"The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Genentech; F. Hoffmann-La Roche; Sanofi","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Clinical endpoint; Physical medicine and rehabilitation; Expanded Disability Status Scale; Physical therapy; Pediatrics; Psychology; Internal medicine; Neuroscience; Clinical trial; Psychiatry","score_opus":0.10770849510027879,"score_gpt":0.3424609425528899,"score_spread":0.2347524474526111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320749905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97888356,0.0022602635,0.0018845854,0.00962396,0.00086579216,0.0058406694,0.0003606566,0.00020646407,0.00007406957],"genre_scores_gemma":[0.9846562,0.0024486918,0.009266717,0.00019285652,0.0011822269,0.0018956134,0.00003849072,0.00014595162,0.00017323106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9930744,0.0006842511,0.00169758,0.0011739605,0.001317143,0.0020526215],"domain_scores_gemma":[0.99272054,0.003136741,0.00072830595,0.0012853446,0.0010447663,0.0010843142],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003931257,0.0007376725,0.0010990747,0.00025822304,0.0019140319,0.00044940377,0.00088853197,0.0003398681,0.00020594176],"category_scores_gemma":[0.008359969,0.0003886552,0.0006807664,0.0005046615,0.0015435899,0.0010300385,0.0005047283,0.0012134926,0.00002408679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050531803,0.0010458415,0.1859689,0.00012292365,0.00018244545,0.000009367731,0.0005389323,0.000003918944,0.23415905,0.000008225185,0.0011648978,0.5717423],"study_design_scores_gemma":[0.024771396,0.0016837063,0.9294865,0.0019320542,0.00007745431,0.000051608975,0.0011334623,0.005507064,0.030179026,0.00010184166,0.0044773724,0.0005984796],"about_ca_topic_score_codex":0.00010682389,"about_ca_topic_score_gemma":0.0011803113,"teacher_disagreement_score":0.74351764,"about_ca_system_score_codex":0.0015437715,"about_ca_system_score_gemma":0.00059899304,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W2322148656","doi":"10.1177/1352458515604382","title":"Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging","keywords":"Autopsy; Medicine; Pathology; Dementia; Multiple sclerosis; Pathological; Magnetic resonance imaging; White matter; Myelin; Neuropathology; Degenerative disease; Alzheimer's disease; Disease; Radiology; Central nervous system; Internal medicine","score_opus":0.42530382815602236,"score_gpt":0.3883962230836556,"score_spread":0.036907605072366734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322148656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98555326,0.008685159,0.00034393635,0.0023158658,0.0011888756,0.0010312187,0.000027137365,0.00024705703,0.00060749124],"genre_scores_gemma":[0.96528965,0.014753723,0.017131392,0.0012518197,0.0013073299,0.000063563035,0.00002999579,0.00009640009,0.00007610889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926688,0.0010455151,0.0018475093,0.0012233745,0.0016197538,0.0015950603],"domain_scores_gemma":[0.99348205,0.0017587338,0.00046013275,0.00067526684,0.0010857664,0.0025380724],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005317524,0.00075320725,0.001648971,0.00044077035,0.0010969188,0.0004599368,0.00057436025,0.0006479736,0.00036160962],"category_scores_gemma":[0.017672867,0.00056558556,0.0005930672,0.00068374124,0.0012136303,0.00054481166,0.00082109176,0.0023753191,0.00030326817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002016072,0.0009477322,0.8976699,0.000030335237,0.0013577907,0.0002534678,0.0008086221,0.00003549794,0.03369003,0.000024419844,0.016884482,0.04628162],"study_design_scores_gemma":[0.01604052,0.0031851528,0.96337485,0.000536643,0.0006700287,0.0010818188,0.0014906693,0.002835248,0.0018835351,0.00013449542,0.008026301,0.00074071094],"about_ca_topic_score_codex":0.000073159594,"about_ca_topic_score_gemma":0.000017700428,"teacher_disagreement_score":0.06570495,"about_ca_system_score_codex":0.0002818431,"about_ca_system_score_gemma":0.00034211305,"threshold_uncertainty_score":0.99992627},"labels":[],"label_agreement":null},{"id":"W2325818210","doi":"10.1177/1352458515596600","title":"Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"Diffusion MRI; Corpus callosum; Fractional anisotropy; White matter; Multiple sclerosis; Magnetic resonance imaging; Medicine; Corticospinal tract; Uncinate fasciculus; Pathology; Nuclear medicine; Radiology","score_opus":0.10584403676174865,"score_gpt":0.28655926243313884,"score_spread":0.1807152256713902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325818210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804977,0.015252595,0.000103862774,0.0016095923,0.00082369865,0.0011191261,0.00009323586,0.00018129472,0.00031890476],"genre_scores_gemma":[0.98423964,0.0090212505,0.0043057767,0.0004541105,0.0012713722,0.00014548258,0.000021503245,0.00015891515,0.0003819382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925651,0.00058938883,0.0015363238,0.0010298241,0.0023590415,0.0019203409],"domain_scores_gemma":[0.9951639,0.000907382,0.00041595925,0.0009015352,0.0010438368,0.0015673959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023087817,0.00075615355,0.0011669636,0.0013891294,0.000639774,0.0003942393,0.000689845,0.00025792108,0.00018681075],"category_scores_gemma":[0.007110325,0.00066257606,0.0004744898,0.0015470142,0.0003826267,0.0007913133,0.00060305337,0.0018495813,0.00033313784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013185118,0.00081025786,0.9202888,0.000053199477,0.000021441216,0.00016910999,0.001320569,0.00005387542,0.0138928965,7.127903e-7,0.0091933245,0.052877307],"study_design_scores_gemma":[0.019199302,0.00059607276,0.96795386,0.0008909991,0.000098003016,0.00018957241,0.0009079134,0.007100538,0.00056599785,0.000021705542,0.0018394355,0.00063660106],"about_ca_topic_score_codex":0.0010871459,"about_ca_topic_score_gemma":0.0004158208,"teacher_disagreement_score":0.052240703,"about_ca_system_score_codex":0.0010505179,"about_ca_system_score_gemma":0.0005051168,"threshold_uncertainty_score":0.9995825},"labels":[],"label_agreement":null},{"id":"W2326274198","doi":"10.1177/1352458516643392","title":"Contribution of different relapse phenotypes to disability in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Intégré de Santé et de Services Sociaux des Laurentides; Cégep de Lévis; Hôpital Charles-Le Moyne; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; National Medical Research Council; University of Tasmania; Univerzita Karlova v Praze; Biogen","keywords":"Multiple sclerosis; Medicine; Incidence (geometry); Internal medicine; Expanded Disability Status Scale; Prospective cohort study; Cohort; Cohort study; Central nervous system disease; Hazard ratio; Confidence interval; Pediatrics; Physical therapy; Immunology","score_opus":0.10061898583111241,"score_gpt":0.30253679249927157,"score_spread":0.20191780666815917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326274198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903657,0.00031456994,0.001615298,0.0056672497,0.00040670863,0.0013491561,0.00013927516,0.00007307088,0.000069011585],"genre_scores_gemma":[0.996122,0.0015936206,0.0014871059,0.00015001633,0.0003602594,0.00014545853,0.000010732154,0.00006166729,0.00006914054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947924,0.00047318835,0.0015099728,0.0007112403,0.0013521248,0.0011610489],"domain_scores_gemma":[0.99532914,0.001711473,0.0003951496,0.0007852532,0.00090443564,0.00087456655],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015817941,0.0004947955,0.0012486036,0.0004443009,0.00032895379,0.00006548292,0.00042963593,0.00022514666,0.00035657562],"category_scores_gemma":[0.012731051,0.00031202615,0.0004885117,0.0006914047,0.0005925246,0.00036690762,0.00037670342,0.0006281863,0.0000876604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014245785,0.00090914965,0.54505163,0.000039971692,0.00010080264,0.000003826414,0.00028331977,0.000016010343,0.41161188,0.000014696665,0.00051516294,0.04002898],"study_design_scores_gemma":[0.012522458,0.00063738006,0.90015894,0.0022177023,0.000057391382,0.000012608801,0.0002007528,0.00031261786,0.08319702,0.00007355876,0.0002890209,0.0003205651],"about_ca_topic_score_codex":0.00028712198,"about_ca_topic_score_gemma":0.0013417517,"teacher_disagreement_score":0.3551073,"about_ca_system_score_codex":0.0012449448,"about_ca_system_score_gemma":0.00010990499,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W2330427014","doi":"10.1177/1352458516643398","title":"Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Université Laval; University of British Columbia Hospital","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Tocilizumab; Medicine; Clinical neurology; Dermatology; Immunology; Neuroscience; Psychology; Rheumatoid arthritis","score_opus":0.12306459713387163,"score_gpt":0.29738383556220654,"score_spread":0.1743192384283349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330427014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1454741,0.001780345,0.0004475999,0.8447956,0.0018612137,0.0032680419,0.0013611182,0.00039635814,0.0006156544],"genre_scores_gemma":[0.39159253,0.018948354,0.0139545305,0.53937465,0.023833983,0.0007376762,0.0001996851,0.0012458431,0.010112761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98655415,0.0017980592,0.0022131049,0.0022994527,0.003659906,0.0034753096],"domain_scores_gemma":[0.98700076,0.0063007735,0.0008145642,0.0020251293,0.0016441165,0.002214624],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0030354012,0.0018879198,0.0028795672,0.0018903236,0.0016500907,0.0009775617,0.0012385014,0.0016561267,0.0010052745],"category_scores_gemma":[0.01696378,0.0014311702,0.0012163674,0.0008593437,0.0010424327,0.0005862556,0.0014582451,0.006451726,0.000838693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050769853,0.00014613305,0.007895202,0.00030009123,0.00077844976,0.0009451625,0.0005665767,0.000006910622,0.14212613,7.546017e-7,0.78698266,0.055174947],"study_design_scores_gemma":[0.0135862995,0.0018564996,0.25005135,0.006165855,0.00033962226,0.0010195235,0.00015014953,0.00024377403,0.0024225942,0.000019188277,0.72260946,0.0015356997],"about_ca_topic_score_codex":0.00022267578,"about_ca_topic_score_gemma":0.000067105255,"teacher_disagreement_score":0.30542094,"about_ca_system_score_codex":0.001400911,"about_ca_system_score_gemma":0.0007657903,"threshold_uncertainty_score":0.99993926},"labels":[],"label_agreement":null},{"id":"W2332060497","doi":"10.1177/1352458515624771","title":"Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; White matter; Lesion; Myelin; Remyelination; Magnetic resonance imaging; Pathology; Medicine; Expanded Disability Status Scale; Voxel; Grey matter; Radiology; Central nervous system; Internal medicine","score_opus":0.1891996869264372,"score_gpt":0.33099808520348234,"score_spread":0.14179839827704513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332060497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856756,0.00073488953,0.0060514556,0.006218382,0.0003693245,0.00063152134,0.000059936916,0.00010623806,0.00015268248],"genre_scores_gemma":[0.98476195,0.0046290862,0.009088037,0.0000863598,0.00093458453,0.000041540734,0.000004133756,0.00005896548,0.0003953513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572855,0.00041863194,0.0009709741,0.0006538387,0.0010877225,0.0011402965],"domain_scores_gemma":[0.9972781,0.0009874224,0.00028635358,0.00049189123,0.0002838149,0.00067243667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014407405,0.00046273204,0.0010031279,0.00061831356,0.0004107641,0.0001288605,0.0004774644,0.0002881142,0.0005186231],"category_scores_gemma":[0.002254872,0.0002764762,0.00033777065,0.0005044134,0.00038777475,0.00038153247,0.00031124236,0.0013963555,0.00028678845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026393312,0.0002847343,0.76806694,0.000036759415,0.00009960954,0.00002035499,0.00038469545,0.0000017418708,0.18517447,7.5070676e-7,0.00092826475,0.04473774],"study_design_scores_gemma":[0.00789191,0.000420767,0.9541924,0.0017925318,0.000049607766,0.000029286502,0.00022709943,0.0008142595,0.033699926,0.00004434836,0.00049488054,0.00034295724],"about_ca_topic_score_codex":0.0003715228,"about_ca_topic_score_gemma":0.0019736178,"teacher_disagreement_score":0.18612547,"about_ca_system_score_codex":0.0005681361,"about_ca_system_score_gemma":0.00018864719,"threshold_uncertainty_score":0.99996877},"labels":[],"label_agreement":null},{"id":"W2332147189","doi":"10.1177/1352458516642315","title":"A prospective cohort study of vitamin D in optic neuritis recovery","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Calgary","funders":"","keywords":"Optic neuritis; Medicine; Multiple sclerosis; Vitamin D and neurology; Optic nerve; Nerve fiber layer; Cohort; Ophthalmology; Prospective cohort study; Retinal; Confounding; Internal medicine; Gastroenterology; Immunology","score_opus":0.04665004356915166,"score_gpt":0.2868216795533337,"score_spread":0.24017163598418206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332147189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760574,0.00015591372,0.000047400426,0.00046288228,0.000184559,0.0012219864,0.000011024762,0.00001939261,0.0002911143],"genre_scores_gemma":[0.9980922,0.00074047426,0.00047133307,0.00001997849,0.00014944936,0.00011882629,4.574914e-7,0.00002892421,0.00037835506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976798,0.00020146187,0.0005933339,0.0003161272,0.0007686304,0.00044061194],"domain_scores_gemma":[0.998557,0.00040656712,0.00018004257,0.00029553866,0.00037005774,0.0001908106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096788787,0.00017960311,0.0005860872,0.00041288213,0.00012140932,0.000027405085,0.00016367529,0.00006302999,0.00011587948],"category_scores_gemma":[0.0023285025,0.00011304518,0.00012873208,0.0003772613,0.00015250093,0.00022641024,0.00013968961,0.00039413292,0.00002178506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002929592,0.0015649603,0.9449857,0.000026453175,0.00023740504,0.00019045726,0.00072874274,0.0000060039483,0.042368505,0.0000011289267,0.0004572093,0.009140509],"study_design_scores_gemma":[0.010981173,0.002454846,0.9814084,0.00088094897,0.000060032744,0.00015788211,0.0012755116,0.000029968349,0.0025945697,0.000023355202,0.000011722519,0.00012157331],"about_ca_topic_score_codex":0.000115056966,"about_ca_topic_score_gemma":0.0002533682,"teacher_disagreement_score":0.039773937,"about_ca_system_score_codex":0.00038951912,"about_ca_system_score_gemma":0.00010057049,"threshold_uncertainty_score":0.46098486},"labels":[],"label_agreement":null},{"id":"W2335803360","doi":"10.1177/1352458516631037","title":"Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Depression (economics); Medicine; Psychiatry; Multiple sclerosis; Hazard ratio; Incidence (geometry); Cohort; Confidence interval; Pediatrics; Internal medicine","score_opus":0.03036268675147872,"score_gpt":0.24777330849048187,"score_spread":0.21741062173900316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335803360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713725,0.0004147495,0.00016417034,0.0009843617,0.0004086453,0.0004855902,0.00001992006,0.000043790402,0.00034150193],"genre_scores_gemma":[0.9957086,0.0030457035,0.00085287285,0.00007480657,0.00017678307,0.000054883432,0.0000026460455,0.000039374994,0.00004435429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704665,0.00041873782,0.00052619906,0.00048849895,0.0006945096,0.00082540757],"domain_scores_gemma":[0.99877757,0.0003100911,0.00025523125,0.00023706618,0.00006770896,0.00035231243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001043615,0.00026845274,0.0003359292,0.00044014273,0.00071804156,0.00019566959,0.00044273978,0.00018508217,0.000097413526],"category_scores_gemma":[0.00047960665,0.00018588615,0.00008201191,0.00069375825,0.00038265268,0.0008764158,0.000103381295,0.00038444652,0.000015679112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013171052,0.00022640137,0.956992,0.0000038297317,0.000014358654,0.0000015022883,0.0022822474,0.000039886778,0.00062019733,0.0000070081833,0.00015373438,0.03952713],"study_design_scores_gemma":[0.005537422,0.000051289328,0.99114865,0.0004653362,0.000011798539,0.000007030681,0.001915982,0.00007179731,0.000072896146,0.00010212825,0.00027918056,0.00033647093],"about_ca_topic_score_codex":0.0039884453,"about_ca_topic_score_gemma":0.03631626,"teacher_disagreement_score":0.039190657,"about_ca_system_score_codex":0.00025324163,"about_ca_system_score_gemma":0.00015483638,"threshold_uncertainty_score":0.98126847},"labels":[],"label_agreement":null},{"id":"W2339425991","doi":"10.1177/1352458515624559","title":"High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Spinal cord; Myelin; Medicine; Pathology; Myelin sheath; Magnetic resonance imaging; Central nervous system disease; High resolution; Neuroscience; Central nervous system; Anatomy; Radiology; Surgery; Biology; Geology; Internal medicine; Immunology","score_opus":0.09933160481106924,"score_gpt":0.31306267660688436,"score_spread":0.21373107179581513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339425991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855384,0.0008236721,0.0021653678,0.00868708,0.0011111798,0.001247143,0.00012335279,0.00021559563,0.00008816486],"genre_scores_gemma":[0.99031174,0.0013269602,0.0059217466,0.00037437092,0.0013317327,0.00019536809,0.000046020232,0.00016652602,0.00032551013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99181324,0.00052136765,0.0022746278,0.0012804976,0.0017917878,0.0023184905],"domain_scores_gemma":[0.99513394,0.00053933245,0.00057834206,0.0011343822,0.0014749378,0.0011390663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032829116,0.00083320134,0.0012695086,0.0012647337,0.0010448791,0.00028643842,0.00047321396,0.00028115528,0.00071564416],"category_scores_gemma":[0.0048067565,0.00052091887,0.00066131586,0.000584668,0.0005813634,0.0010760906,0.00057817076,0.0012582911,0.00035447173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040340554,0.0006510206,0.24302047,0.00006842365,0.0002117847,0.019358533,0.00034310474,0.00004389709,0.60773844,0.0000031698883,0.0016561771,0.12287092],"study_design_scores_gemma":[0.01976787,0.0010953094,0.87594634,0.0028464522,0.00016502939,0.049947172,0.00094489014,0.001803538,0.045455355,0.000023405346,0.0011269263,0.00087771233],"about_ca_topic_score_codex":0.0026356154,"about_ca_topic_score_gemma":0.0020658462,"teacher_disagreement_score":0.63292587,"about_ca_system_score_codex":0.001492598,"about_ca_system_score_gemma":0.00031595177,"threshold_uncertainty_score":0.9997242},"labels":[],"label_agreement":null},{"id":"W2339698996","doi":"10.1177/1352458516643396","title":"Astrocytes in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McGill University; Queen's University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Neuroscience; Myelin; Immune system; Central nervous system; Biology; Oligodendrocyte; Neurodegeneration; Homeostasis; Neuroinflammation; Extracellular matrix; Inflammation; Glial scar; Microglia; Astrocyte; Immunology; Disease; Medicine; Cell biology; Pathology","score_opus":0.28216279110950476,"score_gpt":0.3631466379726531,"score_spread":0.08098384686314836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339698996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009046426,0.9935222,0.00016615036,0.00033250407,0.0010528615,0.0028893417,0.00040636538,0.00020654096,0.0005193695],"genre_scores_gemma":[0.0039767167,0.9885765,0.0030913644,0.00011473529,0.0023906075,0.0006767055,0.00009192568,0.00043454042,0.00064692285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885663,0.001140512,0.0035117636,0.0016689644,0.0023509338,0.0027615516],"domain_scores_gemma":[0.9914675,0.003213124,0.001525616,0.0015306779,0.0007230716,0.0015400564],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0025303445,0.0018830292,0.0064233495,0.0026217964,0.0008383173,0.0004595683,0.0013622943,0.0011157066,0.0010473556],"category_scores_gemma":[0.0069346805,0.0012749555,0.0029881818,0.0016023107,0.0006893799,0.0006167048,0.0009066181,0.0039819945,0.0014149143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025186702,0.00064309454,0.006324152,0.0053168945,0.00093451055,0.00013158387,0.00013467157,0.000002170847,0.0006227928,0.0000028596714,0.0058145802,0.97982085],"study_design_scores_gemma":[0.00972866,0.0004377847,0.023564864,0.16468439,0.00071260106,0.00049746135,0.00011926064,0.00008074391,0.000112612666,0.000005367433,0.79871047,0.0013457639],"about_ca_topic_score_codex":0.000119654986,"about_ca_topic_score_gemma":0.00023617568,"teacher_disagreement_score":0.97847503,"about_ca_system_score_codex":0.0025295774,"about_ca_system_score_gemma":0.0013112361,"threshold_uncertainty_score":0.99986583},"labels":[],"label_agreement":null},{"id":"W2373620900","doi":"10.1177/1352458515596457","title":"Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Biotinidase deficiency; Neuromyelitis optica; Medicine; Myelopathy; Optic neuropathy; Pediatrics; Magnetic resonance imaging; Multiple sclerosis; Spinal cord; Pathology; Radiology; Ophthalmology; Newborn screening; Optic nerve; Immunology","score_opus":0.052856554682078886,"score_gpt":0.25104364854427685,"score_spread":0.19818709386219796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2373620900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939342,0.0027550512,0.0005083991,0.0003389235,0.0005304852,0.000129755,0.000011940431,0.000020948699,0.0017702791],"genre_scores_gemma":[0.9959951,0.0009422575,0.002211637,0.00028057283,0.0004889724,0.0000051848115,0.0000116660885,0.000032505235,0.000032116663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981875,0.00016889138,0.00050264143,0.00035898137,0.00025403337,0.0005279732],"domain_scores_gemma":[0.99914277,0.00003617662,0.00018653125,0.00016477874,0.00021191737,0.000257858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005767558,0.00023509601,0.00023183272,0.00012725862,0.00023593531,0.000112693146,0.00024966462,0.00022459778,0.000008635018],"category_scores_gemma":[0.00087189995,0.00020094764,0.0001381764,0.00020659955,0.00012158436,0.000014149604,0.00019605896,0.00047063528,0.000017305038],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029067087,0.00048708802,0.1364314,0.00004237432,0.00013191192,0.00020708442,0.0018828793,0.001348017,0.822649,0.00004800782,0.0015484778,0.0349331],"study_design_scores_gemma":[0.0334416,0.0042167446,0.56880003,0.0026442844,0.00020864255,0.004421826,0.011560333,0.0044793687,0.35876444,0.00025844574,0.007841905,0.003362387],"about_ca_topic_score_codex":0.00002306791,"about_ca_topic_score_gemma":0.000028092129,"teacher_disagreement_score":0.46388456,"about_ca_system_score_codex":0.000044323548,"about_ca_system_score_gemma":0.00011594263,"threshold_uncertainty_score":0.8194407},"labels":[],"label_agreement":null},{"id":"W2395316927","doi":"10.1177/1352458516649037","title":"Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Institute for Health and Care Research; Biogen","keywords":"Glatiramer acetate; Dimethyl fumarate; Medicine; Adverse effect; Multiple sclerosis; Relapsing remitting; Randomized controlled trial; Interim analysis; Placebo; Discontinuation; Internal medicine; Magnetic resonance imaging; Psychiatry; Radiology; Pathology; Alternative medicine","score_opus":0.052789648144250086,"score_gpt":0.28524989981761084,"score_spread":0.23246025167336076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395316927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925776,0.004345915,0.0011168506,0.000058411435,0.00035208458,0.0014444785,0.000056726694,0.00003602831,0.00001190535],"genre_scores_gemma":[0.99645245,0.002960856,0.00025402798,0.00005452927,0.00007421479,0.00008055142,0.000011907297,0.00005141534,0.00006005623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955761,0.00080913305,0.0018084913,0.0005037381,0.00075117603,0.0005513703],"domain_scores_gemma":[0.9954646,0.0019529868,0.0010352033,0.000618201,0.00041316968,0.00051583175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013780748,0.00042777963,0.0023728262,0.0016060481,0.00013108758,0.000031243588,0.0002771259,0.00020220649,0.00018562621],"category_scores_gemma":[0.0028602541,0.0002541039,0.0013398993,0.0012374782,0.0003542253,0.0002556852,0.00014700726,0.00040531033,0.000013756964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052728716,0.004152324,0.49453205,0.00008870211,0.0044703726,0.00013115576,0.00060909666,0.00014501669,0.42847013,0.000001005987,0.000029508787,0.014641929],"study_design_scores_gemma":[0.20363924,0.00082627434,0.74079275,0.002800322,0.006059977,0.000014885394,0.00012994351,0.0021227438,0.04337952,0.00000622808,6.721217e-7,0.00022741963],"about_ca_topic_score_codex":0.0006128121,"about_ca_topic_score_gemma":0.00030338083,"teacher_disagreement_score":0.38509062,"about_ca_system_score_codex":0.00015748596,"about_ca_system_score_gemma":0.00013578017,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W2401254028","doi":"10.1177/1352458516634873","title":"The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; Manitoba Health","funders":"","keywords":"Checklist; Strengthening the reporting of observational studies in epidemiology; Epidemiology; Observational study; Guideline; Medicine; Context (archaeology); Descriptive statistics; MEDLINE; Family medicine; Systematic review; Incidence (geometry); Environmental health; Psychology; Pathology","score_opus":0.08181151029064399,"score_gpt":0.3236661811289798,"score_spread":0.24185467083833584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401254028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759009,0.00052529626,0.013724413,0.007938811,0.00024790363,0.0012127078,0.00016296792,0.00006201796,0.00022501258],"genre_scores_gemma":[0.99231523,0.0035850604,0.003444935,0.000098568285,0.00026470152,0.00014416757,0.000003916475,0.000057698657,0.00008572223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932971,0.00029378015,0.0029090142,0.0005671619,0.0020375422,0.00089540624],"domain_scores_gemma":[0.9929356,0.001710268,0.0025378405,0.0008960171,0.0013796451,0.0005406471],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0047421865,0.0003686015,0.0009793028,0.0002737507,0.0006939541,0.0000641289,0.00057150976,0.00016396986,0.00007137286],"category_scores_gemma":[0.028598659,0.00019914532,0.0005648185,0.0006155219,0.00071514223,0.00019886409,0.00039964946,0.000531882,0.000011821353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010386386,0.00022559648,0.44376948,0.00004974611,0.00013385362,0.0000014397659,0.00019499182,0.0000508963,0.40177584,0.000016437312,0.0012624669,0.15148059],"study_design_scores_gemma":[0.0043878155,0.0009770858,0.9442625,0.0007023316,0.00007084752,0.000021310334,0.00026907428,0.0010144395,0.04245761,0.00005513202,0.005563117,0.0002187226],"about_ca_topic_score_codex":0.00013893229,"about_ca_topic_score_gemma":0.0003962548,"teacher_disagreement_score":0.500493,"about_ca_system_score_codex":0.00025898058,"about_ca_system_score_gemma":0.00027247702,"threshold_uncertainty_score":0.97958386},"labels":[],"label_agreement":null},{"id":"W2401931641","doi":"10.1177/1352458516628656","title":"Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Cerebral blood flow; Medicine; White matter; Magnetic resonance imaging; Multiple sclerosis; Cardiology; Brain size; Internal medicine; Hyperintensity; Hospital Anxiety and Depression Scale; Expanded Disability Status Scale; Cognitive impairment; Effects of sleep deprivation on cognitive performance; Cognitive decline; Psychology; Nuclear medicine; Cognition; Dementia; Radiology; Anxiety; Disease; Psychiatry","score_opus":0.12396942350784354,"score_gpt":0.3063241538310193,"score_spread":0.18235473032317576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401931641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764496,0.00012640603,0.000013574309,0.0010842188,0.00038083008,0.0006295501,0.000034519002,0.000014766665,0.000071179384],"genre_scores_gemma":[0.9987192,0.0007827751,0.00022234376,0.000023993713,0.00018410866,0.000031436957,0.0000057399266,0.000017434602,0.000012972379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969432,0.00046014218,0.0007163367,0.00030867665,0.0010345571,0.0005371154],"domain_scores_gemma":[0.998062,0.00076612126,0.00030551647,0.00024203792,0.00044234647,0.00018194797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088883284,0.0002391933,0.00047293463,0.0004082835,0.0002119947,0.000041728057,0.00030852424,0.000102005,0.0001475071],"category_scores_gemma":[0.0029760601,0.000121002115,0.00015791574,0.0005343781,0.00039413135,0.0003347593,0.00011049171,0.00044653125,0.0000069851526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022375411,0.00028286755,0.8263408,0.000022492517,0.000034690605,0.000006047716,0.0026645383,0.0000026413554,0.09219681,0.0000018821935,0.00013460277,0.07607512],"study_design_scores_gemma":[0.015526759,0.0008517552,0.9760888,0.0011189,0.000015438629,0.000014954469,0.0025986137,0.000357319,0.0032561943,0.000020303629,0.0000075109733,0.00014342283],"about_ca_topic_score_codex":0.00025088358,"about_ca_topic_score_gemma":0.00021050891,"teacher_disagreement_score":0.14974806,"about_ca_system_score_codex":0.00031159175,"about_ca_system_score_gemma":0.00013091064,"threshold_uncertainty_score":0.49343228},"labels":[],"label_agreement":null},{"id":"W2407833569","doi":"10.1177/1352458515622696","title":"Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Cerebral blood flow; Neuroscience; Psychology; Internal medicine; Immunology","score_opus":0.06829145500142972,"score_gpt":0.2578734595812263,"score_spread":0.1895820045797966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407833569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551857,0.00022631256,0.0005913327,0.0013756063,0.00040024548,0.0015121253,0.00009518377,0.00017211013,0.00010853486],"genre_scores_gemma":[0.98973155,0.0016834767,0.007076779,0.00012378469,0.0008740153,0.00019456053,0.00004823129,0.00015708333,0.00011052915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927716,0.00061733107,0.0015630244,0.0011576522,0.0021881317,0.0017022092],"domain_scores_gemma":[0.99457234,0.0013076506,0.0007097549,0.0005637545,0.0017540113,0.0010924714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014532603,0.00074163603,0.0010895686,0.0008146891,0.0009817826,0.00018456318,0.000376291,0.00036129443,0.00019396382],"category_scores_gemma":[0.0058399932,0.0004953247,0.0004323757,0.0009422889,0.0010159265,0.0010493937,0.00024613933,0.0015297753,0.00006130101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054706004,0.0018917987,0.84950185,0.00007554356,0.00040098449,0.000046065867,0.0013561351,0.000039470582,0.07832239,8.48743e-7,0.0012592138,0.061635077],"study_design_scores_gemma":[0.04501234,0.0014831785,0.9292095,0.011566074,0.00020863149,0.00017772717,0.001123886,0.0022085027,0.008332131,0.0000064007536,0.000051328625,0.00062031473],"about_ca_topic_score_codex":0.00026851718,"about_ca_topic_score_gemma":0.0003676846,"teacher_disagreement_score":0.07970761,"about_ca_system_score_codex":0.00079236494,"about_ca_system_score_gemma":0.0003081919,"threshold_uncertainty_score":0.99974984},"labels":[],"label_agreement":null},{"id":"W2409475002","doi":"10.1177/1352458515617249","title":"Are we in need of NEDA?","year":2015,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.1349304751265959,"score_gpt":0.3102878556201287,"score_spread":0.17535738049353283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409475002","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02728599,0.0028374,0.00010307305,0.00047957269,0.9680516,0.00050054933,0.00017141316,0.00004121233,0.0005291715],"genre_scores_gemma":[0.0351759,0.0019917325,0.0013911923,0.00014116136,0.95928395,0.000022291268,0.00010617105,0.00015922904,0.0017283808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964253,0.00013534901,0.0010460636,0.00032106807,0.0015861104,0.0004861605],"domain_scores_gemma":[0.99657834,0.00020691479,0.0013088326,0.00041902316,0.0009446735,0.00054219115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013736293,0.00038259357,0.0012674071,0.00064267026,0.00006018151,0.000052166255,0.00030339687,0.0010251629,0.00026110458],"category_scores_gemma":[0.0020717815,0.00031883182,0.00037102634,0.00029988872,0.00007036734,0.00014381947,0.00008250378,0.0020683,0.00003497716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069797656,0.0002273421,0.008174774,0.00017863618,0.00009031672,0.00019843914,0.00022926247,0.000008647732,0.005853426,6.079698e-7,0.9809766,0.003363983],"study_design_scores_gemma":[0.008134008,0.0006272311,0.0027797967,0.003311497,0.00016353278,0.000035251647,0.0008044699,0.000042752443,0.0016753994,0.000059057504,0.98206323,0.00030379652],"about_ca_topic_score_codex":0.000040731218,"about_ca_topic_score_gemma":0.0001010552,"teacher_disagreement_score":0.0087676775,"about_ca_system_score_codex":0.00033753444,"about_ca_system_score_gemma":0.0011790377,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W2417261078","doi":"10.1177/135245850000602s08","title":"ESIMS - An Ongoing Clinical Trial in Secondary Progressive Multiple Sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical trial; Expanded Disability Status Scale; Placebo; Mallinckrodt; Physical therapy; Surgery; Internal medicine; Alternative medicine; Family medicine; Pathology; Psychiatry","score_opus":0.26454182621445005,"score_gpt":0.39357294003762494,"score_spread":0.1290311138231749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417261078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919379,0.0013470283,0.000042085943,0.00115134,0.0009315516,0.0027094306,0.000078476856,0.00022462553,0.0015775864],"genre_scores_gemma":[0.98314494,0.004718302,0.007111342,0.0008210494,0.0032494655,0.00031216926,0.00006461363,0.00017493562,0.00040318654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.990291,0.0014609981,0.0029480963,0.0013769541,0.0019285037,0.0019944618],"domain_scores_gemma":[0.9943514,0.0015493052,0.00062627514,0.0011539449,0.00058472494,0.0017343648],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046217656,0.00081882096,0.001864161,0.0007755028,0.0009982284,0.00052740244,0.0008529372,0.0005858501,0.0050971806],"category_scores_gemma":[0.004467908,0.00070141075,0.0009794764,0.0009991012,0.0007966716,0.0012710518,0.0002660478,0.0036592556,0.00036791494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048181236,0.004217385,0.26212987,0.000074903306,0.00038914886,0.00023252687,0.0010846363,0.000105408995,0.008941462,0.0000019882762,0.003081511,0.67155993],"study_design_scores_gemma":[0.16890001,0.0032659457,0.8154606,0.0013506827,0.000112408736,0.0001264047,0.0006702745,0.0050398638,0.0009987439,0.000018912722,0.0033797754,0.00067637634],"about_ca_topic_score_codex":0.00026115405,"about_ca_topic_score_gemma":0.00059348904,"teacher_disagreement_score":0.67088354,"about_ca_system_score_codex":0.00057710195,"about_ca_system_score_gemma":0.000753481,"threshold_uncertainty_score":0.9995437},"labels":[],"label_agreement":null},{"id":"W2462321551","doi":"10.1177/1352458516657440","title":"Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Dalhousie University; University of Saskatchewan; University of Calgary; Health Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Confidence interval; Multiple sclerosis; Odds ratio; Disease; Expanded Disability Status Scale; Prospective cohort study; Generalized estimating equation; Internal medicine; Physical therapy; Psychiatry","score_opus":0.13517138438003656,"score_gpt":0.35119361447973524,"score_spread":0.21602223009969868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462321551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952448,0.0004639099,0.00020053954,0.00046719852,0.00041081608,0.0029560917,0.0001685236,0.00004639499,0.000041716296],"genre_scores_gemma":[0.99699515,0.00059682346,0.0011559856,0.00016405471,0.00028261,0.0005499872,0.0000014812624,0.00009774454,0.00015616429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99370134,0.00031353565,0.0016113381,0.0009716218,0.002032933,0.0013692327],"domain_scores_gemma":[0.9953246,0.0010080326,0.00053736573,0.0008804975,0.0011316553,0.0011178635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014470809,0.0006339173,0.0013319342,0.0006229367,0.00058638223,0.00017077912,0.0007363847,0.000115622985,0.00015283184],"category_scores_gemma":[0.0053838235,0.00042923755,0.00031696845,0.0009181588,0.00040444752,0.0005755416,0.0004927024,0.0006312634,0.000032106793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002604746,0.0012816455,0.8470794,0.00009514862,0.00019410407,0.00009098888,0.0021755104,0.00006044459,0.110700846,3.5793113e-7,0.00034954108,0.03536725],"study_design_scores_gemma":[0.016660683,0.0014344595,0.9626211,0.0032621785,0.00006093122,0.00001572021,0.0019712984,0.00056162995,0.012860097,0.000010736003,0.00006009269,0.00048109287],"about_ca_topic_score_codex":0.034032255,"about_ca_topic_score_gemma":0.2046265,"teacher_disagreement_score":0.17059425,"about_ca_system_score_codex":0.0012841495,"about_ca_system_score_gemma":0.001146874,"threshold_uncertainty_score":0.99981594},"labels":[],"label_agreement":null},{"id":"W2463500418","doi":"10.1177/1352458516653273","title":"Disability progression in aggressive multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Odds ratio; Confidence interval; Internal medicine; Logistic regression; Disease; Pediatrics; Immunology","score_opus":0.13234949142063018,"score_gpt":0.3360754455333122,"score_spread":0.20372595411268202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463500418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890199,0.0011976864,0.00051945803,0.0066243997,0.0005691857,0.0014980524,0.00009489749,0.00017889949,0.00029753917],"genre_scores_gemma":[0.98866147,0.005441131,0.0042850934,0.00019794103,0.0007976635,0.00028117216,0.00001100577,0.00011070388,0.00021380061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932555,0.0006173395,0.0014790089,0.0010507836,0.0018764032,0.001720963],"domain_scores_gemma":[0.9947659,0.0017135767,0.0007636421,0.0009947529,0.0006687733,0.0010933632],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001997347,0.0006726421,0.0011690119,0.000476811,0.00068763393,0.00018732662,0.0005945875,0.0003394924,0.0006855222],"category_scores_gemma":[0.011541933,0.00041022792,0.00060600886,0.0008495677,0.0011423484,0.00079721917,0.0005263895,0.0011394377,0.00022840855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001005977,0.001047951,0.56659436,0.000055510052,0.000094707866,0.000050562845,0.0002720792,0.0000065017975,0.18665074,0.000002916486,0.0013767357,0.24284194],"study_design_scores_gemma":[0.01641787,0.0005409683,0.9505284,0.005881936,0.00005206567,0.000120286764,0.00030869103,0.00059415796,0.023661122,0.000042457323,0.0013449276,0.00050712336],"about_ca_topic_score_codex":0.00016297707,"about_ca_topic_score_gemma":0.00056862953,"teacher_disagreement_score":0.38393402,"about_ca_system_score_codex":0.001393446,"about_ca_system_score_gemma":0.00024176609,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W2466196296","doi":"10.1177/1352458516655218","title":"Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Multiple sclerosis; Medicine; Phenotype; Primary (astronomy); Physical medicine and rehabilitation; Psychology; Psychiatry; Biology; Genetics","score_opus":0.4005976541909824,"score_gpt":0.40358598576063814,"score_spread":0.0029883315696557222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466196296","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017970901,0.01127108,0.00005528082,0.9660428,0.00097234047,0.003128064,0.00027257027,0.00004929444,0.00023767223],"genre_scores_gemma":[0.74448586,0.010608167,0.0026598203,0.21741211,0.020321025,0.004184129,0.000046200883,0.00024877395,0.000033930686],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98914313,0.0016666806,0.002008041,0.0008843112,0.0044327746,0.0018650749],"domain_scores_gemma":[0.9894185,0.006990166,0.00044854282,0.0008854096,0.0019325208,0.00032485684],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040838094,0.000822371,0.0020422954,0.0010944675,0.0002884632,0.000166811,0.0010278857,0.0008974382,0.0007522074],"category_scores_gemma":[0.03033464,0.0004444724,0.00059977546,0.0007899097,0.0013430638,0.0003927842,0.0003957481,0.0048528234,0.0000379607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034711012,0.002622719,0.31208736,0.005063133,0.0006277352,0.006916318,0.0049502593,0.0000011286445,0.0024114707,0.00001074131,0.54597014,0.11586789],"study_design_scores_gemma":[0.009456728,0.0015415521,0.86582685,0.02954062,0.0003936926,0.00031427792,0.00047306393,0.00012128038,0.00037374007,0.00008946565,0.091019474,0.0008492452],"about_ca_topic_score_codex":0.00032276596,"about_ca_topic_score_gemma":0.00077028136,"teacher_disagreement_score":0.7486307,"about_ca_system_score_codex":0.0012508671,"about_ca_system_score_gemma":0.00074971764,"threshold_uncertainty_score":0.9998007},"labels":[],"label_agreement":null},{"id":"W2469906895","doi":"10.1177/1352458516650992","title":"Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Atrophy; Medicine; Multiple sclerosis; Magnetic resonance imaging; Busulfan; Brain size; Transplantation; Hematopoietic stem cell transplantation; Urology; Pathology; Internal medicine; Radiology; Immunology","score_opus":0.09574743666347281,"score_gpt":0.2986649510472075,"score_spread":0.20291751438373473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469906895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802057,0.0014395436,0.009264302,0.005881731,0.00040146158,0.0018243243,0.00083704264,0.00008495483,0.00006093592],"genre_scores_gemma":[0.97475225,0.010811196,0.012228171,0.00019264464,0.00075820915,0.0006039255,0.000035782174,0.00011061667,0.0005071972],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959577,0.00021944602,0.001187829,0.00063362665,0.0009811341,0.0010202826],"domain_scores_gemma":[0.99583125,0.0017937019,0.00044994536,0.00055427174,0.0007579681,0.00061285216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067613344,0.0005425213,0.0011207418,0.0005353511,0.00040541167,0.00007639459,0.00021576363,0.00021908405,0.00036311362],"category_scores_gemma":[0.0012649453,0.00034524055,0.0009855788,0.0003302217,0.00038269718,0.00039932205,0.000048307305,0.0001595912,0.000047765363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067230384,0.00084028416,0.14235516,0.00018895282,0.00045226578,0.000023391913,0.0008512345,0.0000113323895,0.7025064,0.0000037247557,0.0016339545,0.14441024],"study_design_scores_gemma":[0.036173347,0.0030554188,0.80323935,0.0016942691,0.00034736068,0.00010863691,0.00018773333,0.00050076185,0.15000354,0.000031052947,0.0042126784,0.00044586873],"about_ca_topic_score_codex":0.0001075229,"about_ca_topic_score_gemma":0.00024761655,"teacher_disagreement_score":0.6608842,"about_ca_system_score_codex":0.0006035958,"about_ca_system_score_gemma":0.00017636546,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2472793648","doi":"10.1177/1352458516655478","title":"Trajectory of MS disease course for men and women over three eras","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Course (navigation); Disease; Medicine; Physical medicine and rehabilitation; Psychology; Gerontology; Internal medicine; Psychiatry; Physics","score_opus":0.08016473023766907,"score_gpt":0.308326922316592,"score_spread":0.2281621920789229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472793648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398696,0.001290536,0.0014224446,0.0018363367,0.00016107831,0.00087046536,0.00023702819,0.000036965906,0.00015816117],"genre_scores_gemma":[0.9949806,0.0024262841,0.0014592175,0.00011645722,0.0004932341,0.00016363224,0.0000030521176,0.00005239436,0.00030513122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975639,0.000082034014,0.00055273966,0.00035507907,0.0007207556,0.00072551676],"domain_scores_gemma":[0.9972799,0.0007671511,0.00024235582,0.00035317003,0.00042171404,0.00093572476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009412975,0.00026635182,0.000592753,0.00019311783,0.00028451663,0.000045840294,0.00018313095,0.0000833675,0.0003966477],"category_scores_gemma":[0.0016669325,0.00016447068,0.0002432915,0.00012907169,0.00043491102,0.00025407333,0.00011818778,0.00022528102,0.0000070321366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028155516,0.0004885457,0.645992,0.00019949817,0.0005333595,0.000008830128,0.0007596406,0.0000040146697,0.26613688,0.000015946038,0.008399786,0.07464595],"study_design_scores_gemma":[0.013135574,0.0005068659,0.98002315,0.00069226755,0.00011250738,0.000011216568,0.00026054357,0.00057434913,0.0026881995,0.00014426815,0.001647015,0.0002040356],"about_ca_topic_score_codex":0.000022216584,"about_ca_topic_score_gemma":0.000030459838,"teacher_disagreement_score":0.33403116,"about_ca_system_score_codex":0.00025331337,"about_ca_system_score_gemma":0.00023464656,"threshold_uncertainty_score":0.67069197},"labels":[],"label_agreement":null},{"id":"W2497655497","doi":"10.1177/1352458516658559","title":"Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Natalizumab; Multiple sclerosis; Medicine; Peripheral blood mononuclear cell; Immunology; Discontinuation; Progressive multifocal leukoencephalopathy; Interleukin 17; Cytokine; Internal medicine; Biology; In vitro","score_opus":0.04912672049802235,"score_gpt":0.22933993576441605,"score_spread":0.1802132152663937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497655497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268234,0.0057629854,0.000044400433,0.0000823667,0.00050872576,0.0003073041,0.00049185404,0.000035072844,0.000084959385],"genre_scores_gemma":[0.99592,0.0029051332,0.00073364825,0.000011746511,0.000080752165,0.000039929953,0.00003439688,0.000036368587,0.0002380119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745053,0.0004054674,0.00094093534,0.00047032634,0.0001291953,0.0006035358],"domain_scores_gemma":[0.9980918,0.00056439877,0.0005977337,0.00049269985,0.00017768591,0.00007566728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050772587,0.00039007966,0.000801191,0.00038316514,0.0002223134,0.00001779121,0.00034904442,0.0003048834,0.00041408002],"category_scores_gemma":[0.00031689284,0.00026581684,0.0003984199,0.00028759157,0.00019213308,0.00028901544,0.000100100915,0.00013518178,0.000064345884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008069981,0.0005832042,0.20656766,0.000010529216,0.00030270437,0.0000026584955,0.0008273364,0.000021787753,0.616973,0.0000049765094,0.00007044685,0.17382872],"study_design_scores_gemma":[0.009650297,0.0003346024,0.40476596,0.00039732308,0.000092647795,0.000042943204,0.00023362397,0.000014956064,0.5836754,0.000035780602,0.0005642422,0.00019221219],"about_ca_topic_score_codex":0.0010240693,"about_ca_topic_score_gemma":0.00087248394,"teacher_disagreement_score":0.1981983,"about_ca_system_score_codex":0.0005155044,"about_ca_system_score_gemma":0.00016982308,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W2500435921","doi":"10.1177/1352458516662727","title":"ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Immune Tolerance Network","keywords":"Abatacept; Medicine; Multiple sclerosis; Relapsing remitting; Placebo; Internal medicine; Clinical endpoint; Randomized controlled trial; Immunology; Pathology","score_opus":0.1401142698879682,"score_gpt":0.3230997063552762,"score_spread":0.18298543646730797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500435921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95742404,0.0015483708,0.024241315,0.005480517,0.0021980167,0.007936284,0.00035019533,0.0002459146,0.00057535013],"genre_scores_gemma":[0.966386,0.0064566224,0.023090811,0.00019744413,0.0020681503,0.00081835507,0.00002379792,0.0001975675,0.00076125783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9913425,0.00090797525,0.0029780518,0.0010289997,0.0020065464,0.0017359322],"domain_scores_gemma":[0.98387754,0.010513357,0.0017023784,0.0010744018,0.0018732847,0.00095906574],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069570006,0.0008280679,0.0030913225,0.0008591241,0.0010393226,0.0002006321,0.0007530226,0.00044663835,0.00041006645],"category_scores_gemma":[0.044003043,0.0005263608,0.0023657694,0.0006594343,0.0011580313,0.0007196502,0.0004179436,0.00088644464,0.000056640725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52043766,0.0009297516,0.009287459,0.00018297455,0.0011252183,0.0000048792062,0.00065485516,0.00001623626,0.3848407,0.00002256344,0.0064697247,0.076028],"study_design_scores_gemma":[0.9275227,0.0014669801,0.018556362,0.0047071315,0.00057781616,0.000051337516,0.00043147654,0.0022073446,0.042185646,0.000114450275,0.0015367903,0.0006419342],"about_ca_topic_score_codex":0.0001314367,"about_ca_topic_score_gemma":0.000072140676,"teacher_disagreement_score":0.4070851,"about_ca_system_score_codex":0.000569771,"about_ca_system_score_gemma":0.00046306092,"threshold_uncertainty_score":0.9997188},"labels":[],"label_agreement":null},{"id":"W2518294038","doi":"10.1177/1352458516666337","title":"Drinking away fatigue in multiple sclerosis","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Clinical neurology; Medicine; Physical medicine and rehabilitation; Psychology; Neuroscience; Psychiatry","score_opus":0.2298572763530757,"score_gpt":0.31751202773310805,"score_spread":0.08765475138003234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518294038","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10686524,0.0045933886,0.0016306348,0.8722134,0.0049824603,0.005052154,0.0006612232,0.0006840351,0.00331743],"genre_scores_gemma":[0.6759877,0.023812175,0.0074617127,0.25185278,0.034254186,0.00087929616,0.0004264303,0.0011142335,0.004211453],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9860693,0.0010475286,0.002905141,0.002016938,0.004023518,0.003937568],"domain_scores_gemma":[0.99160504,0.0029672962,0.0013453515,0.0018744005,0.001217904,0.0009900278],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0025879645,0.0018543021,0.0031679412,0.002752944,0.0012076943,0.00067418494,0.0015966457,0.0022618435,0.0013909496],"category_scores_gemma":[0.0054914644,0.0014283746,0.0016523929,0.0012067191,0.00089202967,0.00079002423,0.0009568623,0.010882384,0.0006121745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004640243,0.00030699308,0.19121231,0.0004352245,0.00080695975,0.0009931097,0.0005588949,0.000027297221,0.03532318,0.0000011995046,0.7109391,0.058931686],"study_design_scores_gemma":[0.02191384,0.00058761344,0.4308171,0.020341702,0.0003326141,0.00044152793,0.0002488206,0.0010124895,0.0036992591,0.00005712471,0.518305,0.0022429083],"about_ca_topic_score_codex":0.00050094206,"about_ca_topic_score_gemma":0.00067806314,"teacher_disagreement_score":0.6203606,"about_ca_system_score_codex":0.0025901946,"about_ca_system_score_gemma":0.00078704697,"threshold_uncertainty_score":0.9995219},"labels":[],"label_agreement":null},{"id":"W2522756838","doi":"10.1177/1352458516671028","title":"Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Odds ratio; Mononucleosis; Medicine; Confidence interval; Case-control study; Population; Absolute risk reduction; Relative risk; Demography; Internal medicine; Immunology; Environmental health; Virus","score_opus":0.15600224567026771,"score_gpt":0.32803455477323806,"score_spread":0.17203230910297035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522756838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452925,0.00044253064,0.0002546512,0.0027344613,0.00020663533,0.0016311127,0.000074114025,0.000028222805,0.00009901512],"genre_scores_gemma":[0.9953786,0.003446964,0.00031018906,0.00010570828,0.00053454336,0.00014777882,0.0000019833865,0.000045365872,0.000028869345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946366,0.0017059697,0.0011026964,0.0004974745,0.0013615533,0.0006957249],"domain_scores_gemma":[0.9910277,0.006978915,0.00071715354,0.0006638802,0.00038915363,0.00022316763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004693985,0.000397357,0.0007576773,0.00039566678,0.00086523296,0.00016622573,0.0005627307,0.00012565474,0.00006439944],"category_scores_gemma":[0.0075616073,0.00017687751,0.00028262517,0.0005797436,0.0006090564,0.00048489682,0.00033491122,0.0013513877,0.000012089409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044313495,0.000490448,0.8809318,0.000019836838,0.0005584607,0.000005730732,0.01001506,0.000018125113,0.022967046,0.0000014632874,0.00035469816,0.08419423],"study_design_scores_gemma":[0.00882287,0.0007860834,0.9623367,0.0011432521,0.0002922452,0.000025702497,0.02098464,0.0002964056,0.004856609,0.000041445615,0.0002152543,0.0001988001],"about_ca_topic_score_codex":0.00094827265,"about_ca_topic_score_gemma":0.0010028098,"teacher_disagreement_score":0.083995424,"about_ca_system_score_codex":0.00026122178,"about_ca_system_score_gemma":0.000077314784,"threshold_uncertainty_score":0.90524966},"labels":[],"label_agreement":null},{"id":"W2556280554","doi":"10.1177/1352458516679893","title":"Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Hôpital Charles-Le Moyne","funders":"National Health and Medical Research Council; Biogen; Novartis Pharma; Sanofi","keywords":"Medicine; Nomogram; Concordance; Clinically isolated syndrome; Multiple sclerosis; Proportional hazards model; Expanded Disability Status Scale; Magnetic resonance imaging; Quartile; Internal medicine; Confidence interval; Radiology","score_opus":0.0905137699598752,"score_gpt":0.3398284867819918,"score_spread":0.2493147168221166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556280554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834186,0.000105472725,0.00032725965,0.0006166002,0.000118732285,0.00040618653,0.000024847071,0.000010763517,0.0000482623],"genre_scores_gemma":[0.9928307,0.0010318535,0.005964011,0.000022679067,0.00009334822,0.000015495756,0.0000038084913,0.00002084145,0.000017239676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974208,0.0004216734,0.00092961825,0.00023643358,0.00065368257,0.00033783022],"domain_scores_gemma":[0.9971313,0.0015636975,0.0005222992,0.00019441287,0.0003663172,0.00022196826],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021825233,0.00012951018,0.00033096643,0.00025929138,0.0001032845,0.00001536613,0.00008447163,0.00010124637,0.0000364372],"category_scores_gemma":[0.008680272,0.00007558468,0.0001035463,0.00027051312,0.00006403273,0.00048771047,0.00003954198,0.0006058773,0.000018040775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003644761,0.0017318844,0.9675116,0.000021269494,0.00012739646,0.000025106758,0.00021550372,0.000020804036,0.00008300623,0.0000013175285,0.000051415995,0.026565952],"study_design_scores_gemma":[0.022912793,0.0025687625,0.9711227,0.0028447951,0.000070079295,0.000011450573,0.00011196942,0.00013508377,0.00009372861,0.0000088982515,0.000049172897,0.00007060597],"about_ca_topic_score_codex":0.00024947544,"about_ca_topic_score_gemma":0.00046398753,"teacher_disagreement_score":0.026495347,"about_ca_system_score_codex":0.0002615638,"about_ca_system_score_gemma":0.00013319116,"threshold_uncertainty_score":0.99967},"labels":[],"label_agreement":null},{"id":"W2557619543","doi":"10.1177/1352458516681196","title":"Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Medical Research Council; Multiple Sclerosis Society of Canada; McGill University","keywords":"Adiponectin; Mendelian randomization; Odds ratio; Medicine; Adipokine; Single-nucleotide polymorphism; Body mass index; Internal medicine; Confidence interval; Confounding; Endocrinology; Oncology; Genetics; Biology; Obesity; Genotype; Insulin resistance; Gene; Genetic variants","score_opus":0.060635920396734176,"score_gpt":0.26942578680178614,"score_spread":0.20878986640505195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557619543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560326,0.00021204689,0.0011218867,0.00020535693,0.00066781166,0.0017558384,0.00014721179,0.00010548547,0.00018110791],"genre_scores_gemma":[0.9975605,0.0006296571,0.00021996544,0.00013652338,0.00084899535,0.0001566818,0.000012875987,0.00007392314,0.00036087024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995532,0.0011470633,0.0010763035,0.0005844613,0.00091508543,0.0007451224],"domain_scores_gemma":[0.9964056,0.0016155856,0.0005970317,0.00047121028,0.00037976902,0.0005308215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022719314,0.0004919575,0.001040598,0.00063927483,0.00053461967,0.00013947875,0.0002585952,0.00017224408,0.0006754973],"category_scores_gemma":[0.00829112,0.00030283027,0.000372064,0.0003569534,0.000088349756,0.00044087315,0.000066196175,0.00048517773,0.00021230093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008205642,0.001652292,0.9370894,0.000032017302,0.0003007192,0.000019300875,0.0017694234,0.00004382154,0.019206638,0.000003203386,0.00035278816,0.03132477],"study_design_scores_gemma":[0.07575716,0.0017401224,0.9142615,0.0011499631,0.00037802345,0.000013824408,0.00070732046,0.0013911744,0.003847746,0.000011729096,0.00039249647,0.0003488967],"about_ca_topic_score_codex":0.00018694552,"about_ca_topic_score_gemma":0.00059564324,"teacher_disagreement_score":0.067551516,"about_ca_system_score_codex":0.00023450251,"about_ca_system_score_gemma":0.00012668691,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W2565583047","doi":"10.1177/1352458516682105","title":"Breaking down the gut microbiome composition in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; University Hospital","funders":"","keywords":"Multiple sclerosis; Gut microbiome; Microbiome; Medicine; Biology; Neuroscience; Computational biology; Immunology; Bioinformatics","score_opus":0.10553095647538918,"score_gpt":0.3000197623369062,"score_spread":0.194488805861517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565583047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008409737,0.9887309,0.00030750476,0.00024924564,0.0009245654,0.0009160644,0.00038179112,0.000020962018,0.000059233993],"genre_scores_gemma":[0.02860995,0.9687575,0.0004973087,0.00028888194,0.0012150815,0.000069474896,0.00032038378,0.00012363913,0.00011778702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607784,0.00070113805,0.0013088989,0.0007312039,0.00024838332,0.00093253417],"domain_scores_gemma":[0.9977598,0.00017452928,0.0009375713,0.0007273615,0.00016006376,0.00024067635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010492916,0.0007004384,0.0012045042,0.0003346491,0.00070903933,0.00027138388,0.0009682192,0.00075148424,0.0000855955],"category_scores_gemma":[0.00011661286,0.0004415125,0.0009280379,0.00033814006,0.00021998429,0.000018782535,0.00034863103,0.00094455684,0.00016087829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006393541,0.00018937471,0.0004876167,0.0010603757,0.00021263582,0.0000075213425,0.000074036776,0.0000047007475,0.3963771,0.0000027786496,0.005479262,0.59604067],"study_design_scores_gemma":[0.0021714538,0.00013324134,0.004671953,0.021650193,0.00018654221,0.00060125237,0.000028303935,0.0000070425185,0.0010018474,0.0000041727535,0.9687651,0.00077893864],"about_ca_topic_score_codex":0.00008653862,"about_ca_topic_score_gemma":0.00024335463,"teacher_disagreement_score":0.9632858,"about_ca_system_score_codex":0.00031696673,"about_ca_system_score_gemma":0.00040832945,"threshold_uncertainty_score":0.99980366},"labels":[],"label_agreement":null},{"id":"W2568482345","doi":"10.1177/1352458516685169","title":"Smokers with MS have greater decrements in quality of life and disability than non-smokers","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University; Institute of Clinical and Translational Sciences","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Physical medicine and rehabilitation; Gerontology; Audiology; Psychology; Psychiatry","score_opus":0.18988645705395285,"score_gpt":0.3610899609819429,"score_spread":0.17120350392799005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568482345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679,0.00012117304,0.0000695309,0.0016441038,0.000105936866,0.0007046119,0.000038304333,0.000014740231,0.00051161443],"genre_scores_gemma":[0.99722856,0.00077108794,0.0016450065,0.000087226996,0.00014253653,0.00004064591,0.000004910843,0.00003716499,0.000042877873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650216,0.0002433436,0.0009240308,0.00051094824,0.0011254378,0.00069409434],"domain_scores_gemma":[0.9970693,0.00027470724,0.00063982984,0.00091932726,0.0004191433,0.0006777001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020993121,0.0003453729,0.00097004644,0.00016562686,0.00066393125,0.0001991726,0.00039334915,0.00013301324,0.0001072376],"category_scores_gemma":[0.003547174,0.00024375704,0.00017773607,0.00010928193,0.0014643614,0.00045382074,0.00033659468,0.00069698476,0.000004406941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021739362,0.0003966925,0.978819,0.0001821403,0.0003044444,0.000009065488,0.0010356217,0.000012909483,0.011036542,9.337636e-7,0.0001355977,0.005893128],"study_design_scores_gemma":[0.013421692,0.0004032931,0.98044205,0.0007615906,0.00004383473,0.000009967686,0.0011191841,0.00050550024,0.0030008506,0.000008217121,0.0000417293,0.00024211839],"about_ca_topic_score_codex":0.0049284133,"about_ca_topic_score_gemma":0.004629813,"teacher_disagreement_score":0.011247756,"about_ca_system_score_codex":0.00027032266,"about_ca_system_score_gemma":0.00016417514,"threshold_uncertainty_score":0.99401236},"labels":[],"label_agreement":null},{"id":"W2578514106","doi":"10.1177/1352458516688955","title":"Processing speed test: Validation of a self-administered, iPad <sup>®</sup> -based tool for screening cognitive dysfunction in a clinic setting","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Genentech; Cleveland Clinic; Biogen; Novartis Pharma; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Psychology; Test (biology); Natalizumab; Audiology; Reliability (semiconductor); Technician; Medicine; Physical medicine and rehabilitation; Psychiatry","score_opus":0.15296653992387524,"score_gpt":0.3671240710117765,"score_spread":0.21415753108790128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578514106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652744,0.00013275593,0.009948356,0.0011185115,0.000109010456,0.0018352051,0.000097853444,0.00007084344,0.00016004333],"genre_scores_gemma":[0.97031915,0.00010853334,0.02862339,0.00012639894,0.00052265177,0.00011549222,0.000045297576,0.00007036793,0.00006873238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996209,0.00021688627,0.0013197713,0.0005489172,0.0009397956,0.0007656033],"domain_scores_gemma":[0.9943998,0.0021152396,0.0013921708,0.00042870897,0.0014052897,0.00025883305],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0033292875,0.0003668963,0.00081697264,0.0005260787,0.0013379656,0.00041350353,0.00032367412,0.0002022343,0.000067240355],"category_scores_gemma":[0.022091886,0.00033195456,0.00038059597,0.0002464834,0.00025105418,0.0007565103,0.00015028256,0.00077174103,0.000010738685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024690982,0.0008793466,0.857192,0.0006422982,0.00019420077,0.000013757839,0.0016162165,0.00043199165,0.03162519,2.4488884e-7,0.00020893264,0.104726724],"study_design_scores_gemma":[0.024329754,0.0010755712,0.75753975,0.005814427,0.00023262316,0.000028716207,0.0018431054,0.17943624,0.02930266,0.0000070692045,0.000076372104,0.00031370102],"about_ca_topic_score_codex":0.000042847645,"about_ca_topic_score_gemma":0.000020221854,"teacher_disagreement_score":0.17900424,"about_ca_system_score_codex":0.0002618481,"about_ca_system_score_gemma":0.0004642091,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W2579133420","doi":"10.1177/1352458516681198","title":"Infection-related health care utilization among people with and without multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Saskatchewan; Dalhousie University; University of British Columbia","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Environmental health; Immunology","score_opus":0.09660709667929776,"score_gpt":0.31025616591130445,"score_spread":0.2136490692320067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579133420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906021,0.0017654913,0.0028169346,0.002605227,0.00030111906,0.0013890165,0.00006601685,0.00025558885,0.00019853289],"genre_scores_gemma":[0.9848815,0.011838175,0.0022765712,0.00021572073,0.00029022808,0.00012974846,0.000030285382,0.00013140313,0.00020634936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547535,0.00037930923,0.0009786821,0.00079918123,0.0012259213,0.0011415579],"domain_scores_gemma":[0.99629676,0.00040767426,0.000593989,0.0005558663,0.0010431396,0.0011025851],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00085032545,0.00057586265,0.0009984914,0.00059656316,0.0014435844,0.0002340015,0.0001916876,0.00023109542,0.00021724262],"category_scores_gemma":[0.0015402706,0.00036027943,0.0002379364,0.00078993547,0.00057552895,0.00078432565,0.0002014213,0.0007230543,0.00004393579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005378769,0.00020419947,0.90348107,0.0001397224,0.00033847388,0.0000031659072,0.0027089012,0.000030554875,0.014889087,0.0000041658113,0.0011100384,0.07655275],"study_design_scores_gemma":[0.014800026,0.0010257965,0.975759,0.0028132172,0.00011150022,0.00013641539,0.0009548696,0.0009161366,0.0022906263,0.0000048863317,0.00074897707,0.0004384956],"about_ca_topic_score_codex":0.0014605789,"about_ca_topic_score_gemma":0.006031942,"teacher_disagreement_score":0.07611425,"about_ca_system_score_codex":0.0007710874,"about_ca_system_score_gemma":0.0003782681,"threshold_uncertainty_score":0.9998849},"labels":[],"label_agreement":null},{"id":"W2583347849","doi":"10.1177/1352458517690618","title":"Age Related Multiple Sclerosis Severity Score: Disability ranked by age","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Neuroförbundet; National Institute for Health and Care Research; Biogen","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Severity of illness; Physical therapy; Internal medicine; Psychiatry","score_opus":0.14896940791720287,"score_gpt":0.32044612576981957,"score_spread":0.1714767178526167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583347849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886744,0.0009869174,0.00019070573,0.0045593437,0.0012813145,0.001913269,0.00038647276,0.0003495008,0.0016580576],"genre_scores_gemma":[0.9901024,0.004333603,0.0029212818,0.00036150843,0.0007645437,0.00016616084,0.00013786562,0.00019595516,0.0010166747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912045,0.0007051848,0.0019556335,0.0014906498,0.002459046,0.002185013],"domain_scores_gemma":[0.99225235,0.0009820381,0.0012099221,0.0030407663,0.00066103163,0.0018539054],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.003185828,0.0010611962,0.0019683675,0.00025489126,0.005287986,0.001512163,0.0017986294,0.00061694754,0.0008693527],"category_scores_gemma":[0.011951889,0.00090760837,0.0012427316,0.00042273427,0.003449717,0.0013632328,0.001187674,0.0029460632,0.00025886932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013825616,0.0017344335,0.67460465,0.00017578239,0.0009633102,0.00021193924,0.00084087974,0.000017400662,0.25349367,0.000004884069,0.025754107,0.04081637],"study_design_scores_gemma":[0.01854272,0.00039892612,0.9605207,0.0012351294,0.00025484702,0.000113683025,0.00027281282,0.0016959307,0.011341954,0.00008235325,0.0046500536,0.0008909056],"about_ca_topic_score_codex":0.0014350337,"about_ca_topic_score_gemma":0.00094798923,"teacher_disagreement_score":0.285916,"about_ca_system_score_codex":0.0011471014,"about_ca_system_score_gemma":0.00021261796,"threshold_uncertainty_score":0.99952435},"labels":[],"label_agreement":null},{"id":"W2585052441","doi":"10.1177/1352458517691620","title":"Similar birth-cohort patterns in Crohn’s disease and multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Cohort; Disease; Medicine; Etiology; Crohn's disease; Cohort study; Cohort effect; Demography; Pediatrics; Immunology; Internal medicine","score_opus":0.12330985894434834,"score_gpt":0.31283147856904053,"score_spread":0.1895216196246922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585052441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920067,0.0012801614,0.0001773911,0.004012884,0.00050858024,0.0014171015,0.00023857868,0.00010053003,0.0002580264],"genre_scores_gemma":[0.98004127,0.01678355,0.0013690377,0.00045266634,0.0008010655,0.00013191295,0.000020759524,0.00013151737,0.00026824386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451655,0.00027933417,0.0011289566,0.0010497586,0.0015073833,0.0015180132],"domain_scores_gemma":[0.99502206,0.0005259043,0.00059596135,0.0015724115,0.00048264366,0.0018010456],"candidate_categories":["metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0016814881,0.0007018731,0.0011751642,0.0006770784,0.0022660191,0.0010521557,0.000827346,0.00023930856,0.00034980197],"category_scores_gemma":[0.0072893524,0.00060629746,0.0004560493,0.00021521596,0.00072239403,0.0010221273,0.0008937397,0.0014995023,0.000066569424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010557646,0.0005569048,0.95165527,0.00019780023,0.00030125477,0.0003989604,0.00043054632,0.00005077497,0.019569855,0.0000031614848,0.00096409325,0.024815638],"study_design_scores_gemma":[0.011389431,0.00014649723,0.977243,0.0020537514,0.00014810594,0.000052413943,0.0003167267,0.0062905643,0.0010739947,0.000027782824,0.0006754118,0.0005823154],"about_ca_topic_score_codex":0.0010028811,"about_ca_topic_score_gemma":0.001279233,"teacher_disagreement_score":0.02558776,"about_ca_system_score_codex":0.0004573828,"about_ca_system_score_gemma":0.00023953608,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W2587465654","doi":"10.1177/1352458517691149","title":"The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University of Manitoba; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health; American Heart Association","keywords":"White matter; Multiple sclerosis; Perfusion; Medicine; Lesion; Magnetic resonance imaging; Expanded Disability Status Scale; Neurocognitive; Pathology; Internal medicine; Cardiology; Radiology; Cognition; Psychiatry","score_opus":0.10831501326863688,"score_gpt":0.29599001686783943,"score_spread":0.18767500359920256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587465654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846473,0.0005349035,0.00033285943,0.012519857,0.00032288706,0.00091174926,0.0000599169,0.0000322397,0.0006383359],"genre_scores_gemma":[0.9944206,0.00097166776,0.00163959,0.0005337413,0.00063563266,0.00013617912,0.00004300961,0.00009447078,0.0015251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952584,0.00051567756,0.001192957,0.0007187492,0.0009877401,0.0013264661],"domain_scores_gemma":[0.99517393,0.0024523588,0.00053658785,0.0010409503,0.00030828756,0.00048786172],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0030621574,0.00051239337,0.0007877062,0.0004923163,0.0035117469,0.00091034867,0.00060824066,0.0003406065,0.0006734151],"category_scores_gemma":[0.002507848,0.00037457867,0.0002780133,0.00034413373,0.0005690788,0.00077562255,0.0007309211,0.0021298048,0.00030683284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052091066,0.00019462971,0.98669237,0.000041309242,0.000056858553,0.000011321427,0.00062380574,0.00024376028,0.0008878382,0.0000020576506,0.0073505216,0.003374594],"study_design_scores_gemma":[0.009328437,0.000100281824,0.98149186,0.0011784845,0.000057064804,0.000023257053,0.00041685908,0.0060588433,0.00003389981,0.00004138128,0.0008962888,0.00037336728],"about_ca_topic_score_codex":0.00031837967,"about_ca_topic_score_gemma":0.004459285,"teacher_disagreement_score":0.011986115,"about_ca_system_score_codex":0.00036150377,"about_ca_system_score_gemma":0.000092979346,"threshold_uncertainty_score":0.9998706},"labels":[],"label_agreement":null},{"id":"W2589098388","doi":"10.1177/1352458517692887","title":"Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depression","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Carleton University; University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; International Progressive MS Alliance","keywords":"Depression (economics); Cognition; Multiple sclerosis; Anxiety; Psychology; Hospital Anxiety and Depression Scale; Cognitive reserve; Clinical psychology; Psychiatry; Developmental psychology; Cognitive impairment","score_opus":0.19022875316633686,"score_gpt":0.34061062439389556,"score_spread":0.1503818712275587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589098388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127,0.003750179,0.000082811086,0.0020186238,0.00021898402,0.0012531353,0.00009653775,0.0000775428,0.0012322075],"genre_scores_gemma":[0.9879312,0.009115075,0.0012700297,0.00028993996,0.00084103213,0.00017120244,0.00003785384,0.00010156298,0.00024214109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509895,0.00044043365,0.0010829451,0.00093809556,0.001240837,0.0011987342],"domain_scores_gemma":[0.9955428,0.0012349377,0.0008471707,0.00075765484,0.0008147174,0.0008027029],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0020971647,0.0005602715,0.0010132026,0.0005188416,0.003434089,0.0006688555,0.00044655678,0.00030583952,0.0002449263],"category_scores_gemma":[0.013587163,0.0004822315,0.0003219527,0.00019396958,0.0007735245,0.0010877404,0.0011932823,0.0014601357,0.00009927039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020810263,0.00025146385,0.80957586,0.00016733214,0.00019724426,0.00010404289,0.0008202326,0.0000054169655,0.115389526,7.0742095e-7,0.0006768473,0.07073029],"study_design_scores_gemma":[0.019653296,0.0002240482,0.94565225,0.010354105,0.0001708549,0.00018773793,0.0012705374,0.003224163,0.01850591,0.000020139347,0.00026985208,0.0004670933],"about_ca_topic_score_codex":0.0014423443,"about_ca_topic_score_gemma":0.0038025829,"teacher_disagreement_score":0.13607639,"about_ca_system_score_codex":0.0005383083,"about_ca_system_score_gemma":0.00018236101,"threshold_uncertainty_score":0.99976295},"labels":[],"label_agreement":null},{"id":"W2590173415","doi":"10.1177/1352458517694088","title":"Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Multiple Sclerosis Society of Canada; Universitetet i Bergen; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Confounding; Multiple sclerosis; Odds ratio; Confidence interval; Mononucleosis; Logistic regression; Physical activity; Obesity; Internal medicine; Case-control study; Demography; Physical therapy; Immunology","score_opus":0.15330873750413465,"score_gpt":0.3312591454995107,"score_spread":0.17795040799537604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590173415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935997,0.00010470815,0.00018143404,0.002608427,0.00027460034,0.0025096126,0.00022836147,0.00015841781,0.0003347549],"genre_scores_gemma":[0.99709815,0.0006485009,0.00036537592,0.00021059807,0.00092750654,0.00030698336,0.000009239728,0.00015545332,0.00027821682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99274784,0.0010682184,0.0006658237,0.0010667435,0.0028607557,0.0015906356],"domain_scores_gemma":[0.9917066,0.0022312843,0.0015270676,0.0024383774,0.0010393258,0.0010573263],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026594815,0.0008687916,0.0014742591,0.0002735326,0.007872885,0.00134665,0.0015030063,0.00021692304,0.00015544331],"category_scores_gemma":[0.014018912,0.00051835226,0.00077779026,0.00042435635,0.001265026,0.0008637225,0.0007628698,0.0027471283,0.00010897627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021859102,0.0067960145,0.89234,0.000020313244,0.0024890294,0.00007577577,0.004900043,0.00004709766,0.033662017,6.049315e-7,0.002812872,0.05467032],"study_design_scores_gemma":[0.01878349,0.0016924711,0.9530526,0.0007109647,0.000802429,0.0000414422,0.0020006986,0.0113376435,0.01081532,0.000008969037,0.00017998855,0.0005739862],"about_ca_topic_score_codex":0.0019899,"about_ca_topic_score_gemma":0.0022449323,"teacher_disagreement_score":0.0607126,"about_ca_system_score_codex":0.0006096346,"about_ca_system_score_gemma":0.00035971293,"threshold_uncertainty_score":0.99972683},"labels":[],"label_agreement":null},{"id":"W2590833285","doi":"10.1177/1352458517692885","title":"Concurrent autoimmune hepatitis in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Medicine; Liver biopsy; Multiple sclerosis; Hepatitis; Fulminant; Biopsy; Gastroenterology; Immunology; Internal medicine","score_opus":0.14732731596454504,"score_gpt":0.2883125301567545,"score_spread":0.14098521419220947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590833285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946633,0.0016084634,0.00017664244,0.0011973178,0.0013349274,0.00044080985,0.00007120655,0.000056400026,0.0004509127],"genre_scores_gemma":[0.9938892,0.0044980487,0.0005612839,0.00028367466,0.00038990608,0.00003072796,0.00002627439,0.00005035803,0.0002705223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.00015011338,0.0007250607,0.0003419,0.00055332057,0.0006631886],"domain_scores_gemma":[0.99761456,0.00014752283,0.00051406753,0.00096477417,0.0002686038,0.00049044134],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000576894,0.0003236217,0.0006306409,0.0002242221,0.0014074293,0.0004794405,0.0006067838,0.00015350651,0.0006491131],"category_scores_gemma":[0.0012843958,0.0002863189,0.00041846745,0.000120333905,0.00029644664,0.0006816228,0.0003018313,0.0009294319,0.00015023965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015431098,0.00065717014,0.8975097,0.000040398234,0.00010475188,0.000048773454,0.0003339681,0.000014309814,0.02320879,0.000010008388,0.001307594,0.076610245],"study_design_scores_gemma":[0.010629972,0.00025423864,0.9784824,0.0014046651,0.00011004913,0.00007080203,0.00016387759,0.005102089,0.0019221727,0.000016539623,0.0015376848,0.0003054627],"about_ca_topic_score_codex":0.0035841954,"about_ca_topic_score_gemma":0.00041803613,"teacher_disagreement_score":0.08097277,"about_ca_system_score_codex":0.00033643248,"about_ca_system_score_gemma":0.00020623628,"threshold_uncertainty_score":0.9999589},"labels":[],"label_agreement":null},{"id":"W2591732254","doi":"10.1177/1352458517695469","title":"Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Alberta Children's Hospital; University of Calgary; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Medication adherence; Disease; Pharmacy; Quality of life (healthcare); Confidence interval; Physical therapy; Internal medicine; Family medicine; Psychiatry","score_opus":0.23040105985153556,"score_gpt":0.36160562775167177,"score_spread":0.1312045679001362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591732254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992071,0.00063163094,0.0016223552,0.0010616072,0.00093003496,0.0031648907,0.00034038644,0.0000923496,0.00008578989],"genre_scores_gemma":[0.9754348,0.016094815,0.0059384815,0.00019357911,0.0014333165,0.00059409003,0.000022514734,0.0001525894,0.00013582488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426293,0.0002237183,0.0012197645,0.0011017114,0.0014039694,0.0017879136],"domain_scores_gemma":[0.9933388,0.0016118226,0.0008911101,0.0015167389,0.0008142476,0.0018272661],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018705719,0.00076181476,0.0012072576,0.0009061996,0.0031399715,0.00090173766,0.0013100634,0.00023890784,0.00010495075],"category_scores_gemma":[0.017117374,0.00062140444,0.0008139111,0.00045843687,0.00026831214,0.000836731,0.0005037679,0.0012796643,0.000080047415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020594425,0.0006539909,0.92767537,0.00011032633,0.00015873673,0.000015062092,0.0013294707,0.00031790446,0.020182058,8.846986e-7,0.0019661153,0.045530666],"study_design_scores_gemma":[0.01571884,0.0010653543,0.9704188,0.0007238481,0.00011854499,0.00000391283,0.00046238714,0.0075564296,0.0028816934,0.000026473199,0.0003826511,0.00064105395],"about_ca_topic_score_codex":0.0012341778,"about_ca_topic_score_gemma":0.0008245101,"teacher_disagreement_score":0.04488961,"about_ca_system_score_codex":0.0005425465,"about_ca_system_score_gemma":0.00036987822,"threshold_uncertainty_score":0.9996237},"labels":[],"label_agreement":null},{"id":"W2593373425","doi":"10.1177/1352458517698250","title":"Landscape of MS patient cohorts and registries: Recommendations for maximizing impact","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"National Institutes of Health; IC Design Education Center; Eisai; International Progressive MS Alliance; Cleveland Clinic; Multiple Sclerosis Society; Biogen; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; MEDLINE; Clinical neurology; Psychology; Psychiatry; Neuroscience; Biology","score_opus":0.15877560452745693,"score_gpt":0.3640429735893991,"score_spread":0.20526736906194215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593373425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902112,0.00077947124,0.0007069583,0.0063157645,0.00030429187,0.0008766713,0.0002445617,0.000024466804,0.00053660333],"genre_scores_gemma":[0.9866014,0.0036626903,0.009273738,0.000057996833,0.00023500895,0.000052960328,0.000022848682,0.00003093562,0.00006238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982545,0.000057910573,0.0005688837,0.00026401022,0.00041051846,0.00044420754],"domain_scores_gemma":[0.9974505,0.0004083527,0.0006582667,0.0005378325,0.00058608194,0.00035899898],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0007061461,0.0002087395,0.00057112554,0.00018923577,0.0013149267,0.00024071788,0.00020606224,0.00008536389,0.00012764707],"category_scores_gemma":[0.0040806164,0.00015711479,0.0002719408,0.00006544696,0.00027498024,0.0003138386,0.00019002553,0.00031844177,0.0000020937482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010087525,0.00030836568,0.76804966,0.00015603185,0.00060662674,0.0000065530453,0.0012361996,0.000022241424,0.030042298,0.000011091153,0.038622174,0.15992999],"study_design_scores_gemma":[0.006127167,0.00087275606,0.9763925,0.0009159501,0.00011139413,0.00008551119,0.00072714884,0.0019786614,0.0049025463,0.000038834176,0.0076595056,0.00018801335],"about_ca_topic_score_codex":0.00016099785,"about_ca_topic_score_gemma":0.000053629243,"teacher_disagreement_score":0.20834284,"about_ca_system_score_codex":0.00010506832,"about_ca_system_score_gemma":0.00012203622,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W2595065023","doi":"10.1177/1352458517699289","title":"Body size and physical exercise, and the risk of multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Helse Vest; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Forsvaret; Universitetet i Bergen; McGill University Health Centre; McGill University; Harvard T.H. Chan School of Public Health; Biogen; Università degli Studi di Sassari; Sanofi","keywords":"Medicine; Body mass index; Risk factor; Overweight; Cohort; Relative risk; Norwegian; Population; Aerobic exercise; Confidence interval; Cohort study; Lower risk; Internal medicine; Physical fitness; Demography; Physical therapy; Environmental health","score_opus":0.07691653213037271,"score_gpt":0.3022678010100678,"score_spread":0.2253512688796951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595065023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337965,0.0024600592,0.000072176386,0.002357625,0.00022352119,0.0010230185,0.000096595155,0.000039752173,0.00034759572],"genre_scores_gemma":[0.9574455,0.039624706,0.0020003535,0.00007937379,0.00056307367,0.00007550863,0.000002051393,0.00006118789,0.00014822863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964781,0.0003568773,0.00073952763,0.00056307495,0.0011025007,0.0007599435],"domain_scores_gemma":[0.9939764,0.0028079688,0.0009303314,0.0011254303,0.0005574051,0.0006024376],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0020553179,0.0004638456,0.0013091941,0.00015358283,0.0028267142,0.0005096628,0.0005885955,0.00015041772,0.000046662113],"category_scores_gemma":[0.01330586,0.00028407277,0.00046445886,0.00013979313,0.0030421144,0.00048827814,0.0008480557,0.0011718929,0.000012190627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035605056,0.0005270749,0.78325176,0.00017952445,0.0007979183,0.000010029799,0.00308318,0.0000118677535,0.13115187,0.000029335828,0.0013027778,0.07609418],"study_design_scores_gemma":[0.023133378,0.00025895325,0.9565154,0.0012376629,0.00051969127,0.000044131135,0.00074820296,0.008416804,0.008498395,0.0001565226,0.00019807924,0.0002727825],"about_ca_topic_score_codex":0.00084796053,"about_ca_topic_score_gemma":0.00012729705,"teacher_disagreement_score":0.17326365,"about_ca_system_score_codex":0.00007143785,"about_ca_system_score_gemma":0.00008896551,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2595770726","doi":"10.1177/1352458517699992","title":"What is the risk of suicide in multiple sclerosis?","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.15920078828124506,"score_gpt":0.31403154374112946,"score_spread":0.1548307554598844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595770726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54789114,0.037900917,0.000071406146,0.39308715,0.017108388,0.0016692828,0.0007199049,0.00010837066,0.0014434067],"genre_scores_gemma":[0.7421074,0.037735194,0.0003631115,0.20627037,0.009050538,0.00027161065,0.000069902715,0.0003384055,0.0037934652],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99337935,0.001336987,0.0017341212,0.00095367467,0.0011193993,0.001476477],"domain_scores_gemma":[0.99162424,0.002926441,0.0027226524,0.0021321015,0.0004324899,0.00016206315],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022374827,0.00092781085,0.001606452,0.0006103306,0.0014403255,0.0008286779,0.0024865915,0.0012999394,0.0014174056],"category_scores_gemma":[0.0010101805,0.0006538171,0.0012247331,0.00029271844,0.0007562702,0.00069154723,0.0004327074,0.0066742823,0.00047779718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017778376,0.00015519996,0.2839314,0.000038770646,0.0010844532,0.00016196085,0.006567492,0.000014884369,0.00034081985,0.0000012731699,0.6990018,0.008524164],"study_design_scores_gemma":[0.005924186,0.00019438185,0.8628819,0.0011470417,0.00055587356,0.00012624163,0.004059629,0.000097414115,0.00044936975,0.00024702537,0.123329245,0.0009876675],"about_ca_topic_score_codex":0.0045089955,"about_ca_topic_score_gemma":0.0015330031,"teacher_disagreement_score":0.5789505,"about_ca_system_score_codex":0.00020903414,"about_ca_system_score_gemma":0.00011633345,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2596347108","doi":"10.1177/1352458517695468","title":"The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Sanofi Genzyme; IC Design Education Center; Biogen","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Post-hoc analysis; Subgroup analysis; Internal medicine; Disease; Physical therapy; Fingolimod; Confidence interval; Immunology","score_opus":0.21212312926679472,"score_gpt":0.4196669038568602,"score_spread":0.20754377459006546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596347108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395984,0.0031551055,0.000005195856,0.0011247776,0.00026767227,0.0013753313,0.000055519555,0.000009207731,0.000047363068],"genre_scores_gemma":[0.99031043,0.009074944,0.00022399872,0.000037366037,0.00012857791,0.000069064685,0.00000320283,0.000033442615,0.00011894459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967986,0.00032140678,0.001108754,0.00039276824,0.00081873883,0.000559732],"domain_scores_gemma":[0.99597543,0.0009833234,0.0011276858,0.0010427573,0.0005915698,0.00027920003],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.00094057125,0.0003577104,0.0009479302,0.00020230563,0.0016455237,0.00018533337,0.0006273315,0.000069862224,0.000012647048],"category_scores_gemma":[0.009099338,0.00018661581,0.00037708983,0.00017418698,0.0013022941,0.00036026345,0.00057581696,0.00042863682,0.0000010696473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033030147,0.0009770759,0.9015547,0.00009317931,0.0007808998,0.000004979799,0.0011749001,0.000023202512,0.049232334,7.5815717e-7,0.00027317245,0.042581804],"study_design_scores_gemma":[0.0247422,0.00040711975,0.9627725,0.001787579,0.00031586038,0.000002266469,0.0006416042,0.0003591907,0.008686337,0.00000894765,0.000121039,0.00015536042],"about_ca_topic_score_codex":0.0002211554,"about_ca_topic_score_gemma":0.000115383096,"teacher_disagreement_score":0.06121782,"about_ca_system_score_codex":0.0002685095,"about_ca_system_score_gemma":0.00013528459,"threshold_uncertainty_score":0.9996542},"labels":[],"label_agreement":null},{"id":"W2598013794","doi":"10.1177/1352458517697378","title":"Primary and secondary progressive MS have a similar age at onset of progression – Commentary","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Age of onset; Primary (astronomy); Pediatrics; Psychology; Internal medicine; Psychiatry; Disease; Physics","score_opus":0.09066013187015276,"score_gpt":0.3290046580287821,"score_spread":0.23834452615862933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598013794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22575481,0.018394547,0.000014905399,0.7461714,0.00108337,0.004677447,0.0021785994,0.00013765569,0.0015872478],"genre_scores_gemma":[0.20347154,0.044952434,0.023820315,0.6913242,0.022398908,0.0011854848,0.0064566312,0.001160539,0.005229958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99366593,0.0005879209,0.0013648175,0.0009901439,0.0020512438,0.0013399556],"domain_scores_gemma":[0.994561,0.0008040841,0.0019986883,0.0013338275,0.00069114973,0.00061123405],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001179189,0.0009922868,0.0022729128,0.0006503439,0.0015686336,0.0003228279,0.0008131282,0.0010630639,0.0005598857],"category_scores_gemma":[0.0009239402,0.0007651912,0.000721586,0.00010855019,0.001968023,0.00037152774,0.0017136927,0.0059648813,0.000016395512],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009518684,0.00032891278,0.05254292,0.0019628308,0.0011771534,0.0045727934,0.0006148435,4.297642e-7,0.007403557,4.406594e-8,0.8943927,0.036051914],"study_design_scores_gemma":[0.012765303,0.0015069603,0.43464807,0.013029008,0.00069155137,0.0024207113,0.00014003947,0.0001253172,0.0040859547,0.00001701054,0.5296055,0.0009645858],"about_ca_topic_score_codex":0.00008913541,"about_ca_topic_score_gemma":0.000053312295,"teacher_disagreement_score":0.38210514,"about_ca_system_score_codex":0.0008172176,"about_ca_system_score_gemma":0.0003900926,"threshold_uncertainty_score":0.9997312},"labels":[],"label_agreement":null},{"id":"W2599683897","doi":"10.1177/1352458516684559","title":"Primary and secondary progressive MS have a similar age at onset of progression – NO","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Age of onset; Medicine; Primary (astronomy); Pathology; Disease; Physics; Immunology","score_opus":0.08869963894558287,"score_gpt":0.3373501405600668,"score_spread":0.24865050161448393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599683897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060214,0.0029506797,0.00001757022,0.0015096907,0.00028577237,0.0011166332,0.00013225252,0.00004476236,0.0033404818],"genre_scores_gemma":[0.98696786,0.0035776712,0.007893615,0.0001992297,0.0004971482,0.00007967381,0.000033080833,0.00006470788,0.0006870164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967731,0.00018560069,0.0007433749,0.0005180672,0.0010308312,0.0007489864],"domain_scores_gemma":[0.99649984,0.00028974473,0.0009517119,0.0008799066,0.00072417944,0.00065464363],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010283787,0.0003967171,0.0009325582,0.00024122954,0.0018022924,0.0002783118,0.00045976313,0.00020413306,0.00043997384],"category_scores_gemma":[0.0027754998,0.000294536,0.0003012191,0.00006612049,0.0013248392,0.0004547511,0.0010823879,0.0009443509,0.000029940775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025142604,0.0006573592,0.636406,0.00068816077,0.0005186829,0.000565081,0.0010659257,0.0000016127923,0.21863197,0.0000018835059,0.0146732535,0.124275796],"study_design_scores_gemma":[0.008234501,0.00083415036,0.96516234,0.0023922191,0.00010384407,0.00041487307,0.00012901828,0.00044591835,0.017861903,0.000014895142,0.0041273297,0.0002790051],"about_ca_topic_score_codex":0.00004205121,"about_ca_topic_score_gemma":0.00006263458,"teacher_disagreement_score":0.32875633,"about_ca_system_score_codex":0.00026888828,"about_ca_system_score_gemma":0.00022923031,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W2600492335","doi":"10.1177/1352458517702553","title":"Multiple sclerosis and suicide","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Psychiatry; Suicide prevention; Poison control; Population; Injury prevention; Depression (economics); Epidemiology; Multiple sclerosis; Context (archaeology); Clinical psychology; Psychology; Medical emergency; Internal medicine; Environmental health","score_opus":0.45172974809226096,"score_gpt":0.41261152124362754,"score_spread":0.03911822684863342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600492335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052640704,0.9939697,0.00007877232,0.00038083797,0.0010353115,0.0026979079,0.00037772817,0.00019588931,0.00073745544],"genre_scores_gemma":[0.0032038193,0.9891206,0.0031373957,0.00013220667,0.0024016104,0.00037678724,0.00012978414,0.00040680612,0.0010910034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99065715,0.00073850254,0.0025262327,0.0016283899,0.002044519,0.0024052167],"domain_scores_gemma":[0.99076533,0.00205477,0.0021469558,0.0021762308,0.0008377747,0.0020189215],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028430484,0.0018047511,0.006541956,0.0013583878,0.0031864054,0.0013982235,0.0013865798,0.0010893607,0.00033297404],"category_scores_gemma":[0.009921825,0.0013690696,0.0024721662,0.00048440014,0.0011817105,0.00067246426,0.0015473361,0.0041291094,0.00040104447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014548455,0.00032314577,0.005513228,0.007822042,0.0016095219,0.00012276911,0.00014316206,7.6701707e-7,0.00018514231,0.0000027911854,0.006873934,0.977258],"study_design_scores_gemma":[0.0057181157,0.0003820364,0.032603435,0.08032867,0.0022694934,0.0011769764,0.000098065655,0.00012861463,0.000031356227,0.000007066502,0.87601435,0.0012418339],"about_ca_topic_score_codex":0.00023673275,"about_ca_topic_score_gemma":0.0001883332,"teacher_disagreement_score":0.97601616,"about_ca_system_score_codex":0.00087610615,"about_ca_system_score_gemma":0.0010177637,"threshold_uncertainty_score":0.99963844},"labels":[],"label_agreement":null},{"id":"W2601833078","doi":"10.1177/1352458517697831","title":"Oral rather than intravenous corticosteroids should be used to treat MS relapses – Commentary","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Psychiatry","score_opus":0.2559505459955563,"score_gpt":0.3557977262619254,"score_spread":0.09984718026636913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601833078","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13363285,0.0008151851,0.00014020725,0.8589939,0.0020709557,0.0024884017,0.0007195291,0.0002057265,0.0009332252],"genre_scores_gemma":[0.15822913,0.003333971,0.003507735,0.8009578,0.020692581,0.000469221,0.00086280314,0.0008065476,0.011140219],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907311,0.0007163821,0.0015947586,0.0013322675,0.0032290264,0.002396449],"domain_scores_gemma":[0.9937465,0.00092746847,0.00096152857,0.0022949511,0.00079603156,0.0012735114],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0013048595,0.0014593704,0.0026573378,0.0009834917,0.0016621238,0.0011412486,0.0016412275,0.0013075843,0.0011156461],"category_scores_gemma":[0.0022056203,0.0011552641,0.0011675693,0.0002974728,0.00069863175,0.00046481605,0.0009038468,0.007640473,0.000300206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007815154,0.00048542945,0.0293129,0.00025462414,0.00106295,0.0016956588,0.001481972,0.000007976357,0.019231094,1.3299308e-7,0.9211244,0.024561346],"study_design_scores_gemma":[0.0109291,0.0022455165,0.12990901,0.0029740501,0.000886371,0.00075659633,0.00025830444,0.00009342872,0.0034807613,0.000006856581,0.84715635,0.0013036648],"about_ca_topic_score_codex":0.0011114437,"about_ca_topic_score_gemma":0.0007417742,"teacher_disagreement_score":0.100596115,"about_ca_system_score_codex":0.001372728,"about_ca_system_score_gemma":0.00034782809,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W2604614383","doi":"10.1177/1352458517703800","title":"Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Clinique Neuro-Outaouais","funders":"Novartis Pharma; University of Tasmania","keywords":"Expanded Disability Status Scale; Interquartile range; Medicine; Natural history; Multiple sclerosis; Pediatrics; Internal medicine; Physical therapy","score_opus":0.0737981939040684,"score_gpt":0.31860321862702035,"score_spread":0.24480502472295196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604614383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601436,0.00041200602,0.000075193566,0.0015420968,0.00035770063,0.0011314194,0.00008445589,0.000058684065,0.00032405753],"genre_scores_gemma":[0.99715686,0.0011377073,0.0007746516,0.00011214607,0.00047668724,0.00015818786,0.00007631944,0.00005138471,0.000056086472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951167,0.00032563868,0.0011151157,0.0007662202,0.0015860206,0.0010902924],"domain_scores_gemma":[0.9960545,0.00033898826,0.00079026277,0.0011689841,0.000994605,0.0006526655],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011708551,0.0004969228,0.0013072784,0.00045991765,0.0013360432,0.00062035717,0.00076150784,0.0002100148,0.00025119394],"category_scores_gemma":[0.0041028513,0.00038141827,0.00080643303,0.00059306493,0.0011602264,0.00086504366,0.00052513723,0.001189795,0.000021571375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009291022,0.0021096554,0.97516996,0.00017930518,0.0013589527,0.0000656747,0.0006562984,0.000017571792,0.0016784095,0.0000020320626,0.00019781101,0.017635223],"study_design_scores_gemma":[0.008733283,0.00038153888,0.9882098,0.0005678845,0.000532508,0.000011129546,0.000068405745,0.00037692225,0.00072644366,0.000011166069,0.00001903604,0.00036188064],"about_ca_topic_score_codex":0.0003683406,"about_ca_topic_score_gemma":0.0011777595,"teacher_disagreement_score":0.017273342,"about_ca_system_score_codex":0.0012921314,"about_ca_system_score_gemma":0.00017249447,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W2605062403","doi":"10.1177/1352458517703802","title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Cleveland Clinic; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Tolerability; Mesenchymal stem cell; Transplantation; Expanded Disability Status Scale; Adverse effect; Clinical trial; Magnetic resonance imaging; Internal medicine; Oncology; Surgery; Pathology; Immunology; Radiology","score_opus":0.17463848792741368,"score_gpt":0.31318252920312345,"score_spread":0.13854404127570977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605062403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427,0.0004239831,0.00048370464,0.00027154438,0.0008996338,0.0015840774,0.000051568615,0.000046837282,0.0019686392],"genre_scores_gemma":[0.99438554,0.0027015724,0.0016318066,0.000040389146,0.0004970101,0.00006368008,0.000022040405,0.00006725891,0.0005907074],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9951477,0.0004484542,0.0014048538,0.0005823107,0.0014418551,0.0009748089],"domain_scores_gemma":[0.99670994,0.00044469937,0.0009343783,0.00086957595,0.00043317358,0.00060821726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019077794,0.00043734035,0.0010814876,0.0004840958,0.0008408862,0.00027583996,0.00079169235,0.00028007483,0.00018561295],"category_scores_gemma":[0.0006419187,0.00036365996,0.00039481628,0.00025805243,0.0003716813,0.00046553015,0.00012067984,0.0013387114,0.00005446434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06895467,0.0030602973,0.17219768,0.0004851329,0.00016422704,0.00033289517,0.0038489436,0.00014158725,0.6944534,0.000011254075,0.00036797824,0.055981886],"study_design_scores_gemma":[0.1510448,0.0052700513,0.71320367,0.0012665192,0.00016316544,0.00029828673,0.00061167974,0.0019447765,0.12563401,0.000024964975,0.000112774935,0.00042531133],"about_ca_topic_score_codex":0.0009426782,"about_ca_topic_score_gemma":0.0006611338,"teacher_disagreement_score":0.5688194,"about_ca_system_score_codex":0.00033505334,"about_ca_system_score_gemma":0.00038994054,"threshold_uncertainty_score":0.99988157},"labels":[],"label_agreement":null},{"id":"W2607056035","doi":"10.1177/1352458517702534","title":"Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"IC Design Education Center; Biogen Idec; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation; Biogen","keywords":"Multiple sclerosis; Creatine; Lesion; White matter; Choline; Diffusion MRI; Magnetic resonance imaging; Medicine; Hyperintensity; Pathology; Nuclear medicine; Fluid-attenuated inversion recovery; Glutamate receptor; Pathological; Internal medicine; Radiology","score_opus":0.16962576831782925,"score_gpt":0.32282527498752683,"score_spread":0.1531995066696976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607056035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930633,0.0022664312,0.00058584334,0.0020378856,0.00046691802,0.00089827477,0.00005279708,0.000102723025,0.0005258579],"genre_scores_gemma":[0.97847575,0.012237814,0.008300497,0.00015179745,0.00057711767,0.000065604574,0.00001951659,0.00007040036,0.00010152436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551326,0.0003306509,0.001191378,0.000655308,0.0012106285,0.0010987602],"domain_scores_gemma":[0.9964314,0.0006491311,0.00082967605,0.0008972597,0.0005270481,0.0006654932],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0028097776,0.0005020243,0.0009779149,0.0005831163,0.0026796034,0.00087230647,0.0005171915,0.00028335382,0.000067730434],"category_scores_gemma":[0.011193406,0.0004296279,0.0003064821,0.0002512013,0.00051547843,0.0021300246,0.00066473655,0.0014234689,0.000027647451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047549978,0.00024908013,0.7301968,0.00014465483,0.00009794564,0.000016262393,0.0010207342,0.000026411868,0.16318381,0.000003990348,0.0008009251,0.103783935],"study_design_scores_gemma":[0.0100816125,0.00017693301,0.9470814,0.002699652,0.000093095594,0.00013128895,0.00072206906,0.023321439,0.014567217,0.00004181226,0.00071041135,0.00037306058],"about_ca_topic_score_codex":0.00057014934,"about_ca_topic_score_gemma":0.00061223,"teacher_disagreement_score":0.21688466,"about_ca_system_score_codex":0.0004127767,"about_ca_system_score_gemma":0.0001268059,"threshold_uncertainty_score":0.9998155},"labels":[],"label_agreement":null},{"id":"W2609394914","doi":"10.1177/1352458517703799","title":"Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Deutsche Forschungsgemeinschaft; Teva Pharmaceutical Industries; CSL Behring; Bayer","keywords":"Dimethyl fumarate; CD8; Multiple sclerosis; CD19; Lymphocyte; Flow cytometry; Immune system; Immunology; Medicine; Internal medicine; Gastroenterology","score_opus":0.09730746843317647,"score_gpt":0.3382122425898248,"score_spread":0.24090477415664832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609394914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812795,0.0003592089,0.00013558204,0.0158354,0.00049372634,0.001442006,0.00016544526,0.000046687037,0.00024245853],"genre_scores_gemma":[0.9889394,0.004706673,0.0015481608,0.0002176495,0.00050378405,0.0002920447,0.000028640125,0.00006779144,0.0036958428],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964276,0.0003729055,0.00085545925,0.00065129873,0.0008065929,0.00088615244],"domain_scores_gemma":[0.99724776,0.0001647646,0.0005424846,0.00091322936,0.000367892,0.00076385157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014014294,0.00043663508,0.0007947863,0.0004671555,0.0012574664,0.0004537489,0.00039733,0.00015952841,0.00041128343],"category_scores_gemma":[0.0010578753,0.00034315986,0.00032491243,0.00021637851,0.00022258829,0.00054072455,0.00021213731,0.0005899809,0.0002470806],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008002591,0.00080165174,0.046977036,0.000024115787,0.000119369244,0.000037716556,0.00093599246,0.0000068495156,0.8864715,2.033033e-7,0.0036675492,0.052955408],"study_design_scores_gemma":[0.012735018,0.0010849518,0.78242147,0.00028837365,0.000054998247,0.00006565598,0.0001983452,0.0003029166,0.17615137,0.0000068033246,0.026356269,0.0003338633],"about_ca_topic_score_codex":0.00040987317,"about_ca_topic_score_gemma":0.000041409687,"teacher_disagreement_score":0.7354444,"about_ca_system_score_codex":0.0010447224,"about_ca_system_score_gemma":0.00020212734,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W2610258417","doi":"10.1177/1352458517707266","title":"Stop inflammation and you stop neurodegeneration in MS – YES","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Inflammation; Medicine; Neuroscience; Disease; Psychology; Immunology; Internal medicine","score_opus":0.119391536382494,"score_gpt":0.3212886906120689,"score_spread":0.20189715422957488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610258417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302876,0.0003689808,0.00024373586,0.0050295466,0.00032289792,0.00045565178,0.000008997463,0.00003196604,0.00050943514],"genre_scores_gemma":[0.9936503,0.0033982252,0.0017953217,0.00007743249,0.00080790056,0.000034656514,0.000008376126,0.00003118805,0.00019655898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979103,0.00014416312,0.00051881006,0.00034041677,0.0006274462,0.0004588166],"domain_scores_gemma":[0.99848354,0.0001248602,0.0003249451,0.0004930452,0.00028420475,0.0002894172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009919241,0.00022468758,0.00039728353,0.00030999933,0.0011133777,0.0005340705,0.00023192185,0.00011266245,0.00006724543],"category_scores_gemma":[0.0031019035,0.00019013586,0.000099020675,0.00009325508,0.00023391981,0.0007525917,0.00020829373,0.0006238456,0.000022089003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023881024,0.0000901979,0.4990561,0.000044795604,0.000045717246,0.000024026935,0.0008854707,0.00010967699,0.38690445,0.000018188932,0.00056718406,0.11201538],"study_design_scores_gemma":[0.0048747645,0.00017161379,0.96382785,0.0003052661,0.000025084957,0.00005333789,0.00018406738,0.008760254,0.02042744,0.000026430624,0.00117533,0.00016855272],"about_ca_topic_score_codex":0.00025561513,"about_ca_topic_score_gemma":0.0004644824,"teacher_disagreement_score":0.46477175,"about_ca_system_score_codex":0.00015689209,"about_ca_system_score_gemma":0.00008458898,"threshold_uncertainty_score":0.8563314},"labels":[],"label_agreement":null},{"id":"W2614325279","doi":"10.1177/1352458517711274","title":"A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Multiple sclerosis; Cohort; Population; Cohort study; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Psychiatry","score_opus":0.2960447778843172,"score_gpt":0.34373061538578487,"score_spread":0.047685837501467654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614325279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839298,0.0061025247,0.00011935878,0.0045275325,0.0006729092,0.0020793132,0.00066768355,0.00010302848,0.0017978305],"genre_scores_gemma":[0.9916042,0.001779563,0.004155216,0.0004537555,0.0012306138,0.00032113335,0.00007895223,0.000114073046,0.0002625048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993786,0.00050405797,0.0015302208,0.00081695867,0.0020309815,0.0013317844],"domain_scores_gemma":[0.9919974,0.0013396085,0.0021431022,0.002556473,0.0011177378,0.00084568426],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0019246074,0.00063744746,0.0014748159,0.00017138367,0.0028237833,0.0006152565,0.0018000567,0.0002974078,0.00036878994],"category_scores_gemma":[0.010409682,0.000420788,0.0007441944,0.00023041993,0.0021492462,0.00081314315,0.0011020353,0.0015943532,0.00008194106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001978096,0.0008926112,0.7518389,0.00013539889,0.00075844885,0.00008109797,0.0014464292,0.000007708278,0.17644136,0.0000023091109,0.033791088,0.032626506],"study_design_scores_gemma":[0.011440608,0.00042899212,0.95036846,0.0032871985,0.00019219592,0.000042591368,0.001273246,0.0012294106,0.029070646,0.000023458633,0.0022358815,0.0004073204],"about_ca_topic_score_codex":0.0011946104,"about_ca_topic_score_gemma":0.0001366693,"teacher_disagreement_score":0.1985295,"about_ca_system_score_codex":0.00033503797,"about_ca_system_score_gemma":0.0008236599,"threshold_uncertainty_score":0.9998244},"labels":[],"label_agreement":null},{"id":"W2626123729","doi":"10.1177/1352458517715811","title":"Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Atrophy; Multiple sclerosis; Medicine; White matter; Busulfan; Transplantation; Magnetic resonance imaging; Hematopoietic stem cell transplantation; Lesion; Pathology; Urology; Internal medicine; Radiology; Immunology","score_opus":0.07639960166252388,"score_gpt":0.29790946314600264,"score_spread":0.22150986148347876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626123729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997703,0.0005300738,0.00016471694,0.0004769077,0.00012670708,0.0006924514,0.000081634644,0.00002382253,0.00020066144],"genre_scores_gemma":[0.9935337,0.005209838,0.00096752186,0.000041796215,0.00008954606,0.000035317982,0.000012234571,0.00005464301,0.000055445376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972174,0.00021928787,0.0008211291,0.00048752205,0.00063914666,0.0006154781],"domain_scores_gemma":[0.99789655,0.00037831426,0.0006173683,0.0005365619,0.00024244863,0.0003287779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072915066,0.00040802645,0.0008266452,0.0005218616,0.0007965208,0.00027322746,0.00024304783,0.00019651807,0.00008169549],"category_scores_gemma":[0.00018758466,0.00032150137,0.00026791162,0.00014673213,0.00045104834,0.00050612143,0.00012003316,0.0006842683,0.000018859255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012530551,0.0002852535,0.836174,0.0002552454,0.000115212184,0.000018060107,0.0021933499,0.00016450351,0.14846016,8.753541e-7,0.00013027672,0.010949986],"study_design_scores_gemma":[0.009858223,0.00080664526,0.97784865,0.0013660908,0.00008532855,0.00010964117,0.00030716415,0.00257302,0.006763439,0.000011671748,0.000003826295,0.00026629175],"about_ca_topic_score_codex":0.0005467277,"about_ca_topic_score_gemma":0.00016979626,"teacher_disagreement_score":0.14169672,"about_ca_system_score_codex":0.00022166892,"about_ca_system_score_gemma":0.00007720128,"threshold_uncertainty_score":0.9999237},"labels":[],"label_agreement":null},{"id":"W2737769420","doi":"10.1177/1352458517722056","title":"Dilemmas in medical ethics in the age of big data","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Dalhousie University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medical ethics; Medicine; Big data; Psychology; Psychiatry; Computer science; Data mining","score_opus":0.7476369067734334,"score_gpt":0.4815545852736984,"score_spread":0.26608232149973504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737769420","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046065103,0.0006671314,0.00011806382,0.94960755,0.0028195896,0.00037634888,0.000042718908,0.000006211219,0.00029725497],"genre_scores_gemma":[0.6325414,0.0046063177,0.00024359596,0.3446739,0.017153118,0.000020173002,0.00060261675,0.000042579617,0.000116293566],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958796,0.0006666702,0.0011229448,0.0003181694,0.0015817423,0.00043090963],"domain_scores_gemma":[0.9952622,0.0025153437,0.0005170663,0.0013753747,0.00022574472,0.00010428217],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006543533,0.0001961833,0.0005322744,0.0003383268,0.00021264165,0.00009221774,0.0015505715,0.0014793081,0.00014784707],"category_scores_gemma":[0.014975482,0.00013171202,0.000110224464,0.00017604073,0.00030896105,0.0001232077,0.00015504191,0.011522512,0.000022878794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008701254,0.00027569348,0.09540219,0.00052115,0.00003960241,0.0020294937,0.008293231,0.0000026996795,0.000097764125,0.0000028635131,0.7691253,0.124123],"study_design_scores_gemma":[0.0005877236,0.00025295513,0.15251863,0.011637656,0.00011473983,0.00083639094,0.0018704727,0.0006457952,0.0001853071,0.0005643952,0.8304195,0.00036645023],"about_ca_topic_score_codex":0.0057099173,"about_ca_topic_score_gemma":0.008252981,"teacher_disagreement_score":0.6049337,"about_ca_system_score_codex":0.00013893053,"about_ca_system_score_gemma":0.0020240664,"threshold_uncertainty_score":0.99981695},"labels":[],"label_agreement":null},{"id":"W2739122096","doi":"10.1177/1352458517707264","title":"The use of clinical databases in disease outcomes research: Is the ethics of IRB review keeping up?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Confidentiality; Terminology; Harmonization; Conflation; Context (archaeology); Informed consent; Research ethics; Clinical research; Biobank; Medicine; Engineering ethics; Alternative medicine; Political science; Law; Pathology; Psychiatry; Bioinformatics","score_opus":0.9763579248607197,"score_gpt":0.7180419072027514,"score_spread":0.2583160176579683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739122096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52171564,0.020017061,0.00014224158,0.45439446,0.0013987,0.0018960511,0.00018995108,0.000014300187,0.00023159281],"genre_scores_gemma":[0.68173665,0.31321967,0.0010688021,0.0033037171,0.00021655054,0.000016366941,0.0000024151198,0.000024535826,0.00041129897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9893787,0.0035028204,0.0025125027,0.00037338398,0.0036357502,0.00059685396],"domain_scores_gemma":[0.7320609,0.2553137,0.0019994564,0.0050509647,0.0046754335,0.000899553],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch","sts"],"category_scores_codex":[0.08704797,0.00015925324,0.0008689628,0.000118040436,0.0014920849,0.00019023728,0.0016893359,0.00020554439,0.00009300038],"category_scores_gemma":[0.7094941,0.00008013132,0.00061412714,0.00023387677,0.0036542444,0.00030677082,0.0011492348,0.011276665,0.000016228045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061474,0.00033167368,0.97191024,0.0010689356,0.00012789854,0.000022859214,0.0003751869,0.0000027960673,0.000098497534,0.00063363224,0.004815924,0.019997615],"study_design_scores_gemma":[0.0018177843,0.00012103241,0.95829666,0.020544896,0.00008867403,0.0000046076098,0.0001834447,0.0005127041,0.0000996659,0.0012205995,0.017027006,0.00008294146],"about_ca_topic_score_codex":0.0006097461,"about_ca_topic_score_gemma":0.0013106444,"teacher_disagreement_score":0.6224461,"about_ca_system_score_codex":0.00006115621,"about_ca_system_score_gemma":0.0017064197,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W2741187342","doi":"10.1177/1352458517713147","title":"Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Immune system; Immunology; CD8; Peripheral; Lymphocyte; Internal medicine","score_opus":0.08186413505668487,"score_gpt":0.3069887066488017,"score_spread":0.2251245715921168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741187342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448156,0.00066587294,0.00015442264,0.0015289321,0.00085046486,0.0004130076,0.000016809025,0.000016758131,0.001872171],"genre_scores_gemma":[0.99702317,0.0005234952,0.0018516299,0.000035214674,0.00025468098,0.00001413271,0.0000016188895,0.000024931293,0.00027114182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974807,0.00013994458,0.0008177285,0.0002465832,0.00088960835,0.00042541782],"domain_scores_gemma":[0.9972638,0.00013257551,0.00092436164,0.0010603216,0.00045377435,0.0001651572],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010266094,0.0002171575,0.0006748328,0.000116728705,0.0016125694,0.00010041485,0.000655971,0.000115513554,0.00008289261],"category_scores_gemma":[0.004623686,0.0001400088,0.0007944121,0.00012728566,0.00085232453,0.00036167982,0.00036228198,0.00060783705,0.0000029052235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029823344,0.0001866834,0.5130556,0.00007218494,0.0003345495,0.0000069475213,0.000617793,0.000057796296,0.4645918,0.000016787566,0.00031423173,0.020447407],"study_design_scores_gemma":[0.0048378254,0.00017956067,0.9219129,0.0018195751,0.00010400795,0.000070110065,0.00032358742,0.0010493022,0.06921239,0.000016748309,0.0003466707,0.00012733156],"about_ca_topic_score_codex":0.00038744733,"about_ca_topic_score_gemma":0.00010283509,"teacher_disagreement_score":0.4088573,"about_ca_system_score_codex":0.00018044306,"about_ca_system_score_gemma":0.00029844843,"threshold_uncertainty_score":0.9996872},"labels":[],"label_agreement":null},{"id":"W2741653274","doi":"","title":"Effects of mid sagittal plane selection on corpus callosal area","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sagittal plane; Corpus callosum; Selection (genetic algorithm); Medicine; Artificial intelligence; Anatomy; Computer science","score_opus":0.06509693910491117,"score_gpt":0.2850036577089702,"score_spread":0.21990671860405903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741653274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838821,0.00009445934,0.014669451,0.00044324883,0.00010646201,0.00030916213,0.000010892039,0.00011863941,0.00036552746],"genre_scores_gemma":[0.9904281,0.000091261296,0.008894061,0.0001494898,0.00025498265,0.000018634566,0.00001295768,0.000024990748,0.00012553312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909025,0.000025874046,0.00027670932,0.0001657186,0.00024263555,0.00019879563],"domain_scores_gemma":[0.99935853,0.00014528201,0.00018066872,0.00012062996,0.00009904677,0.000095813644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007525903,0.00012858302,0.00021349956,0.00012185686,0.00013425859,0.000017578795,0.00007167294,0.00005705878,0.000017749928],"category_scores_gemma":[0.00008628249,0.000109376255,0.00010757114,0.00016586535,0.000054784232,0.00005640004,0.000015302934,0.00035347164,0.000007209568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020969173,0.000483841,0.049357556,0.000034195964,0.000015977326,0.000017788027,0.000011935013,0.00018377286,0.9400552,0.00009535621,0.0035299137,0.0060047735],"study_design_scores_gemma":[0.0019120036,0.00044208296,0.38484958,0.00027641671,0.00005238864,0.00035147998,0.0000031877241,0.0007204881,0.60915715,0.00032141712,0.0018107209,0.000103090744],"about_ca_topic_score_codex":0.000048917213,"about_ca_topic_score_gemma":0.0000076222395,"teacher_disagreement_score":0.335492,"about_ca_system_score_codex":0.00007827452,"about_ca_system_score_gemma":0.000032404823,"threshold_uncertainty_score":0.44602343},"labels":[],"label_agreement":null},{"id":"W2742808332","doi":"10.1177/1352458517723718","title":"The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Medical Research Council; U.S. Food and Drug Administration; National Institute for Health and Care Research; National Multiple Sclerosis Society","keywords":"Clinical trial; Medicine; Multiple sclerosis; MEDLINE; Physical medicine and rehabilitation; Physical therapy; Medical physics; Psychiatry; Pathology","score_opus":0.44987644071959876,"score_gpt":0.39835689658703183,"score_spread":0.05151954413256693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742808332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01411341,0.9723422,0.0004895314,0.0025786322,0.0015549067,0.008113223,0.0002651774,0.00019036583,0.00035258132],"genre_scores_gemma":[0.034552924,0.9496972,0.012051514,0.00020010768,0.0013500086,0.0015105149,0.000029868375,0.0002596382,0.0003482425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99031836,0.0008418878,0.0023936182,0.0016763522,0.0025589825,0.002210789],"domain_scores_gemma":[0.9908259,0.0024884176,0.0010941952,0.0024750947,0.0010694234,0.0020469865],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0048935637,0.0016488528,0.0046880497,0.00050943455,0.0059052194,0.0016934219,0.0021186103,0.0006183256,0.000013192814],"category_scores_gemma":[0.014552904,0.0009882248,0.0014223736,0.0007550869,0.0009303543,0.0005003277,0.0019381728,0.0028211786,0.00016320967],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020343764,0.00026340186,0.06263429,0.004362669,0.0010819619,0.0000031560683,0.00042015672,0.000007840973,0.000045470442,0.0000021439673,0.0018796389,0.92909586],"study_design_scores_gemma":[0.0022003169,0.0002505371,0.48408744,0.02646932,0.0006885525,0.00010628687,0.0002704659,0.00016766232,0.000026673792,0.0000012551934,0.4846552,0.0010763003],"about_ca_topic_score_codex":0.00013411882,"about_ca_topic_score_gemma":0.00017204664,"teacher_disagreement_score":0.9280195,"about_ca_system_score_codex":0.0018179473,"about_ca_system_score_gemma":0.0007141013,"threshold_uncertainty_score":0.99962586},"labels":[],"label_agreement":null},{"id":"W2744553073","doi":"10.1177/1352458517723717","title":"Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Multiple sclerosis; White matter; Myelin; Magnetic resonance imaging; Nuclear medicine; Medicine; Nuclear magnetic resonance; Internal medicine; Pathology; Central nervous system; Physics; Radiology","score_opus":0.0957134897978565,"score_gpt":0.30535267081058715,"score_spread":0.20963918101273066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744553073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953099,0.0002712225,0.00015379883,0.0016755292,0.00060157775,0.0006856501,0.00012108746,0.000046434085,0.0011348056],"genre_scores_gemma":[0.99507254,0.0011685458,0.0024315934,0.00028124932,0.0005830393,0.000050416784,0.00001749297,0.00008996375,0.0003051446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945652,0.00021949661,0.0014232547,0.00072823215,0.001468036,0.0015958078],"domain_scores_gemma":[0.99674624,0.00015826573,0.0005966396,0.0013879423,0.00046909717,0.0006418106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016197553,0.000557345,0.0012011507,0.0004798387,0.0008803698,0.00047065748,0.0010485983,0.00030830136,0.0013180653],"category_scores_gemma":[0.0011413645,0.00044693775,0.0006020913,0.0002575619,0.0007605575,0.0009535156,0.0011203693,0.0010371046,0.0003502896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008650473,0.0004511935,0.9397751,0.00013534148,0.00023828402,0.00008596442,0.00087898975,0.00032405087,0.045894288,0.0000016039783,0.002092314,0.009257831],"study_design_scores_gemma":[0.011938931,0.00017662882,0.9762147,0.0015995614,0.00007401718,0.00008008112,0.00025770828,0.0017562091,0.006863921,0.00002353295,0.0005642133,0.00045049126],"about_ca_topic_score_codex":0.0013983181,"about_ca_topic_score_gemma":0.0013383222,"teacher_disagreement_score":0.039030366,"about_ca_system_score_codex":0.00057428045,"about_ca_system_score_gemma":0.00013099308,"threshold_uncertainty_score":0.99979824},"labels":[],"label_agreement":null},{"id":"W2745030665","doi":"10.1177/1352458517723991","title":"On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognitive impairment; Physical medicine and rehabilitation; Cognition; Prospective cohort study; Cognitive Assessment System; Medicine; Psychology; Physical therapy; Audiology; Gerontology; Neuroscience; Psychiatry; Internal medicine","score_opus":0.09570227893758988,"score_gpt":0.4052311585412595,"score_spread":0.30952887960366965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745030665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330217,0.000010912291,0.0003641508,0.0006877877,0.00023234215,0.0035561633,0.000087718894,0.000034301414,0.001724485],"genre_scores_gemma":[0.99771667,0.00001575143,0.0010870151,0.00012653304,0.00014479374,0.0006916533,0.0000015346844,0.000057698224,0.00015832954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967236,0.00052203576,0.0006289503,0.0005219454,0.00083451736,0.0007689676],"domain_scores_gemma":[0.99674255,0.00069467747,0.0009978219,0.0005180051,0.00078713347,0.0002598128],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0009983429,0.00037158278,0.00073274045,0.0003276621,0.0029202586,0.000090021436,0.00045481464,0.00008692491,0.000102129445],"category_scores_gemma":[0.0006479442,0.00024414388,0.000080483034,0.00023065036,0.0002595667,0.0003467715,0.0002777964,0.0014124194,0.000022772496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082676206,0.0018343062,0.950095,0.00004993845,0.00041217043,0.00004780817,0.045873,0.00012260246,0.00008641175,0.000010529763,0.00013077263,0.0005106906],"study_design_scores_gemma":[0.015716264,0.0060367715,0.9268083,0.0054677124,0.0001081294,0.000006451432,0.045330215,0.00018274404,0.00003809255,0.000017384202,0.0000026634657,0.0002852717],"about_ca_topic_score_codex":0.001309023,"about_ca_topic_score_gemma":0.023137879,"teacher_disagreement_score":0.02328671,"about_ca_system_score_codex":0.00057742983,"about_ca_system_score_gemma":0.00047241163,"threshold_uncertainty_score":0.9983778},"labels":[],"label_agreement":null},{"id":"W2752579839","doi":"10.1177/1352458517711775","title":"Physician-assisted death should be available to people with MS – YES","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Multiple sclerosis; Medicine; MEDLINE; Medical emergency; Psychiatry; Political science","score_opus":0.23483256454492915,"score_gpt":0.3488085247754639,"score_spread":0.11397596023053477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752579839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698744,0.00032415765,0.0006563985,0.014158693,0.0004393612,0.0011974896,0.00007769208,0.00015455738,0.013117281],"genre_scores_gemma":[0.9833141,0.0007891468,0.010079543,0.0017246255,0.0010526347,0.00013354767,0.00001337477,0.00011697844,0.0027760395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561596,0.00011945783,0.00058993185,0.0007065713,0.0016987339,0.0012693484],"domain_scores_gemma":[0.99579847,0.00025364052,0.00045296687,0.0014784188,0.00088698306,0.0011295456],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00085944997,0.00052602467,0.0009945829,0.00033025324,0.002907152,0.0009563053,0.00086698245,0.00015386197,0.0006850055],"category_scores_gemma":[0.0018964274,0.00037904785,0.00033620713,0.00029188447,0.00026417262,0.00065954577,0.00048782583,0.0010087888,0.00046590783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016821831,0.0008930615,0.70418644,0.000112613845,0.0007755861,0.000102197446,0.0010886297,0.00007328,0.18399453,0.00001401939,0.0770787,0.029998764],"study_design_scores_gemma":[0.006196602,0.00089786865,0.9552537,0.00094666186,0.00015670671,0.00011655716,0.0003040084,0.00067348464,0.013104974,0.000005818407,0.021884449,0.00045911927],"about_ca_topic_score_codex":0.0010700532,"about_ca_topic_score_gemma":0.001956524,"teacher_disagreement_score":0.25106734,"about_ca_system_score_codex":0.00036859585,"about_ca_system_score_gemma":0.00028496943,"threshold_uncertainty_score":0.9998661},"labels":[],"label_agreement":null},{"id":"W2753561811","doi":"10.1177/1352458517728811","title":"Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"U.S. Food and Drug Administration","keywords":"Minocycline; Hydroxychloroquine; Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Pharmacology; Neurotoxicity; Microglia; Toxicity; Immunology; Internal medicine; Disease; Inflammation; Chemistry; Antibiotics","score_opus":0.09880776252245432,"score_gpt":0.3255740117319261,"score_spread":0.2267662492094718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753561811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907958,0.002756435,0.00051343895,0.000564227,0.00018911435,0.004614332,0.00048459086,0.000030495816,0.00005156365],"genre_scores_gemma":[0.99141765,0.0038732418,0.0032659934,0.000016448697,0.00018865413,0.0010531105,0.00006989697,0.0000644424,0.000050563027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967747,0.00017514483,0.0010091048,0.00061896536,0.0007657463,0.00065637496],"domain_scores_gemma":[0.99522984,0.0012220679,0.0012233629,0.0006413601,0.0012035983,0.000479751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047439005,0.00047336103,0.0012879922,0.0005018964,0.0006100022,0.000100089346,0.0003049846,0.00015386852,0.0000134114725],"category_scores_gemma":[0.0054039992,0.00037981846,0.0003806423,0.00019990093,0.0007906907,0.00062063173,0.00020492203,0.00033185683,9.090555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010769689,0.0062800255,0.69239044,0.0010574487,0.0013024735,0.000046300935,0.004038926,0.00025697539,0.22692756,0.000078179204,0.00017822729,0.056673754],"study_design_scores_gemma":[0.036522135,0.0023539255,0.8197338,0.0038206254,0.00026078243,0.000007483488,0.00037439837,0.034188554,0.10219194,0.00027897375,0.000011831579,0.0002555381],"about_ca_topic_score_codex":0.0002420083,"about_ca_topic_score_gemma":0.00020263283,"teacher_disagreement_score":0.12734337,"about_ca_system_score_codex":0.00047657941,"about_ca_system_score_gemma":0.00020982267,"threshold_uncertainty_score":0.99986535},"labels":[],"label_agreement":null},{"id":"W2753716024","doi":"10.1177/1352458517728812","title":"Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Clinique Neuro-Outaouais; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; Sanofi Genzyme; Bayer HealthCare; Multiple Sclerosis Society; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Multiple Sclerosis Society of Canada; Univerzita Karlova v Praze; Fondazione Italiana Sclerosi Multipla; Biogen; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Cladribine; Internal medicine; Gastroenterology; Immunology","score_opus":0.2605903277885955,"score_gpt":0.3522453158798759,"score_spread":0.09165498809128042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753716024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881091,0.0014163634,0.0015998734,0.00449426,0.0016971848,0.001671362,0.00027139284,0.00014357711,0.00059688033],"genre_scores_gemma":[0.9835642,0.004746294,0.009292634,0.00020080131,0.0014338491,0.00023034443,0.000042131163,0.00014002058,0.00034975418],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99562085,0.0001315264,0.0009560392,0.0009067275,0.0010069321,0.0013779097],"domain_scores_gemma":[0.99491227,0.0012021554,0.000703049,0.0013122357,0.0008786916,0.0009916225],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0012462082,0.0006513005,0.0011087975,0.00041704244,0.0035755986,0.001068892,0.0008360236,0.00030811882,0.0001392874],"category_scores_gemma":[0.010363195,0.00055854896,0.00057124905,0.0001388239,0.00083358824,0.00089990994,0.0008290035,0.0010400286,0.000046831057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02737414,0.0012033774,0.2680364,0.00066139,0.0020910997,0.000058594636,0.0017784283,0.000047515034,0.33775446,0.000077974655,0.02505422,0.33586243],"study_design_scores_gemma":[0.056947,0.0027291637,0.89732933,0.0018280203,0.00033513183,0.00012644795,0.0007180246,0.01299025,0.016870167,0.000042434072,0.00927703,0.0008070308],"about_ca_topic_score_codex":0.00034029837,"about_ca_topic_score_gemma":0.0006494236,"teacher_disagreement_score":0.6292929,"about_ca_system_score_codex":0.00046301176,"about_ca_system_score_gemma":0.0001783136,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W2754752946","doi":"10.1177/1352458517728343","title":"Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Multiple sclerosis; Medicine; Extension (predicate logic); Computer science; Immunology","score_opus":0.24047715458720315,"score_gpt":0.3765974129036126,"score_spread":0.13612025831640945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754752946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954108,0.0003533641,0.000084459345,0.0007900721,0.00073305296,0.0017691911,0.0003552301,0.00008212993,0.00042168103],"genre_scores_gemma":[0.9897512,0.0015751346,0.0077888127,0.00007164992,0.00052045187,0.00005381852,0.000052039402,0.00012506873,0.00006182911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924684,0.00065293716,0.0022962778,0.0012217705,0.0021000402,0.0012605668],"domain_scores_gemma":[0.9931783,0.001084717,0.0015884942,0.0023105585,0.0010496161,0.00078828546],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0030511988,0.00068736693,0.0017551577,0.00082948006,0.0015510097,0.00047575135,0.0010586921,0.0002565121,0.00014945354],"category_scores_gemma":[0.0146981375,0.00059320196,0.0004878716,0.00045007988,0.0005380582,0.00093760894,0.00087876566,0.0017580545,0.000058893493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011953263,0.007649099,0.5439851,0.00003479537,0.00044940395,0.00016137665,0.0044380883,0.00024461737,0.38970903,0.0000013328383,0.0011177299,0.040256154],"study_design_scores_gemma":[0.12758505,0.0018579958,0.84306175,0.0026032862,0.00019927774,0.000019238845,0.0063389866,0.010177654,0.0075795013,0.000018664621,0.000092159615,0.00046642363],"about_ca_topic_score_codex":0.013699409,"about_ca_topic_score_gemma":0.008085574,"teacher_disagreement_score":0.38212955,"about_ca_system_score_codex":0.0004965917,"about_ca_system_score_gemma":0.00022748791,"threshold_uncertainty_score":0.9997488},"labels":[],"label_agreement":null},{"id":"W2761348774","doi":"10.1177/1352458517735191","title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Regional Development Fund; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; Generalitat de Catalunya; Bayer HealthCare; Instituto de Salud Carlos III; Oryzon Genomics; Teva Pharmaceutical Industries; Red Española de Esclerosis Múltiple; Biogen; Celgene; Sanofi","keywords":"Medicine; Incidence (geometry); Neuromyelitis optica; Pediatrics; Multiple sclerosis; Epidemiology; Myelin oligodendrocyte glycoprotein; Population; Internal medicine; Immunology; Environmental health","score_opus":0.13099493612578322,"score_gpt":0.3941934759163016,"score_spread":0.2631985397905184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761348774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930738,0.0033137533,0.000030913914,0.0030116125,0.00010017993,0.00042636818,0.000019656349,0.00000496706,0.0000187231],"genre_scores_gemma":[0.9927637,0.0033199214,0.0037287713,0.000069632464,0.00005822618,0.000014544706,5.9320894e-7,0.000013877087,0.00003073112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753684,0.00028095595,0.0009988954,0.00030523792,0.00040072395,0.00047732933],"domain_scores_gemma":[0.9967685,0.0012281338,0.0007738592,0.0007261443,0.0002852734,0.00021812861],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023991433,0.00020001765,0.00080328126,0.00020939497,0.00023027563,0.000019691073,0.00069585466,0.000120233235,0.000025574573],"category_scores_gemma":[0.03291772,0.00013664644,0.00010588262,0.00017016687,0.0010690687,0.0004240916,0.0006403912,0.0006498042,0.0000020089265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019113004,0.000088514375,0.92626375,0.00025679613,0.000025491921,0.000006022134,0.00065645506,0.0002366503,0.06970882,0.0000053833355,0.00020991112,0.0023511015],"study_design_scores_gemma":[0.0026513366,0.00013645327,0.9845305,0.0037452243,0.000023064955,0.000055448665,0.00006085427,0.002009657,0.0065154536,0.00015862324,0.0000109650455,0.00010241786],"about_ca_topic_score_codex":0.004198843,"about_ca_topic_score_gemma":0.002641147,"teacher_disagreement_score":0.063193366,"about_ca_system_score_codex":0.00011056329,"about_ca_system_score_gemma":0.00025592622,"threshold_uncertainty_score":0.9752284},"labels":[],"label_agreement":null},{"id":"W2765125400","doi":"10.1177/1352458517729451","title":"The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS – No","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Optic nerve; Neuroscience; Medicine; Space (punctuation); Pathology; Computer science; Anatomy; Psychology; Immunology","score_opus":0.20074789457623185,"score_gpt":0.3762916006386692,"score_spread":0.17554370606243733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765125400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139003,0.0005122477,0.0006603465,0.081850246,0.0006862448,0.0015782395,0.00003873046,0.000024536082,0.00074912095],"genre_scores_gemma":[0.9938992,0.0011256121,0.003584975,0.00012949375,0.00058112654,0.00014777272,0.000006212712,0.000047593763,0.00047801595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969061,0.0002536961,0.00071770675,0.00033385982,0.0010967986,0.0006918622],"domain_scores_gemma":[0.9935181,0.0036569508,0.0006997182,0.0009792766,0.0008369783,0.00030898492],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.002453137,0.00025136728,0.00051780505,0.00015591992,0.0030255374,0.00064882956,0.0009917397,0.00016298756,0.000036722413],"category_scores_gemma":[0.06437793,0.00015202655,0.00035982975,0.00017600946,0.00063848216,0.0005661672,0.00063983543,0.0010303552,0.000004604376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036384512,0.00198408,0.49094895,0.00039586017,0.0007587686,0.000033180866,0.010502046,0.0002761747,0.39636928,0.0022924661,0.058904275,0.033896454],"study_design_scores_gemma":[0.0044179386,0.0002937473,0.96474135,0.003078337,0.00012488432,0.000034190976,0.0011715649,0.00688781,0.0156065365,0.0006087982,0.0028137306,0.00022110823],"about_ca_topic_score_codex":0.0005207194,"about_ca_topic_score_gemma":0.0010415576,"teacher_disagreement_score":0.4737924,"about_ca_system_score_codex":0.00036206402,"about_ca_system_score_gemma":0.00023230314,"threshold_uncertainty_score":0.99827236},"labels":[],"label_agreement":null},{"id":"W2767123116","doi":"10.1177/1352458517739976","title":"An overview of biosimilars and non-biologic complex drugs in Europe, the United States, and Canada and their relevance to multiple sclerosis","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Reimbursement; Multiple sclerosis; Business; Relevance (law); Public economics; Healthcare system; Competition (biology); Health care; Risk analysis (engineering); Industrial organization; Medicine; Economics; Political science; Economic growth; Immunology","score_opus":0.2728565278470762,"score_gpt":0.35153841585718654,"score_spread":0.07868188801011033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767123116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04225534,0.9551712,0.000022468488,0.0005270303,0.00029287545,0.00070420536,0.0010066945,0.00001133895,0.000008844322],"genre_scores_gemma":[0.020567728,0.977663,0.00067008176,0.0008497587,0.000042961943,0.000020604053,0.000106451735,0.00004609297,0.000033334196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600965,0.0015107301,0.0011000754,0.0006535705,0.00009037763,0.0006355836],"domain_scores_gemma":[0.9962361,0.0018188758,0.0008488998,0.0006485138,0.00024330158,0.00020433773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017021334,0.0006577133,0.0020837907,0.00029130458,0.00065512024,0.00015789803,0.00079669413,0.0004657801,0.00003562512],"category_scores_gemma":[0.0009760133,0.00036924062,0.00015140543,0.0004429401,0.00081818964,0.000106902815,0.0004453115,0.001186264,0.0000015000741],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013708271,0.00014830011,0.007838142,0.0017718172,0.0004823499,0.000006712997,0.00037724298,0.0000043921423,0.0038492633,0.000007639842,0.0035145392,0.98186255],"study_design_scores_gemma":[0.0017131802,0.0003931689,0.08049279,0.011403985,0.0003509848,0.00015213033,0.00030315298,0.00018263288,0.00019253393,0.000019515288,0.904069,0.0007269061],"about_ca_topic_score_codex":0.06642189,"about_ca_topic_score_gemma":0.13676123,"teacher_disagreement_score":0.9811356,"about_ca_system_score_codex":0.00008975699,"about_ca_system_score_gemma":0.00026595168,"threshold_uncertainty_score":0.99987596},"labels":[],"label_agreement":null},{"id":"W2767204380","doi":"10.1177/1352458517740211","title":"Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universiteit Hasselt","keywords":"Physical medicine and rehabilitation; Cognition; Physical therapy; Paced Auditory Serial Addition Test; Expanded Disability Status Scale; Montreal Cognitive Assessment; Psychology; Multiple sclerosis; Quality of life (healthcare); Medicine; Audiology; Cognitive impairment; Neuroscience","score_opus":0.1370018357750346,"score_gpt":0.32639049733939524,"score_spread":0.18938866156436063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767204380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957381,0.00011642315,0.00015922675,0.00061954185,0.000155132,0.0027983508,0.0002190087,0.00011224584,0.00008198779],"genre_scores_gemma":[0.99578315,0.00010837414,0.002922131,0.0003350959,0.00032038926,0.00031695445,0.00007124905,0.00011588094,0.00002680324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455166,0.0012467208,0.0007117117,0.00072912377,0.0016205284,0.0011402582],"domain_scores_gemma":[0.9945308,0.002203228,0.0006568983,0.0008598326,0.000750916,0.0009983231],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014582119,0.0007231539,0.0012852692,0.0007912685,0.0026293406,0.00062078395,0.0007241833,0.0002452986,0.000021125908],"category_scores_gemma":[0.0072343955,0.00057446875,0.00022979212,0.00041906573,0.0014522042,0.0007257953,0.0005106259,0.00264881,0.00000573496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069784564,0.00913302,0.5387469,0.0006828384,0.0015935972,0.000051398885,0.025194306,0.00012194144,0.17200942,0.0000086371565,0.0009611073,0.24451838],"study_design_scores_gemma":[0.019152567,0.009973247,0.93829024,0.0035514184,0.00034351213,0.000036855952,0.0037418155,0.0027848466,0.02151643,0.000029150688,0.000046012512,0.00053387927],"about_ca_topic_score_codex":0.0029077183,"about_ca_topic_score_gemma":0.006763281,"teacher_disagreement_score":0.3995434,"about_ca_system_score_codex":0.00020943048,"about_ca_system_score_gemma":0.00017689481,"threshold_uncertainty_score":0.9996707},"labels":[],"label_agreement":null},{"id":"W2767375489","doi":"10.1177/1352458517739990","title":"The NAIMS cooperative pilot project: Design, implementation and future directions","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Standardization; Protocol (science); Magnetic resonance imaging; Medical physics; Computer science; Reproducibility; Pace; Multiple sclerosis; Medicine; Radiology; Pathology; Physics; Operating system","score_opus":0.1965319599313926,"score_gpt":0.38722713264915065,"score_spread":0.19069517271775804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767375489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92651296,0.0084888805,0.002561198,0.051619325,0.0027794244,0.0056922026,0.00011638172,0.00019538657,0.0020342611],"genre_scores_gemma":[0.9517281,0.042705026,0.0030713356,0.00013853282,0.0017962666,0.00020858683,0.0000055612245,0.00003719983,0.00030937407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787414,0.0002737725,0.00041207232,0.00030287518,0.0005926333,0.00054451165],"domain_scores_gemma":[0.9979156,0.00040952026,0.00032042924,0.00048337018,0.000618568,0.00025247643],"candidate_categories":["sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0012679109,0.00024050123,0.00030982375,0.00012289698,0.0083660735,0.0011131577,0.00028667544,0.00005864452,0.000067841815],"category_scores_gemma":[0.0008826849,0.00014522352,0.00010432563,0.000120527344,0.00048515463,0.0004590706,0.00020604633,0.0006299951,0.000014034067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014796783,0.00035644975,0.101676494,0.0000409207,0.00085287355,0.000021384121,0.0035899046,0.000006405706,0.083779864,0.0000953441,0.031663373,0.7764373],"study_design_scores_gemma":[0.0055359113,0.0009593667,0.9176704,0.000121444325,0.000082513725,0.00012445799,0.005972487,0.00061958766,0.00440556,0.000018478888,0.0642949,0.0001948724],"about_ca_topic_score_codex":0.00026103877,"about_ca_topic_score_gemma":0.00073074317,"teacher_disagreement_score":0.8159939,"about_ca_system_score_codex":0.00017017905,"about_ca_system_score_gemma":0.00022222333,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2782707227","doi":"10.1177/1352458517737369","title":"Gut microbiome and pediatric multiple sclerosis","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Microbiome; Gut microbiome; Gut flora; Immune system; Gut–brain axis; Gut bacteria; Biology; Immunology; Medicine; Bioinformatics","score_opus":0.11438906571410544,"score_gpt":0.29741713897060706,"score_spread":0.1830280732565016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782707227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014775632,0.98288476,0.00010087714,0.00003616897,0.0010886361,0.00064380455,0.0004026472,0.000027639519,0.000039852566],"genre_scores_gemma":[0.003003934,0.98990357,0.0021519526,0.00017634222,0.0038486307,0.00003783206,0.00034712037,0.00017559061,0.00035501257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962123,0.00037379627,0.0012189439,0.0009869492,0.00023547705,0.00097254926],"domain_scores_gemma":[0.9974481,0.00009351836,0.00094368035,0.0006832645,0.00025576176,0.00057568005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007813786,0.00084242737,0.001446811,0.00042015742,0.00071951834,0.00032425803,0.00070180657,0.0010183048,0.0000804067],"category_scores_gemma":[0.00026789942,0.0007181974,0.00084211066,0.0003587312,0.00022895384,0.00001586058,0.00048800957,0.0008263053,0.00018512737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001275696,0.00053740543,0.004138117,0.011256088,0.0008505979,0.000018180404,0.00016120539,0.0000011877552,0.123277165,0.0000020746368,0.119315445,0.74031496],"study_design_scores_gemma":[0.0014919327,0.0003302242,0.003479463,0.0032343282,0.00062287156,0.0005779994,0.000017466275,0.0000032936362,0.00015709038,0.0000020172054,0.98918736,0.0008959615],"about_ca_topic_score_codex":0.000029233808,"about_ca_topic_score_gemma":0.00007053224,"teacher_disagreement_score":0.8698719,"about_ca_system_score_codex":0.00012176887,"about_ca_system_score_gemma":0.000541792,"threshold_uncertainty_score":0.9995269},"labels":[],"label_agreement":null},{"id":"W2782758061","doi":"10.1177/1352458517737397","title":"Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2017: Environmental factors, genetics, and epigenetics in MS susceptibility and clinical course","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Epigenetics; Multidisciplinary approach; Medicine; Neuroscience; Library science; Psychology; Biology; Genetics; Psychiatry; Gene; Sociology; Social science; Computer science","score_opus":0.3667981618820302,"score_gpt":0.42834221320703714,"score_spread":0.061544051325006954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782758061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911479,0.0045132036,0.00008215592,0.001626475,0.00019406114,0.002151852,0.00024554326,0.000020057687,0.00001875991],"genre_scores_gemma":[0.94152945,0.052735634,0.0050063417,0.0000896435,0.00040366847,0.000101331694,0.00003329979,0.00006691951,0.000033678138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99461436,0.0009699876,0.0012505804,0.0010420067,0.00073603017,0.0013870302],"domain_scores_gemma":[0.99448806,0.0035513854,0.00024005542,0.00058146974,0.00022803144,0.0009110161],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0037591998,0.00050027785,0.0011292271,0.00048643167,0.0008703796,0.00019917967,0.00022748671,0.0003136036,0.000040557174],"category_scores_gemma":[0.0017632608,0.00041134888,0.00019290678,0.00029426237,0.003351151,0.00019871218,0.0005248342,0.0008371658,0.0000059889535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011933395,0.0014509261,0.894784,0.00004545436,0.00015442031,0.000008123463,0.0013351113,0.0000031798957,0.021905594,7.155867e-7,0.00053800625,0.078581154],"study_design_scores_gemma":[0.016021967,0.0043839165,0.9646878,0.0003633991,0.00007525951,0.00002594957,0.0038676974,0.006114085,0.002703092,0.000038078462,0.0013759945,0.00034275686],"about_ca_topic_score_codex":0.00082643237,"about_ca_topic_score_gemma":0.0075842785,"teacher_disagreement_score":0.0782384,"about_ca_system_score_codex":0.0005821491,"about_ca_system_score_gemma":0.00015192758,"threshold_uncertainty_score":0.9998338},"labels":[],"label_agreement":null},{"id":"W2783474205","doi":"10.1177/1352458517737391","title":"An introduction to the microbiome and MS","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Multiple sclerosis; Microbiome; Disease; Neuroimmunology; Human microbiome; Autoimmune disease; Intervention (counseling); Immunology; Biology; Gut microbiome; Neuroscience; Gut flora; Medicine; Central nervous system; Bioinformatics; Psychiatry; Pathology","score_opus":0.02469856201168886,"score_gpt":0.25868815176849075,"score_spread":0.2339895897568019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783474205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085706,0.00017573043,0.0017815124,0.0064913644,0.0005528004,0.000105827305,0.000011228966,0.000005817326,0.000018650993],"genre_scores_gemma":[0.9903549,0.00013774766,0.002627622,0.0013283762,0.005410513,0.0000026971918,0.000014530281,0.000013543728,0.000110089866],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992925,0.00007096338,0.00014595673,0.00021537075,0.00005471273,0.00022051967],"domain_scores_gemma":[0.99943346,0.0000035407497,0.00005454127,0.00023809663,0.00011856748,0.00015181761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036020667,0.00009015923,0.00007297098,0.000041801963,0.00043340793,0.00010269892,0.00015900879,0.00006656342,0.000044350236],"category_scores_gemma":[0.00004409074,0.000063170606,0.000032478158,0.0000755793,0.000089705245,0.0000064173187,0.00005486696,0.00010872761,0.000029806923],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005645877,0.000027359434,0.0024765006,0.0000018766028,0.000011220092,1.1532243e-7,0.00017680063,0.0000055449555,0.9626868,0.0000037855395,0.029187467,0.0053660995],"study_design_scores_gemma":[0.0006416561,0.00089212967,0.20416883,0.000011869091,0.000011934727,0.0002579255,0.0001484442,0.00003684926,0.30246913,0.000007870203,0.49119082,0.00016254101],"about_ca_topic_score_codex":0.000021404552,"about_ca_topic_score_gemma":0.00021646862,"teacher_disagreement_score":0.66021764,"about_ca_system_score_codex":0.000014492448,"about_ca_system_score_gemma":0.00003216525,"threshold_uncertainty_score":0.33334672},"labels":[],"label_agreement":null},{"id":"W2784161421","doi":"10.1177/1352458517737373","title":"Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Mendelian randomization; Causal inference; Multiple sclerosis; Confounding; Causation; Disease; Causality (physics); Marginal structural model; Medicine; Epidemiology; Bioinformatics; Genetic variants; Biology; Genetics; Psychiatry; Pathology; Gene","score_opus":0.17799827357021936,"score_gpt":0.34449216425094664,"score_spread":0.16649389068072729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784161421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032750284,0.98741627,0.0009955546,0.00019421555,0.0006758553,0.006791966,0.0004463951,0.0001191176,0.000085594744],"genre_scores_gemma":[0.009088382,0.98025846,0.006511312,0.000096066215,0.0018248727,0.0014520995,0.00024421813,0.00029395698,0.00023063729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99217296,0.0009036083,0.0026134867,0.0013966078,0.001231884,0.0016814445],"domain_scores_gemma":[0.9937992,0.0023736828,0.00117596,0.00079743617,0.0008772174,0.0009765008],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0035523672,0.0012986579,0.0047707623,0.0017861767,0.0009991562,0.00048197538,0.0005909931,0.0008976008,0.000111948335],"category_scores_gemma":[0.0067376504,0.0010367272,0.0013569104,0.0010328894,0.0005386251,0.0005096001,0.0004740373,0.0017448309,0.000059527494],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018683783,0.0010364114,0.0069097914,0.012200847,0.0014516433,0.00002733427,0.00091451866,0.000011234022,0.0009942545,0.000005483252,0.006132585,0.9684475],"study_design_scores_gemma":[0.08240789,0.0016684292,0.024448903,0.12770037,0.0034004601,0.00051340024,0.0008469789,0.0070566335,0.00023728845,0.000048222202,0.7491699,0.0025015685],"about_ca_topic_score_codex":0.00017322844,"about_ca_topic_score_gemma":0.00075871,"teacher_disagreement_score":0.96594596,"about_ca_system_score_codex":0.0010557055,"about_ca_system_score_gemma":0.0006903716,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W2785343395","doi":"10.1177/1352458517751652","title":"Anxiety is more important than depression in MS – Yes","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Depression (economics); Multiple sclerosis; Anxiety; Psychology; Clinical psychology; Medicine; Psychiatry","score_opus":0.1695190595445297,"score_gpt":0.3830606096105337,"score_spread":0.21354155006600398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785343395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024718102,0.99384004,0.000019693367,0.0002579851,0.0007129834,0.0019456131,0.00018285123,0.00009149048,0.00047751554],"genre_scores_gemma":[0.0022176849,0.99283916,0.001633084,0.00017993241,0.0021710796,0.00024604768,0.000095696865,0.00023420966,0.00038313313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99210924,0.00049131457,0.0026414655,0.001229498,0.0019468614,0.0015815976],"domain_scores_gemma":[0.99546593,0.0004667606,0.0013280044,0.0012228088,0.0005484421,0.00096803246],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021501558,0.001185197,0.0039437297,0.0011684131,0.0005673048,0.0002740412,0.0008835765,0.000862128,0.00066580996],"category_scores_gemma":[0.0019807927,0.0008078679,0.0019588955,0.0010943821,0.00047543252,0.00031991294,0.0007141275,0.0030988348,0.00022677735],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016621883,0.00052331825,0.11901438,0.0067722243,0.0007762207,0.00012538285,0.00073582074,5.17997e-7,0.00013754908,3.2814276e-7,0.029941322,0.8418067],"study_design_scores_gemma":[0.0030783897,0.00022355696,0.106955476,0.07540724,0.0006664146,0.0006724391,0.00016189688,0.00018876711,0.00008573942,0.0000042939882,0.8117615,0.00079429586],"about_ca_topic_score_codex":0.00019282497,"about_ca_topic_score_gemma":0.00022889982,"teacher_disagreement_score":0.8410124,"about_ca_system_score_codex":0.00093923195,"about_ca_system_score_gemma":0.0008069766,"threshold_uncertainty_score":0.9994372},"labels":[],"label_agreement":null},{"id":"W2787084164","doi":"10.1177/1352458518757089","title":"The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; University of Manitoba; McGill University; Hospital for Sick Children","funders":"","keywords":"Medicine; Multiple sclerosis; Odds ratio; Secondhand smoke; Confidence interval; Risk factor; Environmental health; Clinically isolated syndrome; Tobacco smoke; Internal medicine; Immunology","score_opus":0.08171314972602026,"score_gpt":0.29659562535028866,"score_spread":0.2148824756242684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787084164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242955,0.0019320813,0.0010585873,0.0014857689,0.001164282,0.0014454154,0.00019446021,0.00009531747,0.0001945614],"genre_scores_gemma":[0.9847949,0.0097557,0.0019029146,0.00026979978,0.002913491,0.00012204216,0.000015854699,0.00008480625,0.00014046786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940123,0.00057387014,0.0015313497,0.0006838664,0.0017341103,0.0014645333],"domain_scores_gemma":[0.99201924,0.0019861541,0.00087944634,0.001031423,0.0030622766,0.0010214495],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0032691122,0.00055263826,0.0009823537,0.00053941057,0.0025332929,0.00032557026,0.00073849654,0.00027613054,0.0002926135],"category_scores_gemma":[0.014145511,0.00038034318,0.0006115529,0.0012548954,0.00064903597,0.00036282724,0.0004737682,0.0012013364,0.00018678262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016137438,0.00036503962,0.8675979,0.000028468612,0.00040006422,0.000004807068,0.0010301959,0.000054640313,0.076064184,0.000008870619,0.0099738445,0.042858284],"study_design_scores_gemma":[0.00870544,0.0020099669,0.9485202,0.00033363243,0.00026077175,0.00003336509,0.0008126109,0.0005668334,0.03459652,0.000021017659,0.0037618382,0.0003778308],"about_ca_topic_score_codex":0.0003186783,"about_ca_topic_score_gemma":0.0011869372,"teacher_disagreement_score":0.08092231,"about_ca_system_score_codex":0.00041372463,"about_ca_system_score_gemma":0.000320271,"threshold_uncertainty_score":0.9998649},"labels":[],"label_agreement":null},{"id":"W2788783358","doi":"10.1177/1352458518760715","title":"Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Marshall Space Flight Center","keywords":"Multiple sclerosis; Expanded Disability Status Scale; White matter; Atrophy; Fractional anisotropy; Psychology; Clinically isolated syndrome; Paced Auditory Serial Addition Test; Magnetic resonance imaging; Medicine; Effects of sleep deprivation on cognitive performance; Voxel-based morphometry; Neuroscience; Cognition; Pathology; Cognitive impairment; Radiology; Psychiatry","score_opus":0.04636843942022612,"score_gpt":0.24225988541371635,"score_spread":0.19589144599349023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788783358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947891,0.001013119,0.00147672,0.0004222526,0.001398202,0.0007265069,0.00011933661,0.000028555283,0.000026211079],"genre_scores_gemma":[0.9990498,0.00009742592,0.000114019684,0.00034296137,0.00017831518,0.00007944978,0.000048020047,0.000025077157,0.00006495858],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976519,0.00062304497,0.0007214882,0.0003900427,0.0001662472,0.0004473021],"domain_scores_gemma":[0.997046,0.0019422426,0.00039246448,0.00017907968,0.00034513033,0.000095097355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061263324,0.00027514575,0.00041816317,0.0003662634,0.00041455968,0.000038277693,0.00016749972,0.00014680691,0.00080742873],"category_scores_gemma":[0.0012939577,0.00024731574,0.0001614554,0.00021586166,0.00035292827,0.00014367554,0.00013498397,0.00029606684,0.00014258634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002808512,0.0017010595,0.3762195,0.00013820916,0.0007169996,0.000015422727,0.001441962,0.000056005738,0.59444785,0.000114757866,0.010755387,0.011584308],"study_design_scores_gemma":[0.013338197,0.0013464264,0.934698,0.0012295482,0.00009325469,0.00006234132,0.0003631411,0.00030114455,0.047977816,0.00006603489,0.00027998234,0.00024410457],"about_ca_topic_score_codex":0.00014741304,"about_ca_topic_score_gemma":0.00018578835,"teacher_disagreement_score":0.5584785,"about_ca_system_score_codex":0.00015856713,"about_ca_system_score_gemma":0.0000973661,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W2789148846","doi":"10.1177/1352458518756517","title":"MSJ 2018—editorial comment","year":2018,"lang":"fr","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Computer science; Cognitive science; Psychiatry","score_opus":0.10011285183027074,"score_gpt":0.3329264860226557,"score_spread":0.23281363419238493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789148846","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014655949,0.0052010464,0.00043738013,0.023688763,0.9648177,0.0016245224,0.0011896914,0.00013239286,0.0014429182],"genre_scores_gemma":[0.00601931,0.008563571,0.00100868,0.0020674916,0.97756165,0.00008622547,0.0005018035,0.00033906783,0.003852214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98208034,0.0028049997,0.0043810955,0.0013526395,0.005592474,0.0037884729],"domain_scores_gemma":[0.98238283,0.0035159565,0.0025173975,0.0015332892,0.004240403,0.00581014],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.013570245,0.0014822546,0.0029955392,0.0007374175,0.0023410104,0.0009074294,0.0012313518,0.0050312392,0.0033606396],"category_scores_gemma":[0.012474211,0.0013090939,0.0011750105,0.0006899135,0.0006104572,0.0005844694,0.0003511086,0.009573454,0.0043499162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007588596,0.000736175,0.0028088132,0.0014457215,0.0006075533,0.000090640046,0.001925304,0.0000032322023,0.00023733973,0.000027848331,0.96691966,0.024438838],"study_design_scores_gemma":[0.011213024,0.0032927068,0.0024390237,0.010819954,0.00026935633,0.00026314132,0.0008039882,0.00023080618,0.0000424639,0.000037388098,0.96956426,0.0010239158],"about_ca_topic_score_codex":0.009969453,"about_ca_topic_score_gemma":0.0008674227,"teacher_disagreement_score":0.023414921,"about_ca_system_score_codex":0.0069776964,"about_ca_system_score_gemma":0.017234726,"threshold_uncertainty_score":0.9997927},"labels":[],"label_agreement":null},{"id":"W2791285120","doi":"10.1177/1352458518755564","title":"Studying the blood–brain barrier will provide new insights into neurodegeneration – No","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Blood–brain barrier; Neuroscience; Medicine; Psychology; Disease; Pathology; Central nervous system; Immunology","score_opus":0.057492595791054674,"score_gpt":0.26372072859207074,"score_spread":0.20622813280101607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791285120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874393,0.0017304326,0.0006782796,0.0062102047,0.002293486,0.00044077175,0.0000011739776,0.00005587789,0.0011505096],"genre_scores_gemma":[0.98231524,0.0006546196,0.002541151,0.003569735,0.007500483,0.000015773574,0.0000026377604,0.00003815243,0.0033622226],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983301,0.00014101139,0.00042685855,0.0002666246,0.000490977,0.0003443878],"domain_scores_gemma":[0.99863106,0.000127963,0.00017948619,0.00030360027,0.0004542569,0.0003036045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044605104,0.00022413764,0.00032132823,0.000116716,0.0010289927,0.0001778385,0.00018908645,0.00006706641,0.0001464053],"category_scores_gemma":[0.0014477484,0.00013239536,0.00015960529,0.00022930118,0.00017134337,0.0003725295,0.000109096225,0.00040581165,0.00010391804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003591996,0.00029079718,0.040708583,0.000025897114,0.0004235434,0.000018790923,0.0174541,0.00001493792,0.78313255,0.00011945143,0.09703796,0.06041419],"study_design_scores_gemma":[0.00847252,0.0011944361,0.34925437,0.00033384174,0.0006642506,0.00006983565,0.00103441,0.0011079649,0.052423276,0.00028390138,0.58473474,0.00042645363],"about_ca_topic_score_codex":0.00007986073,"about_ca_topic_score_gemma":0.00019919513,"teacher_disagreement_score":0.73070925,"about_ca_system_score_codex":0.000036207934,"about_ca_system_score_gemma":0.00018225239,"threshold_uncertainty_score":0.7914284},"labels":[],"label_agreement":null},{"id":"W2794078189","doi":"10.1177/1352458518763089","title":"Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bundesministerium für Bildung und Forschung","keywords":"Allele; HLA-DRB1; Human leukocyte antigen; BETA (programming language); Multiple sclerosis; Antibody; Interferon beta; Genetics; Immunology; Medicine; Virology; Biology; Gene; Antigen; Computer science","score_opus":0.12935881680211836,"score_gpt":0.3512733435486762,"score_spread":0.22191452674655782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794078189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959168,0.00080257835,0.00005727818,0.0019035628,0.0000929433,0.0010371302,0.000017603215,0.0000062530457,0.00016588514],"genre_scores_gemma":[0.9960153,0.0014020754,0.0020733022,0.00025405549,0.00018169443,0.000041973777,0.0000012543165,0.000021124915,0.000009181057],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968591,0.0006727644,0.0010264728,0.0002843216,0.00074961124,0.00040776606],"domain_scores_gemma":[0.9958734,0.0030978487,0.00032746428,0.00026466217,0.00028923637,0.00014740638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006346485,0.00026694086,0.0008827825,0.00028734485,0.00037976803,0.000083226994,0.00028874626,0.00007144874,0.000019644962],"category_scores_gemma":[0.002622701,0.00013151215,0.00011686456,0.0002559056,0.0003926749,0.00007521772,0.00023829179,0.00034837483,0.000002716632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033827461,0.00026018944,0.22480641,0.0003164571,0.0005311308,0.0000054384477,0.018841246,0.000022252092,0.6274783,0.000042669795,0.0008849048,0.123428226],"study_design_scores_gemma":[0.0033084394,0.0023653992,0.8603011,0.0013820742,0.00007415313,0.000024588197,0.0008672759,0.00014591328,0.13125277,0.00002488704,0.00013477332,0.00011862417],"about_ca_topic_score_codex":0.00005661643,"about_ca_topic_score_gemma":0.00034131348,"teacher_disagreement_score":0.6354947,"about_ca_system_score_codex":0.000053368243,"about_ca_system_score_gemma":0.00006310869,"threshold_uncertainty_score":0.536291},"labels":[],"label_agreement":null},{"id":"W2794124086","doi":"10.1177/1352458518761185","title":"Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Teriflunomide; Hypertriglyceridemia; Medicine; Multiple sclerosis; Adverse effect; Leflunomide; Pediatrics; Internal medicine; Dermatology; Psychiatry; Rheumatoid arthritis","score_opus":0.04525619744027388,"score_gpt":0.23622787660334787,"score_spread":0.190971679163074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794124086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712414,0.00034242842,0.00020312368,0.00044157158,0.00037309036,0.00075673865,0.00004109479,0.00010989752,0.00060792605],"genre_scores_gemma":[0.9938411,0.00008147418,0.004381425,0.0008509574,0.00049331045,0.00007635062,0.000032611486,0.00010445802,0.00013830698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651945,0.00019040953,0.0010003395,0.000630915,0.0007675133,0.00089139777],"domain_scores_gemma":[0.997263,0.0002085347,0.00066276395,0.0005865172,0.00064665225,0.0006325073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074815477,0.0004825237,0.00085720164,0.00039441272,0.00045992783,0.00015103444,0.00016314637,0.00022793387,0.00016893084],"category_scores_gemma":[0.0015002177,0.00032993205,0.00018065506,0.0007967624,0.0003272625,0.0004810998,0.00007779131,0.00078996894,0.000028337197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005345803,0.0011785042,0.93643016,0.000033390348,0.00033814285,0.027765019,0.0025318179,0.00014764298,0.011974555,0.0000014386396,0.002187988,0.012065556],"study_design_scores_gemma":[0.02767877,0.0021152047,0.8106965,0.0021425502,0.0003643218,0.14707607,0.0025751058,0.0012788044,0.0033420452,0.0000061836677,0.001991519,0.00073292747],"about_ca_topic_score_codex":0.0009217213,"about_ca_topic_score_gemma":0.0041745594,"teacher_disagreement_score":0.12573364,"about_ca_system_score_codex":0.00033193373,"about_ca_system_score_gemma":0.00050818827,"threshold_uncertainty_score":0.9999153},"labels":[],"label_agreement":null},{"id":"W2798153306","doi":"10.1177/1352458518770086","title":"The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Spatial Neglect and Hemispheric Dysfunction","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Psychology; Depression (economics); Symbol (formal); Audiology; Contrast (vision); Cognitive psychology; Developmental psychology; Medicine; Artificial intelligence; Computer science","score_opus":0.0998675238780978,"score_gpt":0.2777022262227237,"score_spread":0.17783470234462592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798153306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957436,0.000047352787,0.0010735714,0.0020494924,0.00047066767,0.00020169732,0.0000072648168,0.000034623285,0.00037176293],"genre_scores_gemma":[0.9962164,0.001363058,0.00012307627,0.00045123108,0.001625072,0.000012314988,2.8213626e-7,0.000017304264,0.00019125779],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985337,0.00018534934,0.0003527165,0.00028467728,0.0003482781,0.00029527105],"domain_scores_gemma":[0.99611115,0.0032540527,0.00020651164,0.0002201668,0.000069981375,0.00013813631],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00062112656,0.00015206009,0.00015661359,0.000020241434,0.002062766,0.00045468356,0.00026273902,0.00008406246,0.000028524837],"category_scores_gemma":[0.0018001893,0.00007901209,0.000054194155,0.000116690266,0.00049907906,0.00022064033,0.000100238554,0.0004818509,0.000018422556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031373822,0.000038473157,0.21354578,0.0000080644995,0.000017193628,0.0000012339858,0.0004355587,0.000007715338,0.16540436,0.00014266398,0.0005361054,0.6195491],"study_design_scores_gemma":[0.0012232776,0.001559776,0.7252384,0.0002538105,0.00003856134,0.00003295155,0.00021499649,0.015791876,0.25071892,0.0016966494,0.0029634882,0.000267299],"about_ca_topic_score_codex":0.0000105858235,"about_ca_topic_score_gemma":0.000009687284,"teacher_disagreement_score":0.6192818,"about_ca_system_score_codex":0.000023125924,"about_ca_system_score_gemma":0.000030753337,"threshold_uncertainty_score":0.9992364},"labels":[],"label_agreement":null},{"id":"W2799623984","doi":"10.1177/1352458518772913","title":"Rebound disease in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Disease; Medicine; Clinical neurology; Neuroscience; Psychology; Psychiatry; Pathology","score_opus":0.07265709129540794,"score_gpt":0.2474981076029974,"score_spread":0.17484101630758947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799623984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8476004,0.031642534,0.0010244548,0.11331789,0.0034515967,0.0015215175,0.0011814398,0.00008926384,0.00017090663],"genre_scores_gemma":[0.77132916,0.0146606555,0.0018870095,0.18754007,0.021961063,0.00017436469,0.0012294552,0.00032248715,0.0008957491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605024,0.00040955932,0.0008495474,0.0009711627,0.0006571211,0.0010623754],"domain_scores_gemma":[0.99766517,0.0000904902,0.0005304403,0.0009394573,0.00026457786,0.0005098383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060392485,0.00067326805,0.0005440459,0.00031434422,0.00051527086,0.00045583706,0.0009838494,0.0009681354,0.0003697331],"category_scores_gemma":[0.0010082137,0.0006632431,0.0006891154,0.00022427585,0.00026229207,0.000023869188,0.00040999838,0.0016631196,0.0001158731],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048431108,0.00013963203,0.04245589,0.00011472839,0.00017063782,0.00016929292,0.000040923373,0.00008834092,0.05475412,3.3568728e-7,0.8905546,0.011027163],"study_design_scores_gemma":[0.0037421898,0.00025705356,0.061920986,0.0013540192,0.00013803775,0.00003823047,0.000024627516,0.00045597838,0.005333077,0.000111250185,0.92529166,0.0013329042],"about_ca_topic_score_codex":0.00011869847,"about_ca_topic_score_gemma":0.00012219326,"teacher_disagreement_score":0.076271236,"about_ca_system_score_codex":0.00016502777,"about_ca_system_score_gemma":0.00038517846,"threshold_uncertainty_score":0.9995819},"labels":[],"label_agreement":null},{"id":"W2801634700","doi":"10.1177/1352458518768722","title":"Factors affecting continuation of clean intermittent catheterisation in people with multiple sclerosis: Results of the COSMOS mixed-methods study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Multiple Sclerosis Society","keywords":"Discontinuation; Medicine; Continuation; Multiple sclerosis; Cohort; Longitudinal study; Incidence (geometry); Pediatrics; Intensive care medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.07257689750385679,"score_gpt":0.3123649645039088,"score_spread":0.23978806700005204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801634700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721986,0.000038031245,0.0008610394,0.00008162192,0.000417656,0.0012883478,0.000025484842,0.00002282877,0.000045134755],"genre_scores_gemma":[0.9971391,0.0000136473855,0.0026499606,0.000022301843,0.00007445529,0.000023011704,0.000010807057,0.000042075422,0.000024620314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692863,0.0007657888,0.001022154,0.00034509186,0.0006005297,0.0003377772],"domain_scores_gemma":[0.9973602,0.0005100364,0.0010581788,0.0005009486,0.00045276046,0.000117837655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015470043,0.00028745216,0.000641403,0.00027456888,0.0002066309,0.000036023273,0.00024768067,0.000100262434,0.000017335442],"category_scores_gemma":[0.0017518727,0.00017893327,0.00020783323,0.00055096037,0.00020167277,0.00017483084,0.000108829125,0.00036407114,0.000002051722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012389682,0.0016938617,0.88873,0.000027217866,0.00019853408,9.058665e-7,0.024319844,0.00006871409,0.038132746,1.0295116e-7,0.000060838818,0.045528296],"study_design_scores_gemma":[0.015337652,0.0021277196,0.8763854,0.001127152,0.00018717426,0.000008821169,0.022974936,0.0014589169,0.08025085,0.0000031384382,0.0000032001603,0.00013504131],"about_ca_topic_score_codex":0.0012894216,"about_ca_topic_score_gemma":0.007149762,"teacher_disagreement_score":0.045393255,"about_ca_system_score_codex":0.00028133884,"about_ca_system_score_gemma":0.00010300522,"threshold_uncertainty_score":0.7296687},"labels":[],"label_agreement":null},{"id":"W2801723726","doi":"10.1177/1352458518770085","title":"A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Sanofi Genzyme; Dartmouth College","keywords":"Multiple sclerosis; Alemtuzumab; White matter; Medicine; Corpus callosum; Magnetic resonance imaging; Fractional anisotropy; Myelin; Diffusion MRI; Pathology; Nuclear medicine; Radiology; Central nervous system; Internal medicine","score_opus":0.06147646944500618,"score_gpt":0.2814101738456547,"score_spread":0.21993370440064852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801723726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940664,0.0022134422,0.00008615097,0.00019284427,0.00026520737,0.002545519,0.00010427899,0.00015199004,0.00037412276],"genre_scores_gemma":[0.9937627,0.0008621013,0.0042112963,0.00013627441,0.00040153996,0.00021206711,0.000022527773,0.00017046808,0.00022103831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99328816,0.00043573297,0.0014836404,0.001050735,0.0022849473,0.0014567561],"domain_scores_gemma":[0.994174,0.00042287304,0.00073668774,0.001088241,0.0028067513,0.0007714142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007710523,0.000781676,0.0013764906,0.0007219276,0.0010794507,0.00016846365,0.0006333884,0.00013193558,0.0003001921],"category_scores_gemma":[0.001578401,0.0005957533,0.0003111727,0.0013045624,0.0008727373,0.00061978976,0.00037201974,0.00094240304,0.000054917764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470785,0.0035395632,0.7716803,0.000047501926,0.00014463489,0.000026678188,0.0020807595,0.00002553827,0.019527197,2.4214108e-7,0.0011348644,0.19708486],"study_design_scores_gemma":[0.04516076,0.009818221,0.9307861,0.0017183495,0.00024508536,0.000035780504,0.0026522523,0.0034312815,0.00460585,0.0000012670101,0.0009945354,0.0005505323],"about_ca_topic_score_codex":0.0006332831,"about_ca_topic_score_gemma":0.0011774467,"teacher_disagreement_score":0.19653432,"about_ca_system_score_codex":0.00054509036,"about_ca_system_score_gemma":0.00020900118,"threshold_uncertainty_score":0.9996494},"labels":[],"label_agreement":null},{"id":"W2802045380","doi":"10.1177/1352458518771257","title":"We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – Commentary","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Focus (optics); Medicine; Neuroscience; Psychology; Intensive care medicine; Immunology; Physics","score_opus":0.16352540032864646,"score_gpt":0.3594872247878945,"score_spread":0.19596182445924806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802045380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8808791,0.0033028044,0.003338602,0.105730765,0.0016514483,0.0042505986,0.0001183656,0.00011860404,0.0006097388],"genre_scores_gemma":[0.9897125,0.0023747105,0.0013469938,0.0040709404,0.0020054576,0.0002493565,0.000010677573,0.00008947644,0.00013989292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664,0.00018162491,0.0007149732,0.0004475734,0.0009690241,0.0010467545],"domain_scores_gemma":[0.99683017,0.0016916024,0.00024787636,0.00060021295,0.000303355,0.00032680944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017673677,0.0004136171,0.00057651836,0.00041750865,0.0012246397,0.00016050089,0.0005492302,0.00016080098,0.00031357576],"category_scores_gemma":[0.0007188253,0.00026576733,0.0003641126,0.00035524674,0.0005268004,0.00022879239,0.00020859712,0.0011856306,0.000050239785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047022016,0.0012681384,0.41508886,0.00022342817,0.001328389,0.00007217331,0.014717409,0.0002871879,0.18946189,0.000028028522,0.15918267,0.21363963],"study_design_scores_gemma":[0.011545687,0.0011616654,0.911941,0.001231781,0.00011718978,0.000026334823,0.0031347424,0.023441924,0.022109883,0.00006976058,0.024827901,0.0003921311],"about_ca_topic_score_codex":0.000097603974,"about_ca_topic_score_gemma":0.00058139197,"teacher_disagreement_score":0.49685216,"about_ca_system_score_codex":0.00048517284,"about_ca_system_score_gemma":0.0001068377,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W2802785428","doi":"10.1177/1352458518767323","title":"Disease-modifying therapy in multiple sclerosis: Two guidelines (almost) passing in the night","year":2018,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Manitoba","funders":"","keywords":"Multiple sclerosis; Disease; Medicine; Fingolimod; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.26410210078706653,"score_gpt":0.38624842131320664,"score_spread":0.1221463205261401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802785428","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4355289,0.02829723,0.0002474646,0.010174953,0.5174521,0.006685165,0.0009026918,0.00033894228,0.00037256046],"genre_scores_gemma":[0.46820417,0.046834692,0.0026939544,0.0009044638,0.47967654,0.0007535695,0.00033004288,0.00037978284,0.00022276684],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9838464,0.0019068581,0.0036251633,0.001912153,0.005928496,0.0027809038],"domain_scores_gemma":[0.986567,0.0059610414,0.0014120897,0.002102905,0.0028710247,0.0010859312],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.008501103,0.0017363142,0.0026405687,0.0019175016,0.0016338815,0.0012699928,0.0023083864,0.0011018163,0.00028013723],"category_scores_gemma":[0.03012869,0.0011889827,0.0012238198,0.0018784245,0.0009941788,0.0008272268,0.0006674158,0.006855584,0.000114695424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029897343,0.0012728525,0.110412344,0.00023675927,0.0004132296,0.00046958053,0.0019567162,0.00022286168,0.0043012295,6.4778914e-7,0.84641075,0.031313285],"study_design_scores_gemma":[0.042524416,0.0010061219,0.54559326,0.020181047,0.00027389746,0.00008724011,0.0017702114,0.007380971,0.00034195985,0.00006563084,0.37880558,0.0019696946],"about_ca_topic_score_codex":0.0015514308,"about_ca_topic_score_gemma":0.0031009072,"teacher_disagreement_score":0.4676052,"about_ca_system_score_codex":0.001753298,"about_ca_system_score_gemma":0.00189271,"threshold_uncertainty_score":0.99976677},"labels":[],"label_agreement":null},{"id":"W2803403988","doi":"10.1177/1352458518773511","title":"Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of British Columbia","funders":"","keywords":"Medicine; Expanded Disability Status Scale; Internal medicine; Interferon beta-1b; Multiple sclerosis; Clinical trial; Randomization; Randomized controlled trial; Central nervous system disease; Physical therapy; Interferon beta","score_opus":0.1605793611357558,"score_gpt":0.3254991434787016,"score_spread":0.16491978234294583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803403988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554265,0.0003385756,0.00020577699,0.0016814774,0.0006273278,0.0010628748,0.00016312535,0.000011805351,0.00036639962],"genre_scores_gemma":[0.997009,0.0011485298,0.0003244193,0.000121522506,0.0012963333,0.000039835417,0.000009653115,0.000025321906,0.000025410714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634826,0.0008522328,0.00088822586,0.00032237318,0.0011435939,0.00044532277],"domain_scores_gemma":[0.9963352,0.00202679,0.0004400755,0.00052873394,0.00051151024,0.00015768621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263221,0.00025848864,0.0007106642,0.00015463936,0.0003142235,0.00006882042,0.00050528935,0.00012950775,0.00015552578],"category_scores_gemma":[0.0027877092,0.00013928724,0.00030745586,0.00034327997,0.0010682862,0.00019143731,0.00029530033,0.0008480029,0.000006711995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15551504,0.0021468147,0.68250036,0.00009358669,0.0012907205,0.0000090155945,0.026435822,0.000007828144,0.09073994,0.000024196674,0.015853092,0.025383597],"study_design_scores_gemma":[0.08627278,0.0072747013,0.88701206,0.00074204337,0.00022083262,0.000013760937,0.006871371,0.0006362909,0.01029315,0.00009386148,0.00041423907,0.0001549107],"about_ca_topic_score_codex":0.000887123,"about_ca_topic_score_gemma":0.0010286465,"teacher_disagreement_score":0.20451172,"about_ca_system_score_codex":0.00012772286,"about_ca_system_score_gemma":0.00013114022,"threshold_uncertainty_score":0.5679969},"labels":[],"label_agreement":null},{"id":"W2805565017","doi":"10.1177/1352458518779952","title":"Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Hospital for Sick Children; York University; SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; McGill University","funders":"","keywords":"Medicine; Fluid-attenuated inversion recovery; Multiple sclerosis; Magnetic resonance imaging; Nuclear medicine; Neuroradiology; Hyperintensity; CLs upper limits; White matter; Radiology; Lesion; Neurology; Pathology; Ophthalmology","score_opus":0.15982527478503064,"score_gpt":0.35428345154272295,"score_spread":0.1944581767576923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805565017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039614,0.00028877024,0.006671996,0.0005745312,0.0007734279,0.0010859915,0.000052686217,0.000071527444,0.00008494448],"genre_scores_gemma":[0.9860509,0.0067476523,0.005719236,0.0001628654,0.0011455807,0.000051548996,0.000010153888,0.00007107332,0.000040971583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946863,0.00062549673,0.0019395745,0.000774596,0.0010677932,0.00090624025],"domain_scores_gemma":[0.9950538,0.0022552214,0.0005910205,0.00051720726,0.00081554754,0.00076716975],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002319786,0.00046005615,0.0010427084,0.0008879488,0.0006262384,0.00010030772,0.00025150663,0.00043282242,0.00010207316],"category_scores_gemma":[0.009467793,0.00039223887,0.00041281275,0.000788208,0.0008538026,0.0003365117,0.00022156753,0.0016345698,0.000079918565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002125494,0.0015775587,0.9071973,0.000054714346,0.00012857922,0.000011111722,0.00039518793,0.00007437912,0.024131244,0.0000024043497,0.00042328655,0.063878715],"study_design_scores_gemma":[0.015290842,0.0019314172,0.9181459,0.00061296584,0.0001709719,0.00004408345,0.00031065178,0.057967022,0.005121903,0.000007648897,0.00008919915,0.0003074261],"about_ca_topic_score_codex":0.00021539886,"about_ca_topic_score_gemma":0.0017938854,"teacher_disagreement_score":0.06357129,"about_ca_system_score_codex":0.0003292398,"about_ca_system_score_gemma":0.00021313841,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W2809275981","doi":"10.1177/1352458518781999","title":"Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal; Métis National Council","funders":"","keywords":"Magnetization transfer; Multiple sclerosis; Medicine; Sagittal plane; Nuclear medicine; Spinal cord; Lesion; Relapsing remitting; Central nervous system disease; Magnetic resonance imaging; Radiology; Pathology; Surgery","score_opus":0.05180050972590085,"score_gpt":0.28576131476966604,"score_spread":0.2339608050437652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809275981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968191,0.00008584849,0.00062915357,0.00036917548,0.00020064424,0.0017554618,0.000013812011,0.00005273018,0.00007407921],"genre_scores_gemma":[0.9969365,0.0001036382,0.0022306603,0.00011756416,0.00045196104,0.000044958495,0.000009270066,0.00006601834,0.00003940417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996046,0.00040354932,0.0008357353,0.0006212208,0.00128481,0.00080865424],"domain_scores_gemma":[0.99805754,0.00022562958,0.00014871063,0.00035025895,0.0006968024,0.00052103976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008416678,0.00040673945,0.0006325227,0.00041080936,0.0006307332,0.000270681,0.00019554235,0.0001414572,0.00016265058],"category_scores_gemma":[0.0008800006,0.0003121938,0.00009957548,0.00048007802,0.00042712098,0.0005315729,0.00013646478,0.001022597,0.000020855261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009803448,0.0024877188,0.94273204,0.000046113204,0.0001329783,0.000024928251,0.0042573693,0.0000037369775,0.0033279064,0.0000012550576,0.00007073864,0.037111755],"study_design_scores_gemma":[0.038202427,0.011111871,0.9450787,0.0008888932,0.00012272385,0.000013337221,0.0016382447,0.0023698118,0.00022427067,0.0000020524485,0.00004287528,0.00030483195],"about_ca_topic_score_codex":0.00030429428,"about_ca_topic_score_gemma":0.0014853193,"teacher_disagreement_score":0.036806922,"about_ca_system_score_codex":0.00028402553,"about_ca_system_score_gemma":0.00009206066,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W2809364847","doi":"10.1177/1352458518783667","title":"Predicting risk of secondary progression in multiple sclerosis: A nomogram","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Neuroförbundet; Biogen","keywords":"Multiple sclerosis; Nomogram; Medicine; Oncology; Immunology","score_opus":0.10441723568976612,"score_gpt":0.32042407872798306,"score_spread":0.21600684303821693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809364847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473107,0.0015492564,0.00033219304,0.0004118863,0.00059783604,0.0013332991,0.00012707122,0.0001398419,0.000777553],"genre_scores_gemma":[0.9819099,0.0033567823,0.013084056,0.00010480745,0.0012308742,0.00013343003,0.000017751046,0.000107361615,0.00005506099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99382377,0.00060414424,0.0017678242,0.0007814514,0.0016434569,0.0013793614],"domain_scores_gemma":[0.9954061,0.0008846174,0.0010095465,0.00077253615,0.0011906407,0.00073656626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002935279,0.0005632077,0.0011908683,0.0010028909,0.0008908389,0.00014852984,0.0005438849,0.00032851225,0.00041400729],"category_scores_gemma":[0.0069582276,0.00045754464,0.0005451404,0.0012061244,0.0010514398,0.0005635045,0.00048675813,0.0020792508,0.00006699246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001230077,0.0008890593,0.7250111,0.00013479269,0.00026671225,0.000016681615,0.0016625994,0.00002711906,0.1151324,9.383867e-7,0.0008958503,0.15473267],"study_design_scores_gemma":[0.013369165,0.0016510533,0.92642826,0.0041925167,0.00012775825,0.00008033857,0.0013101369,0.013522307,0.03828025,0.000019896323,0.00064510055,0.0003732218],"about_ca_topic_score_codex":0.00052950793,"about_ca_topic_score_gemma":0.0012405454,"teacher_disagreement_score":0.20141716,"about_ca_system_score_codex":0.0003947114,"about_ca_system_score_gemma":0.00039892006,"threshold_uncertainty_score":0.9997876},"labels":[],"label_agreement":null},{"id":"W2809452711","doi":"10.1177/1352458518783345","title":"A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut Universitaire de Gériatrie de Montréal; McGill University; Public Health Ontario; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Royal Victoria Hospital; McGill University Health Centre","funders":"National Institute of Neurological Disorders and Stroke; Multiple Sclerosis International Federation; National Multiple Sclerosis Society","keywords":"Medicine; Harmonization; Comparability; Etiology; Multiple sclerosis; Sample (material); Medical physics; Environmental health; Pathology; Immunology","score_opus":0.5242408385769554,"score_gpt":0.41497392807491307,"score_spread":0.10926691050204229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809452711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688179,0.013945537,0.009793531,0.0033786085,0.00081841747,0.0030357211,0.0000820682,0.000084308725,0.00004391203],"genre_scores_gemma":[0.9227251,0.051484257,0.02080449,0.00019753103,0.004228998,0.00043044813,0.000006308568,0.000084650615,0.00003823391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992536,0.00090364425,0.0014587638,0.0008317867,0.0028728915,0.001396877],"domain_scores_gemma":[0.9843493,0.0054254406,0.00070124475,0.00081585295,0.008262881,0.00044524999],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.01092405,0.00050244865,0.0010112886,0.00086520286,0.0025252334,0.00022725745,0.0006284143,0.000330562,0.00008744864],"category_scores_gemma":[0.047667876,0.0003304524,0.00039387928,0.0018949705,0.0012525053,0.00030441987,0.0005974025,0.0014447729,0.000032286043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020007063,0.00092336134,0.90690637,0.0008491231,0.00097227184,0.0000040054724,0.0055823456,0.000048569804,0.03958431,0.0001293356,0.02338338,0.0196162],"study_design_scores_gemma":[0.007809261,0.0027652476,0.9736392,0.0007794605,0.00059028354,0.00002945598,0.003583679,0.0023911875,0.0060369577,0.00093043386,0.000966064,0.00047878677],"about_ca_topic_score_codex":0.00007159708,"about_ca_topic_score_gemma":0.00008614751,"teacher_disagreement_score":0.06673279,"about_ca_system_score_codex":0.00056764507,"about_ca_system_score_gemma":0.00040544334,"threshold_uncertainty_score":0.99991477},"labels":[],"label_agreement":null},{"id":"W2867129155","doi":"10.1177/1352458518783662","title":"Five years before multiple sclerosis onset: Phenotyping the prodrome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Dalhousie University; University of Saskatchewan; University of Manitoba; Saskatchewan Health Quality Council; Manitoba Health; University of British Columbia","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Cohort; Prodrome; Confidence interval; Population; Cohort study; Specialty; Internal medicine; Relative risk; Pediatrics; Psychiatry; Psychosis","score_opus":0.10413390768599322,"score_gpt":0.3019182711405465,"score_spread":0.19778436345455325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2867129155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901323,0.0008238985,0.000503547,0.004912099,0.0010882464,0.0015913295,0.000102867154,0.00023156265,0.00061418774],"genre_scores_gemma":[0.98942727,0.0010338251,0.0040090764,0.0012093465,0.0031361487,0.00016197718,0.000022489996,0.00015995785,0.000839924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99390167,0.0004416912,0.0011455227,0.0008801035,0.0018914969,0.0017394929],"domain_scores_gemma":[0.9953937,0.00078506314,0.0005122581,0.0012073129,0.0012558564,0.0008458034],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020873935,0.00065135007,0.0009372112,0.0004955229,0.002327291,0.00048278572,0.0009895832,0.00027420974,0.0007663168],"category_scores_gemma":[0.0047951126,0.0004528176,0.00066546845,0.0010772025,0.0015266875,0.0005293356,0.0006477782,0.0017620969,0.0008020541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002050937,0.0011538974,0.52134377,0.00015082618,0.0016507617,0.00008344574,0.015535876,0.000073777606,0.115499355,0.000024626064,0.04471746,0.2977153],"study_design_scores_gemma":[0.006561052,0.0008725811,0.9687683,0.0011904541,0.00018035245,0.00026093423,0.001716739,0.0061161215,0.0051525896,0.000062878215,0.008640413,0.00047759814],"about_ca_topic_score_codex":0.0003954798,"about_ca_topic_score_gemma":0.00087326486,"teacher_disagreement_score":0.44742453,"about_ca_system_score_codex":0.00057617825,"about_ca_system_score_gemma":0.00035367146,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W2883099048","doi":"10.1177/1352458518791683","title":"Multiple sclerosis disease progression: Contributions from a hypoxia–inflammation cycle","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Hypoxia (environmental); Medicine; Inflammation; Disease; Neuroscience; Pathology; Internal medicine; Psychology; Immunology; Chemistry; Oxygen","score_opus":0.035066947406308224,"score_gpt":0.25354632373801106,"score_spread":0.21847937633170283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883099048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883346,0.002576674,0.0044121044,0.0017121257,0.001933819,0.0004471127,0.00021234625,0.00018315646,0.00018806425],"genre_scores_gemma":[0.99688476,0.00038868646,0.0008327712,0.00013530982,0.0009803633,0.00008027057,0.000408476,0.00003976164,0.00024960056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972642,0.00063945126,0.0008246811,0.00040057677,0.00017957563,0.00069148897],"domain_scores_gemma":[0.99775404,0.00046351866,0.0005216544,0.0004889126,0.0005932451,0.00017861642],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00070653396,0.00032642327,0.00036424535,0.00023777572,0.0018055716,0.00021835642,0.0004101999,0.00032120422,0.0023742097],"category_scores_gemma":[0.0016453284,0.00028853415,0.00029966945,0.00027543705,0.0004283819,0.0007471322,0.00014713407,0.0005753348,0.0024552874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017238125,0.00018045318,0.01054684,0.0000056036174,0.00021037839,0.0000056126305,0.00057506136,0.000029825234,0.9277457,0.000044709075,0.004906712,0.054025304],"study_design_scores_gemma":[0.006661443,0.00023919092,0.42621633,0.00052653934,0.00014396814,0.00003464954,0.00021266376,0.0011938874,0.5350175,0.00026502833,0.029056244,0.00043253257],"about_ca_topic_score_codex":0.00009987587,"about_ca_topic_score_gemma":0.00005033471,"teacher_disagreement_score":0.4156695,"about_ca_system_score_codex":0.00017968986,"about_ca_system_score_gemma":0.00019631749,"threshold_uncertainty_score":0.99995667},"labels":[],"label_agreement":null},{"id":"W2884754452","doi":"10.1177/1352458518789884","title":"Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University; NeuroRx Research (Canada)","funders":"Bayer HealthCare; CSL Behring; IC Design Education Center; Teva Pharmaceutical Industries; Biogen; Sanofi; European Commission; Pfizer","keywords":"Medicine; Placebo; Tolerability; Internal medicine; Adverse effect; Pathology; Alternative medicine","score_opus":0.17247687603535283,"score_gpt":0.36080886889632013,"score_spread":0.1883319928609673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884754452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289143,0.0013284272,0.00030919156,0.00042133554,0.00027768195,0.0045585316,0.000051158113,0.000051356263,0.000110886715],"genre_scores_gemma":[0.99185735,0.003559456,0.0039069895,0.00006590217,0.00036555555,0.00012373785,0.000008416921,0.000080583246,0.00003201596],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925193,0.0011984395,0.0028653226,0.00080989045,0.001683039,0.0009240135],"domain_scores_gemma":[0.9936368,0.0021776077,0.0011405925,0.00083761185,0.0016254121,0.0005819865],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061248243,0.00059034716,0.003075239,0.0011969276,0.00070118014,0.00006327979,0.00040722077,0.00023368945,0.0001921689],"category_scores_gemma":[0.012449918,0.0004527992,0.00055393204,0.0010713746,0.0016097764,0.0003565881,0.0006319039,0.0009592842,0.000008783993],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36247456,0.012928463,0.061164197,0.00015143688,0.0010810255,0.000021080888,0.009147295,0.00003598138,0.5005264,0.0000056805798,0.00025491609,0.05220892],"study_design_scores_gemma":[0.49070835,0.0050090207,0.48303196,0.0018624928,0.0002858207,0.000025272326,0.0017371767,0.004783459,0.0122553995,0.000011042511,0.00003208915,0.00025790557],"about_ca_topic_score_codex":0.00043331552,"about_ca_topic_score_gemma":0.0003579723,"teacher_disagreement_score":0.48827106,"about_ca_system_score_codex":0.00018992419,"about_ca_system_score_gemma":0.00023443754,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W2887418736","doi":"10.1177/1352458518792423","title":"Validation of the preference-based multiple sclerosis index","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Convergent validity; Construct validity; Quality of life (healthcare); Multiple sclerosis; Medicine; Clinical psychology; Discriminant validity; Polychoric correlation; Confirmatory factor analysis; External validity; Psychology; Correlation; Physical therapy; Psychometrics; Structural equation modeling; Statistics; Psychiatry; Mathematics; Social psychology","score_opus":0.23015394229862984,"score_gpt":0.3071217690284271,"score_spread":0.07696782672979724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887418736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253345,0.00018735837,0.002283125,0.0022084215,0.00081999693,0.0010710892,0.00007437726,0.00008709984,0.00073506415],"genre_scores_gemma":[0.9950691,0.00031608826,0.00300796,0.00045230179,0.0008242347,0.0000715552,0.000012453014,0.0000729866,0.00017331418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950613,0.00046408523,0.0011123348,0.0005399498,0.0019331865,0.0008891417],"domain_scores_gemma":[0.9952694,0.0006717584,0.00071338506,0.0010185312,0.0018581753,0.00046876154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013601689,0.00044230223,0.00073676516,0.0004231478,0.0010846079,0.00015806688,0.0007616397,0.0002436257,0.0006260755],"category_scores_gemma":[0.0046171416,0.00029453452,0.0006016022,0.0010477849,0.0011150758,0.00032931133,0.00035215254,0.00096792774,0.000083577914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007354326,0.00048893166,0.6350145,0.00007117537,0.00020233475,0.0000012351961,0.0004939945,0.00019406769,0.34252995,0.000003853108,0.0039935387,0.01627102],"study_design_scores_gemma":[0.0059506055,0.0004119622,0.68039757,0.0010483396,0.00008538446,0.000013859776,0.00019056597,0.0070317443,0.30359,0.00001898162,0.0010485627,0.00021244118],"about_ca_topic_score_codex":0.00021079769,"about_ca_topic_score_gemma":0.0001594067,"teacher_disagreement_score":0.045383073,"about_ca_system_score_codex":0.00035501612,"about_ca_system_score_gemma":0.0004971688,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W2887970423","doi":"10.1177/1352458518792772","title":"Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Psychology; Multiple sclerosis; Audiology; Sample (material); Cognition; Medicine; Neuroscience; Psychiatry","score_opus":0.12016024699213118,"score_gpt":0.3354420667650865,"score_spread":0.2152818197729553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887970423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922441,0.00018500499,0.0030838486,0.001259779,0.00014502567,0.0014857415,0.00001065225,0.00005145114,0.0015343474],"genre_scores_gemma":[0.9922615,0.000008477664,0.007092362,0.0001885519,0.00031054826,0.00003785737,0.0000017782896,0.00005117089,0.000047744008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964305,0.00033067435,0.0008903362,0.0003684686,0.0013149007,0.00066512346],"domain_scores_gemma":[0.99697375,0.0002896132,0.0008539933,0.0005171539,0.0011789746,0.00018651862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014398437,0.00030136856,0.0007196958,0.00026894893,0.0005211468,0.00017483393,0.00056644523,0.0000991138,0.00004380602],"category_scores_gemma":[0.0020942716,0.00014910665,0.00016457705,0.0012508704,0.00079897785,0.00031541882,0.00030408052,0.00071185967,0.000001918537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068110833,0.0009793171,0.6683362,0.00036826447,0.00023688389,0.0000031328627,0.033212233,0.0018580061,0.26207337,0.0000032138025,0.0005298409,0.031718392],"study_design_scores_gemma":[0.0033690496,0.00038665635,0.8882055,0.0029422464,0.000069915026,0.00005202023,0.0030724108,0.04919395,0.052501313,0.0000023657803,0.00003867794,0.00016587539],"about_ca_topic_score_codex":0.00023950476,"about_ca_topic_score_gemma":0.00056966173,"teacher_disagreement_score":0.2198693,"about_ca_system_score_codex":0.0002132033,"about_ca_system_score_gemma":0.00046894955,"threshold_uncertainty_score":0.60803926},"labels":[],"label_agreement":null},{"id":"W2889115949","doi":"10.1177/1352458518796676","title":"Pediatric-onset multiple sclerosis is associated with reduced parental health–related quality of life and family functioning","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; Hospital for Sick Children; Montreal Children's Hospital; University of Toronto","funders":"Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Quality of life (healthcare); Interquartile range; Multiple sclerosis; Worry; Psychosocial; Pediatrics; Cohort; Disease; Clinically isolated syndrome; Clinical psychology; Psychiatry; Internal medicine; Anxiety","score_opus":0.1856118286288732,"score_gpt":0.3317250055304869,"score_spread":0.14611317690161368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889115949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939156,0.002269222,0.00017421099,0.0016496895,0.0004543231,0.0009397695,0.0003028139,0.00015314536,0.00014117881],"genre_scores_gemma":[0.9931052,0.0033438862,0.0019540526,0.0007026064,0.00057004404,0.00005043028,0.00006539051,0.000107116124,0.00010127377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99295586,0.00085753785,0.0021878993,0.00085176056,0.0018739084,0.0012730183],"domain_scores_gemma":[0.9935065,0.001228484,0.0016826508,0.00059333077,0.001662796,0.001326275],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003190182,0.00061069254,0.0016906617,0.0006096111,0.0015720843,0.0001825506,0.00030587614,0.00030416207,0.0002630929],"category_scores_gemma":[0.007417604,0.0004979585,0.0003705033,0.001227902,0.00092310656,0.00044602904,0.00028352332,0.0012159998,0.000033347224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020927868,0.0007450429,0.9271686,0.00013809715,0.0008797106,0.000004640165,0.0026418343,0.000014304534,0.05255413,0.0000012512479,0.008451035,0.005308534],"study_design_scores_gemma":[0.015699737,0.0019058402,0.97495514,0.00095077977,0.00015104336,0.000048646845,0.0021589173,0.0014529614,0.0021351548,0.000007158754,0.00007326259,0.00046135028],"about_ca_topic_score_codex":0.0011151293,"about_ca_topic_score_gemma":0.0004751954,"teacher_disagreement_score":0.050418973,"about_ca_system_score_codex":0.000503806,"about_ca_system_score_gemma":0.0007513246,"threshold_uncertainty_score":0.9997472},"labels":[],"label_agreement":null},{"id":"W2889534785","doi":"10.1177/1352458518798048","title":"gMS-Classifier1 does not predict disability progression in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Clinical neurology; Psychology; Neuroscience; Psychiatry","score_opus":0.16620321737933225,"score_gpt":0.3293705557566568,"score_spread":0.16316733837732456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889534785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5416351,0.0011682559,0.00022071223,0.44303122,0.004958303,0.006170293,0.0016154704,0.00063540257,0.0005652453],"genre_scores_gemma":[0.87281585,0.0072591896,0.006866222,0.07975598,0.028441343,0.0012518318,0.00070908485,0.0007122198,0.0021883065],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98318523,0.0016989053,0.0034508393,0.0026973549,0.0052761002,0.0036915955],"domain_scores_gemma":[0.9903252,0.0027230023,0.001594713,0.0025491752,0.0015523066,0.0012555755],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.0038561174,0.0020658844,0.0034154297,0.0012610222,0.0015852628,0.000843775,0.0017718956,0.0027958562,0.0013511266],"category_scores_gemma":[0.00989958,0.0014332201,0.0017309557,0.0012727316,0.0033046873,0.00089568825,0.0013493885,0.012001082,0.00035613813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016713534,0.0012688295,0.4536313,0.0009684396,0.000635984,0.00032927797,0.0005353678,0.0000070657507,0.026737852,2.54846e-7,0.46368966,0.050524622],"study_design_scores_gemma":[0.013969413,0.0011744169,0.79791343,0.011033346,0.00037908283,0.00015835755,0.00029325744,0.0029395358,0.008131529,0.000020978274,0.16235687,0.0016297991],"about_ca_topic_score_codex":0.0005741421,"about_ca_topic_score_gemma":0.0010733763,"teacher_disagreement_score":0.36327526,"about_ca_system_score_codex":0.003022684,"about_ca_system_score_gemma":0.00073276,"threshold_uncertainty_score":0.99971455},"labels":[],"label_agreement":null},{"id":"W2893128590","doi":"10.1177/1352458518802544","title":"Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Hematopoietic stem cell transplantation; Medicine; Transplantation; Stem cell; Hematopoietic cell; Haematopoiesis; Immunology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.13427755147901307,"score_gpt":0.30304183444857696,"score_spread":0.1687642829695639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893128590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927488,0.0009251516,0.0022174565,0.0010461288,0.0007243977,0.0012569034,0.000067139204,0.00019752896,0.0008164969],"genre_scores_gemma":[0.989374,0.0040631215,0.004917261,0.0003393226,0.00075131113,0.00015007198,0.00002753819,0.00012308794,0.0002542782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9942773,0.00042748585,0.0014852367,0.00089119707,0.0013761395,0.0015426379],"domain_scores_gemma":[0.9966051,0.0007625151,0.0004739206,0.0006859384,0.0007095245,0.0007630188],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013672474,0.0006637623,0.0011090981,0.0008956165,0.0009310953,0.0002677674,0.0005408218,0.00036369782,0.00026891183],"category_scores_gemma":[0.00048000523,0.0005733225,0.0004596244,0.00096975325,0.0007070061,0.00059328484,0.00016734716,0.001317459,0.00024098494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014674125,0.0010101586,0.2370068,0.00044301146,0.00017625572,0.000104182574,0.0068983985,0.00007711277,0.67962956,0.000006014114,0.0019297061,0.071251385],"study_design_scores_gemma":[0.012381337,0.0009808235,0.8463681,0.0014661149,0.00012838015,0.00024094555,0.0018561913,0.00693355,0.1287032,0.000020659028,0.0003424513,0.0005782908],"about_ca_topic_score_codex":0.0003577071,"about_ca_topic_score_gemma":0.00086244306,"teacher_disagreement_score":0.6093613,"about_ca_system_score_codex":0.0005522313,"about_ca_system_score_gemma":0.00028223207,"threshold_uncertainty_score":0.9996718},"labels":[],"label_agreement":null},{"id":"W2894758097","doi":"10.1177/1352458518801764","title":"2018 Editors’ commentary","year":2018,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.0765972082841851,"score_gpt":0.32485519521864165,"score_spread":0.24825798693445655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894758097","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011648608,0.0014066866,0.00009217594,0.0049245367,0.98956513,0.0009706439,0.0008395693,0.000209134,0.0008272577],"genre_scores_gemma":[0.0011672686,0.011041442,0.0029894456,0.00080489897,0.98132414,0.00010667547,0.0006986807,0.0003055142,0.0015619387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898479,0.00047566308,0.0016350689,0.0011364582,0.0050835037,0.0018214157],"domain_scores_gemma":[0.9910819,0.0025056638,0.0009508472,0.0013582445,0.0026328813,0.0014704488],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0023552256,0.0011453592,0.0019989111,0.0008364495,0.0014137881,0.00053556217,0.0011094552,0.0016485187,0.0014673013],"category_scores_gemma":[0.010004899,0.00094520784,0.0011202409,0.00049494987,0.000985621,0.00041290082,0.00088921416,0.0058028162,0.0010977617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085659605,0.00057650876,0.002766658,0.0002622081,0.0012673793,0.00008574835,0.00025855924,0.0000011761814,0.0023800288,7.836042e-8,0.9857728,0.005772284],"study_design_scores_gemma":[0.008003034,0.0013004787,0.0075335344,0.0028620148,0.00047023495,0.000051414416,0.000163837,0.00010604046,0.0005706108,0.000009261782,0.97813326,0.0007962906],"about_ca_topic_score_codex":0.00029049983,"about_ca_topic_score_gemma":0.00011501335,"teacher_disagreement_score":0.009634755,"about_ca_system_score_codex":0.001798718,"about_ca_system_score_gemma":0.0009207704,"threshold_uncertainty_score":0.9998862},"labels":[],"label_agreement":null},{"id":"W2894814928","doi":"10.1177/1352458518796675","title":"Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Upper respiratory tract infection; Gastroenterology; Immunology; Interferon beta; Transplantation","score_opus":0.08629071658810852,"score_gpt":0.3352252956619442,"score_spread":0.24893457907383568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894814928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830993,0.014553697,0.00007505331,0.00038027152,0.0001266524,0.001347483,0.00034544728,0.000037523365,0.000034587792],"genre_scores_gemma":[0.98365545,0.014933475,0.0005989294,0.00009155127,0.0005371224,0.000041751526,0.000073841715,0.000043882217,0.000023994995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563754,0.0010093786,0.0007601361,0.00078907405,0.0013041336,0.00049971236],"domain_scores_gemma":[0.9939032,0.002104423,0.0006268804,0.0014547225,0.0016355979,0.0002751784],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001818911,0.0004494661,0.0012924914,0.00035908862,0.0023177727,0.00018663808,0.00042286914,0.00009751606,0.00011438626],"category_scores_gemma":[0.004267226,0.00021567206,0.00020873258,0.00094036607,0.0018891811,0.00034340186,0.0013399104,0.00068834703,0.000005475385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035092086,0.0002989312,0.93778497,0.000037654834,0.013272495,0.000007989777,0.02907454,0.000058587197,0.0025680694,6.6934683e-7,0.0012059794,0.012180916],"study_design_scores_gemma":[0.014804461,0.0015021517,0.94297403,0.0004441813,0.011615386,0.000015695636,0.023208952,0.0047052586,0.00030745481,0.00000458567,0.00018871584,0.00022912941],"about_ca_topic_score_codex":0.015436929,"about_ca_topic_score_gemma":0.024374599,"teacher_disagreement_score":0.0119517865,"about_ca_system_score_codex":0.0001979412,"about_ca_system_score_gemma":0.00013935751,"threshold_uncertainty_score":0.99898106},"labels":[],"label_agreement":null},{"id":"W2895845951","doi":"10.1177/1352458518803785","title":"Recommendations for cognitive screening and management in multiple sclerosis care","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Physical medicine and rehabilitation; Intensive care medicine; Psychiatry","score_opus":0.4229201343831565,"score_gpt":0.41052095395330507,"score_spread":0.012399180429851442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895845951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033005018,0.98873866,0.0016207453,0.0004059244,0.00054438843,0.0069884043,0.0010183383,0.000094003546,0.00025951033],"genre_scores_gemma":[0.0017843359,0.96145415,0.032599155,0.00014881954,0.0009997978,0.001998064,0.00061093766,0.00023913551,0.00016558693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99387074,0.000529254,0.0019723973,0.0012913069,0.0009075664,0.0014287385],"domain_scores_gemma":[0.9944155,0.0023776542,0.0008944308,0.00056468934,0.0010143655,0.000733321],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001524753,0.0010742741,0.002997534,0.0017215408,0.001312446,0.00040410366,0.0004749201,0.00051831524,0.00011226013],"category_scores_gemma":[0.002466126,0.00091486605,0.0011977869,0.0009280079,0.00047794604,0.00035755645,0.00068927184,0.0015590667,0.000049000395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028762335,0.0002596507,0.0017571315,0.0125646405,0.0015087103,0.00001917407,0.0008442462,8.8761533e-7,0.000008815021,0.0000026097232,0.005597732,0.9771488],"study_design_scores_gemma":[0.014552921,0.00062096934,0.015317271,0.16325417,0.0026173727,0.00011850131,0.004065067,0.00032959404,0.000019204128,0.000005709352,0.7980216,0.0010776025],"about_ca_topic_score_codex":0.00007291321,"about_ca_topic_score_gemma":0.00033191085,"teacher_disagreement_score":0.9760712,"about_ca_system_score_codex":0.00080573745,"about_ca_system_score_gemma":0.00024671378,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2896814303","doi":"10.1177/1352458518798147","title":"Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôtel-Dieu de Montréal","funders":"EMD Serono; Canadian Institutes of Health Research; IC Design Education Center; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Neuroimaging; Psychology; Physical medicine and rehabilitation; Radiology; Psychiatry","score_opus":0.20165026201569453,"score_gpt":0.35534809528170225,"score_spread":0.15369783326600772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896814303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869951,0.0006715526,0.0026737384,0.0053203553,0.0009719085,0.0025308314,0.0002446238,0.00016017629,0.00043173475],"genre_scores_gemma":[0.97502106,0.0037465245,0.01796074,0.0006539505,0.0017879339,0.0004458717,0.000047034056,0.00015926077,0.00017764179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938746,0.00032466472,0.0014606621,0.0010984234,0.0013455214,0.0018961156],"domain_scores_gemma":[0.99314165,0.003542906,0.00042860588,0.00087832584,0.00096069055,0.0010478253],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0016025588,0.00077057356,0.0011867442,0.001176976,0.0021181924,0.00032524456,0.0005114471,0.00021363515,0.00020434089],"category_scores_gemma":[0.007462142,0.0006090768,0.0008072801,0.00080947374,0.0005050626,0.00041462743,0.000300144,0.0007041652,0.00021137398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031846869,0.0026967227,0.4316713,0.00003418604,0.00036231108,0.000052722713,0.0028430477,0.00031779453,0.22539963,0.000017918077,0.006930353,0.32648933],"study_design_scores_gemma":[0.022989152,0.0024883675,0.912408,0.003138704,0.00014422333,0.00007681529,0.0016861518,0.028722402,0.02299396,0.00004278567,0.0046670046,0.00064242777],"about_ca_topic_score_codex":0.0005319832,"about_ca_topic_score_gemma":0.0015954181,"teacher_disagreement_score":0.4807367,"about_ca_system_score_codex":0.0018460115,"about_ca_system_score_gemma":0.00036642785,"threshold_uncertainty_score":0.99963605},"labels":[],"label_agreement":null},{"id":"W2898018722","doi":"10.1177/1352458518807061","title":"Diet quality and risk of multiple sclerosis in two cohorts of US women","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Sanofi Genzyme; Multiple Sclerosis Society of Canada; Harvard University","keywords":"Multiple sclerosis; Medicine; Quality (philosophy); Environmental health; Psychiatry","score_opus":0.1418311949610307,"score_gpt":0.3572747824964705,"score_spread":0.2154435875354398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898018722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731034,0.0007011901,0.0001335404,0.00021214833,0.00024991887,0.0007810773,0.00021504097,0.000036600275,0.00036011805],"genre_scores_gemma":[0.9868348,0.0084625445,0.004040202,0.00008526217,0.0003967938,0.00006625349,0.0000071085146,0.000061197105,0.000045790464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942903,0.000768605,0.0019007326,0.0006189388,0.0013452804,0.0010761309],"domain_scores_gemma":[0.9951301,0.0013257164,0.0010552654,0.0007105792,0.0011129891,0.0006653042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043770215,0.00044925962,0.0016406324,0.0006896323,0.0003718508,0.00006110982,0.0003534059,0.00016334042,0.00032778853],"category_scores_gemma":[0.007144877,0.0003773965,0.00031300745,0.0007919768,0.0014391856,0.00032966142,0.00042768178,0.0009241769,0.000012891949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002820983,0.00067584804,0.7991454,0.00017247208,0.00042753146,0.000004477857,0.0027982728,0.000029598456,0.17324452,0.0000035864884,0.00024489523,0.020432394],"study_design_scores_gemma":[0.014005767,0.001377912,0.9513995,0.0011105925,0.00009359783,0.000016891063,0.0012318519,0.0016824442,0.028483426,0.0000499046,0.00024219268,0.00030590882],"about_ca_topic_score_codex":0.00387978,"about_ca_topic_score_gemma":0.0028377583,"teacher_disagreement_score":0.15225409,"about_ca_system_score_codex":0.00039506695,"about_ca_system_score_gemma":0.00018540343,"threshold_uncertainty_score":0.9998678},"labels":[],"label_agreement":null},{"id":"W2899172313","doi":"10.1177/1352458518809326","title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Sanofi Genzyme; Novartis Pharma; Genentech; National Institutes of Health; TG Therapeutics; CSL Behring; IC Design Education Center; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Merck KGaA; Atara Biotherapeutics; MedDay Pharmaceuticals; GlaxoSmithKline; Biogen; Celgene; Sanofi","keywords":"Multiple sclerosis; Consensus conference; Medicine; Quality (philosophy); MEDLINE; Political science; Psychiatry; Internal medicine","score_opus":0.23355792287178148,"score_gpt":0.4088597309730535,"score_spread":0.17530180810127202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899172313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416628,0.0010123935,0.0016170599,0.046136048,0.0022778914,0.0031207488,0.0025576428,0.00019822965,0.0014172058],"genre_scores_gemma":[0.97863823,0.0010147374,0.015340191,0.0025020114,0.0019206668,0.00022520272,0.0000957483,0.00011604791,0.00014718791],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99275607,0.000701539,0.0017179201,0.00093375385,0.0024254823,0.0014652262],"domain_scores_gemma":[0.9923813,0.0024298013,0.0006599453,0.000700476,0.0029641204,0.00086440437],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047601005,0.00058157666,0.0012135255,0.00088732125,0.001163096,0.00026762256,0.0005696235,0.0002600708,0.00034093487],"category_scores_gemma":[0.0155032035,0.0005139719,0.00057828904,0.00057231815,0.00070415,0.00019958235,0.0002309153,0.0011085769,0.00004994775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019219885,0.0016225853,0.3440147,0.0004915149,0.00075426314,0.000023041186,0.00987544,0.00014028308,0.075091235,0.000071821174,0.13114764,0.4175476],"study_design_scores_gemma":[0.040163774,0.0037810046,0.8575075,0.0027363184,0.0000342682,0.00003132055,0.0038641032,0.0030852181,0.008217597,0.000036113728,0.07988023,0.0006625447],"about_ca_topic_score_codex":0.00062672485,"about_ca_topic_score_gemma":0.0036260795,"teacher_disagreement_score":0.5134928,"about_ca_system_score_codex":0.0029808674,"about_ca_system_score_gemma":0.0011285229,"threshold_uncertainty_score":0.9997312},"labels":[],"label_agreement":null},{"id":"W2900475353","doi":"10.1177/1352458518813105","title":"Area postrema syndrome: A short history of a pearl in demyelinating diseases","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Area postrema; Pearl; Medicine; Multiple sclerosis; Demyelinating disease; Internal medicine; Central nervous system; History; Immunology","score_opus":0.26060707284448437,"score_gpt":0.36125533825183737,"score_spread":0.100648265407353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900475353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027796754,0.994115,0.00001804001,0.000048742204,0.0007244641,0.0015549542,0.00018982137,0.0000595284,0.0005097509],"genre_scores_gemma":[0.010783178,0.98641795,0.0011460917,0.00003208177,0.00059354363,0.00019253636,0.00008033773,0.00017976356,0.0005745027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930132,0.00068082433,0.0026188432,0.00085752236,0.0016872088,0.0011424279],"domain_scores_gemma":[0.9953943,0.001143715,0.0010442081,0.0008389387,0.0007912665,0.00078756973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015349174,0.0009182124,0.0045780293,0.0017455618,0.00018434726,0.00006374464,0.00072815066,0.00049049815,0.000433532],"category_scores_gemma":[0.0058739604,0.00071924133,0.0018453049,0.0007806646,0.000686976,0.00024849252,0.0005152654,0.0020306737,0.000057358422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018463956,0.0011556884,0.018481877,0.022512102,0.0013123631,0.00053978217,0.0006775557,0.0000019294966,0.00009953402,8.3863137e-7,0.015037838,0.9399958],"study_design_scores_gemma":[0.0039938083,0.0011525565,0.10511198,0.24518964,0.0025933008,0.0024194685,0.00029481357,0.00045208784,0.000004309734,0.000004995071,0.6375348,0.0012482535],"about_ca_topic_score_codex":0.000116006144,"about_ca_topic_score_gemma":0.00009193252,"teacher_disagreement_score":0.9387476,"about_ca_system_score_codex":0.0037725696,"about_ca_system_score_gemma":0.0022497072,"threshold_uncertainty_score":0.99952585},"labels":[],"label_agreement":null},{"id":"W2900575151","doi":"10.1177/1352458518810924","title":"Month-of-birth-effect in multiple sclerosis in Austria","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Demography; Population; Birth rate; Cohort; Medicine; Geography; Pediatrics; Fertility; Pathology","score_opus":0.14880176159725086,"score_gpt":0.3217018510036634,"score_spread":0.17290008940641252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900575151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952282,0.0008897696,0.00013253557,0.0007890764,0.00063207594,0.00149047,0.000055060103,0.000073777606,0.00070904125],"genre_scores_gemma":[0.993458,0.0020476084,0.0030857774,0.00015424463,0.0008256755,0.0001438594,0.000011944909,0.00010547947,0.00016741283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934883,0.0007212464,0.0018586299,0.00081510824,0.0015204396,0.0015962917],"domain_scores_gemma":[0.9957778,0.0015346695,0.0005307892,0.00082629133,0.00066092587,0.00066952454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033648803,0.00064459717,0.001634623,0.0016380369,0.00037919814,0.00012296186,0.00062523433,0.0003787456,0.0005787113],"category_scores_gemma":[0.0075188903,0.00054510764,0.0005163095,0.001851312,0.0008514191,0.00050631404,0.00039596367,0.0016691602,0.0001539574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022970326,0.0007151541,0.7412206,0.00012846898,0.00013363009,0.0000434079,0.0010662051,0.00009160786,0.21225433,0.000003055183,0.0017492741,0.040297218],"study_design_scores_gemma":[0.021526473,0.0016959187,0.9073268,0.0025569515,0.00004854751,0.000033919638,0.00047190193,0.0059963297,0.059151165,0.00001994992,0.0007450722,0.0004269402],"about_ca_topic_score_codex":0.0013067896,"about_ca_topic_score_gemma":0.0032303662,"teacher_disagreement_score":0.16610621,"about_ca_system_score_codex":0.0007953783,"about_ca_system_score_gemma":0.000277047,"threshold_uncertainty_score":0.99970007},"labels":[],"label_agreement":null},{"id":"W2901155618","doi":"10.1177/1352458518808189","title":"Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Bayer HealthCare; Acorda Therapeutics","keywords":"Ocrelizumab; Medicine; Placebo; Multiple sclerosis; Physical therapy; Internal medicine; Psychiatry; Alternative medicine","score_opus":0.05233094733037293,"score_gpt":0.30837759811251214,"score_spread":0.25604665078213923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901155618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888984,0.0012550149,0.000084630665,0.00076197815,0.0006644074,0.008031687,0.00016418724,0.00007566932,0.000064044434],"genre_scores_gemma":[0.9925303,0.0007278883,0.0044805584,0.00015897352,0.0011009182,0.0007644599,0.00011744155,0.00009902488,0.000020452042],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9916704,0.0012262161,0.0021746308,0.000920284,0.002795587,0.0012128247],"domain_scores_gemma":[0.9935248,0.0018956602,0.0013996678,0.00084379065,0.0017592586,0.0005768436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003154354,0.00075225084,0.0022841922,0.00044049497,0.0009752632,0.00025657928,0.0007208838,0.00028939737,0.00036357337],"category_scores_gemma":[0.00430108,0.00041521442,0.00062848267,0.0009198119,0.0019382962,0.00061820744,0.00045918682,0.0013197366,0.000017442795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64767647,0.0049857497,0.30873895,0.000043590357,0.00070139085,0.000009880368,0.0033061407,0.0000035310843,0.013014068,8.1468767e-7,0.0017186234,0.019800795],"study_design_scores_gemma":[0.5518369,0.0029733237,0.43044376,0.0032750298,0.00020615374,0.0000041778803,0.0004901941,0.00039514675,0.009999026,0.000005904704,0.00007418031,0.00029617848],"about_ca_topic_score_codex":0.00023768039,"about_ca_topic_score_gemma":0.000065818895,"teacher_disagreement_score":0.12170482,"about_ca_system_score_codex":0.0007264341,"about_ca_system_score_gemma":0.00064061565,"threshold_uncertainty_score":0.99982995},"labels":[],"label_agreement":null},{"id":"W2903065994","doi":"10.1177/1352458518809301","title":"Vitamin D deficiency is an etiological factor for MS – Yes","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Etiology; Medicine; vitamin D deficiency; Vitamin D and neurology; Internal medicine; Immunology","score_opus":0.37464956853101894,"score_gpt":0.4168246800033832,"score_spread":0.042175111472364246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903065994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017796395,0.9941701,0.00050593895,0.00018569668,0.00071677065,0.0017937174,0.00062648277,0.00007672618,0.00014487775],"genre_scores_gemma":[0.0016527206,0.9899841,0.004690823,0.00014337095,0.0025053439,0.00024404479,0.00007024338,0.00010958255,0.0005997498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99577516,0.00036437903,0.0011438295,0.00077393936,0.0008630088,0.0010796541],"domain_scores_gemma":[0.9965418,0.00085296825,0.0005803246,0.00060713495,0.00072405435,0.000693714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011767044,0.00069413584,0.0025138238,0.00045881246,0.00080180366,0.0002100647,0.00066271774,0.00062574266,0.00072222593],"category_scores_gemma":[0.0031585114,0.0004180327,0.001479103,0.00035528035,0.0005053954,0.00018553324,0.00024566113,0.0013009107,0.00020816663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050108258,0.0005226792,0.0005788004,0.0065709264,0.00044187502,0.000024919447,0.00038554796,8.925959e-8,0.00009740989,0.00000355103,0.020038417,0.9712857],"study_design_scores_gemma":[0.0019021143,0.0027906848,0.011411282,0.015480642,0.00090686925,0.00050352194,0.00013885733,0.000043047363,0.000029245097,0.00002182036,0.9661753,0.00059661653],"about_ca_topic_score_codex":0.000007116481,"about_ca_topic_score_gemma":0.000009954129,"teacher_disagreement_score":0.97068906,"about_ca_system_score_codex":0.00042411598,"about_ca_system_score_gemma":0.00047860673,"threshold_uncertainty_score":0.99982715},"labels":[],"label_agreement":null},{"id":"W2905522261","doi":"10.1177/1352458518814117","title":"Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Pathology; Neuroscience; Nuclear magnetic resonance; Radiology; Physics; Psychology","score_opus":0.0872391206309767,"score_gpt":0.31939167437962634,"score_spread":0.23215255374864963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905522261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739991,0.017125638,0.0011241242,0.001989987,0.0010340991,0.0015769942,0.00020658507,0.00022029091,0.0027232028],"genre_scores_gemma":[0.98008853,0.008744198,0.008205606,0.00029129031,0.001606862,0.0001513315,0.000016237753,0.000179446,0.00071651355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9929196,0.00049043715,0.0016108888,0.0010810335,0.0020112093,0.0018868324],"domain_scores_gemma":[0.9933917,0.0015853607,0.00072910375,0.001118758,0.0020924078,0.0010826738],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015209797,0.0007884648,0.0013072011,0.0010384689,0.0020935554,0.0002532325,0.0008143999,0.00026157443,0.002599814],"category_scores_gemma":[0.008145767,0.0006908212,0.0008071204,0.0013237734,0.0015903,0.0008402842,0.00079445203,0.0015735667,0.00029187123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001190054,0.0007169595,0.16770686,0.000106070984,0.00018437782,0.000040467825,0.0015171412,0.0000114103905,0.5144641,0.000009230904,0.008599844,0.3054535],"study_design_scores_gemma":[0.0101464335,0.0013182097,0.9046993,0.0048599257,0.00020965494,0.00020806011,0.0014288774,0.012176952,0.05945323,0.000041458803,0.004820559,0.0006373329],"about_ca_topic_score_codex":0.0006027038,"about_ca_topic_score_gemma":0.00044178442,"teacher_disagreement_score":0.7369924,"about_ca_system_score_codex":0.0012587048,"about_ca_system_score_gemma":0.0008178128,"threshold_uncertainty_score":0.9995543},"labels":[],"label_agreement":null},{"id":"W2905971247","doi":"10.1177/1352458518820628","title":"Jacques Jean Lhermitte and Lhermitte’s sign","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurology and Historical Studies","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Sign (mathematics); The Renaissance; Neuropathology; Neuropsychiatry; Neurology; Classics; History; Philosophy; Medicine; Art history; Psychiatry; Pathology","score_opus":0.11358815295851477,"score_gpt":0.2573895085338174,"score_spread":0.14380135557530266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905971247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912609,0.0006456536,0.00045723523,0.0026668007,0.0015459558,0.00013646783,0.00000722109,0.00011788048,0.0031618867],"genre_scores_gemma":[0.9943701,0.0009913165,0.00018537334,0.002780253,0.00086663576,0.0000060056927,1.0883547e-7,0.00002171866,0.00077847374],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984405,0.00022676915,0.00028163384,0.00037041743,0.00025540777,0.00042527332],"domain_scores_gemma":[0.9988704,0.00053694745,0.00014608278,0.00016038209,0.00007420456,0.00021201615],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00025506067,0.00018536748,0.00023015362,0.000092729526,0.0014492134,0.000119233424,0.00025779888,0.00008711421,0.00029633276],"category_scores_gemma":[0.0011583796,0.00015170604,0.000081745166,0.00017361296,0.0006828829,0.00024675537,0.0001356329,0.00042459727,0.00019397687],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032936432,0.00025489472,0.0344836,0.000011707454,0.000032790944,0.00011159367,0.0014675991,0.0000076083934,0.845205,0.00031037937,0.029511143,0.08827429],"study_design_scores_gemma":[0.003697275,0.0020317568,0.37359852,0.00009665713,0.00007876642,0.0005777712,0.00010943472,0.0007411339,0.29059497,0.0023225357,0.32524788,0.0009032783],"about_ca_topic_score_codex":0.00001946625,"about_ca_topic_score_gemma":0.000047491732,"teacher_disagreement_score":0.55461,"about_ca_system_score_codex":0.00004291768,"about_ca_system_score_gemma":0.000017242293,"threshold_uncertainty_score":0.99985075},"labels":[],"label_agreement":null},{"id":"W2909806674","doi":"10.1177/1352458518819096","title":"MSJ 2019 - Editorial comment","year":2019,"lang":"fr","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; MEDLINE; Medicine; Epistemology; Psychology; Cognitive science; Computer science; Philosophy; Psychiatry; Political science","score_opus":0.06745257905109638,"score_gpt":0.3148455261255324,"score_spread":0.24739294707443604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909806674","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013279275,0.013989864,0.0002636049,0.007751454,0.96939874,0.0030569101,0.0025522474,0.00017771254,0.0014815468],"genre_scores_gemma":[0.0042806924,0.06508985,0.001213922,0.00055332744,0.9164113,0.00017039244,0.0009079039,0.00054025324,0.010832372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9759719,0.0020551349,0.0038240526,0.0021929734,0.010908059,0.0050479006],"domain_scores_gemma":[0.975294,0.011952943,0.0023344264,0.0023693512,0.0048889504,0.0031603486],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.007129697,0.0025678023,0.004467647,0.0012706214,0.0023331847,0.0015722424,0.002681324,0.004031037,0.0048940047],"category_scores_gemma":[0.028325327,0.0023089752,0.002593673,0.00095915265,0.0012851999,0.0010253647,0.002009184,0.014924585,0.0121947015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027180964,0.0018377728,0.007583062,0.0009899157,0.0032614262,0.00010507142,0.0011557498,0.00027001835,0.01175223,0.000008860864,0.9501641,0.020153733],"study_design_scores_gemma":[0.027409896,0.0024351047,0.013924117,0.010024757,0.00090824143,0.000069841604,0.00090007513,0.0010367396,0.00064444763,0.000015794067,0.9407291,0.0019019],"about_ca_topic_score_codex":0.001204058,"about_ca_topic_score_gemma":0.00013984673,"teacher_disagreement_score":0.05298745,"about_ca_system_score_codex":0.0077809747,"about_ca_system_score_gemma":0.004755793,"threshold_uncertainty_score":0.9994642},"labels":[],"label_agreement":null},{"id":"W2920869320","doi":"10.1177/1352458519868990","title":"Risk of secondary progressive multiple sclerosis: A longitudinal study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; University of Tasmania","keywords":"Multiple sclerosis; Medicine; Expanded Disability Status Scale; Hazard ratio; Proportional hazards model; Internal medicine; Magnetic resonance imaging; Cohort; Cohort study; Progressive disease; Confidence interval; Pediatrics; Disease; Immunology; Radiology","score_opus":0.11040849336922892,"score_gpt":0.3169504138556149,"score_spread":0.20654192048638598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920869320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919266,0.002410177,0.00013892162,0.00027357016,0.00074467127,0.0035632942,0.0001960098,0.00014061754,0.0006061485],"genre_scores_gemma":[0.9929763,0.001681048,0.0040042223,0.00008984055,0.00060690445,0.00020647484,0.00002028935,0.00014249976,0.0002724355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99250776,0.0007719815,0.001789845,0.0010727899,0.002444811,0.0014128278],"domain_scores_gemma":[0.9937171,0.0011549369,0.001334521,0.0012869948,0.0016205203,0.0008859769],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002494028,0.0007699404,0.0018087649,0.0008301976,0.0007356289,0.00022439878,0.00075808686,0.00026112286,0.0019457021],"category_scores_gemma":[0.003481963,0.00061335013,0.0009061652,0.00096782716,0.0004867962,0.0006585405,0.00063288736,0.0023800144,0.00033563538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002073638,0.003215762,0.9134289,0.00020535379,0.001863119,0.00006390181,0.0018444752,0.00011096039,0.0461741,0.000002016928,0.0016399847,0.029377772],"study_design_scores_gemma":[0.023051508,0.0033377493,0.95738024,0.0013920292,0.0004733609,0.00014803626,0.0045957286,0.00163955,0.0071099773,0.00001202726,0.00032137832,0.00053838996],"about_ca_topic_score_codex":0.00034472765,"about_ca_topic_score_gemma":0.00017680776,"teacher_disagreement_score":0.043951347,"about_ca_system_score_codex":0.00040030258,"about_ca_system_score_gemma":0.0004914843,"threshold_uncertainty_score":0.99992156},"labels":[],"label_agreement":null},{"id":"W2923518038","doi":"10.1177/1352458519832249","title":"Disease-modifying therapies should be stopped in NMOSD patients in remission – No","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Internal medicine; Immunology","score_opus":0.08961643620473426,"score_gpt":0.282346713426991,"score_spread":0.19273027722225677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923518038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942484,0.0028899054,0.000005232424,0.0009709278,0.0008127977,0.0006261981,0.00001567873,0.00003813756,0.00039272406],"genre_scores_gemma":[0.9961677,0.002437706,0.00015929074,0.0006162011,0.00023779567,0.00001910626,0.00002669433,0.00004819349,0.00028731202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745077,0.0001861616,0.0007699716,0.00037868452,0.0007153794,0.0004990458],"domain_scores_gemma":[0.9985992,0.00015203477,0.00024235602,0.00033890564,0.00018371012,0.00048382362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005122586,0.00026700637,0.0005031972,0.00038748397,0.00011463281,0.00008005069,0.00018289729,0.00019398877,0.0004719538],"category_scores_gemma":[0.00048208435,0.00019726448,0.00023717829,0.0003463885,0.000040906227,0.00025780126,0.00006262856,0.0006576304,0.00010971054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011358341,0.00053977035,0.95828515,0.000084163454,0.00004304865,0.000021277883,0.0006006926,0.00018338297,0.030404158,0.0000018050282,0.0007126567,0.007988048],"study_design_scores_gemma":[0.011276062,0.0001543603,0.978087,0.0061992477,0.000043059983,0.000008395583,0.0005501562,0.0024422933,0.00027620344,0.000011246237,0.0007164093,0.00023554543],"about_ca_topic_score_codex":0.00011141398,"about_ca_topic_score_gemma":0.000015234157,"teacher_disagreement_score":0.030127954,"about_ca_system_score_codex":0.0003308704,"about_ca_system_score_gemma":0.00014339096,"threshold_uncertainty_score":0.8044212},"labels":[],"label_agreement":null},{"id":"W2944804677","doi":"10.1177/1352458519845107","title":"The neurologist’s role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectives","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"McGill University","keywords":"Multiple sclerosis; Thematic analysis; Medicine; Qualitative research; Exploratory research; Family medicine; MEDLINE; Disease; Psychiatry","score_opus":0.09075567390144422,"score_gpt":0.3319135197590911,"score_spread":0.24115784585764688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944804677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896485,0.006662142,0.0000066476337,0.00071443757,0.00019493864,0.0026000205,0.000025952271,0.00003664015,0.0001106996],"genre_scores_gemma":[0.99696046,0.0022472537,0.00034870644,0.000050434228,0.00010502687,0.00019801137,0.0000031050783,0.000057365236,0.000029616234],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9950987,0.001111464,0.001065903,0.0006913102,0.0012175107,0.0008151143],"domain_scores_gemma":[0.9957174,0.002055289,0.000496503,0.00058144593,0.00085345266,0.00029589905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013233117,0.00041571396,0.00084890856,0.00036229784,0.00065314106,0.00019398959,0.0003349788,0.000118032534,0.000027806984],"category_scores_gemma":[0.0036341825,0.0002747493,0.00021872419,0.00053013844,0.0004863899,0.00034212344,0.00043663022,0.0011387517,0.000010853364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017200232,0.0012511829,0.5348497,0.000095955795,0.00025895453,0.00000782729,0.42421266,0.00031360326,0.022450695,0.000006470424,0.000059553608,0.014773356],"study_design_scores_gemma":[0.0067552547,0.0019162229,0.45586875,0.00034908802,0.000037751422,0.000008934241,0.53314877,0.0010937909,0.0005807988,0.000009519652,0.000068908805,0.00016220858],"about_ca_topic_score_codex":0.0008326077,"about_ca_topic_score_gemma":0.0019325805,"teacher_disagreement_score":0.10893612,"about_ca_system_score_codex":0.00032558216,"about_ca_system_score_gemma":0.00014358935,"threshold_uncertainty_score":0.9999705},"labels":[],"label_agreement":null},{"id":"W2945419470","doi":"10.1177/1352458519845836","title":"Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Abdominal obesity; Medicine; Waist; Odds ratio; Comorbidity; Body mass index; Obesity; Metabolic syndrome; Confidence interval; Internal medicine; Population; Waist-to-height ratio; Physical therapy; Environmental health","score_opus":0.0630373176336571,"score_gpt":0.27980652368067455,"score_spread":0.21676920604701744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945419470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978943,0.0005215868,0.00012869587,0.00022883168,0.00007081032,0.0010008289,0.0001053211,0.000018173354,0.000031445594],"genre_scores_gemma":[0.9942768,0.0011598131,0.0043743793,0.000026090476,0.00007643216,0.000024510415,0.000013882311,0.000032906795,0.000015178091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967269,0.00033002006,0.00087357283,0.00050300476,0.0009888764,0.00057765597],"domain_scores_gemma":[0.9979701,0.00046049058,0.00041734567,0.00040316285,0.0004238774,0.00032501068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001721957,0.00032679754,0.0011279688,0.00024975208,0.00019816282,0.00004662814,0.00014810126,0.00015304952,0.00006521012],"category_scores_gemma":[0.0010875667,0.00025470348,0.00015558019,0.0004409166,0.0003665602,0.0003833487,0.00023153903,0.00057272875,0.000001515545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018661324,0.00081034075,0.8914831,0.0004099178,0.00012256207,0.0000016604771,0.0011946973,0.00005646409,0.09692263,0.0000044667827,0.000020127585,0.0071078613],"study_design_scores_gemma":[0.011300791,0.0005332906,0.97275746,0.00090507336,0.00007460315,0.00003917863,0.0007230814,0.008936655,0.0044773053,0.00001394566,0.000008855607,0.00022974817],"about_ca_topic_score_codex":0.0033765929,"about_ca_topic_score_gemma":0.0064061773,"teacher_disagreement_score":0.09244533,"about_ca_system_score_codex":0.00020089763,"about_ca_system_score_gemma":0.000077489465,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2945832654","doi":"10.1177/1352458519848100","title":"Three-dimensional MRI sequences in MS diagnosis and research","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Université de Sherbrooke; University of British Columbia","funders":"Canada Research Chairs; National Multiple Sclerosis Society","keywords":"Fluid-attenuated inversion recovery; Multiple sclerosis; Susceptibility weighted imaging; Magnetic resonance imaging; Medicine; Computer science; Nuclear medicine; Nuclear magnetic resonance; Radiology; Physics","score_opus":0.44453599453735654,"score_gpt":0.44510855752473405,"score_spread":0.0005725629873775118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945832654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020503576,0.9931001,0.000009468099,0.0007834989,0.0006692227,0.0030082003,0.000113194044,0.00004352974,0.00022239398],"genre_scores_gemma":[0.0009358953,0.9950056,0.0019209041,0.000063015505,0.0009837488,0.0006811038,0.0000468144,0.00015676254,0.00020616272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99109244,0.0011313341,0.0017883574,0.0012568923,0.0029526805,0.0017782875],"domain_scores_gemma":[0.992021,0.0049092993,0.00052369,0.0008331043,0.0008481514,0.00086471037],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005969195,0.00087560917,0.0037890458,0.0023642508,0.00071489514,0.0004099528,0.0007036884,0.0007300778,0.0005274752],"category_scores_gemma":[0.0041711526,0.0006252007,0.0008629443,0.0016193712,0.00089690386,0.0003489289,0.001010184,0.0055049695,0.00038858564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010314816,0.0004153369,0.030981734,0.0096793575,0.0005598811,0.00018921988,0.00015436711,0.000008938729,0.000033647448,0.0000065381764,0.015083198,0.9427846],"study_design_scores_gemma":[0.0036238905,0.0006685273,0.038758628,0.10464564,0.00048695176,0.000657159,0.00009818366,0.00046472243,0.000012257974,0.000051409945,0.8497286,0.0008040631],"about_ca_topic_score_codex":0.000631729,"about_ca_topic_score_gemma":0.00093863904,"teacher_disagreement_score":0.94198054,"about_ca_system_score_codex":0.0011417676,"about_ca_system_score_gemma":0.0013911554,"threshold_uncertainty_score":0.99961996},"labels":[],"label_agreement":null},{"id":"W2948407181","doi":"10.1177/1352458519852722","title":"Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Biogen","keywords":"Schema crosswalk; Intraclass correlation; Statistics; Bland–Altman plot; Concordance; Psychology; Population; Pearson product-moment correlation coefficient; Index (typography); Gerontology; Medicine; Mathematics; Limits of agreement; Psychometrics; Geography; Computer science; Environmental health; Nuclear medicine; Internal medicine","score_opus":0.19891477684675718,"score_gpt":0.3414105658524792,"score_spread":0.14249578900572202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948407181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94601023,0.00460894,0.0062668854,0.036743235,0.0006469745,0.0052663055,0.00017882166,0.000116261705,0.00016235927],"genre_scores_gemma":[0.98644674,0.006114906,0.0032481446,0.0022740937,0.0009966157,0.00039173587,0.000022561584,0.000102003476,0.00040320426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99444276,0.0006884639,0.0013393536,0.0006851302,0.0013249528,0.0015193622],"domain_scores_gemma":[0.99115217,0.0062359083,0.0006344133,0.0007897208,0.00065389375,0.00053391216],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0057725133,0.00058352615,0.0014427511,0.00028598835,0.0030025328,0.00067046465,0.0006835941,0.00019849138,0.00008409116],"category_scores_gemma":[0.003818314,0.00031660023,0.0006165711,0.00042432235,0.0012748068,0.0003911412,0.0005107047,0.0013250344,0.00003413889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043732356,0.000107207336,0.90435696,0.00043234692,0.0009357061,0.0000011901686,0.005695226,0.000039303348,0.0019239145,0.0001351022,0.0045313705,0.07746846],"study_design_scores_gemma":[0.036933757,0.00041324575,0.9408008,0.0012550261,0.0001102395,0.00003931575,0.0036825915,0.0054123453,0.0005593083,0.00019892817,0.0102185225,0.00037594826],"about_ca_topic_score_codex":0.0006759939,"about_ca_topic_score_gemma":0.00043081105,"teacher_disagreement_score":0.07709251,"about_ca_system_score_codex":0.00048637076,"about_ca_system_score_gemma":0.0006172606,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2952776165","doi":"10.1177/1352458519851428","title":"A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosis","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Social Fund; Ministerio de Economía y Competitividad; Fondazione Italiana Sclerosi Multipla","keywords":"Multiple sclerosis; Pharmacogenetics; Interferon; Immunology; Medicine; Biomarker; Gene expression; Gene; Internal medicine; Oncology; Genotype; Biology; Genetics","score_opus":0.38506351680437056,"score_gpt":0.4197018806197647,"score_spread":0.034638363815394146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952776165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16409813,0.81978136,0.000022076269,0.0011921311,0.000686815,0.013847913,0.00022099406,0.000083601175,0.00006698207],"genre_scores_gemma":[0.24858055,0.74720424,0.00034806435,0.0005828794,0.00051343214,0.002378226,0.00003052299,0.00026033478,0.000101744896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98391545,0.0056584696,0.0036687788,0.0018966423,0.0024463735,0.0024142936],"domain_scores_gemma":[0.9890103,0.0065568057,0.0009475449,0.002121601,0.00046559982,0.00089814997],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0096666785,0.0017369121,0.005274856,0.0032225344,0.00054734485,0.00062331534,0.0027211965,0.0005469851,0.00019534401],"category_scores_gemma":[0.005714974,0.0011587472,0.0015934083,0.0036845705,0.00028241274,0.0003119559,0.0013135651,0.0049397727,0.00083065766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005620301,0.005065717,0.05282583,0.004090491,0.0010637561,0.0003027476,0.006528325,0.00008261844,0.0050059236,1.9280773e-7,0.007138102,0.91227597],"study_design_scores_gemma":[0.027596148,0.005602266,0.3783664,0.07128553,0.0020626392,0.00064677873,0.005926043,0.00035202023,0.000111358575,0.0000024603003,0.50563043,0.0024179318],"about_ca_topic_score_codex":0.0004020627,"about_ca_topic_score_gemma":0.0010035484,"teacher_disagreement_score":0.90985805,"about_ca_system_score_codex":0.0019448752,"about_ca_system_score_gemma":0.0010291863,"threshold_uncertainty_score":0.9999473},"labels":[],"label_agreement":null},{"id":"W2962487873","doi":"10.1177/1352458519851981","title":"Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi Genzyme; Sanofi","keywords":"Teriflunomide; Medicine; Internal medicine; Lymphocyte; Placebo; Multiple sclerosis; Clinical trial; Immunology; Gastroenterology; Pathology","score_opus":0.2252455712472101,"score_gpt":0.42345615740461867,"score_spread":0.19821058615740858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962487873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981863,0.00051275094,0.0000918478,0.00012939828,0.0002248858,0.0005319311,0.000040953106,0.000023841427,0.00025810054],"genre_scores_gemma":[0.98815113,0.010846936,0.00033253134,0.000067817266,0.00027952227,0.000018239214,0.000033491422,0.000025727928,0.00024461868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973139,0.00049791526,0.0011408667,0.00032088143,0.0004203019,0.0003061213],"domain_scores_gemma":[0.9975217,0.0009262276,0.0007264824,0.00027713904,0.00028734992,0.00026112056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024125164,0.00023093488,0.0016118316,0.0005015444,0.0001283353,0.000095304036,0.00007050287,0.00011657268,0.0005043746],"category_scores_gemma":[0.0010963471,0.00014764623,0.00048655627,0.0004325279,0.00014304202,0.0001913219,0.000046573372,0.00023465705,0.00003826587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001376612,0.00021057553,0.853904,0.000043575823,0.004669187,0.0000066027883,0.0001282956,0.000012386606,0.056142498,5.5238297e-7,0.000023243778,0.08348243],"study_design_scores_gemma":[0.009238524,0.000791503,0.9797553,0.0003630857,0.0026186702,0.000025593017,0.000032000098,0.0018739863,0.0048683304,3.1453146e-7,0.0002985698,0.00013411813],"about_ca_topic_score_codex":0.000083640545,"about_ca_topic_score_gemma":0.000056835488,"teacher_disagreement_score":0.12585127,"about_ca_system_score_codex":0.0001735913,"about_ca_system_score_gemma":0.00016160282,"threshold_uncertainty_score":0.60208386},"labels":[],"label_agreement":null},{"id":"W2962683137","doi":"10.1177/1352458519863133","title":"Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Hotchkiss Brain Institute","keywords":"Occludin; Tight junction; Multiple sclerosis; Intestinal permeability; Neuroinflammation; Blood–brain barrier; Barrier function; Internal medicine; Dysbiosis; Endocrinology; Enterocyte; Chemistry; Medicine; Immunology; Biology; Central nervous system; Disease; Small intestine; Biochemistry; Cell biology","score_opus":0.08007929884411687,"score_gpt":0.23184999914244667,"score_spread":0.15177070029832979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962683137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753183,0.00008348151,0.00070253276,0.00017246747,0.0008562301,0.00034455498,0.0000948972,0.000061035564,0.00015295211],"genre_scores_gemma":[0.99936575,0.000061581435,0.00011344724,0.00022469833,0.000081457416,0.000021876314,0.000002742756,0.000038905157,0.00008954592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740744,0.00036289057,0.0004817232,0.00054214074,0.00069681456,0.0005089738],"domain_scores_gemma":[0.9977081,0.0007591894,0.0006717738,0.0003181512,0.00022682296,0.00031600488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045181738,0.00032734763,0.00048200926,0.00035653394,0.00038797746,0.00011094207,0.00026203104,0.00010723187,0.00021605131],"category_scores_gemma":[0.0028399485,0.00025933495,0.00019464568,0.000876162,0.0002668196,0.00064208324,0.00010805471,0.00059278554,0.000023121896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020420502,0.0001659507,0.687662,0.00001763963,0.000054031127,0.000007608645,0.00014028866,0.00034582947,0.30665314,0.0000037313223,0.00018350138,0.0027242408],"study_design_scores_gemma":[0.004083739,0.0003045752,0.95854574,0.00056992774,0.00006081066,0.000011536386,0.0003017173,0.002421356,0.033275858,0.000037966016,0.00009015383,0.00029659443],"about_ca_topic_score_codex":0.000053872078,"about_ca_topic_score_gemma":0.00021946816,"teacher_disagreement_score":0.27337727,"about_ca_system_score_codex":0.0001892143,"about_ca_system_score_gemma":0.000112830545,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W2964398132","doi":"10.1177/1352458519867320","title":"Profiles of cortical inflammation in multiple sclerosis by <sup>11</sup> C-PBR28 MR-PET and 7 Tesla imaging","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; National Multiple Sclerosis Society; National Institute on Drug Abuse; U.S. Department of Defense","keywords":"Neuroinflammation; Multiple sclerosis; Lesion; Microglia; Cortex (anatomy); Inflammation; Pathology; Medicine; Cerebral cortex; Neuroscience; Internal medicine; Psychology; Immunology","score_opus":0.05690443575896179,"score_gpt":0.27756441131024523,"score_spread":0.22065997555128344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964398132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950302,0.0011295618,0.00016994252,0.001662902,0.0001495274,0.0014876998,0.00011749797,0.00007495213,0.00017770544],"genre_scores_gemma":[0.99294764,0.0023156193,0.003936112,0.00014303834,0.00026990878,0.00009365338,0.000054046806,0.00009581327,0.00014417301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946409,0.00044166646,0.0015802197,0.00074858597,0.0014472508,0.0011414147],"domain_scores_gemma":[0.9963827,0.0012917371,0.0005126205,0.00057740964,0.00063253316,0.0006029578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001835256,0.00055071345,0.0011954559,0.00072671653,0.00038015566,0.00020034358,0.0003595977,0.00016909892,0.00029135114],"category_scores_gemma":[0.003670619,0.00047804363,0.00029345698,0.0006702697,0.00054152496,0.0007621201,0.00037938805,0.0012655659,0.00006714072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035540006,0.00025731532,0.5834537,0.00019122595,0.0000866922,0.00001173688,0.00073101063,0.00018993329,0.40299398,0.000005993677,0.001533172,0.010189863],"study_design_scores_gemma":[0.012192914,0.00030033058,0.8555769,0.002015866,0.00007835342,0.00011576987,0.002001566,0.07913833,0.0474797,0.000015234848,0.0006417991,0.00044328504],"about_ca_topic_score_codex":0.0003649308,"about_ca_topic_score_gemma":0.00009508061,"teacher_disagreement_score":0.35551426,"about_ca_system_score_codex":0.00035357295,"about_ca_system_score_gemma":0.00018600172,"threshold_uncertainty_score":0.9997671},"labels":[],"label_agreement":null},{"id":"W2964883388","doi":"10.1177/1352458519866613","title":"Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Javna Agencija za Raziskovalno Dejavnost RS; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Age of onset; Young adult; Disease; Pediatrics; Internal medicine; Psychiatry","score_opus":0.05265890524238829,"score_gpt":0.2615956523236744,"score_spread":0.2089367470812861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964883388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326724,0.0014886776,0.000057375517,0.0007673077,0.00061051483,0.002331427,0.000067914676,0.00027233365,0.0011372034],"genre_scores_gemma":[0.9894504,0.004534806,0.004168131,0.00025482892,0.0002409309,0.00017680209,0.0000983099,0.00023115972,0.0008446219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921866,0.0005968763,0.0017786317,0.0013084755,0.002144898,0.0019845404],"domain_scores_gemma":[0.9944442,0.0015783416,0.0007388147,0.001194696,0.0007727907,0.0012711548],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016119733,0.0009655382,0.001693085,0.0013246799,0.00069760566,0.00038032926,0.00068352744,0.00049422204,0.001007261],"category_scores_gemma":[0.0040053343,0.00075731054,0.0005970856,0.0017392264,0.0008758285,0.001035962,0.00037946482,0.0026217022,0.00043213143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043617906,0.00115215,0.95174444,0.0001928815,0.0005018744,0.00032872867,0.0019090169,0.0005750567,0.027331663,0.0000037411369,0.0024645238,0.009434162],"study_design_scores_gemma":[0.029606642,0.0013253589,0.9447713,0.010996233,0.00015551197,0.0003580308,0.0023593327,0.0061171832,0.0030691489,0.000017357073,0.0003804969,0.00084344187],"about_ca_topic_score_codex":0.0016658047,"about_ca_topic_score_gemma":0.0032370486,"teacher_disagreement_score":0.025244853,"about_ca_system_score_codex":0.0008528821,"about_ca_system_score_gemma":0.00040655318,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2964973090","doi":"10.1177/1352458520985238","title":"Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Transplantation; Magnetic resonance imaging; Internal medicine; Hematopoietic stem cell transplantation; Stem cell; Disease; Surgery; Oncology; Radiology; Immunology","score_opus":0.07899143060625634,"score_gpt":0.2774198866422497,"score_spread":0.19842845603599335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964973090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303275,0.0028503411,0.0005890013,0.0013891311,0.00029448952,0.0014633089,0.00015187648,0.00012873,0.00010039204],"genre_scores_gemma":[0.9807495,0.016157221,0.001860919,0.0004098424,0.00020604114,0.00021079031,0.00014362877,0.00014185288,0.00012021957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416155,0.0004823846,0.0011699132,0.0009895263,0.0018963766,0.0013002582],"domain_scores_gemma":[0.99570316,0.0007849722,0.0006604959,0.0007244254,0.0011307627,0.000996185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058541755,0.0007095467,0.0011333614,0.0005668028,0.00091540226,0.00030213626,0.0003780486,0.00022853559,0.00026979676],"category_scores_gemma":[0.00065214036,0.00056273845,0.0004204205,0.0009789605,0.000288589,0.0005470664,0.00013651865,0.0012183851,0.00007677602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006022713,0.0026641767,0.9370645,0.00045417578,0.0002806987,0.00075290626,0.0022294861,0.0016289145,0.008317018,0.0000016138515,0.00020905369,0.040374737],"study_design_scores_gemma":[0.034912508,0.0009762915,0.9472696,0.0036078296,0.00015696445,0.00010680436,0.00052536436,0.002699972,0.009017365,0.000011214893,0.00013390573,0.00058215583],"about_ca_topic_score_codex":0.00015009644,"about_ca_topic_score_gemma":0.00042028574,"teacher_disagreement_score":0.039792582,"about_ca_system_score_codex":0.0005136848,"about_ca_system_score_gemma":0.0005277585,"threshold_uncertainty_score":0.9996824},"labels":[],"label_agreement":null},{"id":"W2970176706","doi":"10.1177/1352458519861267","title":"Beyond supervised therapy: Promoting behavioral changes in people with MS","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Behavior change; Psychological intervention; Randomized controlled trial; Rehabilitation; Behavior change methods; Intervention (counseling); Persuasion; Psychology; Physical medicine and rehabilitation; Medicine; Behaviour change; Physical therapy; Clinical psychology; Nursing; Social psychology","score_opus":0.2404851620463508,"score_gpt":0.37338002650246044,"score_spread":0.13289486445610965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970176706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03037734,0.9639422,0.000006005834,0.0003553848,0.00041499396,0.0044753742,0.00010762979,0.00009457908,0.0002264819],"genre_scores_gemma":[0.005804072,0.9907148,0.0011609057,0.000082522274,0.00095655664,0.00059806736,0.00014374508,0.00031874084,0.00022057789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935015,0.00065581914,0.0013876482,0.001056996,0.0017630914,0.0016349616],"domain_scores_gemma":[0.9965188,0.0005685392,0.0008360338,0.00092487136,0.00050213566,0.0006496354],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015936964,0.0011999995,0.004609029,0.0013402095,0.00041292794,0.00035265143,0.0007277118,0.000573862,0.0005567255],"category_scores_gemma":[0.00036640058,0.0007819495,0.00089876965,0.0013760015,0.00021562517,0.0002976628,0.00033673836,0.003199258,0.00012992795],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022950758,0.00094225287,0.04010536,0.0076503833,0.00055127847,0.00011464633,0.0013929817,0.0000019135643,0.0002731169,4.5590843e-7,0.00029606035,0.94844204],"study_design_scores_gemma":[0.02848748,0.0061146454,0.17866306,0.18565965,0.0025582542,0.0017805601,0.0009206592,0.00042466342,0.00018553427,0.0000035419002,0.5920154,0.0031865514],"about_ca_topic_score_codex":0.00034652345,"about_ca_topic_score_gemma":0.0023016015,"teacher_disagreement_score":0.9452555,"about_ca_system_score_codex":0.0009564426,"about_ca_system_score_gemma":0.0009999351,"threshold_uncertainty_score":0.99946314},"labels":[],"label_agreement":null},{"id":"W2972393403","doi":"10.1177/1352458519876701","title":"Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Clinical trial; Internal medicine; Logistic regression; Placebo; Oncology; Medicine; Psychology; Physical therapy; Immunology; Alternative medicine; Pathology","score_opus":0.5834111246289764,"score_gpt":0.5235805873865089,"score_spread":0.05983053724246745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972393403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963475,0.000583524,0.000055374643,0.0005387138,0.0006577587,0.0014193777,0.00031926233,0.000017108092,0.000061422834],"genre_scores_gemma":[0.9966733,0.0017359435,0.0008781994,0.00007725343,0.00050505844,0.000011530836,0.00004604862,0.00003297946,0.000039712784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99099404,0.0033266593,0.0027237928,0.0007274449,0.0015756906,0.00065236853],"domain_scores_gemma":[0.99310476,0.0030781238,0.0010693023,0.001811978,0.00038122016,0.0005545961],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02472841,0.0003659269,0.0026895246,0.0007914507,0.00020116092,0.00016509878,0.0009900944,0.0002231822,0.00043233068],"category_scores_gemma":[0.020099629,0.00020157549,0.0010641762,0.0012324742,0.00035760517,0.00050773914,0.0005851223,0.0013663893,0.000011108872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016069155,0.000820652,0.94212395,0.000025659976,0.002532609,0.0000054631564,0.00023975754,0.00027268328,0.0042459625,0.000001178697,0.0004064814,0.033256423],"study_design_scores_gemma":[0.059398353,0.0008142254,0.90174735,0.00019804548,0.0012363883,0.000014451323,0.0003389014,0.035664093,0.00007593876,0.0000053150325,0.00032438553,0.00018254526],"about_ca_topic_score_codex":0.0007464662,"about_ca_topic_score_gemma":0.0010782257,"teacher_disagreement_score":0.043329198,"about_ca_system_score_codex":0.00021293818,"about_ca_system_score_gemma":0.0003853707,"threshold_uncertainty_score":0.9881545},"labels":[],"label_agreement":null},{"id":"W2973206099","doi":"10.1177/1352458519876038","title":"Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver Coastal Health; University of Manitoba","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Myocardial infarction; Hazard ratio; Cohort; Internal medicine; Odds ratio; Population; Cohort study; Retrospective cohort study; Revascularization; Confidence interval; Confounding; Cardiology","score_opus":0.1842097792581606,"score_gpt":0.3525435107377221,"score_spread":0.16833373147956152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973206099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16593078,0.822502,0.000014753953,0.00011533158,0.00074049894,0.010367972,0.00013332511,0.00005742811,0.0001379009],"genre_scores_gemma":[0.21765387,0.7804218,0.0005062963,0.000029072291,0.00013069293,0.000947058,0.000039123108,0.00012929423,0.00014279736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915519,0.001080252,0.0031017237,0.0011657715,0.0019047174,0.0011956531],"domain_scores_gemma":[0.9960487,0.0012012267,0.0010829244,0.0009842898,0.00028466727,0.00039817853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003273019,0.0011135906,0.0064866603,0.0026120748,0.00022966949,0.00020485325,0.0005521737,0.00048664297,0.000057780515],"category_scores_gemma":[0.0013062818,0.00088612037,0.0012113993,0.0011843262,0.00034617874,0.00038917738,0.000871445,0.002200602,0.000036752772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022239072,0.0014070654,0.78811663,0.009519555,0.0026489503,0.000037865182,0.0004407888,0.000021544218,0.0000161121,0.0000016236253,0.00015546508,0.197412],"study_design_scores_gemma":[0.011418313,0.00040892008,0.9480518,0.031530507,0.0017578646,0.00003798806,0.0011625874,0.00011713502,0.0000018335764,0.000004055506,0.004873779,0.00063520984],"about_ca_topic_score_codex":0.0014960616,"about_ca_topic_score_gemma":0.0009107632,"teacher_disagreement_score":0.19677679,"about_ca_system_score_codex":0.0010781253,"about_ca_system_score_gemma":0.00024735692,"threshold_uncertainty_score":0.99935895},"labels":[],"label_agreement":null},{"id":"W2980722980","doi":"10.1177/1352458519877810","title":"The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Instituto de Salud Carlos III; Siemens; Agència de Gestió d'Ajuts Universitaris i de Recerca; European Committee for Treatment and Research in Multiple Sclerosis; Oryzon Genomics; Teva Pharmaceutical Industries; Red Española de Esclerosis Múltiple; Biogen; Celgene; European Regional Development Fund; Sanofi; F. Hoffmann-La Roche; Genzyme","keywords":"Medicine; Interquartile range; Hazard ratio; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Confidence interval; Internal medicine; Magnetic resonance imaging; Natural history; McDonald criteria; Lesion; Proportional hazards model; Cohort study; Surgery; Radiology; Psychiatry","score_opus":0.06686895839198086,"score_gpt":0.31560788350117713,"score_spread":0.24873892510919626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980722980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949037,0.00027173886,0.000053770535,0.0017482324,0.00050707656,0.002035573,0.000027471979,0.000013406056,0.00043907578],"genre_scores_gemma":[0.99625415,0.0023946753,0.00036367713,0.0004695394,0.00017741242,0.000079479236,0.000016123591,0.000040043422,0.00020489904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957673,0.00048406175,0.0009770625,0.00038828154,0.0016374334,0.0007458733],"domain_scores_gemma":[0.9964815,0.001268032,0.0006535309,0.00063898816,0.00071541953,0.00024257241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020142053,0.00031605654,0.00066615496,0.00028891885,0.00045192102,0.00016630469,0.0006611786,0.0001140656,0.00036002847],"category_scores_gemma":[0.0032103583,0.0001687695,0.0003158771,0.00053284486,0.00021169927,0.00023012147,0.00030281287,0.0008695195,0.00027234326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046616813,0.0003051373,0.9360815,0.000046207824,0.0002041783,0.0000059310037,0.0017181258,0.000037224498,0.004718173,9.669898e-7,0.0009946314,0.055421732],"study_design_scores_gemma":[0.004970735,0.00046912185,0.9914785,0.0010658768,0.000048139762,0.000012755286,0.0005772296,0.00013943396,0.00089432095,0.0000060108696,0.0001561752,0.00018169645],"about_ca_topic_score_codex":0.0002001,"about_ca_topic_score_gemma":0.000526922,"teacher_disagreement_score":0.055396978,"about_ca_system_score_codex":0.0003008081,"about_ca_system_score_gemma":0.0000908603,"threshold_uncertainty_score":0.68822205},"labels":[],"label_agreement":null},{"id":"W2980983689","doi":"10.1177/1352458519872895","title":"MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transverse myelitis; Medicine; Neuromyelitis optica; Myelitis; Pathology; Myelin oligodendrocyte glycoprotein; Cerebrospinal fluid; Immunology; Antibody; Spinal cord; Multiple sclerosis; Disease; Experimental autoimmune encephalomyelitis","score_opus":0.05262883973412667,"score_gpt":0.27972925782657765,"score_spread":0.22710041809245096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980983689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227905,0.0010467663,0.00009317787,0.002751848,0.00046175718,0.0015170156,0.00003036646,0.000080766964,0.0017392207],"genre_scores_gemma":[0.99586457,0.0005184784,0.0018592993,0.0006223627,0.0005550938,0.000102178725,0.00001751209,0.00008179691,0.00037870038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951321,0.0005212291,0.00093901675,0.00054705545,0.0016549786,0.001205633],"domain_scores_gemma":[0.99652386,0.0013312032,0.00043790322,0.00069561554,0.0006818718,0.00032952047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026291383,0.00044785286,0.0008261235,0.00039612412,0.00058292574,0.00033874038,0.0005408113,0.00014076801,0.00016290016],"category_scores_gemma":[0.0017311338,0.00027005322,0.00026057186,0.000644964,0.00019827964,0.00035773852,0.00018229893,0.0015702673,0.00019910379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063990935,0.00020938845,0.9412212,0.00040308313,0.00019867052,0.00020095611,0.005181336,0.00029529908,0.043427568,0.000021507627,0.001157321,0.0070438003],"study_design_scores_gemma":[0.012142562,0.000889057,0.94123256,0.006426156,0.000098351644,0.012762237,0.01882793,0.005293402,0.0009215304,0.0000084917565,0.00090713374,0.0004905677],"about_ca_topic_score_codex":0.00017679445,"about_ca_topic_score_gemma":0.00017133125,"teacher_disagreement_score":0.042506035,"about_ca_system_score_codex":0.0003950947,"about_ca_system_score_gemma":0.00024660752,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2981852969","doi":"10.1177/1352458519879094","title":"Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropsychology; Neuropsychological assessment; Cognition; Cognitive test; Reliability (semiconductor); Test (biology); Psychology; Neuropsychological test; Medicine; Psychometrics; Modalities; Clinical psychology; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.3668732935728513,"score_gpt":0.41753565496428635,"score_spread":0.05066236139143504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981852969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001707546,0.98356557,0.00019102251,0.00046811925,0.0011812635,0.01384404,0.00015469674,0.00020078357,0.00022374558],"genre_scores_gemma":[0.0013689402,0.99017483,0.0038434425,0.0013909192,0.00063929224,0.0019427217,0.00017040425,0.00032010008,0.00014932067],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9822682,0.0047440208,0.006031124,0.0019550251,0.0028971033,0.0021045308],"domain_scores_gemma":[0.9890468,0.0036308817,0.003174966,0.002230967,0.0007901737,0.0011261959],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0056897276,0.0020615626,0.014679497,0.0014915067,0.0005622399,0.0005956931,0.0019434914,0.00086074276,0.0003475491],"category_scores_gemma":[0.005518639,0.0013948779,0.0036207477,0.002035051,0.0003581632,0.00045770183,0.0010352518,0.0053146137,0.0007613313],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011196777,0.0011609134,0.0011719437,0.85773957,0.0014117475,0.00021833174,0.000057387424,0.0000044028448,0.000069606394,0.0000016429791,0.002730873,0.1353216],"study_design_scores_gemma":[0.006217556,0.0005588632,0.019196426,0.9098903,0.004616785,0.0009179693,0.000057778296,0.0005839463,7.5397725e-7,0.0000010846304,0.056795895,0.001162651],"about_ca_topic_score_codex":0.00004233957,"about_ca_topic_score_gemma":0.00004952383,"teacher_disagreement_score":0.13415894,"about_ca_system_score_codex":0.0016364934,"about_ca_system_score_gemma":0.0009989402,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W2983107219","doi":"10.1177/1352458519881761","title":"Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Center for Advancing Translational Sciences; Biogen","keywords":"Tolerability; Medicine; Dimethyl fumarate; Adverse effect; Discontinuation; Multiple sclerosis; Internal medicine; Relapsing remitting; Interim analysis; Clinical endpoint; Bioequivalence; Confidence interval; Phases of clinical research; Clinical trial; Gastroenterology; Pharmacokinetics; Immunology","score_opus":0.0795667792310148,"score_gpt":0.29880832560620435,"score_spread":0.21924154637518956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983107219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934898,0.00066458905,0.00007352209,0.00086235866,0.0005341969,0.003728879,0.00035714492,0.000105738145,0.00018376153],"genre_scores_gemma":[0.99656135,0.00091241335,0.0014275402,0.00025588993,0.00040654195,0.00005881502,0.0001207193,0.00014201968,0.00011474118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99252653,0.0009370024,0.0019751254,0.0013306735,0.0018984394,0.0013322269],"domain_scores_gemma":[0.9932554,0.003191268,0.0008837636,0.0012894382,0.00072918314,0.00065097865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002858842,0.0008194682,0.0014185709,0.00042322572,0.0010192553,0.0004893264,0.00068604614,0.00021916103,0.00015563678],"category_scores_gemma":[0.005183024,0.00052675506,0.0002702064,0.0008486724,0.0004194231,0.0007170264,0.0007084076,0.002262672,0.000092395734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024244651,0.0045132944,0.9151208,0.00003037841,0.00063126034,0.000017390137,0.0081003,0.00020950516,0.010924697,3.4093566e-7,0.00064173015,0.035565663],"study_design_scores_gemma":[0.1244188,0.002728756,0.8604944,0.0031438987,0.00016815908,0.000007214119,0.003964314,0.0038221518,0.00039471473,0.0000016112083,0.00034517326,0.0005108509],"about_ca_topic_score_codex":0.0011543893,"about_ca_topic_score_gemma":0.0008213473,"teacher_disagreement_score":0.10017415,"about_ca_system_score_codex":0.00058508315,"about_ca_system_score_gemma":0.00017396332,"threshold_uncertainty_score":0.9997184},"labels":[],"label_agreement":null},{"id":"W2983891338","doi":"10.1177/1352458519881759","title":"Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Regimen; Post-hoc analysis; Internal medicine; Relapsing remitting; Physical therapy; Transplantation; Psychiatry","score_opus":0.06957542812171856,"score_gpt":0.31114459657918003,"score_spread":0.24156916845746146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983891338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398303,0.0039129723,0.000004722246,0.0002054029,0.00033286895,0.0012160579,0.0002612717,0.000024543784,0.000059123682],"genre_scores_gemma":[0.9948254,0.00414428,0.00066156674,0.00007007529,0.0001203336,0.000019742734,0.00003489566,0.00007031641,0.000053362575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99453175,0.0005110037,0.0017126629,0.0006776712,0.0017525526,0.0008143834],"domain_scores_gemma":[0.99365234,0.0026683742,0.0011790019,0.0008346846,0.0013740514,0.00029154736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012921152,0.0004861318,0.0020579963,0.0012359828,0.00033712963,0.00006991138,0.0005119843,0.00024114223,0.000065591594],"category_scores_gemma":[0.005798002,0.00036222153,0.0008247201,0.0020664474,0.0006913331,0.000328065,0.00066535914,0.0010302515,0.000005161454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009601077,0.00035221557,0.9461668,0.00021566072,0.0030176628,0.0000016465838,0.008639264,0.0005283425,0.023301719,0.0000011620078,0.00019049016,0.016624942],"study_design_scores_gemma":[0.016811112,0.0006898023,0.9691455,0.003594275,0.0013748349,0.0000016044306,0.0042121713,0.00079966424,0.0030072923,0.0000017106297,0.000051894916,0.00031015815],"about_ca_topic_score_codex":0.0005787144,"about_ca_topic_score_gemma":0.00047128362,"teacher_disagreement_score":0.022978691,"about_ca_system_score_codex":0.0005516825,"about_ca_system_score_gemma":0.00018436418,"threshold_uncertainty_score":0.999883},"labels":[],"label_agreement":null},{"id":"W2989609353","doi":"10.1177/1352458519888610","title":"Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Relapsing remitting; Magnetic resonance imaging; Physical therapy; Internal medicine; Pediatrics; Surgery; Radiology; Psychiatry","score_opus":0.06075411837023619,"score_gpt":0.33638989736329816,"score_spread":0.27563577899306196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989609353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942702,0.0031294683,0.0000049094338,0.00065760553,0.00037441083,0.00092567276,0.00052160403,0.000011377344,0.00010475652],"genre_scores_gemma":[0.99709857,0.001994328,0.00032648267,0.0001988394,0.00019507763,0.000051346702,0.00005734281,0.000033082135,0.0000449271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957768,0.000601926,0.001189284,0.00045388946,0.0014599942,0.0005181091],"domain_scores_gemma":[0.9938451,0.0026658946,0.0008016622,0.0005831574,0.0019486637,0.00015550943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010751054,0.00033677003,0.0011795955,0.00054020394,0.00038752265,0.000053387786,0.00032651544,0.00010478833,0.00045603572],"category_scores_gemma":[0.006030874,0.00019510892,0.00050548353,0.0010590708,0.00079191366,0.00020326966,0.000395197,0.00078181206,0.000003821591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018275154,0.00042895562,0.9725924,0.00010699954,0.0029135572,0.0000040922887,0.0066735344,0.0010471974,0.004714631,0.0000018889218,0.0019346386,0.0077545536],"study_design_scores_gemma":[0.009334115,0.0002669539,0.97832614,0.0029108683,0.0013127812,0.000008191696,0.004974301,0.0015794609,0.00093183655,0.0000057970537,0.00016652883,0.00018305123],"about_ca_topic_score_codex":0.00018668498,"about_ca_topic_score_gemma":0.00055652583,"teacher_disagreement_score":0.007571502,"about_ca_system_score_codex":0.00028062792,"about_ca_system_score_gemma":0.00020904282,"threshold_uncertainty_score":0.7956311},"labels":[],"label_agreement":null},{"id":"W2989646803","doi":"10.1177/1352458519886070","title":"Trigeminal neuralgia associated with multiple sclerosis: A multimodal assessment of brainstem plaques and response to Gamma Knife radiosurgery","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Multiple Sclerosis Society","keywords":"Medicine; Trigeminal neuralgia; Fractional anisotropy; Fluid-attenuated inversion recovery; Brainstem; Radiosurgery; Trigeminal nerve; Diffusion MRI; Multiple sclerosis; Nuclear medicine; Tractography; Radiology; Surgery; Magnetic resonance imaging; Internal medicine; Radiation therapy","score_opus":0.0485729125166182,"score_gpt":0.2690953399081118,"score_spread":0.22052242739149358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989646803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970703,0.00027988254,0.00010471816,0.00071700086,0.0002958553,0.0012233618,0.000115651135,0.00009401886,0.000099202436],"genre_scores_gemma":[0.99531865,0.00013375208,0.0033867138,0.00021821441,0.00009964476,0.000051024097,0.000029767982,0.000094855546,0.0006673852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959883,0.0005044834,0.0009970849,0.0006555739,0.0010711858,0.0007833789],"domain_scores_gemma":[0.99591714,0.0016583536,0.0006496678,0.0004819055,0.00044800746,0.00084489526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001191808,0.0005538978,0.0012079441,0.00061586616,0.00028033621,0.00014344802,0.00021631925,0.00022038512,0.00017553089],"category_scores_gemma":[0.0010095494,0.0004183424,0.000324329,0.00057869643,0.0001515152,0.00037764484,0.00010291549,0.0006846534,0.000024452624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009325842,0.0007978914,0.7486706,0.00007072164,0.00049092213,0.00013272036,0.0005247476,0.000094516465,0.23469156,0.000001616709,0.00042854066,0.0047703166],"study_design_scores_gemma":[0.018709365,0.003384931,0.9562025,0.0028247952,0.00031891992,0.0005561194,0.00043158833,0.0028227807,0.014204303,0.0000016556203,0.00013870178,0.00040435954],"about_ca_topic_score_codex":0.000079480524,"about_ca_topic_score_gemma":0.00003230219,"teacher_disagreement_score":0.22048725,"about_ca_system_score_codex":0.0004797036,"about_ca_system_score_gemma":0.0003875705,"threshold_uncertainty_score":0.99982685},"labels":[],"label_agreement":null},{"id":"W2991623378","doi":"10.1177/1352458519892555","title":"Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Observational study; Standardization; Real world data; Clinical trial; Harmonization; Disease; Multiple sclerosis; Medicine; MEDLINE; Randomized controlled trial; Data science; Scope (computer science); Medical physics; Computer science; Pathology; Psychiatry","score_opus":0.5877955149699188,"score_gpt":0.4225676752915705,"score_spread":0.16522783967834825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991623378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015065889,0.9710877,0.000024979303,0.0010284284,0.0009191127,0.009094268,0.0023809595,0.00028228408,0.00011636895],"genre_scores_gemma":[0.009845318,0.9786885,0.0055140937,0.00025608967,0.0014907337,0.0016953027,0.0011774121,0.00046818802,0.00086438895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98958063,0.00092781463,0.002485359,0.002755404,0.0020698258,0.0021809938],"domain_scores_gemma":[0.9890726,0.0015627262,0.0012809057,0.0033186122,0.0005517649,0.004213356],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0017348501,0.0019963083,0.005287288,0.0019953742,0.0012061606,0.0010089532,0.0016568808,0.00033851663,0.00017704132],"category_scores_gemma":[0.0028759483,0.0015431399,0.001249753,0.0016472868,0.00065472897,0.00069912936,0.00261822,0.0019695088,0.00037060102],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027431673,0.0009936105,0.10334882,0.0049178773,0.0014455846,0.00014006009,0.00028810464,0.0000067634305,0.0002023264,0.0000011177424,0.0066786255,0.8817028],"study_design_scores_gemma":[0.0053334893,0.00069632597,0.30798373,0.05287477,0.0069554546,0.000110182205,0.00012354445,0.00053435715,0.00003300557,8.8861566e-7,0.62381005,0.001544196],"about_ca_topic_score_codex":0.0012344106,"about_ca_topic_score_gemma":0.0012119662,"teacher_disagreement_score":0.8801586,"about_ca_system_score_codex":0.0019387475,"about_ca_system_score_gemma":0.0017690329,"threshold_uncertainty_score":0.99927795},"labels":[],"label_agreement":null},{"id":"W2994697016","doi":"10.1177/1352458519892914","title":"CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Imatinib; Medicine; Multiple sclerosis; Tyrosine-kinase inhibitor; Myelin oligodendrocyte glycoprotein; Optic neuritis; Tyrosine kinase; Oligodendrocyte; Magnetic resonance imaging; Central nervous system; Pathology; Myelin; Immunology; Internal medicine; Radiology; Experimental autoimmune encephalomyelitis; Cancer; Receptor","score_opus":0.04754278601143761,"score_gpt":0.2807703694467234,"score_spread":0.2332275834352858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994697016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717146,0.00047672747,0.00017273794,0.0009809938,0.0004976008,0.00028636723,0.000012687367,0.00002342787,0.00037800803],"genre_scores_gemma":[0.9970454,0.000092591945,0.0015846902,0.0007555149,0.0003568691,0.000014909935,0.0000075022544,0.000028146598,0.0001143946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984582,0.000094463314,0.00062653504,0.00017662055,0.00040752202,0.00023667586],"domain_scores_gemma":[0.9987399,0.000185202,0.0004129068,0.00026053443,0.0002882124,0.000113246984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005065567,0.000149704,0.0002761985,0.00008621741,0.00014762535,0.000053663334,0.000084306965,0.000048157257,0.00036955118],"category_scores_gemma":[0.000999536,0.00009733433,0.00018987372,0.00019319139,0.000072976225,0.00019435369,0.000055709304,0.00033886256,0.000016520955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085224747,0.00041135654,0.66932076,0.00014048656,0.000071273345,0.0007499796,0.0011661453,0.00029265205,0.30946797,0.000013524489,0.0017693223,0.015744252],"study_design_scores_gemma":[0.010966011,0.0010940768,0.9359884,0.0016014557,0.00020312407,0.0061624483,0.0020491707,0.007983274,0.031411383,0.0000871923,0.0020673596,0.00038607104],"about_ca_topic_score_codex":0.00007977679,"about_ca_topic_score_gemma":0.00005888318,"teacher_disagreement_score":0.2780566,"about_ca_system_score_codex":0.000044405366,"about_ca_system_score_gemma":0.00008296558,"threshold_uncertainty_score":0.40463263},"labels":[],"label_agreement":null},{"id":"W2995945588","doi":"10.1177/1352458519895450","title":"Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Differential item functioning; Polytomous Rasch model; German; Logistic regression; Multiple sclerosis; Item response theory; Psychology; Medicine; Psychometrics; Clinical psychology; Linguistics; Psychiatry; Internal medicine","score_opus":0.052022623413905754,"score_gpt":0.2788268553317233,"score_spread":0.22680423191781754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995945588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951633,0.00091027096,0.00015648808,0.00050914224,0.0010505192,0.002027624,0.000044701366,0.000057499466,0.00008041904],"genre_scores_gemma":[0.99854136,0.0005129272,0.00009024627,0.00012244016,0.00026375253,0.0001410489,0.000014913796,0.000071006536,0.00024228453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99500734,0.0006479103,0.0013097007,0.0006257275,0.0015750502,0.0008342973],"domain_scores_gemma":[0.9974851,0.00066547113,0.000531589,0.0006575469,0.00042774284,0.00023253911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012328024,0.00046432295,0.0009548316,0.0006229065,0.00042590252,0.00016159759,0.00041382556,0.0002094852,0.00048485698],"category_scores_gemma":[0.0020945426,0.00034075647,0.0003400383,0.0010526008,0.00025118736,0.00045960015,0.00031693772,0.0014059318,0.000046769044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014026106,0.0017885102,0.8437798,0.00011870778,0.00017465335,0.0000048254847,0.002748336,0.00040551965,0.14373271,0.0000021694852,0.00057450647,0.00526766],"study_design_scores_gemma":[0.015598566,0.00086395256,0.9639275,0.002211612,0.00009051522,0.000013100024,0.0057663852,0.0044210483,0.00668507,0.0000043308787,0.0001252554,0.00029266957],"about_ca_topic_score_codex":0.001735363,"about_ca_topic_score_gemma":0.0045185876,"teacher_disagreement_score":0.13704765,"about_ca_system_score_codex":0.0006941643,"about_ca_system_score_gemma":0.00019114195,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W2996608443","doi":"10.1177/1352458519895985","title":"Neighbourhood environments and the risk of hospital admission for cardiometabolic and mental health comorbidities in multiple sclerosis: A population cohort analysis using linked administrative data","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of New Brunswick","funders":"Diabetes Canada; Fondation de la recherche en santé du Nouveau-Brunswick","keywords":"Neighbourhood (mathematics); Medicine; Confidence interval; Ethnically diverse; Cohort; Proportional hazards model; Mental health; Cohort study; Demography; Population; Environmental health; Gerontology; Internal medicine; Psychiatry","score_opus":0.135644812071875,"score_gpt":0.3398744522146869,"score_spread":0.20422964014281186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996608443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990693,0.0036204928,0.00059317646,0.00078262715,0.0001842158,0.0029746203,0.0011335941,0.000011928588,0.0000063713405],"genre_scores_gemma":[0.9772733,0.017964974,0.0041600675,0.000055145447,0.00013921244,0.000058456728,0.0002966699,0.000038451795,0.000013710144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961885,0.0006525408,0.0010617233,0.00065013254,0.0008803406,0.00056671223],"domain_scores_gemma":[0.99714047,0.0008244771,0.0008838115,0.0006716988,0.000113539616,0.0003660153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029108992,0.000357874,0.0014744328,0.0005593011,0.00065535336,0.00012711293,0.00029275307,0.000120496785,0.000031306197],"category_scores_gemma":[0.0015438717,0.00025118986,0.00029897538,0.00055882055,0.00042980316,0.00047041333,0.00044682992,0.0005429874,8.8770804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012561986,0.00029947594,0.9817371,0.000090177025,0.0022027718,5.993662e-7,0.0021942055,0.000281347,0.004556417,0.0000035755595,0.000052703166,0.007325464],"study_design_scores_gemma":[0.015190371,0.0004589167,0.87207013,0.00042289105,0.0007087064,0.000007951967,0.0030771184,0.107627235,0.00018111571,0.000008800763,0.000050108792,0.00019662935],"about_ca_topic_score_codex":0.0022822248,"about_ca_topic_score_gemma":0.00047385227,"teacher_disagreement_score":0.10966691,"about_ca_system_score_codex":0.00025654116,"about_ca_system_score_gemma":0.00013302038,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W2998946058","doi":"10.1177/1352458519898591","title":"New applications for independent activities of daily living in measuring disability in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Activities of daily living; Expanded Disability Status Scale; Psychology; Scale (ratio); Rehabilitation; Physical therapy; Medicine; Gerontology; Physical medicine and rehabilitation; Multiple sclerosis; Psychiatry","score_opus":0.22564459639587997,"score_gpt":0.315331861443545,"score_spread":0.08968726504766505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998946058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181295,0.000690661,0.012299748,0.0022680063,0.000113829294,0.0025726787,0.00008325482,0.000064832406,0.00009401129],"genre_scores_gemma":[0.9855367,0.00091100734,0.012333687,0.00013903367,0.0005110145,0.00046526353,0.000008830079,0.000071364804,0.000023080733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956749,0.00025866245,0.0013929479,0.0006946816,0.0010793175,0.00089946465],"domain_scores_gemma":[0.99608845,0.0020499197,0.00041834667,0.00046230492,0.0002748966,0.0007061061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015687466,0.00040549584,0.0010919799,0.00036773566,0.0002953079,0.00010958034,0.00048018014,0.00019383074,0.00011219895],"category_scores_gemma":[0.0052756583,0.00038668019,0.00043245385,0.0008901812,0.0002725649,0.0005078192,0.0003440795,0.001047763,0.000007503443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071762956,0.0006452487,0.7615745,0.00036322212,0.00010580257,0.000001878239,0.0037237396,0.0007142877,0.18210937,0.000005080331,0.00025308947,0.04978612],"study_design_scores_gemma":[0.00789699,0.0002827309,0.9624809,0.001357969,0.000046842677,0.0000061824667,0.0036170466,0.0074023074,0.016345987,0.000023006754,0.00022696592,0.0003130606],"about_ca_topic_score_codex":0.00088646857,"about_ca_topic_score_gemma":0.0027452684,"teacher_disagreement_score":0.20090638,"about_ca_system_score_codex":0.0007206144,"about_ca_system_score_gemma":0.0003452213,"threshold_uncertainty_score":0.9998585},"labels":[],"label_agreement":null},{"id":"W3000484916","doi":"10.1177/1352458519898340","title":"World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Ocrelizumab; Alternative medicine; Public health; Family medicine; Disease; Nursing; Psychiatry; Pathology","score_opus":0.11990439016570688,"score_gpt":0.31856710071957195,"score_spread":0.19866271055386509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000484916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70622444,0.009217881,0.059957318,0.21822485,0.0010932994,0.0037918289,0.00023643972,0.0010241476,0.00022979722],"genre_scores_gemma":[0.97835976,0.0071191727,0.004450918,0.0066232258,0.0028832105,0.000113597394,0.00019780076,0.00017387049,0.000078445744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945085,0.00039011863,0.0013040698,0.0009041541,0.0017990128,0.0010941155],"domain_scores_gemma":[0.99500585,0.00057107245,0.000725016,0.0005938515,0.0010629196,0.0020413199],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0009245219,0.000592782,0.0010046232,0.00050295074,0.0016190101,0.00035994322,0.00053050974,0.00012782679,0.00069849927],"category_scores_gemma":[0.0044834246,0.000513846,0.00036444125,0.0020044087,0.00037965085,0.0005707979,0.0003103059,0.0010554972,0.00013494246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013255994,0.00076525786,0.5954617,0.000661708,0.00062404893,0.000022279328,0.0068000485,0.0005375202,0.28229526,0.000031865162,0.032483533,0.078991145],"study_design_scores_gemma":[0.011047518,0.00042487605,0.935625,0.0014813924,0.00022409449,0.000030568874,0.0019314155,0.028163798,0.010172153,0.000027126072,0.01016913,0.0007029318],"about_ca_topic_score_codex":0.00022631379,"about_ca_topic_score_gemma":0.00032242315,"teacher_disagreement_score":0.34016326,"about_ca_system_score_codex":0.00046319672,"about_ca_system_score_gemma":0.0004954066,"threshold_uncertainty_score":0.9997313},"labels":[],"label_agreement":null},{"id":"W3000974005","doi":"10.1177/1352458519881558","title":"A roadmap to precision medicine for multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"U.S. Department of Defense","keywords":"Multiple sclerosis; Precision medicine; Disease; Medicine; Clinical phenotype; Intensive care medicine; MEDLINE; Phenotype; Pathology; Psychiatry; Biology","score_opus":0.382301072029657,"score_gpt":0.40815659315791053,"score_spread":0.02585552112825351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000974005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087006556,0.97707206,0.00456221,0.0043713325,0.0019016955,0.010627468,0.00079237315,0.00032783553,0.00025799274],"genre_scores_gemma":[0.00069191505,0.96933204,0.0185087,0.00087602116,0.0068686386,0.002235795,0.00030254372,0.0006026348,0.00058171456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874338,0.00081419345,0.0039965184,0.002258817,0.0030754367,0.0024212485],"domain_scores_gemma":[0.98610944,0.0051645283,0.0016302966,0.0016193325,0.0017546273,0.003721772],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030570333,0.0021491528,0.008579645,0.0019520472,0.0014472752,0.00042465137,0.001765849,0.001016106,0.0006002995],"category_scores_gemma":[0.029310152,0.0015414521,0.0034519944,0.0023123492,0.00047078394,0.00038179464,0.001116933,0.0031596369,0.0007423903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000826722,0.0003773344,0.00023338837,0.0082046185,0.0014991544,0.00004373577,0.00060804206,0.00000838313,0.0011035332,0.000003146912,0.097553834,0.8895381],"study_design_scores_gemma":[0.008738902,0.002317661,0.0019849436,0.087458774,0.0024104982,0.0002754072,0.00021365653,0.0005224538,0.00005901599,0.000010025459,0.8948004,0.0012082175],"about_ca_topic_score_codex":0.00011096523,"about_ca_topic_score_gemma":0.00009884349,"teacher_disagreement_score":0.88832986,"about_ca_system_score_codex":0.0017959629,"about_ca_system_score_gemma":0.0011917707,"threshold_uncertainty_score":0.9998527},"labels":[],"label_agreement":null},{"id":"W3001018322","doi":"10.1177/1352458519898108","title":"Recovery of cognitive function after relapse in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Mallinckrodt Pharmaceuticals","keywords":"Multiple sclerosis; Cognition; Expanded Disability Status Scale; Psychology; Verbal memory; Medicine; Paced Auditory Serial Addition Test; Audiology; Cognitive impairment; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.13872051101130903,"score_gpt":0.2850871877057934,"score_spread":0.14636667669448436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001018322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923436,0.0020092071,0.0013230068,0.0022347416,0.00040318328,0.0010605982,0.00015586505,0.00008382298,0.0003859487],"genre_scores_gemma":[0.99191254,0.0041841394,0.0017037239,0.0012183544,0.00063751277,0.00015076742,0.000031816482,0.000096250405,0.000064896725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995272,0.00039353265,0.0013970941,0.00071713555,0.0012932668,0.0009270191],"domain_scores_gemma":[0.9962923,0.001241182,0.0004896965,0.00034623683,0.0008136656,0.00081694924],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009661293,0.00049395015,0.0011172515,0.00058890315,0.00026570723,0.00010101331,0.00026909556,0.0002738578,0.00074634864],"category_scores_gemma":[0.008982457,0.00044070111,0.00059842237,0.001147668,0.0003757247,0.00062975945,0.00029180772,0.0014802066,0.00016008371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016142154,0.00095276005,0.73656285,0.00025400554,0.00059953827,0.00007583586,0.0027234913,0.0001769363,0.17980435,0.0000015760249,0.002715275,0.059991207],"study_design_scores_gemma":[0.015175959,0.0016561222,0.9642646,0.0029026826,0.0002269177,0.000027894623,0.0017637732,0.002943604,0.010282704,0.000015454712,0.00034461968,0.00039569117],"about_ca_topic_score_codex":0.00016419074,"about_ca_topic_score_gemma":0.00022252242,"teacher_disagreement_score":0.22770171,"about_ca_system_score_codex":0.0002724021,"about_ca_system_score_gemma":0.00023060488,"threshold_uncertainty_score":0.9998045},"labels":[],"label_agreement":null},{"id":"W3002308644","doi":"10.1177/1352458519899040","title":"A critical analysis of helminth immunotherapy in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of British Columbia; Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Immunology; Immunotherapy; Helminths; Population; Helminth infections; Helminthiasis; Immune system; Medicine; Biology; Environmental health","score_opus":0.10892685066362992,"score_gpt":0.3036617548643474,"score_spread":0.19473490420071746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002308644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924396,0.0024886006,0.002445054,0.0015997547,0.00047447084,0.00013428633,0.00019479761,0.00003618096,0.00018720776],"genre_scores_gemma":[0.99779254,0.0006623994,0.0007492257,0.00060897024,0.00006171343,0.000014568861,0.00003993932,0.000023426197,0.000047236663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797064,0.0002957566,0.0008359742,0.00032302822,0.0000959645,0.0004786192],"domain_scores_gemma":[0.9983896,0.00081121846,0.0002516295,0.0002378915,0.00020999167,0.000099637444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003054268,0.00023139958,0.00071619794,0.00054131553,0.0002755953,0.0000648652,0.00036849343,0.00021090731,0.002878148],"category_scores_gemma":[0.00094761286,0.00021226425,0.0005746736,0.0010500703,0.00023965086,0.0002781051,0.00007061315,0.00074594433,0.0001800663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004999529,0.00036771843,0.2546965,0.0000066818448,0.0011980074,0.000004098002,0.0014955353,0.0004669121,0.7348437,0.000042917585,0.0007597149,0.005618319],"study_design_scores_gemma":[0.0037970245,0.0003157547,0.93233246,0.0001370165,0.0004470513,0.00002885828,0.0008918737,0.0032230061,0.055494614,0.000016983464,0.0030067116,0.0003086461],"about_ca_topic_score_codex":0.00040260618,"about_ca_topic_score_gemma":0.00033195387,"teacher_disagreement_score":0.67934906,"about_ca_system_score_codex":0.00007686588,"about_ca_system_score_gemma":0.000054148048,"threshold_uncertainty_score":0.99803334},"labels":[],"label_agreement":null},{"id":"W3002601601","doi":"10.1177/1352458519871817","title":"New imaging approaches for precision diagnosis and disease staging of MS?","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Clinical Practice; Disease; Radiology; Pathology; Physical therapy","score_opus":0.3218536051451092,"score_gpt":0.37672179464467476,"score_spread":0.05486818949956557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002601601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058684836,0.98938864,0.005522428,0.0012094043,0.00024632996,0.0031273677,0.00035809833,0.000051852923,0.000037191665],"genre_scores_gemma":[0.00083314534,0.979305,0.017836014,0.00005636346,0.0012318727,0.00042667036,0.000072697985,0.00017088796,0.0000673134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553996,0.00028908436,0.0015344651,0.00084514933,0.0010338489,0.0007575167],"domain_scores_gemma":[0.9940868,0.0020540932,0.0009806792,0.00050910155,0.0003124084,0.0020568962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009753224,0.00075594685,0.0031696567,0.0005923093,0.0004107862,0.00023765049,0.00043210766,0.0001655537,0.00008526279],"category_scores_gemma":[0.008049316,0.00056474446,0.001386905,0.00046053756,0.00020991042,0.00028248673,0.00051731954,0.001049077,0.00000771734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022720588,0.00014625954,0.008261642,0.016573736,0.0006161804,0.000017738705,0.00022357899,0.000003269022,0.000015001432,0.0000051670445,0.0094471425,0.96446306],"study_design_scores_gemma":[0.0041926303,0.00024225544,0.01076994,0.067845866,0.0030573045,0.00006004152,0.00016186824,0.0018151513,0.000022642329,0.000053056603,0.9111311,0.0006481716],"about_ca_topic_score_codex":0.000029383233,"about_ca_topic_score_gemma":0.0000040381888,"teacher_disagreement_score":0.9638149,"about_ca_system_score_codex":0.0003026329,"about_ca_system_score_gemma":0.0011280009,"threshold_uncertainty_score":0.9996804},"labels":[],"label_agreement":null},{"id":"W3002970851","doi":"10.1177/1352458519887324","title":"Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Physical therapy; Clinically isolated syndrome; Intensive care medicine; Pediatrics; Internal medicine; Psychiatry","score_opus":0.272236738966037,"score_gpt":0.3963751725921657,"score_spread":0.1241384336261287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002970851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026601253,0.97082263,0.00033230952,0.0128387865,0.0016910803,0.013288984,0.00029161648,0.00009519791,0.00037336876],"genre_scores_gemma":[0.010263458,0.9796947,0.00086983875,0.0008999101,0.004051101,0.003616835,0.000120652716,0.0002492454,0.00023422406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871105,0.002911387,0.0038744297,0.0014477021,0.0027869225,0.0018690566],"domain_scores_gemma":[0.96348214,0.031050704,0.0021984486,0.0018704529,0.0007851475,0.0006131336],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0062621157,0.0016867102,0.0044988682,0.0005757217,0.003704037,0.00051272515,0.002263599,0.00059325976,0.0005087354],"category_scores_gemma":[0.014185121,0.0006149205,0.0028597813,0.002010699,0.0008846902,0.00024306387,0.0005322681,0.0038714556,0.0001423634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004972983,0.00067587395,0.00047767864,0.0011815599,0.0016568825,0.000043773485,0.0039638956,0.000016293683,0.000067136374,0.000004163824,0.032933448,0.95848197],"study_design_scores_gemma":[0.007652505,0.0024914965,0.0045869336,0.023548305,0.0030004417,0.00030914097,0.0015686904,0.0016242524,0.000048176826,0.00001611397,0.95452946,0.0006244685],"about_ca_topic_score_codex":0.00032676666,"about_ca_topic_score_gemma":0.0008072916,"teacher_disagreement_score":0.95785755,"about_ca_system_score_codex":0.0017321748,"about_ca_system_score_gemma":0.00085114554,"threshold_uncertainty_score":0.9996302},"labels":[],"label_agreement":null},{"id":"W3003152238","doi":"10.1177/1352458519888178","title":"Biosensors to monitor MS activity","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Wearable computer; Relevance (law); Biosensor; Reliability (semiconductor); Multiple sclerosis; Computer science; Wireless; Accelerometer; Medicine; Telecommunications; Nanotechnology; Embedded system; Psychiatry","score_opus":0.2543470391733045,"score_gpt":0.39229217857652643,"score_spread":0.13794513940322195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003152238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066383125,0.9925902,0.00013333428,0.001697222,0.0011416966,0.0028982859,0.00029080792,0.00021052227,0.0003740954],"genre_scores_gemma":[0.0016226158,0.98958147,0.0034567353,0.00021693447,0.00417998,0.00026000908,0.000024942372,0.00028419268,0.00037314973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99341303,0.0006916703,0.0014157965,0.0011446214,0.0018953705,0.0014395395],"domain_scores_gemma":[0.9943112,0.0009254055,0.0007373698,0.00091907376,0.00054466195,0.0025622577],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008880804,0.0012217233,0.0048556277,0.0009832208,0.0007194119,0.00039834983,0.0008315439,0.0005830021,0.0003777311],"category_scores_gemma":[0.0049412996,0.000908297,0.0023135499,0.0014935703,0.00021183907,0.00022654704,0.00074984506,0.0034849932,0.0019243835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018168149,0.00028390094,0.00014290317,0.004600079,0.0011576959,0.00017542904,0.00017048145,0.0000018034309,0.0008271243,4.473199e-7,0.016584424,0.975874],"study_design_scores_gemma":[0.0016284841,0.00054442754,0.004712066,0.026020793,0.001040199,0.00038858948,0.00004964183,0.000055514876,0.00016272951,6.650675e-7,0.9646307,0.0007661723],"about_ca_topic_score_codex":0.000061800114,"about_ca_topic_score_gemma":0.000017303995,"teacher_disagreement_score":0.97510785,"about_ca_system_score_codex":0.0012913656,"about_ca_system_score_gemma":0.00064146775,"threshold_uncertainty_score":0.9993368},"labels":[],"label_agreement":null},{"id":"W3005471950","doi":"10.1177/1352458519900961","title":"Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Microscopic Colitis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Teriflunomide; Medicine; Adverse effect; Multiple sclerosis; Internal medicine; Gastroenterology; Dermatology; Immunology","score_opus":0.15090907807652312,"score_gpt":0.2765302207836492,"score_spread":0.12562114270712607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005471950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925743,0.00035332204,0.002064635,0.0033733544,0.00028268207,0.001143532,0.00012295159,0.000037844555,0.00004740731],"genre_scores_gemma":[0.98187625,0.00026982816,0.014731127,0.0024922502,0.00046256132,0.00006223899,0.00001843021,0.00006113459,0.000026148755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972349,0.00022554693,0.0010628972,0.00037678663,0.0004579162,0.00064194837],"domain_scores_gemma":[0.99731886,0.0013328063,0.00043555288,0.0003592857,0.0002501313,0.0003033689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008900143,0.0002772966,0.00065492064,0.00017415425,0.00029431903,0.00019617286,0.00034639746,0.00014647807,0.0000833385],"category_scores_gemma":[0.0038529283,0.00022768114,0.00035521036,0.00046169554,0.00011932641,0.00032459223,0.000097652875,0.00049759593,0.000009518331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016404758,0.00019094649,0.56719315,0.00034617804,0.000099796256,0.000034631907,0.008790026,0.0002430368,0.4022595,0.000020269177,0.0041431105,0.015038893],"study_design_scores_gemma":[0.01349856,0.00044571364,0.95011485,0.0019962888,0.00014446164,0.00022051617,0.0015223866,0.016615385,0.0131185,0.000021139485,0.0020447816,0.0002574235],"about_ca_topic_score_codex":0.00064808433,"about_ca_topic_score_gemma":0.00038977517,"teacher_disagreement_score":0.389141,"about_ca_system_score_codex":0.0005424572,"about_ca_system_score_gemma":0.00037031807,"threshold_uncertainty_score":0.9284568},"labels":[],"label_agreement":null},{"id":"W3006847841","doi":"10.1177/1352458520910360","title":"Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Ottawa","funders":"","keywords":"General partnership; Scope (computer science); Terminology; Multiple sclerosis; Quality (philosophy); Thematic analysis; Process (computing); Medicine; Public relations; Psychology; Qualitative research; Medical education; Political science; Computer science; Sociology","score_opus":0.6474070569278462,"score_gpt":0.4671535757464389,"score_spread":0.18025348118140727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006847841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93521035,0.0023171864,0.0022562048,0.05150025,0.00043353793,0.0075273896,0.00022619673,0.0001492127,0.00037969887],"genre_scores_gemma":[0.9745356,0.0069637564,0.015102907,0.0008762776,0.0009020597,0.0013053901,0.00003701184,0.00018521652,0.00009177533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9868907,0.0021867198,0.0019903446,0.0013081294,0.0042441054,0.0033800101],"domain_scores_gemma":[0.9834633,0.009466466,0.0004107176,0.0008250913,0.004484081,0.0013503616],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015008966,0.00063811085,0.0013081516,0.0014786593,0.0037765615,0.0006929585,0.0012609881,0.00027309803,0.00012179243],"category_scores_gemma":[0.022572003,0.0004962309,0.0004935407,0.00347677,0.0014268932,0.0005938742,0.0013154754,0.004270839,0.00016161577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015606342,0.0017553798,0.43142614,0.0022669842,0.0014105715,0.00034438277,0.028833542,0.0014410611,0.22800742,0.00013789252,0.0845093,0.204261],"study_design_scores_gemma":[0.044888843,0.002479783,0.76059103,0.0116114225,0.00016507358,0.00007595926,0.041047078,0.066435136,0.047674593,0.00074990804,0.022737835,0.001543364],"about_ca_topic_score_codex":0.00039027474,"about_ca_topic_score_gemma":0.00039965403,"teacher_disagreement_score":0.32916486,"about_ca_system_score_codex":0.0016863636,"about_ca_system_score_gemma":0.0013710597,"threshold_uncertainty_score":0.99974895},"labels":[],"label_agreement":null},{"id":"W3007003980","doi":"10.1177/1352458520908037","title":"Concussion in adolescence and the risk of multiple sclerosis: A retrospective cohort study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Institute for Clinical Evaluative Sciences; Lawson Health Research Institute; London Health Sciences Centre","funders":"Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Roche Canada","keywords":"Concussion; Medicine; Retrospective cohort study; Multiple sclerosis; Hazard ratio; Emergency department; Poison control; Young adult; Injury prevention; Cohort; Cohort study; Physical therapy; Pediatrics; Internal medicine; Emergency medicine; Confidence interval; Psychiatry","score_opus":0.07583156032293883,"score_gpt":0.28721318304441756,"score_spread":0.21138162272147873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007003980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918167,0.0013061534,0.00022755454,0.0026829126,0.0001402101,0.0036174017,0.000057079214,0.000052712978,0.000099299104],"genre_scores_gemma":[0.99042654,0.0079649845,0.0007273204,0.00033161894,0.000307511,0.0001702576,0.0000029734163,0.000055039043,0.000013741899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445873,0.0012265012,0.0012679849,0.0007437932,0.0016023631,0.00070064195],"domain_scores_gemma":[0.99645436,0.001122989,0.0006963383,0.00052103,0.0006272365,0.000578042],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034797376,0.00044637715,0.001488365,0.00026399753,0.0005875197,0.00012658596,0.00044099218,0.00014016617,0.000071882365],"category_scores_gemma":[0.013012122,0.00027375223,0.0003410322,0.0009238552,0.0010015287,0.00028745964,0.000499504,0.0018885714,0.000014274235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043781875,0.0006866464,0.96270746,0.00006937786,0.0004612707,0.000017465296,0.0074782157,0.000083050836,0.018909533,0.000004246902,0.00043521426,0.004769316],"study_design_scores_gemma":[0.033511646,0.0009161386,0.9447269,0.0009076474,0.0002520329,0.000018241122,0.0059013288,0.011959418,0.0015205104,0.0000135221935,0.000027397391,0.00024524445],"about_ca_topic_score_codex":0.00074139656,"about_ca_topic_score_gemma":0.0003684315,"teacher_disagreement_score":0.02913346,"about_ca_system_score_codex":0.00026866878,"about_ca_system_score_gemma":0.0001423779,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W3009271960","doi":"10.1177/1352458520910500","title":"Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Teriflunomide; Fingolimod; Medicine; Urinalysis; Population; Odds ratio; Logistic regression; Internal medicine; Confidence interval; Medical prescription; Multiple sclerosis; Urine; Pharmacology; Immunology; Environmental health","score_opus":0.16945299019508916,"score_gpt":0.33423518974410954,"score_spread":0.16478219954902038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009271960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123573,0.00023011887,0.0010191447,0.0023399096,0.00073786575,0.0039043566,0.00029868577,0.0002106643,0.00002351774],"genre_scores_gemma":[0.98689324,0.00004908583,0.009580025,0.00094560697,0.0014592486,0.0008351593,0.00003938207,0.00017654676,0.000021736598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940533,0.0003638318,0.0012484599,0.001046103,0.0015812523,0.0017070199],"domain_scores_gemma":[0.9932631,0.0008194595,0.0005302218,0.00060789014,0.001488323,0.0032909657],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0014460601,0.0006825055,0.0012001505,0.00073505886,0.0017957439,0.00056287984,0.0006844269,0.00021437882,0.00017790176],"category_scores_gemma":[0.009088976,0.0006559109,0.00044715463,0.0016317238,0.000079508594,0.0005523063,0.00019718085,0.0010858172,0.00007115072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007165549,0.00037224917,0.95934296,0.0001291255,0.00027609494,0.000016755757,0.007767512,0.0022039553,0.015007779,3.9343527e-7,0.0012448083,0.012921827],"study_design_scores_gemma":[0.009982382,0.0016231005,0.9609477,0.0010219825,0.00016732588,0.0000018466754,0.009149707,0.0135984905,0.0026381032,0.0000010592797,0.00025181085,0.00061650923],"about_ca_topic_score_codex":0.06362961,"about_ca_topic_score_gemma":0.121598236,"teacher_disagreement_score":0.057968628,"about_ca_system_score_codex":0.0012907248,"about_ca_system_score_gemma":0.00097638724,"threshold_uncertainty_score":0.9995892},"labels":[],"label_agreement":null},{"id":"W3010156703","doi":"10.1177/1352458520905759","title":"Detection of central vein should be part of MS diagnostic criteria – Commentary","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; U.S. Department of Health and Human Services; National Institutes of Health; National Institute of Neurological Disorders and Stroke; St. Michael’s Hospital Foundation","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.10414636677289922,"score_gpt":0.27588157467710367,"score_spread":0.17173520790420443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010156703","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25304163,0.010202905,0.00023064615,0.7271548,0.0065643396,0.001324258,0.001261445,0.00010203037,0.00011798203],"genre_scores_gemma":[0.7289159,0.005168499,0.00014559421,0.25800636,0.007246407,0.000025503756,0.00035102293,0.00010286493,0.000037831298],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617136,0.00035007842,0.0015119662,0.0003919001,0.0010186826,0.0005560131],"domain_scores_gemma":[0.997014,0.0007787169,0.0011055708,0.00041281374,0.00030025828,0.00038865826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023927481,0.00044890476,0.0012436364,0.0002730596,0.00015160193,0.000052001462,0.00029465882,0.00070956285,0.0007123631],"category_scores_gemma":[0.0010596099,0.00036639514,0.00084198086,0.000264122,0.00020715638,0.00011438286,0.000088267916,0.0021246672,0.000009018149],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026988142,0.0002676234,0.0139091695,0.00075205177,0.0007402436,0.00017427826,0.00029048976,0.00001134649,0.08245451,6.972834e-8,0.89829254,0.0028377993],"study_design_scores_gemma":[0.018240983,0.003114743,0.22724111,0.047193076,0.006966833,0.0010245218,0.00092921476,0.0011469072,0.13039452,0.00002474288,0.56216574,0.001557594],"about_ca_topic_score_codex":0.00021487988,"about_ca_topic_score_gemma":0.000007734246,"teacher_disagreement_score":0.47587427,"about_ca_system_score_codex":0.00021100545,"about_ca_system_score_gemma":0.000142,"threshold_uncertainty_score":0.9998788},"labels":[],"label_agreement":null},{"id":"W3012424809","doi":"10.1177/1352458520910499","title":"Data harmonization for collaborative research among MS registries: A case study in employment","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Harmonization; Logistic regression; Medicine; Pooling; Odds; German; Family medicine; Demography; Computer science; Geography; Internal medicine; Artificial intelligence","score_opus":0.5846707141859904,"score_gpt":0.4511840854524142,"score_spread":0.1334866287335762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012424809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98538643,0.0004974461,0.0016110189,0.006489896,0.00013904275,0.0052859634,0.00044817783,0.00005261207,0.0000894105],"genre_scores_gemma":[0.9941741,0.0008081237,0.003468281,0.0001745399,0.0007137881,0.00040866542,0.00008217724,0.00007182916,0.000098467455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99478644,0.0008303908,0.0009939951,0.00090703304,0.0015654499,0.00091668195],"domain_scores_gemma":[0.9948514,0.0012588445,0.00026201596,0.000851572,0.002019747,0.000756413],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042669824,0.00031089192,0.0007074362,0.00047202472,0.0009839403,0.00037940015,0.00065266486,0.000120013225,0.00009387074],"category_scores_gemma":[0.013472604,0.00026548663,0.00009825473,0.0020415147,0.00036041078,0.00064363104,0.0008062553,0.0012569528,0.000020247604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026248537,0.0021139844,0.8972017,0.00016304365,0.0005382909,0.0024804794,0.024503488,0.0002943911,0.009635485,0.000002638959,0.04961844,0.010823173],"study_design_scores_gemma":[0.040428046,0.0056635453,0.68961185,0.0009611778,0.00020318708,0.00046359384,0.17658648,0.070936434,0.0022670117,0.000011614206,0.012181587,0.00068550365],"about_ca_topic_score_codex":0.0008842029,"about_ca_topic_score_gemma":0.004654231,"teacher_disagreement_score":0.20758991,"about_ca_system_score_codex":0.00051576697,"about_ca_system_score_gemma":0.000606569,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W3012883704","doi":"10.1177/1352458520912172","title":"Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Université du Québec à Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; International Progressive MS Alliance","keywords":"Multiple sclerosis; White matter; Medicine; Pathology; Magnetic resonance imaging; Radiology; Immunology","score_opus":0.10768496490222064,"score_gpt":0.313285688856675,"score_spread":0.2056007239544544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012883704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96961683,0.00046425566,0.0006197658,0.025561633,0.00029712028,0.0028586907,0.00023578321,0.00009892853,0.00024696434],"genre_scores_gemma":[0.9773047,0.00038229808,0.014881688,0.0064144298,0.00052552804,0.0002512725,0.000030918494,0.00012897585,0.000080198566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99359655,0.00037259603,0.0016645729,0.0010451026,0.00188141,0.0014397671],"domain_scores_gemma":[0.99524415,0.00042507699,0.0005086291,0.0006129748,0.00093244395,0.002276728],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008251116,0.0006886865,0.0014163405,0.00089836086,0.00053227757,0.00018284217,0.0007160787,0.00033642148,0.0019397569],"category_scores_gemma":[0.0018135464,0.0005736066,0.0005384465,0.001533907,0.00029555417,0.0005225246,0.0010408467,0.001696918,0.00050947414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034344855,0.0008485954,0.7033986,0.00035897733,0.00016795861,0.00006697136,0.0074986485,0.00010343834,0.23015381,4.2153997e-7,0.023586439,0.030381642],"study_design_scores_gemma":[0.011371003,0.001888401,0.94381636,0.003314543,0.0000774227,0.00003951101,0.0015913596,0.0028439572,0.032830656,0.000001582056,0.0016866213,0.0005385832],"about_ca_topic_score_codex":0.00009595,"about_ca_topic_score_gemma":0.000047663696,"teacher_disagreement_score":0.24041775,"about_ca_system_score_codex":0.00040483044,"about_ca_system_score_gemma":0.00034544378,"threshold_uncertainty_score":0.9996715},"labels":[],"label_agreement":null},{"id":"W3013550746","doi":"10.1177/1352458520914822","title":"Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Aerobic exercise; Effects of sleep deprivation on cognitive performance; Physical medicine and rehabilitation; Neurorehabilitation; Psychology; Aerobic capacity; Functional magnetic resonance imaging; Magnetic resonance imaging; Neuroscience; Audiology; Medicine; Physical therapy; Rehabilitation; Psychiatry","score_opus":0.18210119674070857,"score_gpt":0.309509039072983,"score_spread":0.12740784233227442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013550746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892414,0.0012535967,0.0025294248,0.004133444,0.0002860595,0.002206557,0.00021304566,0.00009919478,0.00003725766],"genre_scores_gemma":[0.98947227,0.0020342425,0.0053491974,0.001674427,0.00094163493,0.00033435514,0.00002981063,0.00013629123,0.000027784634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99489576,0.00016610378,0.0012993673,0.0010523285,0.0011035773,0.0014828616],"domain_scores_gemma":[0.99554974,0.0017010932,0.000348776,0.0003321879,0.0008036376,0.0012645845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001259784,0.0006681241,0.0013060226,0.0004119125,0.00080896856,0.0004863284,0.0003502548,0.00030874234,0.00031108502],"category_scores_gemma":[0.005919335,0.00058095297,0.00046955454,0.00054306607,0.0006593605,0.0006086094,0.00034096613,0.0014862313,0.00011682961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022772213,0.0004189823,0.8076464,0.00031705174,0.00024941185,0.000018556224,0.0010864037,0.00007583036,0.18144262,0.0000035674448,0.0021915988,0.0042723794],"study_design_scores_gemma":[0.016986743,0.00071508606,0.91707575,0.0015455652,0.00017334719,0.00004933633,0.0013308809,0.056313194,0.0048149265,0.000013122957,0.00041324185,0.000568793],"about_ca_topic_score_codex":0.00016853007,"about_ca_topic_score_gemma":0.00021670708,"teacher_disagreement_score":0.1766277,"about_ca_system_score_codex":0.00034492995,"about_ca_system_score_gemma":0.00017177808,"threshold_uncertainty_score":0.9996642},"labels":[],"label_agreement":null},{"id":"W3013906966","doi":"10.1177/1352458520914844","title":"The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Prodrome; Multiple sclerosis; Disease; Medicine; Psychiatry; Psychology; Pathology; Psychosis","score_opus":0.47325557987791134,"score_gpt":0.33089414307172144,"score_spread":0.1423614368061899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013906966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6430506,0.16512503,0.0002532987,0.18733673,0.0007034437,0.002092226,0.000050129845,0.0003849234,0.0010036327],"genre_scores_gemma":[0.6662169,0.33068433,0.0009417114,0.0009503025,0.0008699167,0.00010643261,0.0000039254037,0.00007544249,0.00015098858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99460816,0.00050934363,0.0010971912,0.0007925239,0.0016874394,0.0013053276],"domain_scores_gemma":[0.99459356,0.0020729923,0.00043658284,0.0006083914,0.0007784205,0.0015100574],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0021243892,0.0005925202,0.0008904524,0.0002417745,0.0022582784,0.00052373996,0.00061077886,0.00018070867,0.00012754455],"category_scores_gemma":[0.008477222,0.0004065969,0.00038271488,0.0003525516,0.0008068321,0.00079417136,0.0006679618,0.0014572393,0.00005646923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015953629,0.00026251402,0.03622905,0.00049545616,0.0008828201,0.000097447046,0.00834566,0.00003249861,0.078750975,0.000092532886,0.015639074,0.8575766],"study_design_scores_gemma":[0.008603667,0.0014718928,0.8651254,0.0039316188,0.000310164,0.00029871153,0.012941847,0.0112547185,0.00454974,0.000048651527,0.090513885,0.00094968907],"about_ca_topic_score_codex":0.000038678267,"about_ca_topic_score_gemma":0.00007737129,"teacher_disagreement_score":0.8566269,"about_ca_system_score_codex":0.00020017312,"about_ca_system_score_gemma":0.0002722092,"threshold_uncertainty_score":0.9998748},"labels":[],"label_agreement":null},{"id":"W3015051092","doi":"10.1177/1352458520908163","title":"Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; University of British Columbia; University of Saskatchewan; Dalhousie University; University of British Columbia Hospital","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Prodrome; Multiple sclerosis; Population; Cohort; Internal medicine; Physical therapy; Pediatrics; Odds ratio; Psychiatry; Psychosis","score_opus":0.14336869398935742,"score_gpt":0.2943785699359468,"score_spread":0.15100987594658938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015051092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561183,0.0026355542,0.0013929124,0.03725107,0.00015157825,0.001962126,0.00005568032,0.0001244993,0.0003083151],"genre_scores_gemma":[0.98608667,0.0065169944,0.003419375,0.0030470302,0.00061224535,0.00018696062,0.000022677557,0.000086269065,0.00002179093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445087,0.0010230723,0.0010446267,0.00080937444,0.0014765513,0.0011954805],"domain_scores_gemma":[0.99661034,0.0014646167,0.00030654552,0.00054879306,0.00024968732,0.0008199952],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031181746,0.0005752455,0.0009022956,0.00034776135,0.00083926757,0.00037467942,0.00065744756,0.00021372987,0.00018324304],"category_scores_gemma":[0.008449529,0.00040058568,0.00034036837,0.0011899056,0.000475685,0.0004633671,0.0003344691,0.0018300415,0.000036782378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067150116,0.00053705915,0.7455145,0.00021427392,0.0002266663,0.00004341499,0.006573964,0.00018601184,0.044205286,0.000008685301,0.008977409,0.19284119],"study_design_scores_gemma":[0.008861081,0.0010811721,0.9526553,0.00059779926,0.00007929713,0.000045367236,0.0036371807,0.02622916,0.0008319158,0.000030401286,0.0054876446,0.00046367428],"about_ca_topic_score_codex":0.0002519515,"about_ca_topic_score_gemma":0.00057928835,"teacher_disagreement_score":0.20714077,"about_ca_system_score_codex":0.00019580459,"about_ca_system_score_gemma":0.00011871156,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W3016039455","doi":"","title":"Myelin oligodendrocyte glycoprotein antibody-associated disease in a multi-ethnic Canadian cohort","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Cohort; Medicine; Glycoprotein; Ethnic group; Antibody; Myelin-associated glycoprotein; Myelin; Oligodendrocyte; Disease; Immunology; Biology; Internal medicine; Genetics; Central nervous system; Political science","score_opus":0.07631188518667102,"score_gpt":0.3026599706343902,"score_spread":0.22634808544771917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016039455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968453,0.00048449423,0.00015314274,0.00064306054,0.00065867417,0.00077924324,0.00008458831,0.000050191407,0.0003013181],"genre_scores_gemma":[0.99759215,0.0003030074,0.00053494616,0.0005637171,0.00018641441,0.000027868084,0.00009130493,0.000056756955,0.00064382545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997745,0.00012100173,0.00063195324,0.0003684599,0.00042368338,0.0007098977],"domain_scores_gemma":[0.9980394,0.000080029386,0.00020584962,0.00033914312,0.00025241062,0.0010831637],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057938433,0.0002641929,0.00048334245,0.00060883636,0.00019714423,0.00009555194,0.00018222324,0.00014927376,0.0014107069],"category_scores_gemma":[0.0006190332,0.00024464546,0.0003055503,0.0004892826,0.00004132194,0.0002396945,0.000036085556,0.000996744,0.0004488809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024154328,0.0003375536,0.8316189,0.000020819009,0.00010462788,0.00017138904,0.00020719583,0.00054347183,0.16545518,0.0000033290141,0.0003109997,0.000985],"study_design_scores_gemma":[0.0055284,0.00015454309,0.9637139,0.0012160521,0.000081107,0.00007936356,0.00010505035,0.023648825,0.0040217414,0.0000045686256,0.0011792798,0.00026719074],"about_ca_topic_score_codex":0.056533445,"about_ca_topic_score_gemma":0.08504164,"teacher_disagreement_score":0.16143344,"about_ca_system_score_codex":0.00094831263,"about_ca_system_score_gemma":0.0007905269,"threshold_uncertainty_score":0.9995021},"labels":[],"label_agreement":null},{"id":"W3016748202","doi":"10.1177/1352458520912171","title":"Weighting evidence in MS: Obesity and neurodegeneration","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Weighting; Medicine; Obesity; Neuroscience; Psychology; Internal medicine; Disease; Psychiatry","score_opus":0.21706599298497856,"score_gpt":0.3126813619604641,"score_spread":0.09561536897548553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016748202","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22407949,0.004388365,0.00018053221,0.7695078,0.00057415554,0.0010307427,0.00003517556,0.00009386396,0.00010988433],"genre_scores_gemma":[0.541548,0.026400147,0.004973205,0.41234362,0.014069581,0.000103561186,0.0000768503,0.00019649237,0.0002885044],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99511606,0.0006222153,0.0010202338,0.00087290804,0.0014621062,0.0009064978],"domain_scores_gemma":[0.9972789,0.001075391,0.00044225133,0.00041384014,0.00039463438,0.00039495114],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008557904,0.00057403464,0.0011104636,0.0005515073,0.0005305126,0.00038713356,0.000337211,0.00050004147,0.00013174459],"category_scores_gemma":[0.005855978,0.0004960047,0.00027809906,0.00047205843,0.00024456714,0.0004671512,0.00038434344,0.0062511456,0.00005008553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019088209,0.00008992573,0.27084497,0.0006750457,0.00014610983,0.001147087,0.00057305105,0.000019126377,0.038795,3.4091389e-7,0.6778054,0.009713047],"study_design_scores_gemma":[0.004572665,0.00058400794,0.88161236,0.008023305,0.00021881805,0.00046387227,0.000089996814,0.009320752,0.0025371902,0.00002099799,0.09170841,0.00084765436],"about_ca_topic_score_codex":0.00019002357,"about_ca_topic_score_gemma":0.00012964591,"teacher_disagreement_score":0.61076736,"about_ca_system_score_codex":0.00043169098,"about_ca_system_score_gemma":0.00027515413,"threshold_uncertainty_score":0.9997492},"labels":[],"label_agreement":null},{"id":"W3018479719","doi":"10.1177/1352458520915629","title":"Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Expert opinion; Physical activity; Physical therapy; Exercise prescription; MEDLINE; Rehabilitation; Physical disability; Disease; Expanded Disability Status Scale; Gerontology; Physical medicine and rehabilitation; Family medicine; Psychology; Psychiatry","score_opus":0.1294885872704747,"score_gpt":0.34478317273044207,"score_spread":0.21529458545996738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018479719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9062737,0.0008623879,0.0032680088,0.08606944,0.00017991124,0.0026733065,0.00048672123,0.000154513,0.00003195926],"genre_scores_gemma":[0.9885469,0.004311423,0.004194329,0.0010213004,0.0011147911,0.0005892004,0.000043425574,0.0001134182,0.000065184206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673414,0.0002296556,0.0004321766,0.0007375833,0.00095342007,0.0009130112],"domain_scores_gemma":[0.9955555,0.001520537,0.00033094193,0.0005447611,0.0006073821,0.0014408508],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0005597585,0.0005258857,0.00091253914,0.00009540063,0.0018605294,0.0003718144,0.00037809866,0.00009467188,0.000060668084],"category_scores_gemma":[0.0020933524,0.00033593463,0.0004083933,0.0005412011,0.0004972706,0.00059014716,0.00030115622,0.0009738164,0.000026005626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014279084,0.0047125253,0.60973984,0.00076884293,0.0015509716,0.000026522082,0.01477696,0.00050403277,0.06086143,0.00003616516,0.05936437,0.23337927],"study_design_scores_gemma":[0.011337335,0.00077443314,0.9292379,0.0010326629,0.00075326714,0.000021592445,0.0019095277,0.047512766,0.0032333403,0.00001595954,0.003686564,0.00048462668],"about_ca_topic_score_codex":0.000100605306,"about_ca_topic_score_gemma":0.00012982255,"teacher_disagreement_score":0.3194981,"about_ca_system_score_codex":0.0001368519,"about_ca_system_score_gemma":0.00031497292,"threshold_uncertainty_score":0.9999093},"labels":[],"label_agreement":null},{"id":"W3022190080","doi":"10.1177/1352458520917936","title":"Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Clinical trial; Alemtuzumab; Regimen; Stem cell; Conditioning regimen; Disease; Physical therapy; Oncology; Immunology; Surgery; Internal medicine","score_opus":0.15730785025834546,"score_gpt":0.319929875146604,"score_spread":0.16262202488825853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022190080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274871,0.01079445,0.04074402,0.0133188395,0.0011889214,0.0048550847,0.0006463181,0.00056141044,0.00040387793],"genre_scores_gemma":[0.9846801,0.0075994204,0.0053730505,0.0006206008,0.001096774,0.00039706816,0.000044086883,0.00013683803,0.000052027295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950758,0.00028585037,0.0011402317,0.0009762634,0.0012585962,0.0012632463],"domain_scores_gemma":[0.9957073,0.0009026963,0.000485008,0.00041126163,0.0012433778,0.0012503564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007132034,0.00065490184,0.0011397061,0.0003318058,0.0009945214,0.00026163287,0.0004792453,0.00022359767,0.000119473596],"category_scores_gemma":[0.00090389233,0.00056873047,0.00086877146,0.0006017891,0.0002866365,0.00041164592,0.00013022237,0.0012768558,0.00012830624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011145939,0.003167279,0.11455471,0.0040211906,0.0013150676,0.00012687701,0.05857141,0.0011590832,0.61222684,0.000120491764,0.025544226,0.16804686],"study_design_scores_gemma":[0.05985416,0.0044943052,0.70757425,0.003927847,0.0015232193,0.00044611964,0.025091352,0.049578585,0.13745171,0.0001248187,0.007760877,0.0021727541],"about_ca_topic_score_codex":0.000042480635,"about_ca_topic_score_gemma":0.000036097535,"teacher_disagreement_score":0.59301955,"about_ca_system_score_codex":0.00060586346,"about_ca_system_score_gemma":0.0003645129,"threshold_uncertainty_score":0.9996764},"labels":[],"label_agreement":null},{"id":"W3023412322","doi":"10.1177/1352458520917935","title":"Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acadia University","funders":"","keywords":"PsycINFO; Meta-analysis; Cognition; Physical medicine and rehabilitation; Medicine; Randomized controlled trial; MEDLINE; Cognitive training; Modalities; Physical therapy; Effects of sleep deprivation on cognitive performance; Confidence interval; Expanded Disability Status Scale; Multiple sclerosis; Psychology; Internal medicine; Psychiatry","score_opus":0.7010631597860706,"score_gpt":0.4794287810853546,"score_spread":0.221634378700716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023412322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005719244,0.9880667,0.00009375622,0.00019745191,0.00006216277,0.009887663,0.0010590177,0.000043918437,0.000017435263],"genre_scores_gemma":[0.029417517,0.96595013,0.0021008574,0.00019890223,0.00012875271,0.0019171067,0.000084031126,0.00016165442,0.000041069412],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98097825,0.0058760946,0.008762974,0.0015867852,0.0017537632,0.0010421185],"domain_scores_gemma":[0.9759344,0.015119717,0.0059793107,0.0007978468,0.0008582236,0.0013105015],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.020240817,0.0015352098,0.043009184,0.0018753274,0.00039470242,0.00020555648,0.000523814,0.000593422,0.00013382775],"category_scores_gemma":[0.039848316,0.0009114998,0.0064849425,0.0022358508,0.0008493746,0.00039915714,0.00041653443,0.0030363053,0.000008743004],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029283637,0.0003900107,0.0016970998,0.52967876,0.210355,0.000044711735,0.0014060216,0.0000026379842,0.0000038746425,3.1564923e-7,0.000047144003,0.25608155],"study_design_scores_gemma":[0.004078307,0.0004260782,0.0058953553,0.4300126,0.5561546,0.000104747254,0.0007568286,0.0014494931,0.0000015823152,1.1523212e-7,0.00057397876,0.00054627855],"about_ca_topic_score_codex":0.0000575227,"about_ca_topic_score_gemma":0.00010556103,"teacher_disagreement_score":0.34579962,"about_ca_system_score_codex":0.00016341268,"about_ca_system_score_gemma":0.00074850104,"threshold_uncertainty_score":0.99973965},"labels":[],"label_agreement":null},{"id":"W3029529282","doi":"10.1177/1352458520923970","title":"Five-year longitudinal changes in quantitative spinal cord MRI in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Multiple Sclerosis Society","keywords":"Fractional anisotropy; Expanded Disability Status Scale; Multiple sclerosis; Medicine; Magnetic resonance imaging; Diffusion MRI; Nuclear medicine; Spinal cord; Effective diffusion coefficient; Internal medicine; Radiology","score_opus":0.290651520924661,"score_gpt":0.35783177858425835,"score_spread":0.06718025765959734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029529282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97375834,0.0013551965,0.0005069569,0.022083024,0.000367724,0.0014118364,0.00010791744,0.00012085095,0.00028818363],"genre_scores_gemma":[0.97897947,0.007970303,0.011056447,0.0009375343,0.00069873745,0.00016022052,0.000024926083,0.00011860005,0.000053775173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936065,0.00053146825,0.0013602629,0.0011517981,0.0016463238,0.0017036503],"domain_scores_gemma":[0.9965668,0.00076450873,0.00045743136,0.0004893185,0.0005847388,0.0011372057],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014845049,0.0007356907,0.0015334999,0.0010443195,0.00047499983,0.00024818524,0.000656132,0.00029519064,0.0004829496],"category_scores_gemma":[0.005059299,0.00067290873,0.00042110975,0.0019291946,0.00051779376,0.00056899205,0.00049792597,0.00235729,0.0002712815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009890584,0.00079457444,0.8788841,0.00023297223,0.00022625405,0.00021911167,0.0025917194,0.00037131188,0.08822098,0.000019069583,0.0043128715,0.014236484],"study_design_scores_gemma":[0.016385322,0.003753883,0.95590526,0.002255055,0.00006078123,0.000042122378,0.0040319394,0.01224593,0.0036733262,0.0000132818495,0.0010121675,0.000620903],"about_ca_topic_score_codex":0.00085933733,"about_ca_topic_score_gemma":0.005135257,"teacher_disagreement_score":0.084547654,"about_ca_system_score_codex":0.00073065213,"about_ca_system_score_gemma":0.0002630298,"threshold_uncertainty_score":0.9999443},"labels":[],"label_agreement":null},{"id":"W3031469252","doi":"10.1177/1352458520923945","title":"Frailty in ageing persons with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Ageing; Life expectancy; Gerontology; Frailty Index; Quality of life (healthcare); Cross-sectional study; Healthy ageing; Physical therapy; Internal medicine; Population; Pathology; Environmental health","score_opus":0.1994803860134822,"score_gpt":0.30531104961280514,"score_spread":0.10583066359932294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031469252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448485,0.0009046049,0.0014747868,0.010684348,0.00017567431,0.0010996623,0.000076175915,0.00021508968,0.00088479824],"genre_scores_gemma":[0.9850905,0.0014862634,0.010315807,0.001877155,0.000854461,0.0001070338,0.000019630712,0.00014698553,0.000102150756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945051,0.00031671376,0.0010224819,0.00093482266,0.001698531,0.0015223521],"domain_scores_gemma":[0.9964973,0.00066002714,0.00035071175,0.0005350065,0.0004484964,0.0015084553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083441887,0.00066303374,0.0011904279,0.0005145759,0.00076144945,0.00031458767,0.0005474101,0.00023750929,0.00051901856],"category_scores_gemma":[0.0034713664,0.0005232478,0.00044210415,0.0013939082,0.00041746598,0.00062386034,0.00032892637,0.002222142,0.00016425172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019511103,0.0005247521,0.7387199,0.00015746155,0.0003599137,0.00036707465,0.0047679953,0.00059429323,0.2210236,0.0000028249096,0.005190924,0.026340138],"study_design_scores_gemma":[0.016443226,0.0009819649,0.9520087,0.0015638479,0.00010722761,0.000117826596,0.0029731393,0.015717413,0.0063701705,0.0000031994307,0.0031049699,0.0006082781],"about_ca_topic_score_codex":0.00043323557,"about_ca_topic_score_gemma":0.00084777636,"teacher_disagreement_score":0.21465343,"about_ca_system_score_codex":0.0004848382,"about_ca_system_score_gemma":0.00032747083,"threshold_uncertainty_score":0.9997219},"labels":[],"label_agreement":null},{"id":"W3035067402","doi":"10.1177/1352458520930620","title":"The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Observational study; Randomized controlled trial; Clinical trial; Clinical endpoint; Intensive care medicine; Endpoint Determination; Internal medicine; Psychiatry","score_opus":0.2516052943651522,"score_gpt":0.3397042158387649,"score_spread":0.0880989214736127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035067402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54318094,0.07876543,0.00018245229,0.37510556,0.00043139464,0.0019808433,0.000027271393,0.00007719051,0.00024890984],"genre_scores_gemma":[0.70020556,0.29487893,0.0024346758,0.00018258733,0.002132298,0.0000545578,0.000006015961,0.000034621604,0.000070758346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966278,0.0003150505,0.001000584,0.00054474035,0.000917899,0.00059390476],"domain_scores_gemma":[0.99728805,0.00070907996,0.00042317927,0.00045200667,0.00040732583,0.0007203731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016364043,0.0002985964,0.0006991487,0.0002519445,0.000585719,0.00022076075,0.0007050521,0.00013275752,0.00008391537],"category_scores_gemma":[0.006467709,0.00021211334,0.0001447282,0.00069767924,0.00031657735,0.00047451517,0.00063472765,0.0008526804,0.000021107418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018967495,0.0007531716,0.5212175,0.00050680526,0.00054486445,0.000010232135,0.01404556,0.00014354248,0.04888504,0.00013289195,0.06949996,0.34236366],"study_design_scores_gemma":[0.0068710893,0.0004568889,0.96632105,0.00024250598,0.00011590662,0.000021992582,0.0032882784,0.0016357674,0.002196049,0.00005294442,0.01858549,0.00021203801],"about_ca_topic_score_codex":0.0003696875,"about_ca_topic_score_gemma":0.0006140822,"teacher_disagreement_score":0.44510353,"about_ca_system_score_codex":0.00011453546,"about_ca_system_score_gemma":0.00028251004,"threshold_uncertainty_score":0.8649731},"labels":[],"label_agreement":null},{"id":"W3035357197","doi":"10.1177/1352458520926955","title":"Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Brainstem; Medicine; Cerebellum; Clinical neurology; Physical medicine and rehabilitation; Neuroscience; Psychology; Internal medicine; Psychiatry","score_opus":0.14258555670110581,"score_gpt":0.29936628059456466,"score_spread":0.15678072389345885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035357197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203587,0.0007778518,0.000105398285,0.0055357483,0.00016475405,0.0010643301,0.00010757043,0.000085197025,0.00012330906],"genre_scores_gemma":[0.9954131,0.0015446859,0.0021036877,0.00052589865,0.00025453937,0.000046568282,0.000008365544,0.00008041266,0.000022687764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949949,0.00040321134,0.0015214465,0.0007915105,0.0013143193,0.0009746315],"domain_scores_gemma":[0.9963112,0.0012314927,0.00044122423,0.0005551412,0.00038742193,0.0010735247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011210843,0.00054947333,0.0015775749,0.00025848034,0.00036152243,0.00013787941,0.0004236785,0.0002439632,0.00013445337],"category_scores_gemma":[0.0048492784,0.00044860566,0.00047833985,0.0007879669,0.00092121895,0.00045787796,0.0004914233,0.0011662046,0.000025589703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007707935,0.0005955805,0.896356,0.00023797563,0.00031828342,0.000012470513,0.002302128,0.00004918742,0.07397975,0.0000052188534,0.00022347875,0.025149172],"study_design_scores_gemma":[0.01218971,0.0007647015,0.976908,0.00063387444,0.00008836924,0.00001699035,0.0008346374,0.0035607726,0.0044553266,0.000009739668,0.00016778184,0.00037006687],"about_ca_topic_score_codex":0.0005304891,"about_ca_topic_score_gemma":0.00032171444,"teacher_disagreement_score":0.080552064,"about_ca_system_score_codex":0.0002958008,"about_ca_system_score_gemma":0.00013102894,"threshold_uncertainty_score":0.99979657},"labels":[],"label_agreement":null},{"id":"W3037232559","doi":"10.1177/1352458520934070","title":"Discontinuing cannabis improves depression in people with multiple sclerosis: A short report","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Waterloo; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Cannabis; Depression (economics); Anxiety; Psychiatry; Medicine; Multiple sclerosis; Mood; Tetrahydrocannabinol; Psychology; Internal medicine; Cannabinoid","score_opus":0.07809733676582667,"score_gpt":0.28706166501119806,"score_spread":0.2089643282453714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037232559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821044,0.0014414152,0.0013101153,0.006578979,0.00024401813,0.0015999898,0.000039660412,0.00021165816,0.0003637163],"genre_scores_gemma":[0.9907172,0.0014539756,0.0057316762,0.00054637186,0.00088436215,0.00030208912,0.00004136411,0.00016791777,0.00015509076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934866,0.0002698643,0.0015666086,0.001241681,0.0018671246,0.0015681089],"domain_scores_gemma":[0.9963455,0.00030967512,0.0004687406,0.0007568574,0.0006516408,0.0014675588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011839556,0.00074733375,0.0014508226,0.00047802407,0.00065808016,0.00036929917,0.00054550666,0.00025205195,0.00012015],"category_scores_gemma":[0.0043466412,0.0005593801,0.00044268908,0.0012741782,0.000299828,0.0008507899,0.00049956347,0.0019242364,0.000030425961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015458015,0.00036023898,0.7325471,0.0001593159,0.00021554143,0.00034444992,0.0027047407,0.00023263846,0.23663287,2.622848e-7,0.0022561,0.02300092],"study_design_scores_gemma":[0.008528869,0.00062894466,0.95754164,0.002079922,0.0001320656,0.00059902994,0.002332448,0.010026553,0.016021827,0.0000014812725,0.0014803595,0.00062682666],"about_ca_topic_score_codex":0.00087588205,"about_ca_topic_score_gemma":0.0036612074,"teacher_disagreement_score":0.22499456,"about_ca_system_score_codex":0.00051506737,"about_ca_system_score_gemma":0.00041971786,"threshold_uncertainty_score":0.99968576},"labels":[],"label_agreement":null},{"id":"W3037684639","doi":"10.1177/1352458520930371","title":"A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Randomized controlled trial; Medicine; Multiple sclerosis; Clinical trial; Physical therapy; Internal medicine; Psychiatry","score_opus":0.14528856648769448,"score_gpt":0.30289676692479794,"score_spread":0.15760820043710347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037684639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087036,0.0002689826,0.00063156633,0.0033422762,0.00012334417,0.004394887,0.000117256975,0.00014302005,0.000108310596],"genre_scores_gemma":[0.9954266,0.00019641763,0.0026862484,0.000496349,0.0005206437,0.00043372225,0.000015457805,0.0001664547,0.000058134585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939271,0.00015267737,0.0014103145,0.0012936692,0.0016141189,0.0016020862],"domain_scores_gemma":[0.9967649,0.00038405595,0.00035200585,0.00053743395,0.0004937416,0.0014678793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006508196,0.00085511984,0.001633082,0.0008689365,0.00041629793,0.0006962579,0.00050656893,0.000104277184,0.000051985422],"category_scores_gemma":[0.0017921444,0.00064374786,0.00021503842,0.0023056194,0.00015537399,0.0009150278,0.00038844714,0.0011122889,0.00008015744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073768054,0.008412921,0.74475694,0.000102729326,0.00023902625,0.00011459816,0.012057613,0.0010123147,0.19892812,2.1348968e-7,0.0000747569,0.026923979],"study_design_scores_gemma":[0.04547807,0.019260483,0.911712,0.0013092328,0.00008728376,0.00005746156,0.009005828,0.010474379,0.0018718647,9.1904445e-7,0.0000923947,0.00065011356],"about_ca_topic_score_codex":0.0011476979,"about_ca_topic_score_gemma":0.0065969727,"teacher_disagreement_score":0.19705626,"about_ca_system_score_codex":0.0014475822,"about_ca_system_score_gemma":0.00057180325,"threshold_uncertainty_score":0.99960136},"labels":[],"label_agreement":null},{"id":"W3041549013","doi":"10.1177/1352458520936934","title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG <i>MS</i> study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Bayer Vital; Novartis Pharma; EMD Serono; National Multiple Sclerosis Society; Genentech; National Institutes of Health; Servier; Race to Erase MS; Acorda Therapeutics; Sanofi; GW Pharmaceuticals; MedDay Pharmaceuticals; Chugai Pharmaceutical; Lourie Foundation; GlaxoSmithKline; University of Texas Health Science Center at Houston; Biogen; Celgene; Patient-Centered Outcomes Research Institute; Sanofi Genzyme; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Merck KGaA","keywords":"Fingolimod; Medicine; Multiple sclerosis; Internal medicine; Incidence (geometry); Nadir; Adverse effect; Gastroenterology; Immunology","score_opus":0.09472200258372511,"score_gpt":0.2616161970653984,"score_spread":0.1668941944816733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041549013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612653,0.0004970384,0.000085978834,0.00080393854,0.000043516382,0.00197481,0.00029798693,0.00004816122,0.00012205198],"genre_scores_gemma":[0.9972136,0.0007182635,0.0014158722,0.00019415976,0.00018469297,0.00013974222,0.000061288054,0.00006107238,0.000011302223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996983,0.00033197127,0.00068610016,0.0005060182,0.0010479302,0.00044500743],"domain_scores_gemma":[0.99724233,0.0011211514,0.00045947268,0.00039530286,0.00047300532,0.00030874248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054807996,0.00035436734,0.00058275065,0.00018995636,0.00047021796,0.000113507245,0.00021698719,0.00009015748,0.00003395657],"category_scores_gemma":[0.0010139142,0.00019476436,0.00007409046,0.0010333121,0.0003015075,0.00029301876,0.00009031492,0.0007481692,0.000011126804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058846762,0.0010595528,0.98440325,0.000018504921,0.0002851942,0.0000070857714,0.0039273067,0.0005417475,0.00014963408,6.1255633e-7,0.00069972884,0.0030226794],"study_design_scores_gemma":[0.036604017,0.0032973774,0.95654994,0.00046430898,0.000100827965,0.000005741855,0.0011402341,0.0013081906,0.00009347517,0.0000022929835,0.00020492871,0.00022868473],"about_ca_topic_score_codex":0.00077029876,"about_ca_topic_score_gemma":0.0009970902,"teacher_disagreement_score":0.030719342,"about_ca_system_score_codex":0.00015222892,"about_ca_system_score_gemma":0.00032377633,"threshold_uncertainty_score":0.794226},"labels":[],"label_agreement":null},{"id":"W3041724293","doi":"10.1177/1352458520936823","title":"Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Cohort; Internal medicine; Magnetic resonance imaging; Multiple sclerosis; Hazard ratio; Proportional hazards model; Radiology; Confidence interval; Immunology","score_opus":0.22460600148215748,"score_gpt":0.2984047855449266,"score_spread":0.07379878406276913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041724293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598474,0.00018078632,0.0001589129,0.012548762,0.000068292786,0.00080356136,0.00004687961,0.000034534718,0.00017353757],"genre_scores_gemma":[0.9979815,0.00058907864,0.0006881839,0.0002450311,0.0003755329,0.00006259148,0.0000073872875,0.000029331515,0.000021403346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997678,0.00019530783,0.000510066,0.00034271582,0.0008405426,0.0004333922],"domain_scores_gemma":[0.99852455,0.00044990084,0.00019941856,0.00032473708,0.00018609506,0.0003152893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049962057,0.00025954767,0.0005174183,0.0000834605,0.0002487312,0.000050322982,0.00017915499,0.00006568064,0.00010641874],"category_scores_gemma":[0.0007675179,0.0001307143,0.00019292964,0.00049875793,0.00044552173,0.0001333194,0.0000754308,0.0006318799,0.000011820241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00204181,0.0006056587,0.9395661,0.000059893744,0.00018920373,0.000016791968,0.0032819328,0.0011280349,0.025955766,0.0000027656833,0.0005051226,0.026646923],"study_design_scores_gemma":[0.006365447,0.0024577505,0.97781557,0.0005443259,0.00005991519,0.000019790457,0.0017866492,0.003984066,0.006396573,0.0000025815677,0.0004677599,0.000099575635],"about_ca_topic_score_codex":0.00011418789,"about_ca_topic_score_gemma":0.00019667507,"teacher_disagreement_score":0.03824947,"about_ca_system_score_codex":0.0004102455,"about_ca_system_score_gemma":0.00010102433,"threshold_uncertainty_score":0.5330374},"labels":[],"label_agreement":null},{"id":"W3048383521","doi":"10.1177/1352458520948212","title":"Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Disease; Incidence (geometry); Magnetic resonance imaging; Demography; Pediatrics; Psychiatry; Radiology","score_opus":0.22152345841337936,"score_gpt":0.28927499766777953,"score_spread":0.06775153925440017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048383521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841225,0.00028590765,0.000011425099,0.000488069,0.00013474576,0.0005128575,0.00011554428,0.00000750589,0.000031717263],"genre_scores_gemma":[0.9963065,0.0019591039,0.0014174592,0.00014840683,0.00009823806,0.000012063514,0.000016141696,0.000032927714,0.000009168059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961522,0.0002479538,0.0017140512,0.0004868273,0.0008324313,0.00056652335],"domain_scores_gemma":[0.9975821,0.0005842492,0.00061913644,0.00023849482,0.00035614462,0.00061986747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066401844,0.00030537785,0.0012224098,0.00019931541,0.00011312345,0.00003678938,0.00021583497,0.0001281429,0.00003051829],"category_scores_gemma":[0.0025049597,0.00027952454,0.000112400914,0.0004100028,0.0003748765,0.00019927572,0.00031240846,0.0010945951,5.5997936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013476714,0.00036507606,0.98326486,0.00023354404,0.00009187593,0.00001606332,0.0019864885,0.000024818175,0.0018701329,2.3686563e-7,0.00015151112,0.010647723],"study_design_scores_gemma":[0.009836142,0.00057042117,0.98423266,0.0014369527,0.00003782883,0.0000033744604,0.00082679564,0.0024439448,0.00032475576,8.362905e-7,0.00007597521,0.00021031807],"about_ca_topic_score_codex":0.37066346,"about_ca_topic_score_gemma":0.8757002,"teacher_disagreement_score":0.5050367,"about_ca_system_score_codex":0.0002790935,"about_ca_system_score_gemma":0.0006322009,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W3048874536","doi":"10.1177/1352458520948221","title":"Autofluorescence spectroscopy as a proxy for chronic white matter pathology","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Autofluorescence; Pathology; White matter; Medicine; Physics; Magnetic resonance imaging; Radiology; Optics","score_opus":0.0802062746089193,"score_gpt":0.3177231954661517,"score_spread":0.2375169208572324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048874536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87052447,0.0026288577,0.01837288,0.1009796,0.0008596965,0.004488057,0.00016383966,0.00035310164,0.001629512],"genre_scores_gemma":[0.96615225,0.0011419994,0.025241708,0.0043714694,0.0023455007,0.00026907568,0.000021001799,0.000107576125,0.00034941488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996431,0.00015991414,0.00074118463,0.0006927549,0.0007751479,0.0012000256],"domain_scores_gemma":[0.9976868,0.00023747969,0.0002785182,0.00039582705,0.00049004034,0.0009113308],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00057002075,0.00041750484,0.00079186336,0.0001919776,0.00057673285,0.00018888047,0.00042122707,0.00017602758,0.0014862377],"category_scores_gemma":[0.001725952,0.00034073472,0.0004639064,0.00036768522,0.00031251073,0.0002630167,0.00023216162,0.0010158686,0.000784787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013055896,0.0002530513,0.35164827,0.0003042021,0.0002509837,0.00008478639,0.0014128373,0.00004516213,0.59280175,0.000009609025,0.04729986,0.004583885],"study_design_scores_gemma":[0.013619791,0.0035001913,0.89065814,0.00061842625,0.00019058236,0.00047478365,0.0003340302,0.0124439355,0.06395331,0.00005432817,0.013600202,0.0005522766],"about_ca_topic_score_codex":0.000010343213,"about_ca_topic_score_gemma":0.000009889286,"teacher_disagreement_score":0.53900987,"about_ca_system_score_codex":0.00043147756,"about_ca_system_score_gemma":0.00044284287,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W3087424718","doi":"10.1177/1352458520958353","title":"Rehabilitation should be prescribed acutely in motor relapses – Commentary","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Rehabilitation; Physical medicine and rehabilitation; Multiple sclerosis; Medicine; Physical therapy; Psychology; Psychiatry","score_opus":0.10861580316933336,"score_gpt":0.2849973764605974,"score_spread":0.17638157329126405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087424718","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02914498,0.0006516655,0.00003687968,0.96767026,0.0008483271,0.0011613285,0.00017954517,0.0000728336,0.00023419545],"genre_scores_gemma":[0.020308524,0.0008813202,0.0026303146,0.9719189,0.002848877,0.000081476624,0.00077552936,0.000110541376,0.0004445102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967313,0.00030215312,0.0009777165,0.0005177159,0.0008891686,0.00058199145],"domain_scores_gemma":[0.9983169,0.0005800556,0.00037398003,0.00036879902,0.00012772513,0.00023257865],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034350785,0.0004714378,0.0008273768,0.0004143924,0.00018943977,0.000113118826,0.0002944517,0.0005655875,0.00049273483],"category_scores_gemma":[0.000863253,0.0004258321,0.0005259355,0.0002678752,0.00013737346,0.0002769578,0.000110942055,0.0041676746,0.000028594699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052552565,0.00021823875,0.02525766,0.00024409383,0.00021192324,0.0002653304,0.0008570133,0.0000072134544,0.0030317812,7.531354e-7,0.9675869,0.0017935911],"study_design_scores_gemma":[0.0079466915,0.0012646759,0.052283492,0.0013107843,0.00030941993,0.000047879155,0.00065182184,0.0002318845,0.00018645007,0.00012519734,0.9351419,0.000499801],"about_ca_topic_score_codex":0.00031974545,"about_ca_topic_score_gemma":0.00015131173,"teacher_disagreement_score":0.032444973,"about_ca_system_score_codex":0.00039308166,"about_ca_system_score_gemma":0.000118355434,"threshold_uncertainty_score":0.99981934},"labels":[],"label_agreement":null},{"id":"W3088365521","doi":"10.1177/1352458520961534","title":"Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Health Sciences Centre; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Multiple sclerosis; Medicine; Cognition; Rheumatoid arthritis; Affect (linguistics); Psychology; Psychiatry; Cohort; Clinical psychology; Internal medicine","score_opus":0.051820976834586724,"score_gpt":0.2649230280613283,"score_spread":0.21310205122674156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088365521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935237,0.0009761021,0.000011787452,0.004194568,0.00004371225,0.0006035482,0.000028919978,0.00003674378,0.0005809155],"genre_scores_gemma":[0.9927271,0.005959117,0.00008697736,0.00083363295,0.0002300846,0.00004300137,0.0000021686044,0.00004278495,0.000075110715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981157,0.00014451453,0.0003726835,0.00034380762,0.0005530585,0.0004702338],"domain_scores_gemma":[0.99845004,0.00086802867,0.00012154544,0.00022195335,0.00006074297,0.00027767295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000506945,0.00027962384,0.0004273187,0.00011173729,0.0004296731,0.00016777094,0.00016045006,0.00008794005,0.00017305152],"category_scores_gemma":[0.0017022074,0.00017004745,0.00010213731,0.00022450699,0.00029200548,0.000240086,0.00021912956,0.0007603208,0.000021099337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047103394,0.00013305024,0.9176233,0.00008419494,0.00006341893,0.0000019881136,0.0020415257,0.000075091586,0.05551075,0.0000012845833,0.00090078515,0.023093568],"study_design_scores_gemma":[0.003638185,0.00038764992,0.95947236,0.0007856145,0.0000217436,0.00001679027,0.00051672803,0.03058835,0.0036531717,0.0000058329492,0.00072800263,0.00018558961],"about_ca_topic_score_codex":0.00007633202,"about_ca_topic_score_gemma":0.000028468537,"teacher_disagreement_score":0.051857576,"about_ca_system_score_codex":0.0000690089,"about_ca_system_score_gemma":0.00003409246,"threshold_uncertainty_score":0.69343334},"labels":[],"label_agreement":null},{"id":"W3091784113","doi":"10.1177/1352458520963880","title":"Effect of mood and anxiety disorders on health care utilization in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Calgary; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research","keywords":"Medicine; Anxiety; Multiple sclerosis; Cohort; Mood disorders; Mood; Psychiatry; Cohort study; Drug; Health care; Family medicine; Internal medicine","score_opus":0.11208832246764051,"score_gpt":0.326842431443815,"score_spread":0.21475410897617447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091784113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892091,0.0026241804,0.00024666116,0.0058348617,0.00014591042,0.0015652665,0.00010236653,0.00007049661,0.00020112815],"genre_scores_gemma":[0.97662824,0.021701153,0.0008067027,0.0004944461,0.00019693958,0.00006179438,0.000035894973,0.00007074988,0.000004074112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599844,0.0006646523,0.00092851196,0.00063023285,0.0010115681,0.00076662225],"domain_scores_gemma":[0.9975446,0.0007562021,0.00038015793,0.0003256656,0.00022888016,0.0007645136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010170552,0.00044758152,0.0010782167,0.000379536,0.0004196358,0.00007471991,0.00022879952,0.00016324002,0.000048833946],"category_scores_gemma":[0.003367462,0.00036620157,0.00028968402,0.0007665706,0.0002657497,0.00023331984,0.0001922173,0.0009279901,0.000011329196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024268392,0.0002529007,0.6703368,0.0008115107,0.00011260558,0.0000016164279,0.0048486646,0.0003590116,0.026904747,0.000002385216,0.0007681904,0.2931747],"study_design_scores_gemma":[0.01823188,0.0052577485,0.946853,0.0015671266,0.000053320513,0.000008458778,0.0017638578,0.00937166,0.015971005,0.0000021840478,0.0006151076,0.00030465054],"about_ca_topic_score_codex":0.00028746822,"about_ca_topic_score_gemma":0.00080840406,"teacher_disagreement_score":0.29287007,"about_ca_system_score_codex":0.00033130622,"about_ca_system_score_gemma":0.00015499745,"threshold_uncertainty_score":0.999879},"labels":[],"label_agreement":null},{"id":"W3093711806","doi":"10.1177/1352458520964774","title":"Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Worry; Multiple sclerosis; Cohort; Expanded Disability Status Scale; Coping (psychology); Anxiety; Likert scale; Personalized medicine; Physical therapy; Disease; Cohort study; Clinical psychology; Internal medicine; Psychology; Psychiatry; Bioinformatics","score_opus":0.23851307364063584,"score_gpt":0.3350935979117455,"score_spread":0.09658052427110964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093711806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144597,0.00091858796,0.014349949,0.0014061027,0.00010503719,0.0014948325,0.00007178589,0.00019453328,0.000013178305],"genre_scores_gemma":[0.9772417,0.0015610923,0.019080667,0.0006828462,0.001089683,0.000056258243,0.000083847044,0.00019123631,0.000012690009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932604,0.0003603258,0.0014959349,0.0011731227,0.002030715,0.0016795325],"domain_scores_gemma":[0.9959436,0.00054513436,0.00050729467,0.0005237436,0.0010351212,0.0014451076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010215016,0.0007884005,0.0014650323,0.0005826091,0.0008532642,0.0006132112,0.00056498364,0.00027137637,0.00016333914],"category_scores_gemma":[0.0020938434,0.00063912186,0.00031836453,0.00188511,0.00041290512,0.0011917993,0.00016941933,0.0020396577,0.000023780976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019062099,0.0018180094,0.90399593,0.00043035846,0.00021822353,0.00019430733,0.002896609,0.0068796934,0.05705476,6.827172e-7,0.000048602305,0.024556627],"study_design_scores_gemma":[0.0078054266,0.00083203334,0.6471638,0.002408481,0.00021163549,0.00017222762,0.00071523647,0.33923057,0.0009316852,0.0000012364131,0.0000211678,0.0005064796],"about_ca_topic_score_codex":0.00015061513,"about_ca_topic_score_gemma":0.0012491329,"teacher_disagreement_score":0.33235088,"about_ca_system_score_codex":0.00057522417,"about_ca_system_score_gemma":0.0006754609,"threshold_uncertainty_score":0.999606},"labels":[],"label_agreement":null},{"id":"W3096216217","doi":"10.1177/1352458521992507","title":"Clinical predictors of driving simulator performance in drivers with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Driving simulator; Recall; Multiple sclerosis; Psychology; Poison control; Driving simulation; Cognition; Physical medicine and rehabilitation; Audiology; Simulation; Cognitive psychology; Computer science; Medicine; Medical emergency","score_opus":0.13313182955281228,"score_gpt":0.3553455391069187,"score_spread":0.2222137095541064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096216217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965197,0.0001801209,0.0003546543,0.00037713457,0.0017355847,0.00048752656,0.000028747116,0.0000846894,0.00023185641],"genre_scores_gemma":[0.9936068,0.0019559693,0.0032750631,0.00020760216,0.0006113862,0.000040038525,0.0000065264753,0.00007826121,0.00021836683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445856,0.0010765513,0.0020075277,0.000585088,0.0008163529,0.0010559394],"domain_scores_gemma":[0.99425805,0.0029402364,0.00096721505,0.0005643883,0.0008809104,0.00038921062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018821809,0.00038626813,0.0009972104,0.00029097137,0.001141662,0.0000376863,0.0004391577,0.00031973526,0.00021593149],"category_scores_gemma":[0.0030299807,0.00031972415,0.0002715789,0.0007412153,0.00032986607,0.0005435157,0.00040025933,0.002146898,0.000052511397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000854029,0.0003657015,0.98782605,0.00015605809,0.00020056512,0.00001618421,0.0034425207,0.0023092797,0.0022795785,0.000001607259,0.00070969464,0.0026073754],"study_design_scores_gemma":[0.007788977,0.00023622625,0.9753412,0.0052984543,0.000073689334,0.000007587571,0.003748066,0.0059203873,0.00059414445,0.0000033083522,0.0006615096,0.00032644707],"about_ca_topic_score_codex":0.000079936006,"about_ca_topic_score_gemma":0.004391632,"teacher_disagreement_score":0.012484829,"about_ca_system_score_codex":0.00035704594,"about_ca_system_score_gemma":0.0006442543,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null},{"id":"W3097860851","doi":"10.1177/1352458520969099","title":"Exercise and the brain in multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Remyelination; Neuroscience; Physical medicine and rehabilitation; Medicine; Cognition; Neuroprotection; Psychology; Physical therapy; Psychiatry; Central nervous system","score_opus":0.2268798585612717,"score_gpt":0.34646035468046077,"score_spread":0.11958049611918906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097860851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003127727,0.9894787,0.000040192834,0.0046602394,0.00046774623,0.0045911074,0.00015061529,0.00011405981,0.00018458175],"genre_scores_gemma":[0.0033137687,0.9924511,0.0012233554,0.0005398786,0.0011232701,0.0008108708,0.000051982617,0.0002767937,0.00020899894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911118,0.0015671089,0.0026431533,0.0013296526,0.0017574176,0.0015908814],"domain_scores_gemma":[0.9908849,0.0053802854,0.0011013465,0.0010684939,0.00036228003,0.0012026697],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003580046,0.0014232345,0.006351176,0.0010034838,0.0010193503,0.0006231108,0.0010767537,0.00068869564,0.00018621268],"category_scores_gemma":[0.010682132,0.0008667958,0.001952128,0.0016596026,0.0014409369,0.00034789022,0.0011439321,0.0047695073,0.00021023172],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008040585,0.00024963744,0.0010043666,0.0054590586,0.00065871637,0.00010879504,0.0008821426,0.0000027005235,0.00006603341,0.000008463609,0.008296853,0.9824592],"study_design_scores_gemma":[0.023853818,0.00023511742,0.010579969,0.109237075,0.0016001818,0.00043814312,0.0004683485,0.0011379173,0.000012551431,0.000018968165,0.85136855,0.00104935],"about_ca_topic_score_codex":0.0002970572,"about_ca_topic_score_gemma":0.00025020613,"teacher_disagreement_score":0.98140985,"about_ca_system_score_codex":0.0007274339,"about_ca_system_score_gemma":0.0007373348,"threshold_uncertainty_score":0.99985176},"labels":[],"label_agreement":null},{"id":"W3099273656","doi":"10.1177/1352458520970841","title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2525,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Biogen; Novartis; Multiple Sclerosis Society; Roche; Medical Research Council; Associazione Italiana Sclerosi Multipla; Sanofi; Merck; Bristol-Myers Squibb; University of Tasmania; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Epidemiology; Incidence (geometry); Compendium; Environmental health; Population; Demography; Gerontology; Geography; Pathology","score_opus":0.12565249177555743,"score_gpt":0.2900817352026255,"score_spread":0.16442924342706805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099273656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864407,0.004659822,0.0016079171,0.0050007217,0.0005162474,0.0010367505,0.00039991928,0.00008636324,0.00025153058],"genre_scores_gemma":[0.98446953,0.00806657,0.005031165,0.0005601616,0.0016832127,0.00004054983,0.00003462763,0.00007451793,0.000039649713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9942762,0.0005690844,0.0016762415,0.00066645554,0.0021051967,0.00070681924],"domain_scores_gemma":[0.9937534,0.002603083,0.0010856176,0.00074644276,0.001167148,0.0006443209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078751583,0.0005045192,0.0011384606,0.00023140109,0.0006575694,0.00011583479,0.00085215544,0.00021475293,0.00041704543],"category_scores_gemma":[0.0072836108,0.0003494418,0.0006712191,0.0009701706,0.00077438843,0.0005493232,0.00048066516,0.0013581743,0.000058228256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011342785,0.00041913122,0.30976093,0.0003885635,0.00053023075,0.0000080327545,0.004515795,0.00029346897,0.66040605,0.000008780836,0.013542182,0.008992541],"study_design_scores_gemma":[0.0056287358,0.00046018185,0.8163942,0.002843515,0.00029573476,0.000008791696,0.00091019826,0.005885793,0.16614214,0.000035496894,0.0011094805,0.00028571932],"about_ca_topic_score_codex":0.00058289256,"about_ca_topic_score_gemma":0.00017156485,"teacher_disagreement_score":0.5066333,"about_ca_system_score_codex":0.00018798892,"about_ca_system_score_gemma":0.00024435515,"threshold_uncertainty_score":0.99989575},"labels":[],"label_agreement":null},{"id":"W3100414769","doi":"10.1177/1352458520971819","title":"Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Medicine; Multiple sclerosis; Placebo; Confounding; Marginal structural model; Internal medicine; Physical therapy; Oncology; Pathology; Alternative medicine; Immunology","score_opus":0.05395101021926731,"score_gpt":0.23880066277696482,"score_spread":0.1848496525576975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100414769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926106,0.0057396204,0.00033681132,0.000668975,0.00026182356,0.00026159745,0.00005482175,0.000022789129,0.000042958127],"genre_scores_gemma":[0.99512446,0.0010361848,0.0021163616,0.00060503144,0.0010094622,0.000024750014,0.000034071098,0.00004360651,0.000006086503],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980119,0.00018688392,0.00053868,0.000554604,0.00024532623,0.00046261906],"domain_scores_gemma":[0.9989903,0.000084604886,0.00021201704,0.00022913521,0.000085199536,0.0003987347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041647174,0.00028119594,0.00035391437,0.000047428573,0.00029008475,0.00017451477,0.0002629858,0.00017350467,0.000056470435],"category_scores_gemma":[0.00093883765,0.00025962084,0.0001726786,0.00018181036,0.00023820616,0.000038873153,0.00023840304,0.0004729627,0.00000429523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033932977,0.00011364526,0.4499507,0.000033990924,0.000043518306,0.0000080362925,0.00047790364,0.00018845696,0.5309703,0.0000028328384,0.00019859777,0.017672757],"study_design_scores_gemma":[0.0066280174,0.00027213275,0.821902,0.00024772075,0.000057064302,0.00005271951,0.0012602907,0.00368265,0.1634027,0.00003104214,0.001854386,0.0006092864],"about_ca_topic_score_codex":0.00003531307,"about_ca_topic_score_gemma":0.00006607172,"teacher_disagreement_score":0.37195128,"about_ca_system_score_codex":0.000033521574,"about_ca_system_score_gemma":0.00007261432,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W3104676108","doi":"10.1177/1352458520972557","title":"The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre for Advancing Health Outcomes; McGill University; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Propensity score matching; Medicine; MEDLINE; Internal medicine; Psychiatry","score_opus":0.7278211866591483,"score_gpt":0.48034093295878966,"score_spread":0.24748025370035864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104676108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019866934,0.9927783,0.00014335003,0.00045823678,0.00023117573,0.004173326,0.00017940108,0.00003489807,0.000014594831],"genre_scores_gemma":[0.0009526355,0.97521526,0.023065466,0.00011966012,0.0002310736,0.00021506047,0.000043405238,0.00012821125,0.000029225012],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98033106,0.005342145,0.010537327,0.0010824512,0.0017175507,0.0009894576],"domain_scores_gemma":[0.9744004,0.008021322,0.013347679,0.0014547723,0.0020844238,0.0006914265],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01879944,0.0010160187,0.009024127,0.000536526,0.00056181767,0.0002948661,0.00075162604,0.0004909011,0.000017976272],"category_scores_gemma":[0.14384758,0.00060546387,0.0020832305,0.0022989977,0.000906943,0.00045373954,0.0010879069,0.0034947074,0.00000271897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025318383,0.00024070004,0.03368061,0.10955852,0.00083212234,0.000044076023,0.0003070839,6.604368e-7,0.002257717,0.0000036459314,0.0006148045,0.8522069],"study_design_scores_gemma":[0.0028536217,0.00030108195,0.1842456,0.62301636,0.0012632696,0.0003334549,0.00006581872,0.00008732791,0.0002853314,0.000003407438,0.18690753,0.00063722004],"about_ca_topic_score_codex":0.0002529174,"about_ca_topic_score_gemma":0.00025460185,"teacher_disagreement_score":0.85156965,"about_ca_system_score_codex":0.00038556862,"about_ca_system_score_gemma":0.00083907257,"threshold_uncertainty_score":0.9996397},"labels":[],"label_agreement":null},{"id":"W3107056180","doi":"10.1177/1352458520973618","title":"Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Cohort; Medicine; Cognition; Physical therapy; Prospective cohort study; Psychology; Internal medicine; Psychiatry","score_opus":0.19355678102126586,"score_gpt":0.3466896427692886,"score_spread":0.15313286174802274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107056180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97979695,0.00035058276,0.00089890574,0.018078065,0.0001399284,0.0006083566,0.000025033392,0.000025786856,0.00007639683],"genre_scores_gemma":[0.9970768,0.00090110145,0.00084950274,0.00076751993,0.000345762,0.000017349526,9.864436e-7,0.000023820297,0.000017119346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978224,0.00040287751,0.00043012606,0.00027209206,0.0007090146,0.0003634856],"domain_scores_gemma":[0.99819237,0.0006826486,0.0002172033,0.00024957335,0.0003621932,0.00029602656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009288411,0.0001842851,0.00036141436,0.0000656386,0.0008104586,0.00008253022,0.00015640982,0.000056099736,0.000029766888],"category_scores_gemma":[0.00599586,0.000103955426,0.00016870273,0.00041144402,0.00026291603,0.00014625763,0.00033846073,0.0006748953,0.00000835862],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003182569,0.0000532895,0.09769443,0.00012013472,0.000115230956,0.0000062212303,0.002615082,0.00012367273,0.8901342,0.000002655092,0.00059029745,0.008226496],"study_design_scores_gemma":[0.0009269688,0.00009235441,0.6940054,0.00067863305,0.000056341803,0.00005012826,0.0011701748,0.0014221938,0.30139974,0.0000023492225,0.00010382354,0.00009186602],"about_ca_topic_score_codex":0.00005759334,"about_ca_topic_score_gemma":0.00013852239,"teacher_disagreement_score":0.59631103,"about_ca_system_score_codex":0.000044513898,"about_ca_system_score_gemma":0.00005736989,"threshold_uncertainty_score":0.7178037},"labels":[],"label_agreement":null},{"id":"W3107138502","doi":"10.1177/1352458520974360","title":"Youth with multiple sclerosis have low levels of fitness","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University; Hospital for Sick Children","funders":"","keywords":"Cardiorespiratory fitness; Physical fitness; Medicine; Multiple sclerosis; Depression (economics); Physical therapy; Body mass index; Population; Cardiovascular fitness; Grip strength; Internal medicine; Psychology; Psychiatry","score_opus":0.22115601735784982,"score_gpt":0.2986393585801804,"score_spread":0.07748334122233061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107138502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923635,0.00066673034,0.0038690243,0.0035108153,0.00021826544,0.0012163611,0.0006451405,0.00016801027,0.00046929478],"genre_scores_gemma":[0.98916364,0.00096936227,0.007890898,0.00081546017,0.0008292038,0.00005122752,0.000031663873,0.00016001114,0.000088545894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939549,0.0003048962,0.0013696691,0.00086756016,0.0022144811,0.001288475],"domain_scores_gemma":[0.9949916,0.00062134105,0.00073061907,0.0007123565,0.0014270662,0.0015170187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084427546,0.000721656,0.0015700563,0.0003897188,0.0006390226,0.00018910156,0.0006831747,0.0002548751,0.0005692027],"category_scores_gemma":[0.0032170182,0.00054405973,0.00060863554,0.0008918168,0.00074447785,0.00052678643,0.00038794076,0.0014386593,0.000075032556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037280656,0.0009085543,0.59930575,0.00054345094,0.0010694225,0.00006534958,0.009753768,0.000997504,0.35343075,0.0000039452075,0.001909334,0.028284103],"study_design_scores_gemma":[0.018596316,0.0016588636,0.8577745,0.0024189635,0.00032223968,0.00006876276,0.0062423823,0.0074391547,0.10450517,0.0000036429549,0.00031421162,0.00065580045],"about_ca_topic_score_codex":0.00015584634,"about_ca_topic_score_gemma":0.000110924426,"teacher_disagreement_score":0.25846875,"about_ca_system_score_codex":0.00025173996,"about_ca_system_score_gemma":0.00039739927,"threshold_uncertainty_score":0.9997011},"labels":[],"label_agreement":null},{"id":"W3107949646","doi":"10.1177/1352458520975323","title":"Accurate classification of secondary progression in multiple sclerosis using a decision tree","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Concordance; Medicine; Decision tree; Cohort; Clinical phenotype; Classifier (UML); Multiple sclerosis; Disease; Artificial intelligence; Phenotype; Internal medicine; Computer science","score_opus":0.32070783175027995,"score_gpt":0.36771289318905503,"score_spread":0.047005061438775086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107949646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906259,0.0011872265,0.0046348707,0.0017984408,0.00024541083,0.001183763,0.0000629961,0.000079155696,0.00018224643],"genre_scores_gemma":[0.97042626,0.0019630045,0.02677732,0.00024664428,0.00041602692,0.000052009327,0.00002364358,0.000087485074,0.000007619877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9946863,0.0003766039,0.0017359867,0.0007434902,0.0015760445,0.000881591],"domain_scores_gemma":[0.9962784,0.0008409644,0.00081669475,0.00050681137,0.00074490556,0.0008122407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012736177,0.0004827771,0.0011119092,0.0006547727,0.00045203918,0.00014598113,0.0004840272,0.00028131212,0.00024180618],"category_scores_gemma":[0.0055200253,0.00040164785,0.0004534521,0.0013627451,0.000342536,0.0006976934,0.0003626584,0.0013994743,0.00003593553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019866235,0.00046518026,0.22912732,0.00014966005,0.00009604218,0.000018776702,0.0011298665,0.0004887902,0.57485026,0.000001679014,0.00064712705,0.19103867],"study_design_scores_gemma":[0.011198379,0.0005478862,0.8060867,0.0025479854,0.00006903453,0.000035216384,0.0011016559,0.14919096,0.028631218,0.000010903493,0.0002702289,0.0003098095],"about_ca_topic_score_codex":0.00008218974,"about_ca_topic_score_gemma":0.00015509342,"teacher_disagreement_score":0.57695943,"about_ca_system_score_codex":0.00045200405,"about_ca_system_score_gemma":0.00043916225,"threshold_uncertainty_score":0.99984354},"labels":[],"label_agreement":null},{"id":"W3113005255","doi":"10.1177/1352458520973633","title":"Psychological resilience explains functional variability across people with multiple sclerosis – No","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Resilience and Mental Health","field":"Psychology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Psychology; Psychological resilience; Resilience (materials science); Clinical psychology; Medicine; Physical medicine and rehabilitation; Psychiatry; Psychotherapist","score_opus":0.1328820797603175,"score_gpt":0.3473958744580898,"score_spread":0.2145137946977723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113005255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98466504,0.00012894359,0.009083606,0.0016567747,0.001629512,0.00062238553,0.0001294277,0.00017706331,0.0019072426],"genre_scores_gemma":[0.9923454,0.00016533447,0.0027781238,0.0031503316,0.0010875285,0.00013655068,0.000024193936,0.000057455214,0.00025511018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994752,0.00065927755,0.0009517827,0.0012361021,0.0009774202,0.0014234574],"domain_scores_gemma":[0.9965928,0.0007020761,0.00044545645,0.00066460547,0.00034246652,0.001252592],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013826775,0.0004919275,0.0006238817,0.00007976451,0.001335767,0.00023249295,0.0007667702,0.0003090013,0.002916059],"category_scores_gemma":[0.00077892496,0.0003797275,0.00028875636,0.0007907223,0.0004333533,0.00060424814,0.00017255433,0.0013067063,0.0013554404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051780017,0.001710151,0.91784966,0.000044249693,0.000102673184,0.00004468602,0.0076865586,0.0006400107,0.020879526,0.000080070706,0.017914604,0.02786978],"study_design_scores_gemma":[0.00563898,0.0016317671,0.9848603,0.00011660852,0.000025682624,0.00025559077,0.003147173,0.0010225393,0.0005644043,0.000026947226,0.0022253233,0.00048468207],"about_ca_topic_score_codex":0.00025029763,"about_ca_topic_score_gemma":0.00030534723,"teacher_disagreement_score":0.06701061,"about_ca_system_score_codex":0.00023743919,"about_ca_system_score_gemma":0.00011485586,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W3113197914","doi":"10.1177/1352458520972573","title":"Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Multiple sclerosis; Medicine; Neurofilament; Neuroscience; Physical medicine and rehabilitation; Internal medicine; Psychology; Immunology","score_opus":0.20735537095226855,"score_gpt":0.32083496704267067,"score_spread":0.11347959609040212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113197914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108876,0.00089104974,0.00062485493,0.013759564,0.00038387,0.0026962152,0.00036788895,0.00009581686,0.00009198407],"genre_scores_gemma":[0.9845345,0.0010502684,0.01275889,0.00032342278,0.0006285509,0.0005665231,0.000023085473,0.00009733366,0.00001740118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958107,0.00019099006,0.0015181628,0.0006810394,0.0008149421,0.0009841935],"domain_scores_gemma":[0.99687076,0.00047894524,0.0005910175,0.0004918539,0.0007808392,0.0007865676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005822529,0.0004490287,0.0009588649,0.00038451908,0.00046663865,0.00010629491,0.00042089404,0.00016507857,0.00007325323],"category_scores_gemma":[0.0026763778,0.00039675718,0.0004933442,0.0007869585,0.000152773,0.00034089404,0.00031632377,0.0007951242,0.000019192184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056631555,0.00050244876,0.5735892,0.00019547674,0.00012224384,0.000003549824,0.0015720286,0.0001817231,0.39252162,0.0000037231114,0.0015763339,0.029165328],"study_design_scores_gemma":[0.0075043933,0.0011281591,0.85178745,0.0009570295,0.00006349878,0.000012111778,0.0012217119,0.003199664,0.13254999,0.000008816659,0.0012695254,0.0002976459],"about_ca_topic_score_codex":0.00006451398,"about_ca_topic_score_gemma":0.00003583915,"teacher_disagreement_score":0.27819824,"about_ca_system_score_codex":0.000341345,"about_ca_system_score_gemma":0.00027321855,"threshold_uncertainty_score":0.9998484},"labels":[],"label_agreement":null},{"id":"W3119307399","doi":"10.1177/1352458520981300","title":"Determinants of therapeutic lag in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Multiple Sclerosis International Federation; Agence Nationale de la Recherche; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Therapeutic effect; Internal medicine; Disease; Incidence (geometry); Lag time; Physical therapy; Immunology","score_opus":0.19633632886975733,"score_gpt":0.3327823514985605,"score_spread":0.13644602262880318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119307399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940344,0.0035977238,0.0001617481,0.0007112152,0.0004351595,0.0005460979,0.000057911235,0.000053566997,0.00040214614],"genre_scores_gemma":[0.9867923,0.0075564957,0.0046099685,0.00034236058,0.00030652818,0.000059441765,0.000012478453,0.00009011363,0.00023027665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948042,0.0004764147,0.0015129172,0.0006598381,0.001391959,0.0011546802],"domain_scores_gemma":[0.9962319,0.00096604927,0.0004596371,0.0007770635,0.0010180424,0.000547314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013354217,0.00047639254,0.0013368112,0.0006068628,0.00037798495,0.00012330708,0.00041512423,0.00025809126,0.0005229803],"category_scores_gemma":[0.0035252532,0.00041589743,0.00059422856,0.0011523205,0.00039441063,0.00036341074,0.00034548674,0.0011215748,0.00006318105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037193848,0.00077310024,0.62148094,0.00012450918,0.00013247471,0.00010484331,0.0005448437,0.0000487342,0.31435004,0.000002728182,0.0003164296,0.0617494],"study_design_scores_gemma":[0.009393507,0.00026676393,0.8595177,0.0017677024,0.00008102924,0.0001974773,0.00094406406,0.0037809527,0.12310354,0.000028174118,0.0005954237,0.0003236505],"about_ca_topic_score_codex":0.00023874966,"about_ca_topic_score_gemma":0.0013510331,"teacher_disagreement_score":0.23803677,"about_ca_system_score_codex":0.0003682783,"about_ca_system_score_gemma":0.0005020637,"threshold_uncertainty_score":0.9998293},"labels":[],"label_agreement":null},{"id":"W3120065428","doi":"10.1177/1352458520983584","title":"An enrichment strategy for clinical trials in SPMS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Hotchkiss Brain Institute, University of Calgary","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Clinical trial; Logistic regression; Psychology; Cohort; Baseline (sea); Physical therapy; Internal medicine; Medicine; Physical medicine and rehabilitation; Psychiatry; Biology","score_opus":0.6108981091022821,"score_gpt":0.5257717155352305,"score_spread":0.08512639356705165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120065428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873055,0.0026924107,0.0036393201,0.003218059,0.0010170252,0.0016031817,0.0000939457,0.00006336436,0.00036715018],"genre_scores_gemma":[0.9740424,0.01075804,0.012271224,0.000535604,0.0019291261,0.0001509319,0.00005235494,0.000053658183,0.00020665313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924444,0.002511863,0.0026676983,0.00064909324,0.00085335807,0.0008736119],"domain_scores_gemma":[0.99284595,0.004279916,0.0005204415,0.00057652476,0.0009109517,0.0008662276],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018079761,0.00031486037,0.0017539132,0.00029726664,0.0003153298,0.0002677806,0.0002653459,0.0002446025,0.00045717714],"category_scores_gemma":[0.026407422,0.00024989346,0.00092168094,0.00041405106,0.00015494338,0.00029842585,0.00010326425,0.0010572234,0.000028020791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020008455,0.003335104,0.51897466,0.00011907834,0.00055322226,0.00016031617,0.00039318667,0.00031617435,0.13764882,0.000035319605,0.01280797,0.32365534],"study_design_scores_gemma":[0.020371443,0.001290419,0.95525414,0.00047494084,0.00013027503,0.00009525312,0.0014350091,0.00621694,0.0074559837,0.00009881991,0.0068795667,0.00029719723],"about_ca_topic_score_codex":0.00003184599,"about_ca_topic_score_gemma":0.00021015744,"teacher_disagreement_score":0.4362795,"about_ca_system_score_codex":0.00028586554,"about_ca_system_score_gemma":0.00068674464,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W3120800281","doi":"10.1177/1352458520981370","title":"Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Health Utilities Index; Psychology; Multiple sclerosis; Quality of life (healthcare); Expanded Disability Status Scale; Physical therapy; Index (typography); Medicine; Gerontology; Health related quality of life; Internal medicine; Psychiatry; Disease","score_opus":0.22071223929618813,"score_gpt":0.3529659023259332,"score_spread":0.1322536630297451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120800281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96819687,0.00788743,0.001620176,0.018579362,0.0006145497,0.0026192272,0.0002894128,0.000036747144,0.00015622028],"genre_scores_gemma":[0.99087155,0.005542772,0.0015973283,0.0010196972,0.0003095884,0.00022465145,0.000011480559,0.000044817574,0.00037809077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493617,0.001520053,0.0011221012,0.00049146404,0.0011150867,0.00081513857],"domain_scores_gemma":[0.99138546,0.005386096,0.00065621827,0.0007276969,0.0014699667,0.000374533],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0030526856,0.00039525094,0.0014503653,0.00018041972,0.0018189301,0.00017681338,0.00042123644,0.00013171784,0.00006371011],"category_scores_gemma":[0.0063110753,0.00022117741,0.0006816242,0.00051162293,0.00174455,0.00020547505,0.00047039302,0.00086651713,0.0000024646438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04902186,0.0015347042,0.70172393,0.0014234846,0.003197305,0.0000094836105,0.03705518,0.0004949561,0.1422875,0.00041466753,0.02065646,0.04218045],"study_design_scores_gemma":[0.035917472,0.00033278237,0.92482597,0.0016195397,0.0001318509,0.00007588001,0.010131727,0.0065989443,0.016915685,0.00012121503,0.0030985698,0.00023039717],"about_ca_topic_score_codex":0.0003104317,"about_ca_topic_score_gemma":0.0012205257,"teacher_disagreement_score":0.22310199,"about_ca_system_score_codex":0.0002339669,"about_ca_system_score_gemma":0.000879068,"threshold_uncertainty_score":0.99948055},"labels":[],"label_agreement":null},{"id":"W3121899751","doi":"10.1177/1352458520988637","title":"Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Medicine; Multiple sclerosis; Cohort; Disease; Internal medicine; Clinical trial; Clinical phenotype; Phenotype; Young adult; Age of onset; Pediatrics; Psychiatry","score_opus":0.5241666445560712,"score_gpt":0.4965403499852401,"score_spread":0.0276262945708311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121899751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793092,0.00029732072,0.012553255,0.0028051243,0.0010124994,0.001794567,0.002128423,0.000039540835,0.00006009024],"genre_scores_gemma":[0.9780096,0.0010246389,0.016777951,0.0009333934,0.0024519397,0.00005174193,0.0005496836,0.00006292538,0.00013815123],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99227625,0.0018610948,0.002793441,0.0007743786,0.0014999593,0.00079489313],"domain_scores_gemma":[0.9910155,0.0038889667,0.0014287182,0.0012741819,0.0019425604,0.00045009042],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014614782,0.00038740592,0.0016610648,0.000142612,0.00076054473,0.000553868,0.00069942174,0.00022045147,0.0003517648],"category_scores_gemma":[0.06968299,0.00026336062,0.000515437,0.0005875206,0.0003379657,0.000537348,0.00095731113,0.0011534196,0.000030868458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001370279,0.0006079864,0.24949285,0.00010851251,0.001289546,0.000037353395,0.0058663036,0.000055772867,0.7128984,0.000003454739,0.00602264,0.022246914],"study_design_scores_gemma":[0.008501174,0.00028973536,0.93909734,0.0013708652,0.00040607608,0.000056320674,0.0028672235,0.022091215,0.019356575,0.0000065378426,0.0056538507,0.0003030948],"about_ca_topic_score_codex":0.0010902394,"about_ca_topic_score_gemma":0.0006978511,"teacher_disagreement_score":0.6935418,"about_ca_system_score_codex":0.00028894065,"about_ca_system_score_gemma":0.00044636568,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W3123369010","doi":"10.1177/1352458520987539","title":"A comparison of clinical outcomes in PPMS in the INFORMS original trial data set","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Logistic regression; Paced Auditory Serial Addition Test; Psychology; Test (biology); Clinical trial; Set (abstract data type); Clinical Practice; Physical therapy; Medicine; Cognition; Physical medicine and rehabilitation; Cognitive impairment; Internal medicine; Psychiatry","score_opus":0.5862866117347195,"score_gpt":0.5240522166809142,"score_spread":0.06223439505380535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123369010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946768,0.00042490414,0.000054597982,0.0029815638,0.000627721,0.000769949,0.000095608506,0.000012906315,0.00035590018],"genre_scores_gemma":[0.99510497,0.0014989633,0.0023393393,0.00033503966,0.0005234427,0.000031422784,0.00008509113,0.000021449205,0.00006030512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938685,0.00082897465,0.002624969,0.00046063913,0.0015654804,0.0006513924],"domain_scores_gemma":[0.9948098,0.0027891824,0.00056249666,0.0012465895,0.00034735847,0.0002445385],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0066125677,0.00026885074,0.0015674263,0.00031839055,0.00015883741,0.0001223361,0.0010001627,0.00018514736,0.00019400129],"category_scores_gemma":[0.015374011,0.00016259299,0.00036679863,0.0008034717,0.00030096722,0.00039587583,0.0005860601,0.0020480591,0.000024528961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069587426,0.002092919,0.9640592,0.00004815606,0.00018425181,0.000075157535,0.0015700519,0.000043158274,0.00061884936,0.0000078887015,0.004247501,0.020094128],"study_design_scores_gemma":[0.07463657,0.00055298326,0.9109789,0.0003845356,0.000052579744,0.00004137024,0.0040356386,0.00427932,0.00019737429,0.00001148693,0.00467911,0.00015011246],"about_ca_topic_score_codex":0.00027509022,"about_ca_topic_score_gemma":0.0022109526,"teacher_disagreement_score":0.06767783,"about_ca_system_score_codex":0.000114888746,"about_ca_system_score_gemma":0.0007108718,"threshold_uncertainty_score":0.9929199},"labels":[],"label_agreement":null},{"id":"W3123635300","doi":"","title":"Perceptions of risk and adherence to care in ms patients during the COVID-19 pandemic: a cross-sectional study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Specialty; Cross-sectional study; Family medicine; Coronavirus disease 2019 (COVID-19); Health care; Pediatrics; Emergency medicine; Internal medicine; Disease","score_opus":0.07922829740323901,"score_gpt":0.3430223437525423,"score_spread":0.2637940463493033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123635300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980118,0.00009707245,0.00017346654,0.00032389647,0.00013652717,0.0011225586,0.00009617971,0.00003053411,0.000007919782],"genre_scores_gemma":[0.9984402,0.000071601804,0.00026886744,0.0009211356,0.00021929813,0.000046179048,0.000005794673,0.000020863621,0.0000060546927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980534,0.00027412837,0.00053916493,0.0003149961,0.0005611013,0.00025725097],"domain_scores_gemma":[0.99808645,0.0006305322,0.00021364847,0.0001993545,0.00023447924,0.0006355448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110842,0.00017306693,0.0003060085,0.0001556736,0.00046551158,0.000101062804,0.00020977882,0.00007583883,0.00013334081],"category_scores_gemma":[0.0050684377,0.00012506984,0.000116174815,0.0003137855,0.00011475786,0.00015516217,0.00016238439,0.00062576577,0.00001208481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092090043,0.00022512383,0.9704565,0.00011845452,0.000040552823,0.000010636008,0.021569263,0.0011146188,0.004613308,1.7711707e-7,0.000036450594,0.00089403434],"study_design_scores_gemma":[0.009456511,0.0012315244,0.9861658,0.00009155595,0.000044590255,0.000038489026,0.0026066771,0.00013615594,0.00005182615,0.0000037430332,0.000052260548,0.00012086289],"about_ca_topic_score_codex":0.0006746753,"about_ca_topic_score_gemma":0.0010297151,"teacher_disagreement_score":0.018962586,"about_ca_system_score_codex":0.00037437066,"about_ca_system_score_gemma":0.00018085589,"threshold_uncertainty_score":0.60677594},"labels":[],"label_agreement":null},{"id":"W3124877733","doi":"10.1177/1352458520988632","title":"A multiple sclerosis disease progression measure based on cumulative disability","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Quartile; Multiple sclerosis; Metric (unit); Receiver operating characteristic; Medicine; Cohort; Severity of illness; Longitudinal study; Disease; Cohort study; Physical therapy; Statistics; Internal medicine; Confidence interval; Mathematics; Pathology","score_opus":0.16517394554296938,"score_gpt":0.34511297365983373,"score_spread":0.17993902811686435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124877733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089474,0.0017252958,0.0015204999,0.011094418,0.00084351754,0.0018919352,0.0003531758,0.0003429276,0.0013334884],"genre_scores_gemma":[0.99041986,0.00069698115,0.00629471,0.001021735,0.0008854666,0.00026553238,0.000120244156,0.00014055824,0.0001549241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99167895,0.001101376,0.0011901625,0.0012923029,0.003301959,0.0014352561],"domain_scores_gemma":[0.9924693,0.0017957265,0.00044567697,0.0014194094,0.001716668,0.0021532278],"candidate_categories":["metaresearch","metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017381286,0.00077363075,0.0010945831,0.00029794654,0.0015072188,0.00040030418,0.00043513943,0.00026647837,0.0012518808],"category_scores_gemma":[0.016634973,0.0006266252,0.0011209559,0.0010773988,0.00078573404,0.00045383116,0.00035862176,0.0017599472,0.00014500698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074473154,0.0057942336,0.7900074,0.00033167587,0.00043894752,0.00026940453,0.00044918386,0.002258746,0.07490697,0.0000076220035,0.005304569,0.112783924],"study_design_scores_gemma":[0.012436142,0.0006284717,0.89956766,0.004150263,0.00021605808,0.000027473381,0.00036940508,0.05769921,0.022775216,0.000021258882,0.001509965,0.0005988563],"about_ca_topic_score_codex":0.00004244748,"about_ca_topic_score_gemma":0.000119430195,"teacher_disagreement_score":0.11218507,"about_ca_system_score_codex":0.0010044379,"about_ca_system_score_gemma":0.00084485987,"threshold_uncertainty_score":0.9997927},"labels":[],"label_agreement":null},{"id":"W3125193724","doi":"","title":"COVID19 on U.S. and canadian neurologists' therapeutic approach to multiple sclerosis: A survey of knowledge, attitudes, and practices","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Pandemic; Coronavirus disease 2019 (COVID-19); Family medicine; Inclusion (mineral); Psychiatry; Psychology; Disease; Internal medicine","score_opus":0.31540868239944825,"score_gpt":0.3585578166816011,"score_spread":0.043149134282152835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125193724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98626196,0.00472691,0.0002050773,0.006359269,0.00015595018,0.0013892343,0.0002564372,0.00006369287,0.000581486],"genre_scores_gemma":[0.98973656,0.004940367,0.002080744,0.0028029615,0.00025400816,0.00006785963,0.000023089335,0.00007718932,0.00001721279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958722,0.00078746234,0.0007807948,0.00086025277,0.00077133224,0.00092795724],"domain_scores_gemma":[0.99434125,0.001723733,0.00051415584,0.00042884756,0.00073732,0.0022546952],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018919613,0.0004939106,0.0010030958,0.00049748825,0.00062372576,0.00024232813,0.00039317092,0.00020971653,0.000032998305],"category_scores_gemma":[0.0120698195,0.00040547497,0.00014109112,0.00080142077,0.00045892692,0.00027104927,0.00029639457,0.0011328328,0.000028049617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017256753,0.0006396499,0.9430478,0.00031197324,0.0004217475,0.000010523991,0.00192932,0.00011923208,0.028713493,0.000007910551,0.00257288,0.020499773],"study_design_scores_gemma":[0.0047852704,0.0015768091,0.9837523,0.00035183696,0.00009423867,0.000048276983,0.00023675703,0.0061693196,0.0007788853,0.0000013248696,0.001865458,0.00033951056],"about_ca_topic_score_codex":0.036999676,"about_ca_topic_score_gemma":0.048222184,"teacher_disagreement_score":0.04070449,"about_ca_system_score_codex":0.00017717258,"about_ca_system_score_gemma":0.0005275905,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W3127248578","doi":"10.1177/1352458521993066","title":"Serum neurofilament light in MS: The first true blood-based biomarker?","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Biomarker; Lumbar puncture; Cerebrospinal fluid; Biomarker discovery; Expert opinion; Oncology; Intensive care medicine; Internal medicine; Immunology; Proteomics","score_opus":0.2015667470640221,"score_gpt":0.355650558478286,"score_spread":0.15408381141426392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127248578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006264965,0.9901628,0.000016542534,0.0051076077,0.0009797865,0.00256938,0.00012623594,0.000077977464,0.00033319692],"genre_scores_gemma":[0.0021559293,0.9946808,0.00043986196,0.00065213285,0.0010119518,0.0005519111,0.00007312088,0.0002332129,0.00020105642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914908,0.0013311899,0.0024213505,0.0011440851,0.0019860107,0.001626579],"domain_scores_gemma":[0.99426013,0.0020002346,0.0010019786,0.0015571238,0.0005005094,0.0006800099],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002490747,0.0012398576,0.003995113,0.0010842262,0.0009821028,0.0005479319,0.0011661036,0.0005739611,0.00073382375],"category_scores_gemma":[0.0030869346,0.0007582655,0.0024075161,0.0019884205,0.00033589176,0.00016765445,0.00063466124,0.0036401819,0.00013225968],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011560566,0.0016272713,0.008015331,0.010779217,0.0020473767,0.00096747995,0.00028170864,0.000024632533,0.00016170289,0.0000031582802,0.017424863,0.95855165],"study_design_scores_gemma":[0.004987611,0.00023604334,0.026684498,0.064924404,0.0015139331,0.0005080676,0.00010288865,0.00027636907,0.000080345344,7.657829e-7,0.90003306,0.0006520168],"about_ca_topic_score_codex":0.00009446645,"about_ca_topic_score_gemma":0.00044906687,"teacher_disagreement_score":0.95789963,"about_ca_system_score_codex":0.00088311033,"about_ca_system_score_gemma":0.0014529759,"threshold_uncertainty_score":0.99948686},"labels":[],"label_agreement":null},{"id":"W3127617025","doi":"","title":"The canadian prospective cohort (CANPROCO) study to understand progression in multiple sclerosis: rationale and baseline characteristics","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Clinically isolated syndrome; Cohort; Prospective cohort study; Internal medicine; Cohort study; Physical therapy; Observational study; Disease; Clinical trial; Immunology","score_opus":0.14083598730910388,"score_gpt":0.3140552544641764,"score_spread":0.17321926715507255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127617025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97547317,0.0005094087,0.00024252861,0.016824841,0.00019942752,0.00646298,0.0001257916,0.000059944465,0.00010188613],"genre_scores_gemma":[0.9954969,0.000985811,0.0014106537,0.00104357,0.00056962547,0.00034735698,0.000023169156,0.000069197406,0.000053690015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954832,0.00044310407,0.000963203,0.0007417124,0.0013607679,0.0010080106],"domain_scores_gemma":[0.99604845,0.000702801,0.00024202857,0.00035926144,0.00088148576,0.0017659541],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0024005442,0.00043376317,0.0007098028,0.00033507167,0.0021988247,0.00065232074,0.0003397176,0.00011296292,0.000058680653],"category_scores_gemma":[0.008065622,0.00031000868,0.00012168345,0.0008356041,0.00030472138,0.00029079587,0.0002703311,0.0011665435,0.000035603243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013224479,0.000493023,0.9675771,0.000039114548,0.00022441776,0.000049926497,0.007607058,0.00004914704,0.0060078343,0.000005332858,0.002123157,0.014501454],"study_design_scores_gemma":[0.0069183726,0.0011127869,0.9744776,0.00050110655,0.00007076618,0.000021605385,0.008286583,0.006842127,0.0004188485,0.000007299417,0.0010261581,0.00031673524],"about_ca_topic_score_codex":0.005220631,"about_ca_topic_score_gemma":0.19414288,"teacher_disagreement_score":0.18892224,"about_ca_system_score_codex":0.0011286046,"about_ca_system_score_gemma":0.0007675703,"threshold_uncertainty_score":0.9999352},"labels":[],"label_agreement":null},{"id":"W3128676251","doi":"10.1177/1352458521989090","title":"Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Memorial University of Newfoundland; Montreal Neurological Institute and Hospital; SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children; Institute of Infection and Immunity","funders":"National Institutes of Health; Immune Tolerance Network; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Multiple Sclerosis Society of Canada; American Academy of Neurology; University of Pennsylvania; National Multiple Sclerosis Society","keywords":"Adipokine; Multiple sclerosis; Medicine; Microglia; Adiponectin; CD14; Immunology; Immune system; Inflammation; Myeloid; Internal medicine; Endocrinology; Leptin","score_opus":0.058398732882190954,"score_gpt":0.25798489118946694,"score_spread":0.199586158307276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128676251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99213785,0.0045616752,0.00023489316,0.00081407133,0.00098983,0.00054428406,0.000057983914,0.00013927327,0.0005201658],"genre_scores_gemma":[0.98856354,0.0048696185,0.00305352,0.00055405,0.0020901414,0.000087114364,0.00007939883,0.00009094254,0.0006116884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961009,0.00032128146,0.0012513628,0.0005865561,0.0008825949,0.0008573087],"domain_scores_gemma":[0.9970553,0.00038675903,0.00044327544,0.0005859761,0.00071076065,0.00081796566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091940927,0.00044520784,0.00076672214,0.0005658037,0.0004057013,0.0001922271,0.0002551295,0.0002451028,0.0006536406],"category_scores_gemma":[0.0034846915,0.00041936664,0.0004666965,0.000876093,0.00010229968,0.0005382395,0.000113551636,0.0008150369,0.00018139827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043073154,0.0007215344,0.9571403,0.00016830624,0.000116654366,0.00026315905,0.00072277564,0.00021483123,0.024454292,0.000012630928,0.004096773,0.011657963],"study_design_scores_gemma":[0.008734438,0.00007946056,0.97275776,0.0005045718,0.00034850702,0.00045529188,0.00045944983,0.0009652125,0.009203908,0.000038926228,0.0060178638,0.00043462162],"about_ca_topic_score_codex":0.00006809708,"about_ca_topic_score_gemma":0.00044549024,"teacher_disagreement_score":0.015617401,"about_ca_system_score_codex":0.0002511262,"about_ca_system_score_gemma":0.0010027585,"threshold_uncertainty_score":0.99982584},"labels":[],"label_agreement":null},{"id":"W3130180415","doi":"10.1177/1352458521995484","title":"The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; National Institutes of Health; National Multiple Sclerosis Society; Public Health Agency; European Commission; King's College London; National Institute of Neurological Disorders and Stroke; Jewish General Hospital; National Institute for Health and Care Research; Multiple Sclerosis Society of Canada; Public Health Agency of Canada; University of California, San Francisco; Cancer Research UK; Multiple Sclerosis Society; Wellcome Trust; Canadian Institutes of Health Research; Compute Canada","keywords":"Adiponectin; Mendelian randomization; Internal medicine; Medicine; Vitamin D and neurology; Leptin; Obesity; Endocrinology; Odds ratio; Body mass index; Confidence interval; Biology; Insulin resistance; Genotype; Genetics","score_opus":0.048247771415054035,"score_gpt":0.29500742974744193,"score_spread":0.2467596583323879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130180415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587581,0.0018133754,0.032664403,0.004706023,0.00025603292,0.0011957511,0.0004305492,0.00005812206,0.00011762725],"genre_scores_gemma":[0.9814675,0.012203356,0.005562,0.00010966067,0.00022600201,0.00012489874,0.00008879837,0.000040860272,0.00017695261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99475175,0.001278712,0.0013033486,0.00059987174,0.001316199,0.00075010245],"domain_scores_gemma":[0.9904725,0.004391905,0.00079388457,0.0005801588,0.0030626897,0.0006988485],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0034726937,0.0003796662,0.0011162844,0.00070753327,0.0019588433,0.00026568395,0.00024214225,0.00019954465,0.00015891745],"category_scores_gemma":[0.03363681,0.00028298507,0.000650873,0.0026665388,0.00033190488,0.00038136734,0.00033417784,0.0008774787,0.00002214831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019143433,0.00058312307,0.68673545,0.000046104138,0.005090937,0.000009524567,0.0027918625,0.0015606367,0.27589542,0.000054616838,0.0015421173,0.023775851],"study_design_scores_gemma":[0.016135713,0.0002481338,0.92560226,0.00027651194,0.0015978975,0.000022769751,0.0016426254,0.012332232,0.041383646,0.000046007368,0.0004363969,0.0002758183],"about_ca_topic_score_codex":0.00034319563,"about_ca_topic_score_gemma":0.0027882059,"teacher_disagreement_score":0.23886679,"about_ca_system_score_codex":0.0004863626,"about_ca_system_score_gemma":0.000275993,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W3130831844","doi":"10.1177/1352458521993075","title":"Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health","keywords":"Mendelian randomization; Major depressive disorder; Odds ratio; Depression (economics); Multiple sclerosis; Body mass index; Medicine; Pleiotropy; Odds; Genetic predisposition; Internal medicine; Logistic regression; Psychiatry; Genetics; Genotype; Biology; Genetic variants; Disease","score_opus":0.2607154706881714,"score_gpt":0.35896128066074595,"score_spread":0.09824580997257454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130831844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865276,0.004347809,0.0029141943,0.003802149,0.00026367253,0.0019073269,0.00008029826,0.00006107625,0.00009585028],"genre_scores_gemma":[0.98793787,0.0024521297,0.007864574,0.00022841037,0.0009405834,0.00032961078,0.00006518826,0.000050563514,0.00013109665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959091,0.00084124965,0.0009094728,0.00062010187,0.0010650879,0.00065499055],"domain_scores_gemma":[0.98857,0.009416997,0.0003108975,0.00039551177,0.0009881472,0.00031846872],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030360117,0.0003374601,0.0006300382,0.00037315456,0.0012121726,0.00036641065,0.0002369199,0.00020343761,0.00004846418],"category_scores_gemma":[0.03032166,0.00024329519,0.00027959616,0.00070999615,0.0001971517,0.0006760896,0.00016273675,0.0008508869,0.000014730621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017714369,0.00020277771,0.9090215,0.000121167315,0.00010770855,0.000006088196,0.0010220361,0.00016372191,0.0745218,0.0000054996094,0.0013966933,0.01165958],"study_design_scores_gemma":[0.016137956,0.00021572085,0.96603835,0.0019103253,0.00015586098,0.00007348139,0.0008779673,0.008539532,0.004974849,0.0000904793,0.0007361476,0.00024930842],"about_ca_topic_score_codex":0.00018489326,"about_ca_topic_score_gemma":0.00044068956,"teacher_disagreement_score":0.06954695,"about_ca_system_score_codex":0.00028414195,"about_ca_system_score_gemma":0.00032800858,"threshold_uncertainty_score":0.992129},"labels":[],"label_agreement":null},{"id":"W3136131376","doi":"10.1177/13524585211002097","title":"Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Hyperintensity; Internal medicine; Magnetic resonance imaging; Cohort; Cardiology; Pathology; Radiology; Psychiatry","score_opus":0.09904922201738842,"score_gpt":0.3192905582572728,"score_spread":0.2202413362398844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136131376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887108,0.003892444,0.00016815332,0.005890226,0.00018456529,0.0006157401,0.000044516597,0.00002863896,0.00046491215],"genre_scores_gemma":[0.98844576,0.00963404,0.00069195987,0.00057024276,0.00029678136,0.000059624108,0.000011405336,0.0000339914,0.00025621877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967637,0.0005219724,0.0005556801,0.00040427508,0.00070033415,0.0010540234],"domain_scores_gemma":[0.99749094,0.0010924439,0.00014012352,0.0002765152,0.00040800413,0.0005919545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089529937,0.00027630178,0.00047719057,0.00018895174,0.0006470208,0.00021846232,0.00015946224,0.000107098334,0.0004953514],"category_scores_gemma":[0.0032835167,0.00019008189,0.00019711215,0.0005256543,0.000405002,0.00017332922,0.0002715735,0.0010763002,0.000029408446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006229998,0.0011565227,0.80025554,0.00008190548,0.00032080902,0.00037741262,0.003943596,0.000027129809,0.06014417,0.000008704062,0.0036654833,0.12939572],"study_design_scores_gemma":[0.0075883293,0.00034059692,0.9798471,0.0008162564,0.00009356602,0.00029713818,0.0045527886,0.0010876071,0.0042259884,0.00002612338,0.0009310632,0.00019345134],"about_ca_topic_score_codex":0.00019792785,"about_ca_topic_score_gemma":0.0005507081,"teacher_disagreement_score":0.17959155,"about_ca_system_score_codex":0.00022400376,"about_ca_system_score_gemma":0.00033028267,"threshold_uncertainty_score":0.77513146},"labels":[],"label_agreement":null},{"id":"W3136546709","doi":"10.1177/1352458521999970","title":"Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Manitoba; Memorial University of Newfoundland; Queen's University","funders":"National Institutes of Health; Teva Pharmaceutical Industries; Mylan; Biogen; Celgene; Merck KGaA; Sanofi; National Multiple Sclerosis Society","keywords":"Psychosocial; Quality of life (healthcare); Affect (linguistics); Rehabilitation; Alliance; Multiple sclerosis; Medicine; Depression (economics); Physical medicine and rehabilitation; Physical therapy; Psychology; Gerontology; Psychiatry; Nursing; Political science","score_opus":0.2032232779312036,"score_gpt":0.3883511078204405,"score_spread":0.18512782988923693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136546709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9240881,0.011037302,0.00014102361,0.060723327,0.0011073595,0.0016459681,0.00016151587,0.00010786952,0.0009875228],"genre_scores_gemma":[0.96466094,0.0031766065,0.026843296,0.0007380324,0.0035906716,0.00042181768,0.00010101175,0.00008038779,0.0003872206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99287415,0.0010538475,0.000913319,0.0008282361,0.0032476028,0.0010828765],"domain_scores_gemma":[0.9891163,0.0046243407,0.00039089887,0.0007809168,0.0045624245,0.0005251172],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028531044,0.0003569629,0.0005643844,0.00018057083,0.0014256332,0.0008147018,0.00078503584,0.00019059697,0.00063115504],"category_scores_gemma":[0.026453905,0.0002515072,0.0004096368,0.0008114868,0.00091020926,0.00051401486,0.0007228787,0.0023483355,0.00012752978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001494887,0.0015289582,0.48118317,0.00012570474,0.0014365837,0.0009533672,0.01086866,0.0000396052,0.31348,0.00007512909,0.09018237,0.09863157],"study_design_scores_gemma":[0.0059864307,0.000455948,0.9428813,0.003501166,0.00007749759,0.00027066504,0.0050334167,0.002340009,0.008988306,0.00029036996,0.029847043,0.00032786385],"about_ca_topic_score_codex":0.00021065188,"about_ca_topic_score_gemma":0.00029756958,"teacher_disagreement_score":0.46169809,"about_ca_system_score_codex":0.0008602816,"about_ca_system_score_gemma":0.00080301904,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W3137966630","doi":"10.1177/13524585211001780","title":"Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Myelin; Spinal cord; White matter; Magnetic resonance imaging; Neurology; Internal medicine; Pathology; Radiology; Central nervous system; Immunology","score_opus":0.24686773606196313,"score_gpt":0.36538634391960534,"score_spread":0.1185186078576422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137966630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104106,0.0006420448,0.00024419668,0.005790472,0.0005398048,0.0009651936,0.00025510645,0.0001617182,0.00036039358],"genre_scores_gemma":[0.98972523,0.0033448625,0.0040022046,0.0016395279,0.00076318387,0.000105440704,0.00010541275,0.00012316692,0.00019099255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895101,0.001948094,0.002729095,0.0014918918,0.0024362046,0.0018845674],"domain_scores_gemma":[0.99099696,0.003599257,0.0006893893,0.0013424838,0.0018333975,0.0015384872],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005144132,0.0007909769,0.0021647466,0.0002517857,0.00085817015,0.00035286267,0.00059414876,0.0006182525,0.0014681928],"category_scores_gemma":[0.016189737,0.000640747,0.0009961616,0.0017254631,0.0014461573,0.0005868445,0.00064112054,0.0035100642,0.00012100394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029484385,0.0044474015,0.9514212,0.000097546006,0.00066564133,0.00031034413,0.0004882353,0.00004567632,0.0053841877,0.0000025275015,0.0027721603,0.03141662],"study_design_scores_gemma":[0.021668194,0.0008480199,0.9654482,0.0017847491,0.00019195153,0.00018614955,0.0010192919,0.004864356,0.0025778688,0.00002402354,0.0007311377,0.0006560859],"about_ca_topic_score_codex":0.00059823255,"about_ca_topic_score_gemma":0.006574198,"teacher_disagreement_score":0.030760534,"about_ca_system_score_codex":0.0014196928,"about_ca_system_score_gemma":0.00087796786,"threshold_uncertainty_score":0.9996044},"labels":[],"label_agreement":null},{"id":"W3139293378","doi":"10.1177/13524585211001781","title":"Childhood obesity and multiple sclerosis: A Mendelian randomization study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Medical Research Council; European Commission; King's College London; UK Research and Innovation; Fonds de Recherche du Québec - Santé; National Multiple Sclerosis Society; University of Bristol; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Wellcome Trust; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Mendelian randomization; Body mass index; Medicine; Odds ratio; Obesity; Childhood obesity; Biobank; Confidence interval; Multiple sclerosis; Young adult; Internal medicine; Demography; Overweight; Bioinformatics; Genetics; Genotype; Biology; Genetic variants","score_opus":0.08790835501972588,"score_gpt":0.28955257383391286,"score_spread":0.20164421881418698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139293378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217284,0.0027431883,0.0007556306,0.0015908954,0.00045109846,0.0017722581,0.00005356449,0.00016599345,0.000294561],"genre_scores_gemma":[0.9878613,0.0066741826,0.0038989973,0.00041547726,0.0007147367,0.00009220632,0.000036405443,0.00010082304,0.00020588782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944081,0.0008333271,0.0011796125,0.0009653369,0.0015687244,0.001044907],"domain_scores_gemma":[0.9959375,0.0007307383,0.00037127087,0.00073555764,0.0012238814,0.0010010304],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018693364,0.000593694,0.0012717017,0.00045479325,0.0014864132,0.00052584143,0.00028142787,0.00020689957,0.0003387335],"category_scores_gemma":[0.006035951,0.0005078306,0.00042511817,0.0008810644,0.00024510312,0.00054959254,0.0005122962,0.0012032889,0.000058428162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013042574,0.006502511,0.8566589,0.000094635376,0.0012133382,0.00015694257,0.0045185415,0.00015376133,0.09615034,0.000003912454,0.0021840942,0.031058813],"study_design_scores_gemma":[0.0529196,0.00057980756,0.92756313,0.00070758053,0.00034477128,0.0003137273,0.005267122,0.0026388268,0.008751727,0.000018075496,0.00043412924,0.0004615107],"about_ca_topic_score_codex":0.0001228422,"about_ca_topic_score_gemma":0.00038241583,"teacher_disagreement_score":0.08739861,"about_ca_system_score_codex":0.00031183538,"about_ca_system_score_gemma":0.0003613517,"threshold_uncertainty_score":0.9998135},"labels":[],"label_agreement":null},{"id":"W3143332518","doi":"10.1177/1352458516654311","title":"Haematopoietic stem cell transplants should be a second-line therapy for highly active MS – YES","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Stem cell; Multiple sclerosis; Haematopoiesis; Medicine; Oncology; Immunology; Biology; Cell biology","score_opus":0.31619425303300763,"score_gpt":0.38615720263639114,"score_spread":0.0699629496033835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143332518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011550381,0.986068,0.00061636115,0.0009774371,0.0010424359,0.005975541,0.0036914416,0.00015949638,0.00031425405],"genre_scores_gemma":[0.0022803296,0.9899468,0.0011596455,0.00032995548,0.0021138608,0.0013012355,0.00017842335,0.00041033796,0.0022794167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99233776,0.00064803427,0.0022286281,0.0012648464,0.001675927,0.0018447838],"domain_scores_gemma":[0.99276686,0.0029026477,0.0013709164,0.0010089068,0.00084756943,0.0011031145],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015092505,0.0015562368,0.0052455524,0.00093104655,0.00088160945,0.0002823195,0.0010233762,0.00094235357,0.0010122664],"category_scores_gemma":[0.00028937904,0.0009507005,0.0031245272,0.0004911383,0.00039887757,0.00037783405,0.00017289846,0.0021513733,0.00014486427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011138136,0.00071392517,0.000052857402,0.014638671,0.0021803088,0.000059543825,0.00062764797,5.803967e-7,0.0020272303,0.0000028261609,0.010323824,0.9682588],"study_design_scores_gemma":[0.012214697,0.001356742,0.00053116935,0.046241794,0.0011031196,0.00038121286,0.00015858257,0.000030011799,0.0027094923,0.0000093442895,0.93420506,0.0010587933],"about_ca_topic_score_codex":0.000013660883,"about_ca_topic_score_gemma":0.00004221392,"teacher_disagreement_score":0.9672,"about_ca_system_score_codex":0.0008025231,"about_ca_system_score_gemma":0.001052938,"threshold_uncertainty_score":0.99990094},"labels":[],"label_agreement":null},{"id":"W3153467397","doi":"10.1177/13524585211045545","title":"Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica; Ministero della Salute; Coloplast; Vrije Universiteit Amsterdam; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Medical Research Council; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Argenx","keywords":"Atrophy; Medicine; Spinal cord; Cord; Multiple sclerosis; Voxel-based morphometry; Voxel; Magnetic resonance imaging; Pathology; Internal medicine; Surgery; Radiology; White matter","score_opus":0.08491925645508731,"score_gpt":0.31831939783294166,"score_spread":0.23340014137785436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153467397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951631,0.00065484643,0.002374814,0.0007149586,0.00034633008,0.00042590912,0.00011247108,0.00006512588,0.00014247264],"genre_scores_gemma":[0.9785278,0.0013001487,0.01911542,0.00019437836,0.00045781527,0.000041065912,0.00011276362,0.000068201596,0.00018239688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944396,0.00030747574,0.0015571985,0.00073034916,0.0017379856,0.001227412],"domain_scores_gemma":[0.9960513,0.0004188444,0.00058708433,0.0006943479,0.0013989339,0.0008494834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069543597,0.0005316001,0.0015822018,0.00041931737,0.0007863022,0.00021665049,0.0003915062,0.00020781731,0.0011239212],"category_scores_gemma":[0.0013158156,0.00042995284,0.000990106,0.0013999353,0.0002435008,0.00022568445,0.0006117204,0.0009889605,0.00007114911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571695,0.0013948239,0.5310929,0.00026745687,0.0046397075,0.00007279146,0.0060828053,0.000050584546,0.40185618,0.000002874155,0.00014774507,0.052834973],"study_design_scores_gemma":[0.006957006,0.00016876431,0.91811484,0.00056342036,0.00069365173,0.000029525438,0.003009386,0.0019570987,0.0668682,0.0000021593864,0.0012622037,0.00037372654],"about_ca_topic_score_codex":0.000045312172,"about_ca_topic_score_gemma":0.00054491655,"teacher_disagreement_score":0.387022,"about_ca_system_score_codex":0.00050713687,"about_ca_system_score_gemma":0.00030715665,"threshold_uncertainty_score":0.9998152},"labels":[],"label_agreement":null},{"id":"W3155515376","doi":"10.1177/13524585211008760","title":"Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Neuroprotection; Neuroscience; Medicine; Physical medicine and rehabilitation; Psychology; Immunology","score_opus":0.2547972047859393,"score_gpt":0.3291347734752768,"score_spread":0.0743375686893375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155515376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020478899,0.99279475,0.00023048845,0.00001201811,0.0009027255,0.003668113,0.00028981565,0.000046361147,0.000007840723],"genre_scores_gemma":[0.006170079,0.9927764,0.00011733526,0.00014542644,0.000111152964,0.00049655454,0.000007628629,0.00017003715,0.000005406566],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9874819,0.005927743,0.0029743144,0.0014208852,0.0010961372,0.0010990512],"domain_scores_gemma":[0.993082,0.0026900969,0.0026644394,0.0007511742,0.00028704057,0.0005252873],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008811738,0.0011350377,0.0053457133,0.00069232093,0.00039451788,0.0004898438,0.0007857177,0.00021693212,0.000028678118],"category_scores_gemma":[0.008860412,0.0008871434,0.0010023938,0.0014904963,0.00026068217,0.00051335746,0.0004826062,0.0019738555,0.000015817417],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036396268,0.00078200613,0.000014764585,0.8834825,0.00011428641,0.00033884548,0.00027912474,0.000044845183,0.027797151,0.00026141177,0.000058949016,0.08678968],"study_design_scores_gemma":[0.0012253739,0.0003971925,0.00006032748,0.9772007,0.0016221427,0.0009573561,0.00010802387,0.00024259104,0.012231621,0.0000124664275,0.0049649095,0.0009772928],"about_ca_topic_score_codex":0.000017277416,"about_ca_topic_score_gemma":0.000027973205,"teacher_disagreement_score":0.09371816,"about_ca_system_score_codex":0.00019193592,"about_ca_system_score_gemma":0.0007916179,"threshold_uncertainty_score":0.99948835},"labels":[],"label_agreement":null},{"id":"W3156047582","doi":"10.1177/13524585211010390","title":"Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: A randomized, double-blind, placebo-controlled trial (SAMS-PAP study)","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Continuous positive airway pressure; Obstructive sleep apnea; Medicine; Double blind; Hypopnea; Randomized controlled trial; Multiple sclerosis; Placebo; Anesthesia; Apnea; Polysomnography; Internal medicine; Pathology","score_opus":0.06188024008347666,"score_gpt":0.31193524505193665,"score_spread":0.25005500496846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156047582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968235,0.0054298476,0.00015347208,0.00026177528,0.0009905873,0.024363723,0.0001851955,0.00006577436,0.00031462804],"genre_scores_gemma":[0.9920761,0.001963003,0.0008396276,0.0000225145,0.0006872467,0.003958097,0.00004913727,0.00013922472,0.00026506808],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.986083,0.00527931,0.003647339,0.0012645392,0.0023312017,0.0013946265],"domain_scores_gemma":[0.98452276,0.009742826,0.0019562608,0.0010758208,0.0020168421,0.00068549515],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004870732,0.0012077182,0.0077142077,0.0010887723,0.0005001896,0.0001696802,0.0005133194,0.0004590008,0.00021775239],"category_scores_gemma":[0.008637927,0.00086296874,0.002589962,0.0011943171,0.0008864312,0.00043284314,0.00032985854,0.001158521,0.0000144626165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8640248,0.008635056,0.040453453,0.00022682936,0.009063934,0.00014976568,0.005954802,0.0007919235,0.051076308,0.0000028863246,0.00003896771,0.01958125],"study_design_scores_gemma":[0.855431,0.01209035,0.031033203,0.0011509409,0.0032430878,0.00005946854,0.0027647917,0.0039297603,0.08976003,0.000003666375,0.000017251701,0.00051643397],"about_ca_topic_score_codex":0.00085739983,"about_ca_topic_score_gemma":0.00053453085,"teacher_disagreement_score":0.038683724,"about_ca_system_score_codex":0.00063647854,"about_ca_system_score_gemma":0.00048322903,"threshold_uncertainty_score":0.99971277},"labels":[],"label_agreement":null},{"id":"W3164755758","doi":"10.1177/13524585211016726","title":"Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Comorbidity; Consumption (sociology); Cohort; Population; Health care; Gerontology; Multidisciplinary approach; Cohort study; Demography; Family medicine; Environmental health; Psychiatry; Internal medicine","score_opus":0.056995659457140475,"score_gpt":0.2717866004100312,"score_spread":0.21479094095289075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164755758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967764,0.0013291051,0.00021904851,0.00030318054,0.00011600069,0.0008092015,0.0004038386,0.000033402786,0.000009847242],"genre_scores_gemma":[0.99246716,0.0006237346,0.006126499,0.00017029406,0.00007502868,0.00014618775,0.0003053402,0.000060934486,0.000024805111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99465555,0.00051758956,0.0014288839,0.0007938994,0.0016047336,0.0009993403],"domain_scores_gemma":[0.9960614,0.0009582344,0.0005596632,0.00053215463,0.0014359516,0.0004526075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008103514,0.00033578876,0.0013694437,0.00061526627,0.0004152475,0.0003076947,0.00026508298,0.00018130802,0.00022176065],"category_scores_gemma":[0.0031109906,0.0004442666,0.0003265539,0.0028506902,0.00014335672,0.00029559343,0.00012863817,0.0009584914,0.000001737309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001951002,0.00038917188,0.96239597,0.00040474176,0.00041984822,0.00024769886,0.0011527191,0.01839863,0.0119217355,7.04393e-8,0.00007952742,0.004394764],"study_design_scores_gemma":[0.010225191,0.0001121841,0.9330016,0.0035126274,0.00029949125,0.000068534566,0.0049881586,0.04639176,0.0010023192,7.720058e-7,0.000007687241,0.0003896884],"about_ca_topic_score_codex":0.90922934,"about_ca_topic_score_gemma":0.9990095,"teacher_disagreement_score":0.08978013,"about_ca_system_score_codex":0.0019604778,"about_ca_system_score_gemma":0.0020525188,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W3172159066","doi":"10.1177/13524585211020221","title":"Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Demographic Trends and Gender Preferences","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Proband; Multiple sclerosis; Demography; Relative risk; Medicine; Family history; Internal medicine; Confidence interval; Genetics; Biology; Psychiatry; Gene","score_opus":0.2354180301001107,"score_gpt":0.3266725144321339,"score_spread":0.09125448433202321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172159066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531144,0.0024893775,0.00003288981,0.001598125,0.0001370263,0.00017222628,0.000035710735,0.0000074123454,0.00021579707],"genre_scores_gemma":[0.9825323,0.016909404,0.0002982589,0.00006808468,0.00013191624,0.000023549861,0.0000049318105,0.000007930617,0.000023619506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997438,0.000928274,0.00038032565,0.00029207868,0.00056284183,0.0003984958],"domain_scores_gemma":[0.99899393,0.00042117276,0.00022298229,0.00019204881,0.00004297795,0.00012690143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017753842,0.00017459075,0.0002790624,0.00021441304,0.00041816293,0.00018750525,0.00031731234,0.000114049835,0.00013027206],"category_scores_gemma":[0.0002249256,0.00012305811,0.00012608588,0.0004620559,0.00028704907,0.00019368087,0.0000577601,0.00041048232,0.0000025872225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003164026,0.00023476893,0.85048294,0.0000047748863,0.000022622053,0.000006383744,0.01687625,0.00029723922,0.002245905,0.000025446108,0.00009367861,0.12967832],"study_design_scores_gemma":[0.0010257696,0.00015594997,0.98374283,0.00018703962,0.0000100147145,0.000004172534,0.013124179,0.00030796992,0.0006724852,0.0002709419,0.00034757738,0.00015108913],"about_ca_topic_score_codex":0.0034761236,"about_ca_topic_score_gemma":0.039004277,"teacher_disagreement_score":0.13325985,"about_ca_system_score_codex":0.00008455895,"about_ca_system_score_gemma":0.0001367027,"threshold_uncertainty_score":0.9785314},"labels":[],"label_agreement":null},{"id":"W3172962533","doi":"10.1177/13524585211023345","title":"Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia; University of British Columbia Hospital","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; White matter; Corpus callosum; Diffusion MRI; Neuroinflammation; Myelin; Magnetic resonance imaging; Neurodegeneration; Medicine; T2 relaxation; Pathology; Clinically isolated syndrome; Neuroscience; Central nervous system; Psychology; Radiology; Internal medicine","score_opus":0.04730690347125414,"score_gpt":0.24148815448525948,"score_spread":0.19418125101400535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172962533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910149,0.00029495818,0.0046549556,0.0032829554,0.00012810444,0.0005071275,0.000031827156,0.00005166068,0.00003352432],"genre_scores_gemma":[0.9903142,0.005732397,0.003318595,0.00012652701,0.0002708682,0.000024630013,0.000106268046,0.00005671053,0.000049819675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973338,0.00027730362,0.000697853,0.0005199381,0.00077267137,0.00039839355],"domain_scores_gemma":[0.9979853,0.00024198135,0.0005148861,0.00030813398,0.00065313274,0.0002965365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049150665,0.0003040297,0.0004972242,0.00034588552,0.00059441064,0.00024185888,0.00007407955,0.000087138935,0.000045535904],"category_scores_gemma":[0.0011800942,0.00025828683,0.00009535132,0.00046214173,0.0002027368,0.00073729054,0.00015428814,0.00042595252,0.0000024935473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026304414,0.00010822044,0.35677204,0.00008524791,0.000040765935,0.000010072315,0.0003508622,0.000030281859,0.61706877,0.0000050403255,0.000017965942,0.025247706],"study_design_scores_gemma":[0.0037396427,0.00017102771,0.71498346,0.0006575336,0.00008073849,0.00020216293,0.00016847305,0.027811743,0.25195625,0.0000051033276,0.00005909914,0.00016473913],"about_ca_topic_score_codex":0.000053805277,"about_ca_topic_score_gemma":0.0001602612,"teacher_disagreement_score":0.36511248,"about_ca_system_score_codex":0.00010426936,"about_ca_system_score_gemma":0.000113729264,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W3185484305","doi":"10.1177/13524585211031791","title":"High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Toronto Western Hospital; University of Toronto; University Health Network; North York General Hospital; University of Waterloo; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Comorbidity; Anxiety; Multiple sclerosis; COPD; Population; Depression (economics); Diabetes mellitus; Immigration; Mood disorders; Disease; Mood; Internal medicine; Psychiatry; Physical therapy","score_opus":0.10233025610374344,"score_gpt":0.28516143321338017,"score_spread":0.18283117710963673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185484305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227256,0.004596596,0.000089187146,0.001411089,0.00032233697,0.0007663064,0.00034398012,0.000067016575,0.00013090245],"genre_scores_gemma":[0.96209943,0.03033248,0.0062306365,0.00023976967,0.00027296742,0.00024800506,0.00003569235,0.000102793754,0.00043823483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941065,0.0004816688,0.0013971181,0.0008389795,0.0019461716,0.0012295791],"domain_scores_gemma":[0.9950648,0.001572618,0.00057778816,0.00088766025,0.0012720751,0.00062509155],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010088234,0.0006033909,0.0014184986,0.0005874982,0.00054139935,0.00011938325,0.00047189643,0.00022931417,0.0011948482],"category_scores_gemma":[0.0030437568,0.00049172074,0.00044957918,0.001146733,0.0006984748,0.0004765276,0.00052465516,0.0010624946,0.000051212177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012309548,0.0011666181,0.8577515,0.00067314674,0.00035347336,0.00018744226,0.0010920303,0.00031757492,0.12824863,0.0000062502536,0.00252404,0.00644837],"study_design_scores_gemma":[0.011482137,0.0005209923,0.8378214,0.00451894,0.00015861593,0.0002011366,0.0010559821,0.00047142067,0.14310172,0.000012190737,0.00024521016,0.0004102244],"about_ca_topic_score_codex":0.0012671287,"about_ca_topic_score_gemma":0.004684371,"teacher_disagreement_score":0.030173164,"about_ca_system_score_codex":0.0006591148,"about_ca_system_score_gemma":0.0003893707,"threshold_uncertainty_score":0.9997534},"labels":[],"label_agreement":null},{"id":"W3185886878","doi":"10.1177/13524585211031801","title":"MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Medicine; Logistic regression; Brain size; Physical medicine and rehabilitation; Neuroimaging; Physical therapy; Internal medicine; Psychology; Radiology; Psychiatry","score_opus":0.17610571536707592,"score_gpt":0.37490502779668583,"score_spread":0.1987993124296099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185886878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968778,0.0065721204,0.00029354464,0.021845007,0.0008197528,0.0011458012,0.00012074631,0.0001296599,0.00029537865],"genre_scores_gemma":[0.97503895,0.011204002,0.009560887,0.00124853,0.0017495733,0.00009428101,0.00006470968,0.0001389931,0.00090008153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917992,0.0011422519,0.0025462173,0.0013560987,0.0015819852,0.0015742617],"domain_scores_gemma":[0.99398565,0.0020247104,0.0006530628,0.0008935864,0.001104761,0.0013382301],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033475677,0.00073271355,0.0018095131,0.00061148335,0.0008187729,0.00046221312,0.00045520064,0.00054787635,0.0010137317],"category_scores_gemma":[0.012245496,0.00064612867,0.0007546607,0.0009310061,0.00094096025,0.00066907506,0.0009434653,0.0032810275,0.00014083824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000667848,0.0006791264,0.8151028,0.00018165675,0.00032704155,0.00072481105,0.0005313846,0.000026588345,0.024896195,0.000003106453,0.008153877,0.14870554],"study_design_scores_gemma":[0.018970681,0.00054878765,0.9611228,0.0018977743,0.00012270785,0.00060613593,0.001276092,0.0052677765,0.0016429712,0.000022130072,0.007908238,0.00061392115],"about_ca_topic_score_codex":0.00022535361,"about_ca_topic_score_gemma":0.00057929254,"teacher_disagreement_score":0.14809161,"about_ca_system_score_codex":0.0005250352,"about_ca_system_score_gemma":0.000686823,"threshold_uncertainty_score":0.9998995},"labels":[],"label_agreement":null},{"id":"W3190031979","doi":"10.1177/13524585211032803","title":"CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Tolerability; Multiple sclerosis; Hazard ratio; Adverse effect; Randomized controlled trial; Internal medicine; Confidence interval; Surgery; Anesthesia; Pathology; Immunology","score_opus":0.13549377302478785,"score_gpt":0.36847004121873417,"score_spread":0.23297626819394632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190031979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98645544,0.003935073,0.000360888,0.0007637035,0.0030374427,0.004269697,0.000076783304,0.00008226467,0.0010187104],"genre_scores_gemma":[0.9915596,0.002645154,0.0017075582,0.0012735812,0.0016072245,0.000804253,0.000017853317,0.00007445671,0.00031029515],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98534304,0.0075710504,0.0040605124,0.00058807794,0.0009687347,0.0014685633],"domain_scores_gemma":[0.9845171,0.01109508,0.0021118834,0.0005088441,0.00084209756,0.00092497835],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.008489547,0.0004688541,0.0028332802,0.0004762045,0.0013152395,0.000064785476,0.00041974877,0.00057985884,0.0007565252],"category_scores_gemma":[0.029785179,0.00037496522,0.0010296156,0.00080994854,0.00025368432,0.0003704085,0.00020983907,0.0021178024,0.000073056566],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9144325,0.0008968035,0.07070762,0.00024853103,0.00019637664,0.000040721552,0.0012238697,0.00029388748,0.002909676,0.000020000753,0.0028733644,0.006156636],"study_design_scores_gemma":[0.97887987,0.00019037265,0.012606276,0.0016806837,0.00022714522,0.0000068531153,0.0018388922,0.0031093487,0.0001599791,0.00006575431,0.00087194605,0.00036288993],"about_ca_topic_score_codex":0.00047004138,"about_ca_topic_score_gemma":0.000434566,"teacher_disagreement_score":0.06444735,"about_ca_system_score_codex":0.00045068868,"about_ca_system_score_gemma":0.0035074481,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W3190957947","doi":"10.1177/13524585211035740","title":"Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ocrelizumab; Multiple sclerosis; Internal medicine; Clinical trial; Population; Relapsing remitting; Magnetic resonance imaging; Disease; Lesion; Oncology; Surgery; Radiology; Immunology; Rituximab","score_opus":0.1405478466227287,"score_gpt":0.33812543360792224,"score_spread":0.19757758698519354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190957947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96672314,0.008659123,0.0033314747,0.0051721754,0.0011856841,0.014391418,0.00025913183,0.00022415507,0.000053709246],"genre_scores_gemma":[0.9590877,0.007334169,0.020933831,0.0008240483,0.0018787911,0.00872077,0.000053613603,0.00025922293,0.0009078524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990175,0.0020885991,0.0023543213,0.0015178027,0.0017985238,0.0020657228],"domain_scores_gemma":[0.9860417,0.007959946,0.0007290131,0.0012179171,0.0019220377,0.002129384],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0042194645,0.001130202,0.0031823893,0.0007359272,0.0016446889,0.0007803064,0.0004222374,0.00031715998,0.0004046625],"category_scores_gemma":[0.029936839,0.00086840393,0.0029530874,0.0007978621,0.0002374015,0.00041288283,0.00029606058,0.00086182373,0.00006170801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.812179,0.0032476203,0.0072339983,0.0000742064,0.0018852173,0.00017637969,0.0017170297,0.00037921808,0.15036048,5.303199e-7,0.00091497676,0.021831304],"study_design_scores_gemma":[0.8951763,0.005621093,0.07417179,0.002515817,0.0008125811,0.00009660068,0.00057594385,0.008993263,0.0075666187,0.000008187115,0.0035738687,0.0008879172],"about_ca_topic_score_codex":0.000056447912,"about_ca_topic_score_gemma":0.00007016534,"teacher_disagreement_score":0.14279386,"about_ca_system_score_codex":0.0016201843,"about_ca_system_score_gemma":0.001540498,"threshold_uncertainty_score":0.999655},"labels":[],"label_agreement":null},{"id":"W3193036633","doi":"10.1177/13524585211034826","title":"White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Olav Thon Stiftelsen; IXICO; H. Lundbeck A/S; Genentech; Vlaamse regering; Innovative Medicines Initiative; University College London Hospitals NHS Foundation Trust; Vetenskapsrådet; Eisai; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Servier; Stichting MS Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Research Foundation; UK Dementia Research Institute; European Federation of Pharmaceutical Industries and Associations; National Institute on Aging; National Institute for Health and Care Research; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; Alzheimer's Drug Discovery Foundation; ZonMw; Universiteit Antwerpen; Alzheimer's Association; Stiftelsen för Gamla Tjänarinnor; Hjärnfonden; European Commission; Familjen Erling-Perssons Stiftelse; University of Southern California; Novartis Pharmaceuticals Corporation; Eusko Jaurlaritza; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; F. Hoffmann-La Roche; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Foundation for the National Institutes of Health","keywords":"Fractional anisotropy; Corpus callosum; White matter; Diffusion MRI; Multiple sclerosis; Population; Medicine; Magnetic resonance imaging; Pathology; Radiology; Psychiatry","score_opus":0.060965245182280026,"score_gpt":0.282307210293065,"score_spread":0.22134196511078497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193036633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950301,0.0011674863,0.00030400266,0.00076387083,0.00022517542,0.0021434508,0.00031296298,0.00004836408,0.0000045720367],"genre_scores_gemma":[0.98644346,0.00055571296,0.011870887,0.00028584944,0.0003745391,0.00024779464,0.000081948914,0.00008464078,0.000055169632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568206,0.00051119504,0.001123189,0.0008937933,0.0008211889,0.0009685446],"domain_scores_gemma":[0.9973844,0.0006893002,0.0004003365,0.00052286877,0.0005244243,0.0004786348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005936142,0.00053320633,0.0010236448,0.0004834049,0.0008343553,0.0004326112,0.00026856328,0.00017289307,0.00022910564],"category_scores_gemma":[0.0015715522,0.00044438915,0.00032766414,0.00050771685,0.00014660804,0.00023866522,0.0002127064,0.0008412652,0.000014117268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051763817,0.00070221315,0.98160887,0.00005775387,0.00033418686,0.000014292569,0.00070735783,0.00017287886,0.009169557,1.0469222e-7,0.00030453256,0.006410598],"study_design_scores_gemma":[0.018770639,0.00043376634,0.9734347,0.0005089153,0.0002111948,0.00009286907,0.0008172254,0.0045513175,0.0007231165,0.000012792513,0.0000058627465,0.00043762696],"about_ca_topic_score_codex":0.0006906703,"about_ca_topic_score_gemma":0.0017797144,"teacher_disagreement_score":0.018253,"about_ca_system_score_codex":0.0002622609,"about_ca_system_score_gemma":0.00017474915,"threshold_uncertainty_score":0.9998008},"labels":[],"label_agreement":null},{"id":"W3195795521","doi":"10.1177/13524585211014459","title":"Do isolated cognitive relapses exist? – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Multiple sclerosis; Cognition; Medicine; Immunology; Psychiatry","score_opus":0.12194201583929307,"score_gpt":0.3292829252593618,"score_spread":0.20734090942006875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195795521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683712,0.0060168314,0.0009222546,0.0028079192,0.0014407655,0.0007299435,0.00012573421,0.00023011907,0.019355226],"genre_scores_gemma":[0.9831353,0.008682576,0.0035970805,0.0007701539,0.0011065162,0.00004362634,0.00004889418,0.00008449507,0.00253138],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99601567,0.00035687845,0.00078988523,0.0006296526,0.0012325417,0.00097535935],"domain_scores_gemma":[0.99468935,0.00081363,0.00025819847,0.00045707045,0.0029853904,0.00079635467],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00075416453,0.00040742382,0.000773397,0.00027691296,0.00081851706,0.00034239396,0.00021840264,0.00021070262,0.0021521389],"category_scores_gemma":[0.009287199,0.00034522146,0.0005022168,0.00070038834,0.0003000631,0.0003470959,0.0003069013,0.0014072006,0.0010179317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035883589,0.0024477162,0.29899946,0.00028945194,0.0025572386,0.001830555,0.002253744,0.00004148875,0.51804495,0.00004022853,0.058215775,0.11169102],"study_design_scores_gemma":[0.020740293,0.001162232,0.9098902,0.0042265933,0.0004239039,0.0019065868,0.0032411697,0.002080608,0.03416155,0.000088133274,0.02119015,0.00088858523],"about_ca_topic_score_codex":0.000025888068,"about_ca_topic_score_gemma":0.00002955631,"teacher_disagreement_score":0.61089075,"about_ca_system_score_codex":0.0002785496,"about_ca_system_score_gemma":0.00044839908,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W3196329862","doi":"10.1177/13524585211037909","title":"Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Relapsing remitting; Adverse effect; Placebo; Confidence interval; Internal medicine; Relative risk; Gastroenterology; Pediatrics; Psychiatry; Pathology; Alternative medicine","score_opus":0.10069297423574002,"score_gpt":0.31201764632132717,"score_spread":0.21132467208558714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196329862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995284,0.0004391678,0.0003361838,0.00032344155,0.00037289923,0.0029347872,0.00023422595,0.000043986438,0.000031262603],"genre_scores_gemma":[0.99355084,0.00057168625,0.0050949366,0.00009316055,0.0002175788,0.00010312014,0.00007056519,0.000105512445,0.00019258259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941979,0.0005009098,0.0017782194,0.0010287187,0.0013866724,0.0011075459],"domain_scores_gemma":[0.99468964,0.0019172013,0.00062740635,0.0007230021,0.0013456941,0.00069705915],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022318654,0.00054111786,0.0013357566,0.0006350521,0.0005081582,0.00018158495,0.00032675234,0.00016958574,0.000037922186],"category_scores_gemma":[0.009647178,0.0004653228,0.0002733863,0.001004049,0.00023202079,0.00034968002,0.00046517118,0.00095207576,0.000008223524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020700363,0.0023490756,0.9072998,0.0001330552,0.0004715187,0.00003879588,0.0049699917,0.0005350126,0.013636968,4.0876478e-7,0.00024908304,0.049615923],"study_design_scores_gemma":[0.0796479,0.0025069055,0.91005915,0.0032271524,0.00018282588,0.000014985751,0.001281588,0.00041066232,0.0022068983,7.892025e-7,0.00005269962,0.00040842599],"about_ca_topic_score_codex":0.00014487238,"about_ca_topic_score_gemma":0.00089793955,"teacher_disagreement_score":0.058947533,"about_ca_system_score_codex":0.00037474406,"about_ca_system_score_gemma":0.0002863456,"threshold_uncertainty_score":0.9997798},"labels":[],"label_agreement":null},{"id":"W3196759432","doi":"10.1177/13524585211041108","title":"Risk factors for peripartum depression in women with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Medicine; Psychiatry; Psychology; Physical medicine and rehabilitation","score_opus":0.09636819362826436,"score_gpt":0.29667640407320645,"score_spread":0.20030821044494207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196759432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464715,0.0010601495,0.0016030553,0.00066438294,0.00036489422,0.0011995856,0.00022568593,0.000109075845,0.00012605498],"genre_scores_gemma":[0.98394233,0.004608709,0.009857799,0.00022712584,0.00045538213,0.0004990209,0.000046163197,0.00014673691,0.00021672546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944776,0.00041360047,0.0010271692,0.0009774545,0.0013208248,0.0017833282],"domain_scores_gemma":[0.9950027,0.001688805,0.00046204598,0.00075084553,0.0010468895,0.001048722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012970542,0.0006433631,0.001220237,0.0005237413,0.0010602772,0.00032189416,0.00036409174,0.00027186566,0.00034949998],"category_scores_gemma":[0.0068079107,0.00047963308,0.00039057343,0.00089443906,0.00028687893,0.00052484614,0.00028400932,0.0013960494,0.000021791753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031157446,0.0009237961,0.8404578,0.00011948839,0.0003871319,0.00004731268,0.0030017488,0.00049521774,0.1290185,7.2717324e-7,0.0014745661,0.020957991],"study_design_scores_gemma":[0.01860637,0.0006038393,0.9369914,0.0014360601,0.00010342438,0.00007235718,0.0060019824,0.004290924,0.029380841,0.000012329186,0.0019776793,0.00052279],"about_ca_topic_score_codex":0.00022305404,"about_ca_topic_score_gemma":0.0006875397,"teacher_disagreement_score":0.099637665,"about_ca_system_score_codex":0.00097181194,"about_ca_system_score_gemma":0.00047735422,"threshold_uncertainty_score":0.9997655},"labels":[],"label_agreement":null},{"id":"W3198279588","doi":"10.1177/13524585211017020","title":"Slowly expanding lesions are a marker of progressive MS – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Pathology; Neuroscience; Psychology; Psychiatry","score_opus":0.11723377009200073,"score_gpt":0.3338459565445452,"score_spread":0.21661218645254446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198279588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900296,0.0038250564,0.00039362474,0.001989131,0.0006072125,0.0005348108,0.00007544566,0.00006655533,0.002478602],"genre_scores_gemma":[0.98222333,0.003159718,0.012558438,0.00019730865,0.00079261686,0.00005872166,0.0000158489,0.00005998766,0.00093401066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996415,0.00028390458,0.0008553437,0.00044510083,0.0012355077,0.0007651077],"domain_scores_gemma":[0.99575096,0.00052245293,0.00053032313,0.00051438,0.0021063206,0.000575543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075192226,0.00031649947,0.00082907703,0.0002925346,0.0005537346,0.0001216238,0.00023736904,0.00015282797,0.0016482536],"category_scores_gemma":[0.0064200494,0.00025388482,0.00053435,0.0005811396,0.0002895196,0.00024736676,0.00033354358,0.00086547283,0.000093831404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000615659,0.0009253019,0.4645345,0.00026798216,0.00065041013,0.00039403484,0.00068398385,0.000018138533,0.49333593,0.0000072764205,0.015531797,0.023034984],"study_design_scores_gemma":[0.0056921523,0.0002515575,0.93315583,0.0033490395,0.00012519216,0.00038521527,0.0013799322,0.000746331,0.05107109,0.000015113742,0.0035606525,0.00026790786],"about_ca_topic_score_codex":0.000020691883,"about_ca_topic_score_gemma":0.000027291562,"teacher_disagreement_score":0.4686213,"about_ca_system_score_codex":0.0002247769,"about_ca_system_score_gemma":0.00036222738,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W3198414947","doi":"10.1177/13524585211035951","title":"The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Alcon; Biogen; EMD Serono; Novartis; Genzyme","keywords":"Prodrome; Multiple sclerosis; Medicine; Clinically isolated syndrome; Pediatrics; Psychiatry; Psychosis","score_opus":0.09516910512073876,"score_gpt":0.279761138026281,"score_spread":0.18459203290554224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198414947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969996,0.0033960927,0.00007071705,0.0032499575,0.0012546339,0.0015282515,0.00014134828,0.00015770788,0.00050131127],"genre_scores_gemma":[0.9752389,0.02084486,0.0011932197,0.00079240743,0.00043302195,0.00020900741,0.000082643906,0.00013447819,0.0010714439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916809,0.000871992,0.0019758758,0.0012596536,0.002073957,0.002137572],"domain_scores_gemma":[0.9931578,0.001652905,0.0005816711,0.0012536173,0.0023962518,0.0009577375],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017309946,0.0008238826,0.001418819,0.00046966248,0.0018546032,0.00064071483,0.00090593984,0.0004497343,0.00095697294],"category_scores_gemma":[0.007055293,0.0005705139,0.00076130795,0.0017151947,0.000704137,0.00050373696,0.00066731434,0.0024078256,0.00061580224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020353305,0.0023323055,0.88874835,0.00013062097,0.0009128086,0.00042060105,0.0011054783,0.000092812166,0.056747697,0.0000064715864,0.018153818,0.029313687],"study_design_scores_gemma":[0.014145225,0.0012306622,0.9675199,0.0013709975,0.000100758625,0.0003743858,0.00055588415,0.0036699618,0.0015265879,0.000013559091,0.008857879,0.0006342428],"about_ca_topic_score_codex":0.0000672651,"about_ca_topic_score_gemma":0.00016107848,"teacher_disagreement_score":0.07877149,"about_ca_system_score_codex":0.0010221107,"about_ca_system_score_gemma":0.00042596826,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W3201723867","doi":"10.1177/13524585211049986","title":"Prediction of multiple sclerosis outcomes when switching to ocrelizumab","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Cegep de Saint Jerome","funders":"Novartis Pharma; Sanofi Genzyme; EMD Serono; Dokuz Eylül Üniversitesi; University of Tasmania; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Clinical neurology; Internal medicine; Psychology; Neuroscience; Immunology","score_opus":0.17819417445610608,"score_gpt":0.30784838709603873,"score_spread":0.12965421263993265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201723867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838364,0.0010155983,0.0065435353,0.0055098655,0.0010446374,0.0009430693,0.0002583364,0.00017981346,0.00066875643],"genre_scores_gemma":[0.9677819,0.0018097319,0.028330771,0.00076285994,0.0006164298,0.00009020521,0.000040185714,0.000119585566,0.0004483544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99375355,0.00037501164,0.0016774454,0.0008434132,0.002147891,0.0012026904],"domain_scores_gemma":[0.99448514,0.0009934462,0.00048768253,0.0010036153,0.001877037,0.0011530868],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013210166,0.00059170794,0.0014330902,0.0007088745,0.00080617325,0.00023845352,0.00047624827,0.00025917852,0.00073762535],"category_scores_gemma":[0.009362753,0.0005087907,0.00086245284,0.0008725016,0.0001591856,0.0005125375,0.0006002927,0.0012110736,0.00012320538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004619192,0.00065396,0.48903862,0.00011911276,0.0005914836,0.000036118432,0.0016066345,0.00020868849,0.47249395,0.0000062555337,0.006722045,0.028061206],"study_design_scores_gemma":[0.009167012,0.00048297603,0.9030094,0.0016743598,0.00018068173,0.0001540233,0.0013927935,0.0023894766,0.07811282,0.00003540613,0.0030367172,0.00036429547],"about_ca_topic_score_codex":0.00023319201,"about_ca_topic_score_gemma":0.00021017219,"teacher_disagreement_score":0.41397083,"about_ca_system_score_codex":0.0005737216,"about_ca_system_score_gemma":0.00045749775,"threshold_uncertainty_score":0.99973637},"labels":[],"label_agreement":null},{"id":"W3203173550","doi":"10.1177/13524585211048397","title":"Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Cardiorespiratory fitness; Multiple sclerosis; Physical activity; Cognition; Baseline (sea); Medicine; Physical therapy; Gerontology; Physical medicine and rehabilitation; Physical fitness; Psychology; Psychiatry; Biology","score_opus":0.19073963861643262,"score_gpt":0.33986981178646947,"score_spread":0.14913017317003685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203173550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551785,0.0009907108,0.00020539618,0.0010336813,0.000073654985,0.0014619811,0.0006133812,0.000085402855,0.000017953187],"genre_scores_gemma":[0.9980342,0.00024137528,0.00044260232,0.0002518099,0.00053466705,0.0003397824,0.00004195088,0.00009738323,0.000016233838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99363124,0.0019795292,0.0005317589,0.0009930545,0.0019598512,0.00090454746],"domain_scores_gemma":[0.9921486,0.004644569,0.000619898,0.00076780736,0.0013435903,0.0004755526],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014862572,0.00063772406,0.0013730448,0.00024758658,0.0011732811,0.00043339346,0.00034103545,0.00015483523,0.000053089825],"category_scores_gemma":[0.009208271,0.00039741668,0.00026847058,0.0010751408,0.0006695279,0.0005257343,0.00042717942,0.0017291929,0.0000035186165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016650822,0.004238082,0.9017683,0.000037846527,0.0021620279,0.0004082705,0.004527084,0.00027566185,0.07833005,8.766205e-8,0.000256495,0.006331007],"study_design_scores_gemma":[0.015620083,0.00080206204,0.9362093,0.0046398877,0.0009962193,0.000046006873,0.02343593,0.0070657553,0.0107202595,0.0000011108028,0.000007696582,0.00045564643],"about_ca_topic_score_codex":0.0006647297,"about_ca_topic_score_gemma":0.00841238,"teacher_disagreement_score":0.067609794,"about_ca_system_score_codex":0.00038120308,"about_ca_system_score_gemma":0.0004115286,"threshold_uncertainty_score":0.99984777},"labels":[],"label_agreement":null},{"id":"W3204879978","doi":"10.1177/13524585211049397","title":"Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Reliability (semiconductor); Psychology; Clinical trial; Raw score; Cognitive decline; Test (biology); Physical therapy; Physical medicine and rehabilitation; Medicine; Audiology; Statistics; Internal medicine; Psychiatry; Disease; Raw data; Mathematics; Power (physics)","score_opus":0.42373511052857754,"score_gpt":0.350789731827612,"score_spread":0.07294537870096557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204879978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976021,0.0021886036,0.0006950197,0.018176401,0.00059805403,0.0017904247,0.000071156835,0.00010520472,0.00035412668],"genre_scores_gemma":[0.9846907,0.0038559125,0.006496344,0.0029460553,0.0011461652,0.00054718665,0.000015331852,0.00015639052,0.00014589842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99352175,0.0014294932,0.0010926689,0.0008754991,0.0014514837,0.0016291187],"domain_scores_gemma":[0.9882289,0.008874596,0.00055430154,0.0011077034,0.000849923,0.00038457947],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035295747,0.0006853304,0.0011893696,0.00047223136,0.0018082956,0.00055432884,0.00065871316,0.000255795,0.00023171687],"category_scores_gemma":[0.0122440215,0.00039629475,0.00040953816,0.001552064,0.00058377266,0.0006796048,0.0006621946,0.0024555998,0.000025745481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012607491,0.0008297033,0.8350184,0.00019054556,0.00045362418,0.00013090485,0.027550133,0.00049355393,0.1161435,0.00003899905,0.0008189804,0.017070923],"study_design_scores_gemma":[0.0076865703,0.0009883284,0.86694556,0.012344401,0.0002649358,0.00069611834,0.035926916,0.04719087,0.025984515,0.0000626786,0.0010328364,0.0008762615],"about_ca_topic_score_codex":0.0019170047,"about_ca_topic_score_gemma":0.0029171903,"teacher_disagreement_score":0.090158984,"about_ca_system_score_codex":0.00085556874,"about_ca_system_score_gemma":0.00029841493,"threshold_uncertainty_score":0.9998489},"labels":[],"label_agreement":null},{"id":"W3207434524","doi":"10.1177/13524585211026875","title":"Air pollution is a risk factor for multiple sclerosis – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Risk factor; Medicine; Air pollution; Environmental health; Environmental science; Internal medicine; Immunology; Chemistry","score_opus":0.13961186234561968,"score_gpt":0.2918916959101515,"score_spread":0.15227983356453184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207434524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649474,0.00032081257,0.020476192,0.009959466,0.0012907506,0.00062714244,0.0018658978,0.00010873967,0.00040358907],"genre_scores_gemma":[0.96470445,0.0009315514,0.02397632,0.0092021255,0.0005053443,0.000029178478,0.000010589549,0.00004743825,0.0005929753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99682504,0.00030486326,0.0007152531,0.0005230457,0.000676522,0.0009552962],"domain_scores_gemma":[0.99785364,0.00037659655,0.00047595912,0.0004046034,0.00012222133,0.0007670085],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00089595054,0.0003097594,0.00038760316,0.000068790454,0.0015400449,0.00017132828,0.0003327648,0.0002311806,0.006260808],"category_scores_gemma":[0.0018709467,0.00028974065,0.00038064213,0.0003462922,0.00016446749,0.00070226565,0.00018631182,0.0005787983,0.0010684918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006950066,0.0010385922,0.32617295,0.000111809015,0.00017362287,0.0000105265935,0.006432288,0.004418161,0.138793,0.000013338183,0.15382011,0.36832058],"study_design_scores_gemma":[0.0032046346,0.00021670944,0.91724455,0.00014081274,0.00004141411,0.0000249764,0.00027310004,0.009131538,0.015513212,0.00015716428,0.053658616,0.00039328003],"about_ca_topic_score_codex":0.00039288247,"about_ca_topic_score_gemma":0.0005129015,"teacher_disagreement_score":0.5910716,"about_ca_system_score_codex":0.00062251755,"about_ca_system_score_gemma":0.000119462726,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W3213370463","doi":"10.1177/13524585211055787","title":"Administrative data for observational research in multiple sclerosis: Opportunities and challenges","year":2021,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Observational study; Medicine; MEDLINE; Data science; Physical medicine and rehabilitation; Computer science; Psychiatry; Political science; Pathology","score_opus":0.9765090372684502,"score_gpt":0.5564637936436005,"score_spread":0.42004524362484963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213370463","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00408701,0.009100786,0.0002869056,0.9795555,0.0020105983,0.0019336285,0.002268139,0.000055978577,0.0007014479],"genre_scores_gemma":[0.045152836,0.27543238,0.014462658,0.61088806,0.03199432,0.0027662732,0.01589867,0.0003075378,0.0030972809],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99138707,0.0027931288,0.0020772805,0.0007166745,0.001522172,0.0015036598],"domain_scores_gemma":[0.9839779,0.012245217,0.00093983184,0.0008658241,0.0015034501,0.00046776276],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.011999532,0.0004065052,0.00088152353,0.0006684625,0.0029541072,0.0001786412,0.0009403504,0.0015724913,0.0002899477],"category_scores_gemma":[0.007371063,0.0003696376,0.00010359661,0.00026077538,0.000309553,0.0008088559,0.0006265022,0.009136041,0.000029164032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016137946,0.00007158864,0.003034148,0.0038507993,0.00007210004,0.000041619212,0.003965542,0.0000023495998,0.00001736738,0.0001410951,0.96641815,0.02222388],"study_design_scores_gemma":[0.0033434846,0.00019754292,0.033509277,0.010407263,0.00003086152,0.000017003564,0.01491526,0.0038603144,0.0000033354816,0.00032833844,0.9330112,0.000376159],"about_ca_topic_score_codex":0.0001907309,"about_ca_topic_score_gemma":0.0009951651,"teacher_disagreement_score":0.36866745,"about_ca_system_score_codex":0.0005130163,"about_ca_system_score_gemma":0.0035017612,"threshold_uncertainty_score":0.99987555},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3217358002","doi":"10.1177/13524585211059766","title":"Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Multiple Sclerosis Society of Canada; Sunnybrook Hospital","funders":"Multiple Sclerosis Society; National Institute for Health and Care Research; International Progressive MS Alliance","keywords":"Alliance; Multiple sclerosis; Political science; Medicine; Psychiatry","score_opus":0.47006041406506316,"score_gpt":0.5162722029167015,"score_spread":0.04621178885163835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217358002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006167579,0.987522,0.0001597944,0.0008044161,0.001212829,0.008045639,0.0009498449,0.00015075249,0.00053796434],"genre_scores_gemma":[0.0010998916,0.9701776,0.015851606,0.00005666026,0.00755219,0.0038967337,0.00079630665,0.00025031166,0.00031872766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876998,0.0017673621,0.0024664772,0.0019408246,0.0035021822,0.0026233674],"domain_scores_gemma":[0.988092,0.0011339185,0.0017258421,0.001128636,0.0064668967,0.0014526726],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004753859,0.0012193302,0.0036401267,0.00057211303,0.0016775047,0.0016910806,0.0017823405,0.00082565914,0.0006616659],"category_scores_gemma":[0.0095678745,0.0009348496,0.0018264554,0.0014716795,0.00091902056,0.0008959252,0.0009657621,0.0039799763,0.00009253686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039844066,0.0011028379,0.0012143232,0.00706384,0.00247949,0.00054029597,0.0002605639,0.0000093169765,0.00008473548,0.000117741365,0.0056779804,0.98105043],"study_design_scores_gemma":[0.008599177,0.0029053227,0.0040861964,0.14323416,0.0012919299,0.0027711242,0.0010800691,0.0017365466,0.0001277617,0.00011490159,0.8323598,0.0016930363],"about_ca_topic_score_codex":0.00004431262,"about_ca_topic_score_gemma":0.00006713521,"teacher_disagreement_score":0.9793574,"about_ca_system_score_codex":0.0025583336,"about_ca_system_score_gemma":0.0056174514,"threshold_uncertainty_score":0.99962217},"labels":[],"label_agreement":null},{"id":"W4200021580","doi":"10.1177/13524585211063403","title":"Disease-modifying drugs for multiple sclerosis and subsequent health service use","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; University of Calgary; University of Manitoba; University of Alberta; University of Saskatchewan; Alberta Health Services; University of British Columbia Hospital; Saskatchewan Health Quality Council; University of British Columbia","funders":"Canadian Institutes of Health Research; Agency for Healthcare Research and Quality","keywords":"Medicine; Fingolimod; Multiple sclerosis; Hazard ratio; Confidence interval; Medical prescription; Population; Proportional hazards model; Teriflunomide; Disease; Pediatrics; Internal medicine; Environmental health; Psychiatry","score_opus":0.2395934882397914,"score_gpt":0.34361747662807185,"score_spread":0.10402398838828045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200021580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96114707,0.007862716,0.0027570259,0.024853397,0.0006308556,0.0019321603,0.0005937348,0.00019086753,0.0000321677],"genre_scores_gemma":[0.9558134,0.016094903,0.021746391,0.004720189,0.0007946166,0.00026727453,0.00016390906,0.00015799295,0.00024129341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99417895,0.0004444932,0.0012431402,0.001081246,0.0013863655,0.0016658243],"domain_scores_gemma":[0.99272895,0.0017112871,0.0004850313,0.000828976,0.0018867617,0.0023590038],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001563053,0.0006434888,0.0012114572,0.0003814523,0.0019068931,0.0007602948,0.00030647626,0.0001752012,0.0001120014],"category_scores_gemma":[0.005153137,0.0005855536,0.0005667877,0.0007539087,0.00024583802,0.000800273,0.00047185583,0.00096250355,0.00002746477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00373804,0.0019723834,0.6419729,0.0025301864,0.0014062794,0.00011834006,0.0054359282,0.0004714651,0.20624745,0.000058709207,0.017417531,0.11863079],"study_design_scores_gemma":[0.01701976,0.00031290457,0.9442045,0.0029444091,0.00022043033,0.00013923043,0.0020528825,0.016867524,0.0057098875,0.000042158696,0.009816891,0.00066942675],"about_ca_topic_score_codex":0.00042258308,"about_ca_topic_score_gemma":0.0005968722,"teacher_disagreement_score":0.3022316,"about_ca_system_score_codex":0.00076131214,"about_ca_system_score_gemma":0.0010231935,"threshold_uncertainty_score":0.9996596},"labels":[],"label_agreement":null},{"id":"W4200247492","doi":"10.1177/13524585211063623","title":"Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Context (archaeology); Quality of life (healthcare); Expanded Disability Status Scale; Logistic regression; Medicine; Clinical trial; Multiple sclerosis; Physical therapy; Modalities; Physical medicine and rehabilitation; Psychology; Internal medicine; Psychiatry","score_opus":0.27832148381240585,"score_gpt":0.46042742203661463,"score_spread":0.18210593822420879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901958,0.006120666,0.000015433057,0.0027737431,0.00017437135,0.00043958586,0.000078364756,0.000017515682,0.00018449945],"genre_scores_gemma":[0.9951105,0.0033980494,0.001096669,0.0002330571,0.00009325541,0.000011672349,0.000010336614,0.00003061594,0.000015858557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936529,0.0013895514,0.002939501,0.00042140583,0.0010401286,0.0005565062],"domain_scores_gemma":[0.99484736,0.0019145294,0.0013199332,0.00040083,0.00087301474,0.0006443613],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046502,0.00028043537,0.002038281,0.00034031845,0.00015317502,0.00003962247,0.00015199583,0.00012436174,0.00022417538],"category_scores_gemma":[0.019390272,0.00020293218,0.00071474223,0.00040264675,0.00047057672,0.00016563029,0.00017748056,0.0013347861,0.000002534388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011158112,0.001052057,0.87837464,0.00017378926,0.0006507186,0.00002708577,0.0006331884,0.000028415754,0.006269591,0.0000033067688,0.0005576283,0.11111378],"study_design_scores_gemma":[0.013136559,0.00056776416,0.98345876,0.0012347203,0.000024490206,0.00003513966,0.00056152,0.00029145618,0.0005076549,0.000021785765,0.000013763261,0.00014635963],"about_ca_topic_score_codex":0.0012184867,"about_ca_topic_score_gemma":0.00031067713,"teacher_disagreement_score":0.11096742,"about_ca_system_score_codex":0.00018831446,"about_ca_system_score_gemma":0.0014043625,"threshold_uncertainty_score":0.98886985},"labels":[],"label_agreement":null},{"id":"W4200597408","doi":"10.1177/13524585211061335","title":"Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"bluebird bio; Wellcome Trust; National Institute for Health and Care Research; Sanofi","keywords":"Alemtuzumab; Autoimmunity; Multiple sclerosis; Medicine; Immunology; Adverse effect; Autoimmune disease; Disease; Internal medicine; Antibody","score_opus":0.23129013255489264,"score_gpt":0.3909515843284551,"score_spread":0.15966145177356247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200597408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03625503,0.954207,0.00008043657,0.00014888615,0.0004174752,0.0059898887,0.002855516,0.00003672563,0.00000902836],"genre_scores_gemma":[0.004917475,0.98882043,0.0044514025,0.00005630476,0.00046269613,0.00014937286,0.00093199854,0.00018563909,0.000024654435],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9903088,0.0018195991,0.0040836274,0.0014134254,0.0013557209,0.001018821],"domain_scores_gemma":[0.98040473,0.012389421,0.003305481,0.001960901,0.0012082352,0.00073123164],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011135966,0.0011433003,0.0075829267,0.0006065688,0.0010208149,0.00020064575,0.0009176097,0.00054549414,0.00005322392],"category_scores_gemma":[0.049811944,0.00091548276,0.0015389125,0.0006483453,0.00065249536,0.00039399273,0.002515174,0.0019433182,8.4947925e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050059683,0.00048648703,0.0053224643,0.108328074,0.0031350423,0.000010836611,0.0001414787,4.6889284e-7,0.00024135315,6.470165e-7,0.00018761445,0.87713957],"study_design_scores_gemma":[0.07905239,0.001234268,0.18316717,0.7032095,0.011116324,0.00025614272,0.00021634683,0.00026767745,0.0000209525,7.377424e-7,0.020449081,0.0010093896],"about_ca_topic_score_codex":0.00013481962,"about_ca_topic_score_gemma":0.000074303214,"teacher_disagreement_score":0.87613016,"about_ca_system_score_codex":0.00025943446,"about_ca_system_score_gemma":0.00079479057,"threshold_uncertainty_score":0.99932957},"labels":[],"label_agreement":null},{"id":"W4206659757","doi":"10.1177/13524585211061861","title":"Body mass index as a predictor of MS activity and progression among participants in BENEFIT","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Deutsche Forschungsgemeinschaft; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Body mass index; Obesity; Clinical neurology; Physical activity; Young adult","score_opus":0.08401648301470017,"score_gpt":0.33218769735216047,"score_spread":0.2481712143374603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206659757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780667,0.00044829905,0.00003435741,0.00048549724,0.00016561909,0.00082762365,0.000049840128,0.000032436856,0.00014963189],"genre_scores_gemma":[0.9983911,0.0007201085,0.00035995853,0.000037418486,0.00012868008,0.00023718906,0.000004920194,0.000039452305,0.000081196595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964356,0.00030415136,0.0006367957,0.00040536418,0.0014439711,0.0007741485],"domain_scores_gemma":[0.99833924,0.00029514942,0.0003783989,0.00030762985,0.00018849444,0.0004910835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001417482,0.00025333796,0.0006590915,0.00046967185,0.00049947685,0.000057022535,0.00022243863,0.00009084087,0.00038648935],"category_scores_gemma":[0.0011821989,0.0002149694,0.00015463185,0.00050329004,0.00029997804,0.00028359098,0.0005071681,0.001189338,0.0000026985872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191785,0.0006236704,0.79665035,0.00007087281,0.000118128504,0.000039896775,0.0007402528,0.00018924779,0.18542211,0.0000019905447,0.00012374591,0.014700547],"study_design_scores_gemma":[0.006998517,0.0009079544,0.96310145,0.0005090188,0.00004487642,0.00003492,0.0006816274,0.017552348,0.009856198,0.00003905758,0.000102481514,0.00017153648],"about_ca_topic_score_codex":0.00046720152,"about_ca_topic_score_gemma":0.00019006288,"teacher_disagreement_score":0.17556591,"about_ca_system_score_codex":0.00034022675,"about_ca_system_score_gemma":0.00016441794,"threshold_uncertainty_score":0.87661976},"labels":[],"label_agreement":null},{"id":"W4210827259","doi":"10.1177/13524585211069070","title":"Productivity loss among people with early multiple sclerosis: A Canadian study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Toronto; Centre for Advancing Health Outcomes; St. Michael's Hospital; University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"Government of Alberta; Biogen Idec; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Presenteeism; Absenteeism; Productivity; Work productivity; Medicine; Demography; Psychology; Economics","score_opus":0.07662898989530774,"score_gpt":0.2656726939159828,"score_spread":0.18904370402067505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210827259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239755,0.0003611709,0.00007475874,0.002106312,0.00063967635,0.00372114,0.00022250283,0.00020452804,0.0002723377],"genre_scores_gemma":[0.9960325,0.00016307016,0.0007914771,0.00022015002,0.00077156693,0.0013091053,0.000031764866,0.00020780957,0.00047259446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911362,0.0010451839,0.0010388026,0.0013499223,0.0032072645,0.0022226204],"domain_scores_gemma":[0.99465054,0.00042496217,0.0005084664,0.0013079091,0.00097518734,0.0021329091],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002905478,0.00079861,0.0013095059,0.0012698353,0.004818362,0.0004765175,0.0009195553,0.00012701741,0.00092919514],"category_scores_gemma":[0.0017143561,0.0006781248,0.00042940883,0.00209452,0.00047448132,0.0007816957,0.00072345656,0.003043314,0.00006968886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014586179,0.0024648218,0.9711094,0.000049617778,0.00085738796,0.0002959862,0.009950347,0.00088578573,0.004603755,0.0000010814814,0.0026781145,0.005645068],"study_design_scores_gemma":[0.01317085,0.003246504,0.9675243,0.00026207615,0.0002502949,0.00036100292,0.011668511,0.0010278232,0.00058678543,0.0000036527622,0.0011708197,0.0007273729],"about_ca_topic_score_codex":0.1407739,"about_ca_topic_score_gemma":0.41397652,"teacher_disagreement_score":0.27320263,"about_ca_system_score_codex":0.0021686011,"about_ca_system_score_gemma":0.0011782367,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W4210943743","doi":"10.1177/13524585211061521","title":"The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; SickKids Foundation; University of Manitoba","funders":"Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Health related quality of life; Pediatrics; Disease; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.1579992410503456,"score_gpt":0.33570217654894824,"score_spread":0.17770293549860264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210943743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96688765,0.014867105,0.00005402773,0.011598559,0.00028730236,0.0025617457,0.0036490555,0.000061462284,0.000033119333],"genre_scores_gemma":[0.989605,0.008873503,0.0002559025,0.0006688017,0.00006862097,0.00015035982,0.0002145496,0.00011657152,0.000046658588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9803415,0.0060275854,0.007181778,0.00079739094,0.004218189,0.0014335746],"domain_scores_gemma":[0.9814782,0.0053582303,0.008723636,0.0016824575,0.0016836001,0.0010738559],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014805825,0.0007411176,0.0034794214,0.00041720574,0.0020961314,0.000048977574,0.0015798415,0.00023132724,0.0003631875],"category_scores_gemma":[0.00924968,0.00044215238,0.0010047316,0.0021165297,0.0020343848,0.00022225555,0.0008619943,0.0023305297,0.000004189342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078628715,0.002633887,0.91013503,0.0005051528,0.0042775003,3.6344449e-7,0.010008416,0.00041137246,0.044826746,0.000014054428,0.011003282,0.008321331],"study_design_scores_gemma":[0.01823668,0.0023560582,0.9631404,0.00078795466,0.00009262853,0.000012229796,0.008700082,0.0011101799,0.0050593205,0.000017332799,0.00012301025,0.0003640841],"about_ca_topic_score_codex":0.022945737,"about_ca_topic_score_gemma":0.0014134976,"teacher_disagreement_score":0.053005416,"about_ca_system_score_codex":0.0005340488,"about_ca_system_score_gemma":0.0019071787,"threshold_uncertainty_score":0.99997115},"labels":[],"label_agreement":null},{"id":"W4211236523","doi":"10.1177/13524585211069167","title":"Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; McGill University; Université du Québec à Montréal; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Multiple Sclerosis Society","keywords":"Lesion; Multiple sclerosis; Expanded Disability Status Scale; Medicine; White matter; Magnetic resonance imaging; Pathology; Hyperintensity; Radiology","score_opus":0.14036150020807972,"score_gpt":0.30658480126019444,"score_spread":0.16622330105211472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211236523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960952,0.00029859703,0.000120343764,0.0021681956,0.00018899684,0.00088362,0.00013562018,0.000044854394,0.00006460637],"genre_scores_gemma":[0.99676365,0.00090411294,0.0017899069,0.00010202805,0.00016113899,0.00014033997,0.000019933765,0.000052243882,0.00006662074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468154,0.00088677596,0.0010271003,0.00057758036,0.0020000446,0.0008269902],"domain_scores_gemma":[0.99646336,0.0017662143,0.0004958571,0.00041014358,0.0003903988,0.00047404855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028227095,0.00034032442,0.00089772313,0.00036159737,0.0011424288,0.000075336226,0.0002515753,0.00014097513,0.0003203711],"category_scores_gemma":[0.0039732954,0.00028248335,0.0002311948,0.00087758916,0.00047216215,0.0002817767,0.0004966892,0.0017541328,0.0000044601115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021129628,0.0013463267,0.8511236,0.000068430665,0.00012703582,0.000013666201,0.0008382634,0.00030848547,0.13126239,0.0000047416866,0.00047765087,0.0123164635],"study_design_scores_gemma":[0.011553961,0.0010232589,0.97755456,0.00036761648,0.00009766485,0.00005548071,0.0020710798,0.0043211626,0.0025092901,0.000011398473,0.00016796106,0.00026654452],"about_ca_topic_score_codex":0.00059480744,"about_ca_topic_score_gemma":0.00102975,"teacher_disagreement_score":0.12875311,"about_ca_system_score_codex":0.0014383228,"about_ca_system_score_gemma":0.00022246412,"threshold_uncertainty_score":0.99996275},"labels":[],"label_agreement":null},{"id":"W4214570861","doi":"10.1177/13524585221079731","title":"Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Ofatumumab; Medicine; Adverse effect; Tolerability; Internal medicine; Incidence (geometry); Multiple sclerosis; Teriflunomide; Progressive multifocal leukoencephalopathy; Cumulative incidence; Rituximab; Immunology; Cohort; Fingolimod","score_opus":0.06044288357844394,"score_gpt":0.27766240448708823,"score_spread":0.2172195209086443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214570861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993458,0.000097781834,0.0017933537,0.0005145404,0.00029235016,0.0034311078,0.0003188563,0.000048066962,0.00004596868],"genre_scores_gemma":[0.98577553,0.000057524456,0.012581438,0.0003584314,0.00009157557,0.0008255473,0.000043540367,0.000119388314,0.00014702963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948131,0.00018725375,0.0011204893,0.00074886583,0.001963863,0.0011664378],"domain_scores_gemma":[0.9968618,0.0004800663,0.00044419,0.0006500286,0.0008551184,0.0007087824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010959074,0.00045347083,0.0010570575,0.00080454804,0.00076990057,0.00009476253,0.00054987887,0.00008922947,0.00017776818],"category_scores_gemma":[0.0015475727,0.00036014905,0.00023554797,0.0013837257,0.00018388043,0.00035799146,0.00047048615,0.00080810575,0.000005781052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024761701,0.000823698,0.900663,0.00007400806,0.00022132492,0.000009530917,0.0147520155,0.0039047047,0.032399513,0.000003783022,0.001118307,0.021268377],"study_design_scores_gemma":[0.031558122,0.006183788,0.94801176,0.0013050264,0.000054105047,0.000012288085,0.0069907727,0.00036936998,0.0038216647,0.0000019626525,0.0012401941,0.00045096656],"about_ca_topic_score_codex":0.00015122474,"about_ca_topic_score_gemma":0.00043986604,"teacher_disagreement_score":0.0473487,"about_ca_system_score_codex":0.00087027886,"about_ca_system_score_gemma":0.00023300968,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W4214890189","doi":"10.1177/13524585221078497","title":"Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Saskatchewan; Nova Scotia Health Authority; Dalhousie University; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Emergency department; Medicine; Multiple sclerosis; Emergency medicine; Population; Pediatrics; Environmental health; Immunology; Psychiatry","score_opus":0.04755716566227545,"score_gpt":0.2595398068259643,"score_spread":0.21198264116368884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214890189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974493,0.000037655824,0.00035724282,0.00055022346,0.00029559966,0.0010499553,0.000082127786,0.000103501196,0.000074392236],"genre_scores_gemma":[0.999092,0.000012220236,0.00007586819,0.00020750037,0.000064408814,0.00029260063,0.00003487493,0.000054122385,0.00016641675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978435,0.00033122717,0.00040025378,0.00034154317,0.0007376478,0.00034579964],"domain_scores_gemma":[0.99890804,0.00008057512,0.00028020536,0.0002481301,0.00017997029,0.00030308106],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00025317253,0.0002729012,0.00031231283,0.0003501489,0.0017145129,0.00007368191,0.00007286027,0.0000494414,0.00061031163],"category_scores_gemma":[0.00007468644,0.00019428821,0.0001472841,0.0006984026,0.000028082943,0.00019588174,0.00002529281,0.00080552633,0.000011680432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008202919,0.003258232,0.9796551,0.0000051592465,0.0004994712,0.00007286477,0.0009556591,0.0090128975,0.00438294,0.0000024374613,0.00097097154,0.0003640043],"study_design_scores_gemma":[0.0073100696,0.010321784,0.9785977,0.000096306474,0.00038825776,0.00024805215,0.00076562003,0.0009019543,0.0001739651,0.0000028880104,0.0009347659,0.00025864824],"about_ca_topic_score_codex":0.0010866197,"about_ca_topic_score_gemma":0.0011321044,"teacher_disagreement_score":0.008110943,"about_ca_system_score_codex":0.00072372396,"about_ca_system_score_gemma":0.00019408432,"threshold_uncertainty_score":0.9995851},"labels":[],"label_agreement":null},{"id":"W4214909359","doi":"10.1177/13524585221075990","title":"Pathways to cures for multiple sclerosis: A research roadmap","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Political science; Public relations; Psychiatry","score_opus":0.3983067987374694,"score_gpt":0.3840609125952333,"score_spread":0.014245886142236097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214909359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97338456,0.002646622,0.002204135,0.011938188,0.001605875,0.0062795486,0.00093479286,0.0003407739,0.0006655181],"genre_scores_gemma":[0.9775366,0.0009992109,0.013240505,0.0013397946,0.0017896792,0.004046615,0.00007119882,0.00023268066,0.0007436769],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.988945,0.0011820629,0.001411802,0.001312546,0.0043207244,0.0028278388],"domain_scores_gemma":[0.9917408,0.002677555,0.00033235076,0.0012070264,0.002178139,0.0018641052],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008152337,0.00065661187,0.0012041217,0.001839398,0.006276175,0.00049536023,0.0013358931,0.00018747892,0.0010012749],"category_scores_gemma":[0.011308488,0.0006057711,0.0009038765,0.0020886324,0.00039572458,0.00038018372,0.001878473,0.0030771592,0.00020041286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005878211,0.002386295,0.061181676,0.000227162,0.0006953795,0.00008197752,0.0063803713,0.0020677298,0.59669495,0.00008481791,0.2482144,0.076107055],"study_design_scores_gemma":[0.033404086,0.008535891,0.6063635,0.0014802307,0.0002276737,0.0005320805,0.018385796,0.014116889,0.03416908,0.00035339943,0.28069428,0.0017370981],"about_ca_topic_score_codex":0.00020634662,"about_ca_topic_score_gemma":0.0001785295,"teacher_disagreement_score":0.56252587,"about_ca_system_score_codex":0.0017836444,"about_ca_system_score_gemma":0.00082512724,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W4220781181","doi":"10.1177/13524585221085732","title":"Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSD","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Antibody; Disease; Aquaporin 4; Immunology; Pathology; Neuroscience; Psychology","score_opus":0.04264261778015071,"score_gpt":0.28190948201065247,"score_spread":0.23926686423050175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220781181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93883747,0.017792908,0.00023257695,0.04117878,0.000366148,0.00086188363,0.00071106834,0.0000113955875,0.000007753898],"genre_scores_gemma":[0.97776717,0.0045961537,0.00020804277,0.016282804,0.0005119397,0.000068005036,0.0004740557,0.000042921994,0.000048911472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961924,0.0014709003,0.0007979927,0.0006806799,0.0004048721,0.00045316655],"domain_scores_gemma":[0.9978697,0.0004145587,0.0007181462,0.00074964785,0.000096585194,0.00015137847],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016804772,0.00037864834,0.0007356498,0.000081713115,0.00022355224,0.00007254433,0.00072071014,0.0004986594,0.00011943335],"category_scores_gemma":[0.0018230749,0.00026489064,0.00039550022,0.00015505013,0.0006977746,0.000013056981,0.00064949354,0.0023445848,0.0000013348165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077585034,0.0029760362,0.4179968,0.0013121859,0.0024148014,0.0030732888,0.00025429393,0.00058074156,0.18838851,0.000044516764,0.29078025,0.014593541],"study_design_scores_gemma":[0.015570099,0.0032337771,0.92985296,0.000493624,0.00035091705,0.0008493874,0.000023469336,0.0007779498,0.007717129,0.0006016053,0.039225973,0.0013030769],"about_ca_topic_score_codex":0.000111134315,"about_ca_topic_score_gemma":0.000013817979,"teacher_disagreement_score":0.5118562,"about_ca_system_score_codex":0.000057422094,"about_ca_system_score_gemma":0.00022774856,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W4220926696","doi":"10.1177/13524585221076717","title":"Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharmaceuticals Corporation","keywords":"Atrophy; White matter; Multiple sclerosis; Magnetic resonance imaging; Magnetization transfer; Medicine; Neurodegeneration; Pathology; Radiology; Disease; Immunology","score_opus":0.0797690790076609,"score_gpt":0.3194440112167253,"score_spread":0.23967493220906438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220926696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830405,0.013516477,0.00038148923,0.0007394646,0.00019174184,0.0018997606,0.00020405819,0.000014341001,0.000012176396],"genre_scores_gemma":[0.9972832,0.001619488,0.0002945149,0.0001477543,0.00021451204,0.00032683907,0.000062040825,0.000042076597,0.0000095396235],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99547714,0.0016827049,0.0009321214,0.00048931694,0.0010807,0.00033804082],"domain_scores_gemma":[0.99772054,0.0012715335,0.00030123457,0.00029580932,0.00028393496,0.00012696454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512491,0.00032304524,0.00067889434,0.00041039306,0.00056509295,0.000110640605,0.00017592803,0.00006121299,0.00018636954],"category_scores_gemma":[0.0010022089,0.0002343634,0.00016913412,0.00045700363,0.00028602552,0.0002812003,0.00011768024,0.0006736325,7.589796e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033986386,0.0005544113,0.11123323,0.00008516057,0.00006522499,0.000007914561,0.0018463902,0.000577934,0.65216446,0.000001301223,0.00022314268,0.19925447],"study_design_scores_gemma":[0.09612357,0.0049992017,0.7838993,0.0004924802,0.0002137257,0.000015974681,0.0004901555,0.019617869,0.09387275,0.00000711297,0.000060024347,0.0002078088],"about_ca_topic_score_codex":0.00022309837,"about_ca_topic_score_gemma":0.00007968498,"teacher_disagreement_score":0.6726661,"about_ca_system_score_codex":0.000114036106,"about_ca_system_score_gemma":0.000093914925,"threshold_uncertainty_score":0.9557062},"labels":[],"label_agreement":null},{"id":"W4221089070","doi":"10.1177/13524585221079533","title":"Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University of Saskatchewan; Public Health Agency of Canada; University of Manitoba; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Clinically isolated syndrome; Feces; Gut flora; Medicine; Biology; Gastroenterology; Internal medicine; Immunology; Microbiology","score_opus":0.02774466175595077,"score_gpt":0.21948787709098894,"score_spread":0.19174321533503816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221089070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996488,0.00201708,0.000017732897,0.00051142776,0.00015816299,0.00032047543,0.0004684822,0.00000714188,0.000011497349],"genre_scores_gemma":[0.9987955,0.00034289996,0.0005596555,0.00014017652,0.00005200857,0.000020171736,0.000037980328,0.000028110633,0.000023467444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998132,0.00045026772,0.00047001507,0.0003605696,0.00020440835,0.00038277303],"domain_scores_gemma":[0.9990238,0.000093336974,0.00034131177,0.00031212938,0.00009036747,0.0001390428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005937885,0.00019379609,0.00024852518,0.0000906858,0.00072606717,0.000039271235,0.00031021802,0.00008980984,0.00006523191],"category_scores_gemma":[0.00027541534,0.00014808732,0.00014753493,0.000335324,0.00018810348,0.000011079565,0.0003878118,0.00050052564,5.127007e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013332244,0.00014191493,0.49784365,0.000019843874,0.000024532083,9.5295786e-7,0.00034150106,0.00016748157,0.50053567,4.0452605e-7,0.00031773318,0.00047298288],"study_design_scores_gemma":[0.0028441625,0.0002550414,0.980825,0.00007219906,0.000044149776,0.00010938665,0.0015148324,0.00028253067,0.013556538,0.000005071817,0.00029080943,0.00020026392],"about_ca_topic_score_codex":0.00013196254,"about_ca_topic_score_gemma":0.00035116888,"teacher_disagreement_score":0.48697916,"about_ca_system_score_codex":0.00009684162,"about_ca_system_score_gemma":0.00023632764,"threshold_uncertainty_score":0.6038826},"labels":[],"label_agreement":null},{"id":"W4223522335","doi":"10.1177/13524585221085733","title":"Recommendations for the use of propensity score methods in multiple sclerosis research","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; McGill University; Jewish General Hospital","funders":"","keywords":"Propensity score matching; Covariate; Matching (statistics); Context (archaeology); Weighting; Medicine; Comparative effectiveness research; Computer science; Machine learning; Alternative medicine; Surgery; Pathology","score_opus":0.9297887613391248,"score_gpt":0.5353901558312687,"score_spread":0.3943986055078561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223522335","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38469496,0.00023845657,0.6058565,0.004532675,0.0005477122,0.0036200183,0.00031933832,0.00015534737,0.00003498382],"genre_scores_gemma":[0.4722309,0.00024488106,0.5265816,0.00009301938,0.000058579193,0.0006456513,0.00000739731,0.000048075613,0.00008988482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995428,0.001964553,0.0009771812,0.00033303403,0.0006895285,0.0006076512],"domain_scores_gemma":[0.983339,0.014631576,0.00051897555,0.0006481892,0.00074730755,0.000114926486],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0093441075,0.00020806196,0.0004551576,0.0004590387,0.0016789573,0.00014991667,0.00078998075,0.00008361217,0.00025762556],"category_scores_gemma":[0.012367751,0.0001611058,0.00022419645,0.00094474526,0.00025690495,0.0005111431,0.0006727837,0.0015734634,0.0000014495488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013620916,0.002763355,0.08742945,0.00020149205,0.00031661883,0.0000071857876,0.0071959053,0.0056481604,0.4112886,0.008583336,0.09266907,0.38253474],"study_design_scores_gemma":[0.013010485,0.002883707,0.1794686,0.0025336568,0.00031352212,0.00018818765,0.010840402,0.10328716,0.32713634,0.25039783,0.10777912,0.0021609976],"about_ca_topic_score_codex":0.00026858939,"about_ca_topic_score_gemma":0.00039846628,"teacher_disagreement_score":0.38037375,"about_ca_system_score_codex":0.0004940523,"about_ca_system_score_gemma":0.00015798202,"threshold_uncertainty_score":0.99962074},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4224239226","doi":"10.1177/13524585221091060","title":"All Bruton’s tyrosine kinase inhibitors have similar efficacy and risks: No","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Bruton's tyrosine kinase; Tyrosine kinase; Medicine; Multiple sclerosis; Internal medicine; Immunology; Receptor","score_opus":0.11141581419808595,"score_gpt":0.31920957465301625,"score_spread":0.2077937604549303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224239226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359345,0.0023265667,0.000038114988,0.0022279962,0.00063424546,0.0005695543,0.000046621397,0.000076218384,0.00048722312],"genre_scores_gemma":[0.99498683,0.0009019303,0.0009731532,0.001216974,0.0009791807,0.00004617958,0.000030158257,0.00008279966,0.000782816],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965163,0.00027247905,0.0006126087,0.00047391918,0.0013298725,0.00079482404],"domain_scores_gemma":[0.9979223,0.0003908204,0.00021448616,0.00046038855,0.00025206883,0.00075993215],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012299903,0.00030097557,0.0004844293,0.00032557108,0.00080438657,0.00015108279,0.00028175782,0.000105435814,0.0013991393],"category_scores_gemma":[0.0010802172,0.00026983267,0.00020650555,0.00027613927,0.0002107976,0.0001715707,0.00055037206,0.0013756083,0.000089278925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012069702,0.0053105676,0.12767345,0.0005555714,0.0017512282,0.005250319,0.007314805,0.0048720883,0.44412938,0.000042389005,0.28086582,0.1101647],"study_design_scores_gemma":[0.22846027,0.004643391,0.22098279,0.001011022,0.0007298223,0.010322014,0.0023180987,0.11013272,0.03271506,0.00007625086,0.38703543,0.0015731317],"about_ca_topic_score_codex":0.00061169354,"about_ca_topic_score_gemma":0.000025135781,"teacher_disagreement_score":0.41141433,"about_ca_system_score_codex":0.008047519,"about_ca_system_score_gemma":0.0018871987,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W4225751437","doi":"10.1177/13524585221084577","title":"Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Genentech","keywords":"Medicine; Proportional hazards model; Disease; Internal medicine; Metric (unit); Multiple sclerosis; Severity of illness; Prospective cohort study","score_opus":0.12851125022154924,"score_gpt":0.30454718590989277,"score_spread":0.17603593568834353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225751437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926782,0.0012529835,0.0001167175,0.0022629877,0.0007710047,0.0019384254,0.00057202857,0.00010001941,0.000307605],"genre_scores_gemma":[0.9947488,0.0022034668,0.0013440222,0.0004131343,0.0004478308,0.0005297603,0.00007615621,0.00009045568,0.0001464137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927279,0.0011125547,0.0016959623,0.00070687255,0.002607723,0.0011490154],"domain_scores_gemma":[0.9951964,0.0019722308,0.00093995966,0.00092736393,0.00053300284,0.0004310663],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003928792,0.00052210956,0.0010725321,0.00077761296,0.0017468961,0.00016765691,0.0009833615,0.00016478586,0.0010191432],"category_scores_gemma":[0.0068570534,0.00039490426,0.0006227467,0.0015765679,0.0005605492,0.0005652269,0.0012244777,0.0025863447,0.000018154944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017428052,0.0012788358,0.6560947,0.00013138186,0.0004095502,0.000016859622,0.003822832,0.00075219915,0.28200585,0.0000054977363,0.006596977,0.047142547],"study_design_scores_gemma":[0.013231995,0.0006688338,0.95916176,0.00050392275,0.00012711331,0.000118471355,0.0034853716,0.0086276475,0.010248397,0.000036799265,0.0034637942,0.00032590213],"about_ca_topic_score_codex":0.0011114024,"about_ca_topic_score_gemma":0.00041683335,"teacher_disagreement_score":0.3030671,"about_ca_system_score_codex":0.0008271038,"about_ca_system_score_gemma":0.00046538754,"threshold_uncertainty_score":0.9998941},"labels":[],"label_agreement":null},{"id":"W4226197684","doi":"10.1177/13524585221083194","title":"Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to &gt;5 years","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; Innosuisse - Schweizerische Agentur für Innovationsförderung; European Commission; Sanofi; Bayer HealthCare; Eli Lilly and Company; CSL Behring; Biogen; Merck KGaA; Teva Pharmaceutical Industries; Novartis; Pfizer; National Research Foundation","keywords":"Medicine; Placebo; Hazard ratio; Internal medicine; Multiple sclerosis; Confidence interval; Pathology; Immunology","score_opus":0.04661293181743509,"score_gpt":0.25671859306409295,"score_spread":0.21010566124665786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226197684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691784,0.0020197972,0.0001617475,0.000011391238,0.00009610281,0.00032661288,0.00046190913,0.0000033001122,0.0000013232444],"genre_scores_gemma":[0.998356,0.00031500208,0.000840977,0.00005415253,0.000045595643,0.000011090827,0.00034977548,0.00002319982,0.0000042173588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983529,0.00012234588,0.00048255906,0.0004620718,0.00033751005,0.0002426264],"domain_scores_gemma":[0.998823,0.00005576221,0.00035286654,0.00046872132,0.00014576403,0.00015392162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005187674,0.0001738552,0.00044310777,0.0003005517,0.00016850678,0.000033542423,0.00031046613,0.000064943044,0.000034146928],"category_scores_gemma":[0.00018751976,0.00015722975,0.00006560943,0.0004092144,0.000103779115,0.000025306856,0.000658949,0.00020785209,1.0067799e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025558022,0.00021226142,0.76207423,0.000018815463,0.00036064634,0.000002779114,0.00055583904,0.0010377741,0.21710694,3.7513644e-7,0.000032208645,0.016042342],"study_design_scores_gemma":[0.007057984,0.00048987643,0.9848661,0.00013222545,0.00027543958,0.0000057347947,0.00022666539,0.00057766977,0.006153754,4.4821104e-7,0.00003522211,0.00017887879],"about_ca_topic_score_codex":0.000030284356,"about_ca_topic_score_gemma":0.00006844235,"teacher_disagreement_score":0.22279188,"about_ca_system_score_codex":0.000017189212,"about_ca_system_score_gemma":0.00006615546,"threshold_uncertainty_score":0.6411643},"labels":[],"label_agreement":null},{"id":"W4229375736","doi":"10.1177/13524585221088190","title":"The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Verbal memory; California Verbal Learning Test; Multiple sclerosis; Verbal learning; Cognitive psychology; Psychology; Cognition; Neuroscience; Psychiatry","score_opus":0.137524982595279,"score_gpt":0.32410062158974456,"score_spread":0.18657563899446555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229375736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714906,0.008883171,0.00006468199,0.002631078,0.00012491818,0.0009774386,0.000018848905,0.000055804856,0.000095005205],"genre_scores_gemma":[0.9959732,0.0018872111,0.0011442462,0.0000750453,0.00047237356,0.000075232274,0.000013314394,0.000069136564,0.00029018405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959424,0.0005421291,0.0008322169,0.0006453085,0.0011279506,0.00090997544],"domain_scores_gemma":[0.995757,0.0026963914,0.00045078338,0.00023044835,0.00018577375,0.000679597],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002228585,0.0004056929,0.00066062197,0.00038947214,0.004094289,0.0005393008,0.00023150405,0.00012910004,0.000036303714],"category_scores_gemma":[0.0042540175,0.00032258726,0.00011584004,0.00064215786,0.00060624187,0.00045971485,0.0008426067,0.002436274,0.000002885225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051239226,0.0000787852,0.8912265,0.000084293366,0.0000902883,0.00002403375,0.004956762,0.00007695975,0.007296449,0.0000015630941,0.00035435025,0.095297635],"study_design_scores_gemma":[0.009394245,0.00045965705,0.9735434,0.0006981857,0.00009282777,0.00016888788,0.0077794874,0.0066467905,0.00027572204,0.000045325603,0.00057379133,0.00032170053],"about_ca_topic_score_codex":0.00027199642,"about_ca_topic_score_gemma":0.00014641069,"teacher_disagreement_score":0.09497593,"about_ca_system_score_codex":0.00036197156,"about_ca_system_score_gemma":0.00031768752,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W4235924992","doi":"10.1177/135245850200800105","title":"International consensus statement on the use of disease-modifying agents in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Statement (logic); Multiple sclerosis; Voting; Consensus conference; Medicine; Family medicine; Alternative medicine; Disease; MEDLINE; Political science; Psychiatry; Pathology; Internal medicine; Law","score_opus":0.5148747468519949,"score_gpt":0.3560688506872489,"score_spread":0.15880589616474594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235924992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452616,0.0002873102,0.00009908908,0.012840056,0.0005669089,0.0011051624,0.000229439,0.00004591783,0.00029994716],"genre_scores_gemma":[0.99035007,0.005783136,0.002356806,0.00079296477,0.00026842713,0.00010514545,0.000016262931,0.000063342806,0.00026383746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949275,0.00045789374,0.0013335388,0.00052606483,0.0019149403,0.0008400175],"domain_scores_gemma":[0.99565613,0.002050122,0.0005236928,0.00065147,0.0005615978,0.00055699376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010986618,0.00042119794,0.00062493293,0.0006278153,0.00049593125,0.00021941592,0.000496059,0.00010111838,0.0013608158],"category_scores_gemma":[0.006586192,0.00029683858,0.0004167591,0.0005070659,0.00043231936,0.00026359514,0.000297627,0.0009802483,0.00010114385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024522713,0.0028415304,0.8266862,0.00011205418,0.0007755677,0.00009800231,0.0017288732,0.005491182,0.04691309,0.000024918008,0.07251284,0.040363446],"study_design_scores_gemma":[0.008322515,0.00025745036,0.87966794,0.0017821181,0.000062774605,0.000012695636,0.00044826727,0.09628342,0.0019409417,0.000008205608,0.0109255565,0.00028809166],"about_ca_topic_score_codex":0.00021904989,"about_ca_topic_score_gemma":0.000101235404,"teacher_disagreement_score":0.09079224,"about_ca_system_score_codex":0.000655965,"about_ca_system_score_gemma":0.00007535632,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W4242063709","doi":"10.1177/1352458514547847","title":"ACTRIMS-ECTRIMS MSBoston 2014: Late Breaking News Oral Presentations","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of British Columbia Hospital; McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.10847462147527044,"score_gpt":0.23383507208192714,"score_spread":0.12536045060665668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242063709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60636985,0.0035724277,0.024596328,0.002632229,0.015700823,0.00060552213,0.00050674076,0.00021767277,0.34579837],"genre_scores_gemma":[0.9720389,0.0012104654,0.00217176,0.00041375463,0.0004978881,0.000012129433,0.000011681681,0.000032860662,0.023610536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815226,0.00004341932,0.00075685844,0.00044254298,0.00006948659,0.00053544575],"domain_scores_gemma":[0.99871284,0.00013592555,0.00057219795,0.00031440987,0.000059048165,0.00020555698],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012317083,0.00019898625,0.00044459573,0.00032860614,0.00066538254,0.00047913977,0.00037855885,0.00008611418,0.0047055096],"category_scores_gemma":[0.00029428463,0.00021104439,0.00025468602,0.00018390639,0.00010700674,0.00063819013,0.000117584954,0.00027934936,0.011062764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006803206,0.00024043146,0.30086234,0.000018235796,0.00032598327,0.000003391161,0.0020814857,0.0028206708,0.0006836157,0.01189866,0.64304763,0.037949506],"study_design_scores_gemma":[0.0030471531,0.000080897546,0.13645363,0.00003826684,0.000029440336,0.000018325107,0.000486143,0.016642418,0.00023589387,0.004473398,0.83792037,0.000574064],"about_ca_topic_score_codex":0.0004737874,"about_ca_topic_score_gemma":0.00007058198,"teacher_disagreement_score":0.36566904,"about_ca_system_score_codex":0.000115768926,"about_ca_system_score_gemma":0.000019048777,"threshold_uncertainty_score":0.9962043},"labels":[],"label_agreement":null},{"id":"W4247909607","doi":"10.1177/135245850200800109","title":"The role of MRI as a surrogate outcome measure in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Surrogate endpoint; Clinical trial; Disease; Pathology; Radiology; Psychiatry","score_opus":0.16351152194505092,"score_gpt":0.30151295343829293,"score_spread":0.138001431493242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247909607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98113436,0.010191944,0.000056492707,0.0041302736,0.00047965502,0.0013292364,0.00005668656,0.000102409045,0.002518932],"genre_scores_gemma":[0.98475766,0.012765811,0.0012470828,0.00019731488,0.000365145,0.00012424326,0.000004850008,0.00010380715,0.0004340572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930645,0.00059314317,0.0019090388,0.0006450423,0.0022458546,0.0015423953],"domain_scores_gemma":[0.99490905,0.0017986554,0.0006556373,0.0009816804,0.00092843204,0.0007265578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028373,0.00059287203,0.0012060725,0.0006021141,0.0011233719,0.00023817475,0.00084688485,0.00027542657,0.00050643994],"category_scores_gemma":[0.007653266,0.0004122918,0.0007495295,0.0011174255,0.0007055364,0.000410689,0.00037229038,0.0017645117,0.0002817876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066754944,0.0007862166,0.7821755,0.000054828153,0.00032870553,0.000025410915,0.0015083072,0.00013726541,0.12642644,0.000020531625,0.0016286878,0.08624056],"study_design_scores_gemma":[0.012503333,0.0005161247,0.9426336,0.0011937448,0.00010989788,0.00012125014,0.00280164,0.015625771,0.016512014,0.0000781893,0.0074080005,0.0004963928],"about_ca_topic_score_codex":0.0006981524,"about_ca_topic_score_gemma":0.0013037627,"teacher_disagreement_score":0.16045815,"about_ca_system_score_codex":0.00049247965,"about_ca_system_score_gemma":0.00012377424,"threshold_uncertainty_score":0.99983287},"labels":[],"label_agreement":null},{"id":"W4253683908","doi":"10.1177/1352458511422292","title":"Oral presentations","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Oropharyngeal Anatomy and Pathologies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eisai Canada; Serono Symposia International Foundation; Università di Catania; Medical Research Council; Eisai; Sanofi; Associazione Italiana Sclerosi Multipla; Teva Pharmaceutical Industries; Fondazione Italiana Sclerosi Multipla; Biogen","keywords":"Medicine; Multiple sclerosis; Dermatology; Psychiatry","score_opus":0.26785581781360907,"score_gpt":0.3018293690132866,"score_spread":0.03397355119967754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253683908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880145,0.00056074944,0.0008043818,0.0004681892,0.0004124022,0.00013060083,0.0000069902726,0.00007616115,0.00952599],"genre_scores_gemma":[0.9865408,0.0003894734,0.011948242,0.00035207014,0.00018227159,0.0000056994563,0.0000034197176,0.000011684335,0.0005663272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992654,0.00004860071,0.00020289779,0.000107868946,0.00016753403,0.00020770013],"domain_scores_gemma":[0.9994912,0.00003396659,0.0000699097,0.00012687825,0.00010030666,0.00017772579],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016519026,0.00009028499,0.00015854352,0.00009059551,0.00019337585,0.000025547599,0.00008793304,0.00005449603,0.0011993578],"category_scores_gemma":[0.00011758884,0.00006702368,0.00012198444,0.00011304589,0.000078987934,0.00017377628,0.00002946679,0.00027791839,0.00016175851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032711533,0.00043018392,0.9030022,0.00001899033,0.00009871517,0.0002482123,0.0019790833,0.0000032650073,0.015025905,0.00012807977,0.009837149,0.06890111],"study_design_scores_gemma":[0.0017186493,0.0002264752,0.9830024,0.00004871169,0.000065801185,0.00053371175,0.00038228725,0.00011310829,0.010230702,0.00026074753,0.0033260514,0.00009131618],"about_ca_topic_score_codex":0.000037728867,"about_ca_topic_score_gemma":0.0000129867485,"teacher_disagreement_score":0.080000244,"about_ca_system_score_codex":0.000017357583,"about_ca_system_score_gemma":0.000039486593,"threshold_uncertainty_score":0.99971366},"labels":[],"label_agreement":null},{"id":"W4255607453","doi":"10.1177/135245850100700102","title":"A meta-analysis of genomic screens in multiple sclerosis","year":2001,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Multiple Sclerosis Society","keywords":"Linkage (software); Genetics; Genetic linkage; Multiplex; Lod score; Genotyping; Genome; Biology; Chromosome; Gene mapping; Gene; Genotype","score_opus":0.5874270890392274,"score_gpt":0.39705306277301433,"score_spread":0.19037402626621303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255607453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002095816,0.9926921,0.00019877711,0.00018685903,0.00024344168,0.0029932545,0.001200725,0.000090403344,0.00029861808],"genre_scores_gemma":[0.009155916,0.98445815,0.0041517066,0.00011445259,0.00047216672,0.0005853167,0.00031301772,0.00031846788,0.00043082848],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98592895,0.0017721474,0.005603531,0.0017754142,0.0027510994,0.0021688805],"domain_scores_gemma":[0.9891445,0.0033067008,0.0030634957,0.0021916796,0.0010753443,0.0012182655],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0042961272,0.0019465871,0.019364934,0.007914798,0.00054529705,0.00026418988,0.0015545001,0.0010556955,0.0028393327],"category_scores_gemma":[0.0028156876,0.0014414153,0.017912265,0.007376376,0.00070856063,0.0003708976,0.0008754467,0.0036442054,0.00019724134],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031102166,0.0016631467,0.00956489,0.0052598026,0.49577004,0.00015754638,0.00040502573,0.00034906695,0.0006980674,0.0000029976488,0.0012605754,0.48455784],"study_design_scores_gemma":[0.005489535,0.00040670726,0.07267347,0.008179213,0.70405734,0.00019155724,0.00024901904,0.0015326396,0.000023475715,0.0000035429991,0.20565142,0.0015420894],"about_ca_topic_score_codex":0.0012089118,"about_ca_topic_score_gemma":0.0022536707,"teacher_disagreement_score":0.48301575,"about_ca_system_score_codex":0.0014949252,"about_ca_system_score_gemma":0.000952613,"threshold_uncertainty_score":0.9993277},"labels":[],"label_agreement":null},{"id":"W4280538986","doi":"10.1177/13524585221093789","title":"Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University; Montreal Neurological Institute and Hospital; SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Immunology","score_opus":0.09069882192185148,"score_gpt":0.29772870070088264,"score_spread":0.20702987877903117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280538986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911031,0.0024107823,0.00008539775,0.0026915933,0.00083094055,0.0018634794,0.00039247688,0.00021113854,0.00041106582],"genre_scores_gemma":[0.99045223,0.0035842045,0.003032918,0.00083697616,0.0009974762,0.0006311043,0.00008729115,0.00019819012,0.00017962605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914483,0.0011496628,0.0017117845,0.00112464,0.002476285,0.0020893374],"domain_scores_gemma":[0.99483776,0.0023145878,0.0005626887,0.00090009964,0.00043494202,0.00094991573],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032923326,0.0007688914,0.001321391,0.0012410778,0.0023777853,0.00036335445,0.0009651424,0.00018948532,0.0023146444],"category_scores_gemma":[0.0104799215,0.0007505863,0.0006606679,0.0012920541,0.00032612908,0.000555565,0.0015339045,0.002920107,0.00011201362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051932083,0.001140014,0.8969833,0.000057584068,0.00033989505,0.00008045043,0.0013559561,0.001662961,0.07052317,0.000002119948,0.006797199,0.020538004],"study_design_scores_gemma":[0.0137482025,0.00061655225,0.96977603,0.00084987923,0.00012058617,0.00043867642,0.0015223925,0.007059857,0.0038753585,0.000022259752,0.0012647142,0.00070550025],"about_ca_topic_score_codex":0.0008787412,"about_ca_topic_score_gemma":0.00035582812,"teacher_disagreement_score":0.072792694,"about_ca_system_score_codex":0.001422267,"about_ca_system_score_gemma":0.000327742,"threshold_uncertainty_score":0.9994945},"labels":[],"label_agreement":null},{"id":"W4281725428","doi":"10.1177/13524585221097561","title":"Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Placebo; Multiple sclerosis; Thalamus; Anesthesia; White matter; Internal medicine; Magnetic resonance imaging; Pathology; Radiology","score_opus":0.035560739451013075,"score_gpt":0.2502481043547009,"score_spread":0.21468736490368784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281725428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967488,0.00061595184,0.0000170688,0.001405993,0.00020585705,0.00069452665,0.000057924935,0.000042044503,0.00021181951],"genre_scores_gemma":[0.9977116,0.00066411356,0.00087610784,0.00016786889,0.00014973074,0.00010221154,0.000026266704,0.000059388134,0.00024269694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651647,0.000264982,0.000548325,0.0004800714,0.0014261779,0.00076400203],"domain_scores_gemma":[0.9986983,0.00015130012,0.00022664017,0.00030630926,0.0002560453,0.00036141582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076298503,0.000304238,0.00056589575,0.00048012577,0.0008706028,0.000112483314,0.00026427777,0.000059435322,0.00054800947],"category_scores_gemma":[0.00043328502,0.00023692743,0.00011328245,0.00054559595,0.00028957927,0.00027605033,0.00043680493,0.0012818078,0.000014223038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015705499,0.00068949885,0.9763419,0.000030279256,0.00013692508,0.000050040442,0.0009579601,0.00021381951,0.0024823288,0.0000016032315,0.0016717492,0.015853314],"study_design_scores_gemma":[0.014119775,0.0013218196,0.9804797,0.00022714274,0.000033670225,0.00010234214,0.000880783,0.0010090312,0.0002677939,0.000008811117,0.0012864971,0.00026263818],"about_ca_topic_score_codex":0.00010367226,"about_ca_topic_score_gemma":0.00004154816,"teacher_disagreement_score":0.015590675,"about_ca_system_score_codex":0.0005401856,"about_ca_system_score_gemma":0.00015829846,"threshold_uncertainty_score":0.96616197},"labels":[],"label_agreement":null},{"id":"W4283692377","doi":"10.1177/13524585221102584","title":"Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Innosuisse - Schweizerische Agentur für Innovationsförderung; EMD Serono; Multiple Sclerosis International Federation; Allergan; Shionogi; National Research Foundation; Janssen Pharmaceuticals; Atara Biotherapeutics; European Committee for Treatment and Research in Multiple Sclerosis; Bristol-Myers Squibb; CSL Behring; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Mylan; TG Therapeutics; Pfizer; Bayer HealthCare; European Commission; Sanofi; MedDay Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Medicine; Adverse effect; Internal medicine; Tolerability; Pediatrics","score_opus":0.18876421411032954,"score_gpt":0.3523233674991694,"score_spread":0.1635591533888399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324465,0.0012615802,0.000090899484,0.0010234081,0.0007819276,0.003425355,0.000098371675,0.000018620358,0.000055174794],"genre_scores_gemma":[0.99606705,0.001959322,0.0012193401,0.00024361585,0.00016635862,0.00018076926,0.00002281553,0.00007268504,0.00006804049],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9934423,0.0012571255,0.0018851795,0.00073482393,0.0018069278,0.0008736278],"domain_scores_gemma":[0.9958452,0.0020208631,0.00064134604,0.0008319353,0.00031439803,0.00034625691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005710124,0.00039832154,0.0013606782,0.00094149844,0.00058517605,0.0001392175,0.0010824739,0.00013604837,0.00011310956],"category_scores_gemma":[0.0055861827,0.0003354985,0.00024193864,0.0015366209,0.00028334363,0.000360962,0.0016385773,0.0015234206,0.0000044687704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17664775,0.0050381557,0.30871257,0.00018244982,0.00033846678,0.00011024609,0.019086665,0.0008521574,0.34854493,0.000014433721,0.0014711305,0.13900106],"study_design_scores_gemma":[0.18660998,0.0019779778,0.80467427,0.0016203993,0.000075248834,0.000057406367,0.0026669672,0.0010331287,0.00088239816,0.000006835203,0.0001350098,0.00026036325],"about_ca_topic_score_codex":0.0008363618,"about_ca_topic_score_gemma":0.00089950784,"teacher_disagreement_score":0.49596173,"about_ca_system_score_codex":0.0004802744,"about_ca_system_score_gemma":0.0002829983,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W4283819672","doi":"10.1177/13524585221095427","title":"Therapy with mesenchymal stem cell transplantation in multiple sclerosis is ready for prime time: No","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Mesenchymal stem cell; Multiple sclerosis; Transplantation; Medicine; Stem cell; Surgery; Pathology; Immunology; Biology","score_opus":0.1541644099101174,"score_gpt":0.2887168242659134,"score_spread":0.13455241435579599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283819672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940084,0.00071362295,0.0006952721,0.00078905164,0.00023707203,0.0023392863,0.00025552695,0.00006647332,0.0008952833],"genre_scores_gemma":[0.9902735,0.0012153042,0.0037161137,0.0004399307,0.00028095758,0.00044928762,0.00011796272,0.0001269016,0.0033800956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99542445,0.00043593172,0.0008387974,0.0006489587,0.001660047,0.0009918128],"domain_scores_gemma":[0.9975766,0.00067265285,0.0003459795,0.00045685418,0.00046425816,0.00048365086],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018711484,0.00040575603,0.0006791304,0.00052985485,0.00087210047,0.00014390853,0.00042830678,0.00014250795,0.0018790116],"category_scores_gemma":[0.00006542734,0.00033434315,0.0002711976,0.0006889528,0.000108173066,0.00030201944,0.00007459318,0.0011608868,0.0001335701],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01500225,0.0017653967,0.16891152,0.00022925419,0.00019846333,0.00013043017,0.003948462,0.0006851372,0.77273107,0.0000027630226,0.005260609,0.031134658],"study_design_scores_gemma":[0.07824871,0.010990325,0.46864635,0.0010483735,0.00023738648,0.00088305946,0.0022880204,0.040855985,0.3754298,0.000016291473,0.019909024,0.0014466689],"about_ca_topic_score_codex":0.00018391403,"about_ca_topic_score_gemma":0.000042999087,"teacher_disagreement_score":0.39730123,"about_ca_system_score_codex":0.00059022114,"about_ca_system_score_gemma":0.00043681962,"threshold_uncertainty_score":0.99991083},"labels":[],"label_agreement":null},{"id":"W4285726642","doi":"10.1177/13524585221109761","title":"Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Government of Alberta","keywords":"Minocycline; Medicine; Glial fibrillary acidic protein; Biomarker; Gastroenterology; Clinically isolated syndrome; Internal medicine; Multiple sclerosis; Lesion; Matrix metalloproteinase; Pathology; Immunology; Biology; Immunohistochemistry; Antibiotics","score_opus":0.1407432342174484,"score_gpt":0.33239278824394647,"score_spread":0.19164955402649808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285726642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271834,0.0024050758,0.000048929964,0.0032318765,0.00016104987,0.0011624694,0.00015029649,0.00004779128,0.00007419982],"genre_scores_gemma":[0.9924256,0.0035423804,0.002840346,0.00032739618,0.00010650977,0.00021248564,0.000012897251,0.00005446079,0.00047788653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996229,0.00051432993,0.0010835418,0.0006241231,0.000786631,0.00076240994],"domain_scores_gemma":[0.9980567,0.00053893955,0.00028018924,0.00035505075,0.00014413698,0.0006249548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016718644,0.00039323486,0.00097498536,0.0005004195,0.0008059454,0.00012000773,0.00017876973,0.00010622674,0.00067381776],"category_scores_gemma":[0.0008286636,0.00032231407,0.00020719632,0.00044125464,0.00026017765,0.00021863167,0.0005211627,0.0010638486,0.000009005516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035037678,0.002092106,0.8087902,0.000114885705,0.0009328011,0.0014659322,0.002041163,0.00015535015,0.0770297,0.0000060926936,0.00029261102,0.10357541],"study_design_scores_gemma":[0.015975175,0.005174808,0.96768963,0.00020509226,0.00013039529,0.0019162797,0.0009980117,0.0056669298,0.00037341742,0.00003871622,0.0015031587,0.0003283944],"about_ca_topic_score_codex":0.00030661683,"about_ca_topic_score_gemma":0.00021294366,"teacher_disagreement_score":0.15889943,"about_ca_system_score_codex":0.00039411063,"about_ca_system_score_gemma":0.00017839955,"threshold_uncertainty_score":0.9999229},"labels":[],"label_agreement":null},{"id":"W4287377875","doi":"10.1177/13524585221105465","title":"The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prom; Medicine; Expanded Disability Status Scale; Population; Clinical trial; Physical therapy; Multiple sclerosis; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.1580228270206503,"score_gpt":0.36068609069299035,"score_spread":0.20266326367234005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287377875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737485,0.008266925,0.000008503949,0.014306139,0.00070201274,0.0016718049,0.00008961409,0.00005521076,0.001151279],"genre_scores_gemma":[0.9922437,0.004530777,0.0006130625,0.0007858306,0.000399611,0.0005506038,0.000010353071,0.000056530575,0.0008095198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942419,0.0015397615,0.0012970389,0.0004725503,0.001525809,0.0009229207],"domain_scores_gemma":[0.99483657,0.0034191618,0.00057768123,0.00046105112,0.00025406852,0.00045147192],"candidate_categories":["metaresearch","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0070056915,0.0003601719,0.0011622544,0.00039688905,0.0023270664,0.00033174007,0.0004400781,0.00008457443,0.0011914865],"category_scores_gemma":[0.009897136,0.00022452332,0.000412108,0.0004590949,0.0004097347,0.00023044733,0.00077272253,0.0021120906,0.00002390339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036725423,0.00097184244,0.6029516,0.000077320445,0.0012071322,0.00030373273,0.0034536289,0.00007110864,0.023539623,0.000046752517,0.017257418,0.34644732],"study_design_scores_gemma":[0.012173416,0.00071361585,0.9590167,0.00016429603,0.00008145853,0.00034428423,0.0041668853,0.00038890846,0.00086865685,0.00012838436,0.021693267,0.00026012756],"about_ca_topic_score_codex":0.00015810039,"about_ca_topic_score_gemma":0.000120532095,"teacher_disagreement_score":0.3560651,"about_ca_system_score_codex":0.00043850503,"about_ca_system_score_gemma":0.00039921576,"threshold_uncertainty_score":0.9997216},"labels":[],"label_agreement":null},{"id":"W4288050735","doi":"10.1177/13524585221111677","title":"Prediction of relapse activity when switching to cladribine for multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal; Cegep de Saint Jerome","funders":"","keywords":"Cladribine; Medicine; Hazard ratio; Natalizumab; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Confidence interval; Oncology; Fingolimod; Disease; Immunology","score_opus":0.2039220264750162,"score_gpt":0.30667357104742776,"score_spread":0.10275154457241156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288050735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753421,0.00038345458,0.015330198,0.003897637,0.001083364,0.002709517,0.000983843,0.00015681722,0.00011308478],"genre_scores_gemma":[0.97947556,0.0005005099,0.017597845,0.00039382503,0.0007529369,0.0008293996,0.000052426654,0.00013426688,0.00026321728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9943653,0.0004395065,0.0012182179,0.0008133469,0.002007632,0.0011560104],"domain_scores_gemma":[0.9956575,0.0011868684,0.00064519385,0.00078378414,0.0008778625,0.0008487711],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0028066568,0.00050101976,0.0011138996,0.0009024707,0.0020416966,0.000117336676,0.00059230154,0.0001492546,0.00045176092],"category_scores_gemma":[0.004807235,0.00047591823,0.0007688713,0.0007985161,0.0001303483,0.00045959794,0.0008274619,0.0015002491,0.000015734817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041488656,0.0011784938,0.12674572,0.00015826419,0.00046226042,0.0000061306478,0.0021884746,0.0016197286,0.787045,0.0000057222373,0.01703621,0.0594051],"study_design_scores_gemma":[0.019067349,0.003633114,0.87909305,0.0009290396,0.00029759947,0.00011858899,0.0017586009,0.029560838,0.053870253,0.000060944258,0.011058596,0.0005520343],"about_ca_topic_score_codex":0.000350762,"about_ca_topic_score_gemma":0.00013172775,"teacher_disagreement_score":0.7523473,"about_ca_system_score_codex":0.0011013402,"about_ca_system_score_gemma":0.0003088119,"threshold_uncertainty_score":0.9997693},"labels":[],"label_agreement":null},{"id":"W4288490422","doi":"10.1177/13524585221110585","title":"Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Polytechnique Montréal; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada; Natural Sciences and Engineering Research Council of Canada; Mitacs; Myelin Repair Foundation","keywords":"Multiple sclerosis; Myelin; Axon; Lesion; Pathology; Myelin sheath; Medicine; Anatomy; Central nervous system; Immunology; Internal medicine","score_opus":0.12847332958124513,"score_gpt":0.3127205270181618,"score_spread":0.18424719743691664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288490422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915161,0.0008142805,0.00014453825,0.004958033,0.0003106295,0.0015707092,0.00034750794,0.00014229235,0.0001959176],"genre_scores_gemma":[0.9927889,0.0027226084,0.0017080776,0.000494868,0.0002539691,0.0004419025,0.00012771215,0.00013494241,0.0013270113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938713,0.00081687834,0.0011122659,0.00094682735,0.0020093848,0.0012433433],"domain_scores_gemma":[0.9966889,0.0007840562,0.00054325006,0.000668052,0.00051314896,0.00080259464],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017214174,0.0005942035,0.0010248595,0.000979833,0.0029318475,0.0002496798,0.00042517815,0.0002058408,0.0015654925],"category_scores_gemma":[0.0022494362,0.0005289535,0.0002456171,0.0012830686,0.0003767788,0.0005350119,0.0007336171,0.0026057367,0.0000368732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017284729,0.0024909799,0.48778105,0.00007571648,0.00046818765,0.00016123727,0.0062218793,0.0017539302,0.4532938,0.000002104193,0.01933941,0.026683223],"study_design_scores_gemma":[0.01120468,0.0012372258,0.9579359,0.0009999964,0.00016558985,0.00017629961,0.0035344402,0.0151744345,0.004879467,0.000007599342,0.0041323276,0.0005520147],"about_ca_topic_score_codex":0.00087013235,"about_ca_topic_score_gemma":0.0010570771,"teacher_disagreement_score":0.47015488,"about_ca_system_score_codex":0.001384494,"about_ca_system_score_gemma":0.00034297895,"threshold_uncertainty_score":0.9997162},"labels":[],"label_agreement":null},{"id":"W4292466559","doi":"10.1177/13524585221112605","title":"Machine learning classification of multiple sclerosis in children using optical coherence tomography","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Metropolitan University; SickKids Foundation; University of Toronto; Vector Institute; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Optical coherence tomography; Random forest; Retinal; Clinically isolated syndrome; Demyelinating Disorder; Medicine; Artificial intelligence; Pattern recognition (psychology); Computer science; Ophthalmology; Pathology","score_opus":0.13601664714928968,"score_gpt":0.3078742062840037,"score_spread":0.171857559134714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292466559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958026,0.0015368271,0.00073675916,0.0003691325,0.00019303222,0.0010232977,0.000108193424,0.00007493701,0.00015521244],"genre_scores_gemma":[0.9911501,0.0010248232,0.0072582653,0.000074877295,0.00018546291,0.00012430115,0.00006791373,0.00008180372,0.000032486787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945141,0.0007152722,0.001320765,0.00066057633,0.001831935,0.00095734186],"domain_scores_gemma":[0.99742174,0.00058008207,0.0006319717,0.0004947662,0.00042003318,0.0004513891],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002117153,0.00042150798,0.00092510704,0.0012154696,0.0011164263,0.00009751768,0.0005399939,0.00013468646,0.00049847335],"category_scores_gemma":[0.0019587132,0.000406956,0.00048701148,0.0017327896,0.00040414024,0.000310911,0.000594279,0.002390273,0.000008398337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004930583,0.0006976891,0.66367507,0.000030882173,0.00017592567,0.000006073082,0.00037322508,0.003938231,0.31868768,0.000006240131,0.000067720954,0.011848208],"study_design_scores_gemma":[0.0072628655,0.00056387624,0.91376805,0.0003707066,0.00009131672,0.00016539995,0.0008876039,0.068670586,0.0077553065,0.0000090803305,0.00012734717,0.00032785008],"about_ca_topic_score_codex":0.0006910134,"about_ca_topic_score_gemma":0.00010285318,"teacher_disagreement_score":0.31093237,"about_ca_system_score_codex":0.0006541892,"about_ca_system_score_gemma":0.00024153979,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W4293113303","doi":"10.1177/13524585221116269","title":"Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transparency (behavior); Pharmacovigilance; MEDLINE; Intensive care medicine; Political science; Psychiatry; Drug","score_opus":0.619448626281781,"score_gpt":0.420262667192634,"score_spread":0.199185959089147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293113303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00158355,0.9785124,0.00017067278,0.00078753114,0.0017939401,0.008558708,0.008328075,0.00018422373,0.00008088198],"genre_scores_gemma":[0.0023409708,0.98341393,0.008131284,0.00015859195,0.00067758025,0.002979913,0.0013206508,0.00038760764,0.00058947876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991122,0.0011442485,0.0029497202,0.0013605545,0.001890898,0.0015325466],"domain_scores_gemma":[0.98481804,0.009445077,0.0022215394,0.0014608132,0.0007051391,0.0013494049],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014438886,0.0014103721,0.004447153,0.0016021997,0.00200123,0.0003081026,0.0007392082,0.00039783347,0.00065758044],"category_scores_gemma":[0.012007899,0.0011553639,0.0039987676,0.0010279255,0.00037838749,0.00027589645,0.00053877383,0.0019731421,0.000046660884],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001814438,0.0022892186,0.001743821,0.006617529,0.005325177,0.00003911357,0.0002067671,0.000081938924,0.00017736657,0.000008055221,0.022612186,0.9590844],"study_design_scores_gemma":[0.010966264,0.0012003059,0.0054286784,0.0408523,0.0061932877,0.00007803553,0.00023346455,0.00089855155,0.00003909403,0.00000863137,0.93310887,0.0009925305],"about_ca_topic_score_codex":0.00010124576,"about_ca_topic_score_gemma":0.00003940711,"teacher_disagreement_score":0.95809186,"about_ca_system_score_codex":0.0019503125,"about_ca_system_score_gemma":0.0012341711,"threshold_uncertainty_score":0.99986464},"labels":[],"label_agreement":null},{"id":"W4297183615","doi":"10.1177/13524585221125369","title":"Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Stichting MS Research","keywords":"Multiple sclerosis; Proteome; Medicine; Neurodegeneration; Cerebrospinal fluid; Proteomics; Immunology; Biology; Disease; Bioinformatics; Internal medicine; Biochemistry","score_opus":0.07314315901523498,"score_gpt":0.2720557763605013,"score_spread":0.19891261734526633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297183615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941489,0.0012515119,0.0000413602,0.0024921605,0.0001263444,0.001716296,0.00014953813,0.00006645309,0.0000074533255],"genre_scores_gemma":[0.993182,0.0017935353,0.0038431596,0.0002826715,0.00021780655,0.0005171229,0.000024214118,0.000103314225,0.00003617074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99392366,0.0014515088,0.0011200043,0.0009153416,0.0014659822,0.0011235129],"domain_scores_gemma":[0.9975554,0.00090694195,0.00047508505,0.00035001794,0.0002349199,0.00047764406],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0036624717,0.0005419596,0.0009491757,0.0012248458,0.0014862362,0.0003016666,0.00027200245,0.00013647994,0.000054335203],"category_scores_gemma":[0.0034181557,0.00049957295,0.00013647082,0.0011738464,0.00020403175,0.0005402952,0.00058853696,0.0019517427,0.000003243318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004520997,0.00068123866,0.9064632,0.000079049336,0.00007569714,0.00013317562,0.0026640778,0.0011727905,0.077836156,0.0000010290884,0.000101051504,0.006271543],"study_design_scores_gemma":[0.017369142,0.0019805497,0.9644704,0.0003723111,0.00007003559,0.00043758957,0.0013765699,0.010573671,0.0028515267,0.0000070480846,0.000020559395,0.00047062396],"about_ca_topic_score_codex":0.0003815939,"about_ca_topic_score_gemma":0.00067024253,"teacher_disagreement_score":0.074984625,"about_ca_system_score_codex":0.0007662321,"about_ca_system_score_gemma":0.00037470515,"threshold_uncertainty_score":0.9998137},"labels":[],"label_agreement":null},{"id":"W4298087646","doi":"10.1177/13524585221125382","title":"Recurrent disability progression endpoints in multiple sclerosis clinical trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Multiple sclerosis; Clinical trial; Proportional hazards model; Randomized controlled trial; Expanded Disability Status Scale; Marginal structural model; Clinical endpoint; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Confidence interval; Psychiatry","score_opus":0.5092941805457951,"score_gpt":0.468741093657901,"score_spread":0.04055308688789411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298087646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869333,0.002078072,0.00020737415,0.0044738078,0.0024367934,0.0032527917,0.00027721364,0.00016872116,0.00017192432],"genre_scores_gemma":[0.98866004,0.004441512,0.0040263194,0.00036622238,0.0013000902,0.00091087725,0.000080136946,0.000114750015,0.000100050886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9801613,0.008877181,0.004709327,0.0013853329,0.0031790498,0.0016877998],"domain_scores_gemma":[0.9887977,0.006645047,0.0014919033,0.0012116665,0.000489966,0.0013636767],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033833593,0.0007045961,0.0026580053,0.0005828419,0.0018418165,0.00024051523,0.00086853723,0.00027113303,0.0022053784],"category_scores_gemma":[0.040889826,0.0005725958,0.0016634492,0.0012911625,0.0008609278,0.00043925096,0.0015098487,0.004493107,0.0000796474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043216706,0.004302426,0.6159428,0.00007450323,0.00022246198,0.000043457665,0.0005097554,0.00010829209,0.016219389,0.0000023622804,0.005837767,0.3524151],"study_design_scores_gemma":[0.022684975,0.0018379322,0.9543538,0.0009745011,0.00013708163,0.00010279522,0.0015123218,0.006840102,0.0018440856,0.000033373035,0.009117538,0.000561476],"about_ca_topic_score_codex":0.00013999354,"about_ca_topic_score_gemma":0.00028553634,"teacher_disagreement_score":0.35185364,"about_ca_system_score_codex":0.0019019247,"about_ca_system_score_gemma":0.0004719453,"threshold_uncertainty_score":0.99967253},"labels":[],"label_agreement":null},{"id":"W4307232309","doi":"10.1177/13524585221129963","title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Dalhousie University; University of Saskatchewan; University of British Columbia Hospital; Okanagan University College; Nova Scotia Health Authority; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Canadian Institutes of Health Research; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques","keywords":"Socioeconomic status; Hazard ratio; Medicine; Confidence interval; Proportional hazards model; Multiple sclerosis; Demography; Internal medicine; Environmental health; Population","score_opus":0.11544156771061344,"score_gpt":0.29510060760051626,"score_spread":0.17965903988990284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307232309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950433,0.0007212241,0.000055495402,0.0008875853,0.00060737267,0.0013825446,0.00077793363,0.00018583328,0.0003387351],"genre_scores_gemma":[0.99466544,0.0024545442,0.00080937543,0.0005041636,0.00036369776,0.00053971424,0.00013505158,0.0001814131,0.00034657214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918123,0.0013673637,0.0014768207,0.0010766751,0.0020653184,0.0022015397],"domain_scores_gemma":[0.9950518,0.0013268413,0.0012981299,0.0008649929,0.00045315153,0.0010050755],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031674642,0.0007390783,0.0014690807,0.0008099529,0.0022517277,0.0002620385,0.0006142437,0.00021279354,0.0030412301],"category_scores_gemma":[0.002613758,0.0006529641,0.00059195695,0.0009785512,0.00054342777,0.0005150424,0.00069866923,0.0035504096,0.000090649955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013876699,0.002046674,0.96300685,0.00004502942,0.0011358281,0.00009376653,0.0014485755,0.003619698,0.016416099,0.000002718696,0.0036199372,0.007177151],"study_design_scores_gemma":[0.022294758,0.0009482754,0.9648618,0.00044418068,0.00022178036,0.000030339399,0.0017004206,0.006842532,0.0010547723,0.000025896401,0.00089199195,0.0006832323],"about_ca_topic_score_codex":0.002251552,"about_ca_topic_score_gemma":0.0034912103,"teacher_disagreement_score":0.02090709,"about_ca_system_score_codex":0.0039186166,"about_ca_system_score_gemma":0.0006715673,"threshold_uncertainty_score":0.99990517},"labels":[],"label_agreement":null},{"id":"W4307407860","doi":"10.1177/13524585221122207","title":"Polypharmacy and multiple sclerosis: A population-based study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC","keywords":"Polypharmacy; Medicine; Odds ratio; Interquartile range; Population; Confidence interval; Internal medicine; Cohort; Pediatrics; Environmental health","score_opus":0.14314994726282745,"score_gpt":0.32806266336094864,"score_spread":0.18491271609812118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307407860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348,0.0012882208,0.00012365353,0.0020281316,0.0005621893,0.0021009343,0.0001341732,0.00020082768,0.00008184251],"genre_scores_gemma":[0.9959219,0.00029554605,0.0016756977,0.0009261073,0.0005031295,0.00035961473,0.00004922415,0.00012459952,0.00014418959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938196,0.0008589322,0.0010943958,0.00084596826,0.0022812402,0.0010998804],"domain_scores_gemma":[0.9967787,0.0008525895,0.00043387435,0.0006500106,0.00038211216,0.00090268697],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019988893,0.00055302,0.00091980264,0.00084751664,0.003324727,0.0003108396,0.00046492944,0.000077761266,0.0011163917],"category_scores_gemma":[0.0016824441,0.00050944125,0.00038299314,0.00089987007,0.00014182,0.0003542694,0.00069749984,0.0017459159,0.000027852153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013788113,0.0023746332,0.9402349,0.000050619517,0.00038424137,0.00006405378,0.0011311149,0.0014010543,0.032733582,0.0000015689233,0.0018015933,0.018443845],"study_design_scores_gemma":[0.021039978,0.0013229019,0.95481414,0.0001697938,0.00020914317,0.00011110501,0.0036498187,0.01630516,0.0006881589,0.0000069091184,0.0012086838,0.00047419887],"about_ca_topic_score_codex":0.0009448812,"about_ca_topic_score_gemma":0.00018078819,"teacher_disagreement_score":0.032045424,"about_ca_system_score_codex":0.0007736424,"about_ca_system_score_gemma":0.00027763963,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W4308548584","doi":"10.1177/13524585221135883","title":"A journey with no roadmap—The need for validated criteria of the MS prodrome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prodrome; Prodromal Stage; Intervention (counseling); Stage (stratigraphy); Medicine; Multiple sclerosis; Disease; Psychology; Psychiatry; Cognitive impairment; Pathology","score_opus":0.12507845671618195,"score_gpt":0.31617450492836724,"score_spread":0.1910960482121853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308548584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820389,0.00038938326,0.00039019424,0.012882469,0.0008326995,0.002836774,0.0002381816,0.000049573275,0.00034183764],"genre_scores_gemma":[0.994761,0.00015177416,0.0025260728,0.0005877286,0.0005053679,0.0004864696,0.000013422043,0.00007360755,0.0008945408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960261,0.00054016156,0.00075494574,0.00034408752,0.0016032517,0.0007314363],"domain_scores_gemma":[0.99687773,0.000513493,0.00056070404,0.0007152712,0.0010723083,0.00026050216],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0021037653,0.00030420336,0.00060950994,0.00020054892,0.00214841,0.00013811496,0.0008129403,0.000055890014,0.00080180774],"category_scores_gemma":[0.002077413,0.00015343075,0.0004522377,0.0007756634,0.00040008777,0.00015820874,0.00051558384,0.0011518878,0.000007943445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059034782,0.0012526932,0.115584105,0.00025821032,0.0014229856,0.000015262809,0.004590696,0.0008384127,0.7744558,0.000019399662,0.090501375,0.0051575843],"study_design_scores_gemma":[0.020968081,0.0033245713,0.87448347,0.00081174466,0.00045733343,0.00084069377,0.0039085266,0.010179791,0.028983256,0.000046879417,0.055493854,0.00050181086],"about_ca_topic_score_codex":0.00010654328,"about_ca_topic_score_gemma":0.000039046183,"teacher_disagreement_score":0.75889933,"about_ca_system_score_codex":0.0003052143,"about_ca_system_score_gemma":0.00039401551,"threshold_uncertainty_score":0.99915063},"labels":[],"label_agreement":null},{"id":"W4310295951","doi":"10.1177/13524585221137502","title":"Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; Multiple Sclerosis Society; Università di Catania; Multiple Sclerosis Society of Canada; H. Lundbeck A/S; International Progressive MS Alliance; Universität Basel; Merck KGaA; Univerzita Karlova v Praze; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; GlaxoSmithKline; Sanofi; Fondation Brain Canada; Pfizer","keywords":"Teriflunomide; Cladribine; Fingolimod; Medicine; Discontinuation; Multiple sclerosis; Dimethyl fumarate; Internal medicine; Hazard ratio; Clinical trial; Confidence interval; Immunology","score_opus":0.2799543506146697,"score_gpt":0.3646852724158959,"score_spread":0.08473092180122616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310295951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98257256,0.002008931,0.000983095,0.0003709899,0.0010706069,0.0030196041,0.009710338,0.00011614708,0.0001477048],"genre_scores_gemma":[0.9917329,0.00047263494,0.0051217424,0.00009662444,0.00045483594,0.001072818,0.0007749946,0.00013205942,0.00014137072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9932404,0.001260279,0.0013915402,0.0011203134,0.0018104453,0.0011769946],"domain_scores_gemma":[0.99184066,0.0043808077,0.0010052127,0.0010439124,0.0008105086,0.00091892644],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0021664596,0.0007159424,0.00172588,0.0004570308,0.0017361586,0.00013652556,0.00063098443,0.00014015858,0.00023189628],"category_scores_gemma":[0.0038865802,0.00064016087,0.0008600579,0.00067447225,0.00043775866,0.0003853008,0.00054085406,0.0010566438,0.00001633397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22772501,0.005869907,0.17028211,0.00045208618,0.005032751,0.00007757764,0.0025847878,0.011018968,0.5601115,0.000012794647,0.007761049,0.009071444],"study_design_scores_gemma":[0.12803061,0.002656715,0.8056517,0.0021126578,0.0011306348,0.000012813192,0.0024771418,0.020456249,0.0336315,0.000040303992,0.0030281122,0.00077150675],"about_ca_topic_score_codex":0.0011627355,"about_ca_topic_score_gemma":0.00016111761,"teacher_disagreement_score":0.63536966,"about_ca_system_score_codex":0.0013640963,"about_ca_system_score_gemma":0.00049478054,"threshold_uncertainty_score":0.99960494},"labels":[],"label_agreement":null},{"id":"W4312095631","doi":"10.1177/13524585221137500","title":"Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; McGill University; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"Ontario Institute for Regenerative Medicine; Stem Cell Network; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society","keywords":"Subclinical infection; Optic neuritis; Multiple sclerosis; White matter; Magnetic resonance imaging; Optic nerve; Magnetization transfer; Medicine; Ophthalmology; Nuclear medicine; Pathology; Radiology","score_opus":0.11076823799718633,"score_gpt":0.3151943155756983,"score_spread":0.204426077578512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252397,0.0010950981,0.0005073302,0.0027483883,0.0009062346,0.001698002,0.00026887644,0.00014305292,0.00010906425],"genre_scores_gemma":[0.9901028,0.0044977246,0.0029385113,0.0004408094,0.0010183685,0.00046858218,0.00018986607,0.0001339157,0.0002094153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99172026,0.0014393112,0.0021893512,0.00097099366,0.0023394332,0.0013406242],"domain_scores_gemma":[0.99636227,0.0012407923,0.000379595,0.00070095464,0.00057509117,0.0007412849],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038177457,0.0006060396,0.0011572817,0.0012502228,0.0014225998,0.000262057,0.0005590221,0.00026757512,0.0011558125],"category_scores_gemma":[0.0042569092,0.00058515364,0.00064580137,0.0018987076,0.00021475919,0.0006296988,0.0004310582,0.0027730349,0.000073123454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028520382,0.0014961434,0.8854594,0.00014431043,0.00012102241,0.00010356675,0.001241964,0.0016254274,0.08940635,0.000008653142,0.0068611717,0.01067994],"study_design_scores_gemma":[0.010849475,0.0013589308,0.97474813,0.00023768526,0.00017710128,0.00019799986,0.00068309135,0.009412593,0.001258047,0.00002972461,0.0004712757,0.0005759355],"about_ca_topic_score_codex":0.00020616717,"about_ca_topic_score_gemma":0.00016647161,"teacher_disagreement_score":0.08928873,"about_ca_system_score_codex":0.001061358,"about_ca_system_score_gemma":0.00040875305,"threshold_uncertainty_score":0.9998774},"labels":[],"label_agreement":null},{"id":"W4315699728","doi":"10.1177/13524585221144742","title":"Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Placebo; Multiple sclerosis; Post-hoc analysis; Internal medicine; Mallinckrodt; Lesion; Gastroenterology; Nuclear medicine; Surgery; Pathology; Immunology; Fingolimod","score_opus":0.052434812144482666,"score_gpt":0.28791079438869954,"score_spread":0.23547598224421687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315699728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930569,0.00011204056,0.000052749514,0.0030677144,0.00035487182,0.0031277046,0.000051883726,0.00007681886,0.00009931046],"genre_scores_gemma":[0.9961875,0.001729869,0.00095908454,0.00015375468,0.00031379034,0.00024332294,0.000026374239,0.00007556782,0.0003107571],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99399143,0.0014266442,0.0015700985,0.00059868966,0.0014872183,0.0009258877],"domain_scores_gemma":[0.9960687,0.0017901957,0.0008024039,0.0006933986,0.0003262341,0.00031904437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045707733,0.00046844862,0.0020793776,0.0017550088,0.00051448797,0.00018160907,0.0005265429,0.00015504833,0.00018763755],"category_scores_gemma":[0.0065559037,0.00025175014,0.00095359527,0.0038948245,0.0004134178,0.00022390604,0.00038364148,0.0010472563,0.000010426384],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6775302,0.0003845187,0.23996888,0.000040019633,0.004278539,0.00002885221,0.002612524,0.0016612316,0.06716965,0.0000013699922,0.00044257927,0.005881585],"study_design_scores_gemma":[0.40235263,0.00073362375,0.5798332,0.00090901833,0.0010246144,0.00004783994,0.0003931411,0.012634198,0.0018187728,9.1000726e-7,0.00004187217,0.00021015586],"about_ca_topic_score_codex":0.00031779753,"about_ca_topic_score_gemma":0.0008724163,"teacher_disagreement_score":0.33986434,"about_ca_system_score_codex":0.00036529647,"about_ca_system_score_gemma":0.00033895904,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W4317434080","doi":"10.1177/13524585221144413","title":"Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; SickKids Foundation; University of Manitoba","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Psychological intervention; Socioeconomic status; Health related quality of life; Pediatrics; Psychiatry; Population; Disease; Internal medicine; Environmental health","score_opus":0.36361244332769493,"score_gpt":0.40322223284810377,"score_spread":0.039609789520408833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317434080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380816,0.0040907194,0.000076478536,0.0063781366,0.00025861617,0.0013412327,0.0038888783,0.00014296091,0.000014830358],"genre_scores_gemma":[0.9878819,0.009621779,0.0006565273,0.0004035069,0.000347024,0.000109676184,0.00088614936,0.000064267035,0.000029175726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99278027,0.0014073879,0.0023409063,0.00064767513,0.0016047,0.0012190392],"domain_scores_gemma":[0.98984456,0.0065280735,0.0012659609,0.00046535186,0.00043129633,0.0014647462],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0038036986,0.0004644257,0.0012332196,0.00067852327,0.0025477952,0.00016776696,0.00025034285,0.00020346262,0.000048331025],"category_scores_gemma":[0.007966883,0.00036720096,0.00030880477,0.0012174139,0.0007858574,0.00037857328,0.0003693485,0.0013293037,0.000029903742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039228192,0.00023506359,0.9842054,0.00026666865,0.00025474466,0.0000014239376,0.0021468245,0.000092567105,0.00069456315,0.000027282764,0.009289607,0.0023935458],"study_design_scores_gemma":[0.00841243,0.00042454843,0.9851617,0.00038849638,0.00007415803,0.000018174218,0.0037780832,0.001278563,0.000017866341,0.00009650786,0.000059006812,0.0002904429],"about_ca_topic_score_codex":0.002923178,"about_ca_topic_score_gemma":0.00055651565,"teacher_disagreement_score":0.009230601,"about_ca_system_score_codex":0.00042069342,"about_ca_system_score_gemma":0.0010468801,"threshold_uncertainty_score":0.999878},"labels":[],"label_agreement":null},{"id":"W4317726029","doi":"10.1177/13524585221146270","title":"The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Miscarriage; Pregnancy; Medicine; Obstetrics; First trimester; Population; Gynecology; Abortion; Gestation; Psychiatry; Biology","score_opus":0.11699582429014671,"score_gpt":0.289420003314446,"score_spread":0.1724241790242993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317726029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851032,0.0017521997,0.000019370646,0.0064815846,0.00082211033,0.00481989,0.00021098848,0.000404203,0.00038645294],"genre_scores_gemma":[0.9864046,0.008373386,0.00063922885,0.0004012636,0.0006548111,0.0022198393,0.000035844412,0.00034213698,0.0009289055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98752147,0.00097272947,0.0020630555,0.0016797509,0.0031405042,0.004622505],"domain_scores_gemma":[0.9901741,0.0033606559,0.00065981544,0.0019432371,0.0011682882,0.0026938592],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0040806513,0.0013310309,0.0017802436,0.0020680074,0.0056952094,0.0015046378,0.0016262375,0.00047453513,0.0002177003],"category_scores_gemma":[0.0060674427,0.00092939567,0.0005237428,0.00393449,0.00096090743,0.00089455576,0.0007155084,0.002742841,0.0004526544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024331498,0.0010985802,0.923197,0.00014203842,0.0010142775,0.00030462656,0.009795742,0.00085851864,0.00732245,0.0000015552154,0.009235535,0.044596534],"study_design_scores_gemma":[0.023338113,0.0015708334,0.94884837,0.004099234,0.0001406485,0.00006248987,0.011788836,0.0032672689,0.00092885294,0.000011557663,0.004933848,0.0010099753],"about_ca_topic_score_codex":0.05516221,"about_ca_topic_score_gemma":0.62169343,"teacher_disagreement_score":0.56653124,"about_ca_system_score_codex":0.0033581827,"about_ca_system_score_gemma":0.0015231087,"threshold_uncertainty_score":0.9999441},"labels":[],"label_agreement":null},{"id":"W4318191253","doi":"10.1177/13524585221149886","title":"Should trigeminal neuralgia be considered a clinically isolated syndrome?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Toronto Western Hospital; University of Toronto; University Health Network","funders":"Institute of Neurosciences, Mental Health and Addiction; Canadian Institutes of Health Research; Biogen; Bristol-Myers Squibb","keywords":"Medicine; Trigeminal neuralgia; Multiple sclerosis; Magnetic resonance imaging; Confusion; Clinically isolated syndrome; Lesion; Dermatology; Radiology; Pediatrics; Surgery; Psychiatry; Psychology","score_opus":0.23247750599618605,"score_gpt":0.34816085855762907,"score_spread":0.11568335256144302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318191253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262476,0.00016099174,0.00006054132,0.0052570645,0.00076497364,0.00046946856,0.000048230213,0.0003537291,0.0002602168],"genre_scores_gemma":[0.9950401,0.00056139875,0.0009380885,0.0011608794,0.00018933904,0.00002475197,0.00006167295,0.00007644935,0.001947305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967619,0.00015822936,0.0010625378,0.0004779541,0.0007395958,0.0007997692],"domain_scores_gemma":[0.99759066,0.00063786237,0.00034071773,0.00041652616,0.00025592197,0.0007583338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005556447,0.00038021794,0.000753049,0.00043757743,0.00043878195,0.0001437738,0.00022155879,0.00025736037,0.0006164025],"category_scores_gemma":[0.0008061244,0.00029748186,0.0005299729,0.00086581823,0.00015265575,0.00021179569,0.0000968335,0.0010221096,0.00070905394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008381598,0.001740574,0.7847335,0.00016733272,0.0015812877,0.022105819,0.0008324918,0.000058580663,0.071265526,0.000022138966,0.07713492,0.031976257],"study_design_scores_gemma":[0.016284248,0.0043459856,0.95244056,0.0007157959,0.00069694815,0.016832214,0.00033023886,0.0034349102,0.0018300795,0.00014193311,0.0024531567,0.0004939448],"about_ca_topic_score_codex":0.000023863633,"about_ca_topic_score_gemma":0.0000060780008,"teacher_disagreement_score":0.16770707,"about_ca_system_score_codex":0.000120547906,"about_ca_system_score_gemma":0.00019703203,"threshold_uncertainty_score":0.9999477},"labels":[],"label_agreement":null},{"id":"W4319657027","doi":"10.1177/13524585231154251","title":"A spoonful of sugar: The risks of negative health outcomes of polypharmacy in MS is a bitter reality","year":2023,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Polypharmacy; Medicine; Sugar; Environmental health; Food science; Chemistry; Intensive care medicine","score_opus":0.4001819585483665,"score_gpt":0.4381822156936194,"score_spread":0.0380002571452529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319657027","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24362427,0.0011968131,0.000043139426,0.7505115,0.0006741041,0.0018525828,0.0018820283,0.000040368795,0.00017513796],"genre_scores_gemma":[0.8617227,0.016039299,0.0011384262,0.11789443,0.0018505816,0.00014995616,0.000094446135,0.00024347744,0.0008666635],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99121624,0.0013195372,0.0030303905,0.00061237835,0.002649229,0.0011722317],"domain_scores_gemma":[0.9914528,0.0033049805,0.0028499337,0.0010708437,0.0010586495,0.00026278204],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036187419,0.00066888647,0.0030973149,0.0012852699,0.00024123854,0.000035729456,0.0009049435,0.00046329814,0.00031974353],"category_scores_gemma":[0.0034208228,0.0004279254,0.0012014037,0.0012503755,0.0014360509,0.00014218094,0.0004970732,0.00470654,0.000015343268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005785609,0.00039557717,0.3881494,0.0015333076,0.0016598597,0.000048194892,0.0068472764,0.000020216788,0.0034645372,6.8357707e-7,0.5899577,0.007344676],"study_design_scores_gemma":[0.007285433,0.0004607527,0.97207636,0.0035310502,0.00019177854,0.000023347584,0.0009865052,0.000301707,0.0033330242,0.000033242264,0.011478808,0.0002980052],"about_ca_topic_score_codex":0.01809851,"about_ca_topic_score_gemma":0.00081894087,"teacher_disagreement_score":0.6326171,"about_ca_system_score_codex":0.0004618386,"about_ca_system_score_gemma":0.0008164526,"threshold_uncertainty_score":0.99981725},"labels":[],"label_agreement":null},{"id":"W4320856208","doi":"10.1177/13524585231153992","title":"Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Biogen; Sanofi; Novartis","keywords":"Natalizumab; Medicine; Odds ratio; Multiple sclerosis; Confidence interval; Internal medicine; Cohort; Logistic regression; Cognition; Physical therapy; Immunology; Psychiatry","score_opus":0.20783570689909384,"score_gpt":0.35965672994533526,"score_spread":0.15182102304624143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320856208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420446,0.0001770246,0.00005722992,0.00011702686,0.0003869314,0.004268659,0.00012925938,0.0001622658,0.00049715146],"genre_scores_gemma":[0.9978285,0.0008368583,0.00018855187,0.000041908064,0.00018645113,0.00071881816,0.00008478602,0.00007841854,0.000035713478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932971,0.0015746462,0.0012605385,0.00082613964,0.0020331184,0.0010084646],"domain_scores_gemma":[0.99450254,0.0031771683,0.00044227825,0.00060862675,0.00083956646,0.00042979876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044761337,0.00055541785,0.0017730019,0.0015836038,0.0005171822,0.00010619328,0.00038731567,0.00018618142,0.0000960802],"category_scores_gemma":[0.00317798,0.00047522393,0.00040615018,0.0020141357,0.000382074,0.00034674097,0.00028468776,0.0012400582,0.00022301954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051235785,0.003424403,0.84972584,0.0002494509,0.00085693394,0.00009041772,0.0020859097,0.001025881,0.13398941,0.0000035891967,0.00059868576,0.0028258846],"study_design_scores_gemma":[0.022965737,0.0022075453,0.93335307,0.0037392247,0.00015722404,0.00002426475,0.0040642214,0.0041865516,0.028887741,0.000020239984,0.000027177759,0.0003669849],"about_ca_topic_score_codex":0.0003292969,"about_ca_topic_score_gemma":0.00039765268,"teacher_disagreement_score":0.105101675,"about_ca_system_score_codex":0.0005908611,"about_ca_system_score_gemma":0.0002053543,"threshold_uncertainty_score":0.9997699},"labels":[],"label_agreement":null},{"id":"W4321329773","doi":"10.1177/13524585231151953","title":"A national case–control study investigating demographic and environmental factors associated with NMOSD","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of New Brunswick; University of Calgary; Ottawa Hospital; Health Sciences Centre; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; University of British Columbia; Western University; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Neuromyelitis optica; Medicine; Odds ratio; Menarche; Confidence interval; Logistic regression; Multiple sclerosis; Case-control study; Demography; Pediatrics; Internal medicine; Immunology","score_opus":0.13204145722125427,"score_gpt":0.29929219046200556,"score_spread":0.1672507332407513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321329773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980724,0.00014051497,0.0000312947,0.00036700387,0.00007411996,0.0009175334,0.00022098745,0.00013833948,0.00003782287],"genre_scores_gemma":[0.99921495,0.0001299302,0.00015797059,0.000121476216,0.00016372709,0.00006842452,0.00004282028,0.000058145743,0.000042587453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996461,0.00037370904,0.00052061345,0.00043548245,0.0015305714,0.0006786598],"domain_scores_gemma":[0.99763244,0.0011837289,0.0002561274,0.00017025761,0.0001865502,0.0005709201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016495049,0.00033876137,0.0005282519,0.0005845141,0.0012052999,0.00017241832,0.000119181845,0.0000989666,0.000069122616],"category_scores_gemma":[0.0030424283,0.00024862745,0.00014125672,0.00075231574,0.0003783891,0.0002637098,0.00012943991,0.00079578906,0.000008113535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079592304,0.00040753622,0.97984576,0.00001243059,0.0010644166,0.00033852013,0.002037245,0.00019687804,0.01333842,6.5728096e-7,0.0003115114,0.0023670055],"study_design_scores_gemma":[0.0102761295,0.00077437836,0.9659126,0.00022429672,0.00018418573,0.00037469793,0.009058346,0.012798042,0.0001320318,0.000011113932,0.000013563987,0.00024065783],"about_ca_topic_score_codex":0.00004303245,"about_ca_topic_score_gemma":0.00027615228,"teacher_disagreement_score":0.013933231,"about_ca_system_score_codex":0.00026453138,"about_ca_system_score_gemma":0.00011269517,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W4321376795","doi":"10.1177/13524585231151394","title":"Comparative effectiveness in multiple sclerosis: A methodological comparison","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Novartis Pharma; EMD Serono; Grifols; Multiple Sclerosis Australia; Università di Catania; Multiple Sclerosis Society of Canada; Atara Biotherapeutics; Univerzita Karlova v Praze; Medical Research Council; Biogen; Celgene; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Sanofi; Mylan; Bristol-Myers Squibb","keywords":"Propensity score matching; Marginal structural model; Fingolimod; Observational study; Medicine; Natalizumab; Hazard ratio; Confounding; Multiple sclerosis; Internal medicine; Confidence interval; Disease; Psychiatry","score_opus":0.5957892208114504,"score_gpt":0.446046245875831,"score_spread":0.14974297493561933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321376795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931581,0.0009949101,0.0015799084,0.0009749843,0.000642656,0.001778702,0.000055003737,0.0004038106,0.0004119423],"genre_scores_gemma":[0.98958343,0.0019548747,0.007195663,0.00016261835,0.0004683642,0.0004254645,0.000050367136,0.000083857536,0.00007535416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912018,0.0028786531,0.0014973279,0.0010086512,0.0016449118,0.0017686612],"domain_scores_gemma":[0.9899613,0.007505439,0.00042520577,0.0006388135,0.0006238973,0.00084534776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0067032594,0.0006994034,0.0024635377,0.0013552686,0.00086973934,0.00024608328,0.00059033756,0.00036614848,0.00020286345],"category_scores_gemma":[0.007994262,0.00056283805,0.0006516164,0.0026619793,0.00061352836,0.0004273476,0.00054671324,0.0022751729,0.0006147897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002636935,0.0010641661,0.6964541,0.00017951331,0.00041148197,0.00010840139,0.0023328448,0.0025609888,0.27393767,0.000010119636,0.0044470727,0.015856693],"study_design_scores_gemma":[0.013111774,0.0007084482,0.927581,0.0018260785,0.00007845374,0.000067056644,0.0026448562,0.029068874,0.02353594,0.00005930229,0.00080582005,0.0005123572],"about_ca_topic_score_codex":0.00020423278,"about_ca_topic_score_gemma":0.00032963685,"teacher_disagreement_score":0.25040174,"about_ca_system_score_codex":0.0007534893,"about_ca_system_score_gemma":0.00023067497,"threshold_uncertainty_score":0.9996823},"labels":[],"label_agreement":null},{"id":"W4321996644","doi":"10.1177/13524585231154780","title":"Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Neuromyelitis optica; Acute disseminated encephalomyelitis; Vaccination; Myelitis; Transverse myelitis; Immunology; Cohort; Internal medicine; Myelin oligodendrocyte glycoprotein; Pediatrics; Experimental autoimmune encephalomyelitis","score_opus":0.10433635395973619,"score_gpt":0.343096173128407,"score_spread":0.23875981916867084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321996644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836666,0.000034127665,0.0026635553,0.004222771,0.0015926177,0.002358797,0.000024523219,0.00066747714,0.00006946184],"genre_scores_gemma":[0.99603945,0.000026449725,0.0009657072,0.00074623787,0.0015268514,0.00016445188,0.00029514494,0.000074350115,0.00016133394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956767,0.00049674674,0.0009569247,0.0005259444,0.0016395974,0.0007041095],"domain_scores_gemma":[0.9967579,0.000715019,0.00044664284,0.00052607124,0.000343004,0.0012113313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002540303,0.00035514522,0.00061537616,0.00056056405,0.0009867711,0.0003846173,0.00037069793,0.00017243493,0.00012397338],"category_scores_gemma":[0.0023803106,0.00032477156,0.00035557203,0.00091040065,0.000025155796,0.0011378337,0.00011325839,0.00053601013,0.00011305112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003467412,0.00022718371,0.978343,0.00019173446,0.0006930678,0.0008243659,0.0016020488,0.0048242137,0.008550572,0.000044436525,0.001983037,0.0023696083],"study_design_scores_gemma":[0.008327656,0.0005166564,0.961938,0.00021976585,0.00057926064,0.00030938294,0.0010141252,0.026125057,0.00030245562,0.000025920397,0.00033932223,0.00030235873],"about_ca_topic_score_codex":0.000121352925,"about_ca_topic_score_gemma":0.00010289584,"teacher_disagreement_score":0.021300843,"about_ca_system_score_codex":0.0017819036,"about_ca_system_score_gemma":0.00077271316,"threshold_uncertainty_score":0.9999204},"labels":[],"label_agreement":null},{"id":"W4322500069","doi":"10.1177/13524585221146430","title":"Primary results of a phase-III, randomized controlled trial of the Behavioral Intervention for increasing Physical Activity in Multiple Sclerosis project","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Randomized controlled trial; Medicine; Physical therapy; Multiple sclerosis; Intervention (counseling); Social cognitive theory; Physical activity; Clinical trial; Psychology; Internal medicine; Psychiatry; Developmental psychology","score_opus":0.19678577947251366,"score_gpt":0.3930734756397024,"score_spread":0.19628769616718875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322500069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834155,0.00008700305,0.00022022321,0.00043983775,0.00055529265,0.014882529,0.00027055157,0.000061950595,0.00006714555],"genre_scores_gemma":[0.9962528,0.00052647956,0.00077073183,0.000014287512,0.00044915592,0.0017917375,0.0000434023,0.0000631217,0.00008828307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925306,0.0022654538,0.002335446,0.00054137263,0.0015321219,0.00079500355],"domain_scores_gemma":[0.98956305,0.006937332,0.0019316815,0.00058497535,0.0008004996,0.0001824708],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010053548,0.0004562968,0.0037370576,0.00087998726,0.00037506956,0.000074860225,0.00044887647,0.00019632647,0.000008335025],"category_scores_gemma":[0.018923527,0.00029078027,0.002897546,0.0012383028,0.00072570913,0.00033067062,0.0003440263,0.00084685395,0.0000017692566],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6691147,0.0055281934,0.0018929566,0.00017083994,0.00046963498,0.0000018619373,0.0012830724,0.000042326268,0.3037454,9.73606e-7,0.00039283713,0.017357215],"study_design_scores_gemma":[0.8723389,0.0016170564,0.06845097,0.0021912425,0.0005316748,0.0000055406467,0.0004922819,0.026157249,0.027978167,0.000012715516,0.000015331443,0.00020890468],"about_ca_topic_score_codex":0.00128469,"about_ca_topic_score_gemma":0.00021202766,"teacher_disagreement_score":0.27576724,"about_ca_system_score_codex":0.000391185,"about_ca_system_score_gemma":0.00040002115,"threshold_uncertainty_score":0.99995446},"labels":[],"label_agreement":null},{"id":"W4322617305","doi":"10.1177/13524585231151951","title":"Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; St. Michael's Hospital; Université de Montréal","funders":"National Health and Medical Research Council; Allergan; EMD Serono; Università di Catania; Eisai; Canadian Institutes of Health Research; Ipsen; Fonds Wetenschappelijk Onderzoek; Koning Boudewijnstichting; Mazandaran University of Medical Sciences; Multiple Sclerosis Australia; Multiple Sclerosis Society; Trish Multiple Sclerosis Research Foundation; Multiple Sclerosis Society of Canada; Vlaamse regering; Amicus Therapeutics; International Progressive MS Alliance; Mylan; National Research Foundation; Novartis Pharma; Fondation Brain Canada; Merck KGaA; Univerzita Karlova v Praze; Bristol-Myers Squibb; University of Melbourne; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; Grifols; F. Hoffmann-La Roche; Monash University; Dementia Australia; Genesis Pharma; Alexion Pharmaceuticals; National Institute for Health and Care Research; Royal Melbourne Hospital Neuroscience Foundation; Medical Research Council; Teva Pharmaceutical Industries; Bayer HealthCare; Sanofi; Sanofi Genzyme; Universität Basel","keywords":"Medicine; Multiple sclerosis; Hazard ratio; Relapsing remitting; Confidence interval; Proportional hazards model; Internal medicine; Pediatrics; Clinically isolated syndrome; Disease; Physical therapy; Psychiatry","score_opus":0.1165934781784118,"score_gpt":0.3131029049408966,"score_spread":0.19650942676248478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322617305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635994,0.0002472804,0.00021268237,0.0008286694,0.00048244424,0.0014419538,0.00010456028,0.00023280484,0.000089678375],"genre_scores_gemma":[0.9942574,0.0024054633,0.0023996949,0.000039377475,0.00049521035,0.00013587595,0.00005900798,0.00015004621,0.000057941714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928379,0.00036346575,0.002261893,0.00096620375,0.0021071832,0.0014633212],"domain_scores_gemma":[0.9943761,0.0019475396,0.0012926325,0.00090630964,0.00082084315,0.00065656047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032900495,0.0006508827,0.0014983703,0.00086815417,0.0007467179,0.00019383508,0.00046802324,0.00032395896,0.000069234426],"category_scores_gemma":[0.007856448,0.00052730576,0.00048727167,0.0031246268,0.0006575344,0.0008859516,0.0003836679,0.0015584587,0.000028965984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013306584,0.0006259092,0.922059,0.00030355924,0.00027698255,0.000022502942,0.0032182108,0.0029589473,0.06540251,9.614394e-7,0.00043068832,0.0033700631],"study_design_scores_gemma":[0.0094562,0.0005337521,0.95004916,0.0050666085,0.00013155,0.000028308064,0.0037229534,0.026009057,0.004502044,0.00001134429,0.000029041728,0.0004599811],"about_ca_topic_score_codex":0.0015506158,"about_ca_topic_score_gemma":0.0030700793,"teacher_disagreement_score":0.06090047,"about_ca_system_score_codex":0.0008950401,"about_ca_system_score_gemma":0.00026499637,"threshold_uncertainty_score":0.99971783},"labels":[],"label_agreement":null},{"id":"W4362521630","doi":"10.1177/13524585231161494","title":"Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Teva Pharmaceutical Industries; Biogen; Merck KGaA; Daiichi Sankyo Europe; Sanofi; National Multiple Sclerosis Society; Merck; EMD Serono; Multiple Sclerosis International Federation; Acorda Therapeutics; TG Therapeutics; Pfizer","keywords":"CLARITY; Multiple sclerosis; Cohort; Medicine; Term (time); Cohort study; Internal medicine; Immunology","score_opus":0.11665255913186826,"score_gpt":0.3097119977977462,"score_spread":0.19305943866587796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362521630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946673,0.00025352603,0.00025855022,0.00030654398,0.0006822103,0.003204176,0.00043227753,0.00015823751,0.000037173428],"genre_scores_gemma":[0.99699605,0.00092573505,0.0011115518,0.00008796859,0.00036674782,0.00011805265,0.00020338921,0.00014792463,0.00004258851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916019,0.001182967,0.0016767946,0.001122081,0.0032830602,0.0011332037],"domain_scores_gemma":[0.992048,0.0018928285,0.0011678048,0.0015772588,0.0026903383,0.00062372966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027136714,0.0007144271,0.0016995855,0.0005736492,0.001291705,0.00018434909,0.0008357538,0.00031265343,0.00015902518],"category_scores_gemma":[0.0039830217,0.00047669266,0.0005632779,0.001670492,0.00086829887,0.0007498008,0.00067909254,0.0019314246,0.000024741048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004508828,0.0028328379,0.9301387,0.000066238565,0.0016057515,0.000026052832,0.0044261874,0.00007996571,0.04746429,0.0000010933513,0.000726305,0.008123726],"study_design_scores_gemma":[0.024069764,0.0025552078,0.96135604,0.0018644409,0.0007126983,0.0000055226733,0.0034911763,0.001477211,0.003998312,0.000015072922,0.000011494104,0.00044303687],"about_ca_topic_score_codex":0.002389894,"about_ca_topic_score_gemma":0.0038553495,"teacher_disagreement_score":0.043465976,"about_ca_system_score_codex":0.0004848106,"about_ca_system_score_gemma":0.00029939567,"threshold_uncertainty_score":0.9997685},"labels":[],"label_agreement":null},{"id":"W4362716945","doi":"10.1177/13524585231164296","title":"Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Imperial College London; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Diabetes mellitus; Multiple sclerosis; Population; Internal medicine; Blood pressure; Confidence interval; Type 2 diabetes; Vascular disease; Endocrinology; Environmental health; Psychiatry","score_opus":0.05471533934303182,"score_gpt":0.28309148441163984,"score_spread":0.228376145068608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362716945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623716,0.00035572518,0.00003303759,0.00044054864,0.000077823184,0.0026801112,0.00010043627,0.000050209168,0.00002495353],"genre_scores_gemma":[0.9955404,0.0027694548,0.00076919293,0.000026191108,0.00006128017,0.00064940617,0.000041718788,0.00007428186,0.00006811388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945896,0.00080732314,0.0013456593,0.00057603867,0.0018706111,0.0008107463],"domain_scores_gemma":[0.9960747,0.0019068781,0.00061893254,0.00083968986,0.00033391523,0.00022589655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033886626,0.00041658437,0.0011294311,0.0010848597,0.0003650309,0.000047312886,0.00045777683,0.00011110853,0.00024021599],"category_scores_gemma":[0.0011511312,0.0002799389,0.00035114744,0.0027481595,0.00015773761,0.00016525466,0.0003747909,0.00069745455,0.00003911879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00120437,0.0018440596,0.9625857,0.00022463212,0.0005975364,0.000040097144,0.0035922138,0.017333886,0.0018417847,3.1297202e-7,0.0001322279,0.010603216],"study_design_scores_gemma":[0.022548405,0.0007065313,0.9570207,0.0017636206,0.00020733185,0.000002498331,0.0025176452,0.013714001,0.0012022196,0.000003240201,0.00006342052,0.00025041334],"about_ca_topic_score_codex":0.005058684,"about_ca_topic_score_gemma":0.018089162,"teacher_disagreement_score":0.021344036,"about_ca_system_score_codex":0.0005411236,"about_ca_system_score_gemma":0.00009079791,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W4363645587","doi":"10.1177/13524585231162262","title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Multiple sclerosis; Lesion; Nuclear medicine; Medicine; Concordance; Pathology; Internal medicine; Immunology","score_opus":0.3883739203172658,"score_gpt":0.34031671523631557,"score_spread":0.04805720508095024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363645587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371827,0.003798776,0.00014355077,0.0011504174,0.00021588246,0.00080040377,0.000055044846,0.00008641443,0.00003125889],"genre_scores_gemma":[0.9793804,0.017661612,0.0023421254,0.00006452135,0.00013883272,0.00009815654,0.0000060809475,0.000064057946,0.00024418504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578464,0.00034361435,0.0010886518,0.0006775132,0.0011058943,0.0009997134],"domain_scores_gemma":[0.9971622,0.001102462,0.0003154255,0.0004138436,0.00041284272,0.00059319206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018817802,0.00045140204,0.0009628059,0.0012084565,0.00077457115,0.00017804457,0.0002821967,0.0001970031,0.000065288135],"category_scores_gemma":[0.005188589,0.00036453942,0.00018551984,0.0011698528,0.00088098744,0.00056211,0.0005918675,0.0008943624,0.00002759109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076436833,0.0002060109,0.5075689,0.00024093663,0.00007563532,0.00003734721,0.001470099,0.00007948689,0.45849192,0.0000053203908,0.0005057251,0.030554289],"study_design_scores_gemma":[0.006676263,0.00045869278,0.9576926,0.004322443,0.000067956185,0.0001263686,0.0023863201,0.01199513,0.015847964,0.000020130907,0.000065083106,0.00034100737],"about_ca_topic_score_codex":0.0005090842,"about_ca_topic_score_gemma":0.000407259,"teacher_disagreement_score":0.45012376,"about_ca_system_score_codex":0.00017153879,"about_ca_system_score_gemma":0.00018897353,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W4365810870","doi":"10.1177/13524585231164295","title":"Employment status, productivity loss, and associated factors among people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Toronto; Centre for Advancing Health Outcomes; St. Michael's Hospital; University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Fondation Brain Canada; Government of Alberta; University of Calgary; Biogen Idec; Roche","keywords":"Multiple sclerosis; Productivity; Medicine; Physical medicine and rehabilitation; Environmental health; Psychiatry; Economics","score_opus":0.09547479280071636,"score_gpt":0.28804981876593977,"score_spread":0.1925750259652234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365810870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995216,0.00035863245,0.00008823949,0.0015157728,0.00036230838,0.0016088879,0.00024621328,0.00052720297,0.00007675824],"genre_scores_gemma":[0.9931456,0.004773638,0.0006458763,0.000068919086,0.00036093738,0.00017981557,0.00014538452,0.00017869935,0.0005011465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993233,0.00044603518,0.0009113529,0.0011111133,0.0021853717,0.0021130776],"domain_scores_gemma":[0.9953886,0.0010635769,0.00053276046,0.00071639393,0.0008886412,0.0014099708],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0017145005,0.00078336324,0.0012991085,0.0008113191,0.0016025946,0.00044177,0.00032156147,0.00026069485,0.00014603222],"category_scores_gemma":[0.005266432,0.00058408006,0.0003324486,0.0019401783,0.0007222894,0.0008003042,0.00049741066,0.0014405596,0.00006103784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005476513,0.0006502325,0.9524109,0.00009414003,0.0008204498,0.000038572558,0.0027651414,0.00015260385,0.03282442,0.0000011597193,0.0041414425,0.0055533256],"study_design_scores_gemma":[0.008836331,0.00078786706,0.9788141,0.0009874878,0.00020303966,0.000033889162,0.0018360745,0.0021668698,0.0051133847,0.000007459403,0.00058887637,0.0006245939],"about_ca_topic_score_codex":0.001796088,"about_ca_topic_score_gemma":0.0058766995,"teacher_disagreement_score":0.027711034,"about_ca_system_score_codex":0.000753648,"about_ca_system_score_gemma":0.00030275964,"threshold_uncertainty_score":0.9996972},"labels":[],"label_agreement":null},{"id":"W4367188801","doi":"10.1177/13524585231167740","title":"The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society","keywords":"Comorbidity; Medicine; Quality of life (healthcare); Multiple sclerosis; Disease; Psychological intervention; Intensive care medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.1265485348171381,"score_gpt":0.31131437490942754,"score_spread":0.18476584009228944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367188801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853589,0.0030142278,0.0011342391,0.0058471314,0.0018212136,0.0017070075,0.000069778886,0.0004610264,0.0005864522],"genre_scores_gemma":[0.9783522,0.018014183,0.0011373411,0.00050769845,0.0013158133,0.00021953104,0.000036448066,0.00017649522,0.00024029009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917205,0.0007116332,0.0016267147,0.0009658445,0.0023939314,0.0025813505],"domain_scores_gemma":[0.9938505,0.0030167932,0.00050035806,0.0010893035,0.0006854189,0.00085759035],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005069292,0.00077584124,0.0012017931,0.00090463035,0.002998971,0.00069539435,0.0010135411,0.0003563102,0.00017444696],"category_scores_gemma":[0.008352287,0.0005647519,0.00080266665,0.002348131,0.00066772883,0.0005288799,0.0007582803,0.0027913332,0.0004918374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014831433,0.00047948153,0.62438685,0.00019870886,0.00064192567,0.00021099573,0.0027330616,0.0026794202,0.15482797,0.000020696281,0.025234235,0.18710352],"study_design_scores_gemma":[0.010858923,0.0002757929,0.93527967,0.0015886237,0.00009225225,0.00012083347,0.0015059978,0.024357934,0.010020008,0.00011722957,0.015142409,0.0006403451],"about_ca_topic_score_codex":0.00037438466,"about_ca_topic_score_gemma":0.0022470385,"teacher_disagreement_score":0.31089282,"about_ca_system_score_codex":0.0009592815,"about_ca_system_score_gemma":0.00038052248,"threshold_uncertainty_score":0.9999071},"labels":[],"label_agreement":null},{"id":"W4372347164","doi":"10.1177/13524585231162586","title":"Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); McGill University; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Internal medicine; Brain size; Neurodegeneration; White matter; Disease; Magnetic resonance imaging; Immunology; Rituximab","score_opus":0.09598644962089338,"score_gpt":0.30515463604979015,"score_spread":0.20916818642889679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372347164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98703134,0.0004231457,0.0006067939,0.007936618,0.0006630113,0.0022461175,0.00023960475,0.00070376694,0.00014957976],"genre_scores_gemma":[0.9885714,0.00239835,0.005658641,0.0013228308,0.00073547417,0.00021950537,0.00021186311,0.00031389674,0.00056801294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99116457,0.0005036642,0.0014947435,0.0013548267,0.0027471336,0.0027350541],"domain_scores_gemma":[0.99333704,0.001003711,0.00054471206,0.0010632373,0.0019173202,0.0021339557],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016878248,0.0010042168,0.0015081897,0.0016219113,0.0023951398,0.0005901965,0.0006919903,0.00030384058,0.0003773626],"category_scores_gemma":[0.0038607558,0.00081111054,0.0005108616,0.0032656437,0.00042487914,0.00078637275,0.00062363007,0.0017190365,0.0008912804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027835986,0.0006714226,0.93078464,0.00016885981,0.0005380404,0.0001051122,0.0013009129,0.0014350468,0.01858753,9.0062775e-7,0.027205518,0.016418414],"study_design_scores_gemma":[0.017251858,0.0017347592,0.95964485,0.0030833175,0.0001523548,0.0000406121,0.0008212147,0.008355874,0.003366814,0.000005090262,0.0046889214,0.0008543249],"about_ca_topic_score_codex":0.0003571061,"about_ca_topic_score_gemma":0.0002894223,"teacher_disagreement_score":0.028860213,"about_ca_system_score_codex":0.001185903,"about_ca_system_score_gemma":0.00034977598,"threshold_uncertainty_score":0.99988663},"labels":[],"label_agreement":null},{"id":"W4377565847","doi":"10.1177/13524585231166834","title":"Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Università degli Studi di Sassari; University College London","keywords":"Medicine; Multiple sclerosis; Neuromyelitis optica; Lesion; Magnetic resonance imaging; Optic neuritis; Radiology; Pathology; Psychiatry","score_opus":0.16180857687691566,"score_gpt":0.36998464860034486,"score_spread":0.2081760717234292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377565847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959233,0.0018445674,0.0003422998,0.00092882424,0.0002459907,0.00045928374,0.000017084105,0.000068208734,0.00017044831],"genre_scores_gemma":[0.9870537,0.010689835,0.0017113027,0.000020201473,0.00038514446,0.000024537107,0.000011968516,0.000034038774,0.000069267866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969928,0.00019749963,0.0008742566,0.00034903502,0.00095966965,0.00062671886],"domain_scores_gemma":[0.9983509,0.0004717797,0.00029419447,0.00024367843,0.00030902724,0.00033040866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013173668,0.00023423733,0.00069846713,0.0010514047,0.0002744819,0.000047577872,0.00016925336,0.00015041757,0.00005696466],"category_scores_gemma":[0.0015432236,0.000199142,0.00015871375,0.0013048665,0.00016235358,0.00021970221,0.00023876806,0.0007294893,0.000054428067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027759976,0.00028407716,0.91961193,0.0001783937,0.00003963002,0.000009139289,0.00087161694,0.0004570918,0.06803834,0.000005879777,0.0032507551,0.0069755637],"study_design_scores_gemma":[0.0047914917,0.0003288984,0.9734151,0.00037358768,0.000052756008,0.000018293795,0.00097103417,0.01748511,0.0022106513,0.000032900603,0.00015912208,0.00016109503],"about_ca_topic_score_codex":0.00015770113,"about_ca_topic_score_gemma":0.00018845184,"teacher_disagreement_score":0.06582768,"about_ca_system_score_codex":0.000249902,"about_ca_system_score_gemma":0.00011447307,"threshold_uncertainty_score":0.81207746},"labels":[],"label_agreement":null},{"id":"W4379966936","doi":"10.1177/13524585231175975","title":"Clinical course of multiple sclerosis and patient experiences during breast cancer treatment","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institutes of Health; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.16626702301207255,"score_gpt":0.37074975278318534,"score_spread":0.2044827297711128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379966936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447465,0.0020420493,0.000008378769,0.001630395,0.00063981285,0.0007575089,0.00028453034,0.00013090423,0.000031789237],"genre_scores_gemma":[0.9606624,0.037715454,0.00054800225,0.000079686404,0.0005227495,0.0003156108,0.000010184057,0.00006653812,0.00007933733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956415,0.00029269012,0.0013743212,0.0006828218,0.0010240865,0.0009845751],"domain_scores_gemma":[0.9968069,0.0007531444,0.0005161348,0.00048600015,0.00056622596,0.0008715495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069381174,0.00048023977,0.0011437185,0.00039397355,0.0007529502,0.00011140706,0.00023766466,0.00018882414,0.00028438942],"category_scores_gemma":[0.0006840312,0.00034690337,0.0005252918,0.0007088556,0.00078147464,0.0002977804,0.0003173528,0.0005264529,0.00002797387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009061599,0.000828195,0.754148,0.00007913891,0.00057333277,0.000028636581,0.0074802423,0.00007704385,0.06420524,3.6356948e-7,0.0011305169,0.1705431],"study_design_scores_gemma":[0.009052151,0.0007815924,0.9560958,0.0011188448,0.00012433993,0.00011168574,0.014352033,0.0023761338,0.015322673,0.0000016585091,0.00035963673,0.00030344154],"about_ca_topic_score_codex":0.00039142853,"about_ca_topic_score_gemma":0.00019736245,"teacher_disagreement_score":0.20194778,"about_ca_system_score_codex":0.0002999876,"about_ca_system_score_gemma":0.00025787787,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W4380730561","doi":"10.1177/13524585231176732","title":"Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"Biogen","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Glial fibrillary acidic protein; Biomarker; Medicine; Magnetic resonance imaging; Internal medicine; Oncology; Lesion; Inflammation; Pathology; Gastroenterology; Immunology; Immunohistochemistry; Radiology; Biology","score_opus":0.09247211466150403,"score_gpt":0.31597513072361,"score_spread":0.22350301606210599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380730561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945959,0.0005510306,0.00016135638,0.002042868,0.0002906483,0.0019150928,0.00011519421,0.0002313538,0.00009658603],"genre_scores_gemma":[0.9903113,0.005180559,0.003315968,0.000035021283,0.0007044324,0.00012873253,0.0000719483,0.00009240423,0.00015958866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99478346,0.00032453967,0.0012327597,0.0006338941,0.0020249493,0.0010003828],"domain_scores_gemma":[0.99705434,0.0003595297,0.00064523134,0.0005262698,0.00073913106,0.0006754964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017100752,0.0004896715,0.0009358702,0.0009016507,0.00074718386,0.00019094018,0.00031205956,0.00031554548,0.00009408775],"category_scores_gemma":[0.0019845804,0.0003991161,0.00037373925,0.001070253,0.0005959966,0.00059995876,0.00062005594,0.0008961564,0.0000771756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011499624,0.00014459412,0.16584295,0.00026216524,0.000501014,0.00004185153,0.0007693755,0.00004938541,0.7594987,0.0000051857332,0.0010532077,0.07068162],"study_design_scores_gemma":[0.008346251,0.00073134794,0.71629107,0.002394994,0.00016641713,0.00010280545,0.0005091322,0.006006105,0.26465896,0.00002970102,0.00042659012,0.00033660716],"about_ca_topic_score_codex":0.00007931648,"about_ca_topic_score_gemma":0.000043113083,"teacher_disagreement_score":0.5504481,"about_ca_system_score_codex":0.00023943654,"about_ca_system_score_gemma":0.00022485106,"threshold_uncertainty_score":0.9998461},"labels":[],"label_agreement":null},{"id":"W4385230144","doi":"10.1177/13524585231182708","title":"Quality of life should be the primary outcome for disease modifying therapy trials in MS—No","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Disease; Clinical trial; Outcome (game theory); Intensive care medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.6951723443484941,"score_gpt":0.4761179336233026,"score_spread":0.21905441072519144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97593766,0.0016883494,0.0005097781,0.01798511,0.0005536509,0.002774628,0.00031897397,0.00009177307,0.00014010197],"genre_scores_gemma":[0.9873882,0.008139813,0.0011231825,0.0017725021,0.00084675074,0.00041440164,0.000042771768,0.000067103436,0.00020530871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99309325,0.0014892801,0.0026193508,0.00042277327,0.0015319511,0.00084338745],"domain_scores_gemma":[0.9877382,0.009405031,0.00088920654,0.0006734951,0.0006858182,0.00060825277],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019383885,0.00034885685,0.0018505558,0.0004917517,0.00048551316,0.000110902525,0.00048595233,0.00013217196,0.00013233858],"category_scores_gemma":[0.047576167,0.00020897738,0.001147306,0.00072232855,0.00028563643,0.00021725571,0.00021551388,0.00079054374,0.000020309642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008033726,0.00057583436,0.8487422,0.00052180653,0.00050000544,0.000006466218,0.00093969516,0.00040709839,0.10105808,0.000018117522,0.014355062,0.02484194],"study_design_scores_gemma":[0.015362782,0.00018780351,0.97603226,0.00031056756,0.00004577839,0.0000011562173,0.00044290719,0.003801772,0.0005567021,0.00006963128,0.0029784986,0.0002101597],"about_ca_topic_score_codex":0.00017580586,"about_ca_topic_score_gemma":0.000058797017,"teacher_disagreement_score":0.12729007,"about_ca_system_score_codex":0.00024040799,"about_ca_system_score_gemma":0.00041021162,"threshold_uncertainty_score":0.9604465},"labels":[],"label_agreement":null},{"id":"W4385564318","doi":"10.1177/13524585231190771","title":"Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Crohn's and Colitis Canada","keywords":"Multiple sclerosis; Depression (economics); Anxiety; Quality of life (healthcare); Psychology; Medicine; Clinical psychology; Psychiatry; Physical medicine and rehabilitation; Psychotherapist","score_opus":0.31198383347636255,"score_gpt":0.36934854967965136,"score_spread":0.05736471620328881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385564318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943133,0.001962649,0.000094338975,0.0019725875,0.00026708492,0.0011469859,0.00008377656,0.00010184566,0.000057427027],"genre_scores_gemma":[0.9923583,0.0052567692,0.0018260411,0.00020268337,0.00010439426,0.00009995232,0.00004250706,0.00007347405,0.000035860277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942408,0.0005416125,0.0021412172,0.0006866619,0.0013932571,0.0009964234],"domain_scores_gemma":[0.99676955,0.00088617584,0.0007948377,0.00053422735,0.00031019642,0.0007049965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004675425,0.00040287036,0.001339032,0.0013238753,0.00038545832,0.00009063253,0.00031138313,0.0002638867,0.00013721637],"category_scores_gemma":[0.0058709155,0.0003690966,0.0002593482,0.0021399888,0.00038317495,0.0004190823,0.00028917755,0.0013065297,0.00002175731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044273515,0.00035172823,0.92393047,0.00018090924,0.00013230502,0.000008128908,0.004390725,0.0011859841,0.049181204,0.000007555539,0.0014373153,0.018750923],"study_design_scores_gemma":[0.013340485,0.00015480614,0.9603895,0.0018362734,0.00001840923,0.0000097702605,0.0019224234,0.021505427,0.00045327836,0.000053820222,0.000020369851,0.0002954262],"about_ca_topic_score_codex":0.008401032,"about_ca_topic_score_gemma":0.016043188,"teacher_disagreement_score":0.048727926,"about_ca_system_score_codex":0.00043177407,"about_ca_system_score_gemma":0.00041527508,"threshold_uncertainty_score":0.9998761},"labels":[],"label_agreement":null},{"id":"W4385683574","doi":"10.1177/13524585231189674","title":"Intermediate outcomes for clinical trials of multiple sclerosis rehabilitation interventions: Conceptual and practical considerations","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple sclerosis; Psychological intervention; Rehabilitation; Physical medicine and rehabilitation; Clinical trial; Medicine; Physical therapy; Psychology; Psychiatry; Pathology","score_opus":0.8079637921712822,"score_gpt":0.5836405470830165,"score_spread":0.22432324508826573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024527465,0.9773265,0.0018863507,0.0023039128,0.0023244675,0.010684041,0.0028130414,0.00019471925,0.000014197466],"genre_scores_gemma":[0.0039835423,0.9692767,0.023499252,0.00010105827,0.000982628,0.0015748712,0.00026575802,0.00020254673,0.000113619804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9814026,0.0057705296,0.009654416,0.001094557,0.0011826706,0.00089525233],"domain_scores_gemma":[0.85992146,0.13115168,0.0049463203,0.00082286505,0.00226442,0.0008932546],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024937304,0.000921371,0.00890883,0.001233523,0.0006693416,0.00030447164,0.00022167053,0.0009343907,0.00019256666],"category_scores_gemma":[0.469496,0.0006736751,0.0060762395,0.00062757934,0.001957281,0.00045962204,0.00051060476,0.0023234913,0.000053257325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008875251,0.002604357,0.019069184,0.039937217,0.01064731,0.000036205594,0.0012824022,0.0000034186214,0.00009780048,0.00020525554,0.056109346,0.86912],"study_design_scores_gemma":[0.05220552,0.008539469,0.2106328,0.33506003,0.023730813,0.0006143738,0.0065675196,0.001273146,0.000034390596,0.00050811446,0.35816246,0.0026713528],"about_ca_topic_score_codex":0.000029511606,"about_ca_topic_score_gemma":0.00012854788,"teacher_disagreement_score":0.86644864,"about_ca_system_score_codex":0.0003628758,"about_ca_system_score_gemma":0.0013088944,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W4385683760","doi":"10.1177/13524585231189671","title":"Improving the efficiency of clinical trials in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Calgary; University of Manitoba","funders":"Sanofi Genzyme; Chugai Pharmaceutical; EMD Serono; National Institutes of Health; University College London; Genentech; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Teva Pharmaceutical Industries; National Institute for Health and Care Research; Regeneron Pharmaceuticals; H. Lundbeck A/S; Patient-Centered Outcomes Research Institute; Medical Research Council; Biogen; Merck KGaA; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; U.S. Department of Defense; Sanofi; National Multiple Sclerosis Society","keywords":"Clinical trial; Multiple sclerosis; Medicine; Clinical study design; Sample size determination; Pathology","score_opus":0.7150611902149508,"score_gpt":0.5047581805542488,"score_spread":0.21030300966070203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047895443,0.9859137,0.00024178732,0.00030981816,0.002281341,0.0058585843,0.00036607616,0.0001522257,0.00008691318],"genre_scores_gemma":[0.0077669392,0.987366,0.0012011678,0.000073339885,0.0024803148,0.00054263766,0.000054055075,0.00031896928,0.0001965387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96996397,0.010347991,0.013441084,0.0014702705,0.0028492836,0.0019274224],"domain_scores_gemma":[0.939481,0.048702814,0.0077206693,0.0020419005,0.0010328909,0.0010206944],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.066351436,0.0013385639,0.013534647,0.0018991729,0.0008131048,0.00031794817,0.0019073024,0.0011897905,0.00017604994],"category_scores_gemma":[0.1920253,0.0007770306,0.007163994,0.0030534249,0.0011652455,0.00027098705,0.0012208398,0.006152694,0.0002584389],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003245587,0.000883328,0.0070875813,0.009938727,0.0013723548,0.00004664266,0.00026520411,0.0000139928425,0.000409602,0.0000024456451,0.0027285954,0.976927],"study_design_scores_gemma":[0.042430762,0.0026316019,0.14874476,0.36943692,0.010121925,0.0004432624,0.002257531,0.01038458,0.00027764347,0.000025398327,0.40960294,0.003642661],"about_ca_topic_score_codex":0.00060159975,"about_ca_topic_score_gemma":0.00037939928,"teacher_disagreement_score":0.9732843,"about_ca_system_score_codex":0.00063140923,"about_ca_system_score_gemma":0.002164497,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W4385683865","doi":"10.1177/13524585231189670","title":"Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis","keywords":"CINAHL; Psychological intervention; Rehabilitation; Generalizability theory; Medicine; Clinical trial; MEDLINE; Randomized controlled trial; Intervention (counseling); Physical therapy; Psychology; Clinical psychology; Physical medicine and rehabilitation; Gerontology; Psychiatry; Developmental psychology; Pathology","score_opus":0.8013474077247474,"score_gpt":0.5555542466176322,"score_spread":0.24579316110711524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013530955,0.9802645,0.0007128473,0.000507001,0.00052058225,0.0159484,0.0005965241,0.00009221228,0.0000048717357],"genre_scores_gemma":[0.0021955494,0.98858315,0.0055712764,0.000052555322,0.00045591086,0.0027678958,0.00017294093,0.00016470891,0.000036041154],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9808572,0.005527213,0.009862937,0.001114493,0.0014786364,0.0011595505],"domain_scores_gemma":[0.95752627,0.032948483,0.006044955,0.001131343,0.0015558879,0.0007930538],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.040471625,0.00085178035,0.012502781,0.0012974009,0.00065779866,0.00010308787,0.000706406,0.0004969623,0.000107710875],"category_scores_gemma":[0.13206998,0.00060385297,0.0066921026,0.0018549432,0.00046094085,0.00033048657,0.00092528283,0.0017870388,0.000036890582],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000754407,0.0015171547,0.026820593,0.5114657,0.0024134328,0.0000095878695,0.0006116638,0.000015876067,0.000012496893,0.0000025683128,0.0027579758,0.45361853],"study_design_scores_gemma":[0.008729409,0.0016592131,0.047499564,0.93246865,0.005985997,0.000021828399,0.0004782646,0.00014847759,0.0000020963414,0.0000064723836,0.0024900162,0.00051001884],"about_ca_topic_score_codex":0.00020072551,"about_ca_topic_score_gemma":0.0030884205,"teacher_disagreement_score":0.45310852,"about_ca_system_score_codex":0.00054380705,"about_ca_system_score_gemma":0.0012415888,"threshold_uncertainty_score":0.9996413},"labels":[],"label_agreement":null},{"id":"W4385684499","doi":"10.1177/13524585231189678","title":"Enhancing involvement of people with multiple sclerosis in clinical trial design","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute for Health and Care Research","keywords":"Clinical trial; Medicine; Clinical study design; Multiple sclerosis; Physical therapy; Pathology; Psychiatry","score_opus":0.7573874463475445,"score_gpt":0.4968671606159275,"score_spread":0.260520285731617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029992476,0.93457264,0.0023724604,0.000058320966,0.010096326,0.022195872,0.00044874504,0.00018257395,0.00008058415],"genre_scores_gemma":[0.0022355178,0.9885463,0.0045859735,0.00023656033,0.0015265788,0.0021262947,0.00030209296,0.00024271136,0.00019793813],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9795931,0.00709081,0.008979525,0.0009805536,0.0014850599,0.0018709332],"domain_scores_gemma":[0.98267716,0.00952434,0.0055553587,0.0008671911,0.00040061565,0.0009753265],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014600788,0.0009467889,0.004664718,0.0010353556,0.0011735873,0.000049266935,0.0009413148,0.0010763267,0.0002951323],"category_scores_gemma":[0.0012022627,0.0006959991,0.0010597084,0.001476858,0.00013850574,0.00024413138,0.0004371489,0.004274393,0.0004616541],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032040596,0.004597924,0.07607044,0.13677764,0.0012716925,0.000046485977,0.0073021026,0.00012186373,0.000019661149,0.000018209803,0.004647329,0.73708606],"study_design_scores_gemma":[0.15911525,0.009623414,0.008351755,0.6639227,0.0014513555,0.000009542883,0.005249573,0.00039082827,0.00002774544,0.000044929624,0.14974214,0.0020707168],"about_ca_topic_score_codex":0.0011084976,"about_ca_topic_score_gemma":0.0074696955,"teacher_disagreement_score":0.73501533,"about_ca_system_score_codex":0.0014318887,"about_ca_system_score_gemma":0.0033688182,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W4385684744","doi":"10.1177/13524585231189677","title":"Enhancing diversity of clinical trial populations in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Manitoba","funders":"","keywords":"Clinical trial; Health equity; Diversity (politics); Inclusion (mineral); Ethnic group; Cultural diversity; Equity (law); Medicine; Family medicine; Alternative medicine; MEDLINE; Psychology; Gerontology; Public health; Political science; Nursing; Social psychology; Pathology","score_opus":0.7515324232508435,"score_gpt":0.4915612959204515,"score_spread":0.25997112733039196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044789635,0.9432285,0.00017238635,0.00015630177,0.004293957,0.006449961,0.00054738525,0.00023317772,0.00012872276],"genre_scores_gemma":[0.01994498,0.97394645,0.003076559,0.00003202445,0.0021962237,0.00021974355,0.00014605244,0.00022115608,0.0002167802],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.986118,0.0019634895,0.006748121,0.0012721529,0.0024101594,0.0014880431],"domain_scores_gemma":[0.9887153,0.005233544,0.0030169338,0.0012161676,0.0007989918,0.0010191002],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007905113,0.0010691577,0.007639039,0.0022111614,0.001123614,0.00014411972,0.0011323041,0.0011628037,0.00021060943],"category_scores_gemma":[0.025977368,0.0008887117,0.0041512735,0.0023882124,0.0005844277,0.00037809918,0.0022979875,0.004247148,0.00023623508],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066897226,0.0022811135,0.06418673,0.0109293265,0.0018777498,0.00009911007,0.000528975,0.000024694375,0.00009401891,0.000005246991,0.002465647,0.9108177],"study_design_scores_gemma":[0.20315146,0.002708699,0.46428245,0.21895896,0.005148013,0.00011897108,0.0008683474,0.0008556847,0.000042618278,0.00004290395,0.10133243,0.0024894504],"about_ca_topic_score_codex":0.0009883123,"about_ca_topic_score_gemma":0.002678829,"teacher_disagreement_score":0.90832824,"about_ca_system_score_codex":0.00086602435,"about_ca_system_score_gemma":0.0012381633,"threshold_uncertainty_score":0.9993563},"labels":[],"label_agreement":null},{"id":"W4385684876","doi":"10.1177/13524585231189673","title":"Assessing heterogeneity of treatment effect in multiple sclerosis trials","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Covariate; Multiple sclerosis; Clinical trial; Treatment effect; Medicine; Random effects model; Set (abstract data type); Statistics; Computer science; Meta-analysis; Mathematics; Internal medicine","score_opus":0.9378935239878043,"score_gpt":0.6287405873391883,"score_spread":0.3091529366486161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062502627,0.972103,0.008881298,0.000032094285,0.004599496,0.006467671,0.0013557047,0.0002579434,0.000052507738],"genre_scores_gemma":[0.00053203496,0.8273719,0.17029478,0.0000096312115,0.0010203538,0.00043983196,0.000014676906,0.0002951875,0.000021624606],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.96283877,0.023932869,0.009831165,0.0011253238,0.0011231827,0.0011486885],"domain_scores_gemma":[0.7023052,0.29056495,0.0054730796,0.0009984501,0.00020282879,0.00045548455],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.039481897,0.0014151604,0.01520371,0.0010149179,0.0003111521,0.0004998581,0.0010533999,0.0012595957,0.00016432915],"category_scores_gemma":[0.3692261,0.00092806184,0.0050811768,0.0012894014,0.00030274742,0.00027149133,0.0003381534,0.0016796177,0.000098721015],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001274769,0.00058921915,0.00058545166,0.0095008025,0.0014358369,0.000033608572,0.00005305367,0.0000109016455,0.00012252448,0.00003358726,0.00022665595,0.9872809],"study_design_scores_gemma":[0.06428151,0.007796612,0.005563014,0.741777,0.039306104,0.00025837627,0.00026563124,0.0015530186,0.0043906667,0.07262892,0.054297846,0.007881305],"about_ca_topic_score_codex":0.00008987378,"about_ca_topic_score_gemma":0.00010268855,"teacher_disagreement_score":0.97939956,"about_ca_system_score_codex":0.0015346785,"about_ca_system_score_gemma":0.0006208895,"threshold_uncertainty_score":0.99985987},"labels":[],"label_agreement":null},{"id":"W4386591827","doi":"10.1177/13524585231196786","title":"Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University","funders":"Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Disease; Clinical trial; Medicine; Clinical Practice; Medical physics; Psychology; Data science; Medical education; Computer science; Pathology; Family medicine; Psychiatry","score_opus":0.5135206727010455,"score_gpt":0.4242158015613792,"score_spread":0.08930487113966629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386591827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97922254,0.0014673731,0.00003646718,0.016341409,0.0013597864,0.0013176324,0.00017647468,0.000052718442,0.000025613661],"genre_scores_gemma":[0.9912236,0.007359399,0.00010876383,0.0005026807,0.00059036206,0.0000929165,0.000018320783,0.000047833553,0.000056176286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936752,0.0031823304,0.0008166194,0.00030632818,0.001254177,0.00076539925],"domain_scores_gemma":[0.9941701,0.002992034,0.00038308772,0.00097540853,0.0008819108,0.0005974188],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010685013,0.00032118784,0.00076015224,0.00020719474,0.0017323891,0.0002668452,0.00083269237,0.00011707427,0.000031576783],"category_scores_gemma":[0.011046329,0.00017230668,0.0003652917,0.0012946122,0.001067487,0.00016521651,0.0011871646,0.00257661,0.00002066124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033642762,0.00041301764,0.8351865,0.000059461294,0.0002286585,0.0000017671422,0.0042373077,0.0000069304883,0.0018587736,0.0000014589381,0.037593737,0.120076],"study_design_scores_gemma":[0.0030324038,0.00041026252,0.9854299,0.000774627,0.00009543275,0.000013205484,0.0018105421,0.0009897073,0.00018337749,0.000008226499,0.0070824735,0.00016983073],"about_ca_topic_score_codex":0.0015698753,"about_ca_topic_score_gemma":0.0025838136,"teacher_disagreement_score":0.15024346,"about_ca_system_score_codex":0.00011376896,"about_ca_system_score_gemma":0.00023208509,"threshold_uncertainty_score":0.9997245},"labels":[],"label_agreement":null},{"id":"W4386593437","doi":"10.1177/13524585231199030","title":"Arterial stiffness in persons with multiple sclerosis and controls: Does aerobic fitness account for group differences?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Arterial stiffness; Aerobic exercise; Pulse wave velocity; Medicine; Cardiology; Multiple sclerosis; Internal medicine; VO2 max; Physical therapy; Blood pressure; Heart rate","score_opus":0.09777390901970498,"score_gpt":0.29310113539648697,"score_spread":0.195327226376782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386593437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318385,0.00034319432,0.000526825,0.00203314,0.000702136,0.0026688047,0.00032087503,0.00019947508,0.000021707605],"genre_scores_gemma":[0.99299544,0.0024368465,0.0016010543,0.00018128191,0.000948666,0.0014914103,0.000067061985,0.000127971,0.00015029243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493194,0.00025237518,0.0009606569,0.00096630515,0.0011602296,0.0017284971],"domain_scores_gemma":[0.99597263,0.0019437434,0.0003811978,0.0004969864,0.00046949217,0.0007359372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014556596,0.00068384234,0.001392352,0.000888365,0.0010073478,0.000558677,0.00041744096,0.00026403015,0.00008100096],"category_scores_gemma":[0.002037497,0.00044736266,0.00030990707,0.00093510473,0.00062648684,0.00060125976,0.00026183165,0.0008859161,0.000017751809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008133151,0.0007591962,0.6839905,0.0003774932,0.00058655214,0.00005929553,0.0025133768,0.000083625346,0.248261,0.000015379286,0.001666587,0.053553883],"study_design_scores_gemma":[0.034299448,0.0005202045,0.9492524,0.0015097265,0.00014809352,0.000052582443,0.0033386832,0.008887756,0.00080515316,0.000025937736,0.0006003549,0.0005596094],"about_ca_topic_score_codex":0.00029763853,"about_ca_topic_score_gemma":0.0023556945,"teacher_disagreement_score":0.265262,"about_ca_system_score_codex":0.00036207025,"about_ca_system_score_gemma":0.00016729048,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W4386703670","doi":"10.1177/13524585231195861","title":"GM-CSF is a marker of compartmentalised intrathecal inflammation in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Occupational Cancer Research Centre; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Cytokine; Cerebrospinal fluid; Medicine; Granulocyte macrophage colony-stimulating factor; Immunology; Inflammation; Intrathecal; Blood–brain barrier; Colony-stimulating factor; Granulocyte; Internal medicine; Central nervous system; Biology; Haematopoiesis","score_opus":0.1785297872248042,"score_gpt":0.3206793718710953,"score_spread":0.1421495846462911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386703670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455047,0.00023095647,0.0000718545,0.0028100247,0.00033882927,0.001186363,0.00017413797,0.00013338504,0.0005039588],"genre_scores_gemma":[0.99378985,0.0030605264,0.0019816437,0.00024775686,0.00043062476,0.00015331044,0.0001160198,0.00008497723,0.00013530486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99449855,0.00039835012,0.0016655835,0.0006054346,0.001668157,0.0011639172],"domain_scores_gemma":[0.9967197,0.0008686031,0.00051892106,0.00060671184,0.00060537923,0.0006806918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002054665,0.00049891486,0.0011321119,0.0013059292,0.00042476348,0.00014759264,0.00042646925,0.000248385,0.0007530094],"category_scores_gemma":[0.0029734515,0.0004386972,0.00051897386,0.001895369,0.00043300434,0.0005572252,0.0003464156,0.0009842957,0.00018929853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010765764,0.00044965616,0.5014435,0.00017572386,0.0002743993,0.000032350235,0.0019602145,0.00016942169,0.46268505,0.000005562748,0.012613091,0.019114416],"study_design_scores_gemma":[0.012196882,0.00028094664,0.87722117,0.0013377407,0.00006586574,0.00003061639,0.0012423667,0.029102568,0.077399015,0.000030379715,0.00075480755,0.00033766168],"about_ca_topic_score_codex":0.00029246378,"about_ca_topic_score_gemma":0.00038208286,"teacher_disagreement_score":0.38528603,"about_ca_system_score_codex":0.00056183623,"about_ca_system_score_gemma":0.0002672465,"threshold_uncertainty_score":0.99980646},"labels":[],"label_agreement":null},{"id":"W4386758337","doi":"10.1177/13524585231198751","title":"Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society of Canada; U.S. Department of Defense","keywords":"Medicine; Youden's J statistic; Multiple sclerosis; Magnetic resonance imaging; Area under the curve; Asymptomatic; Biomarker; Nuclear medicine; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Pathology; Receiver operating characteristic; Radiology; Immunology; Chemistry","score_opus":0.17753575343134723,"score_gpt":0.35913334267466857,"score_spread":0.18159758924332134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386758337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920816,0.00048350432,0.00037906028,0.0067470553,0.00086098793,0.0017969105,0.0001544382,0.00020936537,0.00016050329],"genre_scores_gemma":[0.99178284,0.0048693847,0.0018061866,0.0005121695,0.0004671217,0.00020277886,0.000018453846,0.00013336341,0.00020772457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9928341,0.00046576833,0.002041676,0.0008862307,0.0019834563,0.0017887527],"domain_scores_gemma":[0.994456,0.0021243463,0.00057929475,0.00088480907,0.00082210224,0.0011334623],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025579636,0.0006138929,0.0014015738,0.0019745806,0.0007191921,0.00022643173,0.0007076077,0.00023531943,0.00035414516],"category_scores_gemma":[0.012237415,0.0005470186,0.0006036619,0.0028707758,0.00019623963,0.00054915686,0.0007906641,0.0013431837,0.00045027502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040911575,0.00044360748,0.23488855,0.00014705028,0.00017060328,0.00006763837,0.001804782,0.0006499537,0.71227396,0.000003123415,0.0051406766,0.04400096],"study_design_scores_gemma":[0.0070681875,0.00040485142,0.8395202,0.002701978,0.000068086774,0.000032424563,0.0019357358,0.0026868274,0.14421278,0.000010578835,0.0009678268,0.0003905277],"about_ca_topic_score_codex":0.00037644725,"about_ca_topic_score_gemma":0.0012792456,"teacher_disagreement_score":0.60463166,"about_ca_system_score_codex":0.000549459,"about_ca_system_score_gemma":0.000335618,"threshold_uncertainty_score":0.99969816},"labels":[],"label_agreement":null},{"id":"W4386909919","doi":"10.1177/13524585231197926","title":"Intimate partner violence and multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Intimate Partner and Family Violence","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Domestic violence; Medicine; Population; Resource (disambiguation); Multiple sclerosis; Family medicine; Poison control; Psychology; Psychiatry; Medical emergency; Suicide prevention; Nursing; Environmental health","score_opus":0.12239339110365859,"score_gpt":0.31528348877025125,"score_spread":0.19289009766659265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894316,0.00069829496,0.00055663177,0.000542913,0.0014065637,0.00038138503,0.00004164879,0.00044948875,0.0064914264],"genre_scores_gemma":[0.9789547,0.018708527,0.001042894,0.0003504481,0.000553932,0.000025721896,0.0000068764657,0.000041279673,0.00031564964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966774,0.00037454654,0.0005470994,0.0004651408,0.0008075593,0.0011282287],"domain_scores_gemma":[0.9981671,0.00050414965,0.0002273927,0.0002752935,0.000271369,0.00055470294],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0022930624,0.00028560864,0.00035800182,0.0003024606,0.0025309194,0.0006430563,0.0005577504,0.00019542557,0.00022388912],"category_scores_gemma":[0.00097116665,0.00026565697,0.00018062841,0.00088932144,0.0006489405,0.0007302943,0.0002212574,0.0005149709,0.00072900055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020252247,0.0002704678,0.65172416,0.00006990846,0.00014788829,0.00006069759,0.01740025,0.00090845465,0.049995046,0.0030373,0.024334896,0.25184843],"study_design_scores_gemma":[0.0020226245,0.000090946516,0.96266586,0.0014491131,0.000052043426,0.000017666676,0.0062599834,0.011932454,0.0018279206,0.0016315258,0.011303183,0.00074667827],"about_ca_topic_score_codex":0.00091822643,"about_ca_topic_score_gemma":0.00017964581,"teacher_disagreement_score":0.31094173,"about_ca_system_score_codex":0.00012389797,"about_ca_system_score_gemma":0.00012826506,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W4387210069","doi":"10.1177/13524585231201219","title":"Detecting isolated cognitive relapses in persons with MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Logistic regression; Multiple sclerosis; Confidence interval; Neuropsychology; Prospective cohort study; Cohort; Odds ratio; Psychology; Medicine; Cognitive decline; Demographics; Expanded Disability Status Scale; Demography; Cognition; Internal medicine; Disease; Psychiatry; Dementia","score_opus":0.11439181618834966,"score_gpt":0.31672161725117337,"score_spread":0.20232980106282372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387210069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996421,0.00026618098,0.0003190571,0.0012154158,0.00015362144,0.00062084995,0.000027055788,0.00022622483,0.00075063854],"genre_scores_gemma":[0.9970644,0.0011547471,0.00087334146,0.0001447942,0.00028195916,0.00008087393,0.0000145715085,0.00007753356,0.00030779623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968614,0.00021344394,0.00053737534,0.00045588028,0.00089509616,0.0010368007],"domain_scores_gemma":[0.9977691,0.0009697288,0.000190225,0.00022310793,0.00042300014,0.00042484657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010802075,0.00031979405,0.0005741166,0.000916235,0.00062751764,0.00013943615,0.0001723418,0.0001353729,0.00018390625],"category_scores_gemma":[0.0033121048,0.00024138931,0.00018484946,0.0018391643,0.00023746649,0.00029573796,0.00014918766,0.0013881826,0.0001921579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002208551,0.00030939208,0.8793521,0.00009174136,0.00045702228,0.0005421577,0.004881245,0.00033688315,0.07241887,9.94497e-7,0.0015495496,0.037851494],"study_design_scores_gemma":[0.009717895,0.0008267388,0.96164155,0.0023805874,0.00007519318,0.00029492052,0.0059777754,0.015094997,0.0034623314,0.0000049474115,0.00022331109,0.00029974483],"about_ca_topic_score_codex":0.0002550446,"about_ca_topic_score_gemma":0.0007606313,"teacher_disagreement_score":0.08228946,"about_ca_system_score_codex":0.00026790338,"about_ca_system_score_gemma":0.00017721896,"threshold_uncertainty_score":0.984357},"labels":[],"label_agreement":null},{"id":"W4387599047","doi":"10.1177/13524585231202320","title":"Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Sanofi Genzyme; EMD Serono; Atara Biotherapeutics; BioDelivery Sciences International; Acorda Therapeutics; Sanofi; GW Pharmaceuticals; National Institutes of Health; Mylan; TG Therapeutics; Jazz Pharmaceuticals; AveXis; University of Texas Health Science Center at Houston; Pfizer; Biogen; Celgene; AbbVie; Cleveland Clinic Foundation; Bristol-Myers Squibb; Cleveland Clinic; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; CSL Behring; MedDay Pharmaceuticals; Horizon Pharmaceuticals; Genentech; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Proportional hazards model; Clinical trial; Internal medicine; Psychiatry","score_opus":0.15314911866077113,"score_gpt":0.3261595973250584,"score_spread":0.17301047866428726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387599047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948907,0.00040209215,0.00008050706,0.0014631543,0.00069956004,0.0008490821,0.0013777375,0.00013574066,0.00010144023],"genre_scores_gemma":[0.9932883,0.0038010534,0.0012940343,0.00034628363,0.00026083385,0.00007437646,0.00070153986,0.00010099218,0.00013259382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928182,0.0009881047,0.0019422333,0.00090023986,0.0019962094,0.0013550613],"domain_scores_gemma":[0.99450886,0.001732418,0.0008834897,0.0017291433,0.00054025,0.0006058594],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004166096,0.00054642325,0.0015299764,0.0023113925,0.00092529674,0.00021086281,0.0010788298,0.00030884988,0.00019993936],"category_scores_gemma":[0.009104436,0.0004100528,0.00094696425,0.006966694,0.00051405246,0.0007725824,0.0008128467,0.0017870915,0.00006398559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000724246,0.0007538733,0.8339356,0.000090995396,0.0015494578,0.000028640772,0.0014790776,0.009865866,0.1280867,0.0000042705256,0.010229585,0.0132516865],"study_design_scores_gemma":[0.006009371,0.00026754662,0.9264675,0.0015374655,0.0008328122,0.000021591062,0.0022941455,0.056977067,0.004623894,0.00001915968,0.00057720277,0.0003722558],"about_ca_topic_score_codex":0.0010301223,"about_ca_topic_score_gemma":0.0027643994,"teacher_disagreement_score":0.1234628,"about_ca_system_score_codex":0.0005774857,"about_ca_system_score_gemma":0.0002819658,"threshold_uncertainty_score":0.99983513},"labels":[],"label_agreement":null},{"id":"W4387661542","doi":"10.1177/13524585231199321","title":"Establishing the consistency of a voice recognition symbol digit modalities test analogue","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Audiology; Psychology; Reliability (semiconductor); Modalities; Replicate; Test (biology); Consistency (knowledge bases); Medicine; Computer science; Artificial intelligence; Mathematics; Psychiatry; Statistics","score_opus":0.18392184621282115,"score_gpt":0.30967384291786193,"score_spread":0.12575199670504078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387661542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126333,0.0004516785,0.00009832815,0.0049036033,0.00039675078,0.0006861131,0.0003243745,0.00016957342,0.0017062486],"genre_scores_gemma":[0.9946993,0.0033899026,0.00051088794,0.00022459238,0.0006326441,0.00007585646,0.0000701232,0.000050803028,0.0003458871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651766,0.00024800794,0.00091010745,0.00034115475,0.0012254432,0.0007576022],"domain_scores_gemma":[0.9932993,0.0044218246,0.00039712182,0.0004803392,0.0010827977,0.00031860627],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017199316,0.00028742733,0.00062247756,0.00050407846,0.000848914,0.00027616872,0.00037938383,0.00012101955,0.00012554765],"category_scores_gemma":[0.016947746,0.00019368593,0.0003848525,0.0012348031,0.00054297445,0.00051143725,0.00025231214,0.00085806433,0.00016032829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006267434,0.00086050597,0.553575,0.00062338443,0.0010311588,0.000099788915,0.007636075,0.0002452304,0.22452016,0.00002145696,0.041747812,0.1690127],"study_design_scores_gemma":[0.0040868334,0.00052041496,0.96187353,0.0017618914,0.00019848027,0.00016642673,0.012189143,0.0042706686,0.01261806,0.0002788282,0.0017094662,0.00032624276],"about_ca_topic_score_codex":0.00029273753,"about_ca_topic_score_gemma":0.00015787904,"teacher_disagreement_score":0.40829855,"about_ca_system_score_codex":0.00015986004,"about_ca_system_score_gemma":0.00023991693,"threshold_uncertainty_score":0.99133295},"labels":[],"label_agreement":null},{"id":"W4387948473","doi":"10.1177/13524585231204453","title":"The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Gemeinnützige Hertie-Stiftung; Bundesministerium für Bildung und Forschung; Deutschen Multiple Sklerose Gesellschaft; Deutsche Forschungsgemeinschaft","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Action (physics); Neuroscience; Physical therapy; Psychology; Immunology","score_opus":0.36178034326723996,"score_gpt":0.36979427815678834,"score_spread":0.00801393488954838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98486406,0.0054825395,0.00032752423,0.0054045543,0.0015172919,0.0018447038,0.000095643,0.00024845745,0.00021525673],"genre_scores_gemma":[0.92263526,0.07479884,0.001608519,0.000115956034,0.0002611753,0.00030666977,0.000015181933,0.00008873774,0.00016969329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9942135,0.00050421833,0.0015494302,0.0006341705,0.0017452986,0.0013533699],"domain_scores_gemma":[0.99399865,0.0030871914,0.0006315334,0.0007256478,0.001103839,0.0004531655],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0035540035,0.00054675917,0.0011956614,0.0010915996,0.0014917846,0.00015886217,0.0006000518,0.0002194203,0.00007147007],"category_scores_gemma":[0.006930306,0.0003823154,0.0005726864,0.002548985,0.0009333089,0.0004827422,0.0005741217,0.0011006389,0.000118625685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042953533,0.00094768114,0.20035994,0.0006239576,0.0034197979,0.00012359166,0.0062203365,0.0006208917,0.5386161,0.000054826014,0.02801264,0.21670488],"study_design_scores_gemma":[0.010856929,0.00050411717,0.8788985,0.003746625,0.00017758225,0.000038597664,0.024797438,0.0058855577,0.07324152,0.00044119553,0.000924333,0.00048760138],"about_ca_topic_score_codex":0.0001165573,"about_ca_topic_score_gemma":0.0005047266,"teacher_disagreement_score":0.67853856,"about_ca_system_score_codex":0.0005584978,"about_ca_system_score_gemma":0.00025681657,"threshold_uncertainty_score":0.99986285},"labels":[],"label_agreement":null},{"id":"W4387948873","doi":"10.1177/13524585231204459","title":"Safety of exercise training in multiple sclerosis: An updated systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Australia","keywords":"Medicine; Meta-analysis; Adverse effect; Relative risk; Physical therapy; Confidence interval; Population; Internal medicine; Multiple sclerosis; Randomized controlled trial; Psychiatry","score_opus":0.46289720579117344,"score_gpt":0.4002374185569418,"score_spread":0.06265978723423166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000513468,0.9899551,0.000051650222,0.0001923664,0.00010118828,0.008507882,0.00097264437,0.00014313201,0.000024637431],"genre_scores_gemma":[0.0014834126,0.9943157,0.0013806367,0.00011007743,0.00009506599,0.001559338,0.0005064101,0.00029739016,0.00025198658],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9850181,0.0027925116,0.006912776,0.0015544336,0.002212427,0.0015097917],"domain_scores_gemma":[0.9904712,0.001936709,0.003477688,0.0019594673,0.0009774927,0.001177487],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00887422,0.0016808079,0.028588591,0.0035265312,0.0005253924,0.00023863657,0.0011350961,0.0006801678,0.000532295],"category_scores_gemma":[0.005096797,0.0011463799,0.0069071515,0.0058170487,0.00047235494,0.0005392843,0.0005912431,0.0024980032,0.00006137962],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008588846,0.0004096961,0.00012724898,0.7789525,0.19784026,0.000060800336,0.0009286971,0.000027199261,0.000023031609,0.0000019317479,0.00036783682,0.021174915],"study_design_scores_gemma":[0.0018462483,0.00016037689,0.0007428075,0.32341608,0.6707553,0.000086823,0.00061487645,0.00035100433,0.0000037265881,0.000002554476,0.0012427437,0.00077744003],"about_ca_topic_score_codex":0.00022603477,"about_ca_topic_score_gemma":0.0005223339,"teacher_disagreement_score":0.47291505,"about_ca_system_score_codex":0.00054328394,"about_ca_system_score_gemma":0.0006943397,"threshold_uncertainty_score":0.99980325},"labels":[],"label_agreement":null},{"id":"W4387949674","doi":"10.1177/13524585231204456","title":"The MoXFo initiative – study design: Considerations related to study design and methodology in exercise research for people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Research design; Physical medicine and rehabilitation; Physical therapy; Medicine; Psychology; Sociology; Psychiatry","score_opus":0.6401813634985462,"score_gpt":0.4601265371474156,"score_spread":0.18005482635113057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644788,0.00048463876,0.010350467,0.005059102,0.00022080974,0.019201392,0.00003463197,0.00015586473,0.000014313674],"genre_scores_gemma":[0.9461565,0.0017657547,0.045823503,0.000094631316,0.000101642814,0.005819532,0.000006888319,0.00013287274,0.00009866978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9867396,0.0071800756,0.001386511,0.0011227358,0.0017695191,0.0018015641],"domain_scores_gemma":[0.95808667,0.03795901,0.00028082097,0.00080383656,0.0021266954,0.0007429583],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.02591896,0.000559565,0.0013392295,0.001635982,0.0041537127,0.00056135457,0.00046420904,0.00019206222,0.00004375968],"category_scores_gemma":[0.028342897,0.00037984448,0.00015853043,0.0032648172,0.00051264814,0.00036146637,0.0005960301,0.001719767,0.000045054043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013662673,0.0044920854,0.78659916,0.00007719805,0.0018695678,0.00022652505,0.11672647,0.010774266,0.030052949,0.000017315833,0.009730316,0.02577146],"study_design_scores_gemma":[0.020796547,0.0069906153,0.87664825,0.0005053949,0.0001971959,0.00004858523,0.07664707,0.015538747,0.0018925058,0.000319094,0.000031274703,0.00038471213],"about_ca_topic_score_codex":0.0004001237,"about_ca_topic_score_gemma":0.003252565,"teacher_disagreement_score":0.09004908,"about_ca_system_score_codex":0.000418351,"about_ca_system_score_gemma":0.0005277909,"threshold_uncertainty_score":0.99986535},"labels":[],"label_agreement":null},{"id":"W4387949851","doi":"10.1177/13524585231204446","title":"The MoXFo initiative – adherence: Exercise adherence, compliance and sustainability among people with multiple sclerosis: An overview and roadmap for research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Terminology; Context (archaeology); Compliance (psychology); Medicine; Psychological intervention; Sustainability; Categorization; MEDLINE; Psychology; Medical education; Applied psychology; Nursing; Political science; Social psychology","score_opus":0.3970842101185184,"score_gpt":0.42290155061528817,"score_spread":0.02581734049676976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98511696,0.0071943034,0.00018429139,0.0020847332,0.00017580974,0.0048532304,0.0001540176,0.00017437931,0.000062304935],"genre_scores_gemma":[0.9504823,0.045585427,0.001269625,0.000068474306,0.0002838631,0.0018850046,0.00003503821,0.00010289166,0.00028735158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932224,0.0008801838,0.00094091624,0.0011367737,0.0018110132,0.0020087196],"domain_scores_gemma":[0.9893292,0.004313725,0.00037930612,0.00091065204,0.0038685093,0.0011986129],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.006378408,0.0005873999,0.0010702818,0.00049141364,0.0045623416,0.00091841037,0.0006066668,0.00023052523,0.00003689586],"category_scores_gemma":[0.006063653,0.0003886606,0.00020571837,0.0017796397,0.002235072,0.0009532309,0.0006692669,0.0015899324,0.000015450249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034480942,0.00043978792,0.84846616,0.0010475655,0.00030998493,0.000020360543,0.0065164724,0.00007529585,0.0024970057,0.000045902256,0.0047314125,0.13240196],"study_design_scores_gemma":[0.008644517,0.0022649,0.94499534,0.0029524649,0.000098560624,0.000030625957,0.019617476,0.019196395,0.00054957735,0.0004684394,0.0007441833,0.0004375049],"about_ca_topic_score_codex":0.0007439836,"about_ca_topic_score_gemma":0.0041177794,"teacher_disagreement_score":0.13196446,"about_ca_system_score_codex":0.00042260252,"about_ca_system_score_gemma":0.00061526784,"threshold_uncertainty_score":0.99985653},"labels":[],"label_agreement":null},{"id":"W4387949950","doi":"10.1177/13524585231204451","title":"The MoxFo initiative – outcomes: Outcome measures in studies of exercise training in multiple sclerosis; scoping review of reviews and classification according to the ICF framework","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"International Classification of Functioning, Disability and Health; MEDLINE; Medicine; Physical therapy; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Rehabilitation","score_opus":0.6343627842457714,"score_gpt":0.4587632842730354,"score_spread":0.175599499972736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69610333,0.27404305,0.0004306445,0.01910563,0.0007489218,0.009379205,0.00005112261,0.000073646195,0.00006444198],"genre_scores_gemma":[0.5912849,0.4066321,0.0011785262,0.00030312626,0.00006427278,0.00049585477,0.0000024714184,0.000030849955,0.000007944115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99351573,0.0010334273,0.0028907026,0.00050492166,0.0012365034,0.0008187422],"domain_scores_gemma":[0.9901505,0.0070581315,0.0011014828,0.00071354705,0.0007395889,0.00023674755],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01209106,0.0004325267,0.002145855,0.0006768348,0.0006372085,0.000079943835,0.0005574458,0.0001289109,0.000007738015],"category_scores_gemma":[0.06376922,0.0002459582,0.0003794375,0.002283814,0.0004930128,0.00028856497,0.00045842436,0.0011302925,0.000013598107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023609136,0.00011411121,0.8161847,0.007590738,0.0002113916,0.00000474783,0.017592408,0.00011274686,0.006749495,0.000014902352,0.0005519212,0.15063672],"study_design_scores_gemma":[0.0016887266,0.00010500567,0.72130954,0.25705302,0.000081377,0.000003256653,0.01860793,0.00047754904,0.00032950388,0.0000373165,0.000115940195,0.00019080979],"about_ca_topic_score_codex":0.000055081386,"about_ca_topic_score_gemma":0.00070198765,"teacher_disagreement_score":0.24946228,"about_ca_system_score_codex":0.0002807957,"about_ca_system_score_gemma":0.00020953036,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W4387950254","doi":"10.1177/13524585231204460","title":"The MoXFo Initiative: Using consensus methodology to move forward towards internationally shared vocabulary in multiple sclerosis exercise research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Multiple sclerosis; Vocabulary; Physical medicine and rehabilitation; Consensus conference; MEDLINE; Psychology; Medicine; Physical therapy; Political science; Linguistics; Internal medicine","score_opus":0.5887619840314723,"score_gpt":0.4511037067195992,"score_spread":0.13765827731187308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804378,0.0011598966,0.001152371,0.01298144,0.0009895005,0.0025498979,0.00022965997,0.00018840526,0.0003110321],"genre_scores_gemma":[0.96917,0.006366062,0.022185117,0.0004963838,0.0006829675,0.000488467,0.000045057554,0.00016232299,0.00040366722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.98898757,0.0025500325,0.0017422754,0.001068903,0.0031785558,0.0024726652],"domain_scores_gemma":[0.9859315,0.008881063,0.0003830991,0.00093367626,0.0027955552,0.0010750974],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01423357,0.00061467715,0.0012434795,0.0025251512,0.0022209703,0.00056235073,0.0011944799,0.00035211534,0.00019382508],"category_scores_gemma":[0.03551301,0.0004754452,0.0005274646,0.003706137,0.00092333835,0.00034790914,0.0016116342,0.0026873401,0.0003776877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008571038,0.0009045979,0.25490093,0.00024381296,0.0012524601,0.00058595696,0.012902338,0.006603886,0.39855224,0.00005365426,0.041697495,0.2737316],"study_design_scores_gemma":[0.007875884,0.00037855902,0.9180231,0.0022911502,0.00006783832,0.00009868201,0.006510447,0.050461374,0.011323575,0.0002707791,0.002196576,0.00050200673],"about_ca_topic_score_codex":0.00091470615,"about_ca_topic_score_gemma":0.0008290024,"teacher_disagreement_score":0.66312224,"about_ca_system_score_codex":0.0015242812,"about_ca_system_score_gemma":0.00094084285,"threshold_uncertainty_score":0.99976975},"labels":[],"label_agreement":null},{"id":"W4388033279","doi":"10.1177/13524585231205708","title":"Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital; McGill University; NeuroRx Research (Canada); University of Ottawa; University of Toronto; Montreal Neurological Institute and Hospital","funders":"Academy of Military Medical Sciences; Chugai Pharmaceutical; EMD Serono; Eisai; Deutsche Forschungsgemeinschaft; Genentech; Horizon Therapeutics; TG Therapeutics; H. Lundbeck A/S; BeiGene; Federalno Ministarstvo Obrazovanja i Nauke; European Committee for Treatment and Research in Multiple Sclerosis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Greenwich Biosciences; Alexion Pharmaceuticals; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Celgene; Pfizer; Biogen; CSL Behring Foundation for Research and Advancement of Patient Health; Sanofi","keywords":"Tolerability; Dimethyl fumarate; Medicine; Multiple sclerosis; Adverse effect; Relapsing remitting; Clinical endpoint; Confidence interval; Internal medicine; Gastroenterology; Clinical trial","score_opus":0.12902313581335922,"score_gpt":0.31164517626179405,"score_spread":0.18262204044843483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993982,0.00045467194,0.000059039827,0.0015860078,0.00036688885,0.002746011,0.00051399786,0.00020388642,0.000087496315],"genre_scores_gemma":[0.99604964,0.0015847359,0.0010707234,0.00018253809,0.00054885866,0.00009115948,0.0002136803,0.00013578913,0.00012286726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99229014,0.0009148116,0.0018638377,0.00124732,0.0021658426,0.0015180517],"domain_scores_gemma":[0.9925873,0.004268201,0.00072091806,0.0010579693,0.00067742675,0.0006881381],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0036879554,0.0007625919,0.0012273042,0.0005813765,0.0018170058,0.00045340514,0.00061557314,0.00020668225,0.000065239336],"category_scores_gemma":[0.008989276,0.00049899303,0.00025591374,0.0017502262,0.00049885,0.00057401625,0.00066425634,0.002114654,0.00008553065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019728605,0.0033622775,0.9091766,0.00002483282,0.00056851335,0.00005588731,0.0073758583,0.0005327537,0.004081854,3.4873204e-7,0.0023535318,0.052738965],"study_design_scores_gemma":[0.11625733,0.0017796879,0.8684187,0.0021718212,0.00018367241,0.0000065464033,0.003190103,0.0069644046,0.00019032675,0.0000030812682,0.00036163346,0.00047272228],"about_ca_topic_score_codex":0.0009912009,"about_ca_topic_score_gemma":0.0009639624,"teacher_disagreement_score":0.096528724,"about_ca_system_score_codex":0.00046203838,"about_ca_system_score_gemma":0.00020122265,"threshold_uncertainty_score":0.99974614},"labels":[],"label_agreement":null},{"id":"W4388224327","doi":"10.1177/13524585231210178","title":"The CogEx trial – Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis: A randomised, blinded, sham-controlled trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Johns Hopkins University","keywords":"Multiple sclerosis; Medicine; Physical therapy; Rehabilitation; Physical medicine and rehabilitation; Aerobic exercise; Cognition; Cognitive impairment; Randomized controlled trial; Clinical trial; Cognitive rehabilitation therapy; Internal medicine; Psychiatry","score_opus":0.07469608602237887,"score_gpt":0.3252106235059547,"score_spread":0.2505145374835758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388224327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477195,0.001409737,0.00018011476,0.0022325316,0.0005709752,0.047573216,0.00013854873,0.00015050653,0.00002483051],"genre_scores_gemma":[0.965537,0.0033269192,0.00080449285,0.000083781735,0.00082620117,0.02908148,0.0000868785,0.0001329334,0.00012032948],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99266165,0.0010401184,0.0018993518,0.0010588998,0.0017008684,0.0016391235],"domain_scores_gemma":[0.9743199,0.02165741,0.0010061903,0.00039552123,0.001928045,0.00069295877],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0061989822,0.0007730063,0.0021175568,0.00088185875,0.0018894231,0.00058051874,0.00031219242,0.0002925704,0.0000386301],"category_scores_gemma":[0.023923343,0.00048648653,0.00080620736,0.0013695239,0.00088566844,0.000494119,0.00023875273,0.0011074952,0.000024463276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9519511,0.001755257,0.013013703,0.00015509722,0.0010171263,0.00002516983,0.0050520743,0.000034878878,0.0010922279,0.0000019232907,0.0007734959,0.025127942],"study_design_scores_gemma":[0.8267403,0.010101245,0.13496895,0.0042302506,0.00070566265,0.0000266935,0.015913403,0.0063408585,0.00045820247,0.000026507108,0.000024048551,0.00046386584],"about_ca_topic_score_codex":0.00008651861,"about_ca_topic_score_gemma":0.0008400334,"teacher_disagreement_score":0.12521079,"about_ca_system_score_codex":0.000413627,"about_ca_system_score_gemma":0.0006700082,"threshold_uncertainty_score":0.99975866},"labels":[],"label_agreement":null},{"id":"W4389685133","doi":"10.1177/13524585231214360","title":"A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; National Institutes of Health; MedDay Pharmaceuticals; Genentech; Multiple Sclerosis Society; Horizon Therapeutics; Kiniksa Pharmaceuticals; National Institute of Mental Health; NGM Biopharmaceuticals; Race to Erase MS; TG Therapeutics; Alexion Pharmaceuticals; Vertex Pharmaceuticals; Biogen; Celgene; Greenwich Biosciences; EMD Serono; University of Pennsylvania; Sanofi; Bristol-Myers Squibb; Patient-Centered Outcomes Research Institute; Atara Biotherapeutics","keywords":"Medicine; Multiple sclerosis; Fluid-attenuated inversion recovery; McDonald criteria; Magnetic resonance imaging; Receiver operating characteristic; Radiology; Nuclear medicine; Multicenter study; Internal medicine; Randomized controlled trial","score_opus":0.3770258864573576,"score_gpt":0.41873803383433367,"score_spread":0.041712147376976094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389685133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867569,0.00041036334,0.0016303962,0.002719402,0.0010782136,0.006856154,0.0002875806,0.00021290776,0.000048041245],"genre_scores_gemma":[0.9880144,0.002339499,0.005582986,0.00023255499,0.0009199707,0.0025658775,0.000048184356,0.00016573335,0.00013081926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917837,0.0007654905,0.0019333933,0.00090710295,0.0026592412,0.001951076],"domain_scores_gemma":[0.9876753,0.00815676,0.0008442227,0.001082979,0.0015416696,0.0006990444],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0053660306,0.0006919048,0.0013104969,0.00065712916,0.0018647952,0.00033140005,0.00090291124,0.00012493157,0.00024793018],"category_scores_gemma":[0.010527757,0.00048115608,0.00075766235,0.0013469658,0.00040383887,0.00037156921,0.00066482875,0.0011764091,0.000044859826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025079453,0.00424425,0.79045445,0.0002065839,0.0016064207,0.0000113287615,0.0023872077,0.0020863698,0.14249307,0.0000031501145,0.0070035495,0.04699567],"study_design_scores_gemma":[0.02328491,0.0066552064,0.8624994,0.0007913467,0.000582084,0.000008200524,0.0064985896,0.094564565,0.0044008545,0.000009462885,0.00031499006,0.0003903563],"about_ca_topic_score_codex":0.00058843725,"about_ca_topic_score_gemma":0.00058390334,"teacher_disagreement_score":0.13809222,"about_ca_system_score_codex":0.0006055708,"about_ca_system_score_gemma":0.00039291327,"threshold_uncertainty_score":0.999764},"labels":[],"label_agreement":null},{"id":"W4390195771","doi":"10.1177/13524585231219131","title":"Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Magnetic resonance imaging; Glial fibrillary acidic protein; Multiple sclerosis; Pathology; Spinal cord; White matter; Clinically isolated syndrome; Hyperintensity; Radiology; Immunohistochemistry; Immunology","score_opus":0.0797411277178661,"score_gpt":0.27689675066749325,"score_spread":0.19715562294962716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390195771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945518,0.0002935773,0.00024530463,0.0023452165,0.00012813944,0.0019154624,0.00007219391,0.00028835607,0.00015998763],"genre_scores_gemma":[0.99485475,0.00133263,0.0026307811,0.00008895223,0.0001449347,0.00023535205,0.00003879359,0.0001082242,0.0005655601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950406,0.0004464358,0.000896831,0.00075216946,0.0013477587,0.0015161962],"domain_scores_gemma":[0.99737775,0.0005960685,0.00032177925,0.00054699066,0.00040267402,0.0007547314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001061619,0.0005894943,0.001174897,0.00082535937,0.0007105992,0.00018390758,0.000401156,0.00029915592,0.00037831694],"category_scores_gemma":[0.0010992121,0.00038665292,0.00021201382,0.0022963763,0.00061761116,0.00032739635,0.00025558178,0.0017061346,0.00022591658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014302823,0.0011570242,0.76741195,0.000404743,0.0012267694,0.006316421,0.0028002772,0.008274174,0.17381021,0.000015362606,0.003184818,0.02109543],"study_design_scores_gemma":[0.013597686,0.0051381406,0.95992136,0.0023684397,0.00009018718,0.0029584505,0.0006703685,0.013917667,0.0006238677,0.000011270337,0.00018986267,0.0005127216],"about_ca_topic_score_codex":0.00019586133,"about_ca_topic_score_gemma":0.0006475589,"teacher_disagreement_score":0.1925094,"about_ca_system_score_codex":0.0003582122,"about_ca_system_score_gemma":0.00046877348,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W4391685626","doi":"10.1177/13524585241229332","title":"Drop-out, adherence, and compliance in randomized controlled trials of exercise training in multiple sclerosis: Short report","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Randomized controlled trial; Medicine; Physical therapy; Compliance (psychology); Drop out; Patient compliance; Meta-analysis; Intervention (counseling); Multiple sclerosis; Internal medicine; Psychology; Family medicine; Nursing","score_opus":0.34958725539888164,"score_gpt":0.3860948823326166,"score_spread":0.03650762693373494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391685626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477911,0.04025568,0.0010301266,0.0009978785,0.001288012,0.007616851,0.00009085882,0.00013830775,0.00079120934],"genre_scores_gemma":[0.9663915,0.028518708,0.0033499303,0.00003719716,0.00032696643,0.001025853,0.000020741623,0.000088822744,0.00024027773],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9881377,0.0019796113,0.006258643,0.0009544869,0.001553982,0.0011155799],"domain_scores_gemma":[0.9866963,0.010628484,0.0010005696,0.00055362534,0.00055134663,0.00056969834],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.029535655,0.0006993542,0.0094832955,0.0018210235,0.00023295784,0.00031798813,0.00033847868,0.0003060825,0.00020281723],"category_scores_gemma":[0.040409625,0.00049130886,0.0017415503,0.0009663251,0.00083452027,0.00049364474,0.00021074375,0.0015906307,0.000012657081],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21050385,0.0012672291,0.21671233,0.00193512,0.0031246522,0.0012962618,0.017745193,0.00032769222,0.2813328,0.000033474807,0.0012344659,0.26448694],"study_design_scores_gemma":[0.60014635,0.00041369378,0.24226934,0.05210302,0.0009953292,0.00041305315,0.0045463457,0.093041606,0.0048197266,0.000185718,0.00022097897,0.0008448544],"about_ca_topic_score_codex":0.0003289025,"about_ca_topic_score_gemma":0.00066605635,"teacher_disagreement_score":0.38964248,"about_ca_system_score_codex":0.0003273031,"about_ca_system_score_gemma":0.00063875894,"threshold_uncertainty_score":0.99975383},"labels":[],"label_agreement":null},{"id":"W4392290833","doi":"10.1177/13524585241228426","title":"Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Asymptomatic; Medicine; Multiple sclerosis; Spinal cord; Magnetic resonance imaging; Surgery; Concomitant; Radiology","score_opus":0.18783788841020563,"score_gpt":0.35571167098419587,"score_spread":0.16787378257399024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392290833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893503,0.0018493893,0.0018204583,0.0037622913,0.00096911023,0.001513538,0.0003931009,0.00020692228,0.00013489246],"genre_scores_gemma":[0.9917549,0.0021444883,0.004626441,0.00017508278,0.0008917956,0.00018769196,0.000019896772,0.00012364467,0.00007608037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933985,0.00053910987,0.0013994944,0.0011561518,0.0020106577,0.0014960866],"domain_scores_gemma":[0.9950053,0.0012241896,0.00025512595,0.00087794353,0.0006837341,0.0019536875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019262751,0.00069513364,0.0013165417,0.0013889831,0.0004956448,0.00033280952,0.00060296827,0.00026218776,0.00046163928],"category_scores_gemma":[0.004882623,0.0006081499,0.00079677004,0.002051209,0.0004212674,0.0006498941,0.0006424811,0.0019478807,0.00012794702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018780062,0.001830333,0.49940518,0.0010634903,0.00044861247,0.00020129526,0.00056162913,0.0001598754,0.24945141,0.00000922171,0.003915997,0.2241729],"study_design_scores_gemma":[0.0042810515,0.0011853576,0.9335035,0.0059106345,0.00015248107,0.000025223417,0.00031621804,0.041446127,0.0116770435,0.000017322747,0.0009970821,0.00048793366],"about_ca_topic_score_codex":0.00058879744,"about_ca_topic_score_gemma":0.00036633108,"teacher_disagreement_score":0.43409836,"about_ca_system_score_codex":0.00074581755,"about_ca_system_score_gemma":0.000408853,"threshold_uncertainty_score":0.999637},"labels":[],"label_agreement":null},{"id":"W4392376725","doi":"10.1177/13524585241234783","title":"Efficacy and safety results after &gt;3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Placebo; Expanded Disability Status Scale; Adverse effect; Population; Confidence interval; Tolerability; Multiple sclerosis; Immunology; Pathology","score_opus":0.09712180060595654,"score_gpt":0.34536530860207776,"score_spread":0.24824350799612122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882221,0.0035445727,0.000086814085,0.00067788403,0.0005170707,0.0066386415,0.00022980077,0.00006880608,0.000014267058],"genre_scores_gemma":[0.99378294,0.004210496,0.000607205,0.000036090325,0.0006788473,0.00044381456,0.000031852243,0.00013087416,0.000077873505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924365,0.001076744,0.0028229614,0.0011463861,0.0015345255,0.0009828644],"domain_scores_gemma":[0.9943086,0.002857801,0.000776823,0.00091148657,0.00054721214,0.00059808523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040280484,0.00075994345,0.0021204501,0.0006580559,0.0004919332,0.00020949953,0.00034025568,0.00024531613,0.000038595146],"category_scores_gemma":[0.0023213944,0.00045462864,0.00062944257,0.001093346,0.0010954073,0.00036389547,0.0003052076,0.0012097806,0.0000042272386],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77354884,0.00873706,0.09127332,0.00017664154,0.0017277113,0.0002806256,0.0061781346,0.000042597756,0.059102204,4.5078002e-7,0.00018208395,0.058750354],"study_design_scores_gemma":[0.49422425,0.03331491,0.46195254,0.005278936,0.00073753187,0.000058908954,0.0005419223,0.0007890417,0.0027273986,2.8007392e-7,0.000077823424,0.00029643954],"about_ca_topic_score_codex":0.00024597932,"about_ca_topic_score_gemma":0.0013858442,"teacher_disagreement_score":0.37067923,"about_ca_system_score_codex":0.00055198604,"about_ca_system_score_gemma":0.00077550655,"threshold_uncertainty_score":0.99979055},"labels":[],"label_agreement":null},{"id":"W4392813871","doi":"10.1177/13524585241238094","title":"Choroid plexus volume differentiates MS from its mimics","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; EMD Serono; National Institutes of Health; Idorsia Pharmaceuticals; Genentech; Multiple Sclerosis Society; Common Fund; Myelin Repair Foundation; Horizon Therapeutics; National Institute of Mental Health; NGM Biopharmaceuticals; Race to Erase MS; TG Therapeutics; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; Eli Lilly and Company; Biogen; Sanofi; National Multiple Sclerosis Society","keywords":"Choroid plexus; Multiple sclerosis; Medicine; Neuroscience; Central nervous system; Internal medicine; Psychology","score_opus":0.08218949961202789,"score_gpt":0.25643241245643644,"score_spread":0.17424291284440857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392813871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913545,0.0029154492,0.00066515245,0.00074851274,0.003265346,0.00014802326,0.00021001788,0.000247635,0.0004453234],"genre_scores_gemma":[0.9948749,0.0016939886,0.00019922994,0.0003958768,0.0014964842,0.000009736053,0.00001008007,0.00007069794,0.0012490097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997522,0.00012457215,0.00050188816,0.00060714333,0.0006186715,0.000625702],"domain_scores_gemma":[0.99893534,0.0002928039,0.000100439174,0.00025621091,0.000050206694,0.0003650173],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018078682,0.0003217623,0.0003160665,0.00019757006,0.00054778496,0.0012847328,0.00058315316,0.00013146465,0.0023197054],"category_scores_gemma":[0.00039294074,0.00027186173,0.00031689816,0.00036120077,0.000096356285,0.00062547583,0.00016541107,0.0008026509,0.0015098066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046735455,0.00012593264,0.006359641,0.00002289271,0.000031744083,0.00008185476,0.00040745665,0.00009298081,0.9782155,0.00016478497,0.0059576826,0.008492798],"study_design_scores_gemma":[0.002077213,0.00030894822,0.21662939,0.0007223629,0.00013088027,0.00038811655,0.00006792802,0.13741656,0.6117013,0.0017872994,0.027848793,0.00092122774],"about_ca_topic_score_codex":0.00007260464,"about_ca_topic_score_gemma":0.00003587137,"teacher_disagreement_score":0.3665142,"about_ca_system_score_codex":0.00014479122,"about_ca_system_score_gemma":0.00007503684,"threshold_uncertainty_score":0.99997336},"labels":[],"label_agreement":null},{"id":"W4394820159","doi":"10.1177/13524585241242050","title":"Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Tolerability; Placebo; Internal medicine; Multiple sclerosis; Adverse effect; Immunology; Pathology; Alternative medicine","score_opus":0.07754095278387704,"score_gpt":0.28221661118270736,"score_spread":0.2046756583988303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394820159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879307,0.01021439,0.00024156671,0.00032756297,0.00038746628,0.0006920104,0.000036051548,0.00005161497,0.00011862534],"genre_scores_gemma":[0.98165774,0.012766351,0.005135221,0.000082855906,0.00016346395,0.00003500305,0.000022714386,0.00008075843,0.000055916604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972037,0.00016856045,0.00081764976,0.0004502422,0.0007484784,0.00061138754],"domain_scores_gemma":[0.99853224,0.0002367647,0.00018658211,0.00035044504,0.00032699984,0.0003669573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083052035,0.00028760507,0.0005920166,0.0006774341,0.00023179961,0.00041759663,0.0003330719,0.0001180548,0.000112391856],"category_scores_gemma":[0.00048483757,0.00021404948,0.0001052182,0.0007038441,0.00014370799,0.0008735449,0.00019195274,0.00075501215,0.000032228356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024393038,0.0012631912,0.8558606,0.00016295548,0.00009487163,0.000082111656,0.00073533226,0.000029674884,0.058618408,0.0000072079715,0.0012105516,0.07949578],"study_design_scores_gemma":[0.021054462,0.0013785786,0.96532613,0.006711612,0.000025347039,0.00007206111,0.0001760877,0.0023177946,0.002054394,0.00003719139,0.00057195,0.00027439778],"about_ca_topic_score_codex":0.000118562544,"about_ca_topic_score_gemma":0.00009807659,"teacher_disagreement_score":0.10946551,"about_ca_system_score_codex":0.00017870592,"about_ca_system_score_gemma":0.00027847162,"threshold_uncertainty_score":0.8728684},"labels":[],"label_agreement":null},{"id":"W4399756276","doi":"10.1177/13524585241261200","title":"Monitoring cognitive functioning in multiple sclerosis will trigger anxiety in patients: Commentary","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Multiple sclerosis; Anxiety; Cognition; Psychology; Clinical psychology; Cognitive skill; Medicine; Psychiatry","score_opus":0.10376262789482071,"score_gpt":0.3019569323866519,"score_spread":0.19819430449183117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399756276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901852,0.004054214,0.00021827129,0.0021353082,0.0016624595,0.0012990477,0.00009526612,0.00016760037,0.00018260542],"genre_scores_gemma":[0.9890235,0.0080149025,0.00095358613,0.00043544738,0.0010627577,0.00022573091,0.000055815915,0.00012988431,0.00009837472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944728,0.00042813292,0.0013893425,0.00090697967,0.0014290668,0.0013737017],"domain_scores_gemma":[0.9970758,0.0013249699,0.00019665976,0.00035373625,0.0004984399,0.00055041857],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015732966,0.0006100241,0.0009413862,0.001461284,0.00056442915,0.00043630498,0.0002900676,0.00026404634,0.00024749935],"category_scores_gemma":[0.0022919246,0.0005471698,0.00045301477,0.0016438024,0.0002650366,0.0013810546,0.00032483952,0.002465907,0.00008487752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010934055,0.0009478482,0.8646351,0.00015674993,0.00027390345,0.00004750941,0.0016780306,0.00012944237,0.008815238,5.9023495e-7,0.002681623,0.11954058],"study_design_scores_gemma":[0.016186772,0.000442585,0.9605225,0.010289053,0.000097670425,0.000017165226,0.0020628234,0.004723682,0.0036539838,0.00000800649,0.0015079242,0.0004878692],"about_ca_topic_score_codex":0.00057079,"about_ca_topic_score_gemma":0.00029477704,"teacher_disagreement_score":0.11905271,"about_ca_system_score_codex":0.0017011703,"about_ca_system_score_gemma":0.0001659242,"threshold_uncertainty_score":0.99983543},"labels":[],"label_agreement":null},{"id":"W4399972848","doi":"10.1177/13524585241260145","title":"Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero della Salute; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; Horizon Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Spinal cord; White matter; Brain size; Physical medicine and rehabilitation; Nuclear medicine; Radiology","score_opus":0.0541089373139094,"score_gpt":0.2898980175733567,"score_spread":0.2357890802594473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399972848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481493,0.0015555489,0.00022233967,0.001497257,0.00038405042,0.001278835,0.00012111312,0.00008075135,0.000045146313],"genre_scores_gemma":[0.9940271,0.0017346925,0.0036481747,0.00013640698,0.0002303568,0.00006333341,0.000022053597,0.000098388446,0.000039505703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954136,0.00025395016,0.0011378606,0.000740977,0.001454825,0.0009988077],"domain_scores_gemma":[0.9972973,0.000856942,0.0002498627,0.00041696616,0.0004965857,0.00068233645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096699485,0.00053785305,0.0010232553,0.0007940544,0.00026524227,0.00019686001,0.00024684946,0.00018550352,0.00019241206],"category_scores_gemma":[0.00086009817,0.00039610622,0.0002760022,0.0008085143,0.00044166643,0.00042159035,0.00027904924,0.0012709568,0.000036278652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00682842,0.00079273706,0.9384131,0.00045697854,0.00037849197,0.00004591506,0.0004637608,0.00006675273,0.0074979486,0.0000049033993,0.0009833754,0.044067662],"study_design_scores_gemma":[0.01264647,0.004728341,0.9662266,0.0048972056,0.00011649985,0.000053103304,0.0004668646,0.009272539,0.0010000375,0.000009251354,0.00020346722,0.00037962678],"about_ca_topic_score_codex":0.0008307248,"about_ca_topic_score_gemma":0.00054842775,"teacher_disagreement_score":0.043688037,"about_ca_system_score_codex":0.0007377388,"about_ca_system_score_gemma":0.00033269674,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W4401178900","doi":"10.1177/13524585241265961","title":"The first global landscape analysis of multiple sclerosis research funding","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Multiple sclerosis; Portfolio; Government (linguistics); Business; Public relations; Political science; Medicine; Economic growth; Finance; Economics","score_opus":0.25233399842619536,"score_gpt":0.3873816783126662,"score_spread":0.13504767988647082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401178900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648639,0.020291686,0.000840006,0.008542191,0.0013130994,0.001161574,0.0003790473,0.00025085744,0.0023576682],"genre_scores_gemma":[0.98244053,0.015242163,0.00088248955,0.0000880821,0.00083099486,0.00011354929,0.000029779254,0.000075139214,0.00029728093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99179536,0.0005671949,0.001460197,0.00086773373,0.0033653833,0.0019441058],"domain_scores_gemma":[0.99110234,0.0051438306,0.00026846837,0.0010576281,0.0016085036,0.0008192056],"candidate_categories":["metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0072321957,0.00050223526,0.0011732877,0.0016122074,0.0028157886,0.0010933884,0.00096444256,0.00026371688,0.00039057567],"category_scores_gemma":[0.0063358876,0.00033018953,0.0014088064,0.007759284,0.0010214646,0.00042767276,0.0006862558,0.0018941398,0.00014032943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010400639,0.00047343367,0.8585722,0.00031277363,0.009659586,0.00007146356,0.0013625665,0.0009364357,0.020166008,0.00018049892,0.038142823,0.06908214],"study_design_scores_gemma":[0.0024965538,0.00037061644,0.9006413,0.0015666673,0.0012176728,0.000050967992,0.0019298263,0.06908413,0.0014840687,0.000046107532,0.020785453,0.0003266041],"about_ca_topic_score_codex":0.00043934048,"about_ca_topic_score_gemma":0.0023909584,"teacher_disagreement_score":0.06875554,"about_ca_system_score_codex":0.0009767308,"about_ca_system_score_gemma":0.0004592117,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W4401226031","doi":"10.1177/13524585241267211","title":"Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; St. Michael's Hospital; Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; F. Hoffmann-La Roche; Sanofi Genzyme; EMD Serono; Grifols; Monash University; Alexion Pharmaceuticals; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; Atara Biotherapeutics; Medical Research Council; Biogen; Sanofi","keywords":"Medicine; Ocrelizumab; Cladribine; Multiple sclerosis; Natalizumab; Fingolimod; Alemtuzumab; Relapsing remitting; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Oncology; Rituximab; Immunology; Transplantation","score_opus":0.09020544279069158,"score_gpt":0.3128205917848402,"score_spread":0.22261514899414858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401226031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884008,0.006631953,0.0012778429,0.00075958663,0.00069315097,0.0016455012,0.00013795863,0.00018327897,0.0002699279],"genre_scores_gemma":[0.9908305,0.0030169445,0.005361853,0.00008345506,0.00031317567,0.0001471964,0.00003448586,0.00015491358,0.000057486373],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99381286,0.00071338017,0.0016138753,0.001120437,0.0014307597,0.001308703],"domain_scores_gemma":[0.99420255,0.0034060713,0.00027270243,0.0006496219,0.0006216096,0.0008474173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032789316,0.00069410965,0.0016175782,0.0016498542,0.0004872698,0.00035109196,0.00043902945,0.00029143385,0.00010708946],"category_scores_gemma":[0.0054030325,0.00061588647,0.0004600495,0.0017489064,0.00041775164,0.00055045594,0.0006088776,0.0016092123,0.000047348836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004418231,0.0006644461,0.27397838,0.0028306283,0.00067136384,0.00016059181,0.0029280367,0.0014764083,0.6679527,0.00003704928,0.0015630028,0.043319147],"study_design_scores_gemma":[0.012673985,0.0007314181,0.8964492,0.025342451,0.0001316127,0.00029481662,0.00077560986,0.029901808,0.032501295,0.00003894848,0.0005511283,0.00060771574],"about_ca_topic_score_codex":0.0008600767,"about_ca_topic_score_gemma":0.00029503994,"teacher_disagreement_score":0.63545144,"about_ca_system_score_codex":0.0010798728,"about_ca_system_score_gemma":0.00034621154,"threshold_uncertainty_score":0.99962926},"labels":[],"label_agreement":null},{"id":"W4401622512","doi":"10.1177/13524585241264472","title":"Genetics of multiple sclerosis severity: The importance of statistical power in replication studies","year":2024,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Replication (statistics); Genetics; Medicine; MEDLINE; Statistical power; Biology; Psychiatry; Virology; Statistics; Mathematics","score_opus":0.09265093263910182,"score_gpt":0.30723913069638686,"score_spread":0.21458819805728505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401622512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8115855,0.04978257,0.0029461388,0.13099758,0.002241672,0.0012049478,0.001050938,0.00002698172,0.00016367962],"genre_scores_gemma":[0.9668477,0.010915249,0.0016267211,0.019136127,0.0008643144,0.0000854923,0.00021181427,0.00007338105,0.00023919098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973599,0.00025319966,0.0010100354,0.0005809447,0.0004886592,0.0003072894],"domain_scores_gemma":[0.9976924,0.00014421516,0.0007421691,0.00095956604,0.00040488035,0.000056776076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000697189,0.00029564873,0.000456629,0.0001561924,0.000094370494,0.000045873734,0.00050998206,0.0004786475,0.00003223181],"category_scores_gemma":[0.0006847243,0.00021956817,0.00022366976,0.00024271375,0.00029911616,0.0000070301653,0.00020714584,0.00091503514,0.000004139082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086476735,0.00007147394,0.021913905,0.00017370525,0.0002151431,0.0000047166163,0.00026356967,0.00006751847,0.35165945,0.000004796688,0.6216347,0.0039045322],"study_design_scores_gemma":[0.0024085597,0.0005264337,0.23177141,0.0018889883,0.00029465003,0.000063862906,0.0011705512,0.0007643778,0.27740452,0.0004967314,0.48229682,0.00091309554],"about_ca_topic_score_codex":0.000011585463,"about_ca_topic_score_gemma":0.000057978454,"teacher_disagreement_score":0.20985751,"about_ca_system_score_codex":0.00008131562,"about_ca_system_score_gemma":0.00018591504,"threshold_uncertainty_score":0.89537305},"labels":[],"label_agreement":null},{"id":"W4402058562","doi":"10.1177/13524585241266483","title":"The refined Pathways to Cures Research Roadmap for multiple sclerosis cures","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Neuroscience; Intensive care medicine; Psychology; Psychiatry","score_opus":0.36960673013697337,"score_gpt":0.40030614915448676,"score_spread":0.030699419017513385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402058562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85605377,0.035658527,0.0060564014,0.081843436,0.006088606,0.010357846,0.0009708351,0.0012225811,0.0017479805],"genre_scores_gemma":[0.97406274,0.010581553,0.0075832447,0.0006132333,0.003637458,0.0015814746,0.00003729765,0.00026603419,0.0016369779],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901728,0.0007919042,0.0015154163,0.0013241577,0.0032916768,0.0029040144],"domain_scores_gemma":[0.98572177,0.008700269,0.00019005565,0.0013081688,0.002485315,0.0015944211],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008851115,0.0007456274,0.001004062,0.0012466483,0.0048884377,0.0022243324,0.0012950093,0.00034455847,0.0001690039],"category_scores_gemma":[0.020146817,0.00048814432,0.0010209888,0.0019983277,0.0007884633,0.00051657186,0.0008230955,0.0026921942,0.0005013125],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025339038,0.00047622135,0.008278543,0.00039293568,0.0009093968,0.000060799866,0.0028359515,0.00019228643,0.36440426,0.00037728425,0.38977104,0.22976735],"study_design_scores_gemma":[0.009499596,0.0028797034,0.2754912,0.0058264732,0.00024754033,0.00020834719,0.0043218513,0.021468598,0.043179434,0.00068310206,0.63501686,0.0011773132],"about_ca_topic_score_codex":0.00017930786,"about_ca_topic_score_gemma":0.00069282047,"teacher_disagreement_score":0.32122484,"about_ca_system_score_codex":0.0010221936,"about_ca_system_score_gemma":0.0008241653,"threshold_uncertainty_score":0.999757},"labels":[],"label_agreement":null},{"id":"W4402288515","doi":"10.1177/13524585241272939","title":"Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Dalhousie University; University of British Columbia; University of Calgary; University of Ottawa; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Health Sciences Centre; University of Waterloo; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; Western University","funders":"","keywords":"Prodrome; Neuromyelitis optica; Multiple sclerosis; Medicine; Myelin oligodendrocyte glycoprotein; Spectrum disorder; Optic neuritis; Disease; Psychiatry; Immunology; Dermatology; Pathology","score_opus":0.1594880695345992,"score_gpt":0.3303628954360687,"score_spread":0.17087482590146952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402288515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97566944,0.012684596,0.000016571821,0.010703429,0.00011001885,0.0007379185,0.00003537714,0.00002897118,0.000013645361],"genre_scores_gemma":[0.9947081,0.0038612797,0.0009632337,0.00022968398,0.0001245401,0.000037279155,0.000008094622,0.000029456247,0.000038292183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998042,0.00016065521,0.00058524066,0.00030866754,0.0005062898,0.00039715177],"domain_scores_gemma":[0.9989212,0.00028675908,0.00013561272,0.00021441796,0.00021577576,0.00022621658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010131027,0.000193168,0.0004240797,0.0003208046,0.00038469842,0.0002436763,0.00010111395,0.000073956944,0.000011299246],"category_scores_gemma":[0.000736503,0.00012282393,0.00007963445,0.00047283192,0.0003935208,0.00039626437,0.00015265941,0.0006103962,0.0000024222009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067768604,0.000026762924,0.94710153,0.0008911916,0.00009431108,0.000010275583,0.02202767,0.000019781215,0.0026239639,0.000009200798,0.0012725248,0.025855005],"study_design_scores_gemma":[0.0016654835,0.00039837344,0.98774815,0.0027231323,0.00002674932,0.00008695988,0.0028590772,0.003141686,0.00040406146,0.000019177201,0.000839062,0.00008806658],"about_ca_topic_score_codex":0.0006407624,"about_ca_topic_score_gemma":0.0028303799,"teacher_disagreement_score":0.040646628,"about_ca_system_score_codex":0.00024215474,"about_ca_system_score_gemma":0.00023506439,"threshold_uncertainty_score":0.50086147},"labels":[],"label_agreement":null},{"id":"W4402288582","doi":"10.1177/13524585241271988","title":"Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; EMD Serono; National Institutes of Health; Idorsia Pharmaceuticals; Genentech; Multiple Sclerosis Society; Horizon Therapeutics; National Institute of Mental Health; Race to Erase MS; TG Therapeutics; Alexion Pharmaceuticals; Sanofi; Atara Biotherapeutics; Celgene; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Cerebrospinal fluid; Biomarker; Medicine; Sign (mathematics); Pathology; Central nervous system disease; Internal medicine; Immunology; Chemistry","score_opus":0.13378076064570546,"score_gpt":0.3104973616398545,"score_spread":0.17671660099414901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402288582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874156,0.004386415,0.0016449861,0.0011379562,0.003098797,0.0014796419,0.0003975993,0.00019308637,0.00024592507],"genre_scores_gemma":[0.98234206,0.009451636,0.005530432,0.0000807293,0.0018861691,0.00027726652,0.000075314056,0.00014647261,0.00020993111],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994662,0.00016394054,0.0012880423,0.0007623189,0.0014999496,0.0016237627],"domain_scores_gemma":[0.99180627,0.0057431734,0.00027761812,0.00053490035,0.000782798,0.0008552682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012808942,0.0006108318,0.0010493499,0.00066031807,0.00068073324,0.00029514747,0.00050376466,0.00026574798,0.00036275244],"category_scores_gemma":[0.007066817,0.0005115122,0.0009188373,0.0007893217,0.00048132736,0.00059777295,0.00022652747,0.0010707135,0.00006773373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012190691,0.0016583637,0.3241237,0.0029297604,0.0028532438,0.00007792625,0.0028399655,0.0026510875,0.40442,0.00006742279,0.04081653,0.2053713],"study_design_scores_gemma":[0.01939779,0.0032925042,0.8084265,0.0051383376,0.0005204971,0.0000865888,0.00049275224,0.10251175,0.052656535,0.000012307353,0.006764217,0.00070024695],"about_ca_topic_score_codex":0.00009838696,"about_ca_topic_score_gemma":0.000059252412,"teacher_disagreement_score":0.48430276,"about_ca_system_score_codex":0.00059991074,"about_ca_system_score_gemma":0.0005442597,"threshold_uncertainty_score":0.9997336},"labels":[],"label_agreement":null},{"id":"W4402379955","doi":"10.1177/13524585241274620","title":"Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical trial; Multiple sclerosis; Medicine; Cohort; Selection (genetic algorithm); Dosing; Internal medicine; Computer science; Psychiatry; Machine learning","score_opus":0.7745573034653884,"score_gpt":0.6094124903853415,"score_spread":0.16514481308004691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402379955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007372259,0.93009335,0.0037435074,0.00039253416,0.0018678586,0.05969382,0.003318991,0.000120764715,0.000031949785],"genre_scores_gemma":[0.0020686241,0.9384186,0.03376447,0.00013898993,0.0030667682,0.021513363,0.00072327367,0.00026625668,0.00003963903],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.96721137,0.012865114,0.015529656,0.0012783424,0.0013333639,0.0017821373],"domain_scores_gemma":[0.8445318,0.137484,0.012180448,0.00082961697,0.0037109389,0.0012632182],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.07216178,0.0014152791,0.014450777,0.0025845845,0.0007729131,0.00095037697,0.00047397232,0.001061448,0.000121476776],"category_scores_gemma":[0.43177634,0.00095174625,0.0049048723,0.001312273,0.00042718727,0.0007258829,0.00026188893,0.003585025,0.0000249602],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004530781,0.0051210774,0.00022799861,0.012480204,0.003492024,0.000060786824,0.00209469,0.000015485139,0.000022927668,0.0000067942406,0.03565622,0.93629104],"study_design_scores_gemma":[0.32133374,0.021670952,0.00032574727,0.30544496,0.016404105,0.0003032208,0.0016517582,0.015235106,0.00035138236,0.00050858135,0.3136192,0.003151232],"about_ca_topic_score_codex":0.00001428586,"about_ca_topic_score_gemma":0.00005095781,"teacher_disagreement_score":0.9331398,"about_ca_system_score_codex":0.0014916572,"about_ca_system_score_gemma":0.0040469514,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W4402385120","doi":"10.1177/13524585241272938","title":"Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; EMD Serono; ZonMw; Multiple Sclerosis Society; International Progressive MS Alliance; Medical Research Council; Celgene; Biogen; Atara Biotherapeutics; National Institute for Health and Care Research; Teva Pharmaceutical Industries; MedDay Pharmaceuticals; Sanofi","keywords":"Multiple sclerosis; Medicine; Disease; Internal medicine; Immunology","score_opus":0.14280391978690815,"score_gpt":0.3265880378291837,"score_spread":0.18378411804227557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402385120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932481,0.0010083021,0.00054594263,0.002286741,0.00070835365,0.0018081159,0.0001978177,0.00016371405,0.00003290373],"genre_scores_gemma":[0.9975363,0.0008790263,0.0005463813,0.000067796886,0.000490028,0.00018919905,0.0000725885,0.0001126093,0.000106090454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99448633,0.0005855799,0.0013178288,0.0007737147,0.0019772365,0.0008593109],"domain_scores_gemma":[0.9965218,0.00077936746,0.0005522107,0.0005700801,0.0005639857,0.0010126047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017495356,0.00051081873,0.00084077165,0.0011462198,0.00060708827,0.00035230393,0.00025864225,0.00018002714,0.00014605494],"category_scores_gemma":[0.005377354,0.00043219983,0.0004920831,0.0012170969,0.00028415903,0.0011021909,0.00018970869,0.0014022253,0.000013812667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057527065,0.0022338745,0.69791555,0.0005767545,0.0008884863,0.00031176693,0.0023748595,0.0019094718,0.21949963,0.000021203092,0.0009488502,0.015792489],"study_design_scores_gemma":[0.03636171,0.0003472639,0.912151,0.00804574,0.00033250623,0.0000071008044,0.00022149511,0.038864974,0.0031887593,0.000041090985,0.0000357487,0.0004026499],"about_ca_topic_score_codex":0.00015503367,"about_ca_topic_score_gemma":0.00041511917,"teacher_disagreement_score":0.21631087,"about_ca_system_score_codex":0.00122591,"about_ca_system_score_gemma":0.00096609927,"threshold_uncertainty_score":0.99981296},"labels":[],"label_agreement":null},{"id":"W4402466338","doi":"10.1177/13524585241275491","title":"Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Ottawa; Sunnybrook Health Science Centre; University of Manitoba; University of Toronto","funders":"European Genomic Institute for Diabetes","keywords":"Prodrome; Neuromyelitis optica; Spectrum disorder; Aquaporin 4; Multiple sclerosis; Medicine; Serology; Pediatrics; Psychology; Psychiatry; Antibody; Immunology; Pathology","score_opus":0.1661710950545475,"score_gpt":0.3402583352286419,"score_spread":0.1740872401740944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402466338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725086,0.0013897652,0.00014498524,0.023946444,0.0004894635,0.0011691273,0.00003786451,0.00014134115,0.00017238042],"genre_scores_gemma":[0.9956074,0.0007650058,0.001100417,0.001377342,0.0007660532,0.00012914556,0.0000070248525,0.00007459879,0.00017305807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654156,0.00024435527,0.0007702762,0.00058491086,0.0011638857,0.0006950358],"domain_scores_gemma":[0.9976781,0.0005475429,0.00019019148,0.0005928158,0.00046500243,0.0005263592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015278495,0.00035760298,0.0005230429,0.00031867856,0.0010005122,0.0005964996,0.00052962964,0.00014628534,0.00022940584],"category_scores_gemma":[0.0010272143,0.00021938828,0.0003022813,0.000993169,0.0003327398,0.0004548764,0.00027488288,0.0010315123,0.000099811776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053343637,0.00026946995,0.72452974,0.0007175185,0.00065184705,0.00004667056,0.015495275,0.0009317007,0.19348264,0.000018755944,0.025167983,0.03815498],"study_design_scores_gemma":[0.0014337715,0.0016127931,0.9528351,0.0015935543,0.00014759696,0.00014710089,0.0006356313,0.023450958,0.011203238,0.000050428378,0.0066161933,0.000273629],"about_ca_topic_score_codex":0.000112198126,"about_ca_topic_score_gemma":0.00015905738,"teacher_disagreement_score":0.22830538,"about_ca_system_score_codex":0.00019695492,"about_ca_system_score_gemma":0.0001777601,"threshold_uncertainty_score":0.8946395},"labels":[],"label_agreement":null},{"id":"W4402939807","doi":"10.1177/13524585241275471","title":"Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Hazard ratio; Confidence interval; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Pediatrics; Psychiatry","score_opus":0.24372575761850196,"score_gpt":0.33956713603257005,"score_spread":0.09584137841406809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402939807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742379,0.0023533695,0.019667057,0.0005199314,0.00045312534,0.0023799979,0.00020414325,0.00016668378,0.000017767354],"genre_scores_gemma":[0.96176016,0.0020016339,0.03523724,0.000097671335,0.0003517985,0.0002619574,0.00002895035,0.00015932201,0.00010123494],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99542516,0.00011547385,0.0011792625,0.00094619545,0.00091016694,0.0014237539],"domain_scores_gemma":[0.99675703,0.0016054926,0.00021192586,0.000348871,0.0003822802,0.00069440674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013438133,0.0006352602,0.00092787476,0.0010035902,0.00076152314,0.0006301789,0.00023416766,0.00021461412,0.000028897053],"category_scores_gemma":[0.00320156,0.00052381546,0.0004254281,0.00065187627,0.00029461304,0.00064286776,0.00029304088,0.001088579,0.0000062898384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071238185,0.00044670704,0.31527078,0.00089240994,0.00048214404,0.000049517123,0.0042822533,0.007637777,0.60132384,0.000010827639,0.00040558126,0.06848577],"study_design_scores_gemma":[0.006090904,0.0003746444,0.2181842,0.0034297016,0.00017660037,0.000044918488,0.0012589595,0.7629913,0.0067995507,0.00004789058,0.00014508469,0.0004562595],"about_ca_topic_score_codex":0.00032047622,"about_ca_topic_score_gemma":0.00035628947,"teacher_disagreement_score":0.7553535,"about_ca_system_score_codex":0.0007968194,"about_ca_system_score_gemma":0.00033826215,"threshold_uncertainty_score":0.99972135},"labels":[],"label_agreement":null},{"id":"W4403552437","doi":"10.1177/13524585241287388","title":"Trajectories and management of vascular risk following the diagnosis of multiple sclerosis: A population-based matched cohort study between 1987 and 2018 in England","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Multiple sclerosis; Population; Diabetes mellitus; Internal medicine; Vascular disease; Incidence (geometry); Comorbidity; Cohort; Retrospective cohort study; Stroke (engine); Blood pressure; Cohort study; Physical therapy; Cardiology; Endocrinology; Immunology","score_opus":0.07406048083742164,"score_gpt":0.3035266560302018,"score_spread":0.22946617519278015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403552437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145323,0.005491795,0.0001682765,0.00025235678,0.00019127737,0.002298198,0.00009325537,0.000042863958,0.000008761612],"genre_scores_gemma":[0.9870913,0.010918187,0.0014148088,0.000012763543,0.0001470371,0.00033372332,0.000015942662,0.000057541176,0.0000087148455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599624,0.0005428233,0.001150989,0.0005656462,0.0012344575,0.0005098533],"domain_scores_gemma":[0.99695957,0.0018947934,0.0002913174,0.00046403258,0.0001582936,0.0002320212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033778115,0.00038518666,0.0010777978,0.000525636,0.0003951027,0.0001637368,0.000230646,0.00011696531,0.000020044377],"category_scores_gemma":[0.00086544006,0.0002692628,0.0003375777,0.00073169125,0.00023406715,0.00024622088,0.0002167252,0.0006563228,0.0000013177886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017254679,0.00041754314,0.9764636,0.00058101607,0.002223476,0.00001667975,0.0028130522,0.00015537335,0.0014857684,0.0000013612068,0.00004050882,0.015629044],"study_design_scores_gemma":[0.008283213,0.00041263428,0.9811196,0.0027779357,0.0010122055,0.0000023574464,0.0023557881,0.002403429,0.0013357709,0.0000115486355,0.00005814915,0.0002274017],"about_ca_topic_score_codex":0.0033801855,"about_ca_topic_score_gemma":0.0012410535,"teacher_disagreement_score":0.015401642,"about_ca_system_score_codex":0.00017676433,"about_ca_system_score_gemma":0.000060508744,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W4404118886","doi":"10.1177/13524585241292797","title":"How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Medicine; Multiple sclerosis; Medical diagnosis; Intensive care medicine; Differential diagnosis; Immunotherapy; Pediatrics; Aquaporin 4; Immunology; Pathology; Psychiatry","score_opus":0.17282751581581424,"score_gpt":0.36325745018129285,"score_spread":0.19042993436547861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404118886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027246817,0.98686653,0.00034309892,0.008361435,0.0010872859,0.0023099186,0.00041530834,0.00012522987,0.00021874058],"genre_scores_gemma":[0.001911901,0.9902451,0.004106244,0.00011253212,0.0019501547,0.00048340147,0.00004254894,0.00035284102,0.00079524855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99299556,0.0005453935,0.0018978256,0.0011707925,0.0019027775,0.0014876771],"domain_scores_gemma":[0.99494106,0.0013891566,0.0007337806,0.0010692588,0.0004609862,0.0014057708],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010988164,0.0012662701,0.004777215,0.0017409408,0.0004795968,0.0008631054,0.0008348644,0.00046417088,0.00028139964],"category_scores_gemma":[0.006349712,0.000881855,0.0027388842,0.001756197,0.00033638917,0.000258257,0.0008658389,0.0028144899,0.00023425788],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059495636,0.00035861201,0.0007021765,0.02748503,0.0015361928,0.00019983927,0.00029081054,0.0000033447516,0.00012736165,0.0000071268705,0.0137791075,0.9554509],"study_design_scores_gemma":[0.0011883117,0.00063438003,0.0017763037,0.112936124,0.0028357874,0.00052259583,0.00015267963,0.00006460299,0.00006502762,0.0000148675035,0.87910366,0.0007056647],"about_ca_topic_score_codex":0.00007119248,"about_ca_topic_score_gemma":0.000052658987,"teacher_disagreement_score":0.95474523,"about_ca_system_score_codex":0.0006679978,"about_ca_system_score_gemma":0.00075216533,"threshold_uncertainty_score":0.999486},"labels":[],"label_agreement":null},{"id":"W4404194774","doi":"10.1177/13524585241290102","title":"Development and initial validation of the Cognitive Change Scale (CCS)","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Scale (ratio); Cognition; Psychology; Neuroscience; Geography; Psychiatry; Cartography","score_opus":0.2180307942094561,"score_gpt":0.3519636776207886,"score_spread":0.13393288341133253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404194774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957508,0.0014729074,0.00019495995,0.0012025435,0.00042495134,0.0005550908,0.000031466694,0.000034814508,0.00033248402],"genre_scores_gemma":[0.9967226,0.00089556363,0.0015796742,0.00013339307,0.0004986889,0.00006354092,0.000007049584,0.000026478014,0.0000730508],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99821675,0.00011627608,0.00042099823,0.00023333736,0.00070363743,0.00030898466],"domain_scores_gemma":[0.99900395,0.00028578742,0.00010235737,0.00012577037,0.00030424833,0.00017791044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006868803,0.00016844881,0.00027887485,0.00019797753,0.000358713,0.00011485224,0.00010803327,0.0000733703,0.00009539035],"category_scores_gemma":[0.0005863933,0.00010663745,0.00013339888,0.00032565062,0.00025152462,0.00023324028,0.00019869828,0.0004729252,0.000019253803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041693944,0.0003370193,0.19491114,0.0006047568,0.00066941744,0.00002489087,0.019981137,0.0000027007477,0.15647721,0.000016434298,0.0011139084,0.6254444],"study_design_scores_gemma":[0.0019052356,0.00010259025,0.7971947,0.002982935,0.00010260178,0.00010011446,0.0012646809,0.0006364302,0.19311613,0.000009817693,0.002452912,0.00013182689],"about_ca_topic_score_codex":0.0000241565,"about_ca_topic_score_gemma":0.000036868943,"teacher_disagreement_score":0.6253126,"about_ca_system_score_codex":0.00011410604,"about_ca_system_score_gemma":0.00016671301,"threshold_uncertainty_score":0.4348549},"labels":[],"label_agreement":null},{"id":"W4404900898","doi":"10.1177/13524585241295554","title":"Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Tolerability; Relapsing remitting; Internal medicine; Mallinckrodt; Clinical endpoint; Adverse effect; Clinical trial; Immunology","score_opus":0.060693753650087875,"score_gpt":0.2880410208433752,"score_spread":0.2273472671932873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404900898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391997,0.0019064671,0.00008967252,0.0007541148,0.00035575603,0.0026740313,0.000082591054,0.00008922524,0.00012819206],"genre_scores_gemma":[0.99670273,0.001909637,0.0007271296,0.000046811267,0.00037735558,0.0001027012,0.000012822072,0.000095420124,0.000025373725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941793,0.0007252651,0.0015242071,0.0009004636,0.0017319309,0.0009388369],"domain_scores_gemma":[0.9948149,0.002977049,0.0004150899,0.00067614287,0.0007075015,0.00040932378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002762131,0.000564583,0.0011058438,0.0006744185,0.0007330578,0.00026167993,0.00042059488,0.0001666635,0.00005998137],"category_scores_gemma":[0.0038672371,0.0003523254,0.00024161777,0.0014537374,0.00050561747,0.0005335455,0.0004776007,0.0019551732,0.00000962144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027555365,0.0021426515,0.9154043,0.00024350829,0.00040962567,0.000015333588,0.0069748103,0.00023782946,0.0016838189,0.0000015152413,0.00021945238,0.06991157],"study_design_scores_gemma":[0.017186895,0.0017673003,0.97268146,0.001925822,0.00033305006,0.000015823398,0.003179348,0.002118006,0.00037681597,0.0000057502757,0.000072725015,0.00033702416],"about_ca_topic_score_codex":0.00027500626,"about_ca_topic_score_gemma":0.0005895656,"teacher_disagreement_score":0.06957455,"about_ca_system_score_codex":0.00061802525,"about_ca_system_score_gemma":0.00036274496,"threshold_uncertainty_score":0.9998929},"labels":[],"label_agreement":null},{"id":"W4405127548","doi":"10.1177/13524585241303481","title":"Considerations for family planning in adolescent and young adults with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Psychology; Pediatrics; Neuroscience; Psychiatry","score_opus":0.14733193582433557,"score_gpt":0.306836361717758,"score_spread":0.15950442589342245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405127548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854451,0.007827692,0.002171944,0.0028577985,0.00041260195,0.0010101555,0.000033811444,0.00018236559,0.00005856402],"genre_scores_gemma":[0.9825904,0.0012385102,0.015393435,0.0003040797,0.0002708346,0.00012848673,0.00000735896,0.000041330386,0.000025563233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833214,0.00003936101,0.00045496158,0.00046710292,0.00024786798,0.00045856388],"domain_scores_gemma":[0.9989532,0.00033677756,0.000092434355,0.00021369508,0.00019839576,0.00020547668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045441944,0.00021594888,0.00035442566,0.00040597277,0.00033435182,0.00018569632,0.000058151654,0.00012737681,0.0000079337315],"category_scores_gemma":[0.0011118415,0.0001625788,0.00007951894,0.000263575,0.00014513319,0.00024603022,0.000036430036,0.00065488147,0.0000039838756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015076735,0.00026604047,0.91091025,0.0007026245,0.00011573467,0.00012095747,0.0022466574,0.00016383118,0.039473362,0.00009781576,0.0041660042,0.040229026],"study_design_scores_gemma":[0.0058800387,0.0005990639,0.972796,0.005859632,0.00006269942,0.00052374566,0.0023896005,0.0075982553,0.0031686341,0.00018415779,0.0007177432,0.00022040322],"about_ca_topic_score_codex":0.00009228731,"about_ca_topic_score_gemma":0.00014868219,"teacher_disagreement_score":0.061885756,"about_ca_system_score_codex":0.00015643783,"about_ca_system_score_gemma":0.0001993237,"threshold_uncertainty_score":0.6629771},"labels":[],"label_agreement":null},{"id":"W4405263293","doi":"10.1177/13524585241301613","title":"Exercise as a Therapeutic Intervention in Multiple Sclerosis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Intervention (counseling); Medicine; Exercise prescription; Physical therapy; Disease; Physical medicine and rehabilitation; Physical exercise; Exercise therapy; Psychology; Randomized controlled trial; Psychiatry; Pathology","score_opus":0.29444775047756466,"score_gpt":0.39641055776367806,"score_spread":0.1019628072861134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405263293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007838316,0.9925846,0.000054351,0.00029645537,0.0016861594,0.0038593037,0.00016282297,0.00026852937,0.0003039702],"genre_scores_gemma":[0.013652972,0.98146456,0.0006772472,0.00010303693,0.0011292403,0.0011847478,0.00014808257,0.00047972202,0.0011603921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98998046,0.0009451484,0.0033881539,0.0016406738,0.002103833,0.0019417099],"domain_scores_gemma":[0.9951997,0.0009869803,0.0010150559,0.001255203,0.0005136305,0.0010294514],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028243016,0.0017424178,0.005326197,0.0031086798,0.00056777056,0.00086034724,0.001090213,0.0010321192,0.0007649803],"category_scores_gemma":[0.002227973,0.0012947139,0.004211861,0.002341045,0.00044470275,0.00050662825,0.00087342056,0.0053207865,0.002459147],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030425593,0.001043752,0.0006747026,0.018459635,0.0013678304,0.00022887014,0.00044804023,0.000003567035,0.00021041518,0.000005214336,0.0037641942,0.9734895],"study_design_scores_gemma":[0.00806372,0.00071435096,0.006724731,0.4003379,0.0053025438,0.0007258413,0.00053695735,0.0007247555,0.000056503468,0.00006240614,0.57518774,0.0015625188],"about_ca_topic_score_codex":0.00047991783,"about_ca_topic_score_gemma":0.00038174618,"teacher_disagreement_score":0.971927,"about_ca_system_score_codex":0.0021462443,"about_ca_system_score_gemma":0.00084818667,"threshold_uncertainty_score":0.99953216},"labels":[],"label_agreement":null},{"id":"W4405557779","doi":"10.1177/13524585241302170","title":"Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cladribine; Multiple sclerosis; Medicine; Clinically isolated syndrome; Relapsing remitting; Cohort; Pediatrics; Internal medicine; Immunology","score_opus":0.08249131676700497,"score_gpt":0.3470053581187855,"score_spread":0.2645140413517806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405557779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868985,0.0010326974,0.005003714,0.0025544341,0.00096419256,0.0032803894,0.00015089386,0.00008608356,0.000029110712],"genre_scores_gemma":[0.9910711,0.0051093553,0.0025414843,0.00017577491,0.00036134376,0.00029382168,0.00007180634,0.00014133369,0.00023399734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928915,0.0003996938,0.0030746937,0.00093147566,0.0015525817,0.0011500597],"domain_scores_gemma":[0.9893596,0.0074619465,0.0007115654,0.0006470484,0.0012970282,0.00052280346],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052793794,0.00055926346,0.0015983947,0.00049659837,0.00066090084,0.00026202714,0.00063586276,0.00037371484,0.00023904204],"category_scores_gemma":[0.009142634,0.00035606878,0.0008054758,0.0010554241,0.0005542782,0.00042521974,0.00033580113,0.0021144662,0.000020652633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055881026,0.0009715682,0.96861005,0.0005182143,0.0016250425,0.00006404006,0.00064487377,0.00020021213,0.00043106748,0.0000015687976,0.002471794,0.018873466],"study_design_scores_gemma":[0.01775402,0.003495217,0.93329686,0.008966505,0.000470347,0.00004698857,0.000115996976,0.035019137,0.000064437256,0.0000071637455,0.0004041727,0.00035916758],"about_ca_topic_score_codex":0.00009062958,"about_ca_topic_score_gemma":0.0008792305,"teacher_disagreement_score":0.035313204,"about_ca_system_score_codex":0.00049412844,"about_ca_system_score_gemma":0.00050531595,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W4405849416","doi":"10.1177/13524585241309257","title":"Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Trigeminal neuralgia; Multiple sclerosis; Medicine; Multicenter study; Cohort; Disease; Cohort study; Surgery; Internal medicine; Psychiatry; Randomized controlled trial","score_opus":0.046482289508857834,"score_gpt":0.2907720276367278,"score_spread":0.24428973812787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405849416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841422,0.010695841,0.00014241418,0.0038692171,0.00033381052,0.0005515103,0.00020564142,0.000041284155,0.000018074303],"genre_scores_gemma":[0.9981385,0.0010277766,0.00019940732,0.00026843036,0.0001863945,0.000057602516,0.000028073144,0.000032578122,0.00006126672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872714,0.000092118564,0.00042048085,0.0002737635,0.00026630118,0.00022021044],"domain_scores_gemma":[0.99790055,0.0012338273,0.00013533769,0.00029764386,0.00010548964,0.00032715208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001759427,0.00020811254,0.0002780624,0.00008203735,0.00021651413,0.000119376906,0.0001284837,0.000049335664,0.000092686554],"category_scores_gemma":[0.0002547342,0.00011730378,0.00018763958,0.0001781637,0.00019533825,0.000103091115,0.000038466173,0.00038104915,0.000019022062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034025646,0.00037574588,0.9730048,0.00005141513,0.0005635874,0.0001054971,0.0005619155,0.000010093897,0.011195464,0.00003749166,0.00037273596,0.013380984],"study_design_scores_gemma":[0.0017807869,0.00014722673,0.9906146,0.00069112575,0.0015543336,0.00017943319,0.00014515789,0.0029643844,0.0013692768,0.000261389,0.00018689901,0.000105378975],"about_ca_topic_score_codex":0.000071405455,"about_ca_topic_score_gemma":0.000013461531,"teacher_disagreement_score":0.017609794,"about_ca_system_score_codex":0.00005273353,"about_ca_system_score_gemma":0.00012577178,"threshold_uncertainty_score":0.47835094},"labels":[],"label_agreement":null},{"id":"W4405919577","doi":"10.1177/13524585241308134","title":"Recommendations for essential medicines for multiple sclerosis in low-resource settings","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact; University of British Columbia; Multiple Sclerosis Society of Canada","funders":"","keywords":"Fingolimod; Glatiramer acetate; Ocrelizumab; Multiple sclerosis; Medicine; Teriflunomide; Cladribine; Alemtuzumab; Context (archaeology); Interferon beta-1a; Physical therapy; Rituximab; Intensive care medicine; Internal medicine; Interferon beta; Immunology; Lymphoma","score_opus":0.1214893747593575,"score_gpt":0.34436699760239786,"score_spread":0.22287762284304036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405919577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73105055,0.009963729,0.060438327,0.17567201,0.0059132264,0.0130916275,0.0022630896,0.0010614999,0.0005459258],"genre_scores_gemma":[0.9663468,0.0025747104,0.024031285,0.0013145299,0.0031645447,0.0014078115,0.0003171954,0.00021678903,0.000626327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949822,0.00018977195,0.0015052459,0.00094969233,0.00093062356,0.0014424882],"domain_scores_gemma":[0.99387294,0.0040228204,0.00027352048,0.00048239494,0.0007077697,0.00064053776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002699325,0.0005838411,0.0010205207,0.0011539313,0.0009321295,0.0004796502,0.00044839495,0.00028381706,0.0002363876],"category_scores_gemma":[0.00667765,0.00049517263,0.0008331528,0.0009252441,0.00030879994,0.00052862754,0.00020041512,0.001062419,0.000036791604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026495697,0.0012698265,0.02372556,0.002283087,0.0011279302,0.000033930577,0.004676156,0.00043323427,0.30040187,0.00007436558,0.42782506,0.23549943],"study_design_scores_gemma":[0.048989967,0.0021004586,0.14572038,0.028821543,0.00090163486,0.00024763323,0.007239316,0.24899594,0.057226036,0.000307152,0.45748457,0.001965389],"about_ca_topic_score_codex":0.000072455674,"about_ca_topic_score_gemma":0.00026819465,"teacher_disagreement_score":0.24856271,"about_ca_system_score_codex":0.0005976572,"about_ca_system_score_gemma":0.00035187806,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W4406035973","doi":"10.1177/13524585241310104","title":"Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Sequela; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Coronavirus Infections; Pandemic; Virology; Disease; Immunology; Internal medicine; Outbreak; Psychiatry; Infectious disease (medical specialty)","score_opus":0.04335266949194842,"score_gpt":0.3022120717825216,"score_spread":0.25885940229057314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406035973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868578,0.00037004187,0.004155233,0.0062715816,0.00044455857,0.0014158778,0.00012238837,0.00013877948,0.000223752],"genre_scores_gemma":[0.9885866,0.00075260404,0.0056220004,0.004497318,0.00015883484,0.00009812062,0.000053442403,0.000067624474,0.00016345821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961897,0.00044619426,0.0011296632,0.00058596727,0.0009120873,0.0007364013],"domain_scores_gemma":[0.9958815,0.0015753536,0.0006405867,0.0006359532,0.0004987225,0.0007678752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016310059,0.00049327774,0.0010223717,0.0015996045,0.00036852853,0.00015952514,0.00035781585,0.00034764913,0.0001689241],"category_scores_gemma":[0.0049062916,0.00041073814,0.000362481,0.001384405,0.00032109395,0.0005824115,0.00018877807,0.0010731511,0.000022562575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012470636,0.00059539103,0.8843063,0.0004898588,0.00057004596,0.00007271833,0.0008055783,0.0010756791,0.10646494,0.000029445753,0.0012958981,0.0030470847],"study_design_scores_gemma":[0.01991622,0.0010281614,0.9563933,0.002472161,0.00045683462,0.0002519784,0.00017091066,0.00087194616,0.01675181,0.000081339014,0.0012256459,0.00037967713],"about_ca_topic_score_codex":0.0023910766,"about_ca_topic_score_gemma":0.0016140174,"teacher_disagreement_score":0.08971313,"about_ca_system_score_codex":0.0011068585,"about_ca_system_score_gemma":0.0015697348,"threshold_uncertainty_score":0.9998344},"labels":[],"label_agreement":null},{"id":"W4406578583","doi":"10.1177/13524585241311441","title":"Upper cervical spinal cord atrophy in MS: Sex, menopause, and neurodegeneration","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Neurological Disorders and Stroke; Avid Radiopharmaceuticals; Genentech; National Institutes of Health; Horizon Therapeutics; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Mayo Clinic; Biogen; Alexion Pharmaceuticals; Pfizer; National Institute on Aging; Eli Lilly and Company","keywords":"Medicine; Menopause; Expanded Disability Status Scale; Multiple sclerosis; Atrophy; Internal medicine; Biomarker; Gynecology","score_opus":0.0684216378736437,"score_gpt":0.32395946598438247,"score_spread":0.2555378281107388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114966,0.0015597178,0.00060924,0.0049579637,0.0003505079,0.00053470046,0.0000109633,0.000048270103,0.00077896204],"genre_scores_gemma":[0.9919412,0.0031519097,0.0031180214,0.0009275235,0.00039618043,0.000048810183,0.0000074569075,0.000030981995,0.00037787488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973232,0.00025021454,0.00068392616,0.00048468538,0.0006270011,0.0006309547],"domain_scores_gemma":[0.99880993,0.00018568964,0.00011621655,0.00030718872,0.00025301342,0.00032797482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006994662,0.00029658905,0.0005689871,0.0006264919,0.00042791938,0.00020100798,0.0001781273,0.00014290106,0.000114023336],"category_scores_gemma":[0.0008964229,0.00025037484,0.00012697144,0.0005649711,0.00020805202,0.00024728736,0.00023794726,0.00096478907,0.000018173265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002191733,0.00035510844,0.7226808,0.00012934975,0.00013361612,0.000047247555,0.0001569194,0.0000531511,0.19082806,0.0000587442,0.0026737363,0.0806915],"study_design_scores_gemma":[0.0060103303,0.00093269756,0.9797152,0.000595884,0.00005547527,0.00007295376,0.00016169513,0.003762536,0.0054740226,0.000049282626,0.0029758273,0.00019409384],"about_ca_topic_score_codex":0.00015819003,"about_ca_topic_score_gemma":0.00023933065,"teacher_disagreement_score":0.25703436,"about_ca_system_score_codex":0.0002700729,"about_ca_system_score_gemma":0.00016734992,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W4406687131","doi":"10.1177/13524585241303489","title":"DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Pittsburgh; University of Rochester; Cleveland Clinic Foundation; York University; Cleveland Clinic; Vanderbilt University","keywords":"Medicine; Discontinuation; Clinical endpoint; Multiple sclerosis; Magnetic resonance imaging; Randomized controlled trial; Clinical trial; Disease; Internal medicine; Radiology; Psychiatry","score_opus":0.12146672046004658,"score_gpt":0.34939026547267726,"score_spread":0.22792354501263068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406687131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650044,0.0025318118,0.0008534017,0.008060771,0.0004920506,0.0012682707,0.000012961226,0.000023902805,0.00025637567],"genre_scores_gemma":[0.9957147,0.0030255246,0.00046437923,0.00018202825,0.00029579163,0.000098103774,0.0000073121523,0.000020467049,0.00019166342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725974,0.00038696226,0.00083953934,0.00030083506,0.0007758741,0.0004370603],"domain_scores_gemma":[0.998021,0.00079770363,0.0002703563,0.00046681185,0.00029286125,0.00015124575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016038455,0.00022467214,0.00053873356,0.00041588876,0.00040594293,0.000107459506,0.0002839044,0.00006937236,0.00005975101],"category_scores_gemma":[0.0029199277,0.00013235459,0.00032305188,0.00058377435,0.00033751197,0.00024223696,0.00017806396,0.00062976667,0.00000427173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07414671,0.00256505,0.57214457,0.00023556322,0.0006445446,0.00001914078,0.004500581,0.00052576157,0.15534526,0.00023566655,0.0033956284,0.18624152],"study_design_scores_gemma":[0.042213917,0.00025573667,0.94836134,0.001680933,0.00008368,0.0000021240871,0.0014561424,0.0036543298,0.0014991072,0.00016763102,0.0005046946,0.00012037818],"about_ca_topic_score_codex":0.00012983874,"about_ca_topic_score_gemma":0.00017291767,"teacher_disagreement_score":0.37621674,"about_ca_system_score_codex":0.00017894023,"about_ca_system_score_gemma":0.00020801104,"threshold_uncertainty_score":0.5397263},"labels":[],"label_agreement":null},{"id":"W4406827363","doi":"10.1177/13524585251313744","title":"Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and how","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Medicine; Antibody; Immunology; Cerebrospinal fluid; Oligodendrocyte; Immunoglobulin G; Disease; Demyelinating disease; Myelin; Pathology; Central nervous system; Internal medicine; Experimental autoimmune encephalomyelitis","score_opus":0.19025294522413133,"score_gpt":0.3633327092842414,"score_spread":0.17307976406011005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406827363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000970459,0.9903502,0.0012155198,0.0015608468,0.0008437131,0.005303349,0.000307899,0.0001607887,0.00016064919],"genre_scores_gemma":[0.00006296117,0.9656918,0.029386034,0.00026249498,0.001977927,0.00089147314,0.00007862248,0.00024016268,0.0014084966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99307096,0.0006652974,0.001679393,0.0014409118,0.0013494152,0.0017940413],"domain_scores_gemma":[0.9901743,0.0049707727,0.001304988,0.0009821196,0.0016164369,0.00095139584],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002392315,0.0015025059,0.0053506834,0.0013013026,0.0015189789,0.0020547705,0.00079862995,0.00081480335,0.000065571214],"category_scores_gemma":[0.013166248,0.0011718996,0.0015749487,0.0008694611,0.0005578879,0.0010022537,0.00082981726,0.0024600956,0.000018517083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001363195,0.00014014008,0.0005726052,0.053727396,0.0012359709,0.000039000617,0.00015781971,0.0000010478428,0.00024552178,0.0000050431872,0.026106581,0.9176326],"study_design_scores_gemma":[0.0041053086,0.0005449565,0.0008063232,0.26231048,0.0016946148,0.00038430525,0.000357586,0.00032371978,0.000057082827,0.000017076498,0.7285356,0.0008629794],"about_ca_topic_score_codex":0.00008108944,"about_ca_topic_score_gemma":0.00014353286,"teacher_disagreement_score":0.91676956,"about_ca_system_score_codex":0.0007085586,"about_ca_system_score_gemma":0.0012731049,"threshold_uncertainty_score":0.9998413},"labels":[],"label_agreement":null},{"id":"W4407586252","doi":"10.1177/13524585251316519","title":"Presence of slowly expanding lesions in multiple sclerosis predicts progressive demyelination within lesions and normal-appearing tissue over time","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); McGill University; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Multiple sclerosis; Myelin; Medicine; Nuclear medicine; Magnetic resonance imaging; White matter; Hyperintensity; Pathology; Internal medicine; Radiology; Central nervous system; Immunology","score_opus":0.0875757200489801,"score_gpt":0.3272608859989193,"score_spread":0.2396851659499392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407586252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931874,0.0026397114,0.0010317392,0.00092182186,0.00028268204,0.0014898812,0.000059481084,0.00008515649,0.00030209575],"genre_scores_gemma":[0.9884384,0.0028037413,0.00790093,0.00008445536,0.00017936059,0.00015347748,0.000018530463,0.000053160747,0.00036788997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955548,0.00036858165,0.00142172,0.0006793727,0.0010920181,0.0008835288],"domain_scores_gemma":[0.99657136,0.001298665,0.0005740403,0.00047648756,0.00061915733,0.00046029713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016871074,0.0004523221,0.0009320852,0.0012302649,0.00084709143,0.00017848644,0.00038042027,0.00027564834,0.0001244667],"category_scores_gemma":[0.006871171,0.0003991852,0.00020009319,0.0011470381,0.00053948216,0.00072564965,0.0006463696,0.0011314577,0.000014288966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006299397,0.0005946136,0.4889905,0.0003158127,0.00023538226,0.00002663354,0.0023359302,0.00074144424,0.43945763,0.000019247476,0.0010660933,0.0655868],"study_design_scores_gemma":[0.0076425094,0.0002972607,0.8964286,0.0077053877,0.00011300586,0.000032809472,0.0007147347,0.03368781,0.05294454,0.00004138033,0.00010067478,0.0002912999],"about_ca_topic_score_codex":0.0002772489,"about_ca_topic_score_gemma":0.00022552058,"teacher_disagreement_score":0.4074381,"about_ca_system_score_codex":0.00037261608,"about_ca_system_score_gemma":0.00032844677,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W4407985964","doi":"10.1177/13524585251315344","title":"An interdisciplinary approach is necessary in the treatment of cognitive decline in multiple sclerosis: Yes","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Saskatchewan","funders":"","keywords":"Multiple sclerosis; Cognition; Psychology; Medicine; Psychotherapist; Physical medicine and rehabilitation; Psychiatry","score_opus":0.1393346253237682,"score_gpt":0.374380703655447,"score_spread":0.23504607833167881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407985964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902024,0.003069541,0.000597159,0.0031657661,0.00019704182,0.0017864335,0.000118113036,0.00003695926,0.00082658743],"genre_scores_gemma":[0.9890546,0.0074628615,0.0019548861,0.0007039804,0.00024498627,0.00040471312,0.00006475273,0.000046466866,0.00006274401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951705,0.00077745074,0.0014319797,0.0007261767,0.0009883513,0.00090559653],"domain_scores_gemma":[0.9965456,0.0017326548,0.00034002078,0.0006958246,0.00042539407,0.00026049154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016275619,0.00054185005,0.0011864491,0.0012031057,0.00050185673,0.00015267784,0.0006762809,0.00023276858,0.000071964074],"category_scores_gemma":[0.00091529224,0.00036186416,0.00045888717,0.0015193963,0.00055806234,0.0004306995,0.00033040563,0.00089185825,0.000010261988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032275107,0.011281571,0.85443664,0.00015892152,0.0003939244,0.00004343821,0.022896962,0.00023010503,0.019470342,0.0000056446443,0.0007981053,0.08705683],"study_design_scores_gemma":[0.018423872,0.0017281547,0.92721,0.0026593409,0.00013684222,0.000027698841,0.028852431,0.014506955,0.0059809117,0.00007183501,0.00012951961,0.0002724649],"about_ca_topic_score_codex":0.00057680666,"about_ca_topic_score_gemma":0.0014086714,"teacher_disagreement_score":0.08678437,"about_ca_system_score_codex":0.00052361714,"about_ca_system_score_gemma":0.00026499273,"threshold_uncertainty_score":0.99988335},"labels":[],"label_agreement":null},{"id":"W4408546492","doi":"10.1177/13524585251326841","title":"Seizure history and cognitive dysfunction in people with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"Hospital Anxiety and Depression Scale; Paced Auditory Serial Addition Test; California Verbal Learning Test; Population; Anxiety; Expanded Disability Status Scale; Verbal learning; Cognition; Wechsler Adult Intelligence Scale; Medicine; Psychology; Depression (economics); Trail Making Test; Verbal memory; Audiology; Psychiatry; Multiple sclerosis; Cognitive impairment","score_opus":0.06780697561429802,"score_gpt":0.27143376088265436,"score_spread":0.20362678526835634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408546492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880525,0.005171918,0.0015706621,0.0019005755,0.0004828909,0.0011782858,0.000033527438,0.000113267786,0.0014964098],"genre_scores_gemma":[0.9921005,0.003964818,0.0016344978,0.0008144817,0.00022726365,0.00019667528,0.000023484412,0.00006483548,0.0009734529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963715,0.00029311387,0.00076430937,0.00075844425,0.000886839,0.0009258151],"domain_scores_gemma":[0.99717,0.0010042379,0.00026021156,0.00036310463,0.0007320225,0.00047046455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009687848,0.00051037065,0.0009320846,0.0010884799,0.0005206635,0.00013129055,0.00019639145,0.00024278986,0.00022119762],"category_scores_gemma":[0.002344854,0.00041537828,0.000196337,0.00089191244,0.00048285665,0.00048299693,0.00022892845,0.0014254746,0.0000252495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027923791,0.00058885786,0.9146212,0.00020488506,0.000442458,0.000037023354,0.0015583067,0.000044248085,0.029692149,0.0000076104125,0.00541955,0.04459137],"study_design_scores_gemma":[0.019299736,0.00046690067,0.96663916,0.0035792263,0.00023519988,0.00009761103,0.002360416,0.0034563134,0.0014032808,0.0000087968265,0.0020788172,0.00037452843],"about_ca_topic_score_codex":0.0007823327,"about_ca_topic_score_gemma":0.0033955327,"teacher_disagreement_score":0.05201801,"about_ca_system_score_codex":0.0013081059,"about_ca_system_score_gemma":0.0005395293,"threshold_uncertainty_score":0.9998298},"labels":[],"label_agreement":null},{"id":"W4409380838","doi":"10.1177/13524585251329800","title":"Emphasizing complementary in “Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis”","year":2025,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Cognitive impairment; Medicine; Neuroscience; Cognition; Psychology; Clinically isolated syndrome; Psychiatry","score_opus":0.15611338551928458,"score_gpt":0.34889562445534233,"score_spread":0.19278223893605775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409380838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7092902,0.0011362362,0.00019048595,0.28134215,0.00085250754,0.006143005,0.0007514356,0.00006443655,0.00022952557],"genre_scores_gemma":[0.85303736,0.0018656347,0.0105759725,0.13150942,0.001582757,0.0005971179,0.0005636103,0.00019900827,0.00006910196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9862513,0.0022107314,0.00449031,0.0015679456,0.002786217,0.0026934866],"domain_scores_gemma":[0.9898743,0.00668526,0.0013940572,0.0009400123,0.0006494023,0.00045699024],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.006305603,0.0013086605,0.0027926525,0.0032675578,0.00075287075,0.0002489209,0.0013151045,0.00059945736,0.00021354001],"category_scores_gemma":[0.004619381,0.0011180766,0.000736651,0.0027096109,0.0006444072,0.0004001311,0.0016614923,0.008344545,0.000014510689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070055894,0.00082269567,0.80054826,0.00093290524,0.0006037244,0.00024802965,0.007914395,0.0015386353,0.012536098,0.0000014563417,0.16633458,0.007818681],"study_design_scores_gemma":[0.023415241,0.000671795,0.891124,0.058109164,0.00023429374,0.00005112693,0.010850414,0.00857192,0.0020000096,0.000037216294,0.0039486936,0.000986094],"about_ca_topic_score_codex":0.010618,"about_ca_topic_score_gemma":0.009321283,"teacher_disagreement_score":0.1623859,"about_ca_system_score_codex":0.0032255352,"about_ca_system_score_gemma":0.00087910146,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W4409509273","doi":"10.1177/13524585251325086","title":"Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Anesthesia; Cerebellum; Internal medicine; Immunology; Rituximab","score_opus":0.02938604986357733,"score_gpt":0.273589728841536,"score_spread":0.24420367897795867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409509273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747324,0.00092212873,0.00007063006,0.00017337491,0.00010453591,0.0011682401,0.000020223737,0.000019150946,0.000048501362],"genre_scores_gemma":[0.99707997,0.0023135936,0.00037257056,0.000033542703,0.00004270215,0.000050782335,0.000010205732,0.00003585799,0.000060800558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978293,0.00012512339,0.00042056447,0.0004409389,0.00066342816,0.00052064395],"domain_scores_gemma":[0.9985522,0.00042660758,0.00013452901,0.00031067684,0.0002778397,0.00029816397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017538371,0.0003700762,0.0007069696,0.0004190467,0.00022685791,0.00007538609,0.000106115804,0.00010833845,0.000012182506],"category_scores_gemma":[0.0001610327,0.00023600222,0.000075220356,0.0003419565,0.00035321526,0.00014961055,0.000091952315,0.0004035897,0.0000018971875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02397008,0.0009112125,0.9289476,0.00017020936,0.00086255226,0.000058716025,0.00045571465,0.000020583575,0.0008152156,0.0000014368093,0.000032264485,0.043754376],"study_design_scores_gemma":[0.042252,0.01719859,0.93663293,0.0019814651,0.00021412146,0.000007734699,0.00005087455,0.00014797092,0.0013033039,8.869204e-7,0.000016296815,0.00019381683],"about_ca_topic_score_codex":0.00010780742,"about_ca_topic_score_gemma":0.00027220693,"teacher_disagreement_score":0.04356056,"about_ca_system_score_codex":0.00037029642,"about_ca_system_score_gemma":0.0001046685,"threshold_uncertainty_score":0.9623891},"labels":[],"label_agreement":null},{"id":"W4409591550","doi":"10.1177/13524585251330109","title":"Risk factors for incident peripartum mental illness in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; University of Toronto; St. Michael's Hospital; University of Manitoba; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Anxiety; Incidence (geometry); Depression (economics); Mental illness; Poisson regression; Comorbidity; Population; Psychiatry; Mental health; Rate ratio","score_opus":0.11237532660868481,"score_gpt":0.3232877291034818,"score_spread":0.21091240249479698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905818,0.001140667,0.0016981736,0.0016648001,0.0016196127,0.0025628433,0.00037335302,0.00013148764,0.00022722885],"genre_scores_gemma":[0.98888516,0.006245458,0.0030376373,0.0003056549,0.00039416732,0.00049738376,0.00007832415,0.00009850057,0.00045769778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943874,0.00040270376,0.0014918152,0.00092708605,0.0011993619,0.0015916289],"domain_scores_gemma":[0.99567205,0.0018107124,0.00049487036,0.00069351244,0.0006646988,0.00066413125],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018967311,0.0007181734,0.0013049152,0.0012477124,0.0017419684,0.0003405694,0.0006186253,0.0003196031,0.00019651657],"category_scores_gemma":[0.008353129,0.00060371717,0.0008438642,0.0010622486,0.00043559753,0.00052004773,0.0004621001,0.001434456,0.000030208597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014634113,0.0010251543,0.8907367,0.00015518208,0.00049276976,0.000009089398,0.0028549363,0.00022972518,0.06520324,0.000010819767,0.008364219,0.029454732],"study_design_scores_gemma":[0.017428469,0.00036730518,0.93712455,0.0014110154,0.00016918922,0.000013980827,0.005253525,0.011604159,0.020221774,0.000042650667,0.005809159,0.00055425306],"about_ca_topic_score_codex":0.0010445536,"about_ca_topic_score_gemma":0.0015426829,"teacher_disagreement_score":0.0463878,"about_ca_system_score_codex":0.0014563084,"about_ca_system_score_gemma":0.0003814986,"threshold_uncertainty_score":0.99999994},"labels":[],"label_agreement":null},{"id":"W4409591881","doi":"10.1177/13524585251334488","title":"Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; University of Calgary; Université de Montréal; Hotchkiss Brain Institute; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Genzyme; EMD Serono; Biogen; Celgene; Sanofi; Multiple Sclerosis Society; International Progressive MS Alliance; Amgen","keywords":"Multiple sclerosis; Quality of life (healthcare); Cognition; Neuropsychology; Medicine; Confounding; Cognitive impairment; Clinical psychology; MEDLINE; Psychology; Psychiatry; Pathology","score_opus":0.4812248495583127,"score_gpt":0.4693702376745708,"score_spread":0.011854611883741872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016843065,0.9870211,0.0002549816,0.00050973095,0.0019549963,0.0069128643,0.00031347113,0.00023638933,0.0011121661],"genre_scores_gemma":[0.024389453,0.96749693,0.0044778017,0.0004098529,0.0013811215,0.0011977104,0.00022576071,0.00029808073,0.00012327569],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9812815,0.0035699566,0.00714699,0.002304676,0.0030763436,0.0026205224],"domain_scores_gemma":[0.97542983,0.0154486485,0.004077051,0.0013484325,0.0021512534,0.0015447575],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0066203214,0.0019742853,0.0073239394,0.0028280292,0.0013494713,0.00062640297,0.00083462364,0.0014647585,0.00022004254],"category_scores_gemma":[0.0582116,0.0016347469,0.0035378896,0.0023203604,0.000669755,0.0008682965,0.0013451254,0.0077134687,0.00012587973],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010603275,0.0036373278,0.0066919657,0.01089967,0.0031266834,0.00083697104,0.00078953156,0.000010250546,0.00002134681,8.846568e-7,0.00202129,0.97090375],"study_design_scores_gemma":[0.02883391,0.0020063417,0.077825114,0.59215206,0.008037916,0.0014857788,0.004853972,0.00095158146,0.00003446847,0.000005369944,0.281132,0.002681478],"about_ca_topic_score_codex":0.00018765446,"about_ca_topic_score_gemma":0.00011199898,"teacher_disagreement_score":0.96822226,"about_ca_system_score_codex":0.0022948214,"about_ca_system_score_gemma":0.0031929477,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W4409959051","doi":"10.1177/13524585251335510","title":"Physical activity demonstrates protective associations with structural visual metrics in children with multiple sclerosis through time","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Multiple Sclerosis Society","keywords":"Nerve fiber layer; Medicine; Retinal; Multiple sclerosis; Optic neuritis; Ophthalmology; Clinically isolated syndrome; Optical coherence tomography; Immunology","score_opus":0.058178383590443875,"score_gpt":0.31964573691921316,"score_spread":0.2614673533287693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409959051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941435,0.00016836992,0.00166147,0.00092040567,0.00006921936,0.0024835332,0.0001604905,0.00014656947,0.00024646323],"genre_scores_gemma":[0.99328125,0.00016260054,0.0056946953,0.00010394235,0.00028792446,0.00026114823,0.000037312046,0.00008084946,0.00009030211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527735,0.00048176787,0.00058535015,0.00087172975,0.0015402847,0.0012434942],"domain_scores_gemma":[0.9967276,0.0010908805,0.00047171913,0.00044438624,0.00090844155,0.00035695825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006628438,0.0006945367,0.0012812319,0.00083153293,0.0011204566,0.0003394429,0.00038623772,0.0002426629,0.000043181866],"category_scores_gemma":[0.0022311255,0.0004902103,0.00031942132,0.0030288622,0.0005893013,0.0009547055,0.00024228862,0.0020972283,0.000025140773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014810176,0.001308145,0.91635096,0.000035557023,0.001512877,0.000009475353,0.0006758771,0.00056538277,0.0573928,0.000007905235,0.00019268216,0.0204673],"study_design_scores_gemma":[0.012467708,0.0009896847,0.93782014,0.0008422494,0.00028149088,0.00005206235,0.00038999747,0.017290244,0.029338118,0.000037755122,0.000008073193,0.00048245848],"about_ca_topic_score_codex":0.0009935583,"about_ca_topic_score_gemma":0.0007869646,"teacher_disagreement_score":0.02805468,"about_ca_system_score_codex":0.0012530057,"about_ca_system_score_gemma":0.00064038165,"threshold_uncertainty_score":0.99975497},"labels":[],"label_agreement":null},{"id":"W4410210615","doi":"10.1177/13524585251335213","title":"Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sante Montreal","funders":"","keywords":"Multiple sclerosis; Cognition; Placebo; Effects of sleep deprivation on cognitive performance; Psychology; Physical medicine and rehabilitation; Audiology; Medicine; Stroop effect; Cognitive decline; Cognitive test; Physical therapy; Disease; Internal medicine; Psychiatry; Dementia; Pathology","score_opus":0.043397703104542544,"score_gpt":0.32798745565250553,"score_spread":0.284589752547963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410210615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572134,0.0017813665,0.00001505041,0.0005031629,0.000060775765,0.001646797,0.000059979873,0.00001762425,0.00019393148],"genre_scores_gemma":[0.99810034,0.0012235193,0.00026313847,0.00015790005,0.00005220355,0.0001355915,0.000010487252,0.000017182012,0.00003961815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974799,0.00032467622,0.00063332455,0.00046851754,0.0006943058,0.0003992451],"domain_scores_gemma":[0.9979792,0.0005494168,0.00029446738,0.00034210243,0.00044233273,0.00039246926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009978354,0.00026323908,0.0006946149,0.00072834507,0.0004618552,0.00010708816,0.00020227795,0.000067294466,0.000042182968],"category_scores_gemma":[0.0023319407,0.00016787289,0.00014411345,0.0011869824,0.0005851905,0.00032832412,0.0004973604,0.00074753026,4.5552505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088284817,0.0013744857,0.8859415,0.0002059096,0.00068500213,0.000017125009,0.0012171651,0.000015434152,0.0033900305,8.287293e-7,0.000030002686,0.10623967],"study_design_scores_gemma":[0.0063428087,0.0005995854,0.978236,0.0021678589,0.0010472874,0.000006225587,0.002152114,0.0086681,0.0006167093,0.0000029817422,0.000014883277,0.00014544139],"about_ca_topic_score_codex":0.00005756066,"about_ca_topic_score_gemma":0.00014483905,"teacher_disagreement_score":0.10609423,"about_ca_system_score_codex":0.0001491051,"about_ca_system_score_gemma":0.0004590066,"threshold_uncertainty_score":0.6845657},"labels":[],"label_agreement":null},{"id":"W4410622796","doi":"10.1177/13524585251338745","title":"Health care use preceding pediatric multiple sclerosis: A population-based study from Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Waterloo; Nova Scotia Health Authority; Dalhousie University","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Medicine; Prodrome; Pediatrics; Multiple sclerosis; Confidence interval; Population; Cohort; Retrospective cohort study; Demography; Cohort study; Health care; Environmental health; Psychiatry; Internal medicine","score_opus":0.09498750506452376,"score_gpt":0.30490590101886544,"score_spread":0.2099183959543417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410622796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913555,0.0020159942,0.00032449004,0.00165902,0.001490778,0.0026141736,0.0003090328,0.00016223466,0.000068768495],"genre_scores_gemma":[0.9925898,0.00034352348,0.0041877367,0.0013263562,0.0007283295,0.00022386185,0.000236443,0.000097628275,0.00026633556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928449,0.000619364,0.0017620486,0.0011059864,0.0021792117,0.0014885],"domain_scores_gemma":[0.9943559,0.0018105127,0.0006700647,0.0009820972,0.0011237401,0.0010576609],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008516979,0.0007586573,0.0015009933,0.0007534142,0.0032429693,0.00094510213,0.00059130107,0.00019912487,0.00024556214],"category_scores_gemma":[0.0035669522,0.0006925731,0.00043482194,0.0011815912,0.000064470856,0.00049734703,0.0003307772,0.0017966297,0.000011371658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007064275,0.0008278073,0.9721201,0.0001368899,0.0004825234,0.000024735928,0.0020359135,0.0011186528,0.0006633265,4.2138961e-7,0.015768291,0.006114888],"study_design_scores_gemma":[0.013464627,0.00044491253,0.9776855,0.0010895375,0.0003060411,0.0000038111398,0.0038766158,0.0014330043,0.00021556104,0.0000018446505,0.0009828345,0.00049569824],"about_ca_topic_score_codex":0.9760709,"about_ca_topic_score_gemma":0.99533045,"teacher_disagreement_score":0.01925954,"about_ca_system_score_codex":0.008251592,"about_ca_system_score_gemma":0.0071946452,"threshold_uncertainty_score":0.99955255},"labels":[],"label_agreement":null},{"id":"W4411045440","doi":"10.1177/13524585251341174","title":"Gender-affirming interventions and prognosis in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Medicine; Asymptomatic; Internal medicine; Psychiatry","score_opus":0.2677071482437232,"score_gpt":0.3586004048138374,"score_spread":0.09089325657011421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411045440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873627,0.0053658728,0.0013601885,0.00294146,0.0004884615,0.0013817035,0.000038590046,0.00013776391,0.0009232615],"genre_scores_gemma":[0.98399496,0.00702498,0.007824419,0.0003069806,0.00021693515,0.00027973077,0.000013515361,0.000059081918,0.00027938254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563247,0.0003420759,0.0013520995,0.0007630907,0.0007963681,0.0011139141],"domain_scores_gemma":[0.99741805,0.0008484913,0.00028718484,0.00044031028,0.0004808014,0.00052514614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016554745,0.0004961357,0.0009847265,0.0014848039,0.0009070214,0.00035161688,0.00036223177,0.00024412938,0.00015571427],"category_scores_gemma":[0.0040680515,0.00044812373,0.0005991477,0.0012458735,0.0004264069,0.000477922,0.00056436844,0.0013615742,0.00003147636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046731654,0.001022877,0.8521379,0.0005490111,0.0004331318,0.00003472894,0.00079188583,0.000049991533,0.056231722,0.00003323885,0.0026683547,0.08557984],"study_design_scores_gemma":[0.0093350215,0.00023060576,0.9720128,0.005452223,0.0001730588,0.000070281436,0.0014327789,0.004510259,0.0056529567,0.00006228096,0.0007163883,0.00035132086],"about_ca_topic_score_codex":0.0002390119,"about_ca_topic_score_gemma":0.0007746391,"teacher_disagreement_score":0.119874924,"about_ca_system_score_codex":0.00052334584,"about_ca_system_score_gemma":0.00023905448,"threshold_uncertainty_score":0.99979705},"labels":[],"label_agreement":null},{"id":"W4411976832","doi":"10.1177/13524585251347513","title":"Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare data","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Population; Health care; Environmental health","score_opus":0.21337206683488424,"score_gpt":0.40645150820269793,"score_spread":0.1930794413678137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411976832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770689,0.0025015732,0.0071040606,0.008944456,0.0008251993,0.0029104517,0.00033268097,0.0002726518,0.00004005274],"genre_scores_gemma":[0.9764369,0.0009584153,0.020963125,0.0006511277,0.0005958327,0.00011313619,0.00014042998,0.000090241716,0.00005080334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934613,0.00067690783,0.0015359925,0.001438622,0.0012672478,0.0016199374],"domain_scores_gemma":[0.99464047,0.0010257412,0.00041296234,0.0016268239,0.00090389204,0.0013900873],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0021091285,0.00070452446,0.0013136113,0.00043967337,0.0021211703,0.00055888604,0.0008831857,0.00032189282,0.000046706635],"category_scores_gemma":[0.0070045125,0.0005808327,0.00024066881,0.0017480985,0.00069258746,0.00064157805,0.0022680683,0.0015755506,0.000004407948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020614448,0.0006039047,0.88208395,0.0003098162,0.00031073863,0.000016214139,0.00026205633,0.003194817,0.016997738,0.0000019431313,0.0038367826,0.090320565],"study_design_scores_gemma":[0.004391148,0.00028059105,0.560581,0.0020032595,0.00013202766,0.00004323605,0.00016312627,0.4315585,0.00038464877,0.000003531325,0.00019985842,0.00025903492],"about_ca_topic_score_codex":0.0007496029,"about_ca_topic_score_gemma":0.0012595437,"teacher_disagreement_score":0.42836368,"about_ca_system_score_codex":0.00082735607,"about_ca_system_score_gemma":0.00036659825,"threshold_uncertainty_score":0.9996643},"labels":[],"label_agreement":null},{"id":"W4412072012","doi":"10.1177/13524585251349125","title":"Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Cegep de Saint Jerome; Centre Hospitalier Universitaire de Sherbrooke; St. Michael's Hospital; Université de Montréal","funders":"Cliniques Universitaires Saint-Luc; UCB Pharma; Sanofi Genzyme; Trish Multiple Sclerosis Research Foundation; MedDay Pharmaceuticals; CinnaGen; Cilag; Ingham Institute for Applied Medical Research; Mitsubishi Tanabe Pharma Corporation; Sultan Qaboos University; Sanofi; Multiple Sclerosis International Federation; Razi University; Eisai; Monash University; H. Lundbeck A/S; Alexion Pharmaceuticals; University of New South Wales; Multiple Sclerosis Australia; Medical Research Council; Neuraxpharm; Teva Pharmaceutical Industries; Celgene; Biogen; Faculty of Medicine and Health, University of Sydney; Cairo University; Yeditepe Üniversitesi; European Commission; World Health Organization; Bristol-Myers Squibb; Eli Lilly and Company; National Health and Medical Research Council; AstraZeneca; American University of Beirut; Amgen","keywords":"Medicine; Pregnancy; Neuromyelitis optica; Gestation; Obstetrics; Multiple sclerosis; Pediatrics; Immunology","score_opus":0.0805820683593326,"score_gpt":0.33111136717330875,"score_spread":0.2505292988139761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412072012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96859574,0.009422477,0.000060028215,0.019482685,0.0005338263,0.0014827449,0.000077125966,0.000066373555,0.0002790074],"genre_scores_gemma":[0.9783871,0.015802369,0.0008620976,0.0023363216,0.00008555886,0.0002559469,0.00000802009,0.000042902928,0.0022196595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563646,0.00044278236,0.0011248551,0.0007058594,0.0010556718,0.0010343448],"domain_scores_gemma":[0.9971591,0.0009210157,0.00043458742,0.0008339558,0.00016457583,0.00048676628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016220598,0.0004578872,0.0010456509,0.00050002337,0.00057649746,0.00025469804,0.0003478097,0.00015222291,0.00007478122],"category_scores_gemma":[0.0034980006,0.00030600352,0.00019566136,0.00063500844,0.00035540728,0.00021575516,0.0003070596,0.0014747308,0.0000063122907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002441833,0.0003161791,0.861731,0.0003161883,0.00034451816,0.00046853157,0.0028928502,0.000007040564,0.00012444732,0.000021925793,0.004337239,0.12919591],"study_design_scores_gemma":[0.008552622,0.0004169005,0.979675,0.0050986065,0.0000356858,0.00024000595,0.0026213215,0.00022465753,0.00001896606,0.00007234118,0.0028066991,0.00023721377],"about_ca_topic_score_codex":0.00027716017,"about_ca_topic_score_gemma":0.00039582766,"teacher_disagreement_score":0.1289587,"about_ca_system_score_codex":0.00050907367,"about_ca_system_score_gemma":0.00043418462,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W4412111210","doi":"10.1177/13524585251353044","title":"High-risk populations should be screened for MS: Yes","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Biology; Psychiatry","score_opus":0.24383516642815742,"score_gpt":0.3781122068347537,"score_spread":0.1342770404065963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412111210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90970105,0.001891767,0.05027581,0.03129218,0.0018842622,0.0028467777,0.0006344072,0.00030635044,0.0011673889],"genre_scores_gemma":[0.9413035,0.0019900429,0.053102236,0.0011935636,0.0008186865,0.00022790303,0.00007404024,0.00005715027,0.0012328739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968099,0.00018626176,0.00086752174,0.0004905977,0.0007983456,0.00084738596],"domain_scores_gemma":[0.9970381,0.00081640633,0.00029160915,0.00054537185,0.00088806514,0.00042044677],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011692469,0.00036501107,0.00074102904,0.00064841437,0.0015148271,0.00022404872,0.00034349665,0.00020574713,0.00022963382],"category_scores_gemma":[0.005829447,0.0002995988,0.00055483356,0.00062515034,0.00022884877,0.00027572687,0.00019519457,0.0008636265,0.00001970412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018974014,0.0009258735,0.6461596,0.00023157687,0.0014371566,0.0000096583435,0.00046809236,0.000996619,0.05510848,0.00094476325,0.16556022,0.12626055],"study_design_scores_gemma":[0.010505602,0.00039214428,0.9564507,0.00067141984,0.0003949368,0.000013626205,0.00045906697,0.0055671316,0.006358601,0.000550945,0.018335043,0.00030079673],"about_ca_topic_score_codex":0.0006906848,"about_ca_topic_score_gemma":0.00083719136,"teacher_disagreement_score":0.31029108,"about_ca_system_score_codex":0.0003434062,"about_ca_system_score_gemma":0.00024500873,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W4412592901","doi":"10.1177/13524585251355842","title":"Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Janssen Pharmaceuticals; EMD Serono; MedDay Pharmaceuticals; Innosuisse - Schweizerische Agentur für Innovationsförderung; Kiniksa Pharmaceuticals; Shionogi; Genentech; National Multiple Sclerosis Society; Horizon Therapeutics; Celltrion; Atara Biotherapeutics; National Institutes of Health; Mylan; TG Therapeutics; European Committee for Treatment and Research in Multiple Sclerosis; Sanofi; Multiple Sclerosis International Federation; University of Pennsylvania; Alexion Pharmaceuticals; Neuraxpharm; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Celgene; Biogen; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Atrophy; Multiple sclerosis; Physical therapy; Internal medicine; Psychiatry","score_opus":0.2598316333941632,"score_gpt":0.38964884958597784,"score_spread":0.12981721619181463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412592901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919748,0.001379667,0.00105643,0.0019380427,0.00006064675,0.0026581471,0.0008440871,0.000057866215,0.00003032888],"genre_scores_gemma":[0.9953093,0.0015169245,0.002333018,0.00023151575,0.00011100527,0.00018046371,0.00021480003,0.00005908264,0.000043887907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949007,0.0011399402,0.0012374554,0.0011596704,0.00074371067,0.000818506],"domain_scores_gemma":[0.99223155,0.005388827,0.00070971675,0.00040475695,0.0006860183,0.00057910697],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029795708,0.0005650297,0.0016107942,0.00035200693,0.001093469,0.00065405515,0.00014356384,0.00020839594,0.000018185967],"category_scores_gemma":[0.008359599,0.00037293744,0.000062878455,0.0008297456,0.00095727906,0.00087273703,0.00028940133,0.00088091585,0.0000011567357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04939333,0.0020230145,0.84316957,0.000059643535,0.0011645751,0.000037740152,0.0009662607,0.00001565767,0.05335628,9.645022e-7,0.000120889905,0.049692053],"study_design_scores_gemma":[0.13119087,0.0030041984,0.85266864,0.0059138285,0.0011067811,0.000020477699,0.0011014991,0.0028375136,0.001782593,0.000011269058,0.0000066061607,0.0003556934],"about_ca_topic_score_codex":0.0016824786,"about_ca_topic_score_gemma":0.0072446237,"teacher_disagreement_score":0.08179754,"about_ca_system_score_codex":0.0003338524,"about_ca_system_score_gemma":0.00021396164,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4412592969","doi":"10.1177/13524585251356967","title":"Embracing the complexity of rehabilitation in multiple sclerosis empowered by the resolution of the World Health Organization","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rehabilitation; Neurorehabilitation; Perspective (graphical); Health care; Discipline; Medicine; Psychology; Public relations; Political science; Physical therapy; Computer science; Sociology; Social science","score_opus":0.20835418318799806,"score_gpt":0.36747923057072385,"score_spread":0.1591250473827258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412592969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022872258,0.9791431,0.00024270549,0.010643451,0.00086998136,0.0060552605,0.000535404,0.00004529527,0.0001776084],"genre_scores_gemma":[0.090586245,0.90738803,0.0010068215,0.00019697534,0.00023418783,0.0001630327,0.00011908285,0.00009185026,0.00021378418],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99009204,0.0036493982,0.0031426966,0.0006245797,0.0016918427,0.0007994444],"domain_scores_gemma":[0.98782307,0.0064723413,0.002920378,0.001434206,0.0011599978,0.00018998544],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.005093768,0.0006513629,0.0026472476,0.00075866655,0.001399889,0.00011406323,0.001260557,0.00027443623,0.0000653997],"category_scores_gemma":[0.017715672,0.00033212986,0.0010531604,0.00479288,0.0017937914,0.00020343078,0.0006995248,0.002254656,0.000005083496],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006441053,0.0022081232,0.037259106,0.040100966,0.0015487798,0.0000011488796,0.006161106,0.00042324828,0.0028370372,0.00024749935,0.070486836,0.838082],"study_design_scores_gemma":[0.0095653115,0.0007103233,0.59624493,0.25657183,0.001408146,0.00005261633,0.0033172038,0.001566765,0.000688818,0.00019128305,0.12869684,0.0009859245],"about_ca_topic_score_codex":0.0010367238,"about_ca_topic_score_gemma":0.0031316266,"teacher_disagreement_score":0.8370961,"about_ca_system_score_codex":0.001395735,"about_ca_system_score_gemma":0.0014670918,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W4412741669","doi":"10.1177/13524585251359066","title":"Reduced brain volumes in children with radiologically isolated syndrome","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Brain size; Cerebrospinal fluid; Cohort; McDonald criteria; Nuclear medicine; Internal medicine; Magnetic resonance imaging; Radiology","score_opus":0.04181960331690517,"score_gpt":0.2860314713690402,"score_spread":0.24421186805213504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412741669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898623,0.0012663559,0.0005129841,0.0066044996,0.00012736568,0.0010039236,0.000015141161,0.000112357346,0.0004950254],"genre_scores_gemma":[0.99369895,0.0018244311,0.002659329,0.00084612233,0.000109826906,0.000074236865,0.000018800176,0.000038431837,0.0007298659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675065,0.00032957472,0.00076824526,0.0005713372,0.00064575754,0.00093441166],"domain_scores_gemma":[0.9982784,0.0003931776,0.00018835896,0.00044988716,0.00032849947,0.00036166952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010349031,0.00038806468,0.0008852005,0.00077851873,0.00041121372,0.00015359014,0.00039281964,0.00021383997,0.00019641848],"category_scores_gemma":[0.001952282,0.0002734847,0.00022137842,0.0011860547,0.0003394269,0.00022709649,0.00018642533,0.0013640041,0.000034653192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012212272,0.00046571335,0.9175738,0.000029415056,0.00070933474,0.00009843518,0.00017281239,0.000101772624,0.05340138,0.000006991061,0.0072618127,0.018957304],"study_design_scores_gemma":[0.010021533,0.001019725,0.98356014,0.0011071092,0.00006616701,0.0010396749,0.00014962247,0.001708268,0.0007179852,0.00002041307,0.00031904838,0.00027033818],"about_ca_topic_score_codex":0.000121844714,"about_ca_topic_score_gemma":0.00008759931,"teacher_disagreement_score":0.06598631,"about_ca_system_score_codex":0.0004176521,"about_ca_system_score_gemma":0.00031728443,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4413877854","doi":"10.1177/13524585251370884","title":"Neuroimmune interactions: How past lessons can inform the present and future of MS care","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Neuroscience; Immune system; Compartmentalization (fire protection); Neuroimmunology; Central nervous system; Medicine; Neuroinflammation; Psychology; Biology; Immunology; Disease; Pathology","score_opus":0.14985841894266694,"score_gpt":0.37490312403803683,"score_spread":0.2250447050953699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413877854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111510715,0.98431885,0.000011405917,0.011773874,0.0010609222,0.0018723257,0.00036774075,0.000034439043,0.00044893578],"genre_scores_gemma":[0.0019249219,0.993927,0.00023570748,0.000073838964,0.0028348926,0.00024248187,0.000089158784,0.00006718169,0.00060482696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962747,0.000449678,0.0011191999,0.00047325282,0.0010205066,0.00066262565],"domain_scores_gemma":[0.99556994,0.0013287369,0.0009459709,0.00089510495,0.0009290618,0.00033120337],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00054420694,0.00068988843,0.0023772856,0.0006787329,0.0008352378,0.00031178756,0.0006480899,0.0002732312,0.000060969494],"category_scores_gemma":[0.000825969,0.00039790026,0.001091396,0.0007418562,0.0004237324,0.00019502964,0.0007476556,0.0026710697,0.0000038540898],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049834194,0.00009201033,0.0003986638,0.014188667,0.0008714039,0.000009960558,0.0012113085,0.0000011350388,0.000035953723,0.00000574466,0.009888764,0.9732466],"study_design_scores_gemma":[0.0013822434,0.00015537029,0.0144518325,0.033167657,0.0011629689,0.00023022771,0.0035859353,0.0000169155,0.000015072466,0.0000011656227,0.94555736,0.0002732431],"about_ca_topic_score_codex":0.00013381976,"about_ca_topic_score_gemma":0.00021008837,"teacher_disagreement_score":0.9729733,"about_ca_system_score_codex":0.00039485103,"about_ca_system_score_gemma":0.00074466976,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W4414162836","doi":"10.1177/13524585251367343","title":"ECTRIMS 2024 Lecture: Unraveling the spectrum of the antibody-mediated demyelinating diseases: Emerging insights","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Oligodendrocyte; Disease; Myelin; Spectrum disorder; Remyelination","score_opus":0.07237566541092212,"score_gpt":0.3536003491990235,"score_spread":0.2812246837881014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031532274,0.9929035,0.00052099815,0.001213055,0.0019615667,0.0025218222,0.00019328021,0.00006799176,0.00030251543],"genre_scores_gemma":[0.011157789,0.9862038,0.0002443707,0.00017294164,0.0015919412,0.00011562021,0.0000757482,0.00013094531,0.00030685044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921704,0.0014065988,0.0023650236,0.0008100857,0.0020505989,0.0011973084],"domain_scores_gemma":[0.99150026,0.0044359374,0.0017506254,0.0012830303,0.00061365473,0.00041651752],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014709478,0.0010379467,0.0032372498,0.00090217195,0.0018492247,0.00026493907,0.0016037307,0.00044921265,0.00018112481],"category_scores_gemma":[0.012301954,0.0005034348,0.0026955404,0.0030470951,0.00054817623,0.00015651312,0.0010676811,0.0041154795,0.000028521152],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010501727,0.00041290428,0.0032519302,0.022524457,0.0034617758,0.00003776652,0.00088136777,0.00015071739,0.00090361974,0.00001550281,0.0040280656,0.9642269],"study_design_scores_gemma":[0.0054033017,0.000313591,0.022943754,0.27756605,0.00887956,0.00028521603,0.00075483735,0.004116053,0.00036206032,0.00012276217,0.6777496,0.0015032407],"about_ca_topic_score_codex":0.00007636607,"about_ca_topic_score_gemma":0.00007029745,"teacher_disagreement_score":0.9627236,"about_ca_system_score_codex":0.0006586022,"about_ca_system_score_gemma":0.0020480428,"threshold_uncertainty_score":0.99974173},"labels":[],"label_agreement":null},{"id":"W4414354255","doi":"10.1177/13524585251375365","title":"Choroid plexus enlargement correlates with demyelinating lesions and thalamic atrophy in radiologically isolated syndrome","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada; St. Michael's Hospital Foundation","keywords":"Atrophy; Multiple sclerosis; Choroid plexus; Clinically isolated syndrome; Central nervous system disease; Magnetic resonance imaging; Stage (stratigraphy)","score_opus":0.04338374246080682,"score_gpt":0.27994395611770884,"score_spread":0.23656021365690202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414354255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157494,0.003925452,0.0012032407,0.0019170108,0.00014604891,0.00082115066,0.000012188076,0.0000748483,0.00032513158],"genre_scores_gemma":[0.98612654,0.0084829405,0.0047145076,0.00031198765,0.00006367327,0.00007341107,0.000010120963,0.00003227922,0.00018451693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708486,0.0002604883,0.00076993846,0.0005342629,0.000540733,0.00080973963],"domain_scores_gemma":[0.99827886,0.0006299642,0.00020677366,0.0002887199,0.00029157792,0.00030412833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009567051,0.00036923884,0.0007768425,0.0006375091,0.0006224417,0.0001416551,0.00023049903,0.00018197332,0.00009798388],"category_scores_gemma":[0.0012180057,0.00025814938,0.00014077623,0.00075097295,0.00030575687,0.00019840825,0.00027721777,0.0013043139,0.0000123979435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008894055,0.0003886919,0.9245829,0.00010000033,0.00041957642,0.00028601012,0.0003903566,0.0003736167,0.046065696,0.000030742223,0.0004897743,0.025983213],"study_design_scores_gemma":[0.008452972,0.0010599762,0.9741994,0.0019600652,0.000095006144,0.00053502154,0.00070144085,0.012257253,0.00025014905,0.00006497577,0.00017614334,0.0002476021],"about_ca_topic_score_codex":0.0000681523,"about_ca_topic_score_gemma":0.00009282073,"teacher_disagreement_score":0.049616475,"about_ca_system_score_codex":0.0003473946,"about_ca_system_score_gemma":0.00015868888,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W4414374458","doi":"10.1177/13524585251368248","title":"Disease course after pregnancy in women with progressive multiple sclerosis symptoms","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Pregnancy; Disease; Central nervous system disease; Progressive disease; Young adult","score_opus":0.041287198089445504,"score_gpt":0.29023559846381847,"score_spread":0.24894840037437296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414374458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818173,0.011378442,0.000262185,0.0031899756,0.0003636107,0.0024181462,0.000119175005,0.00017238586,0.00027877168],"genre_scores_gemma":[0.99064416,0.003395272,0.001746644,0.00096552225,0.00027636622,0.0022964717,0.000015567233,0.00011499998,0.0005449748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99387443,0.00036749992,0.0011466118,0.0010509747,0.0015494776,0.0020109895],"domain_scores_gemma":[0.995856,0.0005477172,0.00037510513,0.0009889805,0.0008510206,0.0013812159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077633344,0.0007823525,0.0011837552,0.0009127093,0.0006061153,0.00036719217,0.0005657877,0.00022450727,0.00043869275],"category_scores_gemma":[0.0015966863,0.00059414405,0.0003187539,0.001503244,0.00073038426,0.00083154836,0.0004159986,0.0015191812,0.00006258237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010769155,0.0022985407,0.8866578,0.00040515707,0.00077906204,0.00051158696,0.0012905851,0.00016609345,0.004794541,0.0000070482,0.0011727093,0.09114773],"study_design_scores_gemma":[0.018682607,0.0006374437,0.9566822,0.01891178,0.00020545161,0.000030625928,0.0010476225,0.0016161035,0.0008497259,0.000030185747,0.00073983835,0.00056639686],"about_ca_topic_score_codex":0.000056341214,"about_ca_topic_score_gemma":0.00013154728,"teacher_disagreement_score":0.09058133,"about_ca_system_score_codex":0.0012207178,"about_ca_system_score_gemma":0.0009789594,"threshold_uncertainty_score":0.999651},"labels":[],"label_agreement":null},{"id":"W4414514566","doi":"10.1177/13524585251366096","title":"The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Discriminative model; Cognition; Measure (data warehouse); Construct (python library)","score_opus":0.06782779993484835,"score_gpt":0.30073823298014485,"score_spread":0.23291043304529652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414514566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97360253,0.008447837,0.0048508937,0.0057648243,0.00064800394,0.0040150695,0.0008465596,0.00023743397,0.0015868491],"genre_scores_gemma":[0.9927686,0.002303368,0.001688279,0.000563705,0.0005678087,0.00047241512,0.000040290004,0.00009452876,0.0015010269],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956352,0.00021388325,0.0009866072,0.0007848462,0.0010597846,0.0013196458],"domain_scores_gemma":[0.9874345,0.009782924,0.00034307124,0.0005545553,0.0012551355,0.0006297958],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018749345,0.0006098291,0.00088181865,0.0003979065,0.0026897902,0.0010230972,0.00044892117,0.00024851563,0.00003218985],"category_scores_gemma":[0.03228096,0.00042924404,0.0005675329,0.00062280666,0.0009756211,0.0005118736,0.0004370638,0.0010934498,0.00002370424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032929562,0.00095481233,0.28291115,0.0002840575,0.0014258086,0.000030222367,0.0028054933,0.000010518261,0.15958782,0.00001919373,0.014603928,0.53407407],"study_design_scores_gemma":[0.034745976,0.0007994875,0.9135533,0.0037982112,0.0004738774,0.00012304742,0.014668068,0.0076997434,0.018436648,0.00006626989,0.0049112644,0.00072409736],"about_ca_topic_score_codex":0.000106835774,"about_ca_topic_score_gemma":0.0004039543,"teacher_disagreement_score":0.6306422,"about_ca_system_score_codex":0.00032562364,"about_ca_system_score_gemma":0.0003473715,"threshold_uncertainty_score":0.99981594},"labels":[],"label_agreement":null},{"id":"W4415207932","doi":"10.1177/13524585251383381","title":"Affective reserve in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"","score_opus":0.14609817543853573,"score_gpt":0.32923547837194334,"score_spread":0.1831373029334076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415207932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851973,0.002377855,0.00080337125,0.004687704,0.0008667672,0.001679994,0.0000558585,0.00017818899,0.004152937],"genre_scores_gemma":[0.98966974,0.004187608,0.0037434995,0.00072096614,0.00042761932,0.0002558098,0.000018528775,0.00008209001,0.00089413195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942224,0.0006395062,0.0012972426,0.00093719055,0.0013191999,0.0015844444],"domain_scores_gemma":[0.99548227,0.0018196182,0.00030833954,0.0008905954,0.0008604348,0.0006387435],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002310801,0.00063556246,0.0012714589,0.0017313707,0.0009096597,0.00030244884,0.00065376284,0.00035846423,0.00029881805],"category_scores_gemma":[0.009067614,0.0005546633,0.000645353,0.0021488147,0.0004962434,0.0005642303,0.00059623603,0.002180338,0.00014039317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016085226,0.0010591187,0.79140836,0.00016881949,0.00044718196,0.000070660884,0.00073327695,0.00020604537,0.1412938,0.00003181188,0.013213074,0.049759336],"study_design_scores_gemma":[0.016231654,0.00035126877,0.9536208,0.0031608548,0.000095986245,0.00003906886,0.0011485945,0.006014864,0.016295183,0.000110118475,0.0024953887,0.0004362156],"about_ca_topic_score_codex":0.0011005609,"about_ca_topic_score_gemma":0.002790818,"teacher_disagreement_score":0.16221245,"about_ca_system_score_codex":0.0013487183,"about_ca_system_score_gemma":0.00048862264,"threshold_uncertainty_score":0.9996905},"labels":[],"label_agreement":null},{"id":"W4415566526","doi":"10.1177/13524585251382801","title":"Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Manitoba; University of British Columbia; Health Sciences Centre; Manitoba Health","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Prodrome; Multiple sclerosis; Psychosis; Schizophrenia (object-oriented programming); Clinical neurology; MEDLINE; Epidemiology; Neuropsychiatry","score_opus":0.06499577442412431,"score_gpt":0.2907922619629978,"score_spread":0.2257964875388735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415566526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779606,0.0014369087,0.00014310238,0.016612444,0.00092769065,0.002030702,0.0001875227,0.00025172398,0.00044929606],"genre_scores_gemma":[0.99307656,0.0026582987,0.0010567851,0.000808081,0.0012199476,0.00026265075,0.000023603146,0.00009497064,0.0007990795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933978,0.00063453644,0.0012291712,0.0010668893,0.0019595465,0.0017120801],"domain_scores_gemma":[0.9953547,0.0009984878,0.0005697669,0.0014074055,0.0010589755,0.0006106415],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002094017,0.00078414375,0.0011954148,0.0003913757,0.0032860555,0.0004375646,0.000887352,0.00035115145,0.00043307006],"category_scores_gemma":[0.0031552685,0.00048144045,0.00072798296,0.002428724,0.0010073428,0.00048141752,0.00052593375,0.0025153132,0.00004445184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013571521,0.0015010552,0.9571715,0.00022215556,0.0012787222,0.000015803245,0.0008204121,0.000078983554,0.020927181,0.0000055579094,0.008846714,0.0077747568],"study_design_scores_gemma":[0.011159917,0.0003201888,0.9776398,0.0011331534,0.00036019282,0.000061135535,0.0012605325,0.0012908078,0.004714336,0.0000240972,0.0015586566,0.00047721522],"about_ca_topic_score_codex":0.00027315403,"about_ca_topic_score_gemma":0.0010347677,"teacher_disagreement_score":0.020468261,"about_ca_system_score_codex":0.0013186942,"about_ca_system_score_gemma":0.00039625223,"threshold_uncertainty_score":0.9997859},"labels":[],"label_agreement":null},{"id":"W4415654614","doi":"10.1177/13524585251389797","title":"Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Pharmaceuticals; EMD Serono; MedDay Pharmaceuticals; Siemens Healthineers; Schweizerische Multiple Sklerose Gesellschaft; Eisai; Bundesministerium für Bildung und Forschung; Atara Biotherapeutics; National Institutes of Health; Mylan; TG Therapeutics; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Grifols; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Bayer HealthCare; Novartis Pharma; European Commission; Eli Lilly and Company; U.S. Department of Defense; Multiple Sclerosis International Federation; Gemeinnützige Hertie-Stiftung; Sanofi; Neuraxpharm; Teva Pharmaceutical Industries; Novartis; Celgene; Biogen; Deutsche Forschungsgemeinschaft; Genentech; National Multiple Sclerosis Society; GlaxoSmithKline; AstraZeneca; Samsung; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Disease; Central nervous system disease; Degenerative disease; Amyotrophic lateral sclerosis; Clinical neurology","score_opus":0.11141296411895409,"score_gpt":0.34318341111949263,"score_spread":0.23177044700053856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415654614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96584445,0.0004554818,0.024844738,0.005052373,0.0002767914,0.0034038327,0.00008321299,0.00002136101,0.000017741779],"genre_scores_gemma":[0.99215543,0.0017680523,0.0051891846,0.00008863348,0.00011806096,0.00059951824,0.000022932782,0.00004104966,0.000017147993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959948,0.0005690876,0.0014345233,0.00054509536,0.0008642586,0.00059223635],"domain_scores_gemma":[0.98417854,0.0135562,0.00074077304,0.00057967484,0.0007008132,0.00024397497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003876694,0.00032465893,0.00095338863,0.0006346998,0.0002601644,0.00007514197,0.00033698144,0.00013650967,0.000007765252],"category_scores_gemma":[0.029871287,0.0002284565,0.00033410985,0.0011860534,0.00029893336,0.00031919644,0.00018694914,0.0007984049,7.8474545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067665977,0.0028454135,0.6824396,0.00033286383,0.00016714775,0.0000018288259,0.00047299845,0.0013212649,0.28267068,0.000007332661,0.00008185038,0.022892362],"study_design_scores_gemma":[0.013296548,0.00042338413,0.8585848,0.0033011024,0.00021283049,0.0000018060199,0.00035888253,0.06365911,0.059967738,0.000007145396,0.000027126658,0.00015952418],"about_ca_topic_score_codex":0.00030348875,"about_ca_topic_score_gemma":0.00053220976,"teacher_disagreement_score":0.22270295,"about_ca_system_score_codex":0.00035341433,"about_ca_system_score_gemma":0.0005133106,"threshold_uncertainty_score":0.9783005},"labels":[],"label_agreement":null},{"id":"W4415914732","doi":"10.1177/13524585251382796","title":"Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Tolerability; Clinical trial; Disease; Multiple sclerosis; MEDLINE","score_opus":0.18999274652216197,"score_gpt":0.36565114723946923,"score_spread":0.17565840071730726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415914732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930661,0.0023570498,0.00059305946,0.0010611763,0.00047946273,0.002144481,0.000086753455,0.000022577622,0.00018935294],"genre_scores_gemma":[0.99312013,0.0045756483,0.0017915382,0.00014062988,0.00010852779,0.00004285664,0.000019606632,0.000041043637,0.00016001005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943148,0.00076070725,0.0021890118,0.00076890376,0.0012001346,0.0007664249],"domain_scores_gemma":[0.99496806,0.00195948,0.0009558643,0.0010683243,0.0007567882,0.0002914696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029537834,0.00047360163,0.0019914282,0.0014721252,0.0006682808,0.00016940889,0.0009308279,0.00026266446,0.00007626105],"category_scores_gemma":[0.006850416,0.00034027384,0.00056319276,0.003406201,0.00069082977,0.0003882519,0.0013722358,0.0011704589,0.0000017098805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058313735,0.0032542103,0.6827853,0.00019071145,0.0024545628,0.000010487636,0.0008000912,0.0005872814,0.19866644,0.00001839128,0.00030161295,0.052617222],"study_design_scores_gemma":[0.13737781,0.0004962485,0.84313446,0.004275024,0.0013606811,0.0000095741825,0.00024150593,0.008985915,0.0038558166,0.000008306921,0.000031006228,0.00022363364],"about_ca_topic_score_codex":0.0005254045,"about_ca_topic_score_gemma":0.0011731007,"teacher_disagreement_score":0.19481061,"about_ca_system_score_codex":0.00038540922,"about_ca_system_score_gemma":0.00042018897,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W4417520740","doi":"10.1177/13524585251398682","title":"Managing reactivation of multiple sclerosis during treatment with natalizumab","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Trish Multiple Sclerosis Research Foundation; EMD Serono; Sanofi; Multiple Sclerosis International Federation; Eisai; National Research Foundation; Multiple Sclerosis Australia; Università di Catania; Biogen; Celgene; Alnylam Pharmaceuticals; International Progressive MS Alliance; Universität Basel; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Medical Research Council; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Atara Biotherapeutics; Bristol-Myers Squibb","keywords":"Natalizumab; Multiple sclerosis; Dimethyl fumarate; Progressive multifocal leukoencephalopathy; Fingolimod; Clinical trial; Central nervous system disease","score_opus":0.08393791848612009,"score_gpt":0.29502295285249486,"score_spread":0.21108503436637477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417520740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930061,0.0009741862,0.0014719594,0.0016875467,0.00022604714,0.0010459514,0.000042793774,0.00012001168,0.0014253891],"genre_scores_gemma":[0.98764366,0.005731715,0.0055015367,0.0000784797,0.00020721753,0.00012921653,0.000023731232,0.00006589317,0.00061857124],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964355,0.00016749227,0.00094215333,0.0006012251,0.0010284024,0.0008252105],"domain_scores_gemma":[0.9973245,0.00045873746,0.00046490435,0.0006800432,0.00073523883,0.00033652372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004859048,0.0004981807,0.0009527516,0.000978752,0.0007898888,0.00013298978,0.0002872309,0.00015000495,0.00009487317],"category_scores_gemma":[0.0007394318,0.0003715153,0.0003785926,0.0009983599,0.00031276495,0.00045304248,0.00018108229,0.0005632972,0.000013404422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032999814,0.0009096306,0.32314414,0.0003128021,0.0012669051,0.00003186945,0.0007882063,0.0003362644,0.5822554,0.00001333048,0.0002844187,0.08735702],"study_design_scores_gemma":[0.016980698,0.00077321153,0.7489776,0.0030223934,0.00023648227,0.00006826598,0.0009857061,0.0022908954,0.22553234,0.000017086186,0.00083040434,0.00028490854],"about_ca_topic_score_codex":0.00045295956,"about_ca_topic_score_gemma":0.00019532016,"teacher_disagreement_score":0.4258335,"about_ca_system_score_codex":0.0011695961,"about_ca_system_score_gemma":0.00028867624,"threshold_uncertainty_score":0.9998737},"labels":[],"label_agreement":null},{"id":"W7117359334","doi":"10.1177/13524585251398381","title":"Toward a global research agenda for preventing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; Nova Scotia Health Authority","funders":"Multiple Sclerosis Australia; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Developing country; MEDLINE; Clinical neurology; Global health","score_opus":0.40094354077023764,"score_gpt":0.42432199224995537,"score_spread":0.023378451479717732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117359334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95117986,0.0055276975,0.015770622,0.013333742,0.0023718402,0.005893932,0.0004903944,0.00042246687,0.005009441],"genre_scores_gemma":[0.9717636,0.0029353523,0.021278746,0.00064810313,0.0010971109,0.0006998332,0.00004147436,0.00009147368,0.0014442819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99208325,0.00072681863,0.0015699319,0.0011756858,0.001891057,0.0025532714],"domain_scores_gemma":[0.9922362,0.0027834384,0.0003590416,0.00094851194,0.0028390079,0.0008338238],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.005694774,0.00064691715,0.0012332065,0.001004549,0.0025682684,0.0006785853,0.0009729231,0.00039516712,0.000203477],"category_scores_gemma":[0.019003903,0.0005727714,0.0011074591,0.002318167,0.00066912646,0.00048825148,0.0009047551,0.0018037747,0.00010107286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003538994,0.0018128495,0.43003356,0.001176157,0.0018093943,0.00004543723,0.0012159232,0.00012749716,0.16212794,0.00022186672,0.15728012,0.24061026],"study_design_scores_gemma":[0.023569072,0.0009058849,0.9043443,0.005212951,0.00032611185,0.000098034594,0.0027855681,0.010530504,0.017221441,0.0007847146,0.033470344,0.0007510255],"about_ca_topic_score_codex":0.00036584004,"about_ca_topic_score_gemma":0.00040860465,"teacher_disagreement_score":0.47431076,"about_ca_system_score_codex":0.0017114115,"about_ca_system_score_gemma":0.0009988697,"threshold_uncertainty_score":0.99967235},"labels":[],"label_agreement":null},{"id":"W7117366757","doi":"10.1177/13524585251396439","title":"Periventricular gradients in axonal and myelin microstructure are present in people with multiple sclerosis having low and high disability","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Canada First Research Excellence Fund","keywords":"Multiple sclerosis; Myelin; Central nervous system disease; Clinical neurology; Lesion; Degenerative disease","score_opus":0.031639146619924584,"score_gpt":0.2610034982684369,"score_spread":0.2293643516485123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117366757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243695,0.0027619938,0.00012820303,0.0029145512,0.00018188928,0.0014274642,0.00009707244,0.000039005157,0.000012871981],"genre_scores_gemma":[0.99387187,0.0031521774,0.0024062032,0.00016273782,0.0001579054,0.00014206169,0.000021810165,0.00004735338,0.00003791197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957491,0.0003762709,0.00095458486,0.0009753625,0.00086885534,0.0010757863],"domain_scores_gemma":[0.9977509,0.00067238265,0.00027635312,0.00047784104,0.0003177169,0.0005048204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094990997,0.00056240766,0.0011393187,0.00060289784,0.00054277235,0.00028276385,0.00026987743,0.00024026749,0.000053441145],"category_scores_gemma":[0.001545894,0.00044044713,0.00016056409,0.0010655897,0.00071307214,0.000389172,0.0005054378,0.0013854905,0.000002176972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012070197,0.0007080381,0.9665277,0.00043799856,0.0001536177,0.000053719883,0.0011194902,0.0003883066,0.017338043,0.0000029394178,0.0001629949,0.011900159],"study_design_scores_gemma":[0.01502969,0.00019970632,0.9697425,0.004198517,0.00007139638,0.00007711074,0.0019075802,0.006331063,0.0019590575,0.000023924285,0.00008481753,0.0003746706],"about_ca_topic_score_codex":0.0018040363,"about_ca_topic_score_gemma":0.009124755,"teacher_disagreement_score":0.015378986,"about_ca_system_score_codex":0.000743053,"about_ca_system_score_gemma":0.00014455125,"threshold_uncertainty_score":0.99980474},"labels":[],"label_agreement":null},{"id":"W7117368559","doi":"10.1177/13524585251396433","title":"Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Multiple sclerosis; Clinical trial; Phase (matter); Phases of clinical research; Central nervous system disease; Fingolimod","score_opus":0.10943033343178012,"score_gpt":0.3429658681211005,"score_spread":0.23353553468932042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117368559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693955,0.0027393282,0.001310577,0.0013682565,0.00056324294,0.0063934894,0.000054754426,0.000067373534,0.000563418],"genre_scores_gemma":[0.9883725,0.0083653005,0.002151338,0.00017579597,0.00029916235,0.00038486847,0.0000139276535,0.000057381774,0.00017970856],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99208736,0.0015941141,0.0030347342,0.0007715341,0.0012369332,0.0012753153],"domain_scores_gemma":[0.98901147,0.008005409,0.0010131168,0.00066120236,0.0006938678,0.0006149401],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006554848,0.0006565967,0.0045907376,0.0010130948,0.00063740957,0.00018489212,0.00032428966,0.00026285404,0.00013495957],"category_scores_gemma":[0.023447124,0.00044991806,0.0007795629,0.0010079341,0.0011269186,0.00036030877,0.00027290828,0.0013407017,0.000005665011],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.928185,0.0030525601,0.03346572,0.00015714517,0.0016418287,0.000029651175,0.0010624652,0.00027095588,0.0108195525,0.00003115575,0.0002993874,0.020984592],"study_design_scores_gemma":[0.9042261,0.0012658584,0.07630462,0.0054837316,0.00083241006,0.000020812164,0.00067961466,0.008486001,0.0021435984,0.000022439046,0.000189572,0.00034521084],"about_ca_topic_score_codex":0.00031268684,"about_ca_topic_score_gemma":0.00048042426,"teacher_disagreement_score":0.042838905,"about_ca_system_score_codex":0.00037865507,"about_ca_system_score_gemma":0.00059078436,"threshold_uncertainty_score":0.99979526},"labels":[],"label_agreement":null},{"id":"W795514964","doi":"10.1177/1352458515593822","title":"PML in DMF-treated patients with normal lymphocytes: Worried well or well to be worried?","year":2015,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Psychiatry","score_opus":0.056740762744539784,"score_gpt":0.24693289939564025,"score_spread":0.19019213665110046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W795514964","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9126987,0.0014634618,0.000032337604,0.07692799,0.0017943808,0.002563131,0.0006807444,0.00023531789,0.0036039294],"genre_scores_gemma":[0.37272394,0.00088258804,0.0016378474,0.5986731,0.0063715237,0.00019277938,0.001993845,0.0006899282,0.016834453],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947575,0.00023790826,0.0011547271,0.0007765466,0.0016514863,0.0014218622],"domain_scores_gemma":[0.9965523,0.00020079302,0.00058927,0.0007027344,0.0006345193,0.001320367],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031238672,0.00093999814,0.001359914,0.0010264169,0.0002754132,0.00023541166,0.000510393,0.0012105185,0.0017225306],"category_scores_gemma":[0.00032979628,0.0006054349,0.00036283876,0.0009241218,0.0001642321,0.00028634665,0.00015487632,0.0029914267,0.0005269289],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067478493,0.0006662,0.19561006,0.000097030825,0.0004220939,0.0020467166,0.00030940666,0.00013631427,0.000064334534,8.249309e-8,0.7922849,0.0016150232],"study_design_scores_gemma":[0.03874634,0.0021085232,0.2190991,0.00542386,0.0011193567,0.0003089924,0.00017981048,0.00021743587,0.00031292377,0.0000029852824,0.73107797,0.0014026698],"about_ca_topic_score_codex":0.0005487663,"about_ca_topic_score_gemma":0.00027324152,"teacher_disagreement_score":0.53997475,"about_ca_system_score_codex":0.0013312921,"about_ca_system_score_gemma":0.001233063,"threshold_uncertainty_score":0.9996397},"labels":[],"label_agreement":null}]}